<SEC-DOCUMENT>0001534969-22-000130.txt : 20221109
<SEC-HEADER>0001534969-22-000130.hdr.sgml : 20221109
<ACCEPTANCE-DATETIME>20221109161610
ACCESSION NUMBER:		0001534969-22-000130
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		81
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221109
DATE AS OF CHANGE:		20221109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SERA PROGNOSTICS, INC.
		CENTRAL INDEX KEY:			0001534969
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				261911522
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40606
		FILM NUMBER:		221372825

	BUSINESS ADDRESS:	
		STREET 1:		2749 E. PARLEYS WAY
		STREET 2:		SUITE 200
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84109
		BUSINESS PHONE:		(801) 990-0520

	MAIL ADDRESS:	
		STREET 1:		2749 E. PARLEYS WAY
		STREET 2:		SUITE 200
		CITY:			SALT LAKE CITY
		STATE:			UT
		ZIP:			84109
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sera-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:181dff8b-221c-4709-ab07-a5f181ab4d14,g:4b08700b-5ca3-4c7f-8934-f342ec818a3e,d:2084c35b29674161bec45c107b9a92a6--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:sera="http://www.seraprognostics.com/20220930" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sera-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8wLTEtMS0xLTM3MDYy_37ec3da8-89aa-450e-97da-0576822f54b0">0001534969</ix:nonNumeric><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8xLTEtMS0xLTM3MDYy_79beeba9-b328-499a-baee-161e80d4b88b">12-31</ix:nonNumeric><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8yLTEtMS0xLTM3MDYy_373749e9-1363-4885-bfb4-3870aca195a6">2022</ix:nonNumeric><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8zLTEtMS0xLTM3MDYy_febd4e3d-1e94-4514-ad4d-5309b726cd4c">Q3</ix:nonNumeric><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF80LTEtMS0xLTM3MDYy_3599d630-dd4b-4824-a7bb-add29c163bab">false</ix:nonNumeric><ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_0049bb1e-6361-4f5b-bc41-972d98f2f6a3">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i70d0004071444462988600b21699ae89_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_7e1627ae-b748-46d6-9015-15e5ad4fd6be">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i70d0004071444462988600b21699ae89_I20211231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_5469c87e-2e2e-466c-9319-75c619518553">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_a4928ad8-769b-47ab-8011-2c8705edcb02">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i70d0004071444462988600b21699ae89_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_67f2aafd-7934-4f80-a929-ab372ba3fe4d">http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_b288df54-e98f-412a-96c5-369a8ce12b19">http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities</ix:nonNumeric><ix:nonNumeric contextRef="i287e032d20624fe0a98f6658b3eb78b3_I20221010" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfMTA5OTUxMTYyODQyNA_df1e695d-5bfe-4eae-921e-ce6dee848024">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sera-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16957592c4d844449723ff11f81ecd36_I20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i93397e1b4eb84bd58369f6538fc60773_I20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9527d69fa6764ba3bde674ace51bd382_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i70d0004071444462988600b21699ae89_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07dcbd5c00ff43149d052ff104148f12_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib7006217670f4919bc1f54ae58aca198_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92dcff96f0bf4fa39bb22e90238470f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic51ec012d9294cf09bca3ce7057820b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d6832636f54cfb879106d568c3e932_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4568d701d67140978621ef6467b28490_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ccbd1105a654fee862dae8d937f27b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d0d1d5bdbc7440ebc3c7e39076b89a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2e001b0b3e94072999336b8b75218c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d6b66dc7804d95bad33599f8d253ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890f658cedbc4a9488358a5cbd47a54f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4c5d93068fb4cf5875603027219c407_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17b2a2ad4e524d0eaa981607c6fbfc69_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideecafdbfb2e400892c41acad085d37c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i675d2ddbd30b48f6aa38beea1d995af9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe5ac4edad344a23add99975ad28e041_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9acc8d4b939d44c7b49a30479bd930a8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib11ad9b4bb684f7f9f452c732964d9cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d38ca8b46774d8587bad81a1ff3a877_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1632c22e5a9407d8bfd8a93f29344c7_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55bfa45f9f4a4292bcf081e5d15c70c5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i810fc88333fd484d9c7c13ec52d5a637_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63fb294666b2488e821ae0202b6a42af_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b62659d21af4f5a9bfbc2ab6c0f6007_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8fbca8e790a49b79263a594d6204f6e_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92608e502e7d418c9ee082d453136131_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58ea917c84dd4e53aea6ee8957e300ae_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1201920f9ebb4530acebcd6bea512aed_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i371f184bfcdc4926af9860e292313519_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6649d2bf6df4035a225617e298f96cd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26b85ca758534fa690d547a94d0fd16b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7f27b7b00714ca6b49f201a81cb6811_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefdecb634e6746a9bdf022491041a261_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac27b6b2000c4669a337bc703245dd6f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie67812bd33894a75b67f8c3afd3db12f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i407cbb66b130405f954523a0479a7435_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37848c02dbe348d3ba5b833c88ca1596_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf5a14cabce742aeb6dc76b5d7e721f2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i233963b046f2403f9798a7e30959afe5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ea1a93ebbe64e8697b8dc87ea3b8db5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26bb98874bf94130aec2131d39b66870_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia159ea90af2444349d3a5b6dc4fb041c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22c04c1aa9cc4ed1a3a5746977b13f78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i330c66d4416e4935ac95cf6c4b6c1b96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7144665eb1004d61979f59d59cd79ecb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bee12794c5b43c48f79eadf2318e23e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8286f00ec99f411cbde3e81b53bacd01_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b9001f71b5420d9369d32a719c09c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i744e357934604565b8a1ba77622b5d45_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9de38b8fb9704048bc0348159dc7fec2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaad9d062dd346ed999353e204d90789_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib44a2f2d0ad7493db173717bcd13180b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3acb9c650472454d93eaf5d1391c9c14_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12055f8d1ea64059813056f3f8ec3acd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied768dae55ea4525bbb0c49d70717a85_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b5e4c15c48145beb18f34a8858062fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccbc303ef6e74469bc7cc9ef0cc54b9b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8766f56549a44835bf6be9b33f3eae25_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if214de55f4ee4b85877312f75285700c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4792be6cc7d049b68b1601a03021fcbb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i143503177ddd45eebbeb3dfa4a241265_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d1a20885eed4e00b8ec295d3a1a6126_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i368e83cd85ae4b37a1726dba858c0347_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacd7efb6e7484abdb0dd404594377877_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80965f98a9d044e49c5b70117ce9946b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9417167952f443a098281a8844ff48bf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if287f4a4ec254420821d8eb16d49742f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfa9c03858414b669711a350682a6c36_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84aa7b043f54e55b61863de27a42471_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i916da6c7f85d44858c10f7222fefaebe_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb22c494aa524d09ba6a6867b74fdb09_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i919c74b4f87b42dfa028394b09d3d6ac_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic28dedecba064022874b838744cc8acc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44be0a10165d42f2911e8707f403fd1b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1496266b4fc3412b98a1edf4db2a6612_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0211f8c70f4546fab653439ef8421171_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib73f2e6d58834f169b6677f9ed409235_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i581a92110a4843f6a5589fbed073bada_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i793efebda0234678845dfb4d311cf810_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice3e926ca9454ee092de309e776c0053_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i982fe00fe53a4a749b3fe8ea6ceb21a7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349bc20944944c1e90a30491176f1186_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a7b24ecb628442489324a85e9888015_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifef247b0e8bf4cdf83aa0c89d64ed53f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5c668015774084978a3b33807344f8_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i100ed6658c0743798fcbfcfe1fc0bb18_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idef209848fc148788ca3494cf8345024_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i426c150219944b5e9da3b86ec1649f1d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41585eff29234897a3b80b9a1807b068_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i308ca8df8a3c450db8268afabcd6b278_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e8252a2c5ce48f2be393976df7df3e2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia94d6e17beb54943aec8dffc01b527b9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b735bee6644b40a873590cf5490f25_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5dfdc3fff2444683ab97d33895e30f14_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i892e66ef1e914f91954762a487029ccd_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02965420c7c14abd9839a8d8b42176d5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i295341f5241643588814e697d1be3629_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fa9319e62f84c96a99782f165bbd352_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89f3e16ed78043789e8e75c2ef6e3598_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic362baeed4fd478d809c38fe093e5c6f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3211865e368e427c97e8b1ed624dbcf0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f65666786e8428dabc37121eed3caa2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3de9e5774c374348827a38ac65ce15c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ff086cec454294bcec367c74433793_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ee644e2f79d4b719b22c7db29592acb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dfe35561df44ad7a3daf4a423c867c5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14b38fa83e74416baa59ee3c628b9614_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i673eefc904b445ec8b3f3be9c96ef633_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic496e34f317b4d5b8d382d221926650f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3172f410a08245ccaa4689e1ebcfe8fd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic107f77e19a641f2b66165932a7230ef_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80780d051c164ea99d2de7902f458fa1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223dbecf860e4e39a728901fdebb9f9f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33a6f973d8841edaae5debeec90e7b3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a394203b40c4fd299a9d183b56e5da5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2896517d8854cdbb4a8622839fa7044_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76721169755b495daf0275e4edcb974e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ea98596ebc94fb597a9a7ecb322370a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669added0b444346a5f738058ceb934b_I20141231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e9ca69a921249c6a78aa32baee42b33_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib88c7314479a44d4bad72460fdabc6d9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i60a0864fc6dd4e8fbe07647b8d79a429_D20190201-20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i600787d311a2404994266e049f220010_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb4eddf3f2864ba99d2b3f2c498583d7_D20210324-20210324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-24</xbrli:startDate><xbrli:endDate>2021-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e0ee74c3ff34aefb683e6d0f0a83a2c_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9bcf6ae0b3e42c2bef96302713690d0_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1602ad9e54b945c9bc70c8e1b2cb0cef_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib74370533b2343e5948c7c3132692fee_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf7511108faf4cd0906efe6af85f04d8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d63d790f8f54a508f078691f2d26768_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i612e8b546ca046b0bfda86066a454cca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42d2faf58839437f8edcd20d96b207ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1458e22a9c914fb9ae75771117d8fd05_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9902d71bf4ff4310af77e9ffa184e4b1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63a5647d5c0340be84f03046f561d36e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i414b0aaf127042bd88523a0bb531c307_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a43bb4ef084888b75d6e3a33541d4f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96032a7e83741c18f2e92eaa33744cb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8eda479567124bc7814e222145ebc019_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i656a95c6ee6440fc959d2f83704886e6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i918d3cc73cc24feb9a410f56da474f96_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57d6bf244c40409a995f2c8c55e870cb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e9ad3bbced74f1286c9edbd11d60a94_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd27872ed39d473cabd931c1687ec88d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9f7d318c031453095ba85b0e5175e30_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie045a5e26f014139838acb18403afe93_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8f2c42715c1443cb59e29a781e6c0e7_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i395ae800742b4df1825940da3494ba86_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbac569dd2004b2d99ae63842688565b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f27774bd30241ee8942a4cef573525d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib01e4104a4cb425bad5c8fe30243f72a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9132b6cdf5cd402dabd2fca792c7249d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44df0ed744444847a688f0b9b2610c86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f85bd632c0444084e27b6374b41155_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71c26cad06b949fb97802e9a0a40f61c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab4c468c851148af9a6507c50ac2acc0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icafec0a54060431fa19e8c1658de99f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0319da007e0a4472971df069b87d62c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea0875504fe4402ab5ef06f8708cb41d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i664717ae0afe4dc8864dc9d40f13dcea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7738521c4b514f00a138be71f2fa2aa8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bf0489931cb444190182c5a4a0920c2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie44f5ba7c5664328b22fafcd4e4e4729_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i625bf249a07e4f79916f01e5b3ae9a49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ac1738373464afaa4f620044f28dc23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14a569c6473f4caba47df2fbed2a5e31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icacf2d98943d4579b2ae6dce4e1d872e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf16684d7e4b4069b71370834c076b72_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7696d66e3a844c518b0767e034d8b610_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97f06024a3634a4a848d749268fa8321_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f9decf253d24e629dc8d16e78c681cf_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d69dbf6533445b9b4296a542908776_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92b6834e9fa046c889b80dd680ca97ec_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5a4a33f19a4405284072607fbcb712f_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife1874e670534eb286f346549f8030e4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if953534ebfe5400a9f6434aa8ae8fe2c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7171c7eb9dbe490681930536b5adb751_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4dfe18e2ba344628fb42a44cbb4c082_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8faa0127d92747c19730bff7fe96a67d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cbb3338066a4c86bb22691782cdfd99_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if40be873cb3b4110921324e4559ce26b_D20210719-20210719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-19</xbrli:startDate><xbrli:endDate>2021-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4d8885752a4f3f92312b675720aa76_I20210719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8b830e52ae447d8c81bd371da3cbc6_D20210719-20210719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-19</xbrli:startDate><xbrli:endDate>2021-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6cc8adcb35049f99e17c68122feee4f_D20210719-20210719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-19</xbrli:startDate><xbrli:endDate>2021-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied62654e4491444e97d0acab99397010_D20210719-20210719"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-19</xbrli:startDate><xbrli:endDate>2021-07-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59217ebe2e3b446297d6e7d10cdd6508_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="common_stock_class"><xbrli:measure>sera:common_stock_class</xbrli:measure></xbrli:unit><xbrli:unit id="vote"><xbrli:measure>sera:vote</xbrli:measure></xbrli:unit><xbrli:context id="ia28bd723960742d0bc535d70294b0cec_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i795da5fab0804282a9b140098d707bf3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82559b67f9e148dab9ad2b1eed66b0c6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36bc42d96e4e433984ab7a8838c57a60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e079d863e01425487bf0a16e4109cb1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ebe18a147e84a0e88b4ba20920b22e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i600edf893f194531ba73533739a7ffe3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d186423a55d4d4eb1d92c41476d9b48_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5924a4c2b8a04efd9f8a9b105681d3ac_D20111101-20111130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2011Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2011-11-01</xbrli:startDate><xbrli:endDate>2011-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i370eabad665347dea0833447376cc361_D20111101-20111130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2011-11-01</xbrli:startDate><xbrli:endDate>2011-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5105b69dd15f4d468202f02b3beddfd8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b50f0c0967540a28d5b66bd6ed16b1a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5143f467fec4136b943ecc3bf4ebd64_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8612108452442a088e51138f3c2554f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ed6221f242409f8a9dbaaaee40c814_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52f60d8b08f641c0b0ced84d1a9fb159_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ae79d05fb1b4c4ea6d13b1014a59490_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc7ffa070afa4b67be9eacf9bbc4f4a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04312bc62a9c45d6b4ffb2e70999f7ce_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3b67e645ef427c8250de0d5e967256_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2708055ad45048f9b3a01fd826029750_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc13b0c45ef84ef9ba43c43526394594_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i029f08fa15fd4befac391e8926338ac0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b51209f01d949d29b662db2c64c7f22_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75437e864838472e87ecd3c91bc6d984_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727bda5c34a14d11b2577e2b1119b092_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee09ca5ea08d408baf262d9aee778543_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida49535190ff4a67a90335be92a43202_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec090a0935104562aa028436a6704741_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib365f1c968bf458f93bb750efed2e461_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04ebe87305d04e299c0f999d0935e08a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67ed818fbfe34672a57403d2698eb3a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24f885b56b948b4b07a19510189e079_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1f25f3dbc48464aacede203398c9efb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0530edb52e204249ab51018f35efa2ff_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84190d49c208410092379bb47e971ccc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6bde4ed70d0494f837109a7f9176ae6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3480fe1ee8e4d4a882ed4f4391d52f4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:OfficeAndLaboratorySpaceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f3d450f7a124081a7088d0b95d3115c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd78f55213f40769bb6407a882dcb00_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fec57d1a2df4384aef09573ccdf6570_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78569680632f4aa9bc2c2383b785be95_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i287e032d20624fe0a98f6658b3eb78b3_I20221010"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001534969</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-10</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2084c35b29674161bec45c107b9a92a6_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:30pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY4_b295b859-af0e-4154-9403-b24ebc9759a5">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NWIzNDJkNjc5NzMwNDM1YTg2NmQ0MGM0Y2U3NDZiNmEvdGFibGVyYW5nZTo1YjM0MmQ2Nzk3MzA0MzVhODY2ZDQwYzRjZTc0NmI2YV8wLTAtMS0xLTM3MDYy_438857ec-f66a-44e3-842f-72d99a0160f9">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8xODc_583730d4-c224-4bf5-971e-74186596ab51">September 30, 2022</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6ZmMzODZkMWFkOTU0NGFkMjhlNWYxNjlmMDE4YmVkODMvdGFibGVyYW5nZTpmYzM4NmQxYWQ5NTQ0YWQyOGU1ZjE2OWYwMThiZWQ4M18wLTAtMS0xLTM3MDYy_9118d399-8ac0-41a3-a40f-92ace4d9c087">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDYz_cd6224e8-ac2e-45b9-9161-b93368757d93">001-40606</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY0_7bc5f095-f834-416b-a9a5-3f5c1499730d">SERA PROGNOSTICS, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8wLTAtMS0xLTM3MDYy_547e848e-f35d-41c8-ac5f-6fe6f4f86d46">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8wLTItMS0xLTM3MDYy_7d463571-7201-4503-ace2-3643b8e72d14">26-1911522</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfNQ_c4f24fd7-e94d-4ba0-a53d-9eed4df3aac7">2749 East Parleys Way</ix:nonNumeric>, <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfOQ_dacb312b-bcca-46d9-a7ff-fc03630952e2">Suite 200</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfMTI_1c5f5b02-ba5c-489f-a58c-0c18e8f5725a">Salt Lake City</ix:nonNumeric>, <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfMTY_5bb91dfd-ca77-49e5-b4f7-779e6306e5a5">Utah</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTItMS0xLTM3MDYy_19a5c20c-79e5-48e6-93ae-a795fe03bdc3">84109</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY5_c67aba1a-47a7-4591-bb69-01b24c1efc34">801</ix:nonNumeric>) <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY1_d47469a4-85c6-42a0-a55f-adef8589059f">990-0520</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NjQ0ZDNlOGFkNjQ2NDhmOGFlMTdjZDlmNzM4ZGYxNTIvdGFibGVyYW5nZTo2NDRkM2U4YWQ2NDY0OGY4YWUxN2NkOWY3MzhkZjE1Ml8xLTAtMS0xLTM3MDYy_65118ae1-c0b3-4145-969d-ab0e534f71f0">Class A Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NjQ0ZDNlOGFkNjQ2NDhmOGFlMTdjZDlmNzM4ZGYxNTIvdGFibGVyYW5nZTo2NDRkM2U4YWQ2NDY0OGY4YWUxN2NkOWY3MzhkZjE1Ml8xLTItMS0xLTM3MDYy_5fd1bde7-efcc-4d79-a74f-0d0a571cc94e">SERA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">The <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NjQ0ZDNlOGFkNjQ2NDhmOGFlMTdjZDlmNzM4ZGYxNTIvdGFibGVyYW5nZTo2NDRkM2U4YWQ2NDY0OGY4YWUxN2NkOWY3MzhkZjE1Ml8xLTQtMS0xLTM3MDYyL3RleHRyZWdpb246MDYyNDU0Y2NmYTM1NDFjYmI5OGM0NzM0NmYxZGI1NTBfOA_37dbb85a-7ccf-411c-a8d3-337bf7d84dc3">Nasdaq</ix:nonNumeric> Stock Market LLC</span></div></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY2_45ad4baf-7c53-4966-a4a9-c04405131722">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDcw_d26eeae8-f723-49d4-bd30-af6b3614a811">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6MmM0ODc4NzNhMTdmNGQwN2JhMDJhNjhmNDdhN2JkNGMvdGFibGVyYW5nZToyYzQ4Nzg3M2ExN2Y0ZDA3YmEwMmE2OGY0N2E3YmQ0Y18xLTAtMS0xLTM3MDYy_c6f027a3-b1d1-471e-a9d8-7ff8af318c6d">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%">x</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6MmM0ODc4NzNhMTdmNGQwN2JhMDJhNjhmNDdhN2JkNGMvdGFibGVyYW5nZToyYzQ4Nzg3M2ExN2Y0ZDA3YmEwMmE2OGY0N2E3YmQ0Y18xLTMtMS0xLTM3MDYy_d99c4c98-d987-4bea-9500-17308eb8fe9c">x</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6MmM0ODc4NzNhMTdmNGQwN2JhMDJhNjhmNDdhN2JkNGMvdGFibGVyYW5nZToyYzQ4Nzg3M2ExN2Y0ZDA3YmEwMmE2OGY0N2E3YmQ0Y18yLTMtMS0xLTM5ODM3_571f0de6-cd74-4aab-9d3b-d85e4582e375">x</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDcx_ba08659b-65fc-4d8e-b0da-27b653e43fb4">o</ix:nonNumeric></span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY3_13216d7b-8ff3-4e2a-a671-96a892c3c060">x</ix:nonNumeric></span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of November&#160;4, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="i16957592c4d844449723ff11f81ecd36_I20221104" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8xOTUy_1eec3a6d-1a32-4f07-8400-2c91bc7aa2ad">29,611,720</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i93397e1b4eb84bd58369f6538fc60773_I20221104" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8xOTU5_4e42f980-6fa9-4fbf-a34d-8f382298962e">1,405,259</ix:nonFraction> shares of Class A and Class B common stock, $0.0001 par value per share, outstanding, respectively.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_10">Special Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_10">3</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_13">PART I &#8212; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_13">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_19">Condensed Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_22">Condensed Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_25">Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_28">Condensed Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_31">Notes to Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_82">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_82">22</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_118">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_118">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_118">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_121">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_121">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_121">31</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_124">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_124">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_127">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_127">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_127">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_130">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_130">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_130">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_133">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_133">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_136">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_136">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_136">71</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_139">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%;text-decoration:none" href="#i2084c35b29674161bec45c107b9a92a6_139">72</a></span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Sera,&#8221; &#8220;PreTRM,&#8221; &#8220;The Pregnancy Company&#8221; and our logo are our trademarks. All other service marks, trademarks, and trade names appearing in this quarterly report on Form 10-Q are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names, trademarks, or service marks to imply a relationship with, or endorsement or sponsorship of us by, these other companies. Solely for convenience, trademarks and tradenames referred to in this quarterly report on Form 10-Q may appear without the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or &#8482; symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights, or that the applicable owner will not assert its rights, to these trademarks and tradenames. Unless the context otherwise requires, we use the terms &#8220;Sera,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; in this report to refer to Sera Prognostics, Inc.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In some cases, you can identify forward-looking statements by words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or the negative of these words or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimates of our addressable market, market growth, future revenue, key performance indicators, expenses, capital requirements, and our needs for additional financing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the rate and degree of market acceptance of our PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of our PreTRM test on the field of bioinformatics and proteomics and the size and growth of the addressable bioinformatics and proteomics market;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain funding for our operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage and grow our business and commercialize our PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and commercialize new products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to retain the continued service of our key professionals and to identify, hire, and retain additional qualified professionals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pricing and reimbursement of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model, strategic plans for our business, products and technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to our competitors and our industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the accuracy of our estimates regarding expenses, capital requirements, and needs for additional financing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of COVID-19 on our business; </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conditions in general economic and financial markets; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial performance.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in the &#8220;Risk Factors&#8221; section and elsewhere in this report. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the forward-looking events and circumstances discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable as of the date of this report, we cannot guarantee that the future results, levels of activity, performance or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this report to conform these statements to new information, actual results or to changes in our expectations, except as required by law.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8212; FINANCIAL INFORMATION</span></div><div id="i2084c35b29674161bec45c107b9a92a6_16"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements (Unaudited)</span></div><div id="i2084c35b29674161bec45c107b9a92a6_19"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMy0xLTEtMS0zNzA2Mg_8fecb078-e18b-428a-8469-c97906ffc713">38,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMy0zLTEtMS0zNzA2Mg_53de9a6b-18ad-45ad-9280-3ac31a5ccd88">58,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNC0xLTEtMS0zNzA2Mg_176fa2b6-a003-4ba3-8ea7-4f7b6c95fc09">49,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNC0zLTEtMS0zNzA2Mg_f71f7626-7f50-452a-a4b9-1ee925abab97">46,183</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNS0xLTEtMS0zNzA2Mg_6b02bd73-b81b-4437-a388-63fe641b0145">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNS0zLTEtMS0zNzA2Mg_088ba6ca-db77-495c-921b-e2b94c451c57">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNi0xLTEtMS0zNzA2Mg_525188a1-9108-4999-ba2c-1d7682131ccd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNi0zLTEtMS0zNzA2Mg_5cfce639-f989-4af8-a48a-ec9df3815702">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNy0xLTEtMS0zNzA2Mg_47eeda01-865e-4b47-b2f8-1a62a761bcac">1,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNy0zLTEtMS0zNzA2Mg_a2512c2b-43e6-453a-8659-5956c68ab444">1,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOC0xLTEtMS0zNzA2Mg_af3bb34f-818a-464c-94e0-a310465f5cfa">90,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOC0zLTEtMS0zNzA2Mg_9f2ad5a3-4cb9-4139-b28e-af8325f373e6">110,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOS0xLTEtMS0zNzA2Mg_7358380c-49e6-4f40-b02d-a15a22d5a585">3,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOS0zLTEtMS0zNzA2Mg_ccb61e18-e6dc-4ee6-a5ce-439209d1434f">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTAtMS0xLTEtMzcwNjI_6edc0d0f-8c3f-4c42-9457-2ae109b4dac1">22,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTAtMy0xLTEtMzcwNjI_827a5eac-7e4e-40e5-83be-06a3934a67e6">34,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTEtMS0xLTEtMzcwNjI_794a422f-a755-4006-baee-346158051f41">237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTEtMy0xLTEtMzcwNjI_4a8f1353-9d83-4024-9e55-e1fed5096c54">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTItMS0xLTEtMzcwNjI_71f39353-c60c-4ada-a12a-e8579b964f47">116,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTItMy0xLTEtMzcwNjI_d0fb6e76-2cf6-48a3-abb2-4014250e392e">147,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Liabilities and Stockholders' Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTUtMS0xLTEtMzcwNjI_0d2a477c-cb9f-49e3-80f4-ea4a4a308340">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTUtMy0xLTEtMzcwNjI_fc299a85-ec3c-40d5-82af-2a77a87bac06">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTYtMS0xLTEtMzcwNjI_6f0faebf-625e-4bcf-96e4-462389f8d53d">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTYtMy0xLTEtMzcwNjI_b890fbe0-efc4-47fd-8f84-61b1509da81f">3,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Deferred rent, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:DeferredRentCreditCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTctMS0xLTEtMzcwNjI_ec9ffc1b-d29a-4edf-b45e-df1e9418c6d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:DeferredRentCreditCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTctMy0xLTEtMzcwNjI_cd0ab7f9-f3b6-4343-9c67-9f362eac21e8">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Finance lease obligation, current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTgtMS0xLTEtMzcwNjI_6c910842-f82c-40be-93c5-2f250e58b254">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTgtMy0xLTEtMzcwNjI_5c4ec169-4b7d-4ae8-b81d-2f6f7a6ed422">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTktMS0xLTEtMzcwNjI_07bf8f27-6c18-4cd0-94a8-4037cfe0b013">3,091</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTktMy0xLTEtMzcwNjI_04befa9c-234c-4aba-81e7-f59d7c0fb5ad">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjAtMS0xLTEtMzcwNjI_99e2d77a-1fa8-446a-bc13-5f28e313f891">8,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjAtMy0xLTEtMzcwNjI_a247e77e-3238-4058-be6b-8e9350b1dc0a">8,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Finance lease obligation, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjEtMS0xLTEtMzcwNjI_06cff88f-6fc5-4451-982c-6bd058267c41">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjEtMy0xLTEtMzcwNjI_38e28812-1393-4d7d-8051-b2681b64d685">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjItMS0xLTEtMzcwNjI_99075f40-fe29-41d8-98a2-e770d5892415">9,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjItMy0xLTEtMzcwNjI_37bd962f-e9ec-468d-8712-61399d00f761">8,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Commitments and contingencies (Note 13)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjMtMS0xLTEtMzcwNjI_b1db2521-2d43-4f05-9b05-c9348c367c3d"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjMtMy0xLTEtMzcwNjI_db3098fa-51a1-4137-8387-d40c881d8b08"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Stockholders' equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_360533f8-ca7d-451b-90c3-4512f12eab3b"><ix:nonFraction unitRef="usdPerShare" contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_91a52aae-4d40-44a6-bd42-32409e9db8e1"><ix:nonFraction unitRef="usdPerShare" contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_9bafda2d-5cf8-4ef7-a213-40d6243321d3"><ix:nonFraction unitRef="usdPerShare" contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_fb81ffd9-6410-4aa9-b7b4-6576e6c67174">0.0001</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18zMg_0a45ff04-e097-4262-8e64-04deb17b6175"><ix:nonFraction unitRef="shares" contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18zMg_22bd93ec-38a9-4c00-94da-c472511ed929">150,000,000</ix:nonFraction></ix:nonFraction> Class A shares authorized as of September&#160;30, 2022 and December&#160;31, 2021; <ix:nonFraction unitRef="shares" contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM183OA_02efb5f8-ab58-4961-a3d1-a4532a4c48fa"><ix:nonFraction unitRef="shares" contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM183OA_c5ed6a65-2fed-47ff-a660-a18313499feb">29,611,720</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM184NQ_4d220dc1-46ea-488d-b9ab-6d53ce1145a3"><ix:nonFraction unitRef="shares" contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM184NQ_693eb301-fbbe-4637-ab9b-ebd42e12e53e">29,368,867</ix:nonFraction></ix:nonFraction> Class A shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021, respectively; <ix:nonFraction unitRef="shares" contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xNTc_98904ac7-8750-4950-85e8-7eb2e2b6789c"><ix:nonFraction unitRef="shares" contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xNTc_c0f97ef3-d8b7-482b-803e-e415aad1294d">1,500,000</ix:nonFraction></ix:nonFraction> Class B shares authorized as of September&#160;30, 2022 and December&#160;31, 2021; <ix:nonFraction unitRef="shares" contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_91f879d9-ca38-4567-bfbd-d7c7c35865cc"><ix:nonFraction unitRef="shares" contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_b459b7cf-681a-4398-90b7-7ba03d374604"><ix:nonFraction unitRef="shares" contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_c165e02b-eedd-4c10-b401-3f7a2ec5ea6f"><ix:nonFraction unitRef="shares" contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_c9174940-34a5-4c02-acd7-4d55f705aa78">1,405,259</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> Class B shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021.</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMS0xLTEtMzcwNjI_9cd9fe78-4cfe-4c79-83e1-fa307939a817">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMy0xLTEtMzcwNjI_6d7e8b3c-0bac-4874-a1df-f3d9d06aa4a4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjYtMS0xLTEtMzcwNjI_de3a9c65-5633-446c-be6b-894a31ca18a0">309,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjYtMy0xLTEtMzcwNjI_1393938b-8efc-4856-8414-98b1d8f53221">305,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjctMS0xLTEtMzcwNjI_af735ae0-d1bd-4dcc-97fa-669a7260b8b3">1,169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjctMy0xLTEtMzcwNjI_5b8377e1-ab39-4c60-aa6d-09cf869dd152">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjgtMS0xLTEtMzcwNjI_10b00884-5e11-4419-9190-7605459e0b43">200,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjgtMy0xLTEtMzcwNjI_50aa95ef-6c65-4dc7-861f-c4a57689b674">166,468</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjktMS0xLTEtMzcwNjI_15f632d9-721b-4bed-99dd-24ea7db2bc47">107,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjktMy0xLTEtMzcwNjI_21d953f1-8db2-448e-940e-6c22f94d335e">138,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMzAtMS0xLTEtMzcwNjI_298f1db5-91ac-4e84-8571-841cd45f10d8">116,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMzAtMy0xLTEtMzcwNjI_d11d78d2-5403-4420-b0f9-3ca8683204d6">147,029</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi0xLTEtMS0zNzA2Mg_5ba4bbeb-7ce9-4f91-b013-272863376bb6">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi0zLTEtMS0zNzA2Mg_c54ad110-3751-4ff9-806a-60b491d67512">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi01LTEtMS0zNzA2Mg_9f72fbcf-1619-4e8c-b7c8-9c39eeef7a7b">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi03LTEtMS0zNzA2Mg_1231a0f6-cc18-4158-a2e0-823f9b65016f">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC0xLTEtMS0zNzA2Mg_852876b2-6aac-4717-b2ea-b4ad136a5bdb">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC0zLTEtMS0zNzA2Mg_63816436-9e7b-4871-8743-fe2321aa3546">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC01LTEtMS0zNzA2Mg_7b4708c5-67ca-4aee-a4b7-0cdcaa28c162">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC03LTEtMS0zNzA2Mg_c1197b5d-3be5-484f-85af-1fe6abe802af">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS0xLTEtMS0zNzA2Mg_7b11e5ec-ebc0-4d50-b0c4-aedc2951ecfc">4,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS0zLTEtMS0zNzA2Mg_3b8dfb25-a46e-4332-aa2a-020d73436da4">2,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS01LTEtMS0zNzA2Mg_d0940621-b4fa-42e9-82e1-dd11e70f2095">10,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS03LTEtMS0zNzA2Mg_5964cc7a-69b8-4231-af1f-bdf9004e6799">7,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi0xLTEtMS0zNzA2Mg_f5f8d18d-0c48-46a4-bd0a-3c87ad1c83e1">2,967</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi0zLTEtMS0zNzA2Mg_df15e0c1-baa5-48ff-94bf-08865b198a0b">2,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi01LTEtMS0zNzA2Mg_bcdb3d8b-297d-41d9-b7f3-fdbe71c9dd7f">11,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi03LTEtMS0zNzA2Mg_5617fca6-a560-4985-8bd4-9405727d0dc2">5,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy0xLTEtMS0zNzA2Mg_87083130-372c-47f7-9bc3-db62856bb39e">4,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy0zLTEtMS0zNzA2Mg_efb57fc7-7cac-4562-9446-bc4b103311f1">4,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy01LTEtMS0zNzA2Mg_1d95d7c6-b113-4479-975e-1488944ebce5">12,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy03LTEtMS0zNzA2Mg_e352de77-7f05-4447-abe8-8245051fe9ae">9,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC0xLTEtMS0zNzA2Mg_64a093b3-cc90-470d-9aa4-41a276912228">11,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC0zLTEtMS0zNzA2Mg_f8c20840-ca1b-4a6c-b7f1-e7128803c9e4">9,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC01LTEtMS0zNzA2Mg_f11af073-2976-47ae-b938-ec253d2b8274">35,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC03LTEtMS0zNzA2Mg_ca9f9f4f-9422-4111-8237-762a0c008172">22,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS0xLTEtMS0zNzA2Mg_32ab007e-c086-4b65-a37b-88ef4aa540af">11,188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS0zLTEtMS0zNzA2Mg_ec5a6bbb-1e47-4082-af0d-3502fa1d66a5">9,442</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS01LTEtMS0zNzA2Mg_26b05e77-f86a-4f96-ba10-fede19e588a0">35,234</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS03LTEtMS0zNzA2Mg_f7bd8ff5-8243-4160-9867-9713644a21a9">22,848</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtMS0xLTEtMzcwNjI_e3876533-3ff1-4384-80cf-8bb0f91a3909">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtMy0xLTEtMzcwNjI_8b853423-07cd-45ca-b1d2-043c8e9c69fd">439</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtNS0xLTEtMzcwNjI_bddb0a41-cf15-416c-aecd-1422409431cb">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtNy0xLTEtMzcwNjI_07df0778-9d71-4afd-a57b-d520b9d0f44f">744</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtMS0xLTEtMzcwNjI_49ba993f-546c-405c-8b36-f1b55ea983cf">497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtMy0xLTEtMzcwNjI_51c58287-a11c-4dfe-a8c3-42c032319bc1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtNS0xLTEtMzcwNjI_b0f9185e-af6f-465f-8030-9dac14c435fb">837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtNy0xLTEtMzcwNjI_8391f117-a874-413e-ab77-5a39651d14bf">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItMS0xLTEtMzcwNjI_3898b511-dcae-41cb-b315-e89833817aeb">10,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItMy0xLTEtMzcwNjI_97e693b6-37cb-4982-ae57-42c9d264ac54">9,859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItNS0xLTEtMzcwNjI_a588527f-f006-496a-b3ae-d85a900207f4">34,440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItNy0xLTEtMzcwNjI_b081293c-c97d-464c-9436-20c19bf7e0ee">22,525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share, basic and diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMS0xLTEtMzcwNjI_4db46595-4679-427d-8972-1ab3bf9261fd"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMS0xLTEtMzcwNjI_c75a6752-c0af-4b01-ac03-2e425685a39e">0.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMy0xLTEtMzcwNjI_7afbc0f9-7225-4bdc-b4f0-16cba030e110"><ix:nonFraction unitRef="usdPerShare" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMy0xLTEtMzcwNjI_ce3c771d-d504-426c-bc6a-e63cd0aa4078">0.39</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNS0xLTEtMzcwNjI_0c174933-80c8-4369-a04a-bbec70dde7e4"><ix:nonFraction unitRef="usdPerShare" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNS0xLTEtMzcwNjI_e05d92e8-a4a1-4ace-b803-0dcec3e323a5">1.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNy0xLTEtMzcwNjI_81891113-f30a-4b15-bf20-42e7c7929d8b"><ix:nonFraction unitRef="usdPerShare" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNy0xLTEtMzcwNjI_81ceb345-c81b-4463-8ddc-f50685131074">2.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted-average shares of common stock outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMS0xLTEtMzcwNjI_27605259-27d3-4cf2-b4d4-8c34a86dc7a2"><ix:nonFraction unitRef="shares" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMS0xLTEtMzcwNjI_c8f842eb-9285-4ee7-a273-d98a46a94c7b">31,005,978</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMy0xLTEtMzcwNjI_539371d6-e09a-485a-bc2a-01f0f127cda8"><ix:nonFraction unitRef="shares" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMy0xLTEtMzcwNjI_daa4af1f-0963-4ef7-ada1-a79d4daa11c6">25,085,013</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNS0xLTEtMzcwNjI_17a36ce7-a223-49cc-8dbc-e5c3d01ede74"><ix:nonFraction unitRef="shares" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNS0xLTEtMzcwNjI_ba3f14d7-935f-4ef2-825e-70077dd9ee99">30,918,473</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNy0xLTEtMzcwNjI_c4666c14-57de-4408-9623-3c57f5efe480"><ix:nonFraction unitRef="shares" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNy0xLTEtMzcwNjI_fdb21aff-adf9-43c5-b6d4-6686f811a78f">9,707,254</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on available-for-sale debt securities </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtMS0xLTEtMzcwNjI_f5edab1d-2d09-4b03-8420-2a490bf7d70a">351</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtMy0xLTEtMzcwNjI_7ea728e7-4896-4f37-8433-7dc80bb0d4cb">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtNS0xLTEtMzcwNjI_50bf4eaf-bb1c-417e-a1a5-a4eded0f06f3">986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtNy0xLTEtMzcwNjI_a512e5de-e4e5-423e-bef1-2eb15e11dde0">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctMS0xLTEtMzcwNjI_cd4b0270-c43f-4dff-b24b-9ac39d4a6c58">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctMy0xLTEtMzcwNjI_969581db-138b-4657-b3dd-d6ca50725d3f">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctNS0xLTEtMzcwNjI_d31691c8-a9a6-4cfc-a542-1c5f50fdab32">986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctNy0xLTEtMzcwNjI_fc0d7f9a-e5db-4c18-94bd-69dfd6c26ffe">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtMS0xLTEtMzcwNjI_c5460da8-6464-46f7-a9de-f4704835262e">11,063</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtMy0xLTEtMzcwNjI_81f09b3e-50fc-4878-9719-327de0b9ff14">9,884</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtNS0xLTEtMzcwNjI_5c8d4ac3-b688-4165-8cbc-d842b194a059">35,426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtNy0xLTEtMzcwNjI_e5ee1ec2-a210-4e11-985f-4241d9b221cc">22,550</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.450%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Senior Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Junior Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Common Stock<br/>(Class A and B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Total<br/>Stockholders'<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="id7d6832636f54cfb879106d568c3e932_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xLTEtMS0zNzA2Mg_b4c54548-9c5a-4566-b6e0-d05a3bc85446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id7d6832636f54cfb879106d568c3e932_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0zLTEtMS0zNzA2Mg_d7ca551b-c821-4a1b-8a94-fe7c12646ccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i4568d701d67140978621ef6467b28490_I20211231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi01LTEtMS0zNzA2Mg_ce90c46a-8c21-4f65-a78b-06d939c9e162">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4568d701d67140978621ef6467b28490_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi03LTEtMS0zNzA2Mg_4bba6b4b-2f0b-4734-8d26-3164d1e395e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i2ccbd1105a654fee862dae8d937f27b5_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xMC0xLTEtMzcwNjI_b24d8a53-78be-4d45-84d1-56189ce80e09">30,774,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2ccbd1105a654fee862dae8d937f27b5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xMi0xLTEtMzcwNjI_27346ddd-3416-44b3-b6f0-4b6d80552a10">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3d0d1d5bdbc7440ebc3c7e39076b89a5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xNC0xLTEtMzcwNjI_232a1a6b-3bd9-4e04-bb74-f093df96c0dc">305,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ie2e001b0b3e94072999336b8b75218c5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xNi0xLTEtMzcwNjI_29fcc1a5-d7aa-48c4-9600-e5d4b4c6f3cd">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i46d6b66dc7804d95bad33599f8d253ed_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xOC0xLTEtMzcwNjI_d08e4d51-024e-429f-b3b1-d8bce3783405">166,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0yMC0xLTEtMzcwNjI_b0512883-94a7-4adb-b6bd-3e1c654dad91">138,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i890f658cedbc4a9488358a5cbd47a54f_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMy0xMC0xLTEtMzcwNjI_729e59dd-2628-4ca7-b829-d6ffdb1503bb">123,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if4c5d93068fb4cf5875603027219c407_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMy0xNC0xLTEtMzcwNjI_d315a5ce-358f-4004-a374-77898cdf4efa">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMy0yMC0xLTEtMzcwNjI_46cfdce8-4f19-47ab-bd67-7953b9d6a699">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if4c5d93068fb4cf5875603027219c407_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNC0xNC0xLTEtMzcwNjI_8b35f21f-44a8-4fbd-94fd-d2e910f1d747">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNC0yMC0xLTEtMzcwNjI_f3de75cd-9985-406c-b43a-0a28e5186474">1,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i17b2a2ad4e524d0eaa981607c6fbfc69_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNS0xNi0xLTEtMzcwNjI_de9be3ba-f675-4d66-bdd1-2a8e5206d577">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNS0yMC0xLTEtMzcwNjI_4d77fabe-df56-424b-9810-4fd3b41d8d5c">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ideecafdbfb2e400892c41acad085d37c_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNi0xOC0xLTEtMzcwNjI_774443b3-1579-4405-8800-9f96077f201c">12,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNi0yMC0xLTEtMzcwNjI_8d895827-13d4-47a8-98a5-fe8a4737bf18">12,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.2pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of March&#160;31, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i675d2ddbd30b48f6aa38beea1d995af9_I20220331" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xLTEtMS0zNzA2Mg_c46a0c6b-6398-44b5-ad53-c9943fdcc58a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i675d2ddbd30b48f6aa38beea1d995af9_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0zLTEtMS0zNzA2Mg_7d8ae96e-9383-4cf5-aa58-28f7612571c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ibe5ac4edad344a23add99975ad28e041_I20220331" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy01LTEtMS0zNzA2Mg_79a1cab4-9d85-493b-9350-7b82ac58d67a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibe5ac4edad344a23add99975ad28e041_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy03LTEtMS0zNzA2Mg_fd9d5955-15eb-4791-9367-8c43d9af3d0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9acc8d4b939d44c7b49a30479bd930a8_I20220331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xMC0xLTEtMzcwNjI_12379f87-d3ab-43ab-8ffc-9934e4e137bb">30,897,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9acc8d4b939d44c7b49a30479bd930a8_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xMi0xLTEtMzcwNjI_97731af0-d4f2-4b6f-98b8-7b6c921b5ecf">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib11ad9b4bb684f7f9f452c732964d9cd_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xNC0xLTEtMzcwNjI_41148363-9486-4a21-80e5-245aa3f29db8">306,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i6d38ca8b46774d8587bad81a1ff3a877_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xNi0xLTEtMzcwNjI_a95e4c14-5c4c-4008-ac30-736fddf32397">656</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ie1632c22e5a9407d8bfd8a93f29344c7_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xOC0xLTEtMzcwNjI_1ca94930-dc0e-44db-b6bf-116380945125">178,676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i55bfa45f9f4a4292bcf081e5d15c70c5_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0yMC0xLTEtMzcwNjI_bacb8314-b279-46df-aa60-fb2aab1fa4df">127,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i810fc88333fd484d9c7c13ec52d5a637_D20220401-20220630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOC0xMC0xLTEtMzcwNjI_82ba3ae6-51c3-4081-abb2-bc3e16335133">94,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i63fb294666b2488e821ae0202b6a42af_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOC0xNC0xLTEtMzcwNjI_df8528dc-cfa2-4ae2-8920-0413d81cc46f">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOC0yMC0xLTEtMzcwNjI_3a82dcf0-708e-4507-a86e-96ac46ba5f1f">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i63fb294666b2488e821ae0202b6a42af_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOS0xNC0xLTEtMzcwNjI_f6cbab98-c55f-4ceb-b76a-359d949e62cd">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOS0yMC0xLTEtMzcwNjI_1e9c8819-2490-4b70-9ecd-4bb60f4f98c8">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i6b62659d21af4f5a9bfbc2ab6c0f6007_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTAtMTYtMS0xLTM3MDYy_f56963b0-5b3d-4d02-8332-400ec0418975">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTAtMjAtMS0xLTM3MDYy_bff2f277-68d4-42ab-9198-c24d59e89a88">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id8fbca8e790a49b79263a594d6204f6e_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTEtMTgtMS0xLTM3MDYy_bb16b6eb-c3d0-44b0-a64a-062c55a12733">11,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTEtMjAtMS0xLTM3MDYy_d84c1c9f-3eaa-4926-8d31-7ed80b5a9786">11,520</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.2pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i92608e502e7d418c9ee082d453136131_I20220630" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMS0xLTEtMzcwNjI_0ad5d10f-9eac-40f0-8d75-3b45601504bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i92608e502e7d418c9ee082d453136131_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMy0xLTEtMzcwNjI_3f7d8989-d39a-4e72-96f6-41fdc447f441">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i58ea917c84dd4e53aea6ee8957e300ae_I20220630" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItNS0xLTEtMzcwNjI_47196452-8395-49af-bf97-8b74f74f0705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i58ea917c84dd4e53aea6ee8957e300ae_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItNy0xLTEtMzcwNjI_cf397723-7017-433d-ba9d-f18db4f90b0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1201920f9ebb4530acebcd6bea512aed_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTAtMS0xLTM3MDYy_0147aa67-087f-4ab4-ac1d-e69d15640b84">30,991,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1201920f9ebb4530acebcd6bea512aed_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTItMS0xLTM3MDYy_281bfd07-3871-4b6f-b0a6-6d35e0a18511">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i371f184bfcdc4926af9860e292313519_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTQtMS0xLTM3MDYy_cd49d6ce-54f6-4406-8587-09de8f4401ef">307,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="if6649d2bf6df4035a225617e298f96cd_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTYtMS0xLTM3MDYy_4d542c3f-dbd9-4eb0-ba72-968978064691">818</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i26b85ca758534fa690d547a94d0fd16b_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTgtMS0xLTM3MDYy_3029563f-3405-4a95-a834-8c790c760ec5">190,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id7f27b7b00714ca6b49f201a81cb6811_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMjAtMS0xLTM3MDYy_e4fdebba-726e-4595-8007-852049e0d54a">116,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iefdecb634e6746a9bdf022491041a261_D20220701-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTMtMTAtMS0xLTM3MjU5_251f626b-7627-49d1-be5e-e3605eb83670">24,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iac27b6b2000c4669a337bc703245dd6f_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTMtMTQtMS0xLTM3Mjcz_5fba67e2-5d49-45ca-9099-8f71ac39f481">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTMtMjAtMS0xLTM3Mjk0_b34c656e-0d5c-4b8f-b369-ebdf30e145fe">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iac27b6b2000c4669a337bc703245dd6f_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTQtMTQtMS0xLTM3Mjcz_b31396f6-1221-4b12-b9da-eff770e5b3d8">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTQtMjAtMS0xLTM3Mjk0_414829f1-589c-4d4b-a4b4-b4a75757df91">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ie67812bd33894a75b67f8c3afd3db12f_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTUtMTYtMS0xLTM3Mjgw_95c55adf-be32-46db-9a92-7397e87bba18">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTUtMjAtMS0xLTM3Mjk0_94df64f5-51b3-4684-afac-b9675fa16a5c">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i407cbb66b130405f954523a0479a7435_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTYtMTgtMS0xLTM3Mjg3_72395e40-7f0a-484d-8522-4e9e09a4b019">10,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTYtMjAtMS0xLTM3Mjk0_cdc61ae7-4d3b-42f2-b23f-c6b894c218ef">10,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.2pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i37848c02dbe348d3ba5b833c88ca1596_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMS0xLTEtMzcyNDY_0bd5136f-2731-49fa-8ea4-1695279dd035">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i37848c02dbe348d3ba5b833c88ca1596_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMy0xLTEtMzcyNDY_1b067253-d113-4035-96c2-88bf483089ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iaf5a14cabce742aeb6dc76b5d7e721f2_I20220930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctNS0xLTEtMzcyNDY_daa58e40-85d4-4250-b696-ffcc1a20f8e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iaf5a14cabce742aeb6dc76b5d7e721f2_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctNy0xLTEtMzcyNDY_66edb85e-faaf-495d-963b-8f50d9499d9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i233963b046f2403f9798a7e30959afe5_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTAtMS0xLTM3MjU5_df9df3cf-ca8c-4104-9960-43481c06dad6">31,016,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i233963b046f2403f9798a7e30959afe5_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTItMS0xLTM3MjY2_863d4007-784f-4532-b66e-9da2bcb119f0">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2ea1a93ebbe64e8697b8dc87ea3b8db5_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTQtMS0xLTM3Mjcz_8e5860fe-b91a-4bf6-9232-912dc1c552a1">309,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i26bb98874bf94130aec2131d39b66870_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTYtMS0xLTM3Mjgw_956f7ab5-2c33-4882-a220-391979c0fed7">1,169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia159ea90af2444349d3a5b6dc4fb041c_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTgtMS0xLTM3Mjg3_f2b47563-fb44-4148-91a2-97039b7c90c1">200,908</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMjAtMS0xLTM3Mjk0_12ab3c6c-2af6-47fa-9c0e-e4a7f452fcac">107,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share data)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.627%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.450%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Senior Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Junior Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Common Stock<br/>(Class A and B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Total<br/>Stockholders'<br/>Equity<br/>(Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Shares</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i22c04c1aa9cc4ed1a3a5746977b13f78_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xLTEtMS0zNzA2Mg_efebfb5d-baa2-426c-bfb1-845cdddb80f8">5,737,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i22c04c1aa9cc4ed1a3a5746977b13f78_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0zLTEtMS0zNzA2Mg_5eb4000d-2aba-47d3-a1f9-8215e20e45b8">50,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i330c66d4416e4935ac95cf6c4b6c1b96_I20201231" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi01LTEtMS0zNzA2Mg_5f9141db-eb83-4b0e-bc0f-249afea2afa9">9,819,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i330c66d4416e4935ac95cf6c4b6c1b96_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi03LTEtMS0zNzA2Mg_0290fff2-d0db-4c3d-b07d-64016d393d3a">77,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i7144665eb1004d61979f59d59cd79ecb_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xMC0xLTEtMzcwNjI_eb57493d-11eb-4bf3-8674-29d8c4cd4b39">1,700,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7144665eb1004d61979f59d59cd79ecb_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xMi0xLTEtMzcwNjI_f81d0bc7-d9b1-42c4-b1f0-53fae944d690">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i5bee12794c5b43c48f79eadf2318e23e_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xNC0xLTEtMzcwNjI_6606e935-b6c0-4f48-a368-249f2f9d855f">5,889</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i8286f00ec99f411cbde3e81b53bacd01_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xNi0xLTEtMzcwNjI_fa6c2360-6f68-42fa-bbe6-00fe44d92de6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i66b9001f71b5420d9369d32a719c09c9_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xOC0xLTEtMzcwNjI_64636ab4-b674-480e-aad6-dc9f0939ca8f">131,459</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i744e357934604565b8a1ba77622b5d45_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0yMC0xLTEtMzcwNjI_811e94ee-53aa-4b77-9f8a-34540fd8eb8c">125,570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.2pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of Series E senior convertible preferred stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i9de38b8fb9704048bc0348159dc7fec2_I20210630" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjJjODA1MjllYWUxNzRjNjdiNjQ0N2JkMmEyNjI5ZmU5XzYz_1a662813-9fa1-4f5a-87b2-5a79495ffeae">12.46</ix:nonFraction> per share, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="iaaad9d062dd346ed999353e204d90789_D20210401-20210630" decimals="-5" name="sera:TemporaryEquityStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjJjODA1MjllYWUxNzRjNjdiNjQ0N2JkMmEyNjI5ZmU5XzEwMg_be7cb1e0-ed24-4e78-806b-0138f0ab47a6">0.1</ix:nonFraction> million</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ib44a2f2d0ad7493db173717bcd13180b_D20210101-20210331" decimals="INF" name="sera:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0xLTEtMS0zNzA2Mg_176eadb9-eb6f-491d-b3a8-ddaea94c517f">4,938,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib44a2f2d0ad7493db173717bcd13180b_D20210101-20210331" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0zLTEtMS0zNzA2Mg_c72797e5-ae33-4f16-8599-ccdb36ba101a">60,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Fair value of warrants to purchase common stock issued to Series E investor</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNC0xNC0xLTEtMzcwNjI_d28daf90-eb2a-4625-99b4-7f4480329ba6">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNC0yMC0xLTEtMzcwNjI_34e6c279-cf1c-4f86-9394-f6ff37e4d1d8">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i3acb9c650472454d93eaf5d1391c9c14_D20210101-20210331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNS0xMC0xLTEtMzcwNjI_82d75761-ce64-4a87-9dc3-cd103d179e72">281,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNS0xNC0xLTEtMzcwNjI_5b303b09-c58e-45e6-9b14-852fa17aab04">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNS0yMC0xLTEtMzcwNjI_724a7a11-a3e6-4265-bc8e-cd261aa1e316">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNi0xNC0xLTEtMzcwNjI_33145b42-f688-44e6-9e82-d7aec1137b56">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNi0yMC0xLTEtMzcwNjI_2cd960a7-ae2c-4c24-99f8-a467ce1cd827">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i12055f8d1ea64059813056f3f8ec3acd_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNy0xOC0xLTEtMzcwNjI_10abd250-379c-45ea-8b4f-52061501ae61">6,359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNy0yMC0xLTEtMzcwNjI_847716bb-414d-4f17-b236-861eb2d5b300">6,359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of March&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ied768dae55ea4525bbb0c49d70717a85_I20210331" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xLTEtMS0zNzA2Mg_c85a6477-a280-459c-afea-8b732bd660bc">10,675,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ied768dae55ea4525bbb0c49d70717a85_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0zLTEtMS0zNzA2Mg_67d38b87-43ec-4e28-8c37-cfee6c2f9c14">110,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i7b5e4c15c48145beb18f34a8858062fb_I20210331" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC01LTEtMS0zNzA2Mg_25dca2ed-b07d-4839-a5f5-2d0265e0d695">9,819,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7b5e4c15c48145beb18f34a8858062fb_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC03LTEtMS0zNzA2Mg_fa9ba0c0-d28c-48aa-a418-572ddbed810e">77,844</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iccbc303ef6e74469bc7cc9ef0cc54b9b_I20210331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xMC0xLTEtMzcwNjI_ecbff756-4ac7-4a27-8c73-f79c297f587f">1,982,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iccbc303ef6e74469bc7cc9ef0cc54b9b_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xMi0xLTEtMzcwNjI_3aafc148-4b41-42ef-9167-677a43d41dad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i8766f56549a44835bf6be9b33f3eae25_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xNC0xLTEtMzcwNjI_950e80ba-d9bb-4acd-a521-a572ed3027ce">7,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if214de55f4ee4b85877312f75285700c_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xNi0xLTEtMzcwNjI_b69b29bb-8346-45b0-9ab4-fd337c363f10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i4792be6cc7d049b68b1601a03021fcbb_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xOC0xLTEtMzcwNjI_3b5f6464-3909-485d-898f-5d33d5f31615">137,818</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i143503177ddd45eebbeb3dfa4a241265_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0yMC0xLTEtMzcwNjI_2b0ecb80-14b0-4449-a3bd-e95608c0461a">130,390</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.2pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of Series E senior convertible preferred stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i9de38b8fb9704048bc0348159dc7fec2_I20210630" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjlhM2U4YjViMmUyNTQ5NzFhZTQ2N2U1ZmRmY2E5NThiXzYz_5a2c1c31-5c07-4598-92d8-912cb44b8c83">12.46</ix:nonFraction> per share, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="iaaad9d062dd346ed999353e204d90789_D20210401-20210630" decimals="-5" name="sera:TemporaryEquityStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjlhM2U4YjViMmUyNTQ5NzFhZTQ2N2U1ZmRmY2E5NThiXzEwMg_1cafadc4-d912-4a0a-9033-b0687a6b7c0b">0.1</ix:nonFraction> million</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i4d1a20885eed4e00b8ec295d3a1a6126_D20210401-20210630" decimals="INF" name="sera:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0xLTEtMS0zNzA2Mg_cbb54eec-028d-435b-87d2-31412b8a936d">3,115,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4d1a20885eed4e00b8ec295d3a1a6126_D20210401-20210630" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0zLTEtMS0zNzA2Mg_592e1ef6-1d9f-4762-abbe-2dec4f96e2bc">38,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i368e83cd85ae4b37a1726dba858c0347_D20210401-20210630" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTAtMTAtMS0xLTM3MDYy_9e2b3823-ca20-42a2-b1ae-4afbaa46c2dc">22,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iacd7efb6e7484abdb0dd404594377877_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTAtMTQtMS0xLTM3MDYy_2657c6af-52be-4134-beef-a2a714c5267c">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTAtMjAtMS0xLTM3MDYy_1c041171-d614-4e61-8f94-f6a046783918">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iacd7efb6e7484abdb0dd404594377877_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTEtMTQtMS0xLTM3MDYy_e0696fa0-a283-4aa5-ac64-ba60227bd838">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTEtMjAtMS0xLTM3MDYy_3069c8ee-8525-4526-886e-5fe3d300871e">864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i80965f98a9d044e49c5b70117ce9946b_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTItMTgtMS0xLTM3MDYy_0292ed0e-f39a-4d13-a065-b71ef7f49828">6,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTItMjAtMS0xLTM3MDYy_0de366fb-92b9-492f-b76e-e18ba6a1e0b0">6,307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9417167952f443a098281a8844ff48bf_I20210630" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMS0xLTEtMzcwNjI_26b5ae97-6e52-4cdf-92d0-7c18a472e764">13,791,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9417167952f443a098281a8844ff48bf_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMy0xLTEtMzcwNjI_4b63d69d-74a2-4772-9ca0-b66a0a3826d5">149,144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="if287f4a4ec254420821d8eb16d49742f_I20210630" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtNS0xLTEtMzcwNjI_ef822d91-955b-4650-91b9-a1a806301133">9,819,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if287f4a4ec254420821d8eb16d49742f_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtNy0xLTEtMzcwNjI_0c13611f-5d6e-480b-9adc-c255c6e8a6ef">77,844</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="icfa9c03858414b669711a350682a6c36_I20210630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTAtMS0xLTM3MDYy_c2ce1046-9e58-489e-8913-1add6db013a6">2,004,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="icfa9c03858414b669711a350682a6c36_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTItMS0xLTM3MDYy_a8cc49c7-d6a2-4084-a61c-c5ebaef4d722">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if84aa7b043f54e55b61863de27a42471_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTQtMS0xLTM3MDYy_2be947ec-68fe-4d47-b4c7-0ff45167cdc1">8,327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i916da6c7f85d44858c10f7222fefaebe_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTYtMS0xLTM3MDYy_fec25152-11d6-4e12-8870-2d8d9d006173">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="idb22c494aa524d09ba6a6867b74fdb09_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTgtMS0xLTM3MDYy_be9e44bd-6ed4-4f08-b06f-1a662e3488c2">144,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i919c74b4f87b42dfa028394b09d3d6ac_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMjAtMS0xLTM3MDYy_17cb7677-61d3-497b-be9f-6a75d810257f">135,798</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Common stock issuance for initial public offering, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMTAtMS0xLTM3MzEx_e79f1a40-e8f4-46af-9597-dc67611372ef">4,687,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMTItMS0xLTM3MzEx_cb91f895-bc85-49ec-b05a-2a0a1e225550">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMTQtMS0xLTM3MzEx_e2c37e21-b9da-4bf7-9961-e800f16e0895">66,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMjAtMS0xLTM3MzEx_cd35f9f0-e479-4b84-a809-5a51480b8380">66,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Conversion of preferred stock to common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="i44be0a10165d42f2911e8707f403fd1b_D20210701-20210930" decimals="INF" sign="-" name="sera:TemporaryEquitySharesConversionOfPreferredStockToCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMS0xLTEtMzczMTE_56daf640-7ca1-4bd2-b310-9e203faceb27">13,791,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i44be0a10165d42f2911e8707f403fd1b_D20210701-20210930" decimals="-3" sign="-" name="sera:TemporaryEquityValueConversionOfPreferredStockToCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMy0xLTEtMzczMTE_e2555ae0-968b-4b81-8798-36a9c0a4da2b">149,144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="i1496266b4fc3412b98a1edf4db2a6612_D20210701-20210930" decimals="INF" sign="-" name="sera:TemporaryEquitySharesConversionOfPreferredStockToCommonStock" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtNS0xLTEtMzczMTE_6a3f8525-2a36-4026-a0ee-c432eb0754a4">9,819,480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i1496266b4fc3412b98a1edf4db2a6612_D20210701-20210930" decimals="-3" sign="-" name="sera:TemporaryEquityValueConversionOfPreferredStockToCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtNy0xLTEtMzczMTE_a26d587c-f7a4-4eec-b5f9-f28aa6f8c479">77,844</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMTAtMS0xLTM3MzEx_ad193a57-799a-4b97-8a42-6d2dfada14d5">23,839,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMTItMS0xLTM3MzEx_812f6ac4-3d30-4e98-b427-5ac9d505ade5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMTQtMS0xLTM3MzEx_ab249a38-3a03-41b0-aa9b-4e45a1ccef97">226,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfUnits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMjAtMS0xLTM3MzEx_674c25c8-1620-4e45-952a-8f48075ddc2b">226,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Conversion of preferred stock warrants to common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="sera:ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTYtMTQtMS0xLTM3MzEx_7a408aa5-17b5-4500-be13-ef5f1eaa20c0">929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="sera:ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTYtMjAtMS0xLTM3MzEx_6e4bc069-f2d5-4815-b39d-563c5ed882d9">929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTctMTAtMS0xLTM3MzEx_131dd9a6-e4b2-4892-b1f9-1419b7a498db">144,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTctMTQtMS0xLTM3MzEx_7a282a7f-020a-4b92-95e3-83a86c63714c">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTctMjAtMS0xLTM3MzEx_c106145c-7725-4c39-8015-5d3938600e5f">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Stock warrant exercises</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930" decimals="INF" name="sera:StockIssuedDuringPeriodSharesStockWarrantExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTgtMTAtMS0xLTM3MzEx_d25b6f83-a40e-4ed3-bde7-f72ee15ba7b4">22,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTktMTQtMS0xLTM3MzEx_b86b3777-f357-4986-8a50-68e3c45d1e6d">914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTktMjAtMS0xLTM3MzEx_8339aad3-f375-4063-ab5d-d857ab36b000">914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i0211f8c70f4546fab653439ef8421171_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjAtMTYtMS0xLTM3MzEx_f4a44956-c3ca-46b6-b009-776bcf83cb68">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjAtMjAtMS0xLTM3MzEx_0675fe5b-7b21-4fe6-b231-2ca421944422">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ib73f2e6d58834f169b6677f9ed409235_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjEtMTgtMS0xLTM3MzEx_ecab22a7-94fc-4bd9-9b1c-75918c85e651">9,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjEtMjAtMS0xLTM3MzEx_a2e2cd40-2b25-4ee5-9d2e-f6fe9dd11a15">9,859</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:114%">Balance as of September&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i581a92110a4843f6a5589fbed073bada_I20210930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMS0xLTEtMzczMTE_17157b3a-4333-4959-a9df-0f0cc0b971b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i581a92110a4843f6a5589fbed073bada_I20210930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMy0xLTEtMzczMTE_facdb166-0d9c-4a3f-a39a-d0bbd23e904f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i793efebda0234678845dfb4d311cf810_I20210930" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItNS0xLTEtMzczMTE_8fba36c4-585f-4f79-8bef-ab5d43e00c9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i793efebda0234678845dfb4d311cf810_I20210930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItNy0xLTEtMzczMTE_17da6589-c73e-4fb2-8caf-ccb5bcbf5e83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:0.75pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ice3e926ca9454ee092de309e776c0053_I20210930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTAtMS0xLTM3MzEx_bcf70ac3-d694-46b9-8e79-61fd360aa857">30,699,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ice3e926ca9454ee092de309e776c0053_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTItMS0xLTM3MzEx_bbb6a3cc-77e3-4a32-abf9-4602150f2864">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i982fe00fe53a4a749b3fe8ea6ceb21a7_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTQtMS0xLTM3MzEx_a24643a3-1320-4f42-9ee4-68d11515d351">304,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i349bc20944944c1e90a30491176f1186_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTYtMS0xLTM3MzEx_cffd6a47-046f-4102-be84-07e6c8d3ddd6">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i2a7b24ecb628442489324a85e9888015_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTgtMS0xLTM3MzEx_5f1fed0e-e896-4678-8477-0cdc3d59eaf5">153,984</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifef247b0e8bf4cdf83aa0c89d64ed53f_I20210930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMjAtMS0xLTM3MzEx_af9da4e6-faee-4c65-b18e-e0d1a6d50669">150,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMy0xLTEtMS0zNzA2Mg_0a38fea4-6e25-4aa8-a8bb-f58fd221429b">34,440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMy0zLTEtMS0zNzA2Mg_77bf7169-bdd2-4526-9c3a-b622e624b494">22,525</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNS0xLTEtMS0zNzA2Mg_552c4c97-bacb-41a0-b84d-e2dfe7b62de2">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNS0zLTEtMS0zNzA2Mg_f95f09d1-6492-4c8f-b4e2-bc8238ea2434">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNi0xLTEtMS0zNzA2Mg_f35edb2c-d5bf-4533-ae5c-757d72427536">3,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNi0zLTEtMS0zNzA2Mg_1e7d2a51-1a5a-4c8b-a4a2-8511bdb6fbac">2,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0xLTEtMS0zOTY3OQ_09d8cb2f-32a2-43f1-81f6-0caecd661153">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0zLTEtMS0zOTY3OQ_a0df5bd3-cb02-4ec1-a7af-fad09c156669">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:PaidInKindInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNy0xLTEtMS0zNzA2Mg_bf22f6bb-7722-4ea5-9f01-6b7307a094b8">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:PaidInKindInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNy0zLTEtMS0zNzA2Mg_20485783-fb96-46e4-8893-b583e4895bc4">588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Gain on extinguishment of PPP loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0xLTEtMS0zNzA2Mg_16e69f0a-9f3a-4966-874a-67a6b1c27b68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0zLTEtMS0zNzA2Mg_428666ed-84af-44c7-bed3-1c627e8bffb0">1,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOS0xLTEtMS0zNzA2Mg_60e6fefd-a8dc-4fd4-ad6e-088212f1fab8">26</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOS0zLTEtMS0zNzA2Mg_b39d0618-1798-4e5e-94a0-8ac75ec694c6">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTEtMS0xLTEtMzcwNjI_6b881a61-09fb-45e2-8b02-27b4d15d8cf4">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTEtMy0xLTEtMzcwNjI_d566577c-b9e2-4160-8ffb-687ed8595706">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTItMS0xLTEtMzcwNjI_5a6f6e70-fa95-41f7-a906-bcbe7afb23d0">3,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherReceivables" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTItMy0xLTEtMzcwNjI_bafb8049-c335-4f5b-9563-ba4629568aa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTMtMS0xLTEtMzcwNjI_1452685d-6cf5-4c42-b0dd-17accf23ae01">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTMtMy0xLTEtMzcwNjI_8aadcb91-ab4a-46b7-bc26-ae741c12b6f6">2,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTQtMS0xLTEtMzcwNjI_413c12de-81c4-420e-a461-adb5fb9223d6">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTQtMy0xLTEtMzcwNjI_7a1d2f6c-5627-469c-abb4-58bc7a0747b5">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTUtMS0xLTEtMzcwNjI_fab56f72-2fb7-4e90-b69a-ec24abdfe94d">534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTUtMy0xLTEtMzcwNjI_7b28a9f8-b195-47c4-928a-388a88f45faa">365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred rent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="sera:IncreaseDecreaseInDeferredRent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTYtMS0xLTEtMzcwNjI_c5cab9b5-06bd-4116-94cb-d70dd35bf3bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="sera:IncreaseDecreaseInDeferredRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTYtMy0xLTEtMzcwNjI_17079b9b-da60-4a1c-afa7-10d333e03f5d">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTctMS0xLTEtMzcwNjI_e05dd581-20a6-41e8-931e-49b4b1d4a5be">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTctMy0xLTEtMzcwNjI_2a6a535f-c184-4032-b24c-917116967c04">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTgtMS0xLTEtMzcwNjI_f8bb4b9e-8342-418d-9215-d89b3f5f2c5b">27,372</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTgtMy0xLTEtMzcwNjI_53722bb3-33d9-4d66-b113-4e1901d2a411">22,484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjAtMS0xLTEtMzcwNjI_7880f3d9-e617-4133-8080-c1a25328afc0">41,588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjAtMy0xLTEtMzcwNjI_19dc7630-4085-4d3b-be47-bd6faea0692e">67,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from maturities and sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjEtMS0xLTEtMzcwNjI_a04794a8-1f95-45b6-93cf-d2ec6a1e36f2">49,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjEtMy0xLTEtMzcwNjI_3bd51d32-feff-4f2e-aa2e-52691ed3e9d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjItMS0xLTEtMzcwNjI_ee4b94ec-4693-4d71-9d13-004ae7fcc910">598</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjItMy0xLTEtMzcwNjI_e29f0199-39d9-4ccb-a874-b5d0d3c7a90f">555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjMtMS0xLTEtMzcwNjI_4e076d8b-afd2-42ac-b655-1c767712c7dc">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjMtMy0xLTEtMzcwNjI_05f75e2e-5b90-40ea-8d7c-871b4fa2c862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjQtMS0xLTEtMzcwNjI_255ff120-cf81-41ee-ad2e-026159b6b876">7,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjQtMy0xLTEtMzcwNjI_0b07cf86-f4d3-4598-8b22-e5d42a7d2baa">68,127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from issuance of Series E senior convertible preferred stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ice5c668015774084978a3b33807344f8_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjYtMS0xLTEtMzcwNjI_e4cf2c29-3b57-4ebb-af2c-8b0d2b7ee905">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i100ed6658c0743798fcbfcfe1fc0bb18_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjYtMy0xLTEtMzcwNjI_ffba2e65-b1be-4c1c-a8eb-bc0cf5e9cc40">98,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds allocated to issuance of common stock warrants in connection with Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjctMS0xLTEtMzcwNjI_827fe702-749a-4ed8-a38d-5d15bd8d6615">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjctMy0xLTEtMzcwNjI_f7b10158-7c94-4576-a70b-e0016e6e904e">1,071</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from initial public offering of common stock, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMS0xLTEtMzczOTA_04677464-da7e-415f-92c7-08fe767c011d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMy0xLTEtMzczOTA_ab2a12f6-004e-479c-aed4-cdc04c06e532">66,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMS0xLTEtMzcwNjI_f529a45e-6dc6-4db3-83b5-17d2f99973ca">307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMy0xLTEtMzcwNjI_949f4ef3-f322-486b-980f-9ef35038fae9">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Payment of convertible note payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjktMS0xLTEtMzcwNjI_35b627f6-db6c-4cda-b97d-ef2bd8e91080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjktMy0xLTEtMzcwNjI_07eac2eb-aafb-4726-a9ea-b347e7433eb4">4,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Payment of loan payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzAtMS0xLTEtMzcwNjI_c1815865-34c2-4fd3-80d2-c128b4c07c0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzAtMy0xLTEtMzcwNjI_34333cd5-2583-4917-be12-b879c6d7a3f3">3,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Finance lease principal payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzEtMS0xLTEtMzcwNjI_1894de57-d7db-4fd9-97e7-addce27b74e6">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzEtMy0xLTEtMzcwNjI_5d8e934e-8987-49d1-b11b-1960ec7ea43a">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzMtMS0xLTEtMzcwNjI_3923635b-56d6-4af4-828e-5d63fb7338d8">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzMtMy0xLTEtMzcwNjI_dcf15d36-eb82-4fe6-99bf-9e3ef925c3fc">159,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net (decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzQtMS0xLTEtMzcwNjI_d2453bd1-f500-4707-95cd-232a1c0d4272">20,122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzQtMy0xLTEtMzcwNjI_4cbaf007-7273-497d-b3c0-546a6bf2ab82">68,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzUtMS0xLTEtMzcwNjI_135ae0af-eefd-4ccb-bab8-972a8ef7611b">58,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i744e357934604565b8a1ba77622b5d45_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzUtMy0xLTEtMzcwNjI_58c05e4b-100d-4f96-b96e-c340704cd850">13,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzYtMS0xLTEtMzcwNjI_19958610-15de-4c95-8af1-b178fffb067b">38,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifef247b0e8bf4cdf83aa0c89d64ed53f_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzYtMy0xLTEtMzcwNjI_6bbb54fa-b36e-42fe-8720-71481fc6553a">82,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Supplemental disclosure of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash paid for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzgtMS0xLTEtMzcwNjI_20d81935-6201-448d-99fb-d1a4ccd7a7d5">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzgtMy0xLTEtMzcwNjI_d0663818-94c6-4a55-afbf-b9383d2e245b">1,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Supplemental disclosure of non-cash investing and financing information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property and equipment in accounts payable and accruals</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDAtMS0xLTEtMzcwNjI_33db2247-72b3-4796-80f0-f0bad920e7c7">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDAtMy0xLTEtMzcwNjI_e76f69e0-26fc-4bd2-b62c-f49bac618009">170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Series E senior convertible preferred stock offering costs prepaid and deferred in prior period and reclassified to Series E senior convertible preferred stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="sera:PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDItMS0xLTEtMzcwNjI_593e8bbe-2eab-4f17-a0f4-58af506df799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="sera:PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDItMy0xLTEtMzcwNjI_bb88518e-526e-445a-b3f7-6b37b5edb1c1">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of the condensed financial statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERA PROGNOSTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i2084c35b29674161bec45c107b9a92a6_34"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNC9mcmFnOjVmYzllZTQwM2NkYTQ2NGZiOGU0ZDlhZTIyOTIyMDRjL3RleHRyZWdpb246NWZjOWVlNDAzY2RhNDY0ZmI4ZTRkOWFlMjI5MjIwNGNfMzYzNw_811c37bb-9aff-492d-8653-d6e0d4838692" continuedAt="i6e7e149b55f54a2f820843f61251a62a" escape="true">Description of Business and Financial Condition</ix:nonNumeric></span></div><ix:continuation id="i6e7e149b55f54a2f820843f61251a62a"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sera Prognostics, Inc. (the &#8220;Company&#8221;) is a women&#8217;s health company utilizing its proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests with an initial focus on improving pregnancy outcomes. The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;)-certified laboratory.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company&#8217;s activities have consisted of performing research and development, conducting clinical studies, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNC9mcmFnOjVmYzllZTQwM2NkYTQ2NGZiOGU0ZDlhZTIyOTIyMDRjL3RleHRyZWdpb246NWZjOWVlNDAzY2RhNDY0ZmI4ZTRkOWFlMjI5MjIwNGNfMTExNQ_21fc0314-8aac-4046-947a-fb3515dcdd88">200.9</ix:nonFraction>&#160;million as of September&#160;30, 2022. The Company&#8217;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#8217;s commercialization activities for the PreTRM test, and to support additional clinical and preclinical trials and anticipated research and development activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its diagnostic products and could be required to delay, scale back, or abandon some or all of its development programs and other operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all. Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#8217;s future operations are highly dependent on a combination of factors, including (i) the successful commercial launch and market acceptance of the PreTRM test; (ii) the success of clinical trials and other research and development programs; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#8217;s ability to manage growth of the organization; (v) the Company&#8217;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal sources of the Company&#8217;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#8220;IPO&#8221;), which was completed in July 2021. See Note 10&#8212;Capital Structure for additional details about the IPO. As of September&#160;30, 2022, the Company had aggregate cash, cash equivalents, and available-for-sale securities of $<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-5" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNC9mcmFnOjVmYzllZTQwM2NkYTQ2NGZiOGU0ZDlhZTIyOTIyMDRjL3RleHRyZWdpb246NWZjOWVlNDAzY2RhNDY0ZmI4ZTRkOWFlMjI5MjIwNGNfMzQxOQ_8bc056dd-aba7-40d8-92db-d2fe967dc6ea">111.2</ix:nonFraction> million. See Note 3&#8212;Cash, Cash Equivalents and Marketable Securities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these unaudited condensed financial statements.</span></div></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_37"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4NQ_f49d6d8e-c98d-462d-8a36-66afb306614f" continuedAt="i935760aba33746e4b586ab7b698a5b69" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i935760aba33746e4b586ab7b698a5b69" continuedAt="i63ea9be857194a3380e53e57bd5be694"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4Ng_87177415-87ab-47c1-b3d8-7b5c0ea02963" continuedAt="i27c3de1e8b3d4a2890bb3df52a97cb75" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021. The unaudited interim condensed financial statements have been </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><ix:continuation id="i63ea9be857194a3380e53e57bd5be694" continuedAt="i3a518afc97574555ae567b0a5da4f9e8"><ix:continuation id="i27c3de1e8b3d4a2890bb3df52a97cb75"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2021, and, in the opinion of the Company&#8217;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial results. The balance sheet as of December&#160;31, 2021 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2022, or any other period.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div></ix:continuation><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4OA_bca08f99-7447-49be-a0cd-a2e380ef1f5c" continuedAt="i9551a01f34314257a9501e59edef48f9" escape="true"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Topic 842&#8221;) and its subsequent updates effective January 1, 2022. The Company adopted Topic 842 using a modified retrospective method. As such, comparative periods ending prior to January 1, 2022 are presented in accordance with ASC 840, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and periods ending after January 1, 2022 are presented in accordance with Topic 842. There was no impact to the Company&#8217;s accumulated deficit as a result of adopting Topic 842. The Company used the package of practical expedients permitted under Topic 842. As a result, the Company did not reassess its lease population, classifications of existing leases, or initial direct costs of existing leases as of the adoption date. The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. The Company also elected not to separate lease components from non-lease components for all classes of leased assets except for building leases. </span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of Topic 842 resulted in a right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="idef209848fc148788ca3494cf8345024_I20220101" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfMzU2MA_e5d6f706-0dcd-4f76-96b7-1ca2dc194e5b">0.5</ix:nonFraction>&#160;million related to the Company&#8217;s operating lease being recognized in other assets on the condensed balance sheets as of January 1, 2022. A corresponding lease liability of $<ix:nonFraction unitRef="usd" contextRef="idef209848fc148788ca3494cf8345024_I20220101" decimals="-5" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfMzcyNw_07f3141a-600b-461a-8e2b-42469c89d876">0.6</ix:nonFraction>&#160;million related to the Company&#8217;s operating lease was recognized in accrued and other liabilities on the condensed balance sheets as of January 1, 2022. In addition, at January 1, 2022, approximately $<ix:nonFraction unitRef="usd" contextRef="idef209848fc148788ca3494cf8345024_I20220101" decimals="-5" name="sera:OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfMzkyMQ_bc8ee7e0-fe99-4fdc-a2e4-4f5ea245aab6">0.1</ix:nonFraction>&#160;million of lease-related liabilities were removed from deferred rent, current portion as a reduction to the initial operating lease right-of-use asset. </span></div></ix:nonNumeric><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9551a01f34314257a9501e59edef48f9">As a result of adopting Topic 842, leases classified as capital leases under ASC 840 are now called finance leases. Accordingly, the condensed balance sheet items formerly captioned &#8220;Capital lease obligation, current portion&#8221; and &#8220;Capital lease obligation, net of current portion&#8221; will now be captioned &#8220;Finance lease obligation, current portion&#8221; and &#8220;Finance lease obligation, net of current portion&#8221;, respectively, beginning in the current period. Amounts in these balance sheet items were capital leases under ASC 840 in periods ending prior to January 1, 2022, while amounts in these balance sheet items are finance leases under ASC 842 in periods ending subsequent to January 1, 2022. The Company&#8217;s finance lease right-of-use asset and liability balances were not materially affected by the adoption of Topic 842.</ix:continuation> </span></div><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4OQ_3086f215-27b8-4069-aa07-9b349436ae8e" escape="true"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of the condensed financial statements.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM5MA_1326a147-7131-4e7f-95d9-803e8b3fce6d" continuedAt="if48fae62d45d4aee8a5543dc165d708c" escape="true"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The objective of the standard is to provide information about expected credit losses on financial instruments at each reporting date and to change how other-than-temporary impairments on investment securities are recorded. The Company is currently an emerging growth company and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. As such, the guidance is effective for the Company beginning on January 1, 2023. The Company is currently evaluating the impact the standard may have on its financial statements and related disclosures but does not currently expect the standard will have a material impact.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3a518afc97574555ae567b0a5da4f9e8"><ix:continuation id="if48fae62d45d4aee8a5543dc165d708c">Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) and the SEC did not, or are not believed by the Company&#8217;s management to, have a material impact on the Company&#8217;s financial position, results of operations or cash flows.</ix:continuation></ix:continuation></span></div><div id="i2084c35b29674161bec45c107b9a92a6_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMTExMA_914007a0-200a-4707-9ccc-d1422b57943c" continuedAt="ib3359e93a6b24e419033f2e57cbe9c04" escape="true">Cash, Cash Equivalents and Marketable Securities</ix:nonNumeric></span></div><ix:continuation id="ib3359e93a6b24e419033f2e57cbe9c04" continuedAt="i6be56f9ac7a34932919b932c3de3a097"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its marketable securities as available-for-sale. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMTExMQ_9929b1b9-da5e-4733-ac15-7f88d6c3f3d3" continuedAt="i31bd48dd95cd48659b1cb8e5facf225b" escape="true">The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of September&#160;30, 2022 and December&#160;31, 2021 were as follows (in thousands):</ix:nonNumeric></span></div><ix:continuation id="i31bd48dd95cd48659b1cb8e5facf225b"><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy0xLTEtMS0zNzA2Mg_2f7db22a-67b6-413f-b69f-3a4d9dcff556">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy0zLTEtMS0zNzA2Mg_e4e5504a-26bf-4262-896b-f0ed073f5bb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy01LTEtMS0zNzA2Mg_5003b74d-f334-4f4f-9822-2e4006828337">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy03LTEtMS0zNzA2Mg_5d2684f5-b154-458b-af87-a8aa9fe865c0">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i41585eff29234897a3b80b9a1807b068_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC0xLTEtMS0zNzA2Mg_f8cb3664-7444-4162-8976-cca87daae016">1,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i41585eff29234897a3b80b9a1807b068_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC0zLTEtMS0zNzA2Mg_b0df8356-27a9-43f5-bd42-982ec38b3655">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41585eff29234897a3b80b9a1807b068_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC01LTEtMS0zNzA2Mg_8de721f1-abf5-4ebe-87bd-d9add85760d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41585eff29234897a3b80b9a1807b068_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC03LTEtMS0zNzA2Mg_56c9c0ec-2448-4dcd-9316-38858c376bfd">1,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS0xLTEtMS0zNzA2Mg_5028f7ab-2b85-49e0-af8e-545f55b9c9c7">36,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS0zLTEtMS0zNzA2Mg_eb952516-02ef-48cb-8f5a-45e60d0fc2bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS01LTEtMS0zNzA2Mg_fca89d3b-0211-4a2c-afdf-3346e5a578f4">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS03LTEtMS0zNzA2Mg_6afba6f7-92aa-4af3-91d0-d420ef338cde">36,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi0xLTEtMS0zNzA2Mg_13c59880-5854-4001-aaaf-2e7f6f511dea">38,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi0zLTEtMS0zNzA2Mg_807419f3-814f-41fe-9fb5-e3240ba62efe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi01LTEtMS0zNzA2Mg_59977cef-34b4-4afa-854a-943aa177d356">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi03LTEtMS0zNzA2Mg_0098e089-e670-4d76-baf8-8cd5a34b513e">38,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC0xLTEtMS0zNzA2Mg_ee506c93-3314-4cd6-91cc-5c1a9956b44a">15,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC0zLTEtMS0zNzA2Mg_0141a4cd-f752-4789-818a-7f371c56c199">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC01LTEtMS0zNzA2Mg_bcaaaed4-28ce-4234-9384-8bf219788f2c">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC03LTEtMS0zNzA2Mg_c8d27232-11ce-4f8a-b86f-6f5e5cad4402">15,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS0xLTEtMS0zNzA2Mg_8fff4ca1-517a-4792-bd98-a79537c1eb6e">506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS0zLTEtMS0zNzA2Mg_4ee92e1b-7356-453d-aa79-5c122e520bdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS01LTEtMS0zNzA2Mg_ae75c6a3-c9e2-476a-9c99-8656548120b4">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS03LTEtMS0zNzA2Mg_e2dcd490-fd85-4109-ac0d-1c5cc1d42fa1">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtMS0xLTEtMzcwNjI_2d97a4a9-bc8b-436a-8b1b-d2c5f5634abd">25,692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtMy0xLTEtMzcwNjI_2839b82f-b2cb-4d79-ba12-5c40f7943758">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtNS0xLTEtMzcwNjI_44bda6de-f798-4074-a182-b05978ab0a70">515</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtNy0xLTEtMzcwNjI_12d98c3a-9c39-4eef-8da3-8e697b5bd531">25,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtMS0xLTEtMzcwNjI_64380117-6f29-43a7-b9f6-51e71a6ae419">8,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtMy0xLTEtMzcwNjI_c9e884ee-cad7-438b-b9e3-a1b8cb86b24c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtNS0xLTEtMzcwNjI_43b8a3ac-4f69-422b-bc35-98a7ae9c179b">196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtNy0xLTEtMzcwNjI_e57e648e-f63b-469e-a3ea-553297e2de3a">8,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b735bee6644b40a873590cf5490f25_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItMS0xLTEtMzcwNjI_da12f696-85a6-40ac-81b7-7bf8850d5850">50,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b735bee6644b40a873590cf5490f25_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItMy0xLTEtMzcwNjI_dc8d576a-3a74-44cd-bf37-26a0cf233735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27b735bee6644b40a873590cf5490f25_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItNS0xLTEtMzcwNjI_598edc40-2b6f-4934-89e8-feb5095a0b2f">789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b735bee6644b40a873590cf5490f25_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItNy0xLTEtMzcwNjI_13b2eb8f-48cf-4131-953d-7af0f03ea422">49,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtMS0xLTEtMzcwNjI_235f51ff-7907-4ca6-9d73-65e22e50be30">12,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtMy0xLTEtMzcwNjI_10b5b35c-1b04-48d8-80b6-786ba715718c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtNS0xLTEtMzcwNjI_e1cc3633-dc8e-4d12-b018-71f5fb9f32b1">194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtNy0xLTEtMzcwNjI_28836961-a6f0-47e8-bc16-8c51b48099f7">11,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892e66ef1e914f91954762a487029ccd_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtMS0xLTEtMzcwNjI_8b4590d0-a3cf-4f8f-9354-1b91925d6781">10,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892e66ef1e914f91954762a487029ccd_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtMy0xLTEtMzcwNjI_2eaf7d97-95ac-4544-bc67-968305c9fcd9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i892e66ef1e914f91954762a487029ccd_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtNS0xLTEtMzcwNjI_2e9bd87a-a56a-4707-8ce7-7115e1e4e963">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i892e66ef1e914f91954762a487029ccd_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtNy0xLTEtMzcwNjI_460b5684-92a7-4bed-9781-ce85e2530a56">10,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtMS0xLTEtMzcwNjI_07da41ff-b7b0-4f55-8511-a3bec8f1a913">22,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtMy0xLTEtMzcwNjI_22d777b8-5592-48d3-96f0-779ae6be4389">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtNS0xLTEtMzcwNjI_670d2656-9d66-48d5-9e08-7bcef3809d6c">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtNy0xLTEtMzcwNjI_ea094f5a-7918-47a0-80df-407b827d069a">22,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctMS0xLTEtMzcwNjI_19514393-ea59-4c48-b2eb-46f6c754c85f">112,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctMy0xLTEtMzcwNjI_15866a3c-1bfa-450a-bd4d-8fdf8d4c7920">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctNS0xLTEtMzcwNjI_1431508d-fe29-4a78-b8ad-6fcf92b40b5e">1,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctNy0xLTEtMzcwNjI_1282bc18-967e-4a7d-97ba-e1908702e35a">111,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295341f5241643588814e697d1be3629_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy0xLTEtMS0zNzA2Mg_1b6cf1b6-dcc6-46e4-ad63-773ccf4eff6b">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295341f5241643588814e697d1be3629_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy0zLTEtMS0zNzA2Mg_42f8ac48-6228-4c34-839e-785c8f700209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295341f5241643588814e697d1be3629_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy01LTEtMS0zNzA2Mg_3ef5218f-6fce-4278-beda-bc9d176dfdc0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295341f5241643588814e697d1be3629_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy03LTEtMS0zNzA2Mg_2ce021ee-a88f-4828-80d6-abd10a092080">70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC0xLTEtMS0zNzA2Mg_c6a49f29-f688-40eb-b1f4-47c387d3275a">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC0zLTEtMS0zNzA2Mg_3c789aa4-624d-41ce-828e-9d88add5ded7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC01LTEtMS0zNzA2Mg_c8902e0c-b356-4bd0-9a6b-7e8a8fd341ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC03LTEtMS0zNzA2Mg_adacf011-3527-455e-860f-e468835d6c46">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS0xLTEtMS0zNzA2Mg_be597323-274d-404b-a5eb-5b8c02689119">54,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS0zLTEtMS0zNzA2Mg_3e8d04da-1206-4e56-bea0-bdcdd2a0e69b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS01LTEtMS0zNzA2Mg_88d11130-f6a2-4b6d-ba5c-68a6de987102">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS03LTEtMS0zNzA2Mg_6f60ef5a-438e-4fc6-8d4d-9fdb3065c081">54,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi0xLTEtMS0zNzA2Mg_51b9c450-df6c-426f-93bd-fd1a4517dcb7">58,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi0zLTEtMS0zNzA2Mg_cc1f4c2e-95dc-4865-ae58-bf42fda1acef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi01LTEtMS0zNzA2Mg_7e435fd0-eddd-40b5-a765-7bb928bb51a6">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi03LTEtMS0zNzA2Mg_4d76adbe-7c9b-4373-9498-d7a429f6357a">58,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC0xLTEtMS0zNzA2Mg_b74cc653-6dc6-47a3-ad49-a05392a72754">39,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC0zLTEtMS0zNzA2Mg_57f78d4a-e7cc-4537-b9e6-e9812df9ea02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC01LTEtMS0zNzA2Mg_f479b7e3-db71-4029-9441-add0a52ea6af">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC03LTEtMS0zNzA2Mg_7717d214-fb12-4a06-908b-44953e59ebf5">39,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS0xLTEtMS0zNzA2Mg_fcc81d90-d219-4a52-a369-19dc8f8c2056">6,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS0zLTEtMS0zNzA2Mg_57962df5-03e5-46ab-a0cf-be4843e09300">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS01LTEtMS0zNzA2Mg_1809c7a6-3dc0-4c27-8b64-b64e7fdb8f9a">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS03LTEtMS0zNzA2Mg_1ca3d0e9-8e8d-4f7a-9196-03040c028ae4">6,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtMS0xLTEtMzcwNjI_afc2c784-5177-460a-953e-b4b48557d4ea">46,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtMy0xLTEtMzcwNjI_0a1ac08b-c305-489e-832a-56b8e25073f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtNS0xLTEtMzcwNjI_3cf06410-c010-44a3-8ae3-f0968f74b8c2">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtNy0xLTEtMzcwNjI_f1cff219-e50e-4e72-b7c2-ec1d655d0ece">46,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItMS0xLTEtMzcwNjI_0752459f-168e-4c8a-a1bf-8ffe69979d6e">25,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItMy0xLTEtMzcwNjI_b26f0d11-e459-4955-a178-2c0fcdc8b0af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItNS0xLTEtMzcwNjI_685c3d7b-4c7c-4d71-92b9-b5d54e74e3e3">112</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItNy0xLTEtMzcwNjI_b515bf93-97eb-473c-a5d5-2948dba7c493">25,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtMS0xLTEtMzcwNjI_d5eeabc5-3f04-4e43-b559-e91a6f9f0f74">8,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtMy0xLTEtMzcwNjI_1bf2fbba-bae7-49cb-bbfb-a6f47569cba6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtNS0xLTEtMzcwNjI_c9376615-744e-4d60-bc35-b307f87a3559">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtNy0xLTEtMzcwNjI_03ef81fc-7ebb-4e5d-96bb-118990d51fdf">8,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtMS0xLTEtMzcwNjI_633ec9c0-9d35-4ce2-94f2-a580ede46912">520</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtMy0xLTEtMzcwNjI_5f2d85b9-29ab-4035-8a02-346e9c8879b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtNS0xLTEtMzcwNjI_b136ed5b-f439-4dc2-a575-11aa54c3f9bb">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtNy0xLTEtMzcwNjI_4ce7cae7-cb8a-4884-9aec-472f27358318">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ff086cec454294bcec367c74433793_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtMS0xLTEtMzcwNjI_e2584c2d-034a-42b1-a770-df6845957ca0">35,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ff086cec454294bcec367c74433793_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtMy0xLTEtMzcwNjI_8aecb73e-8256-4690-a780-1f973f1078cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia5ff086cec454294bcec367c74433793_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtNS0xLTEtMzcwNjI_1ef1cfdd-c173-485f-a538-c86282b2aa60">153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ff086cec454294bcec367c74433793_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtNy0xLTEtMzcwNjI_f2d16947-34b4-4027-a38c-51194942ce3d">34,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtMS0xLTEtMzcwNjI_44f356e4-9d09-4861-bcc1-a035ca62dcdf">140,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtMy0xLTEtMzcwNjI_205257a2-58a2-4994-bc27-0705b5c64845">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtNS0xLTEtMzcwNjI_6b5e5e09-a4cb-4961-9529-6bb0801e78f6">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtNy0xLTEtMzcwNjI_aea7f613-cd1c-418a-bdf8-0d11363a531c">139,963</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><ix:continuation id="i6be56f9ac7a34932919b932c3de3a097"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfNTQ5NzU1ODE1MzIz_8c41a76f-b35f-4893-bc5d-8bfdbafddc88" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of September&#160;30, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy0xLTEtMS0zODkyMQ_95e67cd1-cc51-4a19-abc6-348f6a413f3a">52,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy0zLTEtMS0zODkyMQ_b1374263-894b-4369-814c-d00cebd0a0e7">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy01LTEtMS0zODkyMQ_d304426c-5a32-4824-b691-7743fbe2bdd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy03LTEtMS0zODkyMQ_562717a4-da8d-4b86-904d-a9dd12061207">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy05LTEtMS0zODkyMQ_e9a13b76-e200-48c8-89f3-c7c121ef2c62">52,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy0xMS0xLTEtMzg5MjE_52e7834a-8052-426c-8247-6679dad337c4">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC0xLTEtMS0zODkyMQ_2af92c03-aa0f-4076-9e93-b5cbce0aee47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC0zLTEtMS0zODkyMQ_fc23513f-e006-49c8-af48-38e54bd8a006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC01LTEtMS0zODkyMQ_490537a9-267c-47e0-8bb2-94607d0d3aed">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC03LTEtMS0zODkyMQ_1ab350c4-808a-47a0-8924-ce195a7fa728">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC05LTEtMS0zODkyMQ_b45003e5-49d3-4e85-8b07-8a397b6d1e0b">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC0xMS0xLTEtMzg5MjE_7889a4d1-5835-49df-a6c7-5acdb24f5286">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS0xLTEtMS0zODkyMQ_7af9afef-bbfd-450b-9e6b-e3681dd589fb">17,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS0zLTEtMS0zODkyMQ_8a562b05-c3a7-46a4-abbc-6f932bd80db2">319</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS01LTEtMS0zODkyMQ_9838ef9f-00ca-43ff-b617-c0521a2ca67d">19,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS03LTEtMS0zODkyMQ_db5b9435-1d64-449e-8b34-66b371d4f718">390</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS05LTEtMS0zODkyMQ_0a0cb36c-a5ef-4f30-960d-0ce616223b40">37,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS0xMS0xLTEtMzg5MjE_56e3a79f-6b8a-4d7f-b4a2-e3f93f74d349">709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi0xLTEtMS0zODkyMQ_8fb45869-df41-4034-8250-0bc016dd2823">14,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi0zLTEtMS0zODkyMQ_28b8cdec-13d1-485b-b411-f0df7cd2a7e3">264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi01LTEtMS0zODkyMQ_4f06a8f1-7483-4b41-90a3-b5e3ba7e5f36">3,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi03LTEtMS0zODkyMQ_dcbb619c-b434-4df4-9d1a-2dee3bbbd211">113</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi05LTEtMS0zODkyMQ_7e2bc751-78c3-4644-b8f1-94b58aff2f78">18,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi0xMS0xLTEtMzg5MjE_d456a83d-e470-4641-8d39-02571bee15ab">377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy0xLTEtMS0zODkyMQ_61e8463f-da38-43ef-884d-521ce622a1e5">85,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy0zLTEtMS0zODkyMQ_5f31458d-d510-4c4d-bd3a-5b07a10b9e25">657</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy01LTEtMS0zODkyMQ_66839318-82ff-4264-ad70-dfbad001adda">23,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy03LTEtMS0zODkyMQ_c781adaa-fe80-4334-9ac5-99d4849711b1">513</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy05LTEtMS0zODkyMQ_9f25a35f-f284-4f18-809a-c7318fd38b4c">108,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy0xMS0xLTEtMzg5MjE_6893cc37-6e8d-4f94-9c67-da56c62be7d0">1,170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had <ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMjU5_65d44360-ab31-4bc5-a236-531ca99eeed5">no</ix:nonFraction> available-for-sale debt securities that had been in a continuous unrealized loss position for a period greater than 12 months. The Company determined that <ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfNDE3_24221665-eb7d-4759-bca1-d6c14ab1f8ff"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfNDE3_c544a6dd-7f07-49ee-abbd-63aec45a5e08">no</ix:nonFraction></ix:nonFraction> available-for-sale securities were other-than-temporarily impaired as of September&#160;30, 2022 and December&#160;31, 2021. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMTExMg_61d6f1b2-0ac9-4712-a039-42d62f3df5d1" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities classified by contractual maturities as of September&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.657%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.719%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMS0xLTEtMS0zNzA2Mg_5162ae9d-e0fb-4352-baca-1629df30d798">50,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMS0zLTEtMS0zNzA2Mg_d89b01ac-755e-4b19-9cc6-3b042168364d">49,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMi0xLTEtMS0zNzA2Mg_f45eb450-158e-42f5-b608-1af4d09770b4">22,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMi0zLTEtMS0zNzA2Mg_0f601655-5376-4c67-bac5-45fe22acf253">22,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMy0xLTEtMS0zNzA2Mg_155a74a1-164e-4dbb-86bd-e18e1664c758">73,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMy0zLTEtMS0zNzA2Mg_ef7f2231-4c4d-48ed-8bb6-de8a780dfd36">72,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_46"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMjY5_8a391920-c339-439e-8442-da8565d2dee5" continuedAt="i1d498419a2164b2992d3ed4fef627b4e" escape="true">Property and Equipment</ix:nonNumeric></span></div><ix:continuation id="i1d498419a2164b2992d3ed4fef627b4e" continuedAt="ia5da01da7bb345e696c6b1e60fc8c065"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMjY4_105fc13c-7cbe-4f79-bf4d-f14897d261b5" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net, as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic496e34f317b4d5b8d382d221926650f_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMS0xLTEtMS0zNzA2Mg_230c6883-e5e7-4e89-9241-bec75872d867">5,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i3172f410a08245ccaa4689e1ebcfe8fd_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMS0zLTEtMS0zNzA2Mg_0639fd42-a861-4c13-80f1-a385a1b8c37b">5,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic107f77e19a641f2b66165932a7230ef_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMi0xLTEtMS0zNzA2Mg_3f721f5e-43b4-40a1-8911-39a0c0319ebd">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i80780d051c164ea99d2de7902f458fa1_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMi0zLTEtMS0zNzA2Mg_e5d3d6d2-1e51-407a-97fe-0fe2f9bb7973">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i223dbecf860e4e39a728901fdebb9f9f_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMy0xLTEtMS0zNzA2Mg_f8ac718e-7de9-49b8-9ef7-2db88556dd8a">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic33a6f973d8841edaae5debeec90e7b3_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMy0zLTEtMS0zNzA2Mg_1261c087-62aa-4b57-b606-d37181e7c08c">710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9a394203b40c4fd299a9d183b56e5da5_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNC0xLTEtMS0zNzA2Mg_6a82452a-58bd-4342-9edb-770d9c689b3a">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie2896517d8854cdbb4a8622839fa7044_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNC0zLTEtMS0zNzA2Mg_ec678c7f-fc78-484c-aa62-7939587a142d">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i76721169755b495daf0275e4edcb974e_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNS0xLTEtMS0zNzA2Mg_1d69636d-8126-48c6-ae15-790f20b3b411">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1ea98596ebc94fb597a9a7ecb322370a_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNS0zLTEtMS0zNzA2Mg_6ae1eace-058b-4426-a31d-7af91bc35d16">320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNi0xLTEtMS0zNzA2Mg_152cc3bf-aa14-4b97-b5b9-58be70358236">9,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNi0zLTEtMS0zNzA2Mg_e3a3f6aa-2e36-418c-afb7-18dfcd9978d5">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNy0xLTEtMS0zNzA2Mg_4cfd28c7-c7b9-4959-8b48-b032853a91a2">6,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNy0zLTEtMS0zNzA2Mg_936f75db-528c-4f86-b3bd-fd0f2c56f3b9">5,967</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfOC0xLTEtMS0zNzA2Mg_f41486ac-8af6-454a-937c-5565da8dcaa1">3,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfOC0zLTEtMS0zNzA2Mg_c476fc17-53e7-4718-a602-e4ebdab1f543">1,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia5da01da7bb345e696c6b1e60fc8c065">Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMTY0_e4224e3b-4bbe-497a-9cc7-3d8657a632b8">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfNTQ5NzU1ODE0MTY0_d2b6184e-77e8-44d2-afe2-c11791738c67">0.1</ix:nonFraction> million for the three months ended September&#160;30, 2022 and 2021, respectively. Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMjQ3_fd41b6ec-774d-467d-9d9e-95125dd53fe9">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfNTQ5NzU1ODE0MTg4_b798a6cf-5bf9-4634-83a5-baab7dafd41d">0.5</ix:nonFraction> million for the nine months ended September 30, 2022 and 2021, respectively.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_49"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RleHRyZWdpb246NDc0OTVhZGE2YTgyNGJmMDgzZDBiODBmMGE1YzA4NmNfMTI5_2bf4befa-aa98-48cf-9f5c-1adaf12c08c5" continuedAt="i65f820cb3ded47e7a12665a2e227a066" escape="true">Accrued and Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="i65f820cb3ded47e7a12665a2e227a066"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RleHRyZWdpb246NDc0OTVhZGE2YTgyNGJmMDgzZDBiODBmMGE1YzA4NmNfMTMw_842fff10-2d01-4585-aadd-a110652e004d" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of accrued and other current liabilities as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMS0xLTEtMS0zNzA2Mg_63c19817-9288-47c4-a771-a38fe61afdee">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AccruedSalariesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMS0zLTEtMS0zNzA2Mg_931dec2d-ac37-43ef-ab41-bd8c078f4702">2,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued paid time off</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AccruedVacationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMi0xLTEtMS0zNzA2Mg_48dbebd4-ec84-4bd6-9ef6-e0db452a977c">504</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AccruedVacationCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMi0zLTEtMS0zNzA2Mg_36983372-f6fd-4123-b79f-854d647d59cc">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued clinical study costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:AccruedClinicalStudyCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0xLTEtMS0zODQ2Nw_a7d41dcb-1385-427b-a309-e69188531b24">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="sera:AccruedClinicalStudyCostsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0zLTEtMS0zODQ2Nw_a230cefe-1a9b-4f6a-b9c0-02ea9278beab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued 401(k) matching contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0xLTEtMS0zODQ2Nw_51498809-d64f-4caa-add7-a009d3ba59af">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0zLTEtMS0zODQ2Nw_1866a6dc-03fe-42b6-9697-3408e2834ef5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0xLTEtMS0zNzA2Mg_111a6a41-feb0-4aef-b831-dd19cb7f2870">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0zLTEtMS0zNzA2Mg_06b30835-df82-483d-bcb4-e657ac4b4856">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0xLTEtMS0zNzA2Mg_4bd37ba3-6176-4e24-9ba3-d2449f58dd5f">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0zLTEtMS0zNzA2Mg_7cf63238-b592-4619-84c3-c982d7a09394">927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNS0xLTEtMS0zNzA2Mg_ca06a971-24ad-41ca-b215-d1f690ede1bf">4,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesAndOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNS0zLTEtMS0zNzA2Mg_5fd2297d-dd00-4a0e-a0ed-d4a5f1609f25">3,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RleHRyZWdpb246NzAxMTRjMDlhNDIwNDM5YThkMmI3YTU4MzhiOGIxZjRfMTI4_98e500a7-5978-4c48-b1a6-fdb96974b274" continuedAt="i95eed39e6d80466291c55506db1ec302" escape="true">Other Income, net</ix:nonNumeric></span></div><ix:continuation id="i95eed39e6d80466291c55506db1ec302"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RleHRyZWdpb246NzAxMTRjMDlhNDIwNDM5YThkMmI3YTU4MzhiOGIxZjRfMTI5_d045455f-d810-45f7-a34e-94c2f1de6063" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of other income, net, for the three and nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi0xLTEtMS0zNzA2Mg_8e437bb4-8a4c-4101-8970-edee40d85c24">128</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi0zLTEtMS0zNzA2Mg_531342d0-b116-4020-a921-dacbceb96439">32</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi01LTEtMS0zNzA2Mg_9847dc88-8380-4f8f-9da2-53667c223c8c">272</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:InterestIncomeOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi03LTEtMS0zNzA2Mg_f983ceb4-b1f8-47f6-84bd-3fae61eaec02">53</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investment income (loss), net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0xLTEtMS0zOTc3MA_f89fabb4-8c5d-45a5-8c30-f018262bc998">369</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0zLTEtMS0zOTc3MA_9606b8ef-0361-4da6-a496-3bd10d7f7384">1</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy01LTEtMS0zOTc3MA_5e4954e6-98c8-4d32-a8a2-d79e3ea24593">565</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy03LTEtMS0zOTc3MA_3a2c210d-66a7-4706-9d65-421b5d50ad1d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Fair value remeasurements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0xLTEtMS0zNzA2Mg_4a8ee47c-361b-48ff-a97f-af6be5c21c9f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0zLTEtMS0zNzA2Mg_021e3497-4817-4cf1-a13a-e103a3c67143">9</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy01LTEtMS0zNzA2Mg_747cfa20-1d8a-439b-a356-d005d245bc06">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:FairValueOptionChangesInFairValueGainLoss1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy03LTEtMS0zNzA2Mg_3f48f8e5-1707-498c-a2fb-77c943b07e65">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gain on extinguishment of PPP loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC0xLTEtMS0zNzA2Mg_44f7ad67-3fa8-45a6-b119-06f9dbf4775b">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC0zLTEtMS0zNzA2Mg_5661b599-a2b5-4327-a396-89768b573233">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC01LTEtMS0zNzA2Mg_fb3c0f89-9710-4de2-87dd-16a03b105a59">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC03LTEtMS0zNzA2Mg_af13e88c-d542-43d3-a940-4953f54bd245">1,050</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other losses, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:OtherNonoperatingGainsLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS0xLTEtMS0zNzA2Mg_dfd4ccde-b7c0-43db-b533-0517f60cd937">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:OtherNonoperatingGainsLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS0zLTEtMS0zNzA2Mg_2781cb28-0709-406b-87f4-61563dbf0702">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:OtherNonoperatingGainsLosses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS01LTEtMS0zNzA2Mg_9fcd0750-40f2-4193-93b7-d3a335113478">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingGainsLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS03LTEtMS0zNzA2Mg_4423d8f2-d55d-4946-9f54-336c5cb37312">20</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi0xLTEtMS0zNzA2Mg_ef45a254-541d-41bb-8502-d03ab536e823">497</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi0zLTEtMS0zNzA2Mg_9b65ef78-2e94-4858-9c62-ab7e208d13a0">22</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi01LTEtMS0zNzA2Mg_a6149364-8cca-4c46-b3ec-f9b896c87737">837</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi03LTEtMS0zNzA2Mg_b5cd4aae-9694-4a35-beee-8a3187dfab4f">1,067</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjYzMQ_a854db5a-2aa4-4e76-8f42-ee2ae3597c3b" continuedAt="icefab287af2b4412abe30f47a5e50890" escape="true">Loans and Convertible Promissory Notes</ix:nonNumeric></span></div><ix:continuation id="icefab287af2b4412abe30f47a5e50890" continuedAt="i0f7caac5aa6e47df8894cd87877f9b42"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Loan</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, through a Loan and Security Agreement with a bank, the Company obtained a term loan for $<ix:nonFraction unitRef="usd" contextRef="i669added0b444346a5f738058ceb934b_I20141231" decimals="-5" name="us-gaap:LongTermLoansFromBank" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTE3_5597fce6-befe-4eea-99da-c5eeeb6013be">10.0</ix:nonFraction>&#160;million. In March 2021, the Company repaid the outstanding principal of $<ix:nonFraction unitRef="usd" contextRef="i9e9ca69a921249c6a78aa32baee42b33_D20210301-20210331" decimals="-5" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTc2_b814b4fe-9ca4-42a8-b1e4-6f040cca24d7">2.0</ix:nonFraction>&#160;million, accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i9e9ca69a921249c6a78aa32baee42b33_D20210301-20210331" decimals="-3" name="sera:RepaymentOfAccruedInterestOnLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjAw_b4644157-11bc-4da6-a8b7-3862d34e8f98">6</ix:nonFraction>&#160;thousand, and the final payment fee of $<ix:nonFraction unitRef="usd" contextRef="ib88c7314479a44d4bad72460fdabc6d9_I20210331" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjMz_f16fd2b1-c19f-41f8-b42a-b8dc026ed55c">0.1</ix:nonFraction>&#160;million related to this loan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Promissory Note</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, the Company authorized the issuance of a $<ix:nonFraction unitRef="usd" contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMzM0_aac0a6c2-1aba-43df-8f56-ea83f86dc7bc">6.4</ix:nonFraction>&#160;million subordinated convertible promissory note (the &#8220;Note&#8221;) to a stockholder of the Company, bearing <ix:nonFraction unitRef="number" contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfNDMy_a7bc404c-bbf3-4656-b48f-6272b11f0d34">12</ix:nonFraction>% interest and a maturity date of February 26, 2021, to provide liquidity and additional working capital. On February&#160;15, 2021, the maturity date was extended to March 28, 2021. The Note was convertible at the option of the holder into shares of Series D Convertible Preferred Stock at a conversion price equal to <ix:nonFraction unitRef="number" contextRef="i60a0864fc6dd4e8fbe07647b8d79a429_D20190201-20190228" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfNzMy_a4b6967d-6888-4645-8d4b-42405b744773">80</ix:nonFraction>% of the issuance price of the Series D Convertible Preferred Stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODA0_2521182b-7f12-46a8-b666-e5dd4808c595">9.03</ix:nonFraction> per share. In July 2019, $<ix:nonFraction unitRef="usd" contextRef="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731" decimals="-5" name="us-gaap:DebtConversionOriginalDebtAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODI1_4132c2f7-f185-452a-8fd3-4e3c17ae63bf">1.9</ix:nonFraction>&#160;million of the $<ix:nonFraction unitRef="usd" contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODM1_aac0a6c2-1aba-43df-8f56-ea83f86dc7bc">6.4</ix:nonFraction>&#160;million Note&#8217;s principal and $<ix:nonFraction unitRef="usd" contextRef="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731" decimals="-5" name="us-gaap:InterestExpenseLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODU5_897a134d-3132-440e-a25c-5e052972ac94">0.1</ix:nonFraction>&#160;million of accrued interest were converted into <ix:nonFraction unitRef="shares" contextRef="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731" decimals="INF" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfOTAy_7e07f368-afab-4698-be9c-30dfbf495d24">277,507</ix:nonFraction> shares of the Company&#8217;s Series D Preferred Stock. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion feature of the Note met the requirements for separate accounting and was recognized as a liability at the measurement date fair value of $<ix:nonFraction unitRef="usd" contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTEwOA_5e2585f7-5bcf-4155-8027-b9cc68479fda">2.4</ix:nonFraction>&#160;million, subject to remeasurement to fair value, with any changes in estimated fair value recognized as a component of other income, net. A corresponding discount, which reduced the carrying value of the Note, was also recorded. The unamortized discount was written off in proportion to the partial conversion, with the remaining discount accreted to interest expense until maturity. The Company recognized additional interest expense of $<ix:nonFraction unitRef="usd" contextRef="i600787d311a2404994266e049f220010_D20210101-20210930" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTU0MQ_a21b8111-d67e-4031-ad8c-39ef7dfde166">0.1</ix:nonFraction>&#160;million from accretion of the discount during the nine months ended September&#160;30, 2021.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><ix:continuation id="i0f7caac5aa6e47df8894cd87877f9b42"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;24, 2021, the Company repaid the outstanding principal of $<ix:nonFraction unitRef="usd" contextRef="ifb4eddf3f2864ba99d2b3f2c498583d7_D20210324-20210324" decimals="-5" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTY2MQ_5136a739-7ef5-44c9-8c56-7e0082fa9f78">4.5</ix:nonFraction>&#160;million and accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ifb4eddf3f2864ba99d2b3f2c498583d7_D20210324-20210324" decimals="-5" name="sera:RepaymentOfAccruedInterestOnLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTY4OA_894bc67a-3229-4103-a303-6fc0c0929d9d">1.1</ix:nonFraction>&#160;million related to the Note.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paycheck Protection Loan</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company obtained a $<ix:nonFraction unitRef="usd" contextRef="i4e0ee74c3ff34aefb683e6d0f0a83a2c_I20200430" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTc2Nw_4be12af4-eab2-4d45-865e-6567e0477b66">1.1</ix:nonFraction>&#160;million loan through a bank under the Paycheck Protection Program (&#8220;PPP&#8221;) under the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;), as amended. The loan&#8217;s purpose was to maintain payroll and make rent and utilities payments as specified under the terms of the PPP. Under the PPP, borrowers may apply for loan forgiveness if the funds are used for payroll costs, mortgage interest, rent, and utilities payments over a specified term following receipt of the loan funds. During the term of the agreement, the Company utilized the loan funds for forgivable purposes and applied for forgiveness. In June 2021, the outstanding $<ix:nonFraction unitRef="usd" contextRef="id9bcf6ae0b3e42c2bef96302713690d0_D20210601-20210630" decimals="-5" name="us-gaap:DebtInstrumentDecreaseForgiveness" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjQwMg_d8ca0c03-5fb0-48a0-a6b0-3388c20be28e">1.1</ix:nonFraction>&#160;million PPP loan was forgiven and removed from the Company&#8217;s balance sheet. As a result of the forgiveness of the PPP loan, a $<ix:nonFraction unitRef="usd" contextRef="i1602ad9e54b945c9bc70c8e1b2cb0cef_D20210101-20210930" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjUyMw_122f6dd4-cd62-4f87-925a-011061b30b44">1.1</ix:nonFraction>&#160;million gain on extinguishment was recorded in other income, net for the nine months ended September 30, 2021.</span></div></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RleHRyZWdpb246ZjYzNTY4ZDIyNTkyNDI5YjgxMDVhZjU1OTI5ZWZkOTdfMTg5MA_65d7489c-6ead-46d1-8883-cea04915f6f1" continuedAt="i4bf1f878323d4d2d8159d90e3323efdd" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i4bf1f878323d4d2d8159d90e3323efdd" continuedAt="if43506f96be34146be3c163715946665"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the carrying amounts of the Company&#8217;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.</span></div><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RleHRyZWdpb246ZjYzNTY4ZDIyNTkyNDI5YjgxMDVhZjU1OTI5ZWZkOTdfMTg5MQ_9c7dd7d4-6fce-4210-b2f5-14a4d5e7ffb2" continuedAt="ia64000e69fc640039fe1c49e4353cf7d" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of September&#160;30, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib74370533b2343e5948c7c3132692fee_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMy0xLTEtMS0zNzA2Mg_3dc462d8-65a2-44ed-b27d-c96347ab38de">1,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="icf7511108faf4cd0906efe6af85f04d8_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMy0zLTEtMS0zNzA2Mg_45388c18-0da4-47bd-993c-8947d1820caf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9d63d790f8f54a508f078691f2d26768_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMy01LTEtMS0zNzA2Mg_5e7dd0c5-039c-4f46-aefc-aeda116916d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i612e8b546ca046b0bfda86066a454cca_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNC0xLTEtMS0zNzA2Mg_58971326-f180-49fa-82eb-c5cc20234599">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i42d2faf58839437f8edcd20d96b207ca_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNC0zLTEtMS0zNzA2Mg_7ac9c760-bd6f-417a-a4b3-760ef25cc3e1">36,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i1458e22a9c914fb9ae75771117d8fd05_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNC01LTEtMS0zNzA2Mg_8d8cc70b-4ac8-4108-93b3-48c2fb94eb41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9902d71bf4ff4310af77e9ffa184e4b1_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNi0xLTEtMS0zNzA2Mg_5c4374df-183c-41a3-a662-c48c2f6f5343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i63a5647d5c0340be84f03046f561d36e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNi0zLTEtMS0zNzA2Mg_dd61ff89-3e24-499c-a72c-b97c0efcf385">15,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i414b0aaf127042bd88523a0bb531c307_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNi01LTEtMS0zNzA2Mg_9fc4e842-64c8-4456-93ca-20f27d680213">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib2a43bb4ef084888b75d6e3a33541d4f_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNy0xLTEtMS0zNzA2Mg_bf24261f-4cd6-433a-b2b1-dd2a23bb937d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="if96032a7e83741c18f2e92eaa33744cb_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNy0zLTEtMS0zNzA2Mg_e79cfc24-d67e-4c82-bae2-3f856a0ad705">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i8eda479567124bc7814e222145ebc019_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNy01LTEtMS0zNzA2Mg_94a8648b-6741-4920-b05b-2816dcc7dcb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i656a95c6ee6440fc959d2f83704886e6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOC0xLTEtMS0zNzA2Mg_0e5604e3-e1dd-4548-b5e1-88e1e045249f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i918d3cc73cc24feb9a410f56da474f96_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOC0zLTEtMS0zNzA2Mg_9d68c44c-3a41-4afd-ad15-d0287c5d82db">37,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i57d6bf244c40409a995f2c8c55e870cb_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOC01LTEtMS0zNzA2Mg_31093fcd-c9c7-4064-882f-d71c11815b45">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i6e9ad3bbced74f1286c9edbd11d60a94_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOS0xLTEtMS0zNzA2Mg_e05a7163-8feb-4b1d-81d8-59c3415cfc4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifd27872ed39d473cabd931c1687ec88d_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOS0zLTEtMS0zNzA2Mg_8fd6119a-c940-4593-9c6a-70005effe4ea">19,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ic9f7d318c031453095ba85b0e5175e30_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOS01LTEtMS0zNzA2Mg_727f2c9a-24a5-4533-b43e-227cf41530f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie045a5e26f014139838acb18403afe93_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMTAtMS0xLTEtMzcwNjI_28624b81-787f-4e47-9cce-dc84e67741d0">1,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib8f2c42715c1443cb59e29a781e6c0e7_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMTAtMy0xLTEtMzcwNjI_5bd4ce9b-a85b-4d07-8ee0-2870cd720c93">109,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i395ae800742b4df1825940da3494ba86_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMTAtNS0xLTEtMzcwNjI_8cfab9d8-f459-45fa-a841-8c3150edb5aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><ix:continuation id="if43506f96be34146be3c163715946665"><ix:continuation id="ia64000e69fc640039fe1c49e4353cf7d"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idbac569dd2004b2d99ae63842688565b_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMy0xLTEtMS0zNzA2Mg_607f6020-3b5b-48b5-a145-d8b824539527">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2f27774bd30241ee8942a4cef573525d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMy0zLTEtMS0zNzA2Mg_1d807364-08ac-477e-9d80-aff8c7cbacb0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib01e4104a4cb425bad5c8fe30243f72a_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMy01LTEtMS0zNzA2Mg_8b4abaf8-111e-4b6b-817f-0caa5e3e99e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i9132b6cdf5cd402dabd2fca792c7249d_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNC0xLTEtMS0zNzA2Mg_89f215dd-57e3-47e4-8827-a8c0978715c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i44df0ed744444847a688f0b9b2610c86_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNC0zLTEtMS0zNzA2Mg_ec28cdb8-e6ab-4e92-b633-ddeb38c227da">54,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i84f85bd632c0444084e27b6374b41155_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNC01LTEtMS0zNzA2Mg_4085458b-3d78-42cf-8423-eafedf1fcf9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i71c26cad06b949fb97802e9a0a40f61c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNi0xLTEtMS0zNzA2Mg_e43579e6-875a-4289-be68-cccc6e97e2ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iab4c468c851148af9a6507c50ac2acc0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNi0zLTEtMS0zNzA2Mg_24aeb0f0-e17f-4bcc-a503-af9425bb37a1">39,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="icafec0a54060431fa19e8c1658de99f5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNi01LTEtMS0zNzA2Mg_65bb94e6-2f55-4b47-9bb1-32bebf48b0e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0319da007e0a4472971df069b87d62c2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNy0xLTEtMS0zNzA2Mg_14494eb4-51d2-4b74-814b-f7a787abda2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="iea0875504fe4402ab5ef06f8708cb41d_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNy0zLTEtMS0zNzA2Mg_d99894aa-7185-4e2f-b8b9-944044261790">7,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i664717ae0afe4dc8864dc9d40f13dcea_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNy01LTEtMS0zNzA2Mg_f2cc4293-4693-4f69-b838-e103782ea587">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7738521c4b514f00a138be71f2fa2aa8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOC0xLTEtMS0zNzA2Mg_23fac792-e275-4e39-bdfc-74ba877c4252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i4bf0489931cb444190182c5a4a0920c2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOC0zLTEtMS0zNzA2Mg_eb42704b-b2ee-4981-80b1-2c4975e00cf1">25,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ie44f5ba7c5664328b22fafcd4e4e4729_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOC01LTEtMS0zNzA2Mg_4a33e6aa-b15d-4b5b-896b-e18b56d12075">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i625bf249a07e4f79916f01e5b3ae9a49_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOS0xLTEtMS0zNzA2Mg_3a789763-fe69-4fa0-be26-ceea773178a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7ac1738373464afaa4f620044f28dc23_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOS0zLTEtMS0zNzA2Mg_b4bde515-09b4-4aa4-9922-690ed989a792">8,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i14a569c6473f4caba47df2fbed2a5e31_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOS01LTEtMS0zNzA2Mg_8136f8c5-e232-4053-a47f-796685c43770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="icacf2d98943d4579b2ae6dce4e1d872e_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMTAtMS0xLTEtMzcwNjI_dfca99c5-5e41-475e-baf3-acdd36382389">4,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ibf16684d7e4b4069b71370834c076b72_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMTAtMy0xLTEtMzcwNjI_f9ee15ee-c5b7-445f-b0a9-ab4da2ee7957">135,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7696d66e3a844c518b0767e034d8b610_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMTAtNS0xLTEtMzcwNjI_dfa9542d-666e-4f1c-920f-5fbe78735757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfNTExNg_d7f39cbe-156f-4a9a-8377-282395b33a9d" continuedAt="i904e432f2a204e14b953074ae35a7d5e" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="i904e432f2a204e14b953074ae35a7d5e" continuedAt="ie48ef548a6dc4b2686000f7757c2bce4"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, the Company entered into a master services agreement with Healthcore Inc. (&#8220;Healthcore&#8221;), a subsidiary of Elevance Health, Inc. (formerly known as Anthem, Inc., &#8220;Elevance Health&#8221;). This agreement covers a range of research projects, including Healthcore&#8217;s role as a contract research organization for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rematurity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">isk Assessment Combined With Clinical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterventions for Improving Neonatal outco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s (&#8220;PRIME&#8221;) study. The Company paid fees related to this agreement of $<ix:nonFraction unitRef="usd" contextRef="i97f06024a3634a4a848d749268fa8321_D20220701-20220930" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTM2OQ_3027bdaa-7d8d-402e-ba8f-b75a7b56d665">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3f9decf253d24e629dc8d16e78c681cf_D20210701-20210930" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTM3Ng_9910d5ac-7fe6-419b-a0e6-e4564274dff3">0.4</ix:nonFraction>&#160;million for the three months ended September&#160;30, 2022 and 2021, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i07d69dbf6533445b9b4296a542908776_D20220101-20220930" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTQzNQ_b359a590-8c79-4db3-a377-c6d3d3fd20c0">1.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i92b6834e9fa046c889b80dd680ca97ec_D20210101-20210930" decimals="-5" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTQ0Mg_543da520-acd7-4a00-8bc0-80382fc4a1ae">1.1</ix:nonFraction> million for the nine months ended September 30, 2022 and 2021, respectively. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. The Company recognized revenues related to this agreement of $<ix:nonFraction unitRef="usd" contextRef="id5a4a33f19a4405284072607fbcb712f_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTc1Ng_7f1c9745-213a-4b66-9599-866062dff571"><ix:nonFraction unitRef="usd" contextRef="ife1874e670534eb286f346549f8030e4_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTc1Ng_838d0bcf-3a42-4aee-a75c-56c681426736">17</ix:nonFraction></ix:nonFraction>&#160;thousand for the three months ended September&#160;30, 2022 and 2021, and $<ix:nonFraction unitRef="usd" contextRef="if953534ebfe5400a9f6434aa8ae8fe2c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTgyMg_59bf839e-dc3b-4f72-a044-4914bd36e325">59</ix:nonFraction>&#160;thousand and $<ix:nonFraction unitRef="usd" contextRef="i7171c7eb9dbe490681930536b5adb751_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromRelatedParties" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTgyOQ_dc92ad8c-f210-498d-812e-d56a21aa9376">41</ix:nonFraction>&#160;thousand for the nine months ended September 30, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#8220;Commercial Collaboration Agreement&#8221;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#8217;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first <ix:nonNumeric contextRef="ia4dfe18e2ba344628fb42a44cbb4c082_D20210201-20210228" name="sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMjMzNQ_0f9986e0-d70d-42e5-b1ae-36f3fdef7487">three years</ix:nonNumeric> of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first three years of the term of the Commercial Collaboration Agreement. The Company received $<ix:nonFraction unitRef="usd" contextRef="i8faa0127d92747c19730bff7fe96a67d_D20220101-20220930" decimals="-5" name="sera:RelatedPartyTransactionCashReceivedFromRelatedParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMjU3Nw_5f5358cb-de43-4368-97e2-80c05300095f">3.1</ix:nonFraction>&#160;million during the nine months ended September 30, 2022, which amount related to the minimum payments for the year ended December&#160;31, 2021. Such minimum payments were initially recorded as deferred revenue at December&#160;31, 2021. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. There were <ix:nonFraction unitRef="usd" contextRef="i9cbb3338066a4c86bb22691782cdfd99_D20210101-20210930" decimals="INF" name="sera:RelatedPartyTransactionCashReceivedFromRelatedParty" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMjkxNQ_f5048181-8105-4be8-a982-31f19dc6d282">no</ix:nonFraction> cash receipts related to the Commercial Collaboration Agreement for the nine months ended September 30, 2021. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elevance Health has been participating in the Company&#8217;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#8217;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie48ef548a6dc4b2686000f7757c2bce4">occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the three and nine months ended September&#160;30, 2022 and 2021.</ix:continuation></span></div><div id="i2084c35b29674161bec45c107b9a92a6_64"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTE0Mw_55eb08cb-8eb9-451e-ab88-88aa5aae5bf2" continuedAt="i01eb041503f84d8baede9b43aaca960b" escape="true">Capital Structure</ix:nonNumeric></span></div><ix:continuation id="i01eb041503f84d8baede9b43aaca960b"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;19, 2021, the Company completed its IPO and issued <ix:nonFraction unitRef="shares" contextRef="if40be873cb3b4110921324e4559ce26b_D20210719-20210719" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNjA_e80c3d0a-be4c-4761-8c1c-559f0c0eb823">4,687,500</ix:nonFraction> shares of its Class A common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9f4d8885752a4f3f92312b675720aa76_I20210719" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTEy_160fd871-f49c-44cc-93a2-51b3c5348132">16.00</ix:nonFraction> per share for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ibe8b830e52ae447d8c81bd371da3cbc6_D20210719-20210719" decimals="-5" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTU5_2f0095ae-c448-43f3-89b8-9f2ccbc6c87a">66.6</ix:nonFraction>&#160;million, after deducting underwriting discounts and commissions and offering expenses payable by the Company. In connection with the IPO, all shares of convertible preferred stock converted into <ix:nonFraction unitRef="shares" contextRef="id6cc8adcb35049f99e17c68122feee4f_D20210719-20210719" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMzQ5_784e1807-e1bd-4009-b60c-887018da59ce">22,434,130</ix:nonFraction> shares of Class A common stock and <ix:nonFraction unitRef="shares" contextRef="ied62654e4491444e97d0acab99397010_D20210719-20210719" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMzg3_b7ddb550-51df-424f-8f8c-484dbaa2441d">1,405,259</ix:nonFraction> shares of Class B common stock and <ix:nonFraction unitRef="shares" contextRef="i59217ebe2e3b446297d6e7d10cdd6508_I20220930" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNDI1_63ecfbcc-b128-4f27-8d3d-a6d77103f224">no</ix:nonFraction> new shares of convertible preferred stock have since been issued.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="common_stock_class" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="sera:NumberOfCommonStockClassesAuthorized" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNTIz_01f1b594-64e2-4bea-9656-b625ee99801a">two</ix:nonFraction> authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to <ix:nonFraction unitRef="vote" contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930" decimals="INF" name="sera:NumberOfVotesPerShare" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNzU2_ea60e030-c27e-42da-925b-6e35a79d6a7e">one</ix:nonFraction> vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to <ix:nonFraction unitRef="number" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="sera:CommonStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfODgy_2d1f76ed-2ffc-4cdb-8d1c-e5ae0cb8c996">one</ix:nonFraction> share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#8217;s amended and restated certificate of incorporation. </span></div><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTE0NA_729d863f-2014-413c-9ad8-195bd6cca821" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares of Class A common stock were reserved for future issuance:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia28bd723960742d0bc535d70294b0cec_I20220930" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMS0xLTEtMS0zNzA2Mg_68bca8e4-967c-4042-8fbd-86f681746718">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i795da5fab0804282a9b140098d707bf3_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMS0zLTEtMS0zNzA2Mg_b4e351db-ddfe-42e7-bd6d-af083a22ea93">2,788,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i82559b67f9e148dab9ad2b1eed66b0c6_I20220930" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMi0xLTEtMS0zNzA2Mg_5ffaa3c9-3052-4c5c-a4e2-1038257f0e7c">8,532,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i36bc42d96e4e433984ab7a8838c57a60_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMi0zLTEtMS0zNzA2Mg_f295acce-7107-4a33-8e27-2a92d2c29a8d">6,287,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i2e079d863e01425487bf0a16e4109cb1_I20220930" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMy0xLTEtMS0zNzA2Mg_b2256230-6864-4f44-89c9-95533a7b7e1c">1,822,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i0ebe18a147e84a0e88b4ba20920b22e4_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMy0zLTEtMS0zNzA2Mg_2c9eb1c2-aeb0-4481-a602-9a9b0026dd44">3,136,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i600edf893f194531ba73533739a7ffe3_I20220930" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNC0xLTEtMS0zNzA2Mg_f4cd07b5-f988-4a6c-822e-84526b38fc9c">598,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5d186423a55d4d4eb1d92c41476d9b48_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNC0zLTEtMS0zNzA2Mg_a5efcf2e-edd1-4fa0-a1a7-3fa99dbddf8f">305,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNS0xLTEtMS0zNzA2Mg_56a740ee-1bcb-4ed8-88ac-708fc52d2fb8">13,730,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNS0zLTEtMS0zNzA2Mg_57ae0b21-269d-4bfa-be05-955b2c4d7346">12,517,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4NA_e175d64a-0b8f-4bd3-aa81-bf069422fb2d" continuedAt="i1064c362de9649189d7e03405fd7b3e8" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i1064c362de9649189d7e03405fd7b3e8" continuedAt="ia45f114c87fd48d19de0ca5aa264f819"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2011 Plan&#8221;) and reserved shares of the Company&#8217;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a <ix:nonNumeric contextRef="i5924a4c2b8a04efd9f8a9b105681d3ac_D20111101-20111130" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4NQ_e2374dba-8152-4d8e-943e-0cd225f7da00">four-year</ix:nonNumeric> period and generally expire <ix:nonNumeric contextRef="i5924a4c2b8a04efd9f8a9b105681d3ac_D20111101-20111130" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMzM2_1449b96d-89fd-4141-8b59-bcfd1d9e0c47">ten years</ix:nonNumeric> from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors, and consultants of the Company. Options generally vest over a <ix:nonNumeric contextRef="i370eabad665347dea0833447376cc361_D20111101-20111130" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4Ng_bbe3c97b-9ad9-44b0-bf5e-46737775076a">four-year</ix:nonNumeric> period and options generally expire <ix:nonNumeric contextRef="i370eabad665347dea0833447376cc361_D20111101-20111130" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfOTY0_f713a246-dc76-47ae-a373-011758bfd8c5">ten years</ix:nonNumeric> from the date of grant. Options are exercisable only to the extent vested. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of September&#160;30, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i5105b69dd15f4d468202f02b3beddfd8_I20220930" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMTM4Nw_0d225167-dab7-4d99-915e-56a2dfd808db">1,822,815</ix:nonFraction> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of September&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i8b50f0c0967540a28d5b66bd6ed16b1a_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMTc0Nw_db188e1b-18a7-4add-8938-2abe273df064">no</ix:nonFraction> shares had been granted under the 2021 ESPP and there were <ix:nonFraction unitRef="shares" contextRef="if5143f467fec4136b943ecc3bf4ebd64_I20220930" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfNTQ5NzU1ODE2NDY3_84b8f723-a811-4b14-8787-4b3649e78065">598,777</ix:nonFraction> shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 ESPP. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><ix:continuation id="ia45f114c87fd48d19de0ca5aa264f819"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, references to &#8220;options&#8221; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4Nw_7905d25f-484e-4de0-8567-6c9abbd5773f" continuedAt="iad5ce6bb79aa4c1eaf0f59c6f205dc7c" escape="true">The following table summarizes information about these options granted and outstanding:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="iad5ce6bb79aa4c1eaf0f59c6f205dc7c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS0xLTEtMS0zNzA2Mg_b0e52e8a-1f25-4ce1-a8c3-bad019525744">6,287,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS0zLTEtMS0zNzA2Mg_edb595db-1c70-47fb-9d7c-7dece6bdff5d">4.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ib8612108452442a088e51138f3c2554f_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS01LTEtMS0zNzA2Mg_bcf4a248-8595-4d53-a7da-9cb071a7dadd">7.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS03LTEtMS0zNzA2Mg_28b2d3a5-701f-4de9-aaac-533c8ed554ba">20,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMi0xLTEtMS0zNzA2Mg_d2480a9f-d92b-446a-a213-834c9f4e1ca7">3,185,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMi0zLTEtMS0zNzA2Mg_c1a2f6c0-0b4c-42b1-ac54-1478b4f8f4ff">3.26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMy0xLTEtMS0zNzA2Mg_6c8c6f51-70e9-4d04-83da-49b7a9a7e63b">1,924</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMy0zLTEtMS0zNzA2Mg_99100338-03a4-44e8-9e47-3b4ffb55bd35">0.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNC0xLTEtMS0zNzA2Mg_d84b91a3-824d-4173-aedc-06f9406af549">694,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNC0zLTEtMS0zNzA2Mg_e3db4658-4589-44e5-af16-161ada02c971">7.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="shares" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNS0xLTEtMS0zNzA2Mg_b1dd3a5b-eed4-4f5f-bfd4-a9e273d9274c">242,853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNS0zLTEtMS0zNzA2Mg_b8f1d6d7-7fb3-44d5-9338-b9a63e0632cf">1.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi0xLTEtMS0zNzA2Mg_3699f145-ed85-402c-a949-0ceb0a9e6dfb">8,532,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi0zLTEtMS0zNzA2Mg_e15f52e7-1995-46e9-b184-ff3285b42cad">3.78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi01LTEtMS0zNzA2Mg_e7a19b97-8a35-4aa7-9706-476a7550e3bb">7.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi03LTEtMS0zNzA2Mg_1039c8e1-a487-4c75-9d08-1c23bb141bce">444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy0xLTEtMS0zNzA2Mg_a00b56be-54ec-4295-9d0f-d5e0ff193781">8,133,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy0zLTEtMS0zNzA2Mg_b2274efa-4770-4218-8a87-df9803c52540">3.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy01LTEtMS0zNzA2Mg_a70bdde3-7835-45a8-8adf-acfd6e11bf9c">7.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy03LTEtMS0zNzA2Mg_4f93169b-1405-48be-8857-188b91417558">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and exercisable at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC0xLTEtMS0zNzA2Mg_1fe40908-abad-41e6-a820-78b8d99d1ac4">3,800,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC0zLTEtMS0zNzA2Mg_03e1c5db-8147-499b-b6a2-a7f8840ddff6">2.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC01LTEtMS0zNzA2Mg_d0c52794-929c-4e9a-ad0b-66b3291bc70e">6.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC03LTEtMS0zNzA2Mg_a95d0beb-9635-4ee8-85ec-60db88bfa94b">276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4OA_7130e4ea-5fe1-4061-9185-b5423ef567f4" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia1ed6221f242409f8a9dbaaaee40c814_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi0xLTEtMS0zNzA2Mg_a963f566-73f9-4fd7-baa1-fba07326768b">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i52f60d8b08f641c0b0ced84d1a9fb159_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi0zLTEtMS0zNzA2Mg_f53af1a1-905d-4b9d-98c8-7fa6d9f35af2">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i7ae79d05fb1b4c4ea6d13b1014a59490_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi01LTEtMS0zNzA2Mg_e98d2d8a-929c-468e-bf07-db089d5a26b5">1,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ifc7ffa070afa4b67be9eacf9bbc4f4a5_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi03LTEtMS0zNzA2Mg_a5a9155b-5fd1-47ae-a686-9a9902998d4b">717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Sales and marketing expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i04312bc62a9c45d6b4ffb2e70999f7ce_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy0xLTEtMS0zNzA2Mg_9290266b-4107-4f35-8a86-50e50af84f9a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0c3b67e645ef427c8250de0d5e967256_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy0zLTEtMS0zNzA2Mg_252c6480-2c97-4aa7-ba49-21e1c51e783f">179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i2708055ad45048f9b3a01fd826029750_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy01LTEtMS0zNzA2Mg_766cb8b4-b457-4a52-867e-24665261b835">420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="idc13b0c45ef84ef9ba43c43526394594_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy03LTEtMS0zNzA2Mg_d08f7a64-3811-4fb5-8993-194c0707e790">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i029f08fa15fd4befac391e8926338ac0_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC0xLTEtMS0zNzA2Mg_d4ad641e-7aae-4593-b1f7-f569b44cc414">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i0b51209f01d949d29b662db2c64c7f22_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC0zLTEtMS0zNzA2Mg_74d7c1df-2be3-43f7-9c9a-ffb12b4a84be">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i75437e864838472e87ecd3c91bc6d984_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC01LTEtMS0zNzA2Mg_07243a83-a2aa-4c80-92ee-00d751e5175a">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i727bda5c34a14d11b2577e2b1119b092_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC03LTEtMS0zNzA2Mg_a4c972cd-e120-4587-9e2d-3af0c6855160">942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total employee stock-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS0xLTEtMS0zNzA2Mg_11774427-dd3e-4312-9557-08d865b23893">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS0zLTEtMS0zNzA2Mg_b57ba982-8bac-42c1-8acc-768cf4a5716c">914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS01LTEtMS0zNzA2Mg_fbd8a47e-ebf9-4efb-8edc-f43a09f5aaf0">3,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usd" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS03LTEtMS0zNzA2Mg_f094c82f-69a3-4b1b-9123-fd87d64b45d5">2,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjMyOQ_9a73a34a-b96b-41eb-b3a4-ae8499cce087">12.0</ix:nonFraction>&#160;million of unrecognized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4Mg_a90ce44e-c7e0-4b6b-8053-b4c97c630a75">2.6</ix:nonNumeric> years.</span></div></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_70"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="sera:WarrantsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RleHRyZWdpb246YWIzNThmZTg4MWY1NDllNWI3ZGFhYjc5ZTY3OWE1ZWZfMzQ1_af7b1dd1-e3ea-4e42-a9b6-9b0af89f2671" continuedAt="ifeb29adde8d347c3a9435c45a478118b" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="ifeb29adde8d347c3a9435c45a478118b" continuedAt="i528fa231dec744dc82f1819191f71cf0"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants to purchase Class A common stock</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RleHRyZWdpb246YWIzNThmZTg4MWY1NDllNWI3ZGFhYjc5ZTY3OWE1ZWZfMzQ2_50768c19-8be3-44f4-84d7-c8f0d8af057d" continuedAt="if8f940ce04034b999018c2e0f97c6675" escape="true">The Company&#8217;s common stock warrants outstanding were as follows:</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="if8f940ce04034b999018c2e0f97c6675"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:31.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.832%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of Warrants Outstanding as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="iee09ca5ea08d408baf262d9aee778543_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMi0wLTEtMS0zNzA2Mg_203b0939-c5af-409e-88f3-5bbd2bb8b033">5.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iee09ca5ea08d408baf262d9aee778543_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMi0yLTEtMS0zNzA2Mg_094f4ec9-97b1-4064-86c4-6e6112e322ad">3,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ida49535190ff4a67a90335be92a43202_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMi00LTEtMS0zNzA2Mg_35ea0c3a-ae2d-44a2-96d4-d9941a39d4d5">15,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="iec090a0935104562aa028436a6704741_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMy0wLTEtMS0zNzA2Mg_42b2293d-0e07-4fce-917f-c593c8b2f1a5">9.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="iec090a0935104562aa028436a6704741_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMy0yLTEtMS0zNzA2Mg_a92f75a1-6871-4916-86f8-fb6c41843628">1,032,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ib365f1c968bf458f93bb750efed2e461_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMy00LTEtMS0zNzA2Mg_65e0537c-74e9-47ba-9c12-c61c47456038">1,032,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i04ebe87305d04e299c0f999d0935e08a_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNC0wLTEtMS0zNzA2Mg_b538305d-23f5-49d8-8702-40219b86eed6">10.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i04ebe87305d04e299c0f999d0935e08a_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNC0yLTEtMS0zNzA2Mg_b453c2d3-4650-4113-9589-c8327200a4c3">1,009,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i67ed818fbfe34672a57403d2698eb3a4_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNC00LTEtMS0zNzA2Mg_a3635cbc-d95f-46a4-9b0c-443b333ff798">1,009,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic24f885b56b948b4b07a19510189e079_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNS0wLTEtMS0zNzA2Mg_023f25a3-7d15-4396-ad52-cac49095d9a1">12.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ic24f885b56b948b4b07a19510189e079_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNS0yLTEtMS0zNzA2Mg_e4b7c343-061e-4a09-a266-bdb37ffc9ff4">8,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="id1f25f3dbc48464aacede203398c9efb_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNS00LTEtMS0zNzA2Mg_60b9f59f-cd9b-4f9f-b41a-b5154ac35654">8,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0530edb52e204249ab51018f35efa2ff_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNi0wLTEtMS0zNzA2Mg_ada10b57-0f6f-4591-ac8a-2d97230127a5">20.77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i0530edb52e204249ab51018f35efa2ff_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNi0yLTEtMS0zNzA2Mg_11063818-5ab0-4bfd-8884-d3b974749e90">722,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i84190d49c208410092379bb47e971ccc_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNi00LTEtMS0zNzA2Mg_e58d5592-b2e1-40a1-a2bf-86a3291b0f6b">722,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNy0yLTEtMS0zNzA2Mg_63c7e4c4-d747-4649-a719-83721e4add28">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNy00LTEtMS0zNzA2Mg_2a87f42e-791c-4638-827d-e623908bbc22">2,788,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i528fa231dec744dc82f1819191f71cf0">During the nine months ended September 30, 2022, <ix:nonFraction unitRef="shares" contextRef="ic6bde4ed70d0494f837109a7f9176ae6_D20220101-20220930" decimals="INF" name="sera:ClassOfWarrantOrRightExpired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RleHRyZWdpb246YWIzNThmZTg4MWY1NDllNWI3ZGFhYjc5ZTY3OWE1ZWZfNTQ5NzU1ODE0NDMy_49f1b307-7edb-4e8e-a0d9-e7f3868c22db">12,506</ix:nonFraction> common stock warrants expired unexercised.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">17</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_73"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1Mg_1b43d263-bd6b-43e8-b0b4-cdb084216899" continuedAt="ief17e6c982f94198bf275fb2dbdbac8f" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="ief17e6c982f94198bf275fb2dbdbac8f" continuedAt="ic4f12179de1742898b4cdb38f7f52f55"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#8217;s leases, the Company&#8217;s incremental borrowing rate or the Company&#8217;s intent to exercise or not exercise options available in lease contracts. </span></div><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1Mw_6f7f1b44-c48f-42ca-a5d4-85466670ea65" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of September&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.324%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease-Related Assets and Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Statement Line Items</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_0049bb1e-6361-4f5b-bc41-972d98f2f6a3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_7e1627ae-b748-46d6-9015-15e5ad4fd6be">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi00LTEtMS0zNzA2Mg_73076723-1718-4bdc-8291-1ddbfe64c751">116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_5469c87e-2e2e-466c-9319-75c619518553"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_a4928ad8-769b-47ab-8011-2c8705edcb02">Property and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy00LTEtMS0zNzA2Mg_cd460f54-02d4-4a12-a1da-8bca3887e90e">1,401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:RightOfUseAssetTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNC00LTEtMS0zNzA2Mg_af1a1f9a-2a0f-40d4-a2dc-e58ef935f837">1,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_67f2aafd-7934-4f80-a929-ab372ba3fe4d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_b288df54-e98f-412a-96c5-369a8ce12b19">Accrued and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy00LTEtMS0zNzA2Mg_3f74fbd0-b91c-4873-91ec-25bf027a92fc">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfOC00LTEtMS0zNzA2Mg_9c1b71f5-1381-491b-ba8c-3798de2f0fd7">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfOS00LTEtMS0zNzA2Mg_87e445c8-7ce9-437f-be39-53af07c80e67">735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilitiesTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMTAtNC0xLTEtMzcwNjI_cf0890bb-61fb-4b37-a998-4b0ec6c02563">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1NA_c206719b-9164-4d23-8777-d64d3b54e8c1" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.687%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.901%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNC0yLTEtMS0zNzA2Mg_0597bdf7-405f-439d-8568-a32a28555251">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNC00LTEtMS0zNzA2Mg_18d71eb0-35f5-421f-977a-04d855585332">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNS0yLTEtMS0zNzA2Mg_df3aae68-15c4-4153-9508-f9fb2b854369">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNS00LTEtMS0zNzA2Mg_295c17ed-5fba-443f-ada3-2f75da1ac513">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNi0yLTEtMS0zNzA2Mg_614e5ca7-80e5-4fdd-8109-069d1b525ca9">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNi00LTEtMS0zNzA2Mg_c83f479c-1428-468c-9018-d4d90ad9659a">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNy0yLTEtMS0zNzA2Mg_349a6613-01d1-4432-9805-2d67fadb5533">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNy00LTEtMS0zNzA2Mg_2c28e2e8-ffe5-4a90-9d71-d30488c88655">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTEtMi0xLTEtMzcwNjI_d4b80f03-a0e7-4bca-942d-96d7a68d16b7">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTEtNC0xLTEtMzcwNjI_c2e22063-fb0f-4dbf-86bf-95953f83a2b5">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTItMi0xLTEtMzcwNjI_53c44f1f-ceb8-444a-870c-720980344126">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTItNC0xLTEtMzcwNjI_5c61261c-1cb0-4913-84e9-65f6ed634e11">186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTMtMi0xLTEtMzcwNjI_368e92f8-4dea-49dd-af32-99c310a92260">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTMtNC0xLTEtMzcwNjI_dfc6c902-02b9-4c05-b541-64ab2f8297d0">1,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTQtMi0xLTEtMzcwNjI_179d41db-213b-4ece-a7ea-cd33006f8182">2.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTQtNC0xLTEtMzcwNjI_46119b14-bd28-416a-8451-8313aea0e98c">2.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTUtMi0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo0YjJkOTExMTAyNmE0NjViYWIxZGRlZTk4ZGNhYWUwZV80_9a01b0f3-46a0-4301-a735-36e26388b730">6.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTUtNC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo2MmY3YTlhMDU2NGY0ZDZiOWNmZTE4NDZiNDUzYjI0MF80_f9571f51-de90-47fc-8be1-73ecdfe4593e">6.4</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTctMi0xLTEtMzcwNjI_1e91f11a-788b-4dc9-b97f-b42c798f42ad">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTctNC0xLTEtMzcwNjI_b8a4f123-9dac-461b-a922-1cdb041b007e">453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTgtMi0xLTEtMzcwNjI_cb47499e-95e7-4851-9cbc-4b629310ee86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTgtNC0xLTEtMzcwNjI_78be28fa-f379-4fc7-b82b-e2b73c2b49ef">453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTktMi0xLTEtMzcwNjI_ab0ab5d2-8f6e-4dca-b75f-4271b70aaee7">0.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTktNC0xLTEtMzcwNjI_4aa43446-d84e-41aa-b292-b5d75e0e0b4d">0.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMjAtMi0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1MDM5NDBjYjU1NGM0YzI2OTZlZTY5MjVlNjBlNmUwNV80_2565caaf-64ce-4bdb-8fb3-f067659d2b21">4.5</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMjAtNC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjpjMGY2MzgxMDk3ZjQ0MjYzYjEyMmI4YWIxMGY2NTBjZV80_8e6e81df-1b76-45f4-b58d-d1663664ff4c">4.5</ix:nonFraction>%</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><ix:continuation id="ic4f12179de1742898b4cdb38f7f52f55" continuedAt="if46f7421403f4b28bd477cc4545a03e7"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1NQ_17662460-228b-4921-808e-ec39d9c8464e" escape="true"><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1NQ_d5077bd0-4c2b-43da-8ea9-bbe483bf973b" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of September&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.860%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.902%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMS0yLTEtMS0zNzA2Mg_175eab11-2ee0-4008-bcb8-fcb373d4e31d">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMS00LTEtMS0zNzA2Mg_22d3f8ec-1716-4a09-b662-77b74facfabb">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityToBePaidRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMS02LTEtMS0zNzA2Mg_7eb7a424-39ea-4452-a9c7-ed4846d1b4fc">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMi0yLTEtMS0zNzA2Mg_cabf5bbb-7d41-49b9-9e3d-0a7f537cf1ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMi00LTEtMS0zNzA2Mg_d842a815-f33f-4e04-8f8d-00f7654adcd2">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityToBePaidYearOne" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMi02LTEtMS0zNzA2Mg_be7641ba-84ae-443b-9ce6-26e82597d1fd">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMy0yLTEtMS0zNzA2Mg_a978e131-2cb1-441b-9607-3cddaae9c53f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMy00LTEtMS0zNzA2Mg_4461aa3c-1864-460b-8446-935c7f18524d">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityToBePaidYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMy02LTEtMS0zNzA2Mg_9a55d4f6-d7d5-415f-97db-6315f80bc164">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNC0yLTEtMS0zNzA2Mg_135660bb-dbfd-4c1c-af10-c4b51fc368c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNC00LTEtMS0zNzA2Mg_f6e4a861-251f-48fc-9241-ae02dc438506">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityToBePaidYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNC02LTEtMS0zNzA2Mg_f7ed6f52-e05b-4fc9-ae17-93536c7836ba">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNS0yLTEtMS0zNzA2Mg_30e72e91-51f6-4942-b855-32451aec75a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:FinanceLeaseLiabilityToBePaidYearFourAndThereafter" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNS00LTEtMS0zNzA2Mg_50694b33-bb9f-4f65-82c1-4e3862c060b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityToBePaidYearFourAndThereafter" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNS02LTEtMS0zNzA2Mg_c1155acd-e6c7-4a87-96fc-f75ee0d6c5e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNi0yLTEtMS0zNzA2Mg_57b60266-5891-4864-aea1-7fadd15f13a1">151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNi00LTEtMS0zNzA2Mg_6ddf6c31-b095-46a0-922e-24cfd2a75d06">1,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityPaymentDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNi02LTEtMS0zNzA2Mg_76e22ef1-ae70-4cf4-8395-ba2d83771bea">1,457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNy0yLTEtMS0zNzA2Mg_3367765f-b3ec-481c-95f2-7b4da3a971d7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNy00LTEtMS0zNzA2Mg_268e5f2b-37df-4a1c-9bdb-10030cbe488a">99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNy02LTEtMS0zNzA2Mg_6df8af43-abd1-4ff5-a972-2afe26f52a11">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOC0yLTEtMS0zNzA2Mg_98cef492-6312-43c6-9067-33cb087e0f85">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOC00LTEtMS0zNzA2Mg_df26efec-26ff-46aa-b2e3-875d267c3c12">1,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilitiesTotal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOC02LTEtMS0zNzA2Mg_bd12aca4-d984-49d0-a22c-049c1ce5ae2a">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOS0yLTEtMS0zNzA2Mg_6f7fdcf9-da78-4fcb-976c-d5c5ade0d7e6">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOS00LTEtMS0zNzA2Mg_7a3ea570-b2e1-422a-847e-c40c638a8374">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOS02LTEtMS0zNzA2Mg_5e0cef03-f4e7-4211-aa08-220ccc412ca8">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMTAtMi0xLTEtMzcwNjI_59dec747-482b-4c59-84e9-dc5149c06caa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMTAtNC0xLTEtMzcwNjI_9c496c14-e6bc-4bf7-b71b-c011e185d937">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="-3" name="sera:LeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMTAtNi0xLTEtMzcwNjI_88db63d6-d555-4d68-8f61-cab7a59de4f1">735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a total of approximately <ix:nonFraction unitRef="sqft" contextRef="if3480fe1ee8e4d4a882ed4f4391d52f4_I20220930" decimals="0" name="sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfMTA2Mw_378b7366-2760-4b88-8f68-eb1be9bcf8ee">24,100</ix:nonFraction> square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2022. The terms of the lease agreement included an option to renew the lease for one additional <ix:nonNumeric contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1Ng_b769d3ef-6c8d-4194-9bc3-ebe4dcdb6277">five-year</ix:nonNumeric> rental period, which the Company did not exercise. Instead, in October 2022, the Company entered into an amendment for its operating lease. See Note 15&#8212;Subsequent Events</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company includes lease extension options in the right-of-use asset and lease liability when the Company is reasonably certain it will exercise the options. The rate implicit in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#8217;s current finance leases include bargain purchase options that the Company is reasonably certain to exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#8217;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#8217;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has <ix:nonFraction unitRef="usd" contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930" decimals="INF" name="sera:IndemnificationLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfMzA0NA_247c02eb-ebc2-47ff-ae0a-417453750451"><ix:nonFraction unitRef="usd" contextRef="i70d0004071444462988600b21699ae89_I20211231" decimals="INF" name="sera:IndemnificationLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfMzA0NA_d0346fc7-1dd4-4fae-991f-c3ca2cb9cc8b">no</ix:nonFraction></ix:nonFraction> liabilities recorded for these agreements as of September&#160;30, 2022 and December&#160;31, 2021. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><ix:continuation id="if46f7421403f4b28bd477cc4545a03e7"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#8217;s future results of operations, cash flows, or financial position.</span></div></ix:continuation><div id="i2084c35b29674161bec45c107b9a92a6_76"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RleHRyZWdpb246ZGQ4OWM3NmU5M2QzNDA5Y2FiZWQ4NTlhYWQyNDc4ZmVfMjQ2NQ_9ee8e214-f2a8-4e9d-92e9-ea23c9e69d93" continuedAt="i9419c58b8a6140689136d92a4d969eaf" escape="true">Net loss per share</ix:nonNumeric></span></div><ix:continuation id="i9419c58b8a6140689136d92a4d969eaf"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the three and nine months ended September&#160;30, 2022 and 2021, the Company reported net losses and as such, basic and diluted net loss per share are the same. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the three and nine months ended September&#160;30, 2022 and 2021. </span></div><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RleHRyZWdpb246ZGQ4OWM3NmU5M2QzNDA5Y2FiZWQ4NTlhYWQyNDc4ZmVfMjQ2Ng_41e62e2f-20a8-4630-beec-f6cca9d78010" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A and Class B common stock during the three and nine months ended September&#160;30, 2022 and 2021 (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi0xLTEtMS0zNzA2Mg_ebf88fcb-cd16-4cd4-8fb9-1df7b168314d">10,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi0zLTEtMS0zNzA2Mg_481c4702-a174-4dfa-9664-83731b120454">485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi01LTEtMS0zNzA2Mg_29f3509b-d9e9-4482-9026-64d505b8f418">32,875</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi03LTEtMS0zNzA2Mg_1b3832ff-78da-4f48-8f06-ac32a82f72e9">1,565</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common stock outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0xLTEtMS0zNzA2Mg_04881b4e-0ac9-437f-ad7d-c11f9890afab"><ix:nonFraction unitRef="shares" contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0xLTEtMS0zNzA2Mg_baa21ec3-9053-490d-9e3e-ee7c66607e6f">29,600,719</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0zLTEtMS0zNzA2Mg_0328ab52-6b6b-4607-a0a3-41195fac3947"><ix:nonFraction unitRef="shares" contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0zLTEtMS0zNzA2Mg_6b39ce45-1af5-4f73-b99e-b41a5cc2ac76">1,405,259</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy01LTEtMS0zNzA2Mg_045022b6-c42e-4128-92a2-5f855d986534"><ix:nonFraction unitRef="shares" contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy01LTEtMS0zNzA2Mg_469ea544-f669-4bd0-b835-f2eeb0c3f271">29,513,214</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy03LTEtMS0zNzA2Mg_5b6f3b3c-6476-4b53-9997-cb4364756f28"><ix:nonFraction unitRef="shares" contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy03LTEtMS0zNzA2Mg_9e5806be-5647-4871-bff1-a9c720888565">1,405,259</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0xLTEtMS0zNzA2Mg_870de139-03e3-4a38-aec3-7478d3516978"><ix:nonFraction unitRef="usdPerShare" contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0xLTEtMS0zNzA2Mg_f84e4e98-de02-4ebd-b758-c9085d0f2d95">0.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0zLTEtMS0zNzA2Mg_0034aab7-5a41-48db-8cd8-a222616db4ba"><ix:nonFraction unitRef="usdPerShare" contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0zLTEtMS0zNzA2Mg_2be3a57e-503b-47cc-985c-7c8c7ab72acc">0.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC01LTEtMS0zNzA2Mg_1758bcf3-0b58-48a2-bf56-a651f245f621"><ix:nonFraction unitRef="usdPerShare" contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC01LTEtMS0zNzA2Mg_d3914c5d-e9b4-432c-807b-10980fb202e6">1.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC03LTEtMS0zNzA2Mg_c1350b8f-e26c-45e0-aa0a-6009c2514699"><ix:nonFraction unitRef="usdPerShare" contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC03LTEtMS0zNzA2Mg_ec77644e-3028-4e80-8347-ad57fcb37642">1.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.354%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS0xLTEtMS0zNzA2Mg_0082877c-5ded-4d1b-a2e3-02a62929163f">9,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS0zLTEtMS0zNzg4Ng_9b5d1e61-6f76-47e1-8428-7fd5bd441069">444</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS0zLTEtMS0zNzA2Mg_b2fbf59b-381a-4bd5-8bb1-59262e9de49d">21,641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usd" contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS03LTEtMS0zNzg5NA_e0cf8310-a4b9-48b1-9b23-c768218b6c40">884</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common stock outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0xLTEtMS0zNzA2Mg_8e3d8a03-cefb-42c3-b534-40fe6ceb3dea"><ix:nonFraction unitRef="shares" contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0xLTEtMS0zNzA2Mg_b9973be3-acd3-4838-acdf-83a4d58a1ba7">23,954,696</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzg4Ng_88656ad5-1af2-4753-846f-00e53870b7b1"><ix:nonFraction unitRef="shares" contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzg4Ng_8ec02904-0fd6-46be-9acc-801614c9eb20">1,130,317</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzA2Mg_46545ea7-4b83-4967-8307-b035e3d63340"><ix:nonFraction unitRef="shares" contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzA2Mg_bfce9e66-dcdb-4396-be34-0ad23d5de184">9,326,341</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi03LTEtMS0zNzg5NA_259c45d1-ba9b-4a32-9820-0748d06f04e8"><ix:nonFraction unitRef="shares" contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi03LTEtMS0zNzg5NA_80b31ae4-1257-4986-988f-55e558b3a1dc">380,913</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0xLTEtMS0zNzA2Mg_7e3c1437-61e9-4175-8bd3-8e931e962a79"><ix:nonFraction unitRef="usdPerShare" contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0xLTEtMS0zNzA2Mg_db275870-efa5-4146-9273-cc59fe0ba6d5">0.39</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzg4Ng_53ea1705-018e-4a71-9180-025d9fb1698d"><ix:nonFraction unitRef="usdPerShare" contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzg4Ng_f1efdec1-d5e2-4a04-aa21-a6c75d41494f">0.39</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzA2Mg_3a48bb2d-9f0c-4690-8fba-ab2893d69efa"><ix:nonFraction unitRef="usdPerShare" contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzA2Mg_da5a52e3-794f-48ee-a458-40c0eb727530">2.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy03LTEtMS0zNzg5NA_a0877b53-6eb9-4d16-9847-47c0ead068e8"><ix:nonFraction unitRef="usdPerShare" contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy03LTEtMS0zNzg5NA_aa8f013a-af40-4e34-a2d9-13ce55754d7f">2.32</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RleHRyZWdpb246ZGQ4OWM3NmU5M2QzNDA5Y2FiZWQ4NTlhYWQyNDc4ZmVfMjQ2Nw_b9e5baa4-6963-426d-9d57-159c4f81ad5c" escape="true"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i3f3d450f7a124081a7088d0b95d3115c_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNS0xLTEtMS0zNzA2Mg_11094d6b-9791-4157-b1e8-bf843876a579">2,775,978</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i5fd78f55213f40769bb6407a882dcb00_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNS0zLTEtMS0zNzA2Mg_064b4e19-b9a3-48d6-8dc8-e66076681531">2,788,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i1fec57d1a2df4384aef09573ccdf6570_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNi0xLTEtMS0zNzA2Mg_af0b773a-2686-4889-88a6-1da2b242d1fb">8,532,949</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i78569680632f4aa9bc2c2383b785be95_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNi0zLTEtMS0zNzA2Mg_65eaf8ce-e4aa-4021-9234-30774f705d0d">6,018,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNy0xLTEtMS0zNzA2Mg_28c7c3aa-7410-489e-a1e8-628ec19870a4">11,308,927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonFraction unitRef="shares" contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNy0zLTEtMS0zNzA2Mg_f055f111-d7e1-4dfc-9bb0-10072bcb140d">8,806,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">20</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfMTM_4bdb29f4-fe6d-4016-9957-12b58dc462d8" continuedAt="i9322163db0b2487499b7f55c4de86c73" escape="true">Subsequent Events</ix:nonNumeric></span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i9322163db0b2487499b7f55c4de86c73" continuedAt="i2b582c0685cb4d40b5a239ba91002cb8">Lease Amendment</ix:continuation></span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2b582c0685cb4d40b5a239ba91002cb8">On October 10, 2022, the Company entered into the Second Amendment to the Lease (the &#8220;Second Amendment&#8221;) with Eastland Regency, L.C. for its headquarters located in Salt Lake City, Utah. The Second Amendment modified the lease agreements, dated August 1, 2017 and amended on June 7, 2021 (the &#8220;Lease&#8221;), to extend the term of the Lease an additional <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfMTA5OTUxMTYyODQyNA_df1e695d-5bfe-4eae-921e-ce6dee848024">three</span> years to expire on December 31, 2025 (the &#8220;Extended Term&#8221;), and provide the Company with an early termination right which termination would occur under certain circumstances as provided in the Second Amendment after July 1, 2024 if exercised. Subject to adjustment as set forth in the Second Amendment, the rent payable to Eastland Regency, L.C. during the Extended Term is an amount equal to approximately $<ix:nonFraction unitRef="usd" contextRef="i287e032d20624fe0a98f6658b3eb78b3_I20221010" decimals="-5" name="sera:AdditionalMinimumOperatingLeasePaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfNTQ5NzU1ODE0MzQz_76296578-3689-4328-a113-89f12d1094d9">1.9</ix:nonFraction> million.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">21</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis or set forth elsewhere in this Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the &#8220;Risk Factors&#8221; section of this Form 10-Q, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investors and others should note that we routinely use the Investors section of our website to announce material information to investors and the marketplace. While not all of the information that we post on the Investors section of our website is of a material nature, some information could be deemed to be material. Accordingly, we encourage investors, the media, and others interested in us to review the information that we share on the Investors section of our website, investors.seraprognostics.com.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_85"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a women&#8217;s health company utilizing our proprietary proteomics and bioinformatics platform to discover, develop, and commercialize clinically meaningful and economically impactful biomarker tests, with an initial focus on improving pregnancy outcomes. We believe that our method of combining the disciplines of proteomics and bioinformatics with rigorous clinical testing and economic analysis enables us to provide physicians and patients with actionable data and information designed to result in better maternal and neonatal health at lower cost. Our vision is to deliver pivotal and actionable information to pregnant women, their physicians, and health care payers to significantly improve maternal and neonatal health and to dramatically reduce health care costs. We have built an advanced, proprietary, and scalable proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are highly accurate predictors of dynamic changes that occur during pregnancy. By incorporating our proprietary technology platform into our rigorous data-driven development process, we have created a differentiated approach for effectively addressing major conditions of pregnancy. We envision that our comprehensive approach will enable us to fully characterize one of the most important periods in the lives of women and children, and will help to improve their well-being. Our goal is to develop and commercialize tests that inform important decisions during all pregnancies. We also believe that the work we perform in pregnancy can ultimately be leveraged more broadly to address other areas in medicine and health care.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our first commercial product, the PreTRM test, is the only broadly validated, commercially available blood-based biomarker test to accurately predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides an accurate prediction of the expectant mother&#8217;s risk of delivering spontaneously before 37 weeks&#8217; gestation. Our commercialization strategy includes conducting clinical trials to demonstrate the health and economic benefits of early and accurate detection of preterm birth risk coupled with well-recognized interventions in higher risk patients. Elevance Health, Inc. (formerly known as Anthem, Inc.), or Elevance Health, whose health plans cover more than 10% of U.S. pregnancies annually, agreed to make our PreTRM test available to eligible pregnant members as part of a multi-year contract. Elevance Health is one of the nation&#8217;s largest health insurers with greater than 47 million members nationwide. Through this collaboration, a significant number of physicians and patients in the U.S. gain access to early and accurate predictions of preterm birth to enable more informed decision-making during pregnancy. Sera believes that its commercial collaboration with Elevance Health further validates the clinical and economic value of its PreTRM test. We are actively discovering and developing several additional biomarker tests to predict other major conditions of pregnancy, such as preeclampsia, and gestational diabetes, among others, that have the potential to offer significant health benefits to women and their babies.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are approximately 140 million births globally each year. Of these, it is estimated that as many as 25% are affected by various complications, including: preterm birth, preeclampsia, fetal growth restriction, stillbirth, hypertension of pregnancy, gestational diabetes, and others. In the United States, there are approximately 3.6 million births annually, and over 10% of those pregnancies result in preterm births with profound short- and long-term health consequences to the mother and baby. These health consequences are estimated to lead to associated costs of approximately $25 billion annually in the United States. Traditional methods to detect prematurity risk in time for proactive management have been limited and fail to identify the vast majority of women who will deliver prematurely. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our blood-based biomarkers were demonstrated to be predictive of very early preterm birth of any cause, length of neonatal hospital stay, and neonatal morbidity and mortality in the Multicenter Assessment of a Spontaneous Preterm Birth Risk Predictor (TREETOP) study, a large prospective U.S. study. Additional new data published in May 2022 showed improved PreTRM Test predictive performance for women whose due dates are more reliably determined by ultrasound. We believe our actionable blood-based biomarker test for prematurity risk can enable patients, physicians, and payers to more proactively manage and mitigate the complications and associated costs of prematurity. Given that pregnancy is the launch point for the future health of babies and a key determinant in the future health of mothers and babies, we believe this area is ripe for innovation and better tools to improve patient outcomes.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations are located in Salt Lake City, Utah, including a CLIA-certified laboratory. Since our inception, we have devoted the majority of our efforts and resources to performing research and development, acquiring product rights, raising capital, establishing facilities, conducting clinical trials, and establishing commercial operations to market the PreTRM test. During this period, we have incurred annual net losses. We have largely funded our operations with proceeds from the sale and issuance of convertible preferred stock, debt financings, bank loans, and the sale and issuance of Class A common stock in our IPO, which was completed in July 2021. See Note 10&#8212;Capital Structure for additional details about the IPO. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses since inception. Our net losses were $10.7&#160;million and $9.9&#160;million for the three months ended September&#160;30, 2022 and 2021, respectively, and $34.4 million and $22.5 million for the nine months ended September 30, 2022 and 2021, respectively. We expect to incur significant additional operating losses and negative cash flows from operations for the foreseeable future, principally as a result of our commercialization activities for the PreTRM test, and to support additional clinical studies, publications, and anticipated research and development activities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have signed an agreement with Elevance Health, pursuant to which Elevance Health agreed to purchase our PreTRM test, and we continue to negotiate contracts with private and governmental payers, health systems, and self-insured employers that could eventually result in revenues. If we are unable to secure payer contracts that result in significant revenues or access additional funds, we may be required to delay, scale back or abandon some, or all, of our development programs and other operations. Until such time as we can generate significant revenue from the sales of our products, if ever, we may need to continue to finance our cash needs through equity offerings, debt financings or other capital sources, potentially including collaborations or other similar arrangements. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making acquisitions or capital expenditures or declaring dividends and may require the issuance of warrants. If we raise additional funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, or product candidates or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may have to significantly delay, reduce, or eliminate some or all of our product development or future commercialization efforts, or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to access capital when needed is not assured and, if not achieved on a timely basis, will materially harm our business, financial condition, and results of operations.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_88"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. While it appears its most severe effects have subsided, COVID-19 could re-emerge or new public health threats could appear. The future impact of the COVID-19 pandemic or a similar health disruption is highly uncertain and subject to change. We cannot predict the full extent of potential delays or impacts on our business, our clinical trials, health care systems or the global economy as a whole. To date, the primary impacts to our business have been the early cessation of enrollment in our Serum Assessment of Preterm Birth Outcomes Compared to Historical Controls study, or the AVERT PRETERM TRIAL study, in March 2020, the delayed commencement of enrollment in our PRIME study until November 2020 and slower than expected enrollment thereafter, and limited access to ordering clinicians as we have initiated the commercialization of our PreTRM test. We expect to enroll sufficient numbers of PRIME study patients to enable the interim analysis to occur in 2023, depending on several factors that include potential further disruption due to COVID-19 conditions. If COVID-19 re-emerges as a serious public health threat, or if another serious pathogen appears, then we may experience additional disruptions that could severely impact our business, preclinical studies, and clinical trials, including potential delays. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">23</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Components of Our Results of Operations</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to derive substantially all of our revenue in the near term from sales of the PreTRM test. We generally expect revenue to increase as sales volume continues to increase and as we continue to engage with payers, employers, and health systems to close payment contracts. These additional contracts may enable an upfront negotiated payment rate which could eventually result in additional revenues when health care providers order the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue reflects the aggregate costs incurred in delivering the proteomic testing results to clinicians and includes expenses for third-party specimen collection and shipping costs, as well as our lab personnel, materials and supplies, equipment, and infrastructure expenses associated with clinical testing, and allocated overhead including rent and equipment depreciation. We expect costs of revenue will generally move in line with the sales of the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consist of costs incurred for our research activities and development of our product candidates. These expenses include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical studies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory processes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research and bioinformatic activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">biobanking and publication efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personnel-related expenses, including salaries, payroll taxes, employee benefits, and stock-based compensation charges for employees engaged in these research and development activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">direct clinical study expenses incurred under agreements with clinical study sites or contract research organizations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">consultants engaged in our research and development efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laboratory materials and supplies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">facilities costs; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">depreciation, amortization, and other direct and allocated expenses, including rent, insurance, and other operating costs, incurred as a result of our research and development activities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense all research and development costs, both internal and external, in the period in which they are incurred. We expect that our research and development expenses will increase slightly for the remainder of 2022 as we continue enrollment in the PRIME study. Research and development costs may increase in the medium to long-term as we support current and additional clinical studies, publications, and other product development activities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and Marketing Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling and marketing expenses consist primarily of salaries, payroll taxes, employee benefits, and stock-based compensation charges for sales, marketing, and payer access personnel. Other significant costs include travel, consulting, public relations, and legal costs related to commercial efforts. Selling and marketing expenses decreased in the third quarter of 2022 compared to the second quarter of 2022 as we took steps to streamline our sales force and focus our commercial strategy in response to market dynamics. We expect selling and marketing expenses to remain relatively consistent for the remainder of 2022. We expect selling and marketing expenses to increase in the medium-term as we hire personnel to implement our refocused sales strategy, and then in the long-term as we expand our dedicated sales force to more completely cover U.S. sales channels over time as we enter into contracts with payers, health systems, and employers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries, payroll taxes, employee benefits, and stock-based compensation charges for personnel in executive, finance, information technology, human resources, and other administrative functions. Other significant costs include facilities, corporate and intellectual property legal fees, accounting, insurance, consulting, and other professional fees.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses decreased slightly in the third quarter of 2022 compared to the second quarter of 2022 as we realized operational efficiencies that maintain the appropriate level of support for our current level of operations. We expect general and administrative expenses will remain relatively consistent for the remainder of 2022. We expect general and administrative expenses to increase in the medium to long-term as needed to support future operations and anticipated revenue growth. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense in 2022 represents interest incurred on our finance leases. Interest expense in 2021 represents interest incurred on our finance leases, loans payable and convertible promissory note, amortization of a discount feature on a convertible promissory note, and periodic fair value adjustments on certain liabilities. As of September&#160;30, 2022, we had no outstanding debt. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists of interest earned on our cash, cash equivalents, and marketable securities, and other gains and losses. In 2021, other income, net also included periodic fair value adjustments on certain liabilities.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_97"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations presented below should be reviewed in conjunction with the condensed financial statements and related notes included elsewhere in this report.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended September 30, 2022 and 2021</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the three months ended September 30, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$ Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,176&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,724&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,452&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,967&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,690&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,074&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,275&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,465&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,810&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,188)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9,442)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,746)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(439)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">418&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">497&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,712)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9,859)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(853)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our research and development expenses for the three months ended September 30, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$ Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Clinical studies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,073&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">769&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,304&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and bioinformatics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,084&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,019&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,172&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total research and development expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,176&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,724&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.5&#160;million increase was due to a $1.3&#160;million increase in clinical study costs, and a $0.3&#160;million increase in research and bioinformatics expenses, partially offset by a $0.2&#160;million decrease in laboratory operations costs. The $1.3&#160;million increase in clinical study costs is primarily due to a $1.0&#160;million increase resulting from the increased enrollment and site setup activity in the PRIME study and a $0.2&#160;million increase in personnel costs driven by increased average headcount, and a $0.1 million increase in stock-based compensation expense. The $0.3&#160;million increase in research and bioinformatics costs is primarily due to a $0.2 million increase in personnel costs driven by increased average headcount, and a $0.1 million increase in stock-based compensation expense. The $0.2&#160;million decrease in laboratory operations costs is primarily due to a $0.3&#160;million decrease in costs related to lab supplies, partially offset by a $0.1 million increase in personnel costs driven by increased average headcount. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and Marketing Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.3&#160;million increase was due primarily to increases of $0.2 million of severance costs related to efforts to streamline our sales force in the current period, $0.2&#160;million of marketing programs and materials development, $0.2&#160;million of IT systems to support sales efforts, $0.1&#160;million of travel expenses, and $0.1&#160;million in personnel-related costs driven by increased average headcount in certain departments compared to the corresponding period in the prior year. These increases were partially offset by decreases of $0.3 million in consulting and other professional service fees, and $0.1 million in stock-based compensation expense. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the three months ended September 30, 2021 included $0.4 million related to fair value adjustments on certain liabilities which were extinguished in that period. Interest expense for the three months ended September 30, 2022 is related to our finance leases. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.5&#160;million increase in other income, net was due to a $0.4 million increase related primarily to investment income on our marketable securities and a $0.1 million increase in interest income related primarily to our marketable securities. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Nine Months Ended September 30, 2022 and 2021</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the nine months ended September 30, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$ Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating expenses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,864&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,900&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,743&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">35,437&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22,904&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,533&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Loss from operations</span></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(35,234)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,848)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(12,386)</span></td><td style="border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(744)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">837&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,067&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(230)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(34,440)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,525)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(11,915)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our research and development expenses for the nine months ended September 30, 2022 and 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$ Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Clinical studies</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,347&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,068&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and bioinformatics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory operations</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,070&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,299&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total research and development expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10,759&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,944&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,815&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $2.8&#160;million increase was due to a $2.1&#160;million increase in clinical study costs, and a $1.0&#160;million increase in research and bioinformatics expenses, partially offset by a $0.2&#160;million decrease in laboratory operations costs. The $2.1&#160;million increase in clinical study costs is primarily due to a $1.1&#160;million increase resulting from the increased enrollment and site setup activity in the PRIME study, a $0.6&#160;million increase in personnel costs driven by increased average headcount, and a $0.3&#160;million increase in stock-based compensation expense. The $1.0&#160;million increase in research and bioinformatics expenses was primarily due to an increase of $0.6&#160;million in personnel costs driven by increased average headcount, a $0.2&#160;million increase in stock-based compensation expense, and a $0.1 million increase in lab supplies related to ongoing product enhancement efforts. The $0.2&#160;million decrease in laboratory operations costs is primarily due to a $0.5&#160;million decrease in costs related to lab supplies, partially offset by a $0.3 million increase in personnel costs driven by increased average headcount.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling and Marketing Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $5.9&#160;million increase was due primarily to increases of $3.5&#160;million in personnel-related costs driven by increased average headcount compared to the corresponding period in the prior year, $0.9&#160;million of travel expenses, $0.5 million of severance costs related to efforts to streamline our sales force in the current period, $0.5 million of IT systems to support sales efforts, $0.5&#160;million of marketing programs and materials development, and $0.1 million in stock-based compensation expense. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $3.7&#160;million increase was due primarily to increases of $1.5&#160;million of personnel expenses driven by increased average headcount, $1.1&#160;million of stock-based compensation expense, $1.0&#160;million of director and officer insurance costs which increased as a result of our becoming a public company, $0.3 million of consulting fees, and $0.2&#160;million of professional services and fees related to public company compliance, partially offset by a $0.4 million decrease in recruiting fees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the nine months ended September 30, 2021 included $0.4 million related to fair value adjustments on certain liabilities which were extinguished in that period and $0.3 million related to debt that was fully repaid during that period. Interest expense for the three months ended September 30, 2022 is related to our finance leases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $0.2&#160;million decrease in other income, net for the nine months ended September 30, 2022 compared to the corresponding period in 2021 was primarily due to a one-time $1.1 million gain on extinguishment of the PPP loan in the period in the prior year, partially offset by a $0.6 million increase related primarily to investment income on our marketable securities and a $0.2 million increase in interest income related primarily to our marketable securities.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have not generated a significant amount of commercial revenue from product sales or any other sources and have incurred significant operating losses and negative cash flows from operations. We anticipate that we will continue to incur net losses for the foreseeable future. We have financed our operations primarily through proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in our IPO, which was completed in July 2021. As of September&#160;30, 2022, we had aggregate cash, cash equivalents, and available-for-sale securities of $111.2 million, and an accumulated deficit of $200.9 million.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the periods indicated:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:63.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(in thousands)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(27,372)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(22,484)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(68,127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">159,557&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net (decrease) increase in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(20,122)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">68,946&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The net cash used in operating activities during the nine months ended September 30, 2022 was primarily due to a net loss of $34.4&#160;million partially offset by non-cash charges of $4.6 million and an increase in operating assets and liabilities of $2.5&#160;million. The net cash used in operating activities during the nine months ended September 30, 2021 was primarily due to a net loss of $22.5&#160;million and a decrease in operating assets and liabilities of $2.1&#160;million, partially offset by non-cash charges of $2.1&#160;million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities for the nine months ended September 30, 2022 was primarily due to $49.3&#160;million in proceeds from maturities and sales of marketable securities, partially offset by $41.6&#160;million in purchases of marketable securities and $0.6 million in purchases of property and equipment. Net cash used in investing activities for the nine months ended September 30, 2021 was primarily due to $67.6 million in purchases of marketable securities and $0.6 million in purchases of property and equipment.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the nine months ended September 30, 2022 was due to $0.3 million in proceeds from options exercised, partially offset by $0.2 million of finance lease principal payments. Net cash provided by financing activities for the nine months ended September 30, 2021 was primarily due to net proceeds of $100.1&#160;million from the sale of Series E convertible preferred stock, including $1.1 million allocated to common stock warrants issued in connection with the sale of Series E convertible preferred stock, net proceeds of $66.6 million from our IPO, and $0.5&#160;million in proceeds from options exercised, partially offset by $3.1 million and $4.5 million of loan and note repayments, respectively. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future Funding Requirements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to incur significant additional operating losses and negative cash flows for the foreseeable future. We expect our losses in the future to be principally as a result of our commercialization activities for the PreTRM test, and to support additional clinical studies and anticipated research and development activities. There can be no assurance that we will eventually achieve significant revenues or profitability, or if achieved, can sustain either on a continuing basis. If we are unable to achieve significant revenues or raise additional funding, when needed, we may not be able to continue the development or commercialization of our diagnostic products and could be required to delay, scale back, or abandon some or all of our development programs and other operations. No assurance can be given that we will be successful in raising the required capital at reasonable cost and at the required times, or at all. Any additional equity financing may not be available on favorable terms, most likely will be dilutive to our current stockholders, and debt financing, if available, may involve restrictive covenants and dilutive financing instruments. Further, our operating plan may change, and we may need additional funds to meet operational needs and capital requirements for product development and commercialization sooner than planned. We currently have no credit facility or committed sources of capital. Our future funding requirements will depend on many factors, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, receipt, and amount of sales from the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing sales, marketing, and other commercialization capabilities in the United States and abroad;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and commercialize other products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the terms and timing of any collaborative, licensing, and other arrangements that we may establish;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost, timing, and outcomes of regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope, rate of progress, results, and cost of our clinical studies, and other related activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of preparing, filing, prosecuting, defending, and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in businesses, products or technologies, although we currently have no commitments or agreements relating to any of these types of transactions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">partnerships and other strategic options for our product and other product candidates; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors described in the &#8220;Risk Factors&#8221; section and elsewhere in this report.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents will enable us to fund our operating expenses and capital expenditure requirements for at least the next 12 months.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">29</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contractual obligations and commitments for the year ended December&#160;31, 2021 are set forth in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 filed with the SEC on March 29, 2022. Material changes that have occurred during the nine months ended September 30, 2022 include the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future minimum lease payments increased as a result of entering new finance leases during the nine months ended September 30, 2022. Future minimum lease payments are detailed in Note 13&#8212;Commitments and Contingencies.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_109"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies, Significant Judgments and Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our critical accounting policies, significant judgments, and use of estimates is included in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 filed with the SEC on March 29, 2022. There have been no significant changes in the application of our critical accounting policies, significant judgments and use of estimates during the nine months ended September 30, 2022.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_112"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company, or EGC, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. We elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that we (1) are no longer an EGC or (2) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies, reduce disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and are exempt from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. As an EGC, we are also not required to have our internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section 404 of the Sarbanes-Oxley Act. As a result, our financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates and we are not required to provide auditor attestation regarding requirements of Section 404(b) of Sarbanes-Oxley.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will remain an EGC until the earliest to occur of: (1) the last day of the fiscal year in which we have at least $1.235&#160;billion in annual revenue; (2) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) December 31, 2026.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a &#8220;smaller reporting company&#8221; as defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies until the fiscal year following the determination that the market value of our voting and non-voting common stock held by non-affiliates is more than $250 million measured on the last business day of our second fiscal quarter, or our annual revenues are less than $100 million during the most recently completed fiscal year and the market value of our voting and non-voting common stock held by non-affiliates is more than $700 million measured on the last business day of our second fiscal quarter.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_115"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of recent accounting pronouncements that may potentially impact our financial position, results of operations or cash flows is disclosed in Note 2&#8212;Significant Accounting Policies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">30</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to changes in interest rates relates primarily to interest earned and market value on our cash and cash equivalents and marketable securities. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents and marketable securities consist of cash held in banks, money market funds, commercial paper, U.S. government securities, U.S. federal agency securities and investment grade corporate securities. Our investment policy and strategy are focused on preservation of capital and supporting our liquidity requirements. Changes in U.S. interest rates affect the interest earned on our cash and cash equivalents and marketable securities, and the market value of those securities. A hypothetical 100 basis point increase in interest rates would have resulted in a decrease of $0.6 million in the market value of our available-for-sale debt securities as of September&#160;30, 2022. Any realized gains or losses resulting from such interest rate changes would only occur if we sold the investments prior to maturity. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not regularly incur expenses with vendors outside the United States or that are denominated in currencies other than the U.S. dollar. We may incur such expenses in the future at which point exchange rate fluctuations might adversely affect our expenses, results of operations, financial position and cash flows. To date, exchange rate fluctuations have not had a material effect on our results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effects of Inflation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe inflation has had a material effect on our results of operations during the periods presented. However, the current inflationary environment could affect us by increasing our costs of labor, laboratory supplies, and clinical trials and could adversely affect our business, results of operations, financial position and cash flows. In addition, increased inflation has had, and may continue to have, an effect on interest rates and may adversely affect our borrowing rate and our ability to obtain any potential additional funding. </span></div><div id="i2084c35b29674161bec45c107b9a92a6_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer (our principal executive officer) and Chief Financial Officer (our principal financial officer and principal accounting officer), evaluated the effectiveness of our disclosure controls and procedures as of September&#160;30, 2022. Based on the evaluation of our disclosure controls and procedures as of September&#160;30, 2022, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8212; OTHER INFORMATION</span></div><div id="i2084c35b29674161bec45c107b9a92a6_127"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any material litigation or other material legal proceedings. We may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect our future results of operations, cash flows, or financial position.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_130"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our Class A common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, the section of this Quarterly Report Form 10-Q entitled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and related notes, before investing in our Class A common stock. The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, operating results and prospects could be materially harmed. In that event, the price of our Class A common stock could decline, and you could lose part or all of your investment. </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties, including those highlighted in this section below, that represent challenges that we face in connection with the successful implementation of our strategy. The occurrence of one or more of the events or circumstances described in more detail in the risk factors below, alone or in combination with other events or circumstances, may have an adverse effect on our business, cash flows, financial condition, and results of operations. Such risks include, but are not limited to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have incurred net losses since our inception and we anticipate that we will continue to incur losses for the foreseeable future, which could harm our future business prospects.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operating our business requires a significant amount of cash, and our ability to generate sufficient cash depends on many factors, some of which are beyond our control and if we cannot raise additional capital when needed, we may have to curtail or cease operations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our quarterly and annual results may fluctuate from period to period, which could adversely impact the value of our Class A common stock.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have derived substantially all of our revenues to date from the PreTRM test, and if our efforts to further increase the use and adoption of the PreTRM test or to develop new products and services in the future do not succeed, our business will be harmed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the near future, we expect to rely on sales to a limited number of direct customers for a significant portion of our revenue from the sale of the PreTRM test, making us subject to customer concentration risk.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to establish sales and marketing capabilities, we may not be successful in commercializing the PreTRM test.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competition in the life science industry, including companies engaged in molecular diagnostics and proteomics, is intense. If we are unable to compete successfully with respect to our current or future products or services, we may not be able to increase or sustain our revenues or achieve profitability.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our CLIA-certified laboratory facility becomes inoperable, we will be unable to perform our tests and our business will be harmed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interim, top-line and preliminary data from our clinical trials that we announce or publish from time to time may change as more patient data become available and are subject to confirmation, audit, and verification procedures that could result in material changes in the final data.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business would be materially harmed if our proprietary biobank were to become contaminated, lost or destroyed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on third parties for specimen collection, including phlebotomy services, and commercial courier delivery services, and if these services are disrupted, our business will be harmed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on a limited number of suppliers or, in some cases, single suppliers, for some of our laboratory instruments and materials and may not be able to find replacements or immediately transition to alternative suppliers on a cost-effective basis, or at all.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A re-emergence of COVID-19, or the emergence of a new pathogen, could materially affect our operations, as well as the business or operations of third parties with whom we conduct business. Our business could be adversely affected by the effects of other future public health threats in regions where we, or third parties on which we rely, have significant business operations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we lose the services of our Chairman, President and Chief Executive Officer or other members of our senior management team, we may not be able to execute our business strategy.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our estimates of total addressable market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at a similar rate.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The inflationary environment could materially adversely impact our business and results of operations. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If third-party payers do not adequately reimburse for the PreTRM test or any new tests we may develop, such tests may not be purchased or used, which may adversely affect our revenue and profits.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">New reimbursement methodologies applicable to the PreTRM test, and other future tests, including new CPT codes, may decrease reimbursement rates from third-party payers.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Billing disputes with third-party payers, including disagreement regarding the selection and use of CPT codes when submitting claims, may decrease realized revenue and may lead to requests for recoupment of past amounts paid.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">When third-party payers deny coverage, we are often unable to collect from the patient or any other source and risk disputes if we attempt to do so.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our revenues may be adversely impacted if third-party payers withdraw coverage or provide lower levels of reimbursement due to changing policies, billing complexities or other factors.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Status as an out-of-network provider with a large commercial insurer may cause health care providers to avoid recommending our tests.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the validity of an informed consent from a patient is challenged, we could be precluded from billing for such patient&#8217;s testing, be forced to stop performing certain tests, forced to exclude the patient&#8217;s data or specimens from clinical trial results or be subject to lawsuits or regulatory enforcement.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the way the FDA regulates laboratory developed tests or the reagents, other consumables, and testing equipment we use when developing, validating, and performing our tests could result in delay or additional expense in bringing our tests to market or performing such tests for our customers.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with federal and/or state laboratory licensing requirements, we could lose the ability to perform our tests or experience disruptions to our business.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any failure to obtain, maintain, and enforce our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Issued patents covering our tests and technology could be found invalid or unenforceable if challenged.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our intellectual property may be infringed by a third party.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to prevent disclosure of our trade secrets and other proprietary information, the value of our tests and technology could be significantly diminished.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of our Class A common stock may be volatile, and you could lose all or part of your investment.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales of a substantial number of shares of our Class A common stock by our existing stockholders in the public market could cause our stock price to fall.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Financial Position and Need for Additional Capital</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred net losses since our inception and we anticipate that we will continue to incur losses for the foreseeable future, which could harm our future business prospects.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses each year since our inception in 2008. To date, we have financed our operations primarily through private placements of our equity and debt securities, bank loans and the sale and issuance of Class A common stock in our IPO. Our net loss for the nine months ended September 30, 2022 and 2021 was $34.4 million and $22.5 million, respectively. As of September&#160;30, 2022, we had an accumulated deficit of $200.9 million. Our losses may continue to increase in the future as we continue to devote a substantial portion of our resources to efforts to increase the adoption of, and reimbursement for, the PreTRM test, make improvements to this product, and research, develop, and commercialize new products.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently receive and expect to continue to receive substantially all of our revenues from the sales of the PreTRM test for the foreseeable future. It is possible that we will not generate sufficient revenue from the sale of our products to cover our costs, including research and development expenses related to furthering our product pipeline, and achieve or sustain profitability. A significant element of our business strategy is to increase and maintain our in-network coverage with third-party payers. However, third-party payers, such as commercial insurers and government health care programs, may decide not to reimburse for the PreTRM test, may not reimburse for uses of the PreTRM test for the pregnant patient population, or may set the amounts of such reimbursements at prices that do not allow us to cover our expenses. Many third-party payers currently either have negative coverage determinations or otherwise do not reimburse for low-risk patient preterm birth screening tests. State Medicaid programs currently do not reimburse for our tests; third-party payers are increasingly requiring that prior authorization be obtained prior to conducting testing as a condition to reimbursing for it, which may reduce and/or delay the reimbursement amounts.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As there is a possibility that our company, any collaborators and/or licensees may not successfully develop additional products, obtain required regulatory authorizations for such products, manufacture such products at an acceptable cost or with sufficient quality or successfully market and sell such products with desired margins, our expenses may continue to exceed any revenues we may receive. Our operating expenses also will increase as, or if, among other factors:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our earlier-stage products move into later-stage development, which is generally more expensive than early-stage development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we select additional technologies or products for development;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we increase the number of patents we are prosecuting or otherwise expend additional resources on patent prosecution or defense; or</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we acquire or in-license additional technologies, product candidates, products or businesses.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating our business requires a significant amount of cash, and our ability to generate sufficient cash depends on many factors, some of which are beyond our control and if we cannot raise additional capital when needed, we may have to curtail or cease operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we expect to incur significant costs in connection with our operations, including, but not limited to, the development, marketing authorization, and commercialization of new tests, and other products. These development activities generally require a substantial investment before we can determine commercial viability. We expect to need to raise additional funds through public or private equity or debt financings, collaborations or licensing arrangements to continue to fund or expand our operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our actual liquidity and capital funding requirements will depend on numerous factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve broad commercial success with the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and duration of, and expenditures associated with, our discovery efforts and research and development programs, including for our proprietary proteomics and bioinformatics platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs to fund our commercialization strategies for any product candidates which we launch and to prepare for potential product marketing authorizations, as required;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of any acquisitions of complementary businesses or technologies that we may pursue;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential licensing or partnering transactions, if any;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our facility expenses, which will vary depending on the time and terms of any facility lease or sublease we may enter into, and other operating expenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and extent of the expansion of our sales and marketing efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the commercial success of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain more extensive coverage and reimbursement for the PreTRM test and other products, if any; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to collect our accounts receivable.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability of additional capital, whether from private capital sources, such as banks, or the public capital markets, may fluctuate as our financial condition and market conditions in general change. There may be times when the private capital sources and the public capital markets lack sufficient liquidity or when our securities cannot be sold at attractive prices, or at all, in which case we would not be able to access capital from these sources. In addition, any weakening of our financial condition or deterioration in our credit ratings could adversely affect our ability to obtain necessary funds. Even if available, additional financing could be costly or have adverse consequences.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional capital, if needed, may not be available on satisfactory terms or at all. Furthermore, any additional capital raised through the sale of equity or equity-linked securities will dilute our stockholders&#8217; ownership interests and may have an adverse effect on the price of our Class A common stock. In addition, the terms of any financing may adversely affect stockholders&#8217; holdings or rights. Debt financing, if available, may include restrictive covenants. To the extent that we raise additional funds through collaborations and licensing arrangements, it may be necessary to relinquish some rights to our technologies or grant licenses on terms that may not be favorable to us.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to obtain adequate funding when needed, we may be required to delay development programs or sales and marketing initiatives. If we are unable to raise additional capital in sufficient amounts or on satisfactory terms, we may have to reduce our workforce and may be prevented from continuing our discovery, development and commercialization efforts and leveraging other corporate opportunities. In addition, it may be necessary to work with a partner on one or more of our tests or products under development, which could lower our economic value of those products. Each of the foregoing factors may harm our business, operating results, and financial condition and may impact our ability to continue as a going concern.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our quarterly and annual results may fluctuate from period to period, which could adversely impact the value of our Class A common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly and annual results of operations, including our revenues, gross margin, net loss, and cash flows, may vary from period to period as a result of a variety of factors, many of which are outside of our control, including those listed elsewhere in this &#8220;Risk Factors&#8221; section, and as a result, period-to-period comparisons of our operating results may not be meaningful. Our quarterly and annual results should not be relied upon as an indication of future performance. In addition, to the extent that we continue to spend considerably on our internal sales and marketing and research and development efforts, we expect to incur costs in advance of achieving the anticipated benefits of such efforts. We also face competitive pricing and reimbursement pressures, and we may not be able to maintain our premium pricing in the future, which would adversely affect our operating results. Fluctuations in quarterly and annual results and key metrics may cause our results to fall below our financial guidance, if any, or other projections or goals, or the expectations of analysts or investors, which could adversely affect the price of our Class A common stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have derived substantially all of our revenues to date from the PreTRM test, and if our efforts to further increase the use and adoption of the PreTRM test or to develop new products and services in the future do not succeed, our business will be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently receive and expect to continue to receive substantially all of our revenues from the sales of the PreTRM test for the foreseeable future. We intend to establish early reimbursement for the PreTRM test by collaborating with payers to perform rigorous analysis to demonstrate the health and economic benefits of our biomarker tests within their own network using customized inputs based on the plan&#8217;s patient population. We plan to leverage early payer reimbursement decisions to obtain widespread commercial coverage of the PreTRM test from many regional and national plans and medical groups with doctors ordering the PreTRM test. If we are unable to execute on this commercial strategy </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and increase our revenues from the sale of the PreTRM test, our business may be materially adversely impacted. Our ability to increase sales of the PreTRM test and establish greater levels of adoption and reimbursement for the PreTRM test is uncertain for many reasons, including, among others:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to demonstrate to clinics, clinicians, physicians, payers, and patients that the PreTRM test is superior to alternatives with respect to value, convenience, accuracy, scope of coverage, and other factors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party payers may set the amounts of reimbursement at prices that reduce our profit margins or do not allow us to cover our expenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to maintain and grow effective sales and marketing capabilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our sales and marketing efforts may fail to effectively reach customers or communicate the benefits of the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">superior alternatives to the PreTRM test may be developed and commercialized and we may not be able to compete against these alternatives;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may face competitive pressures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may experience supply constraints, including due to the failure of our key suppliers to provide required sequencing instruments and reagents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may encounter difficulties with transportation logistics and regulations associated with shipping blood specimens, including infrastructure conditions and transportation delays;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. or foreign regulatory or legislative bodies may adopt new regulations or policies or take other actions that impose significant restrictions on our ability to market our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be unable to compete successfully with respect to our current or future products or services, as a result of which we may not be able to increase or sustain our revenues or achieve profitability; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to protect our intellectual property position.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our market share for the PreTRM test fails to grow or grows more slowly than expected, our business, operating results, and financial condition would be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends on broad scientific and market acceptance of the PreTRM test, which we may fail to achieve.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to achieve and maintain scientific and commercial market acceptance of the PreTRM test will depend on a number of factors. We expect that the PreTRM test will be subject to the market forces and adoption curves common to other new technologies. The market for proteomics and bioinformatics technologies and products is in its early stages of development. If widespread adoption of the PreTRM test or any other products that we commercialize in the future takes longer than anticipated, we will continue to experience operating losses. The success of life sciences technologies and products is due, in large part, to acceptance by the scientific and medical communities and their adoption of certain products in the applicable field of research. The life sciences scientific community is often led by a small number of early adopters and key opinion leaders who significantly influence the rest of the community through publications in peer-reviewed journals. In such journal publications, the researchers will describe their discoveries, and also the methods, and typically the products used, to fuel such discoveries. Mentions in peer-reviewed journal publications may be a driver for the general acceptance of products for the life sciences industry, such as the PreTRM test. In addition, continuing collaborative relationships with opinion leaders will be vital to maintaining any market acceptance we achieve. If too few researchers describe the use of our products, too many researchers shift to a competing product and publish research outlining their use of that product, or too many researchers negatively describe the use of our products in publications, it may drive customers away from our products. Other factors in achieving commercial market acceptance include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to market and increase awareness of the capabilities of the PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of the PreTRM test to demonstrate comparable performance in intended use applications broadly in the hands of customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our customers&#8217; willingness to adopt new products and workflows;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the PreTRM test&#8217;s ease of use and whether it reliably provides advantages over other alternative technologies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate of adoption of the PreTRM test by patients, physicians, payers and the medical community at large;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prices we charge for the PreTRM test;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop new products and solutions for customers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether competitors develop and commercialize products that perform similar functions as the PreTRM test; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of our investments in product innovation and commercial growth.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure that we will be successful in addressing each of these criteria or other criteria that might affect the market acceptance of any products we commercialize, particularly the PreTRM test. If we are unsuccessful in achieving and maintaining market acceptance of the PreTRM test, our business, financial condition, and results of operations would be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In the near future, we expect to rely on sales to a limited number of direct customers for a significant portion of our revenue and cash flows related to the sale of the PreTRM test, making us subject to customer concentration risk.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that a significant portion of our revenue and cash flows in the near future will be related to sales to a limited number of customers, including Elevance Health, the loss of any of which could adversely affect our business, financial condition, cash flows, and results of operations. Accordingly, we are subject to customer concentration risk. Furthermore, any termination of our relationship with Elevance Health would also adversely impact our strategy to rapidly accelerate commercialization of the PreTRM test and help incentivize broader market adoption.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish sales and marketing capabilities, we may not be successful in commercializing the PreTRM test.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience as a company in sales and marketing and our ability to achieve profitability depends on our being able to attract customers for the PreTRM test and our future products, once approved. Although members of our management team have considerable industry experience, we must expand our sales, marketing, distribution, and customer service and support capabilities with the appropriate expertise in order to successfully commercialize the PreTRM test. To perform sales, marketing, distribution, and customer service and support successfully, we will face a number of risks, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, retain, and manage the sales, marketing, and customer service and operations workforce necessary to commercialize and gain market acceptance for our technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and cost of establishing a specialized sales, marketing, and customer service and operations workforce; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our sales, marketing, and customer service and support force may be unable to initiate and execute successful commercialization activities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may seek to enlist one or more third parties to assist with sales, distribution, and customer service and support. There is no guarantee, if we do seek to enter into such arrangements, that we will be successful in attracting desirable sales and distribution partners or that we will be able to enter into such arrangements on favorable terms. If our sales and marketing efforts, or those of any third-party sales and distribution partners, are not successful, the PreTRM test may not gain market acceptance, which could materially impact our business operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if the PreTRM test achieves broad scientific and market acceptance, if we fail to improve it or introduce compelling new products, our future revenues and prospects could be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to achieve broad scientific and market acceptance for the PreTRM test, our ability to grow our business will depend in large part on our ability both to enhance and improve the PreTRM test and to introduce compelling new products, including for major pregnancy related conditions beyond preterm birth. The success of any enhancement to the PreTRM test or introduction of new products depends on several factors, including completion of certain clinical development requirements, timely completion and delivery of the product, competitive pricing, adequate quality testing, integration with existing technologies, appropriately timed and staged product introductions, and overall market acceptance. Any new product or enhancement to the PreTRM test that we develop may not be introduced in a timely or cost-effective manner, may contain defects, errors or vulnerabilities or may not achieve the market acceptance necessary to generate significant revenue.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The typical development cycle of new life sciences products can be lengthy and complicated and may require new scientific discoveries or advancements, considerable resources, and complex technology and engineering. Such developments may involve external suppliers and service providers, making the management of development projects complex and subject to risks and uncertainties regarding timing, timely delivery of required components or services and satisfactory technical performance of such components or assembled products. If we do not achieve the required technical specifications or successfully manage new product development processes, or if development work is not performed according to schedule, then such new technologies or products may be adversely impacted. To date, we have only completed the development process for one product. We cannot assure you that we will ever succeed in completing that process for another product, including for major pregnancy related conditions beyond preterm birth, or that even if we do, it will be launched successfully in the market and find commercial acceptance. If we are unable to successfully develop new products, enhance the PreTRM test to meet customer requirements, compete with alternative products or otherwise gain and maintain market acceptance, our business, results of operations, and financial condition could be harmed.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Competition in the life science industry, including companies engaged in molecular diagnostics and proteomics, is intense. If we are unable to compete successfully with respect to our current or future products or services, we may not be able to increase or sustain our revenues or achieve profitability.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a women&#8217;s health diagnostic company utilizing our proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests, and our first commercial product, the PreTRM test, is designed to accurately predict the risk of premature delivery. The proteomics and bioinformatics industry is characterized by rapid technological changes, frequent new product introductions, reimbursement challenges, emerging competition, intellectual property disputes and litigation, price competition, aggressive marketing practices, evolving industry standards and changing customer preferences. We cannot guarantee that research, discoveries or other advancements by other companies will not render our existing or potential products and services uneconomical or result in products and services that are superior or otherwise preferable to our current or future products and services.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition with respect to the PreTRM test and expect to face competition with respect to any product candidates that we may seek to develop or commercialize in the future. Many of the companies against which we are competing or may compete against in the future have significantly greater financial resources and expertise in research and development, manufacturing, and commercialization. Mergers and acquisitions in our industry may result in even more resources being concentrated among a smaller number of our competitors. Smaller and early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel and conducting clinical trials, as well as in acquiring technologies complementary to, or necessary for, our products and services.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To remain competitive over time, we will need to continually research and develop improvements to our products and services. However, we cannot assure you that we will be able to develop and commercialize any improvements to our products and services on a timely basis. Our competitors may develop and commercialize competing or alternative products and services and improvements faster than we are able to do so, which would negatively affect our ability to increase or sustain our revenue or achieve profitability.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our products do not perform as expected, our operating results, reputation, and business will suffer.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on the market&#8217;s confidence that we can provide reliable, high-quality testing results. There is no guarantee that the accuracy and reproducibility we have demonstrated to date will continue as our test volumes continue to increase and our product portfolio continues to expand. We believe that patients that rely on our tests are particularly sensitive to test limitations and errors, including inaccurate test results. As a result, if our tests do not perform as expected or favorably in comparison to competing tests, our operating results, reputation, and business will suffer. We may also become subject to legal claims arising from such limitations, errors or inaccuracies.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PreTRM test uses, and our future tests will use, a number of complex and sophisticated proteomic and bioinformatics processes and advanced mass spectrometry techniques, which are highly sensitive to external factors. An operational, technological or other failure in one of these complex processes may result in sensitivity or specificity rates that are lower than we anticipate. In addition, we regularly evaluate and refine our testing processes, and any refinements we make may not improve our tests as we expect and may result in unanticipated issues that may adversely affect our test performance as described above. Such operational, technical, and other difficulties adversely affect test performance, may impact the commercial attractiveness of our products and may increase our costs or divert our resources, including management&#8217;s time and attention, from other projects and priorities. Furthermore, any changes to our testing process may require us to use new or different suppliers or materials with whom or which we are unfamiliar, and which may not perform as we anticipate, and could cause delays, downtime or other operational issues.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our CLIA-certified laboratory facility becomes inoperable, we will be unable to perform our tests and our business will be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate a CLIA-certified laboratory facility in Salt Lake City, Utah, which processes the PreTRM test that represents the source of substantially all of our revenues. Our facility could be harmed or rendered inoperable, or our supplies or other assets could be damaged or destroyed, by natural or man-made disasters, including earthquakes, severe weather, flooding, power outages, and contamination, including as a result of a public health threat, which may render it difficult or impossible for us to operate our business and/or perform our tests for some period of time. The inability to perform our tests or the backlog of tests that could develop if our facility is inoperable&#8201;&#8212;&#8201;for even a short period of time&#8201;&#8212;&#8201;may harm our reputation and result in a material adverse effect on our revenues.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The marketing, sale, and use of the PreTRM test and any other products that we develop in the future could result in substantial damages arising from product liability or professional liability claims, associated with product recalls or otherwise, that exceed our resources.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketing, sale, and use of the PreTRM test and any other products that we develop and commercialize in the future could lead to product liability claims against us if someone were to allege that the PreTRM test or any future product failed to perform as it was designed or as claimed in our promotional materials, was performed pursuant to incorrect or inadequate laboratory procedures, if we delivered incorrect or incomplete test results or if someone were to misinterpret test results. In addition, we may be subject to liability for errors in, a misunderstanding of, or inappropriate reliance upon, the information we provide, or for failure to provide such information, in connection with our marketing and promotional activities or as part of the results generated by the PreTRM test and other future tests. Even though the PreTRM test is highly accurate, no test is 100% accurate, and we may report false results. In such a scenario, the patient or her family may file a lawsuit against us claiming product or professional liability. In addition, any manufacturing or design defects in our products could lead to product recalls, either voluntary or as required by government authorities, which could result in the removal of a product from the market.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A product liability or professional liability claim could result in substantial damages and be costly and time-consuming for us to defend. Although we maintain product and professional liability insurance, our insurance may not fully protect us from the financial impact of defending against product liability or professional liability claims or any judgments, fines or settlement costs arising out of any such claims, or the financial and reputational consequences of a product recall. Any product liability or professional liability claim brought against us, with or without merit, could increase our insurance rates, cause our insurance coverage to be terminated or prevent us from securing insurance coverage in the future. As we attempt to bring new products to market, we may need to increase our product liability coverage, which would be a significant additional expense that we may not be able to afford. Additionally, any product liability or professional liability lawsuit could harm our reputation, result in a cessation of PreTRM testing or cause our partners to terminate our agreements with them, any of which could adversely impact our results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The results of our clinical trials may not support the use of our tests and other product candidates, or may not be replicated in later studies.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have conducted and are currently conducting a variety of observational and interventional studies for the PreTRM test and our other tests in development that involve clinical investigators at multiple sites in the United States. We may need to conduct additional studies for the PreTRM test, as well as other tests we may offer in the future, to drive test adoption in the marketplace and reimbursement. Should we not be able to perform these studies, or should their results not provide clinically meaningful data and value for clinicians, or if our results are unfavorable, adoption of our tests could be impaired.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The administration of clinical and economic utility studies is expensive and demands significant attention from certain members of our management team. Data collected from these studies may not be positive or consistent with our existing data, or may not be statistically significant or compelling to the medical community or payers. If the results obtained from our ongoing or future studies are inconsistent with certain results obtained from our previous studies, adoption of our products would suffer and our business would be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Peer-reviewed publications regarding our products and product candidates may be limited by many factors, including delays in the completion of, poor design of, or lack of compelling data from clinical studies, as well as delays in the review, acceptance, and publication process. If our products or product candidates or the technology underlying our current or future products or product candidates do not receive sufficient favorable exposure in peer-reviewed publications, or are not published, the rate of health care provider adoption of our tests and positive reimbursement coverage decisions for our tests and other products could be negatively affected. The publication of clinical data in peer-reviewed journals can be a crucial step in commercializing and obtaining reimbursement for tests, and our inability to control when, if ever, results are published may delay or limit our ability to derive sufficient revenues from any test that is the subject of a study. The performance achieved in published studies may not be repeated in later studies that may be required to obtain FDA marketing authorizations should we decide to do so for business reasons, or should we be required to submit applications to the FDA or other health authorities seeking such authorizations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, clinical trials must be conducted in accordance with applicable laws and subject to the oversight of Institutional Review Boards, or IRBs, at the medical institutions where the clinical trials are conducted. We rely on clinical trial sites to ensure the proper and timely conduct of our clinical trials and while we have agreements governing their committed activities, we have limited influence over their actual performance. We depend on our collaborators and on medical institutions to conduct our clinical trials in compliance with applicable human subject protection regulations and Good Clinical Practice, or GCP, requirements. To the extent our collaborators fail to enroll participants for our clinical trials, fail to conduct our trials in compliance with applicable law and GCP requirements, or are delayed for a significant time in the execution of trials, including achieving full enrollment, we may be affected by increased costs, program delays, or both.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interim, top-line and preliminary data from our clinical trials that we announce or publish from time to time may change as additional data become available and are subject to confirmation, audit, and verification procedures that could result in material changes in the final data.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may publicly disclose interim, top-line or preliminary data from our clinical trials, which is based on a preliminary analysis of then-available data, and these results and related findings and conclusions may be subject to change following a more comprehensive review of the data. We also make assumptions, estimations, calculations, and conclusions as part of our analyses of data, and we may not have received or have had the opportunity to fully and carefully evaluate all data. As a result, the interim, top-line or preliminary data that we report may differ from future results of the same trials, or different conclusions or considerations may qualify such results once additional data have been received and fully evaluated. Interim data from clinical trials are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary, interim or top-line data also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary top-line data we previously published. As a result, preliminary, interim, and top-line data should be viewed with caution until the final data are available. Adverse differences between preliminary, interim, and top-line data and final data could significantly harm our business prospects and may cause the price of our Class A common stock to fluctuate or decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, payers, physicians, and others may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could adversely impact the potential of the particular product or program, the prospects for commercialization of any product, and the business prospects of our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is derived from information that is typically extensive, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the preliminary, interim or top-line data that we report differ from actual results, or if payers, physicians or others disagree with the conclusions reached, our ability to commercialize our product candidates may be significantly impaired, which could materially harm our business, operating results, prospects or financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business would be materially harmed if our proprietary biobank were to become contaminated, lost or destroyed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A fundamental component of our platform is our proprietary biobank, consisting of comprehensive, clinically and demographically annotated blood specimens collected from thousands of pregnant U.S. women, representing the broad demographic and geographic diversity inherent in the U.S. population. This biobank is maintained at our facility in Salt Lake City, Utah, in a secure environment. If the specimens and information contained in the biobank were to become compromised or destroyed, through contamination, theft, a cybersecurity breach, a natural disaster or otherwise, our ability to rely on the data represented in the biobank could be significantly impaired, which could materially harm our business, operating results, prospects or financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International expansion of our business will expose us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside the United States.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we decide to market our products and services outside the United States, our business will be subject to the risks associated with doing business outside the United States, including an increase in our expenses and diversion of our management&#8217;s attention from the development of future products and services. Accordingly, our business and financial results in the future could be adversely affected due to a variety of factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing laws and regulations such as privacy, security and data use regulations, tax laws, export and import restrictions, economic sanctions and embargoes, employment laws, anti-corruption laws, regulatory requirements, reimbursement or payer regimes and other governmental approvals, permits, and licenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure by us or our distributors to obtain any necessary regulatory clearance, authorization or approval for the use of our products and services in various countries;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additional potentially relevant third-party patent rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complexities and difficulties in obtaining intellectual property protection and maintaining, defending, and enforcing our intellectual property outside the United States;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in staffing and managing foreign operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employment risks related to hiring employees outside the United States;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">complexities associated with managing multiple payer reimbursement regimes, government payers or patient self-pay systems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in negotiating favorable reimbursement negotiations with governmental authorities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">logistics and regulations associated with shipping specimens, including infrastructure conditions and transportation delays;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limits in our ability to penetrate international markets if we are not able to sell our products or conduct services locally;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local and regional financial crises on demand and payment for our products and services and exposure to foreign currency exchange rate fluctuations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters, political and economic instability, including wars, terrorism, and political unrest, outbreak of disease, boycotts, curtailment of trade, and other business restrictions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory and compliance risks that relate to maintaining accurate information and control over sales and distributors&#8217; activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act, or FCPA, its books and records provisions, or its anti-bribery provisions, or laws similar to the FCPA in other jurisdictions in which we may operate, such as the United Kingdom Bribery Act of 2010, or the U.K. Bribery Act; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">onerous anti-bribery requirements of several member states in the European Union, the United Kingdom, Japan, and other countries that are constantly changing and require disclosure of information to which U.S. legal privilege may not extend.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors could significantly harm our future international expansion and operations and, consequently, our revenue and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to obtain and maintain the third-party relationships that are necessary to develop and commercialize some or all of our tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to depend on collaborators, partners, licensees, and other third parties to support our test development and validation efforts, to deliver needed supplies, and to transport specimens for testing, among other things. Any problems we experience with any of these third parties could delay the development, validation, commercialization, and performance of our testing, which could harm our results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that we will be able to successfully negotiate agreements for, or maintain relationships with, collaborators, partners, licensees, and other third parties on favorable terms, if at all. If we are unable to obtain or maintain these agreements, we may not be able to develop, validate, obtain regulatory authorizations for, or commercialize any future tests, which will in turn adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to expend substantial management time and effort to enter into relationships with third parties and, if we successfully enter into such relationships, to manage these relationships. In addition, substantial amounts will be paid to third parties in these relationships. However, we cannot control the amount or timing of resources our future contract partners will devote to our business endeavors, and we cannot guarantee that these parties will fulfill their obligations to us under these arrangements in a timely fashion, if at all. In addition, while we manage the relationships with third parties, we cannot control all of the operations of and protection of intellectual property by such third parties.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for specimen collection, including phlebotomy services, and commercial courier delivery services, and if these services are disrupted, our business will be harmed.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties to perform specimen collection, including phlebotomy services, and to transport specimens to our laboratory facility in a timely and cost-efficient manner. Disruptions in these services, whether due to any natural or other disasters, pandemics, acts of war or terrorism, shipping embargoes, labor unrest, political instability or similar events could adversely affect specimen integrity and our ability to process specimens in a timely manner and to service our customers, and ultimately our reputation and our business. In addition, if we are unable to continue to obtain expedited delivery services on commercially reasonable terms, our operating results may be adversely affected.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our relationships with these service providers could be scrutinized under federal and state health care laws such as the federal Anti-Kickback Statute and the Stark Law, and their implementing regulations, to the extent, for example, that these services provide a financial benefit to or relieve a financial burden for a potential referral source. If our operations are found to be in violation of any of these laws and regulations, we may be subject to administrative, civil and/or criminal penalties, damages, fines, individual imprisonment, refunding of payments received by us, exclusion from government health care programs, and/or curtailment or cessation of our operations, among other potential penalties, any of which could harm our reputation and adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on a limited number of suppliers or, in some cases, single suppliers, for some of our laboratory instruments and materials and may not be able to find replacements or immediately transition to alternative suppliers on a cost-effective basis, or at all.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We source components of our technology from third parties and certain components are sole sourced. Obtaining substitute components may be difficult or require us to re-design our products. We expect to continue to depend on third-party contract suppliers for the foreseeable future. Any natural or other disasters, such as re-emergence of COVID-19 pandemic, acts of war or terrorism, shipping embargoes, labor unrest or political instability or similar events at our third-party suppliers&#8217; facilities that cause a loss of manufacturing capacity or a reduction in the quality of the items manufactured would heighten the risks that we face. In addition, inflation and/or global supply chain disruptions may have a negative impact on our third-party contract suppliers&#8217; ability to acquire the materials necessary for our business and we could incur higher costs for certain goods or services due to inflation or increased freight costs. Changes to, failure to renew or termination of our existing agreements or our inability to enter into new agreements with other suppliers could result in the loss of access to important components of our tests and could impair, delay or suspend our commercialization efforts. Our failure to maintain a continued and cost-effective supply of high-quality components could materially and adversely harm our business, operating results, and financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully scale our operations, or attract and retain highly skilled employees, our business could suffer.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our test volumes grow and we develop future product offerings, we will need to continue to ramp up our testing capacity and implement increases in scale, such as increased headcount, additional or upgraded equipment, additional qualified laboratory personnel, increased office and laboratory space, expanded customer service capabilities, improved billing and systems processes, enhanced controls and procedures and expanded or internal quality assurance program and technology platform. The value of the PreTRM test and our other testing products that we may develop in the future depends on our ability to perform, and our reputation for performing, these tests on a timely basis and with an exceptionally high standard of quality. Failure to implement necessary procedures, transition to new facilities, purchase and maintain equipment, establish processes, or hire the necessary personnel in a timely and effective manner could result in higher processing costs or an inability to meet market demand or could otherwise affect our operating results.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To execute our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel is intense, especially for sales, scientific, medical, laboratory, research and development, and other technical personnel. The turnover rate of such personnel can be high. We may, from time to time, experience difficulty in hiring and retaining employees with appropriate qualifications. Many of the companies with which we compete for highly qualified personnel have greater resources than we have. If we hire employees from competitors or other companies, their former employers may attempt to assert that these employees or our company have breached their legal obligations to their former employers, which occurs from time to time. Furthermore, to the extent that we are unable to retain our employees and they leave our company to join one of our competitors, we cannot assure you that any invention, non-disclosure or non-compete agreements we have in place will provide meaningful protection against a departing employee&#8217;s unauthorized use or disclosure of our confidential information.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our growth may place a significant strain on our operating and financial systems and our management, sales, marketing, and administrative resources. As a result of our growth, our operating costs may escalate faster than we anticipate, we may face difficulties in obtaining additional office or laboratory space and some of our internal systems may need to be enhanced or replaced. If we cannot effectively manage our expanding operations and our costs, we may not be able to grow successfully or we may grow at a slower pace, and our business could be adversely affected.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may engage in acquisitions, dispositions or other strategic transactions that could disrupt our business, cause dilution to our stockholders or reduce our financial resources.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may enter into transactions to acquire or dispose of businesses, products or technologies or to engage in other strategic transactions. Because we have not made any such acquisitions to date, our ability to do so successfully is unproven. Even if we identify suitable transactions, we may not be able to complete such transactions on favorable terms or at all. Any acquisitions or other strategic transactions we consummate may not strengthen our competitive position, and these transactions may be viewed negatively by customers or investors. We may decide to incur debt in connection with an acquisition or issue shares of our common stock or other equity securities to the stockholders of the acquired company, which would cause dilution to our existing stockholders. We could incur losses resulting from such strategic transactions, including undiscovered liabilities of an acquired business that are not covered by any indemnification we may obtain from the seller. In addition, we may not be able to successfully integrate any acquired personnel, technologies, and operations into our existing business in an effective, timely and non-disruptive manner. Any dispositions may also cause us to lose revenue and may not strengthen our financial position. Strategic transactions may also divert management attention from day-to-day responsibilities, increase our expenses, result in accounting charges, and reduce our cash available for operations and other uses. We cannot predict the number, timing or size of future strategic transactions or the effect that any such transactions might have on our operating results.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to raise additional funds through equity or debt financings, corporate collaborations or licensing arrangements to continue to fund or expand our operations. Additional capital, if needed, may not be available on satisfactory terms or at all. Furthermore, any additional capital raised through the sale of equity or equity-linked securities, or grant of equity or equity-linked securities in connection with any debt financing, will dilute stockholders&#8217; ownership interests in us and may have an adverse effect on the price of our Class A common stock. In addition, the terms of any financing may adversely affect stockholders&#8217; holdings or rights. To the extent that we raise capital through collaborations and licensing arrangements, it may be necessary to relinquish some rights to our technologies or grant licenses on terms that may not be favorable to us.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to obtain adequate funding when needed, we may have to delay development programs or sales and marketing initiatives. In addition, we may have to work with a partner on one or more of our tests or programs, which could lower the economic value of those programs to our company.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A re-emergence of COVID-19, or the emergence of a new pathogen, could materially affect our operations, as well as the business or operations of third parties with whom we conduct business. Our business could be adversely affected by the effects of other future public health threats in regions where we, or third parties on which we rely, have significant business operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and operations, including, but not limited to, our laboratory operations, sales and marketing efforts, supply chain operations, research and development activities, and fundraising activities, could be adversely affected by public health disruptions in regions where we have business operations, and such health disruptions could cause significant disturbance in the operations of third parties upon whom we rely. As a recent example, in March 2020, the World Health Organization declared the COVID-19 outbreak a pandemic, and the U.S. government imposed restrictions on travel between the United States, Europe, and certain other countries. In the years following the initial outbreak, numerous state and local jurisdictions, including the jurisdictions where our headquarters and laboratory are located, imposed quarantines, shelter-in-place orders, executive orders, and similar government orders for their residents to control the spread of COVID-19. A re-emergence of COVID-19, or the emergence of a new pathogen, as a serious public health threat could result in similar restrictions being imposed. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of new variants of the COVID-19 virus or any future severe public health threats, together with any executive orders or shelter-in-place orders, may negatively impact productivity, disrupt our business and delay our clinical programs and timelines, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business in the ordinary course. These and similar, and perhaps more severe, disruptions in our operations could negatively impact our business, operating results and financial condition. We have processes in place to respond to any future state and local quarantine, shelter-in-place orders, executive orders, and similar government orders. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarantines, shelter-in-place orders, executive orders, and similar government orders, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, could impact personnel at third-party manufacturing facilities, or the availability or cost of materials we use or require to conduct our business, which would disrupt our supply chain. In particular, some of our suppliers of certain materials used in our laboratory operations and research and development activities may be located in areas that are subject to executive orders and shelter-in-place orders. While many of these materials may be obtained from more than one supplier, port closures and other restrictions resulting from the COVID-19 pandemic or future pandemics may disrupt our supply chain or limit our ability to obtain sufficient materials to operate our business. Furthermore, the COVID-19 pandemic resulted in a sharp decrease in the number of patient visits to health care providers. As a result of the COVID-19 pandemic, or similar pandemics, we have experienced disruptions that impacted our business and may see further disruptions that could cause further impacts, including on our ability to successfully commercialize the PreTRM test in the United States.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our clinical trials were affected by the COVID-19 pandemic. The primary impacts to our business have been the early cessation of enrollment in our AVERT PRETERM TRIAL in March 2020, the delayed commencement of enrollment in our PRIME study until November 2020 and slower than expected enrollment thereafter, and limited access to ordering clinicians as we have initiated the commercialization of our PreTRM test. We expect to enroll sufficient numbers of PRIME study patients to enable the interim analysis to occur in 2023, depending on several factors that include potential further disruption due to COVID-19 conditions. If COVID-19 re-emerges as a serious public health threat in the United States and elsewhere, or if another serious pathogen appears, then we may experience additional disruptions that could severely impact our business, preclinical studies, and clinical trials, including potential timing delays.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Public health threats like COVID-19, which has caused a broad impact globally, may materially affect us economically, including by causing a significant reduction in laboratory testing volumes. In addition, reimbursements for our tests may also be delayed if third-party payers&#8217; processing is impacted by a public health threat and work-from-home policies and other operational limitations mandated by federal, state, and local governments in response. While the potential economic impact brought by a public health disruption, and the duration of such impact, may be difficult to assess or predict, COVID-19 has shown that a widespread public health threat can result in significant disruption of global financial markets, which could reduce our ability to access capital and negatively affect our future liquidity. In addition, a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recession or market correction resulting from a public health threat and related government orders and restrictions could materially affect our business and the value of our Class A common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to evolve. Its most severe effects appear to have subsided, but this virus could re-emerge, or new public health threats could appear. The future impact of the COVID-19 pandemic or a similar health disruption is highly uncertain and subject to change. We cannot predict the full extent of potential delays or impacts on our business, our clinical trials, health care systems or the global economy as a whole.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot ensure that our employees will fully adhere to compliance policies and procedures.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented and strive to continuously develop and improve compliance policies and procedures intended to train our sales, billing, marketing, and other personnel regarding compliance with state and federal laws applicable to our business. Our efforts to implement appropriate monitoring of compliance with such policies and procedures are likewise ongoing. Despite our compliance policies and procedures, and related training and monitoring, we may experience situations in which employees may have failed to fully adhere to our policies and applicable laws in the past or in which they fail to adhere to applicable policies and/or laws in the future. Such failures may subject us to administrative, civil, and criminal actions, penalties, damages, fines, individual imprisonment, exclusion from participation in federal health care programs, refunding of payments received by us, and curtailment or cessation of our operations. In addition, commercial third-party payers may refuse to provide all or any reimbursement for tests administered, seek repayment from us of amounts previously reimbursed and harm our ability to secure network contracts with third-party payers. Any of the foregoing could adversely affect our revenue, cash flow, and financial condition, and reduce our growth prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we lose the services of our Chairman, President and Chief Executive Officer or other members of our senior management team, we may not be able to execute our business strategy.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part upon the continued service of our senior management team. In particular, our Chairman, President and Chief Executive Officer, Gregory C. Critchfield, M.D., M.S. is critical to our vision, strategic direction, culture, products and technology. In addition, we do not maintain key-man insurance for Dr. Critchfield or any other member of our senior management team. The loss of our Chairman, President and Chief Executive Officer or one or more other members of our senior management team could have an adverse effect on our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a significant amount of net operating loss, or NOL, carryforwards that can be used to offset potential future taxable income and related income taxes. As of December 31, 2021, we had federal NOL carryforwards of approximately $159.9 million, of which, $70.3 million, if not utilized, begin to expire in 2028. Approximately $89.6 million of these federal NOLs can be carried forward indefinitely. Under Section 382 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#8220;ownership change&#8221; (generally defined as a greater than 50% change, by value, in equity ownership over any three-year period), the corporation&#8217;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. We may experience ownership changes in the future as a result of shifts in our stock ownership, some of which may not be within our control. Our ability to use these carryforwards could be limited if we experience an &#8220;ownership change.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our estimates of total addressable market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at a similar rate.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total addressable market opportunity estimates and growth forecasts are subject to significant uncertainty and are based on assumptions and estimates that may not prove to be accurate. Our publicly announced estimates and forecasts relating to the size and expected growth of our market may prove to be inaccurate. Even if the market in which we compete meets our size estimates and forecasted growth, our business could fail to grow at similar rates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The inflationary environment could materially adversely impact our business and results of operations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results could be materially impacted by changes in the overall macroeconomic environment and other economic factors that impact customer confidence and spending, including capital spending. Changes in economic conditions, supply chain constraints, logistics challenges, labor shortages, global conflicts, and steps taken by governments and central banks, particularly in response to public health threats as well as other stimulus and spending programs, have led to higher inflation, which is likely, in turn, to lead to an increase in costs and may cause changes in fiscal and monetary </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">policy, including increased interest rates. In a higher inflationary environment, we may be unable to raise the prices of our products sufficiently to keep up with the rate of inflation. Impacts from inflationary pressures could be more pronounced and materially adversely impact aspects of our business where revenue streams and cost commitments are linked to contractual agreements that extend further into the future, as we may not be able to quickly or easily adjust pricing, reduce costs, or implement counter measures. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Reimbursement</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If third-party payers do not adequately reimburse for the PreTRM test or any new tests we may develop, such tests may not be purchased or used, which may adversely affect our revenue and profits.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and markets in other countries, patients generally rely on third-party payers to reimburse all or part of the costs associated with their treatment or tests. Adequate coverage and reimbursement from third-party payers such as federal and state health care programs (e.g., Medicare and Medicaid) and commercial payers is critical to new product acceptance. Our business depends on our ability to obtain or maintain adequate reimbursement from third-party payers. We expect third-party payers such as third-party commercial insurers to be our most significant source of payment in the near future. In particular, we believe that for our company to achieve commercial success, it will be necessary to gain acceptance from third-party payers for the PreTRM test, and to obtain positive coverage determinations and favorable reimbursement rates from third-party payers for our tests over time. We do not yet know, however, whether and to what extent certain of our products, including those under development, will be covered or reimbursed. If we are unable to obtain or maintain coverage or adequate reimbursement from, or achieve in-network status with, third-party payers for our existing or future tests or other products, our ability to generate revenues will be limited. For example, health care providers may be reluctant to order our tests or other products due to the potential of a substantial cost to the patient if coverage or reimbursement is unavailable or insufficient. Such coverage and reimbursement may depend upon a number of factors, including the determination that the test and its use or administration for a particular patient are:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a covered benefit;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">safe, effective, and medically necessary;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appropriate for the specific patient;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supported by guidelines established by the relevant professional societies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approved in any states where specific assay approval is necessary;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cost-effective; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">neither experimental nor investigational.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Centers for Medicare &amp; Medicaid Services, or CMS, an agency within the United States Department of Health and Human Services, or HHS, and its Medicare Administrative Contractors make decisions regarding Medicare coverage for new tests. Other third-party payers, including commercial insurers, often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates, and both CMS and certain commercial insurers may have sufficient market power to demand significant price reductions. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining coverage and reimbursement approval for a test from each third-party payer is a time-consuming and costly process that could require us to provide to each payer supporting scientific, clinical, patient insurance eligibility and benefits, and billing-related information. We may not be able to provide data sufficient to satisfy third-party payers that the test should be covered and reimbursed. There is substantial uncertainty whether any particular payer will cover and reimburse the use of any test incorporating new technology. Even when a payer determines that a test is eligible for reimbursement, the payer may impose coverage limitations that preclude payment under certain circumstances or for certain patient populations. Moreover, eligibility for coverage does not imply that any test will be reimbursed in all cases or at a rate that allows us to make a profit or even cover our costs. Interim payments for new tests, if applicable, may also not be sufficient to cover our costs and may not be made permanent. In some instances, payment may only be obtained by obtaining prior authorization and/or engaging in lengthy and costly appeals processes. Reimbursement rates may vary, for example, according to the use of the test and the clinical setting in which it is used, and may reflect budgetary constraints and/or imperfections in Medicare, Medicaid or other data used to calculate these rates.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been, and we expect that there will continue to be, federal and state proposals to constrain expenditures for health care products and services, which may affect payments for our tests. Third-party payers, including CMS, frequently change coverage policies, product and service codes and payment methodologies and reimbursement amounts. Due in part </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to actions by third-party payers, the health care industry is experiencing a trend toward containing or reducing costs through various means, including lowering reimbursement rates and negotiating reduced payment schedules with service providers for certain products and/or services.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inability to promptly obtain coverage and profitable reimbursement rates from third-party payers for our tests could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, leading professional societies may recommend alternatives to our tests, which may provide a basis for third-party payers not to cover or reimburse our tests. In making coverage determinations, third-party payers often rely on practice guidelines issued by professional societies. Test-ordering providers may also rely on such guidelines when deciding whether to order testing for their patients. If any relevant professional societies issue guidelines suggesting, or otherwise make recommendations, that providers not use our tests or instead use alternatives to our tests, payers may make unfavorable coverage and reimbursement decisions and test-ordering providers may not order our tests. Any such outcomes could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New reimbursement methodologies applicable to the PreTRM test, and other future tests, including new CPT codes, may decrease reimbursement rates from third-party payers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If eligible for reimbursement, laboratory tests are generally classified for reimbursement purposes under CMS&#8217;s Healthcare Common Procedure Coding System, or HCPCS, and the American Medical Association&#8217;s, or AMA, Current Procedural Terminology, or CPT, coding systems. We, and payers, generally must use those coding systems to bill, and pay for, testing, respectively. Once an HCPCS or CPT code is created or established, CMS establishes payment rates and coverage rules for that code under Medicare. Commercial insurers likewise establish their own payment rates and coverage rules for that code.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The AMA has issued a unique CPT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary Laboratory Analysis, or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLA, code for the PreTRM test. This code was priced at $750 by CMS in November 2021. Before the AMA issued a CPT PLA code for the PreTRM test, we submitted claims for reimbursement using CPT codes existing at the time based on the guidance of outside coding experts.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that we will be able to negotiate favorable rates for our unique code, nor can we guarantee that we will receive reimbursement at all, especially if we are unable to collect and publish additional data and obtain positive coverage determinations for the PreTRM test or our other future tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currently have specific CPT codes assigned for any of our other tests under development and there is a risk that we may not be able to obtain such codes or, if obtained, we may not be able to negotiate favorable rates for such codes.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, third-party payers may not establish positive coverage policies for our tests or adequately reimburse for any CPT code we may use, or seek recoupment for testing previously performed, which is a common occurrence in our industry.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Billing disputes with third-party payers, including disagreement regarding the selection and use of CPT codes when submitting claims, may decrease realized revenue and may lead to requests for recoupment of past amounts paid.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that payers could dispute our billing or coding from time to time. Payers may likewise seek to recoup reimbursements already paid, and we expect that such disputes and requests for recoupment may arise. Third-party payers may also decide to deny payment or recoup payment for testing that they contend to have been not medically necessary, against their coverage determinations, or for which they have otherwise overpaid. There is also a risk that the CPT codes we previously submitted, are currently submitting, or will submit in the future on claims will be rejected or withdrawn or that third-party payers will seek refunds of amounts that they claim were inappropriately billed based on, for example, the CPT code used, the modifier attached, or the number of units billed. Claims for recoupment require the time and attention of our management and other key personnel, which can be a distraction from operating our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If third-party payers deny payment for testing, reimbursement revenue for our testing could decline. If a third-party payer successfully challenges that payment for prior testing was in breach of contract or otherwise contrary to policy or law, they may recoup payment, which amounts could be significant and would impact our operating results and financial condition, and it may decrease reimbursement going forward. We may also decide to negotiate and settle with a third-party payer in order to resolve an allegation of overpayment. Any of these outcomes, including recoupment or reimbursements, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">might also require us to restate our financials from a prior period, any of which could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with laws and regulations related to submission of claims for our services could result in substantial financial penalties and/or potential civil or criminal liability.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of complex federal and state laws and regulations applicable to the submission of claims for payment for our services. If a third-party payer or a regulatory or enforcement agency, or, in some cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> relators, believe or allege that we engaged in improper billing practices, including, but not limited to, submitting improper CPT codes, multipliers or modifiers on our claims, we may be subject to investigation and/or enforcement actions under federal and/or state law.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Responding to and defending such investigations and/or enforcement actions may require significant time and attention from management and key personnel, include significant expenditures, and result in significant penalties, damages, fees, and reputational harm, all of which could have a material adverse effect on our business, operating results, and financial condition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See &#8220;&#8212; Risks Related to Government Regulation&#8201;&#8212;&#8201;If we, or our employees or contractors on our behalf, engage in conduct that violates health care laws, are suspected or accused of engaging in such conduct, or are subject to investigation for actual or alleged such conduct, we could face substantial penalties and damage to our reputation, and our business operations and financial condition could be adversely affected</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Most favored nation&#8221; provisions in contracts with third-party payers may limit potential for revenue growth and may lead to claims for recoupment.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our contracts with third-party payers may in the future contain &#8220;most favored nation&#8221; provisions, pursuant to which we typically agree that we will not bill the third-party payer more than we bill any other third-party payer. These contract provisions limit the amount we are able to charge for our products and can negatively impact revenue. We monitor our billing and claims submissions for compliance with these contractual requirements with third-party payers. If we do not successfully manage compliance with these most favored nation provisions, we may be required to forego revenues from some third-party payers or reduce the amount we bill to each third-party payer with a most favored nation clause in its contract that is violated, which would adversely affect our business, operating results, and financial condition. This situation could also subject us to claims for recoupment, which could ultimately result in an obligation to repay amounts previously earned.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">When third-party payers deny coverage, we are often unable to collect from the patient or any other source and risk disputes if we attempt to do so.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a third-party payer denies coverage, or if the patient has a large deductible or co-insurance amount, it may be difficult for us to collect from the patient, and we may not be successful in doing so. If we are in-network, we may be contractually prohibited from seeking payment from the patient. If we are out-of-network, we may be unable to collect the full amount of a patient&#8217;s responsibility, despite our good faith efforts to collect. As a result, we may not always be able to collect the full amount due for our tests if third-party payers deny coverage, cover only a portion of the billed amount or the patient has a large deductible, which could cause payers to raise questions regarding our billing policies and patient collection practices.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our practices with respect to billing and collecting patient responsibility amounts are compliant with applicable laws; however, we may in the future receive inquiries from third-party payers regarding our practices in these areas. There is no guarantee that we will be successful in addressing such concerns, and if we are unsuccessful, this may result in a third-party payer deciding to reimburse for our tests at a lower rate or not at all, seeking recoupment of amounts previously paid to us, or bringing legal action to seek reimbursement of previous amounts paid. Any such occurrences could cause reimbursement revenue for our testing, which constitutes the large majority of our revenue, to decline. Additionally, if we were required to make a repayment, such repayment could be significant, which could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenues may be adversely impacted if third-party payers withdraw coverage or provide lower levels of reimbursement due to changing policies, billing complexities or other factors.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we become an in-network provider by entering into an agreement with any of the third-party payers from which we receive reimbursement, this means that we will have an agreement that governs approval or payment terms. However, such a contract would not guarantee reimbursement for all testing we perform.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the terms of any such agreement may require a physician or qualified practitioner&#8217;s signature on test requisitions or require other controls and procedures prior to conducting a test. In particular, third-party payers have been increasingly requiring prior authorization to be obtained prior to conducting a test as a condition to reimbursing for the test. If the payers were to do so for the PreTRM test, it could place a burden on our billing operations and require us to dedicate resources to monitor that these prior authorization requirements are met. To the extent we or the health care providers ordering our tests do not follow the prior authorization requirements, we may be subject to claims for recoupment of reimbursement amounts previously paid to us, or may not receive some or all of the reimbursement amounts to which we would otherwise be entitled. This may occur in the future, which could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are considered to be an out-of-network provider, which we expect to be the case with at least some of the largest third-party payers from which we may receive reimbursement in the future, such third-party payers could withdraw coverage and decline to reimburse for our tests, for any reason. They can also impose prior authorization requirements through the terms of the patients&#8217; health plans. Managing reimbursement on a case-by-case basis is time-consuming and contributes to an increase in the number of days it takes us to collect on accounts, which also increases our risk of non-payment. Negotiating reimbursement on a case-by-case basis also typically results in the receipt of reimbursement at a significant discount to the list price of our tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are being reimbursed for our tests, third-party payers may unilaterally review and adjust the rate of reimbursement, require co-payments from patients or stop paying for our tests. Federal and state health care programs as well as commercial insurers continue to increase their efforts to control the cost, utilization, and delivery of health care services by demanding price discounts or rebates and limiting coverage of, and amounts they will pay for, molecular tests. These measures have resulted in reduced payment rates and decreased utilization in the clinical laboratory industry. Because of these cost-containment measures, third-party payers&#8201;&#8212;&#8201;including those that may reimburse our tests in the future&#8201;&#8212;&#8201;may reduce, suspend, revoke or discontinue payments or coverage at any time. Reduced reimbursement of our tests may harm our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billing for clinical laboratory testing services is complex. We perform tests in advance of payment and without certainty as to the outcome of the billing process. In cases where we expect to receive a fixed fee per test due to our reimbursement arrangements, we may nevertheless encounter variable reimbursement, leading to disputes over pricing and billing. Each third-party payer typically has different billing requirements, and the billing requirements of many payers have become increasingly difficult to meet. Among the factors complicating our billing of third-party payers are:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disparity in coverage among various payers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disparity in information and billing requirements among payers, including with respect to prior authorization requirements and procedures and establishing medical necessity; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incorrect or missing billing information, which is required to be provided by the ordering health care provider.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks related to billing complexities, and the associated uncertainty in obtaining payment for our tests, could harm our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Status as an out-of-network provider with a large commercial insurer may cause health care providers to avoid recommending our tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be considered to be an out-of-network provider with respect to the large commercial insurers from which we may receive reimbursement from in the future. Physician groups and other health care providers may view this negatively and may insist upon only using laboratories that are in-network with their patients&#8217; insurance companies. These types of decisions could reduce our revenue and harm our financial condition.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in government health care policy could increase our costs and negatively impact coverage and reimbursement for our tests by governmental and other third-party payers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. government is pursuing health care reform and aiming to reduce health care costs. Government health care policy has been, and will likely continue to be, a topic of extensive legislative and executive activity in the U.S. federal government and many U.S. state governments. As a result, our business could be affected by significant and potentially unanticipated changes in government health care policy, which could in turn substantially impact our revenues, increase costs, and divert management attention from our business strategy. We cannot predict the impact of governmental health care policy changes on our future business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Affordable Care Act, or ACA, was signed into law in March 2010 and significantly impacted the U.S. pharmaceutical and medical device industries, including the diagnostics sector, in a number of ways. The ACA restricts insurers from charging higher premiums or denying coverage to individuals with pre-existing conditions, and requires insurers to cover certain preventative services without charging any copayment or coinsurance, including screening for lung, breast, colorectal and cervical cancers. The ACA also created a new system of health insurance &#8220;exchanges&#8221; designed to make health insurance available to individuals and certain groups through state- or federally-administered marketplaces in addition to existing channels for obtaining health insurance coverage. In connection with such exchanges, certain &#8220;essential health benefits&#8221; are intended to be made more consistent across plans, setting a baseline coverage level. The states (and the federal government) have some discretion in determining the definition of &#8220;essential health benefits&#8221; and we do not know whether our tests or other products will fall into a benefit category deemed &#8220;essential&#8221; for coverage purposes across the plans offered in any or all of the exchanges. If any of our tests are not covered by plans offered in the health insurance exchanges, our business, operating results and financial condition could be adversely affected.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been multiple attempts to repeal the ACA or significantly scale back its applicability, as a result of which, certain sections of the ACA have not been fully implemented or were effectively repealed. This could negatively impact reimbursement for our testing, adversely affect our test volumes and adversely affect our business, operating results, and financial condition. However, following several years of litigation in the federal courts, in June 2021, the United States Supreme Court upheld the ACA when it dismissed a legal challenge to the Act&#8217;s constitutionality. Further legislative and regulatory changes under the ACA remain possible, although the current Democrat-led presidential administration has been taking steps to strengthen the ACA and the 117th Congress is not expected to have the same interest in repealing the law, in part due to the health care economic impacts of the COVID-19 pandemic on many subsets of the U.S. population. Future changes or additions to the ACA, the Medicare and Medicaid programs, and changes stemming from other health care reform measures, especially with regard to health care access, financing or other legislation in individual states, could have a material adverse effect on the health care industry in the U.S. The uncertainty around the future of the ACA, and in particular the impact to reimbursement levels and the number of insured individuals, may lead to delay in the purchasing decisions of our customers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the ACA, various health care reform proposals have also emerged from federal and state governments. The Protecting Access to Medicare Act of 2014, or PAMA, for example, introduced a multi-year pricing program for services payable under the Clinical Laboratory Fee Schedule, or CLFS, that is designed to bring Medicare allowable amounts in line with the amounts paid by private payers. The rule issued by CMS to implement PAMA required certain laboratories to report third-party payer rates and test volumes.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implementation of Medicare rates pursuant to PAMA has negatively impacted overall pricing and reimbursement for many clinical laboratory testing services and may do so in the future. Since January 1, 2018, the Medicare payment rate for these tests is equal to the weighted median private payer rate reported to CMS, which for many tests is lower than the previous CLFS payment rates due to the often lower negotiated commercial insurer rates applicable to large commercial laboratories that were required to report data to CMS. Likewise, because commercial insurers often base their pricing for laboratory testing on a percentage of the price set on the CLFS, PAMA has in turn affected rates paid by commercial insurers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have not historically submitted claims to Medicare or other state and federal health care programs, the rates paid by these programs have been the subject of controversy in the industry, including a lawsuit by the American Clinical Laboratory Association, and it is unclear whether and to what extent the new rates may change.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted in the United States since the ACA was enacted. In August 2011, the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#8217;s automatic reduction to several state and federal health care programs. This includes aggregate reductions of Medicare payments to providers up to 2% per fiscal year, and, due to subsequent legislative amendments, will remain in effect through 2030 unless additional Congressional action is taken. Pursuant to the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, as well as subsequent legislation, these reductions were suspended from May 1, 2020 through March 31, 2021 due to the COVID-19 pandemic. The suspension was subsequently extended through March 31, 2022. From April 2022 through June 2022, a 1% sequester cut was in effect, with the full sequester resuming thereafter. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether future health care initiatives will be implemented at the federal or state level or how any such future legislation, regulation, or initiative may affect us. Current or potential future federal legislation and the expansion of government&#8217;s role in the U.S. health care industry, as well as changes to the reimbursement amounts paid by third-party payers for our current and future tests, may adversely affect our test volumes and adversely affect our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the validity of an informed consent from a patient is challenged, we could be precluded from billing for such patient&#8217;s testing, be forced to stop performing certain tests, forced to exclude the patient&#8217;s data or specimens from clinical trial results or be subject to lawsuits or regulatory enforcement.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to ensure that all clinical data and blood specimens that we receive have been collected from subjects who have provided appropriate informed consent for us to perform our testing, both commercially and in clinical trials. Among other things, in our consent forms, we seek to ensure that the subjects from whom the data and specimens are collected do not retain or have conferred on them any proprietary or commercial rights to the data or any discoveries derived from them. A subject&#8217;s informed consent could be challenged in the future, and the informed consent could prove invalid, unlawful or otherwise inadequate for our purposes. Any such findings against us, or our partners, could deny us access to, or force us to stop, testing specimens in a particular territory or could call into question the results of our clinical trials. We could also be precluded from billing third-party payers for tests for which the underlying informed consents are challenged, or we could be requested to refund amounts previously paid by third-party payers for such tests. We could become involved in legal challenges or regulatory enforcement, which could require significant management and financial resources and adversely affect our operating results.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Government Regulation</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely impacted by changes in laws and regulations, or in their application.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health care industry in which we operate is highly regulated, and failure to comply with applicable regulatory, supervisory, accreditation, registration, or licensing requirements may adversely affect our business, operating results, and financial condition. The laws and regulations governing our research and marketing efforts are extremely complex and in many instances there are no clear regulatory or judicial interpretations of these laws and regulations, which increases the risk that we may be found to be in violation of these laws.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, the industry is growing, and regulatory agencies such as HHS or the FDA may apply heightened scrutiny to new developments. While we have taken steps to ensure compliance with current regulatory frameworks in all material respects as historically enforced by the applicable regulatory agencies, given the highly complex and often unclear guidelines, there could be areas where we are unintentionally and unknowingly noncompliant. Any change in the federal or state laws or regulations relating to our business may require us to implement changes to our business or practices, and we may not be able to do so in a timely or cost-effective manner. Should we be found to be noncompliant with current or future regulatory requirements, we may be subject to sanctions that could include changes to our operations, adverse publicity, substantial financial penalties, exclusion from state and federal health care programs, and criminal proceedings, which may adversely affect our business, operating results, and financial condition by increasing our cost of compliance or limiting our ability to develop, market, and commercialize our products.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there has been a recent trend of increased U.S. federal and state regulation of payments made to physicians, which are governed by laws and regulations including the Stark Law, the federal Anti-Kickback Statute, the Physician Payments Sunshine Act, the Eliminating Kickbacks in Recovery Act of 2018, and the federal False Claims Act, as well as state equivalents of such laws. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have implemented and strive to continuously develop and improve compliance policies and procedures intended to address compliance with applicable federal and state laws and regulations, including applicable fraud and abuse laws and regulations such as those described in this risk factor, the evolving commercial compliance environment and the need to build and maintain robust and scalable systems to comply with regulations in multiple jurisdictions with different compliance and reporting requirements increases the possibility that we could inadvertently violate one or more of these requirements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the way the FDA regulates laboratory developed tests or the reagents, other consumables, and testing equipment we use when developing, validating, and performing our tests could result in delay or additional expense in bringing our tests to market or performing such tests for our customers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the sequencing instruments, reagents, kits, and other consumable products used to perform our testing, as well as the instruments and other capital equipment that enable the testing, are offered for sale as analyte specific reagents, or ASRs, or for research use only, or RUO. ASRs are medical devices and must comply with FDA quality system requirements provisions and other device requirements, but most are exempt from premarket review by the FDA as an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">in vitro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diagnostic product. Products that are intended for RUO and are labeled as RUO are exempt from compliance with most FDA requirements, including the approval or clearance and other product quality requirements for medical devices. A product labeled RUO but which is actually intended for clinical diagnostic use may be viewed by the FDA as adulterated and misbranded under the Federal Food, Drug and Cosmetic Act, or the FD&amp;C Act, and subject to FDA enforcement action. The FDA has said that when determining the intended use of a product labeled RUO, it will consider the totality of the circumstances surrounding distribution and use of the product, including how the product is marketed and to whom. The FDA could disagree with a supplier&#8217;s assessment that the supplier&#8217;s products are RUOs, or could conclude that products labeled as RUO are actually intended for clinical diagnostic use, and could take enforcement action against the supplier, including requiring the supplier to cease offering the product while it seeks appropriate marketing authorization from FDA. Suppliers of ASRs and RUO products that we employ in our tests may cease selling their respective products, and we may be unable to obtain an acceptable substitute on commercially reasonable terms or at all, which could significantly and adversely affect our ability to provide timely testing results to our customers or could significantly increase our costs of conducting business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with federal and/or state laboratory licensing requirements, we could lose the ability to perform our tests or experience disruptions to our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a clinical laboratory, our business is subject to regulation by CMS through its Clinical Laboratory Improvement Amendments of 1988, or CLIA, program. The CLIA program regulates the quality of most laboratory testing performed on human specimens in the United States. CLIA regulations establish quality standards for laboratory testing in an effort to ensure the accuracy, reliability, and timeliness of patient results. To that same end, CLIA regulations require clinical laboratories to obtain a CLIA certificate and to meet specific standards with respect to operations, personnel, facilities, quality control and assurance, administration, participation in proficiency testing, and patient test management. CLIA certification is also required in order for us to be eligible to bill federal and state health care programs, as well as commercial insurers for our tests. To renew and maintain our CLIA certification, we are subject to survey and inspection every two years. Our laboratory holds a CLIA Certificate of Accreditation. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our laboratory is also accredited by the College of American Pathologists, or CAP. CMS has deemed CAP standards to be equally or more stringent than CLIA regulations and has approved CAP as a recognized accrediting organization. Inspection by CAP is performed in lieu of inspection by CMS for CAP-accredited laboratories. Because we are accredited by the CAP Laboratory Accreditation Program, we are deemed to also comply with CLIA. Many commercial insurers require CAP accreditation as a condition to contracting with clinical laboratories to cover their tests.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has the authority to impose a wide range of sanctions, including revocation of the CLIA certification, directed plans of correction, onsite monitoring, civil monetary penalties, civil injunctive suits, a bar on the ownership or operation of a CLIA-certified laboratory by any owners or operators of the deficient laboratory, and many others, depending on the nature of the CLIA violation. Any sanction imposed under CLIA and its implementing regulations, including but not limited to those applicable to proficiency testing, or our failure to renew a CLIA certificate, could have a material and adverse effect on our business, operating results and financial condition. If we were to lose our CLIA certification, we would not be able to operate our clinical laboratory or conduct our testing, which would adversely impact our business, operating results, and financial condition. In such case, even if we were able to bring our laboratory back into compliance, we could incur significant expenses and lose revenue while doing so. Failure to maintain CAP accreditation could likewise have a material adverse effect on the sales of our tests and the results of our operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our laboratory is located in Salt Lake City, Utah. Utah requires that laboratories located in this state hold a CLIA certificate (which we do), as well as approval from the Utah Department of Health, or UT DOH, to operate a laboratory. In addition to meeting CLIA requirements and holding a valid CLIA certificate, Utah requires that our laboratory timely notify the UT DOH of certain changes and demonstrate successful performance of proficiency testing in an approved proficiency testing program or approved alternative testing program. If our clinical laboratory is out of compliance with these standards, the UT DOH may revoke our approval to perform testing or potentially impose other remedial measures, any of which could materially affect our business. We maintain an approval in good standing with the UT DOH.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, several states require that out-of-state laboratories hold laboratory licenses from those states in order to test specimens from patients, or accept specimens from laboratories, in those states. One such state is New York. As part of the laboratory licensure process, the New York Department of Health, or NY DOH, requires that laboratories seeking licensure establish the analytic and clinical performance characteristics of all tests performed, and also imposes specific review and approval requirements on certain categories of testing, including laboratory developed tests, or LDTs. As an LDT, our PreTRM test is thus subject to this NY DOH review and approval process. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained licenses from states where we believe we are required to be licensed. From time to time, we may become aware of other states that require out-of-state laboratories to obtain licensure in order to accept specimens from those states, and it is possible that other states do have such requirements or will have such requirements in the future. If we identify any other state with such requirements or if we are contacted by any other state advising us of such requirements, we expect to seek to comply with such requirements. However, there is no assurance that we will be able to obtain any such required license for the particular state.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a clinical laboratory is out of compliance with state laboratory licensure laws and regulations, the state authority may suspend, restrict or revoke the license to operate the clinical laboratory, assess substantial civil money penalties, or impose specific corrective action plans. If we were to lose a required state license, we would not be able to operate our clinical laboratory and conduct our tests, in full or in particular states, which would adversely impact our business, operating results, and financial condition. Any such actions could materially affect our business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The FDA may undertake rulemaking to regulate Laboratory Developed Tests or Congress may reform the current legal requirements applicable to LDTs, in which case we may become subject to extensive regulatory requirements and may be required to conduct additional clinical trials prior to continuing to sell our existing tests or launching any other tests we may develop, which may increase the cost of conducting, or otherwise harm, our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently market the PreTRM test as an LDT and may in the future market other tests as LDTs. The FDA has adopted a policy of enforcement discretion with respect to LDTs whereby the FDA does not generally actively enforce its regulatory requirements for such tests. However, in the past the FDA has stated its intention to modify its enforcement discretion policy with respect to LDTs. If there are changes in FDA regulations and legislative authorities such that the agency begins to exercise oversight over LDTs, or if the FDA disagrees that our marketed tests are within the scope of its criteria used for defining LDTs, we may become subject to extensive regulatory requirements and may be required to stop selling our existing test or launching any other tests we may develop and to conduct additional clinical trials or take other actions prior to continuing to market our tests. If the FDA allows our tests to remain on the market but there is uncertainty about our tests, if they are labeled investigational by the FDA or if labeling claims the FDA allows us to make are very limited, orders from health care providers or reimbursement for our tests may decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that we are currently in material compliance with applicable laws and regulations as historically enforced by the FDA with respect to LDTs, we cannot assure you that the FDA will agree with our determination. A determination that we have violated these laws and regulations, or a public announcement that we are being investigated for possible violations, could adversely affect our business, prospects, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if the FDA were to disagree with our conclusion that the PreTRM test falls within the scope of the agency&#8217;s LDT definition and that the PreTRM test is thus subject to FDA&#8217;s medical device authorities and implementing regulations, the agency could require that we obtain premarket approval or another type of device premarket authorization in order for us to commercialize the PreTRM test. As part of this process, we may also be required to conduct additional clinical testing before applying for commercial marketing authorization. Clinical trials must be conducted in compliance with FDA regulations in order to support a marketing submission to the agency for a regulated product, or the FDA may take certain enforcement actions or reject the data. Performing additional, new clinical studies and trials in order to obtain product approval from the FDA, if any were to become necessary, would take a significant amount of time and would substantially delay our ability to commercialize the PreTRM test, all of which would adversely impact our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, since 2017, Congress has been working on legislation to create an LDT and In Vitro Diagnostic, or IVD, regulatory framework that would be separate and distinct from the existing medical device regulatory framework. The most recent version of such legislation being considered by the 117th Congress, called the Verifying Accurate, Leading-edge IVCT Development, or VALID Act, would codify the term &#8220;in vitro clinical test&#8221;, or IVCT, and create new medical product category separate from medical devices that includes products currently regulated as IVDs as well as LDTs, among other provisions. The VALID Act would also create a new system for laboratories to use to submit their tests electronically to the FDA for approval, which is aimed at reducing the amount of time it would take for the agency to approve such tests, and establish a new program to expedite the development of diagnostic tests that can be used to address a current unmet need for patients. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Congress were to pass the VALID Act or any other legislation applicable to the FDA&#8217;s regulation of LDTs, or if the FDA were to promulgate new regulations for such products through notice-and-comment rulemaking, we will likely be subject to increased regulatory burdens such as registration and listing requirements, adverse event reporting requirements, and quality control requirements. Any legislation or formal FDA regulatory framework affecting LDTs is also likely to have premarket application requirements prohibiting commercialization without FDA authorization and controls regarding modification to the tests that may require further FDA submissions. Any such process would likely be costly and time-consuming.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome and ultimate impact on our business of any changes to the federal government&#8217;s regulation of LDTs is difficult to predict. Potential future increased regulation of our LDTs could result in increased costs and administrative and legal actions for noncompliance, including warning letters, fines, penalties, product suspensions, product recalls, injunctions and other civil and criminal sanctions, which could have a material and adverse effect upon our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, should it be required in the future, we cannot be sure that the PreTRM test, or any new tests that we may develop will be reviewed and authorized for marketing by the FDA in a timely or cost-effective manner, if authorized at all. Even if such tests are authorized for marketing by the FDA, the agency could limit the test&#8217;s indications for use, which may significantly limit the market for that product and may adversely affect our business and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Federal Trade Commission and/or state enforcement or regulatory agencies may object to the methods and materials we use to promote our tests and initiate enforcement against us, which could adversely affect our business and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Federal Trade Commission, or FTC, and/or state enforcement or regulatory agencies (including but not limited to the offices of state attorneys general) may object to the materials and methods we use to promote our current tests or other LDTs we may develop in the future, including with respect to the product claims in our promotional materials, and may initiate enforcement actions against us. Enforcement actions by the FTC may include, among others, injunctions, civil penalties, and equitable monetary relief.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards, and other requirements could adversely affect our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global data protection landscape is rapidly evolving, and we are or may become subject to numerous state and federal laws, requirements, and regulations governing the collection, use, disclosure, retention, and security of personal information. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact future laws, regulations or standards or perception of their requirements may have on our business. This evolution may create uncertainty in our business, affect our ability to operate in certain jurisdictions or to collect, store, transfer, use and share personal information, necessitate the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. The cost of compliance with these laws, regulations, and standards is high and is likely to increase in the future. Any failure or perceived failure by us to comply with federal or state laws or regulations, our internal policies and procedures or our contracts governing our use and disclosures of personal information could result in negative publicity, government investigations and enforcement actions, claims by third parties, and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance, and business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our operations and business grow, we may become subject to or affected by new or additional privacy and security laws and regulations and face increased scrutiny or attention from regulatory authorities. In the United States, the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic and Clinical Health Act of 2009, or HITECH (collectively, HIPAA) requires organizations like ours to develop and implement policies and procedures with respect to information that is protected under HIPAA, called protected health information, or PHI, that is used or disclosed in connection with our testing services, including the adoption of administrative, physical, and technical safeguards to protect such information.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA further requires organizations subject to HIPAA, called &#8220;covered entities&#8221; to notify affected individuals without unreasonable delay and in no case later than 60 calendar days following discovery, of certain unauthorized access, uses, or disclosures of PHI. If a breach affects 500 individuals or more in a particular state or jurisdiction, covered entities must report it to the HHS and local media contemporaneously with notice to affected individuals, and HHS will post information regarding the breach, including the name of the entity reporting the breach, on its public website. If a breach affects fewer than 500 individuals, the covered entity must notify HHS within the first 60 days of the following calendar year in which the breach occurred.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Penalties for failure to comply with HIPAA and HITECH are substantial and could include corrective action plans, and/or the imposition of civil monetary or criminal penalties. HIPAA also authorizes state attorneys general to enforce HIPAA on behalf of state residents. Courts can award damages, costs, and attorneys&#8217; fees related to violations of HIPAA in such cases. While HIPAA does not create a private right of action allowing individuals to sue us in civil court for HIPAA violations, its standards have been used as the basis for a duty of care claim in state civil suits such as those for negligence or recklessness in the misuse or breach of PHI.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have also adopted privacy and security laws and regulations, some of which may be more stringent than HIPAA and/or regulate information other than PHI. Such laws and regulations will be subject to interpretation by various courts and other governmental authorities, thus creating potentially complex compliance issues for us and our future customers and strategic partners. At the state level, for example, California has enacted the California Consumer Privacy Act, or CCPA, an extremely comprehensive and stringent privacy law. The CCPA took effect on January 1, 2020, and became enforceable by the California Attorney General on July 1, 2020. It creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal data. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches. CCPA does not apply to information that is protected by HIPAA, but CCPA still applies to other types of personal information held by HIPAA covered entities, such as personnel or marketing information. The regulations issued under the CCPA have been modified several times, and there is still some uncertainty about how the law will be interpreted and enforced.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, California voters also approved a new privacy law, the California Privacy Rights Act, or CPRA, on November 3, 2020. The CPRA will modify the CCPA significantly, potentially resulting in further uncertainty, additional costs and expenses stemming from efforts to comply, and additional potential for harm and liability for failure to comply. The CPRA imposes additional obligations on companies covered by the legislation and will expand consumers&#8217; rights with respect to certain sensitive personal information. The CPRA also creates a new state agency that will be vested with authority to implement and enforce the CCPA and the CPRA. In addition, in February 2021, the Virginia legislature became the second to enact a state-specific law called the Consumer Data Protection Act, or CDPA, which includes key differences from California&#8217;s law, further complicating compliance by industry and other stakeholders. Many similar laws have also been proposed in other states and at the federal level.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCPA, the CDPA, and similar laws may increase our compliance costs and potential liability. Any liability from failure to comply with the requirements of these laws could adversely affect our financial condition. All U.S. states have implemented data breach notification laws that overlap and often conflict with HIPAA and apply simultaneously. We must comply with all of these laws simultaneously in the event of a data breach which is a complicated and expensive proposition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory framework governing the collection, storage, use, and sharing of certain information, particularly financial and other personal information, is rapidly evolving and is likely to continue to be subject to uncertainty and varying interpretations. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our existing practices. Any failure or perceived failure by us, or any third parties with which we do business, to comply with our privacy policies, changing expectations, evolving laws, rules and regulations, industry standards, or contractual obligations to which we or such third parties are or may become subject, may result in actions or other claims against us by governmental entities or private actors, the expenditure of substantial costs, time and other resources or the incurrence of significant fines, penalties or other liabilities. In addition, any such action, particularly to the extent we were found to be guilty of violations or otherwise liable for damages, would damage our reputation and adversely affect our business, financial condition, and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work to comply with applicable laws, regulations and standards, our contractual obligations, and other legal obligations, these requirements are evolving and may be modified, interpreted, and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Any failure or perceived failure by us or our employees, representatives, contractors, consultants, Contract Research Organizations, or CROs, collaborators, or other third parties to comply with such requirements or adequately address privacy and security concerns, even if unfounded, could result in additional cost and liability to us, damage our reputation, and adversely affect our business and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches, losses of data, and other disruptions could compromise sensitive information related to our business or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and reputation.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, including PHI (such as patient medical records, including test results), and personally identifiable information. We also store business and financial information, intellectual property, research and development information, trade secrets, and other proprietary and business critical information, including that of our customers, payers and collaboration partners. We manage and maintain our data utilizing a combination of on-site systems, managed data center systems and cloud-based data center systems. We are highly dependent on information technology networks and systems, including the internet, to securely process, transmit and store critical information. Although we take measures to protect sensitive information from unauthorized access or disclosure, our information technology and infrastructure, and that of our third-party billing and collections provider and other service providers, may be vulnerable to attacks by hackers, viruses, disruptions and breaches due to employee error or malfeasance.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A security breach or privacy violation that leads to unauthorized access, disclosure or modification of, or prevents access to, patient information, including PHI, could implicate state and federal breach notification laws, subject us to fines and mandatory corrective action and require us to verify the correctness of, or to reconstruct, database contents. Such a breach or violation also could result in legal claims or proceedings brought by a private party or a governmental authority, liability under laws and regulations that protect the privacy of personal information, such as HIPAA, HITECH and laws and regulations of various U.S. states, as well as penalties imposed by the Payment Card Industry Security Standards Council for violations of the Payment Card Industry Data Security Standards. If we are unable to prevent such security breaches or privacy violations or implement satisfactory remedial measures, we may suffer loss of reputation, financial loss, and civil or criminal fines or other penalties. In addition, these breaches and other forms of inappropriate access can be difficult to detect, and any delay in identifying them may lead to increased harm of the type described above.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unauthorized access, loss or dissemination of information could disrupt our operations, including our ability to perform tests, provide test results, bill payers or patients, process claims and appeals, provide customer assistance services, conduct research and development activities, develop and commercialize tests, collect, process and prepare company financial information, provide information about our tests, educate patients and health care providers about our service, and manage the administrative aspects of our business, any of which could damage our reputation and adversely affect our business. Any breach could also result in the compromise of our trade secrets and other proprietary information, which could adversely affect our competitive position.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, health-related, privacy, and data protection laws and regulations in the U.S. are subject to interpretation and enforcement by various governmental authorities and courts, resulting in complex compliance issues and the potential for varying or even conflicting interpretations, particularly as laws and regulations in this area are in flux. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our practices. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business and our reputation. Complying with these laws could cause us to incur substantial costs or require us to change our business practices and compliance procedures in a manner adverse to our business, operating results, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure or perceived failure by us or any third-party collaborators, service providers, contractors or consultants to comply with privacy, confidentiality, data security or similar obligations, or any data security incidents or other security breaches that result in the accidental, unlawful or unauthorized access to, use of, release of, or transfer of sensitive information, including personally identifiable information, or PHI, may result in negative publicity, harm to our reputation, governmental investigations, enforcement actions, regulatory fines, litigation or public statements against us, could cause third parties to lose trust in us or could result in claims by third parties, including class action lawsuits, any of which could have a material adverse effect on our reputation, business, financial condition or results of operations. While we have implemented data security measures intended to protect our information, data, information technology systems, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applications and infrastructure, there can be no assurance that such measures will successfully prevent service interruptions or data security incidents or that these measures will be satisfactory to regulatory authorities in the event of an audit, investigation or complaint.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we, or our employees or contractors on our behalf, engage in conduct that violates health care laws, are suspected or accused of engaging in such conduct or are subject to investigation for actual or alleged such conduct, we could face substantial penalties and damage to our reputation, and our business operations and financial condition could be adversely affected.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in one of the most highly regulated industries in the United States. Our business activities are, or may in the future be, subject to comprehensive compliance obligations under state and federal laws and regulations, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal and state laws governing laboratory testing, including but not limited to the Clinical Laboratory Improvement Amendments of 1988 and state laboratory licensure and related laws.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Anti-Kickback Statute, or AKS, which generally prohibits, among other things knowingly and willfully offering, paying, soliciting, or receiving any remuneration, directly or indirectly, covertly or overtly, in cash or in kind in return for (i) referring an individual to a person for the furnishing or arranging of any item or service, or (ii) purchasing, leasing, ordering, or arranging for or recommending the purchasing, leasing, or ordering of any good, facility, service, or item, for which payment may be made by federal health care programs. A person or entity does not need to have actual knowledge of the AKS or specific intent to violate it to have committed a violation. Safe harbors and exceptions to the AKS protect specified arrangements and conduct if every element of the applicable safe harbor or exception is met. However, failure to satisfy each such requirement does not necessarily mean that the arrangement or conduct at issue violates the AKS. In such circumstances, a facts-and-circumstances analysis is necessary to determine AKS compliance or lack thereof. Violations of the AKS are subject to civil and criminal fines and penalties for each violation, plus up to three times the remuneration involved, imprisonment, and exclusion from federal health care programs. In addition, claims submitted to federal health care programs for items or services resulting from a violation of the AKS are deemed to be false or fraudulent claim for purposes of the False Claims Act, or FCA.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Stark Law, also known as the physician self-referral prohibition, which, unless an exception applies, generally prohibits physicians or an immediate family member from making referrals for certain designated health services covered by Medicare or Medicaid, including clinical laboratory services, if the physician or an immediate family member has a prohibited financial relationship with the entity providing the services at issue. State enforcement agencies may assert that a claim including items or services resulting from a violation of the state physician self-referral law constitutes a false or fraudulent claim for purposes of any state false claims statute. If we submit claims to Medicare or Medicaid in the future, our business activities will also be subject to the federal Stark Law.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal False Claims Act, which imposes civil liability on any person or entity that, among other things, knowingly presents, or causes to be presented, to the federal government, claims for payment that are false or fraudulent; and/or knowingly makes, uses, or causes to be made or used, a false statement of record material to a false or fraudulent claim or obligation to pay or transmit money or property to the federal government. The FCA also prohibits the knowing retention of overpayments (sometimes referred to as &#8220;reverse false claims&#8221;) and permits private individuals acting as &#8220;whistleblowers&#8221; to bring actions on behalf of the federal government alleging violations of the FCA and to share in any monetary recovery. The federal government may elect or decline to intervene in such matters, but if the government declines intervention, the whistleblower may still proceed with the litigation on the government&#8217;s behalf.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal Civil Monetary Penalties Law, or CMP Law, which, unless an exception applies, prohibits, among other things, (1) the offering or transfer of remuneration to a beneficiary of Medicare or a state health care program, if the person knows or should know it is likely to influence the beneficiary&#8217;s selection of a particular provider, practitioner, or supplier of services reimbursable by Medicare or a state health care program; (2) employing or contracting with an individual or entity that the provider knows or should know is excluded from participation in a federal health care program; (3) billing for services requested by an unlicensed physician or an excluded provider; and (4) billing for medically unnecessary services.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal health care fraud statute, which imposes criminal liability for knowingly and willfully executing or attempting to execute a scheme to defraud any health care benefit program (which includes commercial insurers). Violations of this statute are punishable by imprisonment, fines, or both.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The federal statute prohibiting false statements relating to health care matters, which criminalizes knowingly and willfully falsifying, concealing or covering up by any trick or device a material fact or making any materially </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">false, fictitious, or fraudulent statements or representations in connection with the delivery of, or payment for, health care benefits, items or services relating to health care matters. Violations of this statute are punishable by imprisonment, fines, or both.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by HITECH and their respective implementing regulations, including the Final Omnibus Rule published in January 2013, which impose requirements on certain covered health care providers, health plans, and health care clearinghouses as well as their respective business associates. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce HIPAA and seek attorneys&#8217; fees and costs associated with pursuing federal civil actions. In addition, there are additional federal, state, and non-U.S. laws which govern the privacy and security of health and other personal information, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Eliminating Kickbacks in Recovery Act of 2018, or EKRA, which is an all-payer anti-kickback law that criminalizes the offer, payment, solicitation or receipt of any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in return for referring, to induce referrals of, or in exchange for referring patients to recovery homes, clinical treatment facilities, or laboratories, unless an exception applies. Most of the safe harbors applicable under the AKS are not reiterated in the text of EKRA, which could be interpreted to expand the universe of arrangements that could be subject to enforcement. A violation of EKRA is punishable by imprisonment and fines.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">State data privacy and security laws, which may be more stringent than HIPAA. For example, the CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal data. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches. The CCPA is expected to increase data breach litigation and may increase our compliance costs and potential liability. Many similar laws have been proposed at the federal level and in other states; in the event that we are subject to or affected by any such privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Federal, state, and local regulations relating to the handling and disposal of regulated medical waste, hazardous waste, and biohazardous waste and workplace safety for health care employees.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Laws and regulations relating to health and safety, labor and employment, public reporting, taxation, and other areas applicable to businesses generally, all of which are subject to change, including, for example, the significant changes to the taxation of business entities were enacted in December 2017.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Additionally, we are subject to state equivalents of each of the health care laws and regulations described above, among others, some of which may be broader in scope and may apply regardless of the payer. Many U.S. states have adopted laws similar to the AKS, Stark Law, and FCA, which may apply to our business practices, including, but not limited to, research, distribution, sales or marketing arrangements, and claims involving health care items or services reimbursed by non-governmental payers, including commercial insurers. In addition, many states have fraud and abuse laws, such as fee-splitting restrictions, insurance fraud laws, anti-markup laws, prohibitions on waiving coinsurance, copayments, deductibles and other amounts owed by patients, and prohibitions on the provision of tests at no or discounted cost to induce physician or patient adoption. Some states also prohibit certain health care practices, such as billing physicians for tests that they order and business corporations practicing medicine or employing or engaging physicians to practice medicine. There are ambiguities as to what is required to comply with these state requirements and if we fail to comply with an applicable state law requirement, we could be subject to penalties. Finally, there are state and foreign laws governing the privacy and security of health information, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we develop our LDTs solely for use by or within our own laboratory, we believe we are exempt from the reporting requirements imposed under the federal Physician Payments Sunshine Act, or the Sunshine Act. The Sunshine Act requires, among other things, certain manufacturers of drugs, devices, biologics, and medical supplies reimbursed under Medicare, Medicaid or the Children&#8217;s Health Insurance Program to collect and report annually to CMS certain data and information related to payments and other transfers of value provided to physicians, teaching hospitals, and advanced non-physician health care practitioners, as well as ownership and investment interests, including such ownership and investment interests held by a physician&#8217;s immediate family members. For reporting beginning January 1, 2022, U.S.-licensed physicians assistants, clinical nurse specialists, certified nurse anesthetists, certified nurse midwives, and nurse practitioners must be included in the types of providers subject to Sunshine Act reporting. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe that the Sunshine Act does not apply to our business, we cannot guarantee that the federal government or other regulators will agree with our determination. Moreover, we could become subject to Sunshine Act reporting requirements if the FDA requires us to obtain premarket authorization for our tests as medical devices or Congress enacts legislative reforms to the federal oversight of LDTs to subject them to FDA regulation and/or the reporting requirements of the Sunshine Act. A determination that we have violated these laws and related CMS regulations, or a public announcement that we are being investigated for possible violations, could adversely affect our business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, rapid growth and expansion of our business may increase the risk of violating these laws or related internal compliance policies and procedures, as well as the possibility that we may be accused of and/or investigated for violating these laws, regulations, and related internal policies and procedures. We likewise may be accused of, and subject to investigation and/or enforcement for, violating these laws on the basis of conduct engaged in by our employees, contractors and/or other related third parties. Such accusations and investigations may stem from allegations made by whistleblowers under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the FCA or state law equivalents, as well as investigative efforts undertaken by state and federal regulatory and enforcement agencies. The evolving interpretations of these laws and regulations by courts and regulators increase the risk that we may be alleged to be, or in fact found to be, in violation of these or other laws and regulations.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the breadth of these laws and the narrowness of the statutory exceptions and safe harbors available, it is possible that some of our business activities could be subject to challenge and may not comply under one or more of such laws, regulations, and guidance. Law enforcement authorities are increasingly focused on enforcing fraud and abuse laws, and it is possible that some of our practices may be challenged under these laws. Efforts to ensure that our current and future business arrangements with third parties, and our business generally, will comply with applicable health care laws and regulations will involve substantial costs. If our operations, including our arrangements with physicians and other health care providers, are found to be in violation of any of such laws or any other governmental regulations that apply to us, we may be subject to penalties, including, without limitation, administrative, civil and criminal penalties, damages, fines, disgorgement, contractual damages, reputational harm, diminished profits and future earnings, the curtailment or restructuring of our operations, exclusion from participation in federal and state health care programs (such as Medicare and Medicaid), and imprisonment, as well as additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement to resolve allegations of non-compliance with these laws, any of which could adversely affect our ability to operate our business and our financial results.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies in our industry occasionally receive investigative demands, subpoenas, or other requests for information from state and federal governmental agencies. We cannot predict the occurrence, timing, outcome, or impact of any such investigations. Any adverse outcome in one or more of these investigations could include the commencement of civil and/or criminal proceedings, substantial fines, penalties, administrative remedies and/or entry into corporate integrity agreements with governmental agencies, among other penalties. In addition, resolution of any of these matters could involve the imposition of additional costly compliance obligations. These potential consequences, as well as any adverse outcome from government investigations, could have a material and adverse effect on our business, operating results, and financial condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to obtain, maintain, and enforce our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success and ability to compete depend, in part, on our ability to obtain, maintain, and enforce patents, trade secrets, trademarks, and other intellectual property rights and to operate without having third parties infringe, misappropriate, or circumvent the rights that we own or license. If we are unable to obtain, maintain, and enforce intellectual property protection covering our current and future tests or technology, others may be able to make, use or sell tests or technology that are substantially the same as ours without incurring the sizeable development costs that we have incurred, which would adversely affect our ability to compete in the market. Our ability to stop third parties from making, using, selling, offering to sell or importing our tests or technology is dependent upon the extent to which we have rights under valid and enforceable patents that cover these activities. However, the patent positions of diagnostic companies, including ours, can be highly uncertain and involve complex legal and factual questions for which important legal principles remain unresolved. The U.S. Supreme Court and U.S. Court of Appeals for the Federal Circuit have in recent years issued a number of decisions relating to the patent-eligibility of diagnostic method claims. We cannot predict what impact these decisions may have on our ability to obtain or enforce patents relating to diagnostic methods in the future. We believe that no consistent policy regarding the scope of valid patent claims in these fields has emerged to date in the United </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States. The patent situation in the diagnostics industry outside the United States also is uncertain at least in a number of countries. Moreover, U.S. patent laws frequently change, including changes regarding how patent laws are interpreted, and the U.S. Patent and Trademark Office, or USPTO, frequently issues new procedures to the patent system. We cannot accurately predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law. Those changes may materially affect our patents or our ability to obtain patents. Therefore, there can be no assurance that any current or future patent applications will result in the issuance of patents or that we will develop additional proprietary tests or technology which are patentable. Moreover, patents or pending applications that may issue in the future may not provide us with any competitive advantage. Our patent position is subject to numerous additional risks, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may fail to seek patent protection for inventions that are important to our success;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any current or future patent applications may not result in issued patents;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we cannot be certain that we were the first to file patent applications for the inventions covered by pending patent applications and, if we are not, we may be subject to priority or derivation disputes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to disclaim part or all of the term of certain patents or part or all of the term of certain patent applications;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may file patent applications but have claims restricted or we may not be able to supply sufficient data to support our claims and, as a result, may not obtain the original claims desired or we may receive restricted claims. Alternatively, it is possible that we may not receive any patent protection from an application;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could inadvertently abandon a patent or patent application, resulting in the loss of protection of certain intellectual property rights in a particular country. We or our patent counsel may take action resulting in a patent or patent application becoming abandoned which may not be able to be reinstated or if reinstated, may suffer patent term adjustments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the claims of our issued patents or patent applications when issued may not cover our tests or technology;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no assurance can be given that our patents would be declared by a court to be valid and enforceable or that a competitor&#8217;s test or technology would be found by a court to infringe our patents. Our patents or patent applications may be challenged by third parties in patent litigation or in proceedings before the USPTO or its foreign counterparts, and may ultimately be declared invalid or unenforceable, or narrowed in scope;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there may be prior art of which we are not aware that may affect the validity of a patent claim. There also may be prior art of which we are aware, but which we do not believe affects the validity or enforceability of a claim, which may, nonetheless, ultimately be found to do so;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third parties may develop tests or technology that have the same or similar effect as our tests and technology without infringing our patents. Such third parties may also intentionally circumvent our patents by means of alternate designs or processes or file applications or be granted patents that would block or hurt our efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there may be patents relevant to our tests or technology of which we are not aware;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain of our intellectual property was partly supported by a U.S. government grant awarded by the National Institutes of Health, and the government accordingly has certain rights in this intellectual property, including a non-exclusive, non-transferable, irrevocable worldwide license to use applicable inventions for any governmental purpose. Such rights also include &#8220;march-in&#8221; rights, which refer to the right of the U.S. government to require us to grant a license to the technology to a responsible applicant if we fail to achieve practical application of the technology or if action is necessary to alleviate health or safety needs, to meet requirements of federal regulations or to give preference to U.S. industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our patent counsel, lawyers or advisors may have given us, or may in the future give us incorrect advice or counsel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patent and patent enforcement laws of some foreign jurisdictions may not protect intellectual property rights to the same extent as laws in the United States, and many companies have encountered significant difficulties in protecting and defending such rights in foreign jurisdictions. If we encounter such difficulties or we are otherwise precluded from effectively protecting our intellectual property rights in foreign jurisdictions, our business prospects could be substantially harmed, and we may not pursue or obtain patent protection in all major markets; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not develop additional tests or technology that are patentable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these factors could hurt our ability to gain patent protection for our tests and technology.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issued patents covering our tests and technology could be found invalid or unenforceable, if challenged.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patents and patent applications may be subject to validity, enforceability and priority disputes. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. Some of our patents or patent applications may be challenged at a future point in time in opposition, derivation, reexamination, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review or interference or other similar proceedings. Any successful third-party challenge to our patents in this or any other proceeding could result in the unenforceability or invalidity of such patents, which may lead to increased competition to our business, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. In addition, if we initiate legal proceedings against a third party to enforce a patent covering our tests or technology, the defendant could counterclaim that such patent covering our tests or technology, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. There are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the relevant patent office, or made a misleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex parte</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> re-examination</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review, derivation and equivalent proceedings in non-U.S. jurisdictions, such as opposition proceedings. Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer cover and protect our tests or technology. With respect to the validity of our patents, for example, we cannot be certain that there is no invalidating prior art of which we, our licensor, our or its patent counsel and the patent examiner were unaware during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant or other third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection on certain aspects of our tests and technology, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license intellectual property or develop or commercialize current or future tests and technology.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be aware of all third-party intellectual property rights potentially relating to our tests or technology. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We might not have been the first to make the inventions covered by each of our pending patent applications and we might not have been the first to file patent applications for these inventions. To determine the priority of these inventions, we may have to participate in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO, or other similar proceedings in non-U.S. jurisdictions, that could result in substantial cost to us and the loss of valuable patent protection. The outcome of such proceedings is uncertain. No assurance can be given that other patent applications will not have priority over our patent applications. In addition, changes to the patent laws of the United States allow for various post-grant opposition proceedings that have not been extensively tested, and their outcome is therefore uncertain. Furthermore, if third parties bring these proceedings against our patents, regardless of the merit of such proceedings and regardless of whether we are successful, we could experience significant costs and our management may be distracted. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our intellectual property may be infringed upon by a third party.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties may infringe one or more of our patents, trademarks or other intellectual property rights. We cannot predict if, when or where a third party may infringe our intellectual property rights. To counter infringement, we may be required to file infringement lawsuits, which can be expensive and time consuming. There is no assurance that we would be successful in a court of law in proving that a third party is infringing one or more of our issued patents or trademarks. Any claims we assert against perceived infringers could also provoke these parties to assert counterclaims against us, alleging that we infringe their intellectual property. In addition, in a patent infringement proceeding, a court may decide that a patent of ours is invalid or unenforceable, in whole or in part, construe the patent&#8217;s claims narrowly and/or refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question, any of which may adversely affect our business. Even if we are successful in proving in a court of law that a third party is infringing our intellectual property rights, there can be no assurance that we would be successful in halting their infringing activities, for example, through a permanent injunction, or that we would be fully or even partially financially compensated for any harm to our business. We may be forced to enter into a license or other agreement with the infringing third party at terms less profitable or otherwise commercially acceptable to us than if the license or agreement were negotiated under conditions between those of a willing licensee and a willing licensor. We may not become aware of a third-party infringer within legal timeframes for compensation or at all, thereby possibly losing the ability to be compensated for any harm to our business. Such a third party may be operating in a foreign country where the infringer is difficult to locate and/or the intellectual property laws may be more difficult to enforce. Some third-party infringers may be able to sustain the costs of complex infringement litigation more effectively than we can because they have substantially greater resources. Any inability to stop third-party infringement could result in loss in market share of some of our tests and technology or even lead to a delay, reduction and/or inhibition of the development, manufacture or sale of certain tests and technology by us. There is no assurance that a test or technology produced and sold by a third-party infringer would meet our or other regulatory standards or would be safe for use. Such third-party infringer tests or technology could irreparably harm the reputation of our tests or technology thereby resulting in substantial loss in our market share and profits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Developments or uncertainty in the patent statute, patent case law or USPTO rules and regulations may impact the validity of our patent rights.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patent rights may be affected by developments or uncertainty in the patent statute, patent case law or USPTO rules and regulations. For example, the patent position of companies engaged in the development and commercialization of diagnostic tests are particularly uncertain. Changes in either the patent laws or interpretation of the patent laws in the United States or in other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. For instance, under the Leahy-Smith America Invents Act, or the America Invents Act, enacted in September 2011, the United States transitioned to a first inventor to file system in which, assuming that other requirements for patentability are met, the first inventor to file a patent application is entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. These changes include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to challenge the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review and derivation proceedings. The America Invents Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various courts, including the U.S. Supreme Court, have rendered decisions that impact the scope of patentability of certain inventions or discoveries relating to the life sciences technology. Specifically, these decisions stand for the proposition that patent claims that recite laws of nature are not themselves patentable unless those patent claims have sufficient additional features that provide practical assurance that the processes are genuine inventive applications of those laws rather than patent drafting efforts designed to monopolize the law of nature itself. What constitutes a &#8220;sufficient&#8221; additional feature is uncertain. Furthermore, in view of these decisions, since December 2014, the USPTO has published and continues to publish revised guidelines for patent examiners to apply when examining process claims for patent eligibility.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the USPTO, the laws and regulations governing patents could change in unpredictable ways that may have a material adverse effect on our ability to obtain new patents and to defend and enforce our existing patents and patents that we might obtain in the future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that our patent portfolio will not be negatively impacted by the current uncertain state of the law, new court rulings or changes in guidance or procedures issued by the USPTO or other similar patent offices around the world. From time to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability, scope and validity of patents within the life sciences technology and any such changes, or any similar adverse changes in the patent laws of other jurisdictions, could have a negative impact on our business, financial condition, prospects, and results of operations.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims that former employees, collaborators or other third parties have an interest in our patents, trade secrets or other intellectual property as an inventor or co-inventor. For example, we may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our tests and technology. In addition, counterparties to our consulting, sponsored research, software development and other agreements may assert that they have an ownership interest in intellectual property developed under such arrangements. In particular, certain software development agreements pursuant to which certain third parties have developed parts of our proprietary software may not include provisions that expressly assign to us ownership of all intellectual property developed for us by such third parties. As such, we may not have the right to use all such developed intellectual property under such agreements, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain such licenses and such licenses are necessary for the development, manufacture, and commercialization of our tests and technology, we may need to cease the development, manufacture, and commercialization of our tests and technology. Litigation may be necessary to defend against these and other claims challenging inventorship of our patents, trade secrets or other intellectual property. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our business, including our software, workflows, consumables, and reagent kits. In such an event, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all, or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture, and commercialization of our tests and technology. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and certain customers or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ individuals who were previously employed at other biotechnology or diagnostic companies. We may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed confidential information of our employees&#8217; former employers or other third parties. We may also be subject to claims that former employers or other third parties have an ownership interest in our patents. Litigation may be necessary to defend against these claims. There is no guarantee of success in defending these claims, and if we do not prevail, we could be required to pay substantial damages and could lose rights to important intellectual property. Even if we are successful, litigation could result in substantial cost and be a distraction to our management and other employees.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to prevent disclosure of our trade secrets and other proprietary information, the value of our tests and technology could be significantly diminished.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on trade secret protection to protect our interests in proprietary know-how and in processes for which patents are difficult to obtain or enforce, including the proprietary algorithm that we use for our tests and technology, including the PreTRM test. We may not be able to protect our trade secrets adequately. We have a policy of requiring our consultants, advisors, and collaborators to enter into confidentiality agreements and our employees to enter into invention, non-disclosure, and non-compete agreements. However, no assurance can be given that we have entered into appropriate agreements with all parties that have had access to our trade secrets, know-how or other proprietary information. There is also no assurance that such agreements will provide for a meaningful protection of our trade secrets, know-how or other proprietary information in the event of any unauthorized use or disclosure of information. Furthermore, we cannot provide assurance that any of our employees, consultants, contract personnel or collaborators, either accidentally or through willful misconduct, will not cause serious damage to our programs and our strategy, for example by disclosing important trade secrets, know-how or proprietary information to our competitors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is also possible that our trade secrets, know-how or other proprietary information could be obtained by third parties as a result of breaches of our physical or electronic security systems. Any disclosure of confidential data into the public domain or to third parties could allow our competitors to learn our trade secrets and use the information in competition against us. In addition, others may independently discover our trade secrets and proprietary information. Any action to enforce our rights is likely to be time consuming and expensive, and may ultimately be unsuccessful, or may result in a remedy that is not commercially valuable. These risks are accentuated in foreign countries where laws or law enforcement practices may not protect proprietary rights as fully as in the United States or Europe. Any unauthorized disclosure of our trade secrets or proprietary information could harm our competitive position.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Class A Common Stock</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our Class A common stock may be volatile, and you could lose all or part of your investment.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our Class A common stock is likely to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control, including limited trading volume. In addition to the factors discussed in this &#8220;Risk Factors&#8221; section and elsewhere in this report, these factors include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully meet our obligations under our commercial agreement with Elevance Health and obtain broader market adoption of our PreTRM test;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated variations in our and our competitors&#8217; results of operations, as well as how those results compare to analyst and investor expectations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to successfully commercialize our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of new products, significant acquisitions, other strategic transactions, including strategic and commercial partnerships and relationships, joint ventures, divestitures, collaborations or capital commitments;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in reimbursement practices by current or potential payers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of analysts to initiate or maintain coverage of our company, issuance of new securities analysts&#8217; reports or changed recommendations for our Class A common stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">forward-looking statements related to our financial guidance or projections, our failure to meet or exceed our financial guidance or projections or changes in our financial guidance or projections;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in regulatory oversight of our products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">development of disputes concerning our intellectual property or other proprietary rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement of, or our involvement in, litigation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcement or expectation of additional debt or equity financing efforts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any major change in our management;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to establish collaborations, if needed;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of key scientific or management personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to effectively manage our growth;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overall performance of the equity markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our common stock by us, our directors and officers, or our other stockholders in the future;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trading volume of our Class A common stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in accounting practices;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ineffectiveness of our internal controls;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general political and economic conditions; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other events or factors, many of which are beyond our control.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market in general, and the market for diagnostics companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of the companies, including as a result of the COVID-19 pandemic and inflationary pressures. Broad market and industry factors may negatively affect the market price of our Class A common stock, regardless of our actual operating performance. In the past, securities class action litigation has often been instituted against companies following periods of volatility in the market price of a company&#8217;s securities. This type of litigation, if instituted, could result in substantial costs and a diversion of management&#8217;s attention and resources.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends on our Class A common stock, so any returns will be limited to the value of our Class A common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. Furthermore, future debt or other financing arrangements may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our Class A common stock. Any return to stockholders will therefore be limited to the appreciation of their stock.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our executive officers, directors and their affiliates and our stockholders holding 5% or more of our common stock own a significant percentage of our Class A common stock and will be able to exert significant control over matters subject to stockholder approval.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive officers, directors and our stockholders holding 5% or more of our common stock and their affiliates beneficially hold a significant percentage of our outstanding Class A common stock. These stockholders, acting together, would be able to significantly influence our management and affairs and the outcome of matters submitted to our stockholders for approval, including the election of directors and any sale, merger, consolidation, or sale of all or substantially all of our assets. This concentration of ownership control may adversely affect the market price of our Class A common stock by:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delaying, deferring or preventing a change in control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">entrenching our management and the board of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impeding a merger, consolidation, takeover or other business combination involving us that other stockholders may desire; and/or</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of us.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The dual class structure of our common stock may limit your ability to influence corporate matters and may limit your visibility with respect to certain transactions.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The dual class structure of our common stock may limit your ability to influence corporate matters. Holders of our Class A common stock are entitled to one vote per share, while holders of our Class B common stock are not entitled to any votes per share. Nonetheless, each share of our Class B common stock may be converted at any time into one share of our Class A common stock at the option of its holder by providing written notice to us, subject to the limitations provided for in our amended and restated certificate of incorporation. Consequently, if holders of our Class B common stock exercise their option to make this conversion, this will have the effect of increasing the relative voting power of those prior holders of our Class B common stock, and correspondingly decreasing the voting power of the holders of our Class A common stock, which may limit your ability to influence corporate matters. Additionally, stockholders who hold, in the aggregate, more than 10% of our Class A common stock and Class B common stock, but 10% or less of our Class A common stock, and are not otherwise an insider, may not be required to report changes in their ownership due to transactions in our Class B common stock pursuant to Section 16(a) of the Exchange Act, and may not be subject to the short-swing profit provisions of Section 16(b) of the Exchange Act.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an emerging growth company and a smaller reporting company, and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies will make our Class A common stock less attractive to investors.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company, or EGC, as defined in the JOBS Act. For as long as we continue to be an EGC, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not EGCs, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in this report and our periodic reports and proxy statements and exemptions from the requirements of holding nonbinding advisory votes on executive compensation and stockholder approval of any golden parachute payments not previously approved. We may remain an EGC until the earliest to occur of: (1) the last day of the fiscal year in which we have at least $1.235 billion in annual revenue; (2) the last day of the fiscal year in which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our common stock held by non-affiliates exceeded $700.0 million as of the last business day of the second fiscal quarter of such year; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) December 31, 2026.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a smaller reporting company, meaning that the market value of our Class A common stock held by non-affiliates plus the approximate aggregate amount of gross proceeds to us as a result of our IPO is less than $700.0 million and our annual revenue is less than $100.0 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (1) the market value of our Class A common stock held by non-affiliates is less than $250.0 million or (2) our annual revenue is less than $100.0 million during the most recently completed fiscal year and the market value of our Class A common stock held by non-affiliates is less than $700.0 million. If we are a smaller reporting company at the time we cease to be an EGC we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may choose to take advantage of some, but not all, of the available exemptions. We have taken advantage of reduced reporting burdens in this report. In particular, we have not included all of the executive compensation information that would be required if we were not an EGC. We cannot predict whether investors will find our Class A common stock less attractive if we rely on certain or all of these exemptions. If some investors find our Class A common stock less attractive as a result, there may be a less active trading market for our Class A common stock and our stock price may be more volatile.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the JOBS Act, EGCs can also delay adopting new or revised accounting standards until such time as those standards apply to private companies, which may make our financial statements less comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of a substantial number of shares of our Class A common stock by our existing stockholders in the public market could cause our stock price to decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our shares of Class A common stock and Class B common stock are eligible for public sale, if they are registered under the Securities Act, or if they qualify for an exemption from registration under the Securities Act, including under Rules 144 or 701. If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our Class A common stock in the public market, the trading price of our Class A common stock could decline. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain holders of shares of our common stock will be entitled to rights with respect to the registration of their shares under the Securities Act as provided under the terms of an investors&#8217; rights agreement between us and the holders of our stock. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by affiliates, as defined in Rule 144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have registered on Form S-8 all shares of common stock that are issuable under our existing equity compensation plan, including the 2011 Employee, Director and Consultant Equity Incentive Plan, as amended, or the 2011 Plan, which expired in 2021, the 2021 Equity Incentive Plan, or the 2021 Plan, and the 2021 Employee Stock Purchase Plan, or the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 ESPP, as well as the shares of common stock underlying option awards outstanding under the 2011 Plan. Additionally, the number of shares of our Class A common stock reserved for issuance under our 2021 Equity Plan automatically increases on January 1 of each year, beginning on January 1, 2022, by 4% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Furthermore, the number of shares of our Class A common stock reserved for issuance under our 2021 ESPP automatically increases on January 1 of each year, beginning on January 1, 2022, by 1% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors or compensation committee. Unless our board of directors elects not to increase the number of shares available for future grant each year, our stockholders may experience additional dilution. As a consequence, these shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions under our charter documents and Delaware law could delay or prevent a change in control which could limit the market price of our Class A common stock and may prevent or frustrate attempts by our stockholders to replace or remove our current management.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could delay or prevent a change in control of our company or changes in our board of directors that our stockholders might consider favorable. Some of these provisions include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a board of directors divided into three classes serving staggered three-year terms, such that not all members of the board will be elected at one time;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a prohibition on stockholder action through written consent, which requires that all stockholder actions be taken at a meeting of our stockholders;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a requirement that special meetings of stockholders be called only by the board of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice requirements for stockholder proposals and nominations for election to our board of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a requirement that no member of our board of directors may be removed from office by our stockholders except for cause and, in addition to any other vote required by law, upon the approval of not less than two-thirds of all outstanding shares of our voting stock then entitled to vote in the election of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a requirement of approval of not less than two-thirds of all outstanding shares of our voting stock to amend any bylaws by stockholder action or to amend specific provisions of our certificate of incorporation; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the authority of the board of directors to issue convertible preferred stock on terms determined by the board of directors without stockholder approval and which convertible preferred stock may include rights superior to the rights of the holders of common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the General Corporation Law of the State of Delaware, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These anti-takeover provisions and other provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make it more difficult for stockholders or potential acquirers to obtain control of our board of directors or initiate actions that are opposed by the then-current board of directors and could also delay or impede a merger, tender offer or proxy contest involving our company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing or cause us to take other corporate actions you desire. Any delay or prevention of a change in control transaction or changes in our board of directors could cause the market price of our Class A common stock to decline.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our Class A common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. We do not have any control over these analysts. If few analysts commence coverage of us, the trading of our stock would likely decrease. Even if we do obtain sufficient analyst coverage, there can be no assurance that analysts will provide favorable coverage. If one or more of the analysts who covers us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price may decline. If one or more of these analysts ceases coverage of our company or fails to publish reports on us regularly, demand for our stock could decrease, which might cause our stock price and trading volume to decline.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated certificate of incorporation designates certain courts as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders, which could limit our stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation provides that, unless we consent in writing to an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any state law claims for (i) any derivative action or proceeding brought on our behalf, (ii) any action or proceeding asserting a claim of breach of fiduciary duty owed by any of our current or former directors, officers and employees, to us or our stockholders, (iii) any action or proceeding asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware, our amended and restated certificate of incorporation or our bylaws (in each case, as they may be amended from time to time), (iv) any action or proceeding to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or bylaws, (v) any action or proceeding as to which the Delaware General Corporation Law confers jurisdiction to the Court of Chancery of the State of Delaware, or (vi) any action asserting a claim against us or any of our directors, officers or employees that is governed by the internal affairs doctrine; provided, however, that this exclusive forum provision will not apply to any causes of action arising under the Exchange Act. Our amended and restated certificate of incorporation will further provide that, unless we consent in writing to an alternative forum, the United States District Court for the District of Utah will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. We have chosen the United States District Court for the District of Utah as the exclusive forum for such Securities Act causes of action because our principal executive offices are located in Salt Lake City, Utah. In addition, our amended and restated certificate of incorporation will provide that any person or entity purchasing or otherwise acquiring any interest in shares of our Class A common stock is deemed to have notice of and consented to the foregoing provisions. We recognize that the forum selection clause in our amended and restated certificate of incorporation may impose additional litigation costs on stockholders in pursuing any such claims, particularly if the stockholders do not reside in or near the State of Delaware or the State of Utah, as applicable. Additionally, the forum selection clause in our amended and restated certificate of incorporation may limit our stockholders&#8217; ability to bring a claim in a forum that they find favorable for disputes with us or our directors, officers, or employees, which may discourage such lawsuits against us and our directors, officers, and employees even though an action, if successful, might benefit our stockholders. The Court of Chancery of the State of Delaware or the United States District Court for the District of Utah may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders. Alternatively, if a court were to find the choice of forum provisions contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the applicability of the exclusive forum provision is limited to the extent permitted by applicable law, we do not intend that the exclusive forum provision would apply to suits brought to enforce any duty or liability created by the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. We also acknowledge that Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder and that there is uncertainty as to whether a court would enforce an exclusive forum provision for actions arising under the Securities Act.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain reporting requirements of the Exchange Act. Our disclosure controls and procedures are designed to reasonably assure that information required to be disclosed by us in reports we file or submit under the Exchange Act is accumulated and communicated to management, recorded, processed, summarized, and reported within the time periods specified in the rules and even if we are successful in remediating our material weakness, any disclosure controls and procedures or internal controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements or insufficient disclosures due to error or fraud may occur and not be detected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to continue incurring significant costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we expect to continue incurring significant legal, accounting, and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, which require, among other things that we file with the SEC annual, quarterly, and current reports with respect to our business and financial condition. In addition, the Sarbanes-Oxley Act, as well as rules subsequently adopted by the SEC and The Nasdaq Global Market to implement provisions of the Sarbanes-Oxley Act, impose significant requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial reporting controls and changes in corporate governance practices. Further, in July 2010, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, was enacted. There are significant corporate governance and executive compensation related provisions in the Dodd-Frank Act concerning areas such as &#8220;say on pay&#8221; and proxy access. EGCs are permitted to implement many of these requirements over a longer period, which may be up to five years from the pricing of our IPO. Stockholder activism, the current political environment and the current high level of government intervention and regulatory reform may lead to substantial new regulations and disclosure obligations, which may lead to additional compliance costs and impact the manner in which we operate our business in ways we cannot currently anticipate.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rules and regulations applicable to public companies have substantially increased and are expected to increase our legal and financial compliance costs and to make some activities more time-consuming and costly. If these requirements divert the attention of our management and personnel from other business concerns, they could have an adverse effect on our business. The increased costs will decrease our net income or increase our net loss, and may require us to reduce costs in other areas of our business or increase the prices of our products or services. For example, these rules and regulations make it more difficult and more expensive for us to obtain director and officer liability insurance and we incur substantial costs to maintain the same or similar coverage as when we were a private company. We cannot predict or estimate the amount or timing of additional costs we may incur to respond to these requirements. The impact of these requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results or prevent fraud. As a result, stockholders could lose confidence in our financial and other public reporting, which would harm our business and the trading price of our Class A common stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation could cause us to fail to meet our reporting obligations. In addition, any testing by us conducted in connection with Section 404, or any subsequent testing by our independent registered public accounting firm, may reveal deficiencies in our internal controls over financial reporting that are deemed to be material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Inferior internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our stock.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to disclose changes made in our internal controls and procedures on a quarterly basis and our management are required to assess the effectiveness of these controls annually. However, for as long as we are an EGC, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404. We could be an EGC for up to five years. An independent assessment of the effectiveness of our internal controls over financial reporting could detect problems that our management&#8217;s assessment might not. Undetected material weaknesses in our internal controls over financial reporting could lead to restatements of our financial statements and require us to incur the expense of remediation.</span></div><div id="i2084c35b29674161bec45c107b9a92a6_133"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;Sales of Unregistered Securities</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;Use of Proceeds from Public Offering of Class A Common Stock</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 19, 2021, we completed our IPO, which resulted in the sale of 4,687,500 shares of our Class A common stock, at a price to the public of $16.00 per share. The offer and sale of the shares in our IPO was made pursuant to the Registration Statement on Form S-1 (File No. 333-257038) which was declared effective by the SEC. Shares of our Class A common stock began trading on The Nasdaq Global Market on July 15, 2021. The offering closed on July 19, 2021.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters of our IPO were Citigroup Global Markets Inc., Cowen and Company, LLC and William Blair &amp; Company, L.L.C.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid to the underwriters of our initial public offering an underwriting discount totaling approximately $5.3 million. In addition, we incurred expenses of approximately $3.1 million. We received net proceeds, after deducting underwriting discounts and offering expenses, of approximately $66.6 million. No offering expenses were paid directly or indirectly to any of our directors or officers (or their associates) or person owning 10% or more of any class of our equity securities or to any other affiliates. There has been no material change in the planned use of proceeds from our IPO from those that were described in our final prospectus dated as of July 14, 2021 and filed with the SEC pursuant to Rule 424(b) under the Securities Act on July 16, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">70</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit</span></div><div style="margin-top:0.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Description</span></td></tr><tr><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921094030/tm2122556d1_ex3-1.htm">Amended and Restated Certificate of Incorporation of Sera Prognostics, Inc., as amended (incorporated by reference to Exhibit 3.1 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-40606) filed with the SEC on July 20, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921094030/tm2122556d1_ex3-2.htm">Restated Bylaws of Sera Prognostics, Inc. (incorporated by reference to Exhibit 3.2 of the Registrant&#8217;s Current Report on Form 8-K (File No. 001-40606) filed with the SEC on July 20, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921089973/tm2110724d14_ex4-1.htm">Specimen Class A Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registrant&#8217;s Registration Statement on Form S-1/A (File No. 333-257038) filed on July 8, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-2.htm">Form of Common Stock Purchase Warrant&#8201;&#8211;&#8201;I (incorporated by reference to Exhibit 4.2 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-3.htm">Form of Common Stock Purchase Warrant&#8201;&#8211;&#8201;II (incorporated by reference to Exhibit 4.3 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-4.htm">Form of Series E Warrant (incorporated by reference to Exhibit 4.4 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1534969/000110465921080206/tm2110724d11_ex4-5.htm">Fourth Amended and Restated Investors&#8217; Rights Agreement, dated as of February 23, 2021 (incorporated by reference to Exhibit 4.5 of the Registrant&#8217;s Registration Statement on Form S-1 (File No. 333-257038) filed on June 11, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sera-20220930x10qxex101.htm">Second Amendment to Lease, effective October 10, 2022, by and between Eastland Regency, L.C. and the Registrant.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sera-20220930x10qxex311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sera-20220930x10qxex312.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sera-20220930x10qxex321.htm">Certification of Principal Executive Officer and Principal Financial Officer and Principal Accounting Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;The Certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Sera Prognostics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-Q, irrespective of any general incorporation language contained in such filing.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">71</span></div></div></div><div id="i2084c35b29674161bec45c107b9a92a6_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i2084c35b29674161bec45c107b9a92a6_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt;padding-left:0.5pt;padding-right:0.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.476%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">SERA PROGNOSTICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: November&#160;9, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Gregory C. Critchfield, M.D., M.S.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gregory C. Critchfield, M.D., M.S.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chairman, President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Date: November&#160;9, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">/s/ Jay Moyes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Jay Moyes</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:114%">(Principal Accounting Officer and Principal Financial Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">72</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>sera-20220930x10qxex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5915a96f49c241bfbffeddf2638d3bda_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECOND AMENDMENT TO LEASE</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Second Amendment to Lease (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Second Amendment</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is entered into as of the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">10th</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">October</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> 2022 (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by and between EASTLAND REGENCY, L.C., a Utah limited liability company (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Landlord</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and SERA PROGNOSTICS, INC., a Delaware corporation (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Tenant</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Landlord and Tenant entered into that certain Lease dated August 1, 2017 (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Lease</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), for certain premises located at 2749 East Parleys Way, commonly known as Suite 200, Salt Lake City, Utah 84109 (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Original Leased Premises</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), currently consisting of approximately 24,058 square feet of gross rentable area, located in Regency Office Building&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, on or about June 7, 2021, Landlord and Tenant entered into that certain First Amendment to Lease&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, the Rental Term is set to expire of its own terms on December 31, 2022&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Landlord and Tenant desire to extend the Rental Term for an additional three (3) year period&#59; and </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">WHEREAS, Landlord and Tenant desire to modify the Lease as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration and furtherance of the foregoing, the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which are acknowledged, Landlord and Tenant hereby agree to the following terms and conditions&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Original Leased Premises shall be expanded by approximately 209 square feet of gross rentable area (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Expansion Space</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), for an amended total of approximately 24,267 square feet of gross rentable area (hereinafter &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Leased Premises</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), as substantially depicted on Exhibit &#8220;A-1&#8221; attached hereto and by this reference incorporated herein. Tenant shall have the quite enjoyment of the Leased Premises (as defined herein) as set forth in Section 25.01 of the Lease. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Expansion Space shall be delivered to Tenant in &#8220;as-is&#8221; condition within five (5) days of the Effective Date (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Delivery of Expansion Space</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;From and after the Delivery of Expansion Space, all references to Leased Premises in the Lease and any subsequent amendments or extensions thereof, shall refer to the Leased Premises as defined in this Second Amendment. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Exhibit &#8220;A-1&#8221; of the Lease shall be stricken in its entirety and replaced with Exhibit &#8220;A-1&#8221; attached hereto. All references to Exhibit &#8220;A-1&#8221; in the Lease and any subsequent amendments shall refer to Exhibit &#8220;A-1&#8221; attached hereto and by this reference incorporated herein. </font></div><div style="height:105.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The Rental Term shall be extended for an additional three (3) year period commencing January 1, 2023 and ending December 31, 2025 (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">First Extension Term</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;Base Monthly Rent shall be as follows&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Commencing upon Delivery of Expansion Space and continuing through December 31, 2023, Base Monthly Rent shall be Fifty-Two Thousand Three Hundred Two and 06&#47;100 Dollars ($52,302.06). </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;Escalations in Base Monthly Rent during the First Extension Term shall occur as follows&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.692%"><tr><td style="width:1.0%"></td><td style="width:64.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Escalation Date</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Base Monthly Rent</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">January 1, 2024 &#8211; December 31, 2024</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$53,871.12</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">January 1, 2025 &#8211; December 31, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">$55,487.25</font></td></tr></table></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;Tenant shall continue to pay its proportionate share of Operating Expenses for the Leased Premises in accordance with the Lease.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;Subject to Landlord&#8217;s prior written approval, not to be unreasonably withheld, Tenant shall be allowed the right to install, at its sole cost and expense, its typical crown signage on the west side of the Building in a location designated by Landlord, subject to Tenant&#8217;s compliance with all applicable governmental codes, ordinances and regulations. Prior to any installation of such crown signage, Tenant must obtain Landlord&#8217;s prior written consent regarding the size of such crown signage. Tenant shall be responsible for all costs associated with the fabrication, installation and maintenance of such crown signage. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;Provided Tenant is not and has not been in default beyond any applicable cure period under any of the terms and provisions contained in the Lease and any subsequent amendments and provided Landlord and Tenant mutually agree to relocate Tenant to a property managed or owned by Woodbury Corporation or its affiliate, Tenant shall have the one time right to terminate the Lease at any time after July 1, 2024 (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Termination right</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) during the First Extension Term. Tenant shall provide Landlord with ninety (90) days prior written notice of its intent to exercise this Termination Right. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;In lieu of any other provisions in the Lease and this Second Amendment, all notices, demands, requests, consents, approval and other communications required or permitted to be given pursuant to the Lease and this Second Amendment (collectively &#8220;Notice(s)&#8221;) shall be in writing and shall be sent by certified mail with return receipt requested, or by nationally known courier service with verification of receipt or refusal (including date of delivery or refusal), in each case with postage or delivery fees prepaid and addressed to a party at the addresses set forth below&#58; </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If to Tenant at&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Sera Prognostics, Inc. </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">One Financial Center </font></div><div style="margin-bottom:12pt;padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Boston, MA 02111&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Initial here </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; JM</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="height:105.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;text-align:justify"><font><br></font></div></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With a copy to&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Sera Prognostics, Inc. </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; General Counsel </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2749 East Parleys Way, Suite 200 </font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salt Lake City, UT 84109&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Initial here </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; JM</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With a copy to&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;legal&#64;seraprognostics.com&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Initial here </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; JM</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If to Landlord at&#58;&#160;&#160;&#160;&#160;Eastland Regency, L.C. </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c&#47;o Woodbury Corporation </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Lease Administration </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58; #1603 &#8211; Sera Prognostics, Suite 200 </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2733 East Parleys Way, Suite 300 </font></div><div style="margin-bottom:12pt;padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salt Lake City, UT 84109 </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">With a copy to&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Eastland Regency, L.C. </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">c&#47;o Woodbury Corporation </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Attn&#58; Legal Department </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Ref&#58; #1603 &#8211; Sera Prognostics, Suite 200 </font></div><div style="padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2733 East Parleys Way, Suite 300 </font></div><div style="margin-bottom:12pt;padding-left:180pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salt Lake City, UT 84109 </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notices are deemed given upon receipt at the Notice address or refusal of delivery. From time to time a party may specify any other address in the United States of America upon twenty (20) days&#8217; advance Notice thereof, similarly given, to the other party hereto. Notices sent by facsimile transmission, electronic mail or any other method not specifically mentioned herein shall not satisfy the requirements of this Section 11. No party may have more than three (3) addresses for Notices at any time. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;Tenant represents and warrants to Landlord that the person executing this Second Amendment on behalf of such party has the authority to execute this Second Amendment and the signature of such person is sufficient to bind them to the terms and provisions hereof. Tenant hereby covenants and warrants that as of the Effective Date (a) Tenant is a duly constituted entity, qualified to do business in the state where the Leased Premises is located, (b) Tenant has paid all applicable franchise fees and taxes, and (c) Tenant shall file when due all future forms, reports, fees and other documents necessary to comply with applicable laws. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;Each party&#8217;s signature, or an electronic image thereof, shall be deemed to be an original signature. Such signatures may be delivered to the other party by facsimile, electronic mail, or other electronic transmission device under which the signature of or on behalf of such delivering party can be seen, and such execution and delivery shall be considered valid, binding and effective for all purposes&#59; provided, however, the parties agree that in the event original counterparts of this Second Amendment are so delivered electronically by either party, such party shall contemporaneously deliver an original counterpart of this Second Amendment bearing the original handwritten signature to the other party via United States Mail or reputable overnight courier service. </font></div><div style="height:105.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;Except as specifically modified, altered, or changed by this Second Amendment&#59; the Lease and any amendments or extensions shall remain unchanged and in full force and effect throughout the Rental Term. Capitalized terms used in this Second Amendment that are not defined herein shall have the meanings ascribed to them in the Lease. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Pages to Follow&#93;</font></div><div style="height:105.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS THEREOF, the parties hereto have executed this Second Amendment as of the date and year first above written.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LANDLORD</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;EASTLAND REGENCY, L.C., a Utah limited liability company  </font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;WOODBURY CORPORATION, a Utah corporation,  </font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Its Manager  </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; O. Randall Woodbury</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">O. Randall Woodbury, President </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">October 10, 2022</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; W. Richards Woodbury</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">W. Richards Woodbury, Chairman </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">October 10, 2022</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TENANT</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;SERA PROGNOSTICS, INC., a Delaware corporation </font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Jay  Moyes</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Jay Moyes, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">CFO</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:216pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dated&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">October 7, 2022</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="height:105.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;text-align:justify"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT &#8220;A-1&#8221;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LEASED PREMISES </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(Page 1 of 2)</font></div><div style="margin-bottom:12pt;text-align:center"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:726px;margin-bottom:5pt;vertical-align:text-bottom;width:552px"></div><div style="height:105.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;text-align:justify"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LEASED PREMISES</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(page 2 of 2)</font></div><div style="margin-bottom:6pt;text-align:center"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:730px;margin-bottom:5pt;vertical-align:text-bottom;width:564px"></div><div style="height:105.12pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.739%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.831%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 10, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.06pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>sera-20220930x10qxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2a2e282fbb1f422caced212d881564a6_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Gregory C. Critchfield, M.D., M.S., certify that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Sera Prognostics, Inc.&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;9, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>sera-20220930x10qxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8d8c6965eab748f7a2c061f5b794eeb9_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SARBANES-OXLEY SECTION 302(a) CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jay Moyes, certify that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q of Sera Prognostics, Inc.&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.852%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;9, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Jay Moyes</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jay Moyes</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Accounting Officer and Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>sera-20220930x10qxex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifb4aa256c5ec4be58ee4251638088775_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="margin-top:10pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Sera Prognostics, Inc., a Delaware corporation (the &#8220;Company&#8221;), does hereby certify, to such officer&#8217;s knowledge, that&#58;</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Quarterly Report on Form 10-Q for the quarter ended September&#160;30, 2022 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;9, 2022</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;9, 2022</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Jay Moyes</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gregory C. Critchfield, M.D., M.S.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jay Moyes</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal Accounting Officer and Principal Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>sera-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:181dff8b-221c-4709-ab07-a5f181ab4d14,g:4b08700b-5ca3-4c7f-8934-f342ec818a3e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sera="http://www.seraprognostics.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.seraprognostics.com/20220930">
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sera-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.seraprognostics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheetsunaudited" roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited">
        <link:definition>0000002 - Statement - Condensed Balance Sheets (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheetsunauditedParenthetical" roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical">
        <link:definition>0000003 - Statement - Condensed Balance Sheets (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofOperationsandComprehensiveLossunaudited" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited">
        <link:definition>0000004 - Statement - Condensed Statements of Operations and Comprehensive Loss (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited">
        <link:definition>0000005 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical">
        <link:definition>0000006 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofCashFlowsunaudited" roleURI="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited">
        <link:definition>0000007 - Statement - Condensed Statements of Cash Flows (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandFinancialCondition" roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition">
        <link:definition>0000008 - Disclosure - Description of Business and Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.seraprognostics.com/role/SignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecurities" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities">
        <link:definition>0000010 - Disclosure - Cash, Cash Equivalents and Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipment" roleURI="http://www.seraprognostics.com/role/PropertyandEquipment">
        <link:definition>0000011 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilities" roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities">
        <link:definition>0000012 - Disclosure - Accrued and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenet" roleURI="http://www.seraprognostics.com/role/OtherIncomenet">
        <link:definition>0000013 - Disclosure - Other Income, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansandConvertiblePromissoryNotes" roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotes">
        <link:definition>0000014 - Disclosure - Loans and Convertible Promissory Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.seraprognostics.com/role/FairValueMeasurements">
        <link:definition>0000015 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactions">
        <link:definition>0000016 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructure" roleURI="http://www.seraprognostics.com/role/CapitalStructure">
        <link:definition>0000017 - Disclosure - Capital Structure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.seraprognostics.com/role/StockBasedCompensation">
        <link:definition>0000018 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://www.seraprognostics.com/role/Warrants">
        <link:definition>0000019 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingences" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingences">
        <link:definition>0000020 - Disclosure - Commitments and Contingences</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Netlosspershare" roleURI="http://www.seraprognostics.com/role/Netlosspershare">
        <link:definition>0000021 - Disclosure - Net loss per share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.seraprognostics.com/role/SubsequentEvents">
        <link:definition>0000022 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>0000023 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesTables" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables">
        <link:definition>0000024 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentTables" roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentTables">
        <link:definition>0000025 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesTables" roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables">
        <link:definition>0000026 - Disclosure - Accrued and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenetTables" roleURI="http://www.seraprognostics.com/role/OtherIncomenetTables">
        <link:definition>0000027 - Disclosure - Other Income, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsTables">
        <link:definition>0000028 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureTables" roleURI="http://www.seraprognostics.com/role/CapitalStructureTables">
        <link:definition>0000029 - Disclosure - Capital Structure (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationTables">
        <link:definition>0000030 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://www.seraprognostics.com/role/WarrantsTables">
        <link:definition>0000031 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesTables" roleURI="http://www.seraprognostics.com/role/CommitmentandContingenciesTables">
        <link:definition>0000032 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareTables" roleURI="http://www.seraprognostics.com/role/NetlosspershareTables">
        <link:definition>0000033 - Disclosure - Net loss per share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandFinancialConditionDetails" roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails">
        <link:definition>0000034 - Disclosure - Description of Business and Financial Condition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails">
        <link:definition>0000035 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails">
        <link:definition>0000036 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails">
        <link:definition>0000037 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesNarrativeDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails">
        <link:definition>0000038 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails">
        <link:definition>0000039 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails">
        <link:definition>0000040 - Disclosure - Property and Equipment - Components of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNarrativeDetails" roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails">
        <link:definition>0000041 - Disclosure - Property and Equipment - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesDetails" roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails">
        <link:definition>0000042 - Disclosure - Accrued and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherIncomenetDetails" roleURI="http://www.seraprognostics.com/role/OtherIncomenetDetails">
        <link:definition>0000043 - Disclosure - Other Income, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansandConvertiblePromissoryNotesBankLoanDetails" roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails">
        <link:definition>0000044 - Disclosure - Loans and Convertible Promissory Notes - Bank Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails" roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails">
        <link:definition>0000045 - Disclosure - Loans and Convertible Promissory Notes - Convertible Promissory Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails" roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails">
        <link:definition>0000046 - Disclosure - Loans and Convertible Promissory Notes - Paycheck Protection Loan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
        <link:definition>0000047 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails">
        <link:definition>0000048 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureNarrativeDetails" roleURI="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails">
        <link:definition>0000049 - Disclosure - Capital Structure - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStructureCommonStockDetails" roleURI="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails">
        <link:definition>0000050 - Disclosure - Capital Structure - Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>0000051 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionsDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails">
        <link:definition>0000052 - Disclosure - Stock-Based Compensation - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationExpenseDetails" roleURI="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails">
        <link:definition>0000053 - Disclosure - Stock-Based Compensation - Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsCommonStockWarrantsOutstandingDetails" roleURI="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails">
        <link:definition>0000054 - Disclosure - Warrants - Common Stock Warrants Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsNarrativeDetails" roleURI="http://www.seraprognostics.com/role/WarrantsNarrativeDetails">
        <link:definition>0000055 - Disclosure - Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesLeasesinFinancialStatementDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails">
        <link:definition>0000056 - Disclosure - Commitments and Contingences - Leases in Financial Statement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesLeaseCostandOtherInformationDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails">
        <link:definition>0000057 - Disclosure - Commitments and Contingences - Lease Cost and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails">
        <link:definition>0000058 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>0000058 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencesNarrativeDetails" roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails">
        <link:definition>0000059 - Disclosure - Commitments and Contingences - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails" roleURI="http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails">
        <link:definition>0000060 - Disclosure - Net loss per share - Computation of the Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" roleURI="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails">
        <link:definition>0000061 - Disclosure - Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.seraprognostics.com/role/SubsequentEventsDetails">
        <link:definition>0000062 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sera_CommonStockWarrantAt2077SharePriceMember" abstract="true" name="CommonStockWarrantAt2077SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_NumberOfCommonStockClassesAuthorized" abstract="false" name="NumberOfCommonStockClassesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sera_PlanEspp2021Member" abstract="true" name="PlanEspp2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_JuniorConvertiblePreferredStockMember" abstract="true" name="JuniorConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LeaseLiabilitiesAbstract" abstract="true" name="LeaseLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_RightOfUseAssetTotal" abstract="false" name="RightOfUseAssetTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_RelatedPartyTransactionCashReceivedFromRelatedParty" abstract="false" name="RelatedPartyTransactionCashReceivedFromRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_ElevanceHealthIncMember" abstract="true" name="ElevanceHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" abstract="false" name="CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommonStockConversionRatio" abstract="false" name="CommonStockConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="sera_SeriesDConvertiblePreferredStockMember" abstract="true" name="SeriesDConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" abstract="false" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" abstract="false" name="LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:decimalItemType"/>
  <xs:element id="sera_RepaymentOfAccruedInterestOnLongTermDebt" abstract="false" name="RepaymentOfAccruedInterestOnLongTermDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" abstract="false" name="ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_SeniorConvertiblePreferredStockMember" abstract="true" name="SeniorConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_AdditionalMinimumOperatingLeasePaymentsDue" abstract="false" name="AdditionalMinimumOperatingLeasePaymentsDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock" abstract="false" name="TemporaryEquitySharesConversionOfPreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CurrentMarketableSecuritiesMember" abstract="true" name="CurrentMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_HealthcoreIncMember" abstract="true" name="HealthcoreIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidYearOne" abstract="false" name="LeaseLiabilityToBePaidYearOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" abstract="false" name="PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" abstract="false" name="PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_NumberOfVotesPerShare" abstract="false" name="NumberOfVotesPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sera_CommonStockWarrantAt1238SharePriceMember" abstract="true" name="CommonStockWarrantAt1238SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_PaycheckProtectionProgramLoanMember" abstract="true" name="PaycheckProtectionProgramLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_SeriesESeniorConvertiblePreferredStockMember" abstract="true" name="SeriesESeniorConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_MasterServicesAgreementMember" abstract="true" name="MasterServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" abstract="false" name="CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseLiabilityCurrent" abstract="false" name="LeaseLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_February2019ConvertibleNoteMember" abstract="true" name="February2019ConvertibleNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_CapitalSharesReservedForFutureIssuanceAxis" abstract="true" name="CapitalSharesReservedForFutureIssuanceAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sera_CommonStockWarrantAt9.03SharePriceMember" abstract="true" name="CommonStockWarrantAt9.03SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_WarrantsToPurchaseCommonStockMember" abstract="true" name="WarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_CommitmentsAndContingenciesLineItems" abstract="true" name="CommitmentsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" abstract="false" name="LeaseLiabilityToBePaidRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_IndemnificationLiability" abstract="false" name="IndemnificationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommonStockWarrantAt520SharePriceMember" abstract="true" name="CommonStockWarrantAt520SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_IncreaseDecreaseInDeferredRent" abstract="false" name="IncreaseDecreaseInDeferredRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommonStockWarrantAt10.84SharePriceMember" abstract="true" name="CommonStockWarrantAt10.84SharePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidYearFourAndThereafter" abstract="false" name="LeaseLiabilityToBePaidYearFourAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsAmortizedCost" abstract="false" name="CashAndCashEquivalentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseLiabilityNoncurrent" abstract="false" name="LeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" abstract="true" name="CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" abstract="false" name="ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sera_LeaseLiabilitiesTotal" abstract="false" name="LeaseLiabilitiesTotal" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_TemporaryEquityStockIssuanceCosts" abstract="false" name="TemporaryEquityStockIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock" abstract="false" name="TemporaryEquityValueConversionOfPreferredStockToCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_FinanceLeasesOtherInformationAbstract" abstract="true" name="FinanceLeasesOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_Plan2021Member" abstract="true" name="Plan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LaboratoryServicesAgreementMember" abstract="true" name="LaboratoryServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_RightOfUseAssetAbstract" abstract="true" name="RightOfUseAssetAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_StockIssuedDuringPeriodSharesStockWarrantExercised" abstract="false" name="StockIssuedDuringPeriodSharesStockWarrantExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sera_OfficeAndLaboratorySpaceMember" abstract="true" name="OfficeAndLaboratorySpaceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" abstract="false" name="OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseOtherInformationAbstract" abstract="true" name="LeaseOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" abstract="true" name="CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_CommitmentsAndContingenciesTable" abstract="true" name="CommitmentsAndContingenciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="sera_CommercialCollaborationAgreementMember" abstract="true" name="CommercialCollaborationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidYearTwo" abstract="false" name="LeaseLiabilityToBePaidYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_NonCurrentMarketableSecuritiesMember" abstract="true" name="NonCurrentMarketableSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityUndiscountedExcessAmount" abstract="false" name="LeaseLiabilityUndiscountedExcessAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" abstract="false" name="RelatedPartyTransactionCommercialCollaborationAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sera_CapitalSharesReservedForFutureIssuanceDomain" abstract="true" name="CapitalSharesReservedForFutureIssuanceDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityToBePaidYearThree" abstract="false" name="LeaseLiabilityToBePaidYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_WarrantsTextBlock" abstract="false" name="WarrantsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sera_OperatingLeasesOtherInformationAbstract" abstract="true" name="OperatingLeasesOtherInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="sera_ClassOfWarrantOrRightExpired" abstract="false" name="ClassOfWarrantOrRightExpired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="sera_Plan2011Member" abstract="true" name="Plan2011Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LeaseLiabilityPaymentDue" abstract="false" name="LeaseLiabilityPaymentDue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_AccruedClinicalStudyCostsCurrent" abstract="false" name="AccruedClinicalStudyCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter" abstract="false" name="FinanceLeaseLiabilityToBePaidYearFourAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_LoanAndSecurityAgreementMember" abstract="true" name="LoanAndSecurityAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" abstract="false" name="CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sera_LeaseLiabilityPaymentDueAbstract" abstract="true" name="LeaseLiabilityPaymentDueAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>sera-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:181dff8b-221c-4709-ab07-a5f181ab4d14,g:4b08700b-5ca3-4c7f-8934-f342ec818a3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedBalanceSheetsunaudited"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_240ec2ba-f007-4fcc-a546-c3382b56c5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9b74780f-2efc-416f-bde4-cae7e5b2dda0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_240ec2ba-f007-4fcc-a546-c3382b56c5a6" xlink:to="loc_us-gaap_LiabilitiesCurrent_9b74780f-2efc-416f-bde4-cae7e5b2dda0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_151a1367-f6d2-4c6d-83dc-d066cae09b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_240ec2ba-f007-4fcc-a546-c3382b56c5a6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_151a1367-f6d2-4c6d-83dc-d066cae09b12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_724215f9-2add-4fb3-b961-16f58cfea5cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a43522e3-de07-4a43-a77e-0319a8cec448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_724215f9-2add-4fb3-b961-16f58cfea5cb" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_a43522e3-de07-4a43-a77e-0319a8cec448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_af9d6d32-1fce-4b00-9c98-877f5cf414d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_724215f9-2add-4fb3-b961-16f58cfea5cb" xlink:to="loc_us-gaap_AccountsPayableCurrent_af9d6d32-1fce-4b00-9c98-877f5cf414d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditCurrent_e8d8f2cf-28f6-43a8-8a06-07adbfe7c859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentCreditCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_724215f9-2add-4fb3-b961-16f58cfea5cb" xlink:to="loc_us-gaap_DeferredRentCreditCurrent_e8d8f2cf-28f6-43a8-8a06-07adbfe7c859" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_6280aeef-edc5-47ad-aadc-fd485ca3767d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_724215f9-2add-4fb3-b961-16f58cfea5cb" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_6280aeef-edc5-47ad-aadc-fd485ca3767d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_23151dc1-cf63-4b88-af78-ddfb726914f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_724215f9-2add-4fb3-b961-16f58cfea5cb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_23151dc1-cf63-4b88-af78-ddfb726914f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_280728dd-3aff-4b72-8281-f9c326757307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_e36ea509-4675-41a0-8af7-bf475705e302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_280728dd-3aff-4b72-8281-f9c326757307" xlink:to="loc_us-gaap_AdditionalPaidInCapital_e36ea509-4675-41a0-8af7-bf475705e302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ddfded39-fb1f-4df3-9aa5-7f227a41f9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_280728dd-3aff-4b72-8281-f9c326757307" xlink:to="loc_us-gaap_CommonStockValue_ddfded39-fb1f-4df3-9aa5-7f227a41f9bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dbea3442-57b6-425b-8fc1-a8df061d459b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_280728dd-3aff-4b72-8281-f9c326757307" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_dbea3442-57b6-425b-8fc1-a8df061d459b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42c00241-13e7-4090-9d9a-6210fc524037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_280728dd-3aff-4b72-8281-f9c326757307" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42c00241-13e7-4090-9d9a-6210fc524037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_df22f420-3a92-4d3f-9f79-f929d5346c76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_417c4347-b6a5-48c4-b6f8-ba64bb29eeea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_df22f420-3a92-4d3f-9f79-f929d5346c76" xlink:to="loc_us-gaap_StockholdersEquity_417c4347-b6a5-48c4-b6f8-ba64bb29eeea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_69e400d3-af4e-4db4-9d12-3b82e3a21992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_df22f420-3a92-4d3f-9f79-f929d5346c76" xlink:to="loc_us-gaap_CommitmentsAndContingencies_69e400d3-af4e-4db4-9d12-3b82e3a21992" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_6a7b59b0-979d-4d1f-8852-5043de332f68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_df22f420-3a92-4d3f-9f79-f929d5346c76" xlink:to="loc_us-gaap_Liabilities_6a7b59b0-979d-4d1f-8852-5043de332f68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e6fea3c9-69d4-42c7-9664-580edb9a7058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_7082529d-1b39-4c12-986e-238c209607b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6fea3c9-69d4-42c7-9664-580edb9a7058" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_7082529d-1b39-4c12-986e-238c209607b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7f4c088d-4777-4cdc-a880-c9fa0c09afb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6fea3c9-69d4-42c7-9664-580edb9a7058" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7f4c088d-4777-4cdc-a880-c9fa0c09afb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f13b5acd-c755-4242-ae30-e9e21f0c3d28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6fea3c9-69d4-42c7-9664-580edb9a7058" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f13b5acd-c755-4242-ae30-e9e21f0c3d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ce950ae1-c6eb-4098-a8fd-2f633e8fac41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6fea3c9-69d4-42c7-9664-580edb9a7058" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ce950ae1-c6eb-4098-a8fd-2f633e8fac41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3e1ad4e8-c500-4969-86f3-f7d73d798564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e6fea3c9-69d4-42c7-9664-580edb9a7058" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3e1ad4e8-c500-4969-86f3-f7d73d798564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2d7fc306-09f6-40c5-82e8-d6e7332a977e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e59bdcd2-7cfe-47a6-a816-c71b977771dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2d7fc306-09f6-40c5-82e8-d6e7332a977e" xlink:to="loc_us-gaap_AssetsCurrent_e59bdcd2-7cfe-47a6-a816-c71b977771dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_27172b67-146f-4e5c-b01e-33742ef62a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2d7fc306-09f6-40c5-82e8-d6e7332a977e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_27172b67-146f-4e5c-b01e-33742ef62a8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_991a7055-725a-489a-8d3e-95ba4786cb5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2d7fc306-09f6-40c5-82e8-d6e7332a977e" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_991a7055-725a-489a-8d3e-95ba4786cb5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_724d42ee-6c48-4481-b406-da9617eee5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2d7fc306-09f6-40c5-82e8-d6e7332a977e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_724d42ee-6c48-4481-b406-da9617eee5b5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofOperationsandComprehensiveLossunaudited"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c8150f99-b31f-4c4f-9e75-984f077e7d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7c62e7f4-0734-4055-8e0c-7cc933b79ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c8150f99-b31f-4c4f-9e75-984f077e7d2d" xlink:to="loc_us-gaap_OperatingExpenses_7c62e7f4-0734-4055-8e0c-7cc933b79ee5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c8a6701-f428-48d1-8362-7e97fce9a058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c8150f99-b31f-4c4f-9e75-984f077e7d2d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c8a6701-f428-48d1-8362-7e97fce9a058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f75fd1b2-5c92-4870-a958-894c555ff949" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0a4f1256-a0bc-4451-8ddb-056db6dab396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f75fd1b2-5c92-4870-a958-894c555ff949" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0a4f1256-a0bc-4451-8ddb-056db6dab396" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_fbd283e9-d035-4863-a13c-a4e3a4dbe307" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_3fcf726f-8872-43ba-b91c-ce7ffffeb860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_fbd283e9-d035-4863-a13c-a4e3a4dbe307" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_3fcf726f-8872-43ba-b91c-ce7ffffeb860" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_164c878c-21c4-4213-a2c5-bfddf6cd3d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_fbd283e9-d035-4863-a13c-a4e3a4dbe307" xlink:to="loc_us-gaap_SellingAndMarketingExpense_164c878c-21c4-4213-a2c5-bfddf6cd3d8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_907e3477-8318-4a38-b87b-a7bc5e6f470d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_fbd283e9-d035-4863-a13c-a4e3a4dbe307" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_907e3477-8318-4a38-b87b-a7bc5e6f470d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_82abace7-dcff-4123-bffc-f4fc0fce5234" xlink:href="sera-20220930.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_fbd283e9-d035-4863-a13c-a4e3a4dbe307" xlink:to="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_82abace7-dcff-4123-bffc-f4fc0fce5234" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5314ec4c-9e9f-42d2-9616-1694e98cb603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5c9ae75b-b996-4c7b-ad96-d832c211b65d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5314ec4c-9e9f-42d2-9616-1694e98cb603" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_5c9ae75b-b996-4c7b-ad96-d832c211b65d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f97b8078-7224-46c5-ade2-cb5906123406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5314ec4c-9e9f-42d2-9616-1694e98cb603" xlink:to="loc_us-gaap_NetIncomeLoss_f97b8078-7224-46c5-ade2-cb5906123406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1fb035cf-5703-4bd1-9beb-70ac50f7156f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_143167c9-1ba6-4bcf-af77-8d7360ac7994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1fb035cf-5703-4bd1-9beb-70ac50f7156f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_143167c9-1ba6-4bcf-af77-8d7360ac7994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_930dd08f-ba3d-4c6e-ab98-3e8d7330c916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1fb035cf-5703-4bd1-9beb-70ac50f7156f" xlink:to="loc_us-gaap_InterestExpense_930dd08f-ba3d-4c6e-ab98-3e8d7330c916" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_49a82f97-c112-419e-b25a-a3320517a2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1fb035cf-5703-4bd1-9beb-70ac50f7156f" xlink:to="loc_us-gaap_OperatingIncomeLoss_49a82f97-c112-419e-b25a-a3320517a2f5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofCashFlowsunaudited"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_5c66c10e-e1b1-4425-b744-ef1366be6a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_5c66c10e-e1b1-4425-b744-ef1366be6a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_39f63e1d-bde9-42fd-a20a-b7e6a16f8e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_PaidInKindInterest_39f63e1d-bde9-42fd-a20a-b7e6a16f8e19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_3bbe0e43-6403-4c31-8f14-73b517fa1c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_3bbe0e43-6403-4c31-8f14-73b517fa1c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cf2472a7-a154-4dc7-b12a-0f813b810abb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cf2472a7-a154-4dc7-b12a-0f813b810abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b5dbd81f-711a-4b9d-bfa6-055cfb1fd57a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b5dbd81f-711a-4b9d-bfa6-055cfb1fd57a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_acab81bd-9033-48e4-a039-f6d0893695bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_NetIncomeLoss_acab81bd-9033-48e4-a039-f6d0893695bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4633d0cb-cc60-4d85-8aab-3104e3b8b70d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_ShareBasedCompensation_4633d0cb-cc60-4d85-8aab-3104e3b8b70d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a033972b-edfd-4127-be55-94d4d8cf60db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_a033972b-edfd-4127-be55-94d4d8cf60db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IncreaseDecreaseInDeferredRent_712b7c68-8980-4575-9ddc-ce16681f4920" xlink:href="sera-20220930.xsd#sera_IncreaseDecreaseInDeferredRent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_sera_IncreaseDecreaseInDeferredRent_712b7c68-8980-4575-9ddc-ce16681f4920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_687636a5-1b4d-4690-aa03-952818cb9203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_687636a5-1b4d-4690-aa03-952818cb9203" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_07d21ea7-0462-4329-a14d-078b7fff546c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_07d21ea7-0462-4329-a14d-078b7fff546c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a5afc9e7-6eaa-41f1-8645-e89b6d5ab29a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a5afc9e7-6eaa-41f1-8645-e89b6d5ab29a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3b038adc-4835-45b0-a1cc-5618a0b98f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3b038adc-4835-45b0-a1cc-5618a0b98f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c16526d0-fc37-490a-bff0-c5608a5bd68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_378f5649-309d-403b-8d43-83f20eac8be4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c16526d0-fc37-490a-bff0-c5608a5bd68d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c649135-e291-4715-aac7-7a70cc47963f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0597fc4b-9a5d-45bb-bf5b-233936b85f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c649135-e291-4715-aac7-7a70cc47963f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0597fc4b-9a5d-45bb-bf5b-233936b85f4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_326979cd-325c-4f00-b5c0-8bd8a28494f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c649135-e291-4715-aac7-7a70cc47963f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_326979cd-325c-4f00-b5c0-8bd8a28494f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1c5cbb8-3484-4e5c-ac70-f2d805269eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c649135-e291-4715-aac7-7a70cc47963f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b1c5cbb8-3484-4e5c-ac70-f2d805269eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_334df392-4995-4a5f-9bfe-6cf1386f261f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_8443d30f-c86f-4b61-a404-e1fab5068227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_334df392-4995-4a5f-9bfe-6cf1386f261f" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_8443d30f-c86f-4b61-a404-e1fab5068227" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8d3fa4d8-8b6a-4261-9711-1db2288f63a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_334df392-4995-4a5f-9bfe-6cf1386f261f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8d3fa4d8-8b6a-4261-9711-1db2288f63a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d3deee91-d5cc-432a-8c69-59d6fbf8f3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_334df392-4995-4a5f-9bfe-6cf1386f261f" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d3deee91-d5cc-432a-8c69-59d6fbf8f3e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_807a3be9-ffd7-49b5-b1c0-7036c0e0dabc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_334df392-4995-4a5f-9bfe-6cf1386f261f" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_807a3be9-ffd7-49b5-b1c0-7036c0e0dabc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_c044ef76-e4fb-4db3-8e96-20c23f291985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_c044ef76-e4fb-4db3-8e96-20c23f291985" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_80bb40a5-4213-47a9-9ca9-1d17a3fcee5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_80bb40a5-4213-47a9-9ca9-1d17a3fcee5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_acf59664-9580-4a96-b19b-612f2db4dc66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:to="loc_us-gaap_RepaymentsOfDebt_acf59664-9580-4a96-b19b-612f2db4dc66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e1b47d01-355b-49df-88c1-396431f0bb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e1b47d01-355b-49df-88c1-396431f0bb42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_24ecaad1-fdec-474d-be4a-38a9e5f62bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_24ecaad1-fdec-474d-be4a-38a9e5f62bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_f7cba211-f3fb-48c1-ad0f-78b417c263c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_f7cba211-f3fb-48c1-ad0f-78b417c263c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_62f6df84-4344-442b-aea9-f349f1e24e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ffdaebb1-4197-4777-96ef-82ff76cec701" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_62f6df84-4344-442b-aea9-f349f1e24e4e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost_bf59c3d5-52d9-4a01-84eb-3021f915399a" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_a4fd457f-cd3c-449a-924b-1402f0b775c2" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost_bf59c3d5-52d9-4a01-84eb-3021f915399a" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_a4fd457f-cd3c-449a-924b-1402f0b775c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3abf0861-2620-4ab5-9bb4-adb6c2ddca2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost_bf59c3d5-52d9-4a01-84eb-3021f915399a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_3abf0861-2620-4ab5-9bb4-adb6c2ddca2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_ba6c3a1a-ead0-40e8-9f82-f870835f4f49" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost_bf59c3d5-52d9-4a01-84eb-3021f915399a" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_ba6c3a1a-ead0-40e8-9f82-f870835f4f49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b12be007-01a5-4135-9760-3862930be10f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fec7dc86-14fc-4a17-bde5-88e77bcca6f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b12be007-01a5-4135-9760-3862930be10f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fec7dc86-14fc-4a17-bde5-88e77bcca6f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_182a167a-1e19-4cd4-96c7-c02120b949af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b12be007-01a5-4135-9760-3862930be10f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_182a167a-1e19-4cd4-96c7-c02120b949af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_db23ec30-12ce-4878-81e9-f1903e805aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b12be007-01a5-4135-9760-3862930be10f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_db23ec30-12ce-4878-81e9-f1903e805aa1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b42ff147-3243-4326-ab69-d3600dd78652" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_60c02474-01fe-4702-bb5b-a5fe4ef3fdcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b42ff147-3243-4326-ab69-d3600dd78652" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_60c02474-01fe-4702-bb5b-a5fe4ef3fdcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_1c761dba-aadf-4506-8f3e-0c0a548c8a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b42ff147-3243-4326-ab69-d3600dd78652" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_1c761dba-aadf-4506-8f3e-0c0a548c8a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9740b050-fcd5-44d8-91d8-4a73322cebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d307b485-d3f6-4827-9279-a04dad20bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9740b050-fcd5-44d8-91d8-4a73322cebd6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_d307b485-d3f6-4827-9279-a04dad20bc4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9c441f59-b397-4b18-8b21-b215a3085c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9740b050-fcd5-44d8-91d8-4a73322cebd6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9c441f59-b397-4b18-8b21-b215a3085c69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2b8b2a8c-587a-461d-a23c-1e2811835167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_681a0c72-8f39-4a9d-93fd-fff7dbe7b3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2b8b2a8c-587a-461d-a23c-1e2811835167" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_681a0c72-8f39-4a9d-93fd-fff7dbe7b3f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_fdc46170-c08b-48e4-bb2e-7e8a7bc2b64b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2b8b2a8c-587a-461d-a23c-1e2811835167" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_fdc46170-c08b-48e4-bb2e-7e8a7bc2b64b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c463d084-fd46-41c5-9cfa-b96e213cac14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_fa0ec0b8-8020-4908-ae5f-7530c72628b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c463d084-fd46-41c5-9cfa-b96e213cac14" xlink:to="loc_us-gaap_AccruedSalariesCurrent_fa0ec0b8-8020-4908-ae5f-7530c72628b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ea35292a-e48b-4c9c-ae87-4de0cb0af439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c463d084-fd46-41c5-9cfa-b96e213cac14" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ea35292a-e48b-4c9c-ae87-4de0cb0af439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_bd2f0a64-133e-47e6-a402-b78832a06a75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c463d084-fd46-41c5-9cfa-b96e213cac14" xlink:to="loc_us-gaap_AccruedVacationCurrent_bd2f0a64-133e-47e6-a402-b78832a06a75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b02c8cb8-15a2-43fc-bf15-7aea7fa1ff80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c463d084-fd46-41c5-9cfa-b96e213cac14" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b02c8cb8-15a2-43fc-bf15-7aea7fa1ff80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_AccruedClinicalStudyCostsCurrent_ecd9514e-58f2-4f7d-9590-d73f4fbdca2d" xlink:href="sera-20220930.xsd#sera_AccruedClinicalStudyCostsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c463d084-fd46-41c5-9cfa-b96e213cac14" xlink:to="loc_sera_AccruedClinicalStudyCostsCurrent_ecd9514e-58f2-4f7d-9590-d73f4fbdca2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_b10c9462-22a7-4455-be5e-c0767f6caaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_c463d084-fd46-41c5-9cfa-b96e213cac14" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_b10c9462-22a7-4455-be5e-c0767f6caaa6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#OtherIncomenetDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_073821b8-bd8a-4715-84c4-e84855515d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_da4ebed7-c9af-4bff-a95f-4750d8c43e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_073821b8-bd8a-4715-84c4-e84855515d5c" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_da4ebed7-c9af-4bff-a95f-4750d8c43e2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_8f547d64-0da5-48f0-9d39-61b39561b9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_073821b8-bd8a-4715-84c4-e84855515d5c" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_8f547d64-0da5-48f0-9d39-61b39561b9d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_270eb538-b2f9-4124-9cb7-d830d620b751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_073821b8-bd8a-4715-84c4-e84855515d5c" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_270eb538-b2f9-4124-9cb7-d830d620b751" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_c2ccd169-1d2a-4682-8ffd-b35b49a65aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_073821b8-bd8a-4715-84c4-e84855515d5c" xlink:to="loc_us-gaap_InterestIncomeOther_c2ccd169-1d2a-4682-8ffd-b35b49a65aa4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ee9c4300-5d39-45fc-b520-ae64f1ad712c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_073821b8-bd8a-4715-84c4-e84855515d5c" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ee9c4300-5d39-45fc-b520-ae64f1ad712c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_ac96034b-3242-4e57-863e-ca60e8cd146a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_085ad391-08af-44da-8362-a26dcc69142a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ac96034b-3242-4e57-863e-ca60e8cd146a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_085ad391-08af-44da-8362-a26dcc69142a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_10041626-7958-4bc3-8d2e-a5edadbed93d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_ac96034b-3242-4e57-863e-ca60e8cd146a" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_10041626-7958-4bc3-8d2e-a5edadbed93d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesLeasesinFinancialStatementDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_ab01d80c-10ad-48d1-a184-a04770e5c6a9" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7227e9aa-58db-4acf-ba3e-995fe889ab61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_ab01d80c-10ad-48d1-a184-a04770e5c6a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_7227e9aa-58db-4acf-ba3e-995fe889ab61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5f5f1532-2b7c-4ffd-84d1-9d7c3407bc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_ab01d80c-10ad-48d1-a184-a04770e5c6a9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5f5f1532-2b7c-4ffd-84d1-9d7c3407bc2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e24b990e-ab94-413b-b190-5c0006bed633" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_ab01d80c-10ad-48d1-a184-a04770e5c6a9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e24b990e-ab94-413b-b190-5c0006bed633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetTotal_7d9686ee-ed0a-49e3-b084-3b2db4dae026" xlink:href="sera-20220930.xsd#sera_RightOfUseAssetTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ade44765-192d-4b07-b6e6-79061f844e44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_RightOfUseAssetTotal_7d9686ee-ed0a-49e3-b084-3b2db4dae026" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ade44765-192d-4b07-b6e6-79061f844e44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_98c3b9d7-158c-427e-98e5-876b65a5d0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_RightOfUseAssetTotal_7d9686ee-ed0a-49e3-b084-3b2db4dae026" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_98c3b9d7-158c-427e-98e5-876b65a5d0bb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesLeaseCostandOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_e97a36d1-2a89-4101-85ea-c8322dc64b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_128e48dd-8d2d-454d-a0b6-1d889a0ba746" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e97a36d1-2a89-4101-85ea-c8322dc64b3d" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_128e48dd-8d2d-454d-a0b6-1d889a0ba746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_71295110-be43-4759-bec4-061eeb4ede18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e97a36d1-2a89-4101-85ea-c8322dc64b3d" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_71295110-be43-4759-bec4-061eeb4ede18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_df8e2955-c7c4-4a80-b5ef-d2f31ebd0c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_e97a36d1-2a89-4101-85ea-c8322dc64b3d" xlink:to="loc_us-gaap_OperatingLeaseCost_df8e2955-c7c4-4a80-b5ef-d2f31ebd0c8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6fd2e067-b153-491d-bd1b-a646dac9e535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_12fb3554-5256-48b1-989f-d4c98eb840c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6fd2e067-b153-491d-bd1b-a646dac9e535" xlink:to="loc_us-gaap_OperatingLeaseLiability_12fb3554-5256-48b1-989f-d4c98eb840c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3efcd887-61db-4cf6-adf8-36d58a0ed226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6fd2e067-b153-491d-bd1b-a646dac9e535" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3efcd887-61db-4cf6-adf8-36d58a0ed226" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a16fb98c-77f1-4669-8948-eba0de70d21c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ddd6446e-43c0-4a06-8315-aae24f32521d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a16fb98c-77f1-4669-8948-eba0de70d21c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ddd6446e-43c0-4a06-8315-aae24f32521d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_50a955c8-63be-4ef9-afc2-0b79a0316bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a16fb98c-77f1-4669-8948-eba0de70d21c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_50a955c8-63be-4ef9-afc2-0b79a0316bbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3e347a6c-fa73-485d-846e-26bc4d177328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_893715d7-92fa-4635-a3af-6fd0281a1a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3e347a6c-fa73-485d-846e-26bc4d177328" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_893715d7-92fa-4635-a3af-6fd0281a1a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_25bb1004-f54c-4a90-b73b-83beba1c1691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_3e347a6c-fa73-485d-846e-26bc4d177328" xlink:to="loc_us-gaap_FinanceLeaseLiability_25bb1004-f54c-4a90-b73b-83beba1c1691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_0cd15338-aa07-42e6-b757-d700473ecf9a" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityCurrent_f0fd89e5-4a1d-4efd-b576-643548fcdbb2" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_0cd15338-aa07-42e6-b757-d700473ecf9a" xlink:to="loc_sera_LeaseLiabilityCurrent_f0fd89e5-4a1d-4efd-b576-643548fcdbb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityNoncurrent_53682f98-c3d4-4441-bfd2-05d25d7badfb" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilitiesTotal_0cd15338-aa07-42e6-b757-d700473ecf9a" xlink:to="loc_sera_LeaseLiabilityNoncurrent_53682f98-c3d4-4441-bfd2-05d25d7badfb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue_7cac5820-19a1-4058-bae7-97ed7eb36b95" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearFourAndThereafter_fdbe3768-5335-4d44-a8a3-a5203a0da4e2" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_7cac5820-19a1-4058-bae7-97ed7eb36b95" xlink:to="loc_sera_LeaseLiabilityToBePaidYearFourAndThereafter_fdbe3768-5335-4d44-a8a3-a5203a0da4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_bc1b3ac7-68bc-4c8b-886b-cba5ce1dfb81" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_7cac5820-19a1-4058-bae7-97ed7eb36b95" xlink:to="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_bc1b3ac7-68bc-4c8b-886b-cba5ce1dfb81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearTwo_ed93722a-9c7f-4a6e-8790-a933d42f12ed" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_7cac5820-19a1-4058-bae7-97ed7eb36b95" xlink:to="loc_sera_LeaseLiabilityToBePaidYearTwo_ed93722a-9c7f-4a6e-8790-a933d42f12ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearThree_4cc3cda5-1bcc-4c5b-b0bd-eb770434e4aa" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_7cac5820-19a1-4058-bae7-97ed7eb36b95" xlink:to="loc_sera_LeaseLiabilityToBePaidYearThree_4cc3cda5-1bcc-4c5b-b0bd-eb770434e4aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearOne_7ec77bac-0028-4eb5-91e7-0246ade85c77" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearOne"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_7cac5820-19a1-4058-bae7-97ed7eb36b95" xlink:to="loc_sera_LeaseLiabilityToBePaidYearOne_7ec77bac-0028-4eb5-91e7-0246ade85c77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_4b8ba13d-4828-48c6-8e37-851d950f5233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_940d3d6d-59ca-4bb6-be88-0b02d32d9ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_4b8ba13d-4828-48c6-8e37-851d950f5233" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_940d3d6d-59ca-4bb6-be88-0b02d32d9ccd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_1057f5a6-dbc2-4b5d-976f-1f544476a647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_4b8ba13d-4828-48c6-8e37-851d950f5233" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_1057f5a6-dbc2-4b5d-976f-1f544476a647" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a779a9eb-9375-413a-a124-46df3fb0d844" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4674530e-232d-4e25-9c10-3354bfcfe9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a779a9eb-9375-413a-a124-46df3fb0d844" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4674530e-232d-4e25-9c10-3354bfcfe9b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_84f9f4d4-200f-489b-9440-ebb67eef6f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a779a9eb-9375-413a-a124-46df3fb0d844" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_84f9f4d4-200f-489b-9440-ebb67eef6f20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_57d328a2-5369-40ac-b1f8-ab54c48ab7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a779a9eb-9375-413a-a124-46df3fb0d844" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_57d328a2-5369-40ac-b1f8-ab54c48ab7f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a7c213bd-c185-4258-ba6a-17afa1f85767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a779a9eb-9375-413a-a124-46df3fb0d844" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a7c213bd-c185-4258-ba6a-17afa1f85767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_62bdc5fd-db3a-46fa-b166-38e683336e9e" xlink:href="sera-20220930.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a779a9eb-9375-413a-a124-46df3fb0d844" xlink:to="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_62bdc5fd-db3a-46fa-b166-38e683336e9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a574a65e-6d6b-4df0-9874-e7c20efcec44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ae5d5d28-6878-4e22-9db4-24eac65be886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a574a65e-6d6b-4df0-9874-e7c20efcec44" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_ae5d5d28-6878-4e22-9db4-24eac65be886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_be34e913-ab8a-4f61-8c8a-16315148d378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a574a65e-6d6b-4df0-9874-e7c20efcec44" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_be34e913-ab8a-4f61-8c8a-16315148d378" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d5549e7f-63ac-4f4d-8a72-a073806b7db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a574a65e-6d6b-4df0-9874-e7c20efcec44" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_d5549e7f-63ac-4f4d-8a72-a073806b7db5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c9aa74ae-9a9b-47fe-b136-128e27320f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a574a65e-6d6b-4df0-9874-e7c20efcec44" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_c9aa74ae-9a9b-47fe-b136-128e27320f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter_0f023e78-8b89-4b0c-b3f2-529c9ec39b16" xlink:href="sera-20220930.xsd#sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_a574a65e-6d6b-4df0-9874-e7c20efcec44" xlink:to="loc_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter_0f023e78-8b89-4b0c-b3f2-529c9ec39b16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue_1195660a-878e-4cee-9bcd-df6e483f301f" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_4633fcd3-893f-4881-a2b4-bc341ccaff38" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_1195660a-878e-4cee-9bcd-df6e483f301f" xlink:to="loc_sera_LeaseLiabilitiesTotal_4633fcd3-893f-4881-a2b4-bc341ccaff38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityUndiscountedExcessAmount_f26293b7-ffd7-4081-b59f-d64bad6dea31" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sera_LeaseLiabilityPaymentDue_1195660a-878e-4cee-9bcd-df6e483f301f" xlink:to="loc_sera_LeaseLiabilityUndiscountedExcessAmount_f26293b7-ffd7-4081-b59f-d64bad6dea31" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>sera-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:181dff8b-221c-4709-ab07-a5f181ab4d14,g:4b08700b-5ca3-4c7f-8934-f342ec818a3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Cover" xlink:type="simple" xlink:href="sera-20220930.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/Cover" xlink:type="extended" id="ibde5a5449e3b42278c8a826b2738d14c_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1698aade-b898-441a-8c02-06bc856920c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentType_1698aade-b898-441a-8c02-06bc856920c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_74700370-a0eb-47ad-b96b-8915fdac534e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentQuarterlyReport_74700370-a0eb-47ad-b96b-8915fdac534e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4ac8ae04-4449-44f2-9fef-0f211d2f555f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentPeriodEndDate_4ac8ae04-4449-44f2-9fef-0f211d2f555f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_84bfcf99-134e-47d3-8ae1-befe12effdf2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentTransitionReport_84bfcf99-134e-47d3-8ae1-befe12effdf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_74ac126e-b7ca-46b0-8645-79dd23de6431" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityFileNumber_74ac126e-b7ca-46b0-8645-79dd23de6431" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3b8520e8-6067-437f-bd3a-ee8e920aeae5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityRegistrantName_3b8520e8-6067-437f-bd3a-ee8e920aeae5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ae3f7ad9-684a-46ec-b5e6-5425c31bd933" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ae3f7ad9-684a-46ec-b5e6-5425c31bd933" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_473e1b9d-5c49-4e98-9ce4-6e32d90387bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityTaxIdentificationNumber_473e1b9d-5c49-4e98-9ce4-6e32d90387bb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_868fc294-0a9f-4bb5-b2d7-086c7cd03397" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressAddressLine1_868fc294-0a9f-4bb5-b2d7-086c7cd03397" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_23834d92-437f-45cb-a388-0e7457b5de87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressAddressLine2_23834d92-437f-45cb-a388-0e7457b5de87" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_34837305-f517-4d19-8180-6de530914589" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressCityOrTown_34837305-f517-4d19-8180-6de530914589" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_08cdd5e0-7802-4732-ac0f-abe5c59f2866" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressStateOrProvince_08cdd5e0-7802-4732-ac0f-abe5c59f2866" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_51f2b4d3-97ef-42c8-957b-59c71ddef7c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressPostalZipCode_51f2b4d3-97ef-42c8-957b-59c71ddef7c3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b4d40523-e037-47e5-a618-26588798a1d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_CityAreaCode_b4d40523-e037-47e5-a618-26588798a1d9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7939e62c-943e-4d55-b315-4e2e61a16ec5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_LocalPhoneNumber_7939e62c-943e-4d55-b315-4e2e61a16ec5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_948a8cdf-de8a-47f7-bf4f-d3ee063454a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_Security12bTitle_948a8cdf-de8a-47f7-bf4f-d3ee063454a9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_798e12d2-4919-4f31-8e61-c3b9bf1ee7ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_TradingSymbol_798e12d2-4919-4f31-8e61-c3b9bf1ee7ff" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_60bfe19a-45c4-42af-94f5-cffc558b3911" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_SecurityExchangeName_60bfe19a-45c4-42af-94f5-cffc558b3911" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c9525399-6b8c-4884-bf1d-24ab2fc0a519" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityCurrentReportingStatus_c9525399-6b8c-4884-bf1d-24ab2fc0a519" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ce831c40-8c45-4573-903b-d42282ee649f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityInteractiveDataCurrent_ce831c40-8c45-4573-903b-d42282ee649f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_04cc9085-8537-4788-9520-fd8246ff9ea5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityFilerCategory_04cc9085-8537-4788-9520-fd8246ff9ea5" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1f9d1398-b97c-4ca2-bb07-870508280e7f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntitySmallBusiness_1f9d1398-b97c-4ca2-bb07-870508280e7f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_adccb908-0484-4dac-8558-a60f55a94a05" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityEmergingGrowthCompany_adccb908-0484-4dac-8558-a60f55a94a05" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_85075639-6224-4d5f-97a1-9779c1976364" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityExTransitionPeriod_85075639-6224-4d5f-97a1-9779c1976364" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2e3572d7-5618-477f-b9ce-ea89b811f55a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityShellCompany_2e3572d7-5618-477f-b9ce-ea89b811f55a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_895076d1-6914-409b-a443-79abfe52c43b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_895076d1-6914-409b-a443-79abfe52c43b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_186fcf23-f99c-4ab2-ac9e-57f83d85a4ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityCentralIndexKey_186fcf23-f99c-4ab2-ac9e-57f83d85a4ff" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_02cb6d2b-f7f1-467e-87cf-2963f13fe1a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_CurrentFiscalYearEndDate_02cb6d2b-f7f1-467e-87cf-2963f13fe1a8" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f2141942-503e-409e-9be6-4c9882ad789b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentFiscalYearFocus_f2141942-503e-409e-9be6-4c9882ad789b" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e863def6-7b79-4e03-8a7a-43379195910e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e863def6-7b79-4e03-8a7a-43379195910e" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b1454f18-86d2-4ea3-9afc-36d49b0f71eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_AmendmentFlag_b1454f18-86d2-4ea3-9afc-36d49b0f71eb" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_00a5c90c-8292-4845-bf63-6d0320e2776b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentInformationTable_00a5c90c-8292-4845-bf63-6d0320e2776b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bf925884-7677-4f46-ab06-21a99deb35b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_00a5c90c-8292-4845-bf63-6d0320e2776b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bf925884-7677-4f46-ab06-21a99deb35b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bf925884-7677-4f46-ab06-21a99deb35b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bf925884-7677-4f46-ab06-21a99deb35b5" xlink:to="loc_us-gaap_ClassOfStockDomain_bf925884-7677-4f46-ab06-21a99deb35b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bf925884-7677-4f46-ab06-21a99deb35b5" xlink:to="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a9027035-f078-49a8-8c04-63c489eaf853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:to="loc_us-gaap_CommonClassAMember_a9027035-f078-49a8-8c04-63c489eaf853" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e385a6ef-7780-43aa-b088-4e91e6d2023e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:to="loc_us-gaap_CommonClassBMember_e385a6ef-7780-43aa-b088-4e91e6d2023e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedBalanceSheetsunauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="extended" id="i06281a59043d4552a04f5424f5e2a667_CondensedBalanceSheetsunauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1cc8d15-4624-4c4a-b240-868e6d31ceec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1cc8d15-4624-4c4a-b240-868e6d31ceec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0eee3270-28e4-41d3-9376-41d0cf5d3b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0eee3270-28e4-41d3-9376-41d0cf5d3b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_86b81244-a4a9-4397-9019-a7ae33cf9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockSharesIssued_86b81244-a4a9-4397-9019-a7ae33cf9cbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_62ceec29-b1fb-4ed0-9ba9-d1dcb4921bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_62ceec29-b1fb-4ed0-9ba9-d1dcb4921bac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_baa9d13b-ac67-4cca-a359-5a4e004564ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_StatementTable_baa9d13b-ac67-4cca-a359-5a4e004564ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_828f14d6-79c4-4e1a-8043-10cb01ca4238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_baa9d13b-ac67-4cca-a359-5a4e004564ab" xlink:to="loc_us-gaap_StatementClassOfStockAxis_828f14d6-79c4-4e1a-8043-10cb01ca4238" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_828f14d6-79c4-4e1a-8043-10cb01ca4238_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_828f14d6-79c4-4e1a-8043-10cb01ca4238" xlink:to="loc_us-gaap_ClassOfStockDomain_828f14d6-79c4-4e1a-8043-10cb01ca4238_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_828f14d6-79c4-4e1a-8043-10cb01ca4238" xlink:to="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_66b5d742-90c2-4649-95c4-0e65c84b7ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:to="loc_us-gaap_CommonClassAMember_66b5d742-90c2-4649-95c4-0e65c84b7ef4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_5e8809fc-2249-427e-aebf-bc12c2b92b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:to="loc_us-gaap_CommonClassBMember_5e8809fc-2249-427e-aebf-bc12c2b92b12" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="extended" id="ica7db60d73264a8cabcce54f818c5433_CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e3c5fe87-85c1-4a57-87d8-f697fee8cacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e3c5fe87-85c1-4a57-87d8-f697fee8cacc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_388aed4d-3770-4bf3-8add-e92370bbf6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_388aed4d-3770-4bf3-8add-e92370bbf6c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_64f03cae-ba84-498d-b57c-191154ce8358" xlink:href="sera-20220930.xsd#sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_64f03cae-ba84-498d-b57c-191154ce8358" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b0c9fc39-586c-49fb-a882-dd64793b03ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b0c9fc39-586c-49fb-a882-dd64793b03ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock_c1f0aa94-e3c8-49ab-b31f-f4a7dd44d044" xlink:href="sera-20220930.xsd#sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock_c1f0aa94-e3c8-49ab-b31f-f4a7dd44d044" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock_19fa5fe1-3e9e-49c8-bea0-b083f9a0dfea" xlink:href="sera-20220930.xsd#sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock_19fa5fe1-3e9e-49c8-bea0-b083f9a0dfea" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_17d38c30-23b0-4219-b2fd-77c60cc1d72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_033c9461-5b5a-41d5-acbe-9231f9996a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_794de28e-4ba9-4b87-9dc3-31c44fc5edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_CommonStockSharesIssued_794de28e-4ba9-4b87-9dc3-31c44fc5edf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5cfaa4c1-1252-4418-8ccb-bd96b91cb519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockholdersEquity_5cfaa4c1-1252-4418-8ccb-bd96b91cb519" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea8a35b9-3acd-4fe3-b6b6-b225f69f8eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea8a35b9-3acd-4fe3-b6b6-b225f69f8eef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b14dc5e-6109-4109-b978-279a1306de31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b14dc5e-6109-4109-b978-279a1306de31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a24857ce-8b27-4cbc-a282-2e2d14d0072c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a24857ce-8b27-4cbc-a282-2e2d14d0072c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_9997a258-d74d-43fb-bfcc-c32bff0bd8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_9997a258-d74d-43fb-bfcc-c32bff0bd8e6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_e8f9a1d4-d347-444b-aa23-6d3a8da5a7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_e8f9a1d4-d347-444b-aa23-6d3a8da5a7c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment_1f310440-887c-4a43-806a-4089d1861a86" xlink:href="sera-20220930.xsd#sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment_1f310440-887c-4a43-806a-4089d1861a86" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d86fa1ef-37bc-4798-8541-84c99493bd48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d86fa1ef-37bc-4798-8541-84c99493bd48" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6a8ca979-766b-499a-988f-a8a4fa36c691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6a8ca979-766b-499a-988f-a8a4fa36c691" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_StockIssuedDuringPeriodSharesStockWarrantExercised_e2ced1e4-0114-4be1-9a61-7f45c91f30dd" xlink:href="sera-20220930.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_sera_StockIssuedDuringPeriodSharesStockWarrantExercised_e2ced1e4-0114-4be1-9a61-7f45c91f30dd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9f9b200d-a873-4b7f-9e67-bc497fbbbb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9f9b200d-a873-4b7f-9e67-bc497fbbbb3a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27e22ad4-e733-4097-8b44-11f036e86f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27e22ad4-e733-4097-8b44-11f036e86f0f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b50a54a5-bc71-4219-9e56-edb3844e8f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_NetIncomeLoss_b50a54a5-bc71-4219-9e56-edb3844e8f32" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eebb91e9-8a38-44cd-b449-6b22431a9bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_df38594e-e8e3-4ae6-a37f-ca94e43cb184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:to="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a0006441-84a3-4271-9b55-350f541c4d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a0006441-84a3-4271-9b55-350f541c4d3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a0006441-84a3-4271-9b55-350f541c4d3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a0006441-84a3-4271-9b55-350f541c4d3a" xlink:to="loc_us-gaap_ClassOfStockDomain_a0006441-84a3-4271-9b55-350f541c4d3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a0006441-84a3-4271-9b55-350f541c4d3a" xlink:to="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeniorConvertiblePreferredStockMember_8b48f533-0e38-4766-9a0f-3fe26cc6b498" xlink:href="sera-20220930.xsd#sera_SeniorConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:to="loc_sera_SeniorConvertiblePreferredStockMember_8b48f533-0e38-4766-9a0f-3fe26cc6b498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_JuniorConvertiblePreferredStockMember_2335cc82-443a-4aff-a37c-d98cf3a906ad" xlink:href="sera-20220930.xsd#sera_JuniorConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:to="loc_sera_JuniorConvertiblePreferredStockMember_2335cc82-443a-4aff-a37c-d98cf3a906ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7f003781-e431-4dd8-baea-e5dc179806a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7f003781-e431-4dd8-baea-e5dc179806a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7f003781-e431-4dd8-baea-e5dc179806a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7f003781-e431-4dd8-baea-e5dc179806a3" xlink:to="loc_us-gaap_EquityComponentDomain_7f003781-e431-4dd8-baea-e5dc179806a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7f003781-e431-4dd8-baea-e5dc179806a3" xlink:to="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3297f119-177f-4c56-a272-c012912d1b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_CommonStockMember_3297f119-177f-4c56-a272-c012912d1b7e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d4e02d21-1d81-456f-ae5c-9350f52f22ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d4e02d21-1d81-456f-ae5c-9350f52f22ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_da1fd61d-50bd-4ade-9526-6d29a27fab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_da1fd61d-50bd-4ade-9526-6d29a27fab8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a27e5032-3880-4829-9b3c-7ab664da8f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_RetainedEarningsMember_a27e5032-3880-4829-9b3c-7ab664da8f4e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="extended" id="ied9faf8bf89c43e38e51ff86a11a7b13_CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e2f9f54c-efd9-4744-b377-d8adc0ca5696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e2f9f54c-efd9-4744-b377-d8adc0ca5696" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityStockIssuanceCosts_d5c774de-217d-499b-b968-ac5290f6112c" xlink:href="sera-20220930.xsd#sera_TemporaryEquityStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:to="loc_sera_TemporaryEquityStockIssuanceCosts_d5c774de-217d-499b-b968-ac5290f6112c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7c99fbcc-bcb5-48f4-9f4f-cf60a3d5c556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:to="loc_us-gaap_StatementTable_7c99fbcc-bcb5-48f4-9f4f-cf60a3d5c556" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d96409c0-f9b7-470c-b0f2-3e504df0e7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7c99fbcc-bcb5-48f4-9f4f-cf60a3d5c556" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d96409c0-f9b7-470c-b0f2-3e504df0e7ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d96409c0-f9b7-470c-b0f2-3e504df0e7ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d96409c0-f9b7-470c-b0f2-3e504df0e7ef" xlink:to="loc_us-gaap_ClassOfStockDomain_d96409c0-f9b7-470c-b0f2-3e504df0e7ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9aa70d4e-b1bc-4b88-9d84-bfcd7d4dc4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d96409c0-f9b7-470c-b0f2-3e504df0e7ef" xlink:to="loc_us-gaap_ClassOfStockDomain_9aa70d4e-b1bc-4b88-9d84-bfcd7d4dc4e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesESeniorConvertiblePreferredStockMember_8fd6127b-6c08-419c-8713-2e6eceafda52" xlink:href="sera-20220930.xsd#sera_SeriesESeniorConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_9aa70d4e-b1bc-4b88-9d84-bfcd7d4dc4e9" xlink:to="loc_sera_SeriesESeniorConvertiblePreferredStockMember_8fd6127b-6c08-419c-8713-2e6eceafda52" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofCashFlowsunaudited"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="extended" id="i435940ff04744705807d27ce18763671_CondensedStatementsofCashFlowsunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f46555c6-0ae5-447a-ac00-d6f3bd5c347e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:to="loc_us-gaap_NetIncomeLoss_f46555c6-0ae5-447a-ac00-d6f3bd5c347e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5f7a90b7-846b-45a3-b978-5315679ca36f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5f7a90b7-846b-45a3-b978-5315679ca36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_04119257-cfc7-46e3-b356-ce3109ae91a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_04119257-cfc7-46e3-b356-ce3109ae91a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_dcb8e1ee-f5e7-4684-8e2e-707bef5418fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_ShareBasedCompensation_dcb8e1ee-f5e7-4684-8e2e-707bef5418fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_d9088433-9090-4c8e-84fa-343eb2934058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaidInKindInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_PaidInKindInterest_d9088433-9090-4c8e-84fa-343eb2934058" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dd57dad3-ded9-4e77-87a5-25d149cc8304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dd57dad3-ded9-4e77-87a5-25d149cc8304" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e2318389-3db8-4856-93f3-95a3904a32ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e2318389-3db8-4856-93f3-95a3904a32ed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_243a64a7-eef4-4440-afda-be13405cd4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_243a64a7-eef4-4440-afda-be13405cd4b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_ddcca4d1-8e5f-4f1c-82fe-93931cf83743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_ddcca4d1-8e5f-4f1c-82fe-93931cf83743" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_082e4b27-7e19-43b3-b3ce-41342301ddcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_082e4b27-7e19-43b3-b3ce-41342301ddcf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ced7bb99-9f0a-401c-bca1-e99182a1fb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ced7bb99-9f0a-401c-bca1-e99182a1fb60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b1b19072-7919-44f1-9b69-e9b26d2bc383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b1b19072-7919-44f1-9b69-e9b26d2bc383" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IncreaseDecreaseInDeferredRent_6a94fcce-aebb-47af-bc19-6ce63a6498d0" xlink:href="sera-20220930.xsd#sera_IncreaseDecreaseInDeferredRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_sera_IncreaseDecreaseInDeferredRent_6a94fcce-aebb-47af-bc19-6ce63a6498d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d7e04610-b58f-4732-8117-cb81bb1aa5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d7e04610-b58f-4732-8117-cb81bb1aa5f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_800990af-6d47-41e0-ac9b-c05b7245ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_800990af-6d47-41e0-ac9b-c05b7245ce11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_879056a3-c97b-4e57-af19-28e8c15ee71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_879056a3-c97b-4e57-af19-28e8c15ee71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bc1121d1-a542-4933-ac78-b3733bae3878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bc1121d1-a542-4933-ac78-b3733bae3878" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_53054d8e-4925-49a6-9d9d-27858ac0c29d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_53054d8e-4925-49a6-9d9d-27858ac0c29d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e7e51fa7-07bc-4f70-a9e5-589805196532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e7e51fa7-07bc-4f70-a9e5-589805196532" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21e65405-fa7f-4fcf-b88b-76cfe02f6217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21e65405-fa7f-4fcf-b88b-76cfe02f6217" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_af65d398-29dc-4564-b840-fd23ca1d1c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_af65d398-29dc-4564-b840-fd23ca1d1c82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_347fe74e-658e-4716-802f-42f2cc630ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_347fe74e-658e-4716-802f-42f2cc630ffb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5d0ce548-89c7-4bef-918d-3f1dc80d3f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5d0ce548-89c7-4bef-918d-3f1dc80d3f9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c20dfae8-da52-49a7-a211-0e1b2208a585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c20dfae8-da52-49a7-a211-0e1b2208a585" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_95effff5-913f-4f4f-8f94-1eb49f562811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_95effff5-913f-4f4f-8f94-1eb49f562811" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_c5ffcc23-7983-4aea-933b-ab8c83dfc116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_RepaymentsOfDebt_c5ffcc23-7983-4aea-933b-ab8c83dfc116" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_63675a48-20bb-4b95-8973-ae26654510e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_63675a48-20bb-4b95-8973-ae26654510e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_83ff83f4-1e71-4d5a-b458-70122fff29c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_83ff83f4-1e71-4d5a-b458-70122fff29c4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c3b867e-4494-4fe1-9995-6a0c45f59729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c3b867e-4494-4fe1-9995-6a0c45f59729" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8975bdaa-341a-4924-854a-c9bcf539cc38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8975bdaa-341a-4924-854a-c9bcf539cc38" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99a0c14c-8753-4f90-9d00-f1cd1b47ae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b516bf3d-1940-4b8a-b7f9-f0885133edeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b516bf3d-1940-4b8a-b7f9-f0885133edeb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_43905b14-71f0-41e3-a3b1-ba2549300d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b516bf3d-1940-4b8a-b7f9-f0885133edeb" xlink:to="loc_us-gaap_InterestPaidNet_43905b14-71f0-41e3-a3b1-ba2549300d7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_855deb76-5c32-4369-a713-bdad8bb4617a" xlink:href="sera-20220930.xsd#sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:to="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_855deb76-5c32-4369-a713-bdad8bb4617a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock_a345839b-cf8d-42b6-9f04-629cd5ca6acf" xlink:href="sera-20220930.xsd#sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:to="loc_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock_a345839b-cf8d-42b6-9f04-629cd5ca6acf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9cc2118d-b876-4577-a4d1-4919463bf8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_StatementTable_9cc2118d-b876-4577-a4d1-4919463bf8aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d2a110e3-d0d9-4818-b7b1-107f8d329bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9cc2118d-b876-4577-a4d1-4919463bf8aa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d2a110e3-d0d9-4818-b7b1-107f8d329bda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d2a110e3-d0d9-4818-b7b1-107f8d329bda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2a110e3-d0d9-4818-b7b1-107f8d329bda" xlink:to="loc_us-gaap_ClassOfStockDomain_d2a110e3-d0d9-4818-b7b1-107f8d329bda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1bda8c0-5d64-44c0-b145-1d78a2667fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2a110e3-d0d9-4818-b7b1-107f8d329bda" xlink:to="loc_us-gaap_ClassOfStockDomain_a1bda8c0-5d64-44c0-b145-1d78a2667fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesESeniorConvertiblePreferredStockMember_e7d7d49e-90aa-4b7f-b94e-506baec1abee" xlink:href="sera-20220930.xsd#sera_SeriesESeniorConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a1bda8c0-5d64-44c0-b145-1d78a2667fd8" xlink:to="loc_sera_SeriesESeniorConvertiblePreferredStockMember_e7d7d49e-90aa-4b7f-b94e-506baec1abee" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#SignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended" id="i5090f67add9641d189553c9a88bb9d36_SignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_634461ae-c271-45ea-8175-06023bae791f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_634461ae-c271-45ea-8175-06023bae791f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7cd6bef5-e3a8-4dce-98eb-db66eb9721f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:to="loc_us-gaap_OperatingLeaseLiability_7cd6bef5-e3a8-4dce-98eb-db66eb9721f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent_4c88540d-21e9-4638-b64b-93275e1ea096" xlink:href="sera-20220930.xsd#sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:to="loc_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent_4c88540d-21e9-4638-b64b-93275e1ea096" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3104b27f-0310-4502-9c63-e6fa15804422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3104b27f-0310-4502-9c63-e6fa15804422" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_20b73359-1311-4982-bdec-a4c97ef37598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3104b27f-0310-4502-9c63-e6fa15804422" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_20b73359-1311-4982-bdec-a4c97ef37598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_20b73359-1311-4982-bdec-a4c97ef37598_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_20b73359-1311-4982-bdec-a4c97ef37598" xlink:to="loc_us-gaap_TypeOfAdoptionMember_20b73359-1311-4982-bdec-a4c97ef37598_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_88c9fa8b-3a36-4c58-881a-e08d721351ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_20b73359-1311-4982-bdec-a4c97ef37598" xlink:to="loc_us-gaap_TypeOfAdoptionMember_88c9fa8b-3a36-4c58-881a-e08d721351ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_59a50714-0abd-4e73-a59e-860e7c5ba4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_88c9fa8b-3a36-4c58-881a-e08d721351ca" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_59a50714-0abd-4e73-a59e-860e7c5ba4f1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="extended" id="ib703a05f8a954968b8622d9ef21a7bf2_CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost_7e8ff6fe-9894-430b-8063-268addd0cd0a" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsAmortizedCost_7e8ff6fe-9894-430b-8063-268addd0cd0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_607f5688-2ec8-4717-b2ff-aa3571f3cc6a" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_607f5688-2ec8-4717-b2ff-aa3571f3cc6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_2c007fcb-6439-44c0-8d99-c4c2356c1b55" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_2c007fcb-6439-44c0-8d99-c4c2356c1b55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8a15104c-4ece-4489-b4e1-c0c9d27b67a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8a15104c-4ece-4489-b4e1-c0c9d27b67a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fd9f6aa4-cbb9-4bb4-b0ec-12d7870bf14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fd9f6aa4-cbb9-4bb4-b0ec-12d7870bf14f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a59f29c3-5610-4edc-a2b6-6839162ef3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a59f29c3-5610-4edc-a2b6-6839162ef3a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3645a992-1de8-49a5-8a6f-a4ed775df609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3645a992-1de8-49a5-8a6f-a4ed775df609" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_435b2286-f0a3-4ebe-9675-7b2966032d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_435b2286-f0a3-4ebe-9675-7b2966032d05" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_9d09f5b8-2570-40d4-8bef-0598ad2b8ebe" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_9d09f5b8-2570-40d4-8bef-0598ad2b8ebe" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_2d8ee240-ee48-4c80-beeb-50a7b9f4a340" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_2d8ee240-ee48-4c80-beeb-50a7b9f4a340" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_d692d4e4-17f6-4b37-b3cd-8d48cc618bf5" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_d692d4e4-17f6-4b37-b3cd-8d48cc618bf5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_cff4b63c-9803-4786-a395-66e386c9a0a1" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_cff4b63c-9803-4786-a395-66e386c9a0a1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a822bf3-d5ae-4bc9-b301-099b7a1feedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a822bf3-d5ae-4bc9-b301-099b7a1feedc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7a822bf3-d5ae-4bc9-b301-099b7a1feedc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a822bf3-d5ae-4bc9-b301-099b7a1feedc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7a822bf3-d5ae-4bc9-b301-099b7a1feedc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a822bf3-d5ae-4bc9-b301-099b7a1feedc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_1dcd129b-cb0c-4903-9f9c-a65e4f5fa9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_1dcd129b-cb0c-4903-9f9c-a65e4f5fa9b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CurrentMarketableSecuritiesMember_b04c0028-28ac-474e-af2c-9c2ee97b957e" xlink:href="sera-20220930.xsd#sera_CurrentMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:to="loc_sera_CurrentMarketableSecuritiesMember_b04c0028-28ac-474e-af2c-9c2ee97b957e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NonCurrentMarketableSecuritiesMember_30567342-7a8b-4547-9a9c-8ee8ea1884c7" xlink:href="sera-20220930.xsd#sera_NonCurrentMarketableSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:to="loc_sera_NonCurrentMarketableSecuritiesMember_30567342-7a8b-4547-9a9c-8ee8ea1884c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_302a1e6f-6fb6-476a-acff-7cce8cec4c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_302a1e6f-6fb6-476a-acff-7cce8cec4c7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_302a1e6f-6fb6-476a-acff-7cce8cec4c7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_302a1e6f-6fb6-476a-acff-7cce8cec4c7a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_302a1e6f-6fb6-476a-acff-7cce8cec4c7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_302a1e6f-6fb6-476a-acff-7cce8cec4c7a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_3d93bce9-e8cc-48ee-886b-9934588282eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:to="loc_us-gaap_CashMember_3d93bce9-e8cc-48ee-886b-9934588282eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_b0c7eb2e-b7ab-4355-9ee5-2cdf105fa2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:to="loc_us-gaap_MoneyMarketFundsMember_b0c7eb2e-b7ab-4355-9ee5-2cdf105fa2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b379d94b-a7b8-4f47-81d2-a19c12938d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:to="loc_us-gaap_CommercialPaperMember_b379d94b-a7b8-4f47-81d2-a19c12938d6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b94163f5-df26-4ef3-83d8-660d5851febd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b94163f5-df26-4ef3-83d8-660d5851febd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b94163f5-df26-4ef3-83d8-660d5851febd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b94163f5-df26-4ef3-83d8-660d5851febd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b94163f5-df26-4ef3-83d8-660d5851febd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b94163f5-df26-4ef3-83d8-660d5851febd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ca831f9d-b0d2-48bb-9d80-d62e513381b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_CommercialPaperMember_ca831f9d-b0d2-48bb-9d80-d62e513381b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_065c59e2-c84e-4212-bd79-8508c05b066e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_065c59e2-c84e-4212-bd79-8508c05b066e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_db851b1a-7d67-4584-896a-33a79225ea87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_db851b1a-7d67-4584-896a-33a79225ea87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_201e99b2-72b5-4a06-8475-303f35e9c756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_201e99b2-72b5-4a06-8475-303f35e9c756" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="extended" id="i86018e1076224bce9fda9569419a47d6_CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_67cefc83-8071-44f5-ab39-a20aa54b0f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_67cefc83-8071-44f5-ab39-a20aa54b0f60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_15ee780b-c8ef-4676-b266-7277f24152c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_15ee780b-c8ef-4676-b266-7277f24152c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_db55df50-0b8f-4228-9c31-e154a682189d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_db55df50-0b8f-4228-9c31-e154a682189d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0461edb-dcbc-43fa-9c90-098da4db0d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0461edb-dcbc-43fa-9c90-098da4db0d6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0402d5fb-e812-4cab-ae2f-59cc4596b0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0402d5fb-e812-4cab-ae2f-59cc4596b0c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_046ce435-6703-4482-b502-eccd78c073db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_046ce435-6703-4482-b502-eccd78c073db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_5e9e613a-08e8-491c-ba3d-a18378ea58d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_5e9e613a-08e8-491c-ba3d-a18378ea58d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f552093f-2083-4eb9-822c-413e2dbe4cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_5e9e613a-08e8-491c-ba3d-a18378ea58d6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f552093f-2083-4eb9-822c-413e2dbe4cc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f552093f-2083-4eb9-822c-413e2dbe4cc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f552093f-2083-4eb9-822c-413e2dbe4cc7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f552093f-2083-4eb9-822c-413e2dbe4cc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f552093f-2083-4eb9-822c-413e2dbe4cc7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8a221cdc-a0ec-467a-a30e-46b4275c5b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_CommercialPaperMember_8a221cdc-a0ec-467a-a30e-46b4275c5b79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ee4ed24b-36c8-4ef3-a826-09c97a8a7c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ee4ed24b-36c8-4ef3-a826-09c97a8a7c9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6d76c66-bf19-4bae-9e1d-f05d95d60f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6d76c66-bf19-4bae-9e1d-f05d95d60f4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_69ba28d0-bd04-4cc4-ac30-8d74f3243715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_69ba28d0-bd04-4cc4-ac30-8d74f3243715" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="extended" id="ic1df93c62e8046f9959ac7eb00f7f429_PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_2c8fc50a-6bbc-4e43-ade7-06c898d08752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_2c8fc50a-6bbc-4e43-ade7-06c898d08752" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c051f73f-cea6-4d35-a01f-cfc451bcfc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c051f73f-cea6-4d35-a01f-cfc451bcfc0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_790a001f-bb79-461c-a5b8-b14dd73ad13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_790a001f-bb79-461c-a5b8-b14dd73ad13f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df0640c6-062e-45c9-aded-791da5dcda28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df0640c6-062e-45c9-aded-791da5dcda28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9f683ec0-6b05-4ada-9ca9-b172447d5686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df0640c6-062e-45c9-aded-791da5dcda28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9f683ec0-6b05-4ada-9ca9-b172447d5686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f683ec0-6b05-4ada-9ca9-b172447d5686_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9f683ec0-6b05-4ada-9ca9-b172447d5686" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_9f683ec0-6b05-4ada-9ca9-b172447d5686_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9f683ec0-6b05-4ada-9ca9-b172447d5686" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryEquipmentMember_8a3d2124-db1c-4eaa-be79-fc7f354e9369" xlink:href="sera-20220930.xsd#sera_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_sera_LaboratoryEquipmentMember_8a3d2124-db1c-4eaa-be79-fc7f354e9369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_1bb62440-e802-4eb5-813d-1834dc992702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_ComputerEquipmentMember_1bb62440-e802-4eb5-813d-1834dc992702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_31f76ae4-ae72-4749-8649-a99b2a9a58d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_31f76ae4-ae72-4749-8649-a99b2a9a58d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e97d02cb-e5da-4d62-97db-fd53cab2c1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e97d02cb-e5da-4d62-97db-fd53cab2c1c7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_396833e2-0e56-4e8e-90b7-8e4549d87ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_396833e2-0e56-4e8e-90b7-8e4549d87ec5" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#LoansandConvertiblePromissoryNotesBankLoanDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails" xlink:type="extended" id="ie655208f198a406e9c3c532bf3ee8def_LoansandConvertiblePromissoryNotesBankLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansFromBank_b0a0b142-201f-4604-9e75-e48888ee8575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansFromBank"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_us-gaap_LongTermLoansFromBank_b0a0b142-201f-4604-9e75-e48888ee8575" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_6f6b5c14-3f70-45df-a70a-8564618d1453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_6f6b5c14-3f70-45df-a70a-8564618d1453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_a05fa076-a06c-4057-af73-2aca98e7e067" xlink:href="sera-20220930.xsd#sera_RepaymentOfAccruedInterestOnLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_a05fa076-a06c-4057-af73-2aca98e7e067" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_10ca8cfb-ece7-43d4-8037-f5781875979d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_10ca8cfb-ece7-43d4-8037-f5781875979d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f9b79e0c-99ad-463b-b4d2-395f0fd3092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_us-gaap_DebtInstrumentTable_f9b79e0c-99ad-463b-b4d2-395f0fd3092a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d59d7433-2d2a-4ff1-8758-fd57e64f480d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_f9b79e0c-99ad-463b-b4d2-395f0fd3092a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d59d7433-2d2a-4ff1-8758-fd57e64f480d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d59d7433-2d2a-4ff1-8758-fd57e64f480d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d59d7433-2d2a-4ff1-8758-fd57e64f480d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d59d7433-2d2a-4ff1-8758-fd57e64f480d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7953baf7-cd4c-492d-ae39-6ab0b3727cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d59d7433-2d2a-4ff1-8758-fd57e64f480d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7953baf7-cd4c-492d-ae39-6ab0b3727cfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LoanAndSecurityAgreementMember_a06d54d0-4e22-40e5-af91-74b5403506bb" xlink:href="sera-20220930.xsd#sera_LoanAndSecurityAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7953baf7-cd4c-492d-ae39-6ab0b3727cfc" xlink:to="loc_sera_LoanAndSecurityAgreementMember_a06d54d0-4e22-40e5-af91-74b5403506bb" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails" xlink:type="extended" id="i9a76ad2531ab4652ad26207d570b0f46_LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e0ea3a91-c58d-4e26-abee-027ea06c22e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e0ea3a91-c58d-4e26-abee-027ea06c22e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b7b22a43-a891-4120-be87-ed90fcdd4642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b7b22a43-a891-4120-be87-ed90fcdd4642" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_379d185c-37f7-4056-bb1d-599f7552a964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_379d185c-37f7-4056-bb1d-599f7552a964" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1cd2b815-b00a-4cf1-b4f7-87b673aa8581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1cd2b815-b00a-4cf1-b4f7-87b673aa8581" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_3a2435ae-df00-40b1-b7b5-06342fbec98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_3a2435ae-df00-40b1-b7b5-06342fbec98f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseLongTermDebt_0af9fee4-61e3-4a3a-b390-d36df57e5021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_InterestExpenseLongTermDebt_0af9fee4-61e3-4a3a-b390-d36df57e5021" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fe2b6ba9-2818-4ccc-8106-03d4737d7ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fe2b6ba9-2818-4ccc-8106-03d4737d7ebd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3b74710a-9bc8-4099-b367-45ef6f76917c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3b74710a-9bc8-4099-b367-45ef6f76917c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_82293f47-5850-450f-b5e4-b2f151c29464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_82293f47-5850-450f-b5e4-b2f151c29464" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_e8b7e4de-ab40-43d8-aec1-18438ed4894f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_e8b7e4de-ab40-43d8-aec1-18438ed4894f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_cda4eda7-cc81-4d48-9efc-66849072048c" xlink:href="sera-20220930.xsd#sera_RepaymentOfAccruedInterestOnLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_cda4eda7-cc81-4d48-9efc-66849072048c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dd875b8e-dedc-453f-9e40-6ec1d565510e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dd875b8e-dedc-453f-9e40-6ec1d565510e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dd875b8e-dedc-453f-9e40-6ec1d565510e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd875b8e-dedc-453f-9e40-6ec1d565510e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dd875b8e-dedc-453f-9e40-6ec1d565510e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0f913c8a-c9fa-4508-9334-a1903c5e998f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd875b8e-dedc-453f-9e40-6ec1d565510e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0f913c8a-c9fa-4508-9334-a1903c5e998f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_February2019ConvertibleNoteMember_6daaf99d-3f2c-4bc9-b122-efb162b7e8d1" xlink:href="sera-20220930.xsd#sera_February2019ConvertibleNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f913c8a-c9fa-4508-9334-a1903c5e998f" xlink:to="loc_sera_February2019ConvertibleNoteMember_6daaf99d-3f2c-4bc9-b122-efb162b7e8d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ae76dd6b-fa67-496a-876a-aeb48774cb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ae76dd6b-fa67-496a-876a-aeb48774cb16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ae76dd6b-fa67-496a-876a-aeb48774cb16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ae76dd6b-fa67-496a-876a-aeb48774cb16" xlink:to="loc_us-gaap_ClassOfStockDomain_ae76dd6b-fa67-496a-876a-aeb48774cb16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_83c01f06-e8ef-4e28-95e9-1ad6ba27c352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ae76dd6b-fa67-496a-876a-aeb48774cb16" xlink:to="loc_us-gaap_ClassOfStockDomain_83c01f06-e8ef-4e28-95e9-1ad6ba27c352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesDConvertiblePreferredStockMember_df853945-91fd-49cb-a570-77c386193934" xlink:href="sera-20220930.xsd#sera_SeriesDConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_83c01f06-e8ef-4e28-95e9-1ad6ba27c352" xlink:to="loc_sera_SeriesDConvertiblePreferredStockMember_df853945-91fd-49cb-a570-77c386193934" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails" xlink:type="extended" id="iaa5b007537984b15a55b6fc1d2320d49_LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b432b21e-ac89-4890-b2b8-529b78976393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b432b21e-ac89-4890-b2b8-529b78976393" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDecreaseForgiveness_76581833-b5d6-4551-b794-14209c024409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:to="loc_us-gaap_DebtInstrumentDecreaseForgiveness_76581833-b5d6-4551-b794-14209c024409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_876b1b8d-7ab6-4767-a99e-0ac3f6a6b778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_876b1b8d-7ab6-4767-a99e-0ac3f6a6b778" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7a046172-9b31-431e-94d2-23aa4d239cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:to="loc_us-gaap_DebtInstrumentTable_7a046172-9b31-431e-94d2-23aa4d239cf5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_59825725-2ffb-49a9-a3fd-094d3dfa70b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7a046172-9b31-431e-94d2-23aa4d239cf5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_59825725-2ffb-49a9-a3fd-094d3dfa70b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_59825725-2ffb-49a9-a3fd-094d3dfa70b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_59825725-2ffb-49a9-a3fd-094d3dfa70b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_59825725-2ffb-49a9-a3fd-094d3dfa70b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5efa3326-4ca6-42c5-a8a7-49fb0722fd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_59825725-2ffb-49a9-a3fd-094d3dfa70b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5efa3326-4ca6-42c5-a8a7-49fb0722fd29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PaycheckProtectionProgramLoanMember_14e82fb0-4827-4c7d-9336-150307d40836" xlink:href="sera-20220930.xsd#sera_PaycheckProtectionProgramLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5efa3326-4ca6-42c5-a8a7-49fb0722fd29" xlink:to="loc_sera_PaycheckProtectionProgramLoanMember_14e82fb0-4827-4c7d-9336-150307d40836" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended" id="i5351c295d297469189480e5a2295b0ce_FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62feb95a-b4ed-44eb-9e7e-88b5d69d1a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62feb95a-b4ed-44eb-9e7e-88b5d69d1a06" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_181169db-60b9-48e1-9955-3dceeb8bab69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_181169db-60b9-48e1-9955-3dceeb8bab69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3c587cfe-73a7-4776-8034-be43f96c62e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3c587cfe-73a7-4776-8034-be43f96c62e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2897891d-a61d-463c-b12e-c73126a5c586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2897891d-a61d-463c-b12e-c73126a5c586" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62feb95a-b4ed-44eb-9e7e-88b5d69d1a06" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c52ee249-b102-4a76-9456-324ec8a1985b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c52ee249-b102-4a76-9456-324ec8a1985b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c52ee249-b102-4a76-9456-324ec8a1985b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c52ee249-b102-4a76-9456-324ec8a1985b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c52ee249-b102-4a76-9456-324ec8a1985b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c52ee249-b102-4a76-9456-324ec8a1985b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_739f57cf-7bc6-40a7-8df8-4523eb5af7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_739f57cf-7bc6-40a7-8df8-4523eb5af7d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e8e42f37-ab13-431e-a7ad-40d7cc16bf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e8e42f37-ab13-431e-a7ad-40d7cc16bf5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_885718aa-be59-4b9d-8d48-3dab0b3089b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_885718aa-be59-4b9d-8d48-3dab0b3089b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_843417bc-6bad-4548-8153-f6da67d08cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_843417bc-6bad-4548-8153-f6da67d08cd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_843417bc-6bad-4548-8153-f6da67d08cd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_843417bc-6bad-4548-8153-f6da67d08cd2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_843417bc-6bad-4548-8153-f6da67d08cd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c10d7dbd-0d52-4e48-8d9d-8e0f9f4e04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_843417bc-6bad-4548-8153-f6da67d08cd2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c10d7dbd-0d52-4e48-8d9d-8e0f9f4e04a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_bb00b3b0-44a4-46ee-8e6b-e63b061962ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c10d7dbd-0d52-4e48-8d9d-8e0f9f4e04a0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_bb00b3b0-44a4-46ee-8e6b-e63b061962ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_304a56cb-aed6-4919-899b-fad7fb2ebab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_304a56cb-aed6-4919-899b-fad7fb2ebab5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_304a56cb-aed6-4919-899b-fad7fb2ebab5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_304a56cb-aed6-4919-899b-fad7fb2ebab5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_304a56cb-aed6-4919-899b-fad7fb2ebab5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_304a56cb-aed6-4919-899b-fad7fb2ebab5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_4da15d33-bc32-431e-b2dc-1d38950a364d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:to="loc_us-gaap_MoneyMarketFundsMember_4da15d33-bc32-431e-b2dc-1d38950a364d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_954ecd06-d59f-4baa-8598-9c3d1130ad16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:to="loc_us-gaap_CommercialPaperMember_954ecd06-d59f-4baa-8598-9c3d1130ad16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_877d6cc8-2342-4fd9-9e80-65516e78e169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_FinancialInstrumentAxis_877d6cc8-2342-4fd9-9e80-65516e78e169" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_877d6cc8-2342-4fd9-9e80-65516e78e169_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_877d6cc8-2342-4fd9-9e80-65516e78e169" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_877d6cc8-2342-4fd9-9e80-65516e78e169_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_877d6cc8-2342-4fd9-9e80-65516e78e169" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_cf594233-56cf-4e08-b743-9fc297c33692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_CommercialPaperMember_cf594233-56cf-4e08-b743-9fc297c33692" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ba5a376f-cf38-4f88-a3ba-3849ef90caf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ba5a376f-cf38-4f88-a3ba-3849ef90caf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f9dfc2e1-f4f1-4718-81d9-3ede67f37784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f9dfc2e1-f4f1-4718-81d9-3ede67f37784" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_c97281fb-2469-4851-b7cf-39049c595699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_c97281fb-2469-4851-b7cf-39049c595699" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="i8466b41f68294f7989ae5b62ac4b5e0a_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_149ff056-2d0d-4f37-82fc-4bea949a4744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_149ff056-2d0d-4f37-82fc-4bea949a4744" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_36114340-be6c-45db-813e-9bcd79cbab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_us-gaap_RevenueFromRelatedParties_36114340-be6c-45db-813e-9bcd79cbab9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_7f1dca02-3ff8-47be-aa35-3d78c555ed23" xlink:href="sera-20220930.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_7f1dca02-3ff8-47be-aa35-3d78c555ed23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_427c0e1c-131a-4bc3-ab8a-2e44ce88c5fe" xlink:href="sera-20220930.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_427c0e1c-131a-4bc3-ab8a-2e44ce88c5fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_677e39ca-4188-4ac5-a390-374b0def883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_677e39ca-4188-4ac5-a390-374b0def883a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_677e39ca-4188-4ac5-a390-374b0def883a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_677e39ca-4188-4ac5-a390-374b0def883a" xlink:to="loc_us-gaap_RelatedPartyDomain_677e39ca-4188-4ac5-a390-374b0def883a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_677e39ca-4188-4ac5-a390-374b0def883a" xlink:to="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_HealthcoreIncMember_4a3d5c25-ec24-4a4c-be10-727683a6309d" xlink:href="sera-20220930.xsd#sera_HealthcoreIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:to="loc_sera_HealthcoreIncMember_4a3d5c25-ec24-4a4c-be10-727683a6309d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ElevanceHealthIncMember_285d5a9e-6845-4149-97d5-5afd539d44ae" xlink:href="sera-20220930.xsd#sera_ElevanceHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:to="loc_sera_ElevanceHealthIncMember_285d5a9e-6845-4149-97d5-5afd539d44ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_MasterServicesAgreementMember_903a8b0d-a8ef-4b76-9425-c8814ba4a274" xlink:href="sera-20220930.xsd#sera_MasterServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:to="loc_sera_MasterServicesAgreementMember_903a8b0d-a8ef-4b76-9425-c8814ba4a274" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryServicesAgreementMember_0f961c91-a6ee-4c0f-be25-0917f4d9b750" xlink:href="sera-20220930.xsd#sera_LaboratoryServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:to="loc_sera_LaboratoryServicesAgreementMember_0f961c91-a6ee-4c0f-be25-0917f4d9b750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommercialCollaborationAgreementMember_5e4d5515-c706-423b-952d-a271efcab942" xlink:href="sera-20220930.xsd#sera_CommercialCollaborationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:to="loc_sera_CommercialCollaborationAgreementMember_5e4d5515-c706-423b-952d-a271efcab942" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CapitalStructureNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="extended" id="i4b76bdb312954f1fba20a8810a0a8f0b_CapitalStructureNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2358a497-867c-49cc-ad07-788c8046821a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2358a497-867c-49cc-ad07-788c8046821a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_27038a17-9f00-4274-b025-49f33c2bc7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_27038a17-9f00-4274-b025-49f33c2bc7d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_30304b3e-258c-42eb-9f39-821e61ffd6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_30304b3e-258c-42eb-9f39-821e61ffd6c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d94db035-a5bd-4b76-8a40-458b1504c0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d94db035-a5bd-4b76-8a40-458b1504c0f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4dcf1780-1243-4734-b63d-606dd0e831c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4dcf1780-1243-4734-b63d-606dd0e831c7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfCommonStockClassesAuthorized_4d2fe2c0-c43d-4085-9c78-9e41fc5179d2" xlink:href="sera-20220930.xsd#sera_NumberOfCommonStockClassesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_sera_NumberOfCommonStockClassesAuthorized_4d2fe2c0-c43d-4085-9c78-9e41fc5179d2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfVotesPerShare_141eac93-c17c-46d3-a2ae-76120f9e1a55" xlink:href="sera-20220930.xsd#sera_NumberOfVotesPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_sera_NumberOfVotesPerShare_141eac93-c17c-46d3-a2ae-76120f9e1a55" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockConversionRatio_ba05ae02-1f9e-4f4d-9e79-d1151b63f74c" xlink:href="sera-20220930.xsd#sera_CommonStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_sera_CommonStockConversionRatio_ba05ae02-1f9e-4f4d-9e79-d1151b63f74c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4e864e61-735c-48e4-b281-2b60959df7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4e864e61-735c-48e4-b281-2b60959df7db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4e864e61-735c-48e4-b281-2b60959df7db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4e864e61-735c-48e4-b281-2b60959df7db" xlink:to="loc_us-gaap_ClassOfStockDomain_4e864e61-735c-48e4-b281-2b60959df7db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4e864e61-735c-48e4-b281-2b60959df7db" xlink:to="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5841fa3a-e037-487e-b5e7-bf14191ec2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:to="loc_us-gaap_CommonClassAMember_5841fa3a-e037-487e-b5e7-bf14191ec2a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_03eb3cdf-dceb-422f-baf7-1969ca3923d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:to="loc_us-gaap_CommonClassBMember_03eb3cdf-dceb-422f-baf7-1969ca3923d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_86b4ac64-5e40-46df-955f-11e7f0661d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_86b4ac64-5e40-46df-955f-11e7f0661d1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e70af6e8-44e9-4e43-828c-4f0b4e2e08ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e70af6e8-44e9-4e43-828c-4f0b4e2e08ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_518e2ddd-cb99-4c61-87a4-1fd6adc65843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e70af6e8-44e9-4e43-828c-4f0b4e2e08ae" xlink:to="loc_us-gaap_IPOMember_518e2ddd-cb99-4c61-87a4-1fd6adc65843" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CapitalStructureCommonStockDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="extended" id="ic3e3eb30136f41df9dc1c7676adef8de_CapitalStructureCommonStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8185f4f5-0c32-4c14-b70e-7bda06f7e887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_074cef4a-ea3e-4009-818d-36c99f77eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8185f4f5-0c32-4c14-b70e-7bda06f7e887" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_074cef4a-ea3e-4009-818d-36c99f77eb1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_8185f4f5-0c32-4c14-b70e-7bda06f7e887" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7f6fc1a7-62fd-40b2-9722-4960db0a6408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7f6fc1a7-62fd-40b2-9722-4960db0a6408" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7f6fc1a7-62fd-40b2-9722-4960db0a6408_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7f6fc1a7-62fd-40b2-9722-4960db0a6408" xlink:to="loc_us-gaap_ClassOfStockDomain_7f6fc1a7-62fd-40b2-9722-4960db0a6408_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_16a4fab1-95b4-43c3-9de3-8694bc8463e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7f6fc1a7-62fd-40b2-9722-4960db0a6408" xlink:to="loc_us-gaap_ClassOfStockDomain_16a4fab1-95b4-43c3-9de3-8694bc8463e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_3e44b810-4beb-4c88-8869-a0f33fde9b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_16a4fab1-95b4-43c3-9de3-8694bc8463e2" xlink:to="loc_us-gaap_CommonClassAMember_3e44b810-4beb-4c88-8869-a0f33fde9b80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_dcea7dd3-da2a-41ed-aa4f-caf50b694996" xlink:href="sera-20220930.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_dcea7dd3-da2a-41ed-aa4f-caf50b694996" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_dcea7dd3-da2a-41ed-aa4f-caf50b694996_default" xlink:href="sera-20220930.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_dcea7dd3-da2a-41ed-aa4f-caf50b694996" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_dcea7dd3-da2a-41ed-aa4f-caf50b694996_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:href="sera-20220930.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_dcea7dd3-da2a-41ed-aa4f-caf50b694996" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_06413558-a7db-4ae2-9e39-0bd1f8de0224" xlink:href="sera-20220930.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_06413558-a7db-4ae2-9e39-0bd1f8de0224" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5e457629-4e58-4067-8266-b775388f4355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5e457629-4e58-4067-8266-b775388f4355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_f9f5e7fd-230c-4069-981f-c1452b1342cb" xlink:href="sera-20220930.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_f9f5e7fd-230c-4069-981f-c1452b1342cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_44cd05fc-383a-4120-bb02-c882d051d86d" xlink:href="sera-20220930.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_44cd05fc-383a-4120-bb02-c882d051d86d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended" id="i3a08837a1259400d9d309137f9bf2e52_StockBasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e58d72f7-33a5-422b-a7a6-f9f73e5d26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e58d72f7-33a5-422b-a7a6-f9f73e5d26c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c38d8e8e-f260-4751-b6c9-c7ec6e247f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c38d8e8e-f260-4751-b6c9-c7ec6e247f73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b6e6856d-604d-4aa8-ab1d-7ae26e7bb8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b6e6856d-604d-4aa8-ab1d-7ae26e7bb8d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1cc9adb1-1411-463f-8906-00247949a19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1cc9adb1-1411-463f-8906-00247949a19c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ca8a5bca-14d3-49d5-b15f-1a1bf450bbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ca8a5bca-14d3-49d5-b15f-1a1bf450bbaa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df05fa83-3c82-4e86-9620-e1c3e94bc1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df05fa83-3c82-4e86-9620-e1c3e94bc1f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a9856b5d-13cd-419d-982d-727136c8f19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:to="loc_us-gaap_PlanNameAxis_a9856b5d-13cd-419d-982d-727136c8f19f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a9856b5d-13cd-419d-982d-727136c8f19f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_a9856b5d-13cd-419d-982d-727136c8f19f" xlink:to="loc_us-gaap_PlanNameDomain_a9856b5d-13cd-419d-982d-727136c8f19f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_a9856b5d-13cd-419d-982d-727136c8f19f" xlink:to="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2011Member_668973b9-8316-45e8-ae91-be3e3a9e7b5e" xlink:href="sera-20220930.xsd#sera_Plan2011Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:to="loc_sera_Plan2011Member_668973b9-8316-45e8-ae91-be3e3a9e7b5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2021Member_eed05322-413b-4a32-b264-8d739f433f7b" xlink:href="sera-20220930.xsd#sera_Plan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:to="loc_sera_Plan2021Member_eed05322-413b-4a32-b264-8d739f433f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PlanEspp2021Member_07c91b95-d53d-442e-9585-86a2c7a5c5bd" xlink:href="sera-20220930.xsd#sera_PlanEspp2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:to="loc_sera_PlanEspp2021Member_07c91b95-d53d-442e-9585-86a2c7a5c5bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9651f2c5-54d0-4b1d-8108-44123dc2e4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9651f2c5-54d0-4b1d-8108-44123dc2e4ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9651f2c5-54d0-4b1d-8108-44123dc2e4ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9651f2c5-54d0-4b1d-8108-44123dc2e4ba" xlink:to="loc_us-gaap_ClassOfStockDomain_9651f2c5-54d0-4b1d-8108-44123dc2e4ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6bbb5561-f5af-45c5-9981-6e3e5ac7d2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9651f2c5-54d0-4b1d-8108-44123dc2e4ba" xlink:to="loc_us-gaap_ClassOfStockDomain_6bbb5561-f5af-45c5-9981-6e3e5ac7d2b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d7f0b695-2f92-4e54-a438-e66d4e69efdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_6bbb5561-f5af-45c5-9981-6e3e5ac7d2b0" xlink:to="loc_us-gaap_CommonClassAMember_d7f0b695-2f92-4e54-a438-e66d4e69efdc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#StockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="extended" id="i8995c68a92ef4235bd0b5b7e7b102ceb_StockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_fa794871-49c6-4b1f-8c5e-d9b0da9eee67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fe5ec377-67d1-4859-ba20-77276f5b7c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_fa794871-49c6-4b1f-8c5e-d9b0da9eee67" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fe5ec377-67d1-4859-ba20-77276f5b7c4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3af0a185-cf44-46bc-9b84-2685796b7c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_fa794871-49c6-4b1f-8c5e-d9b0da9eee67" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3af0a185-cf44-46bc-9b84-2685796b7c6c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ed30e7ac-999e-44db-8405-fd87186d666a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3af0a185-cf44-46bc-9b84-2685796b7c6c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ed30e7ac-999e-44db-8405-fd87186d666a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ed30e7ac-999e-44db-8405-fd87186d666a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ed30e7ac-999e-44db-8405-fd87186d666a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ed30e7ac-999e-44db-8405-fd87186d666a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ed30e7ac-999e-44db-8405-fd87186d666a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a778c5d-1940-414b-b2b5-3ab866d79558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a778c5d-1940-414b-b2b5-3ab866d79558" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_49788c27-fad6-4b79-8651-b46e32773840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_49788c27-fad6-4b79-8651-b46e32773840" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_306e04b9-93c7-4e2f-a3f4-afd67342c064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_306e04b9-93c7-4e2f-a3f4-afd67342c064" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#WarrantsCommonStockWarrantsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="extended" id="ica784771352b47b7a87ffa56f27bd10f_WarrantsCommonStockWarrantsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_77c3c54d-e7a8-4d73-854b-b6bd5fbd1f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_77c3c54d-e7a8-4d73-854b-b6bd5fbd1f1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_3e99afc7-be74-4658-91e4-66fff63d4ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_3e99afc7-be74-4658-91e4-66fff63d4ee4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_11be537b-8b35-4be4-9ce3-8c8cf75ba590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_11be537b-8b35-4be4-9ce3-8c8cf75ba590" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a72e5990-6b56-4967-9e5c-d5f8b2262bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_11be537b-8b35-4be4-9ce3-8c8cf75ba590" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a72e5990-6b56-4967-9e5c-d5f8b2262bb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a72e5990-6b56-4967-9e5c-d5f8b2262bb7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a72e5990-6b56-4967-9e5c-d5f8b2262bb7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a72e5990-6b56-4967-9e5c-d5f8b2262bb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a72e5990-6b56-4967-9e5c-d5f8b2262bb7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember_da78f565-7bfa-488b-9203-df9cc6dbf39f" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt520SharePriceMember_da78f565-7bfa-488b-9203-df9cc6dbf39f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt9.03SharePriceMember_e4838ddf-f24f-4eee-9e26-53719385b535" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt9.03SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt9.03SharePriceMember_e4838ddf-f24f-4eee-9e26-53719385b535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt10.84SharePriceMember_2c0fb133-4c15-4d25-ad8f-3165f487b20a" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt10.84SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt10.84SharePriceMember_2c0fb133-4c15-4d25-ad8f-3165f487b20a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt1238SharePriceMember_2cacad70-01ac-4b62-831b-0ecdbcbbe7a9" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt1238SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt1238SharePriceMember_2cacad70-01ac-4b62-831b-0ecdbcbbe7a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt2077SharePriceMember_b5a2e661-6a43-4fad-82c6-0fad5e6fdaa6" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt2077SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt2077SharePriceMember_b5a2e661-6a43-4fad-82c6-0fad5e6fdaa6" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#WarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/WarrantsNarrativeDetails" xlink:type="extended" id="i39b9637ddadb4471b4c2440e32eaa826_WarrantsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_dc7e57d6-6fdd-4fef-8fa0-fb20e1d3157a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ClassOfWarrantOrRightExpired_9798404c-a417-4ce4-86f9-1b9266b36fbd" xlink:href="sera-20220930.xsd#sera_ClassOfWarrantOrRightExpired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_dc7e57d6-6fdd-4fef-8fa0-fb20e1d3157a" xlink:to="loc_sera_ClassOfWarrantOrRightExpired_9798404c-a417-4ce4-86f9-1b9266b36fbd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_91c681d4-0ebc-4690-9f57-7481cd84ccd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_dc7e57d6-6fdd-4fef-8fa0-fb20e1d3157a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_91c681d4-0ebc-4690-9f57-7481cd84ccd7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a8f9d73d-5481-4d47-ab7c-d4194078f717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_91c681d4-0ebc-4690-9f57-7481cd84ccd7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a8f9d73d-5481-4d47-ab7c-d4194078f717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8f9d73d-5481-4d47-ab7c-d4194078f717_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a8f9d73d-5481-4d47-ab7c-d4194078f717" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a8f9d73d-5481-4d47-ab7c-d4194078f717_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cc0f227-6575-490d-ad40-79a1d88c6e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a8f9d73d-5481-4d47-ab7c-d4194078f717" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cc0f227-6575-490d-ad40-79a1d88c6e87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember_d9c18707-cbe5-4bef-8c81-70908aa66c9f" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cc0f227-6575-490d-ad40-79a1d88c6e87" xlink:to="loc_sera_CommonStockWarrantAt520SharePriceMember_d9c18707-cbe5-4bef-8c81-70908aa66c9f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="extended" id="ib005ec20d290481fbcf0bb9f104f19df_CommitmentsandContingencesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:href="sera-20220930.xsd#sera_CommitmentsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_a64e73b1-b474-4eb8-96f5-87d633730845" xlink:href="sera-20220930.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:to="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_a64e73b1-b474-4eb8-96f5-87d633730845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7335f842-703b-4b07-9c26-d718901602c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7335f842-703b-4b07-9c26-d718901602c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IndemnificationLiability_18dc7ca4-2301-46ab-a93d-8d9b3a306e95" xlink:href="sera-20220930.xsd#sera_IndemnificationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:to="loc_sera_IndemnificationLiability_18dc7ca4-2301-46ab-a93d-8d9b3a306e95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesTable_027b8635-28fc-42e3-8efe-34d33c52aef4" xlink:href="sera-20220930.xsd#sera_CommitmentsAndContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:to="loc_sera_CommitmentsAndContingenciesTable_027b8635-28fc-42e3-8efe-34d33c52aef4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b54b2ab6-ae55-4311-a088-425c25bae34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sera_CommitmentsAndContingenciesTable_027b8635-28fc-42e3-8efe-34d33c52aef4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b54b2ab6-ae55-4311-a088-425c25bae34d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b54b2ab6-ae55-4311-a088-425c25bae34d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b54b2ab6-ae55-4311-a088-425c25bae34d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b54b2ab6-ae55-4311-a088-425c25bae34d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_113e4e22-156e-4e13-881a-c3afbf39399e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b54b2ab6-ae55-4311-a088-425c25bae34d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_113e4e22-156e-4e13-881a-c3afbf39399e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OfficeAndLaboratorySpaceMember_7e29b83d-799e-486c-9661-382cb827634a" xlink:href="sera-20220930.xsd#sera_OfficeAndLaboratorySpaceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_113e4e22-156e-4e13-881a-c3afbf39399e" xlink:to="loc_sera_OfficeAndLaboratorySpaceMember_7e29b83d-799e-486c-9661-382cb827634a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails" xlink:type="extended" id="ib0eda3f41aa64a41bccff76dc0c361ef_NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eaae04a2-065b-4bb0-b78e-10260eedf219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_NetIncomeLoss_eaae04a2-065b-4bb0-b78e-10260eedf219" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f5e91bc-c1f4-43c6-bb8f-296da39e8a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f5e91bc-c1f4-43c6-bb8f-296da39e8a5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d46c231c-fe68-4a1f-a933-811d024a0380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d46c231c-fe68-4a1f-a933-811d024a0380" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_416dbff5-f2cc-4d55-9df6-f5e2eca72480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_EarningsPerShareBasic_416dbff5-f2cc-4d55-9df6-f5e2eca72480" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d4bbfb30-0c02-4a85-bab7-fc0fc6a2b8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d4bbfb30-0c02-4a85-bab7-fc0fc6a2b8f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_9510d661-b340-4b51-8d2c-981081893c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_9510d661-b340-4b51-8d2c-981081893c78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_9510d661-b340-4b51-8d2c-981081893c78" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712" xlink:to="loc_us-gaap_ClassOfStockDomain_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712" xlink:to="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_02e5d40c-f354-4b17-b787-a11e9dd75888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:to="loc_us-gaap_CommonClassAMember_02e5d40c-f354-4b17-b787-a11e9dd75888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_6f9ce91d-b84c-43af-bff8-ebdeec7a10d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:to="loc_us-gaap_CommonClassBMember_6f9ce91d-b84c-43af-bff8-ebdeec7a10d0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="extended" id="i5cda73cca79e4f3fa0626ca30bbeaaa3_NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_efadb867-98df-4100-af77-485106ab6931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8f4357c8-93d7-4fbf-82cf-8bf9aaeb4c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_efadb867-98df-4100-af77-485106ab6931" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8f4357c8-93d7-4fbf-82cf-8bf9aaeb4c4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f50f43e2-6a74-4e20-867d-e909226bb96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_efadb867-98df-4100-af77-485106ab6931" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f50f43e2-6a74-4e20-867d-e909226bb96f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea60385c-a263-4111-9954-31c1eb57b39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f50f43e2-6a74-4e20-867d-e909226bb96f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea60385c-a263-4111-9954-31c1eb57b39d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ea60385c-a263-4111-9954-31c1eb57b39d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea60385c-a263-4111-9954-31c1eb57b39d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ea60385c-a263-4111-9954-31c1eb57b39d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea60385c-a263-4111-9954-31c1eb57b39d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_JuniorConvertiblePreferredStockMember_64b552cb-2c30-4b7d-9576-0c0efd919554" xlink:href="sera-20220930.xsd#sera_JuniorConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_sera_JuniorConvertiblePreferredStockMember_64b552cb-2c30-4b7d-9576-0c0efd919554" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeniorConvertiblePreferredStockMember_8734bb21-1557-403d-8f68-f2ff805b6d8a" xlink:href="sera-20220930.xsd#sera_SeniorConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_sera_SeniorConvertiblePreferredStockMember_8734bb21-1557-403d-8f68-f2ff805b6d8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_0406caa7-ad2f-42a4-8014-8074f8776fbf" xlink:href="sera-20220930.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_0406caa7-ad2f-42a4-8014-8074f8776fbf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd79ceb8-4828-4dd6-8c94-a1f9f7a0c439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd79ceb8-4828-4dd6-8c94-a1f9f7a0c439" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.seraprognostics.com/role/SubsequentEventsDetails" xlink:type="extended" id="i3d5412dfbef34944a537e6973f3ea920_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fbc3006b-4239-4e0b-9bbf-f883bed0d912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fbc3006b-4239-4e0b-9bbf-f883bed0d912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_AdditionalMinimumOperatingLeasePaymentsDue_ce476ce5-17b0-4658-9957-64cd7631668d" xlink:href="sera-20220930.xsd#sera_AdditionalMinimumOperatingLeasePaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:to="loc_sera_AdditionalMinimumOperatingLeasePaymentsDue_ce476ce5-17b0-4658-9957-64cd7631668d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_77de4fe4-6aca-4138-bfe3-fa5bbe940de5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:to="loc_us-gaap_SubsequentEventTable_77de4fe4-6aca-4138-bfe3-fa5bbe940de5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e88637b5-0b5e-478d-a26f-07ad20a7e937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_77de4fe4-6aca-4138-bfe3-fa5bbe940de5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e88637b5-0b5e-478d-a26f-07ad20a7e937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e88637b5-0b5e-478d-a26f-07ad20a7e937_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e88637b5-0b5e-478d-a26f-07ad20a7e937" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e88637b5-0b5e-478d-a26f-07ad20a7e937_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7888262d-cf66-446c-bdc7-2c3a34d3dbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e88637b5-0b5e-478d-a26f-07ad20a7e937" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7888262d-cf66-446c-bdc7-2c3a34d3dbda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cc8d66f2-bf84-431e-9ceb-ff50f32925f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7888262d-cf66-446c-bdc7-2c3a34d3dbda" xlink:to="loc_us-gaap_SubsequentEventMember_cc8d66f2-bf84-431e-9ceb-ff50f32925f7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>sera-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:181dff8b-221c-4709-ab07-a5f181ab4d14,g:4b08700b-5ca3-4c7f-8934-f342ec818a3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_9d0291d6-a4bd-421c-875b-50b295c40d3e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CurrentMarketableSecuritiesMember_4685ec79-018e-4d31-b443-fe83b1400c3f_terseLabel_en-US" xlink:label="lab_sera_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current marketable securities:</link:label>
    <link:label id="lab_sera_CurrentMarketableSecuritiesMember_label_en-US" xlink:label="lab_sera_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Marketable Securities [Member]</link:label>
    <link:label id="lab_sera_CurrentMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_sera_CurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CurrentMarketableSecuritiesMember" xlink:href="sera-20220930.xsd#sera_CurrentMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CurrentMarketableSecuritiesMember" xlink:to="lab_sera_CurrentMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc06a941-4da5-46f6-b6b6-ad0aa9782fb4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_19880fc4-3ae0-432b-b491-28fbfac0652a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_d38ee033-6e1e-4fd0-954e-2c18eb66e044_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_82cc492a-f3a3-441b-aca0-8ef3cbbe8ba4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities and Cash Equivalents in Unrealized Loss Positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_FinanceLeasesOtherInformationAbstract_cae6312d-8744-4c38-be7a-a1ab285b1363_terseLabel_en-US" xlink:label="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_sera_FinanceLeasesOtherInformationAbstract_label_en-US" xlink:label="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases, Other Information [Abstract]</link:label>
    <link:label id="lab_sera_FinanceLeasesOtherInformationAbstract_documentation_en-US" xlink:label="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases, Other Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeasesOtherInformationAbstract" xlink:href="sera-20220930.xsd#sera_FinanceLeasesOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract" xlink:to="lab_sera_FinanceLeasesOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_6075cc4d-7ec1-415a-9115-24ba0113051b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_eeadecd7-4acc-4d0e-b6f5-a73ad6d5f9d1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RightOfUseAssetAbstract_b1d4ce2b-74c2-4bf3-86b2-9172312d5be7_terseLabel_en-US" xlink:label="lab_sera_RightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets:</link:label>
    <link:label id="lab_sera_RightOfUseAssetAbstract_label_en-US" xlink:label="lab_sera_RightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset [Abstract]</link:label>
    <link:label id="lab_sera_RightOfUseAssetAbstract_documentation_en-US" xlink:label="lab_sera_RightOfUseAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetAbstract" xlink:href="sera-20220930.xsd#sera_RightOfUseAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RightOfUseAssetAbstract" xlink:to="lab_sera_RightOfUseAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_41c3f721-eda9-4db4-b47c-c7cc3fa81a52_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_5944aa64-5b37-4dc1-acc0-fccfe874a9a8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of Series E senior convertible preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e6e388be-f625-4f46-a1db-8acef7be2789_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_40625bb5-71df-48fe-af3d-6562bec56739_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees paid</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_a8f48042-b967-46a7-ae41-8b92e6c1f655_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_35afca01-930f-4938-8672-c5248ce77c7f_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued 401(k) matching contributions</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_db4d046e-e650-41a1-94fd-187f3b18bcdf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_6bc68b37-9eb3-4a12-9fbf-403ad044b3eb_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_0692fba1-c283-49ea-b7be-966440ac1d3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Other Income, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8d02bace-4017-413b-9ede-89126b97d5b6_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_e85fdd8a-be2f-422c-a559-103bf2d95296_terseLabel_en-US" xlink:label="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leases in Financial Statement</link:label>
    <link:label id="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_label_en-US" xlink:label="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leases In Statement Of Financial Position [Table Text Block]</link:label>
    <link:label id="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_documentation_en-US" xlink:label="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leases In Statement Of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:href="sera-20220930.xsd#sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:to="lab_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_bc6b24e3-045d-4d8c-a0ec-e1ed4481c1df_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a12813d5-15e5-4ac7-87b1-3972385354e4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a4295047-1a5a-4071-96d0-05384d5021bd_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_5811c6a3-e12f-4e31-8bc5-5756d8465734_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_454145e8-805f-493d-a073-96ffe909133d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_803d0172-fded-46a2-ba19-8bf84cf847b8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities and sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_721ce402-cb9b-4664-b510-912970c50e12_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_462791c4-f62a-49ac-8231-5fc29cce8f41_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of loan payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_09f6cc5f-0fd8-4fa5-81e3-695e29a861bf_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_744ad540-877c-41ad-8594-6edc48435130_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_d90b97b2-4694-4e3e-893d-2e0092e9b3e3_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearThree_a024a5f1-184d-4509-817a-b88737ba95d2_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearThree_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Three</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearThree_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearThree" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidYearThree" xlink:to="lab_sera_LeaseLiabilityToBePaidYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_a1989d7c-1566-44b8-80b0-dff84105805b_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_89d49dde-3dde-4bcd-ab4b-56e21750130c_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the ending (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_4568f39a-eab5-47fe-bc8a-692eb273d3f9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_28d11a2f-18ac-494b-bd0f-f1beb4f7a2a2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0b3ac112-6516-44de-ac76-a51dbb362fa2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_851a81b1-1824-485e-b295-aacf6631cec8_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_1499014f-4e58-4e1d-b7b3-b183d11dbce7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_55fb2352-5462-41d6-b136-901d183890d3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bc861d1d-31fa-4671-9d88-9def0be186ef_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_b2d08b5e-28b3-45c7-91e1-9e5b7fc5e9a0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_52e8820a-98f7-4c31-85cc-ef6792032223_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_2d942c6c-ec6d-477e-b76e-13f05d3c3232_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt520SharePriceMember_c899311e-c8c2-4d27-9b6c-150f847f7f58_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.20</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt520SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 5.20 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt520SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 5.20 Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt520SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt520SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_e3892551-c93e-4ac0-9bda-a6dc6477e114_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2e2a8d01-3f43-4433-9534-0e8f455047d5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_4b236fd0-01a2-4725-80fc-0190514f9761_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_07680ed5-e0d3-47f7-a9b5-ea3dbd31eb2f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_9df439ae-c905-46b7-beb8-0d67e0c6f212_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_7e602edb-ef56-4ffe-9725-cdc36576dc79_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_cf8c0886-de01-49ff-8f5d-238b1418b522_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_2e2fa0c4-0a84-4720-bb00-dcdafc292083_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of outstanding principal</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6cfba94c-e95e-4848-bce8-b7b32902f24d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_d88ee751-e425-4d43-9ae8-08d4e7899cee_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_f8bd25d6-c4c3-49bf-aaa4-f96f21aae73e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_8cd14ebe-33d8-4bba-848f-f248ee084a27_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6e41f511-5dbf-4efd-a901-6edaf603a535_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_85879769-f644-4101-be33-52478b05e80f_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_1e019964-ddd6-4db2-a44f-86b144be42c2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_08c66e38-dfaa-4454-9435-87d0aede8c34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_13d4845f-b843-454b-a498-33a8f258dee6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_aba45565-c189-4947-be7b-353f5e990c64_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_bb950aaf-b590-476a-9362-1cdb2f2e7af7_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_8d1c7e98-8f04-49a0-b5c3-0ca9837e3431_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d885c7a0-4881-4d18-b46f-5d911f2c8515_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_138aa398-f37a-4d52-aeb8-80ce1a891e2c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_7365f34e-cfef-45d9-a60e-1fc65575da30_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_978f22e1-5592-442f-94ab-443bab271a0f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_aff52ac0-bfcb-4981-81cf-cef1b01fa28a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life, outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_252a338e-7a77-4336-8d4d-5efeed3aff6a_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue price per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_7ff7ac9c-206b-46df-9b9f-85099cdef58b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3b6495b3-1356-41b6-830c-7974aa31a372_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_09e16f92-a1d6-4285-b4aa-89215c6efff9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_5908c2d0-f00c-4b47-a785-4cd5714ee1a2_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_cea0c31f-2943-4d10-9e7a-91990e69114e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_a71a9fd2-a27f-43c6-b366-e4235b84b349_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_c120b045-2492-4ae9-8fcf-6fd9efe310dd_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_0e7cefdc-2141-428a-b46a-38df6282cc2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_8b04a7e6-9f61-451d-848d-9b8d6b32993a_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommitmentsAndContingenciesTable_e3e992fb-2098-4321-8306-60ed66ea34b5_terseLabel_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesTable_label_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Table]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesTable_documentation_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the table relating to information of commitments and contingencies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesTable" xlink:href="sera-20220930.xsd#sera_CommitmentsAndContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommitmentsAndContingenciesTable" xlink:to="lab_sera_CommitmentsAndContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_863b38d9-1781-425e-862f-34025a536dd1_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a6df42ff-5f0d-4e6b-a50e-9ecb91a0d5bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_73eb29bf-77dc-413b-80da-7d12266278ff_terseLabel_en-US" xlink:label="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of agreement</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_label_en-US" xlink:label="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Commercial Collaboration Agreement Term</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_documentation_en-US" xlink:label="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:href="sera-20220930.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:to="lab_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_43de2c24-6277-4ce7-9eca-e5e4048cbe00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt2077SharePriceMember_9e794393-5e2e-49d3-a132-ac4811f0551f_verboseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">20.77</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt2077SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 20.77 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt2077SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant issued by the company that allows the purchase of shares of common stock at a price of $20.77 per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt2077SharePriceMember" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt2077SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt2077SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt2077SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_d483f78f-56f1-4382-8ff6-cb08cb179e97_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income (loss), net</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Net, Amortization of Discount and Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:to="lab_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8865d9f3-8376-4674-b55a-625c4f7d4876_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_0f64f131-8de1-4fd8-be95-afa119c22d0b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issuance for initial public offering, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1b0091d9-25a0-4d93-8b79-bad2b079610f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_3dfa1105-ac81-4c5c-8ea1-97a265a9e111_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_8ce6b79e-6221-4ae6-985f-f31ccebc4aae_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_13e4e7ae-ca29-4da1-9f2a-e2405a83291e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_OperatingLeasesOtherInformationAbstract_7994393e-d43b-48e4-82cc-fbbd161d275e_terseLabel_en-US" xlink:label="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_sera_OperatingLeasesOtherInformationAbstract_label_en-US" xlink:label="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Other Information [Abstract]</link:label>
    <link:label id="lab_sera_OperatingLeasesOtherInformationAbstract_documentation_en-US" xlink:label="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Other Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OperatingLeasesOtherInformationAbstract" xlink:href="sera-20220930.xsd#sera_OperatingLeasesOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract" xlink:to="lab_sera_OperatingLeasesOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_7bbab0f3-d2ec-4285-8869-ccd8140064b0_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d66b2240-8ac7-4985-aa7d-8b221f9ef1ce_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1b5698e9-6d72-49eb-83a2-70f886354d7d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LoanAndSecurityAgreementMember_913abacf-7a8a-490d-99ea-06170d24f8fd_terseLabel_en-US" xlink:label="lab_sera_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan and Security Agreement</link:label>
    <link:label id="lab_sera_LoanAndSecurityAgreementMember_label_en-US" xlink:label="lab_sera_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan And Security Agreement [Member]</link:label>
    <link:label id="lab_sera_LoanAndSecurityAgreementMember_documentation_en-US" xlink:label="lab_sera_LoanAndSecurityAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for loan and security agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LoanAndSecurityAgreementMember" xlink:href="sera-20220930.xsd#sera_LoanAndSecurityAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LoanAndSecurityAgreementMember" xlink:to="lab_sera_LoanAndSecurityAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_OfficeAndLaboratorySpaceMember_df3de665-79a6-4795-9868-e0c6a7c8b448_terseLabel_en-US" xlink:label="lab_sera_OfficeAndLaboratorySpaceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office and laboratory space</link:label>
    <link:label id="lab_sera_OfficeAndLaboratorySpaceMember_label_en-US" xlink:label="lab_sera_OfficeAndLaboratorySpaceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office And Laboratory Space [Member]</link:label>
    <link:label id="lab_sera_OfficeAndLaboratorySpaceMember_documentation_en-US" xlink:label="lab_sera_OfficeAndLaboratorySpaceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the information pertaining to office and laboratory space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OfficeAndLaboratorySpaceMember" xlink:href="sera-20220930.xsd#sera_OfficeAndLaboratorySpaceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_OfficeAndLaboratorySpaceMember" xlink:to="lab_sera_OfficeAndLaboratorySpaceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0f6c2126-0709-41c7-a4c8-b5e58ec83405_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Exercise Price Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ElevanceHealthIncMember_ea9da942-a00b-4b95-a2ef-dbf3b0bb871d_terseLabel_en-US" xlink:label="lab_sera_ElevanceHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elevance Health, Inc</link:label>
    <link:label id="lab_sera_ElevanceHealthIncMember_label_en-US" xlink:label="lab_sera_ElevanceHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elevance Health, Inc [Member]</link:label>
    <link:label id="lab_sera_ElevanceHealthIncMember_documentation_en-US" xlink:label="lab_sera_ElevanceHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elevance Health, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ElevanceHealthIncMember" xlink:href="sera-20220930.xsd#sera_ElevanceHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ElevanceHealthIncMember" xlink:to="lab_sera_ElevanceHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_AdditionalMinimumOperatingLeasePaymentsDue_a02bb2c5-d62d-4429-859b-32fc476b1fd5_terseLabel_en-US" xlink:label="lab_sera_AdditionalMinimumOperatingLeasePaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Minimum Operating Lease Payments Due</link:label>
    <link:label id="lab_sera_AdditionalMinimumOperatingLeasePaymentsDue_label_en-US" xlink:label="lab_sera_AdditionalMinimumOperatingLeasePaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Minimum Operating Lease Payments Due</link:label>
    <link:label id="lab_sera_AdditionalMinimumOperatingLeasePaymentsDue_documentation_en-US" xlink:label="lab_sera_AdditionalMinimumOperatingLeasePaymentsDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Minimum Operating Lease Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_AdditionalMinimumOperatingLeasePaymentsDue" xlink:href="sera-20220930.xsd#sera_AdditionalMinimumOperatingLeasePaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_AdditionalMinimumOperatingLeasePaymentsDue" xlink:to="lab_sera_AdditionalMinimumOperatingLeasePaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_36273a02-643a-4f3a-9f6c-b1a03ee99a48_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsAmortizedCost_07ec0cb9-4774-4c87-8371-82d9104c83da_totalLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAmortizedCost_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAmortizedCost_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsAmortizedCost" xlink:to="lab_sera_CashAndCashEquivalentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_732c56da-8e67-478a-958d-f3f7e0b2da1d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and Convertible Promissory Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_c5b7fdf7-9eee-4929-9ac6-e2d2c2cfa93b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_39dbbdfe-7827-473d-a4b3-c22622955f89_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9f7cd874-b203-46fc-80cd-095359ec7350_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_8307adee-ec37-46a2-a3fb-cd7292bebd24_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class B common stock</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_4abbcd63-3199-4383-8968-96af3d804b4a_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5caabc8e-0a72-44a3-8371-cec5a93f8a47_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_59ee64aa-f28d-4e3e-b397-640b7db4f30f_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_5a0494d1-d118-494a-9486-4b6ba1767932_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_271ade22-9692-4560-b1fd-5b7c217e2625_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseOtherInformationAbstract_40994dfd-c0e5-4c45-845e-06e95f56a49f_terseLabel_en-US" xlink:label="lab_sera_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other information</link:label>
    <link:label id="lab_sera_LeaseOtherInformationAbstract_label_en-US" xlink:label="lab_sera_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Other Information [Abstract]</link:label>
    <link:label id="lab_sera_LeaseOtherInformationAbstract_documentation_en-US" xlink:label="lab_sera_LeaseOtherInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Other Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseOtherInformationAbstract" xlink:href="sera-20220930.xsd#sera_LeaseOtherInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseOtherInformationAbstract" xlink:to="lab_sera_LeaseOtherInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_194fdd85-16c9-4d8f-8585-163314116d88_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_7581a525-b9c4-4e82-add9-c5c01a1620b8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_878937cc-2a29-4354-85e1-978fb7fea923_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_95211d2e-773a-468d-9929-884143c35847_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ab5b9645-7be0-4fc6-8634-3517c5a09fc8_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityNoncurrent_457fc3e3-cb19-4a1b-b6b5-27db5cd32c71_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_sera_LeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_sera_LeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Noncurrent</link:label>
    <link:label id="lab_sera_LeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityNoncurrent" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityNoncurrent" xlink:to="lab_sera_LeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f08df1af-77aa-408b-98df-058a0fb8e840_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_7d23b131-fcde-4019-90b3-8e651cabd7e2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_ba779257-368c-4898-b7bd-3e76c95e27a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_25ff7349-465f-4e14-a40e-5c1daef81437_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_443de05f-f815-491a-b270-10572b68b266_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_41e48acc-e5f3-45c6-a8c1-92c5c238acda_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c30895b6-951d-480f-91d5-8c0e0b6e84e3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_13d50137-043b-4879-b97d-8ec7cfa9e4e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_3c4c9d36-ce4c-49a5-8ae9-aeb6027fa915_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_bd8ba222-28c3-4f09-b844-e25a9d0129b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, available-for-sale, other than temporary impairment</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_NumberOfVotesPerShare_279adb54-f47f-4462-aa09-2240a8203907_terseLabel_en-US" xlink:label="lab_sera_NumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of votes per share</link:label>
    <link:label id="lab_sera_NumberOfVotesPerShare_label_en-US" xlink:label="lab_sera_NumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes Per Share</link:label>
    <link:label id="lab_sera_NumberOfVotesPerShare_documentation_en-US" xlink:label="lab_sera_NumberOfVotesPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Votes Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfVotesPerShare" xlink:href="sera-20220930.xsd#sera_NumberOfVotesPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_NumberOfVotesPerShare" xlink:to="lab_sera_NumberOfVotesPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c1f25693-d8e5-4eb9-9d19-729fe0d4d226_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_4be4946a-a0b0-4f66-bf88-d4390838a872_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the ending</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_455a5b12-5ce7-41e2-baa9-98ec3d555b84_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_15500878-f89c-4767-85ca-6ab002366dcf_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceDomain_b4a9cc3b-d4d3-4bc4-adc2-a109e207d5df_terseLabel_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved for Future Issuance [Domain]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceDomain_label_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved For Future Issuance [Domain]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceDomain_documentation_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information on capital stock reserved for future issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:href="sera-20220930.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:to="lab_sera_CapitalSharesReservedForFutureIssuanceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_IndemnificationLiability_6417f456-a490-4fde-94c8-2ea2b35bd38f_terseLabel_en-US" xlink:label="lab_sera_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liability</link:label>
    <link:label id="lab_sera_IndemnificationLiability_label_en-US" xlink:label="lab_sera_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification Liability</link:label>
    <link:label id="lab_sera_IndemnificationLiability_documentation_en-US" xlink:label="lab_sera_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of indemnification liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IndemnificationLiability" xlink:href="sera-20220930.xsd#sera_IndemnificationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_IndemnificationLiability" xlink:to="lab_sera_IndemnificationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_MasterServicesAgreementMember_b557d786-2ca5-4557-a15c-aa5912e1cc13_terseLabel_en-US" xlink:label="lab_sera_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Master services agreement</link:label>
    <link:label id="lab_sera_MasterServicesAgreementMember_label_en-US" xlink:label="lab_sera_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Master Services Agreement [Member]</link:label>
    <link:label id="lab_sera_MasterServicesAgreementMember_documentation_en-US" xlink:label="lab_sera_MasterServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the master services agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_MasterServicesAgreementMember" xlink:href="sera-20220930.xsd#sera_MasterServicesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_MasterServicesAgreementMember" xlink:to="lab_sera_MasterServicesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_6f591ae3-08b2-4da0-983a-54cbb5829955_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_JuniorConvertiblePreferredStockMember_e6d6c054-57c7-43a3-9b97-e6297ce957bd_terseLabel_en-US" xlink:label="lab_sera_JuniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Junior Convertible Preferred Stock</link:label>
    <link:label id="lab_sera_JuniorConvertiblePreferredStockMember_label_en-US" xlink:label="lab_sera_JuniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Junior Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_sera_JuniorConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_sera_JuniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Junior Convertible Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_JuniorConvertiblePreferredStockMember" xlink:href="sera-20220930.xsd#sera_JuniorConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_JuniorConvertiblePreferredStockMember" xlink:to="lab_sera_JuniorConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0c783c8b-89a6-4d5c-bc7a-d7b256c52e42_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_cb02c107-ad06-4872-8106-dd8de986d479_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_261a6ea7-56e8-46a9-afd9-e94fd6330acd_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_649ee353-f8a8-43cf-b981-95d4ab47d234_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_d9d67c91-7366-43b2-b853-7107d30a694a_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized stock-based compensation cost expected to be recognized over a weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_faf8ccfd-298c-475d-9c87-45d375347d60_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_98e4ad83-a0f7-49b0-a5a6-e28a1e3ad39b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_4717bf74-aeed-4793-b779-1e103239c589_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of PPP loan</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_9166d792-adf9-4546-95c5-e770c26a1353_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_85dbfa94-f057-4a88-83fc-831b4451798c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_417232ad-2670-4c76-9b63-27a268da91c4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_0e0035ee-0751-47a6-9837-94aef4581c97_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_18f164e5-7f4a-4a10-9619-1ac39d2176b8_terseLabel_en-US" xlink:label="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash receipts</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_label_en-US" xlink:label="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Cash Received From Related Party</link:label>
    <link:label id="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_documentation_en-US" xlink:label="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Cash Received From Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:href="sera-20220930.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:to="lab_sera_RelatedPartyTransactionCashReceivedFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_a1c3b03a-d4a0-41ba-ac7e-82d786480856_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1_label_en-US" xlink:label="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option, Changes in Fair Value, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:to="lab_us-gaap_FairValueOptionChangesInFairValueGainLoss1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_56778e15-af79-469e-b20c-814fe128006f_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_eb74f345-31cb-4fdc-bc80-0cc0721950d2_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseLongTermDebt_32cfe57c-c3f0-4703-8d93-8dca16ff6b6e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseLongTermDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseLongTermDebt" xlink:to="lab_us-gaap_InterestExpenseLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_ddd62f04-cd26-43ab-a923-4a7e6d563b8f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_eeafd23e-a2b6-44b9-819b-b0a8062a0940_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Effects on Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Effects on Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:to="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_14fa0718-cc9e-4e78-a7e2-0fbdbab2ba10_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, conversion price percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_IncreaseDecreaseInDeferredRent_d4521b10-0f76-4aa5-95d9-efc766e4df57_terseLabel_en-US" xlink:label="lab_sera_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_sera_IncreaseDecreaseInDeferredRent_label_en-US" xlink:label="lab_sera_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Rent</link:label>
    <link:label id="lab_sera_IncreaseDecreaseInDeferredRent_documentation_en-US" xlink:label="lab_sera_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of increase (decrease) in deferred rent.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IncreaseDecreaseInDeferredRent" xlink:href="sera-20220930.xsd#sera_IncreaseDecreaseInDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_IncreaseDecreaseInDeferredRent" xlink:to="lab_sera_IncreaseDecreaseInDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_b2bc1b97-fe24-4d76-b386-aaacef675661_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ee29fa58-1ae6-49eb-a079-079b1716b8c1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_73db9734-90de-46df-a4bf-3f17a60dad8d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_62836d5c-a711-428b-89a4-84783fbc290b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c7976bf6-09b8-4a00-829b-fc6e8e27b2d7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c440d11a-5154-43a1-b63f-f6e0c73581ae_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_3516eafd-56be-4722-9558-38f9114a4d9c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_344c5d53-600f-4562-890d-210df931a70d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ac86bf2f-3d53-4637-a132-1e86be989e31_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_6d201aa6-9bbd-442a-a8c5-1bec8d3a37df_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_6a43f16b-8b55-4984-9d68-901b4a621e93_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life, vested and exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommitmentsAndContingenciesLineItems_6f3082b4-ee2a-44e1-97a9-9aa6d16f74e3_terseLabel_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesLineItems_label_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:label id="lab_sera_CommitmentsAndContingenciesLineItems_documentation_en-US" xlink:label="lab_sera_CommitmentsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesLineItems" xlink:href="sera-20220930.xsd#sera_CommitmentsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems" xlink:to="lab_sera_CommitmentsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_2216e783-97a2-443a-a101-40196d8ce38a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_69aa3c94-7b82-4601-8159-99b736f7d09a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_Plan2011Member_a13d78ca-f5f2-4787-ba38-6d2af76eadb5_terseLabel_en-US" xlink:label="lab_sera_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan</link:label>
    <link:label id="lab_sera_Plan2011Member_label_en-US" xlink:label="lab_sera_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan2011 [Member]</link:label>
    <link:label id="lab_sera_Plan2011Member_documentation_en-US" xlink:label="lab_sera_Plan2011Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to 2011 Employee, Director and Consultant Equity Incentive Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2011Member" xlink:href="sera-20220930.xsd#sera_Plan2011Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_Plan2011Member" xlink:to="lab_sera_Plan2011Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1d2dfe46-af00-4e04-92fc-1da200d52bbd_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_de9815f5-a0ec-4597-a568-827f3e665688_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_d50b3b72-1755-4c4a-b499-190420dfd42b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_d9d82cf4-e9a8-4cc7-82d9-11fd2ff64d72_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_e1a10ba6-2f79-4208-b6e2-94246fd95f58_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_a4aed475-9f19-4a91-b9e0-44495371a57e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Final payment fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_5f716c58-c7fb-4fcc-8ce3-8fe0e4d828d4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LaboratoryServicesAgreementMember_174f41a3-4a36-4954-b6f2-70c990b291b1_terseLabel_en-US" xlink:label="lab_sera_LaboratoryServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Services Agreement</link:label>
    <link:label id="lab_sera_LaboratoryServicesAgreementMember_label_en-US" xlink:label="lab_sera_LaboratoryServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Services Agreement [Member]</link:label>
    <link:label id="lab_sera_LaboratoryServicesAgreementMember_documentation_en-US" xlink:label="lab_sera_LaboratoryServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the laboratory services agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryServicesAgreementMember" xlink:href="sera-20220930.xsd#sera_LaboratoryServicesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LaboratoryServicesAgreementMember" xlink:to="lab_sera_LaboratoryServicesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2478d30c-d764-4627-9aee-aeebdc26f9aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_c8e69be4-a499-4477-81b5-069aa76fb9b1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_73ad0156-4684-403d-971c-bd0755487eeb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_c12c8262-48c0-46ea-805d-095252dccd3c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4fa096f5-b5e3-4431-86f6-de551dd9c166_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7260437b-448c-4c5c-a339-cc03e184d953_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share &#8212; basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_WarrantsToPurchaseCommonStockMember_1e5035d3-6c2a-4057-9b07-4704a98ce91e_terseLabel_en-US" xlink:label="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase Class A common stock</link:label>
    <link:label id="lab_sera_WarrantsToPurchaseCommonStockMember_label_en-US" xlink:label="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants To Purchase Common Stock [Member]</link:label>
    <link:label id="lab_sera_WarrantsToPurchaseCommonStockMember_documentation_en-US" xlink:label="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember" xlink:href="sera-20220930.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_WarrantsToPurchaseCommonStockMember" xlink:to="lab_sera_WarrantsToPurchaseCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d3753c41-761e-478b-95a8-cfeac647e2ba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter_a69caeba-d2a6-4b56-b8fb-c316429d1ec9_terseLabel_en-US" xlink:label="lab_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter_label_en-US" xlink:label="lab_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four and Thereafter</link:label>
    <link:label id="lab_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter_documentation_en-US" xlink:label="lab_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter" xlink:href="sera-20220930.xsd#sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter" xlink:to="lab_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_b5d94cb7-a03d-46ae-a54b-b09adbd6c770_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of convertible note payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_8f1c4976-7cc8-4d5f-a84d-ddffc7305cbf_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_14e60e81-c5dc-472d-a8cc-2f5bcbb28bb6_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_73c374bc-7e69-4414-91bc-cb848abc1d44_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_37a86881-424c-4adb-b05f-3df3fb523e35_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the ending</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_bf1cca95-bd9a-454e-a710-1a57b7c34c1f_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_29d90e36-6d0e-4f92-9e65-e1d114095bfb_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LaboratoryEquipmentMember_ad8f01e7-ba07-47c0-8f06-d0ebe3d48d68_terseLabel_en-US" xlink:label="lab_sera_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_sera_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_sera_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_sera_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_sera_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to laboratory equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryEquipmentMember" xlink:href="sera-20220930.xsd#sera_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LaboratoryEquipmentMember" xlink:to="lab_sera_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_6d5358c8-1f9a-4cac-b15c-ddb7d9719c10_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3a4d5537-7771-420e-bb39-6cb755c37c6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_e534ed81-15c5-4954-bb86-8774b1472dcd_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b1b9768c-a08e-4008-b176-ea7cc02e0b20_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_c50254f5-da17-4d4a-8351-b09ebe10847b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized stock-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDecreaseForgiveness_f3b2ec99-b1fd-4785-95c0-211feb57ece8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of debt outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDecreaseForgiveness_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Decrease, Forgiveness</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:to="lab_us-gaap_DebtInstrumentDecreaseForgiveness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_7d53c738-3bcd-4962-96ff-0cd930d2b244_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_f7bf6898-e59c-4676-ab71-458856ddd640_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_173ad600-e266-487f-ac8a-c6b38ba4614f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock (Class A and B)</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityPaymentDueAbstract_3812fe33-1b4e-4ee8-ae5a-afd3126beaeb_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDueAbstract_label_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDueAbstract_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDueAbstract" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityPaymentDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract" xlink:to="lab_sera_LeaseLiabilityPaymentDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_AccruedClinicalStudyCostsCurrent_c2be2d09-04af-4896-bae3-c32778267416_terseLabel_en-US" xlink:label="lab_sera_AccruedClinicalStudyCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued clinical study costs</link:label>
    <link:label id="lab_sera_AccruedClinicalStudyCostsCurrent_label_en-US" xlink:label="lab_sera_AccruedClinicalStudyCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Study Costs, Current</link:label>
    <link:label id="lab_sera_AccruedClinicalStudyCostsCurrent_documentation_en-US" xlink:label="lab_sera_AccruedClinicalStudyCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Clinical Study Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_AccruedClinicalStudyCostsCurrent" xlink:href="sera-20220930.xsd#sera_AccruedClinicalStudyCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_AccruedClinicalStudyCostsCurrent" xlink:to="lab_sera_AccruedClinicalStudyCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_abcf3fc1-de5f-4fe3-a5c2-df0c196975a1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Impact of Stock-based Compensation Expense in the Statements of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_cd66b2e3-5d0f-48ef-b2f9-6b12d14715d2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Cost and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_2c8f208d-0ed0-4aee-9a21-55b103f1fd03_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dc3e2ceb-b2ef-40b3-a471-01233e44ef63_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_dfc0a23f-0a93-440b-b6c1-2ca537be81b2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Renewal period of lease</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_fb5adf6b-c38a-49d0-8bdf-4d8d6a9a84b4_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_052daf00-6feb-49d3-9967-2e738ac8ccb3_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_5563ffdb-53dc-41a6-88a4-5e2410d92e00_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_95cdc048-a37c-4b25-8d5f-e92af91fd646_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_bac6a49c-8381-4298-b098-f3c2684cd5d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_47c980c9-e590-49f0-aef2-c5cfe9c125b2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_ef8a8e21-8589-41ab-9413-05c2bfaba1cd_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceAxis_6969be61-327f-4daa-a005-4e88acb44d70_terseLabel_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved for Future Issuance [Axis]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceAxis_label_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Shares Reserved for Future Issuance [Axis]</link:label>
    <link:label id="lab_sera_CapitalSharesReservedForFutureIssuanceAxis_documentation_en-US" xlink:label="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The table relating to information on capital stock reserved for future issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:href="sera-20220930.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:to="lab_sera_CapitalSharesReservedForFutureIssuanceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c599b3a6-18c0-49a5-ab2d-2a1f1414b2d1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_db191022-5f22-439c-a5f5-16b9d5d0ade0_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability at the measurement date fair value</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_bee04576-6af9-4619-881c-794a9ff6670a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_232b1475-1e8a-46a7-8d1a-30f86c48c358_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_82743f5c-3449-4c6f-80ec-e2ecf394c574_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_daba1ae3-a207-4842-a1d6-15dedd144263_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_e4dc2a7e-c980-4553-baf7-678b62fc98a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_719a3a23-9a90-4d3d-96f1-f51535f674e8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_18c692f2-c103-42f7-9458-e6e7770beee1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_59d7dbd7-b343-4075-bb07-3c708574f985_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_733a925c-46f9-4d70-a9b0-ca67f77542aa_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease principal payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_eba97c63-815d-43b8-862d-7b1693c19c64_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash outflows</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_b8c55497-eb91-4838-a451-638440070a20_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_eddc42c5-fb38-48ae-82bc-3d63649ee022_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_530c9b39-bd42-444e-809f-56a6daec60fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_526d48d8-dfbf-42e6-94aa-35a734ce802a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_NonCurrentMarketableSecuritiesMember_72329d73-ae9d-404d-9282-bdc005ef6d44_terseLabel_en-US" xlink:label="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term marketable securities:</link:label>
    <link:label id="lab_sera_NonCurrentMarketableSecuritiesMember_label_en-US" xlink:label="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Marketable Securities [Member]</link:label>
    <link:label id="lab_sera_NonCurrentMarketableSecuritiesMember_documentation_en-US" xlink:label="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Marketable Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NonCurrentMarketableSecuritiesMember" xlink:href="sera-20220930.xsd#sera_NonCurrentMarketableSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_NonCurrentMarketableSecuritiesMember" xlink:to="lab_sera_NonCurrentMarketableSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_069d535b-ee99-45c9-9d5a-3e490b518414_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_be6b24ac-9607-429d-acbd-c25389923c34_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_fabfe340-1c7f-46dc-b580-fe08781ccdad_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1828c5df-003b-455b-b788-b59e6603c22b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_984260bc-0a9e-4a5c-ac21-583f5f6d474c_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0a24da9b-afd3-407c-98ff-95407dfa3f64_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3a0c40fa-e73a-4295-9303-0764571f0273_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Options Granted and Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a36b02ca-d831-4c16-bf10-3463d87bbc74_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityPaymentDue_38b6daf7-07e7-481e-b2be-a641c7223c23_totalLabel_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDue_label_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due</link:label>
    <link:label id="lab_sera_LeaseLiabilityPaymentDue_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityPaymentDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityPaymentDue" xlink:to="lab_sera_LeaseLiabilityPaymentDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_dea62eb1-fc5e-4951-9cf6-1f94d8a9e189_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_f43eee5a-9ae9-4f1d-9737-0d1627d5147e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt conversion, converted instrument, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ead88417-84ad-4187-b535-256130d2bbc6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_99a5326f-d3be-4ce6-925f-b5f08755dbd8_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_66dc2637-9cbf-4ca3-bbb8-5a97e9944598_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_9584fc0f-efe0-44c0-b20d-e39a4e84a663_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:to="lab_us-gaap_AccruedLiabilitiesAndOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_cb6e7641-5be1-4ede-9379-cc51db24d28e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ad74ba63-c216-4f28-8532-c50b6fc49df1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_af5f7378-7da3-4cda-b2b1-e3db4d4d9469_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_6b94a4b1-5f31-4e16-92b3-9e6cf694d96e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_a3e925be-45fe-4780-a884-159e97670ca7_negatedLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_37bac7e0-ad42-4a52-8adf-9dabe126e612_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4a65b9d2-2946-4539-a155-0740614b176d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_038ee06b-99dd-4859-b3ed-8351e56e53e5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_6d22541a-a5ad-4096-a33a-0dd6e65c2875_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_331dd4d2-730c-4c9e-b6f3-e67b1c5817cb_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_414c1200-9db9-40cc-bab0-bdf058acb1b9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares of common stock outstanding, diluted (In shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f395acb6-baa8-4f20-b78a-c60dd421a8d6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_Plan2021Member_895a2df2-8c1c-476d-b0e1-e283cfc1a504_terseLabel_en-US" xlink:label="lab_sera_Plan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Plan</link:label>
    <link:label id="lab_sera_Plan2021Member_label_en-US" xlink:label="lab_sera_Plan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan2021 [Member]</link:label>
    <link:label id="lab_sera_Plan2021Member_documentation_en-US" xlink:label="lab_sera_Plan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to 2021 Equity Incentive Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2021Member" xlink:href="sera-20220930.xsd#sera_Plan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_Plan2021Member" xlink:to="lab_sera_Plan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_bb33e349-735f-4e5b-b6f0-b06a8ba6eeae_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_NumberOfCommonStockClassesAuthorized_96c114b9-32e2-4a8d-8583-284c8c758b73_terseLabel_en-US" xlink:label="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock classes authorized</link:label>
    <link:label id="lab_sera_NumberOfCommonStockClassesAuthorized_label_en-US" xlink:label="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Common Stock Classes Authorized</link:label>
    <link:label id="lab_sera_NumberOfCommonStockClassesAuthorized_documentation_en-US" xlink:label="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Common Stock Classes Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfCommonStockClassesAuthorized" xlink:href="sera-20220930.xsd#sera_NumberOfCommonStockClassesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_NumberOfCommonStockClassesAuthorized" xlink:to="lab_sera_NumberOfCommonStockClassesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_afdd06ef-f8e1-461d-ba16-1c4b1f00f756_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_f0ea3c9d-516c-4223-9d68-5c4a7b3c0278_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.0001 par value; 150,000,000 Class A shares authorized as of September&#160;30, 2022 and December&#160;31, 2021; 29,611,720 and 29,368,867 Class A shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021, respectively; 1,500,000 Class B shares authorized as of September&#160;30, 2022 and December&#160;31, 2021; 1,405,259 Class B shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021.</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_e52c541b-6cc3-4c26-b545-63c07f2afd80_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of original debt converted</link:label>
    <link:label id="lab_us-gaap_DebtConversionOriginalDebtAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Original Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="lab_us-gaap_DebtConversionOriginalDebtAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_a1ee9a01-d09e-4a49-a61b-ce944becab63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, convertible, conversion price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3746e5eb-652d-4af8-a194-652fddb96c1c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c249c471-6baf-4d77-bd25-9ff2aa224f24_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt10.84SharePriceMember_91b7d4a9-817f-4ccd-b00c-a3f6840a13fe_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">10.84</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt10.84SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At10.84 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt10.84SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant issued by the company that allows the purchase of shares of common stock at a price of $10.84 per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt10.84SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt10.84SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d92c0eb8-04ee-4cd6-bbd1-1c630446e592_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3ef2f104-4960-4e9a-bdad-066964983491_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_HealthcoreIncMember_f77220c5-94db-4dcf-b68f-4c6b1d7494d5_terseLabel_en-US" xlink:label="lab_sera_HealthcoreIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcore Inc</link:label>
    <link:label id="lab_sera_HealthcoreIncMember_label_en-US" xlink:label="lab_sera_HealthcoreIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcore Inc [Member]</link:label>
    <link:label id="lab_sera_HealthcoreIncMember_documentation_en-US" xlink:label="lab_sera_HealthcoreIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Healthcore Inc., a wholly-owned subsidiary of Anthem Inc. ("Anthem").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_HealthcoreIncMember" xlink:href="sera-20220930.xsd#sera_HealthcoreIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_HealthcoreIncMember" xlink:to="lab_sera_HealthcoreIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3e1090af-9929-4880-8cfd-ad157a825c52_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingences</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_2b20aca8-e673-46f2-91c9-c5a918953bc4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of warrants to purchase common stock issued to Series E investor</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_2b89cdca-0ad9-42c5-a8cc-a023e93dbeaf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_20c2bde1-ec1d-4d3b-9ee1-d996279fd023_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_16e61e6f-aaa4-41ab-a90d-3e0da0dfff79_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b6227886-cb50-40e3-8e54-4181f026b1be_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_125b27ee-c53f-4e9a-9ed7-aa244a5c12e4_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at the ending (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_6c74cf98-5cf4-4d5c-af22-e8238592c6ff_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual life, vested and expected to vest at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_bef49b0d-6377-4c2f-b022-3a5848b1b6c5_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_13a1454b-bb4f-4c91-89a8-926c7382fd2e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment_d56a917b-4398-4c0a-ab75-046bcb6de3bc_terseLabel_en-US" xlink:label="lab_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock warrants to common stock warrants</link:label>
    <link:label id="lab_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment_label_en-US" xlink:label="lab_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Preferred Stock Warrants to Common Stock Warrants, Adjustment</link:label>
    <link:label id="lab_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment_documentation_en-US" xlink:label="lab_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Preferred Stock Warrants to Common Stock Warrants, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" xlink:href="sera-20220930.xsd#sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" xlink:to="lab_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_f1317d91-fabb-48e5-8d84-f0084d635281_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_SeniorConvertiblePreferredStockMember_5f75d7cb-fbaa-4d19-b20c-6a6bc581b53f_terseLabel_en-US" xlink:label="lab_sera_SeniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Preferred Stock</link:label>
    <link:label id="lab_sera_SeniorConvertiblePreferredStockMember_label_en-US" xlink:label="lab_sera_SeniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_sera_SeniorConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_sera_SeniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeniorConvertiblePreferredStockMember" xlink:href="sera-20220930.xsd#sera_SeniorConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_SeniorConvertiblePreferredStockMember" xlink:to="lab_sera_SeniorConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f22322d9-5c42-4b3e-a6f8-c0ea1fb407b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_bea94355-8d93-4db5-867d-2b5c4526bbc0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation, current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_d039605a-e9c3-4119-99b5-2dd7e065f22b_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_bc3ba0dd-de8d-4148-bfa5-fff4f9025d2a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_43f31234-d10c-4d78-9c84-32fe6f7688aa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bbb3c4e3-2d01-47ff-b33a-3c2dd3c01c62_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_192c74f8-93f7-4ec4-9a98-5c16a0187830_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_5f324fc8-7c27-41bc-ad13-360c5f9eb131_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_b285c368-f411-490e-8c21-e3d6da3ded07_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_558fa75f-a168-4991-9238-ae41f64ce635_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9ee4a682-4f66-4523-93f3-30381d286fd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_defb8688-72c6-4eb9-a495-202110e030b9_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3fe8ce09-6298-41ff-a063-ca430bb6f4d8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_96b22dbd-d05c-4dd8-bfcb-1cca7fd7043c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockConversionRatio_45b00f43-461e-4e2b-ac38-60b4b174d72d_terseLabel_en-US" xlink:label="lab_sera_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, conversion ratio</link:label>
    <link:label id="lab_sera_CommonStockConversionRatio_label_en-US" xlink:label="lab_sera_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:label id="lab_sera_CommonStockConversionRatio_documentation_en-US" xlink:label="lab_sera_CommonStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockConversionRatio" xlink:href="sera-20220930.xsd#sera_CommonStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockConversionRatio" xlink:to="lab_sera_CommonStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_c3a9f354-d1f7-45c0-bc65-4ec45be49e08_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_63699f6d-dc93-41c5-9ea5-56df792b9c39_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_49bafd68-e22e-447f-aa3f-ea570f20ed26_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_67652c6d-af2d-42aa-abf7-d58f73db5559_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock_7f147527-37d1-4f58-88b4-5044cff54ab3_terseLabel_en-US" xlink:label="lab_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E senior convertible preferred stock offering costs prepaid and deferred in prior period and reclassified to Series E senior convertible preferred stock</link:label>
    <link:label id="lab_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock_label_en-US" xlink:label="lab_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid And Deferred Offering Costs Reclassified To Senior Convertible Preferred Stock</link:label>
    <link:label id="lab_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock_documentation_en-US" xlink:label="lab_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of senior convertible preferred stock offering costs prepaid and deferred in prior period and reclassified to Series E senior convertible preferred stock in the current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" xlink:href="sera-20220930.xsd#sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" xlink:to="lab_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ba110405-167a-4310-968d-54a0290a2af1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_49e71b66-0a94-4be0-aff8-66c503de0876_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_3b8b4e96-b29d-4adc-9403-cee72f4780d8_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_9522ba13-afca-4645-bd3a-0b85eefd4b77_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_504ae7bb-6603-4936-b0a6-6eb5cf1185d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_0aa448f2-08f5-484d-b594-b40789818b34_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_84915028-501e-4a2d-9c33-17f53bca4d6c_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_492aaa45-0def-484b-a955-d628db93788d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ddb25694-943c-43d7-b1d9-27fe8b53deb9_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_cdbab5cf-5214-4626-8a68-e79bf9f3a3c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_096b7887-bb2c-4404-b3e4-3eb216dbbb90_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing expense</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9fee2f0d-b6b6-4d38-8b1e-d1c000136675_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase Class A common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock_9de779bd-eb79-4247-9658-c26dab540122_terseLabel_en-US" xlink:label="lab_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock</link:label>
    <link:label id="lab_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock_label_en-US" xlink:label="lab_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Value, Conversion Of Preferred Stock To Common Stock</link:label>
    <link:label id="lab_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock_documentation_en-US" xlink:label="lab_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Value, Conversion Of Preferred Stock To Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock" xlink:href="sera-20220930.xsd#sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock" xlink:to="lab_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_68ac3d95-0aa0-478d-8713-ecb893af3795_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income, net</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3a191854-bc24-4a74-86c8-c1c95ee05203_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_aade584d-ace7-439a-9369-77e0167e005a_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_282d14f3-83d9-4c39-bd21-2786dbcd6221_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e43d2937-ee28-4762-aa8c-a0a6fbd92d1c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_172d3dbe-b74c-413d-93ca-4390c621d313_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_17bff734-9b4b-4f4f-9c31-ead2ff448ca4_verboseLabel_en-US" xlink:label="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment in accounts payable and accruals</link:label>
    <link:label id="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities</link:label>
    <link:label id="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:href="sera-20220930.xsd#sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:to="lab_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearOne_614defe6-811c-44c9-a33d-f4c3ed0ef91e_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearOne_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year One</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearOne_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearOne" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidYearOne" xlink:to="lab_sera_LeaseLiabilityToBePaidYearOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_4c3ab7c0-7e70-49a7-bca3-81d0a30745ba_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_TemporaryEquityStockIssuanceCosts_bb76e1b3-45ef-4f60-954c-031d86faedad_terseLabel_en-US" xlink:label="lab_sera_TemporaryEquityStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_sera_TemporaryEquityStockIssuanceCosts_label_en-US" xlink:label="lab_sera_TemporaryEquityStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issuance Costs</link:label>
    <link:label id="lab_sera_TemporaryEquityStockIssuanceCosts_documentation_en-US" xlink:label="lab_sera_TemporaryEquityStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs of new stock classified as temporary equity issued during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityStockIssuanceCosts" xlink:href="sera-20220930.xsd#sera_TemporaryEquityStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_TemporaryEquityStockIssuanceCosts" xlink:to="lab_sera_TemporaryEquityStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_afc454cb-5473-4436-90fa-f10d1e3d1d24_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_WarrantsTextBlock_4848938e-2b98-4156-8bed-b25f3f0eb19f_terseLabel_en-US" xlink:label="lab_sera_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_sera_WarrantsTextBlock_label_en-US" xlink:label="lab_sera_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants [Text Block]</link:label>
    <link:label id="lab_sera_WarrantsTextBlock_documentation_en-US" xlink:label="lab_sera_WarrantsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsTextBlock" xlink:href="sera-20220930.xsd#sera_WarrantsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_WarrantsTextBlock" xlink:to="lab_sera_WarrantsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_7537798d-2e44-4604-acb8-ca0ffd536222_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_7cd85497-75e5-4dc1-abe7-79a40848c6b7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4ce637dd-7f39-4a9f-a45c-ea577aafcc9d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8f1141ff-2a50-4fda-a615-1fc2c45d7c80_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_SeriesDConvertiblePreferredStockMember_9fea8caa-be5d-4af1-98fc-258a2350b822_terseLabel_en-US" xlink:label="lab_sera_SeriesDConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Convertible Preferred Stock</link:label>
    <link:label id="lab_sera_SeriesDConvertiblePreferredStockMember_label_en-US" xlink:label="lab_sera_SeriesDConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_sera_SeriesDConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_sera_SeriesDConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Series D Convertible Preferred Stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesDConvertiblePreferredStockMember" xlink:href="sera-20220930.xsd#sera_SeriesDConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_SeriesDConvertiblePreferredStockMember" xlink:to="lab_sera_SeriesDConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_f80ec420-bbd2-40bd-851d-c83aa62e4b35_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b4c85edf-621c-4774-bee9-69fd9f5a11b0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_0ae97ce6-586a-43b8-99a0-24a111da31bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Warrants or Rights</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_432d84c7-b94e-4c5e-9052-4cec41a1815d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_906b4351-b6ac-473f-bd63-b6c59c747752_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Structure</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_90c7e146-b876-46f7-abac-526c63f4ba54_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_3dd49419-88d9-4eef-8c0b-202e78613f28_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearTwo_d357f8b1-7f39-4458-ba26-5c96cef1f247_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearTwo_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Two</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearTwo_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearTwo" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidYearTwo" xlink:to="lab_sera_LeaseLiabilityToBePaidYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_02d663e0-46bc-41de-85c7-5615570b6707_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_d4270ca2-7637-4d39-be18-322f25f46ed0_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2a568b88-9b8c-4c10-b0bf-2553c1589896_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares Subject to Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLoansFromBank_0cdf42bb-63f4-41e2-b392-1cd16bdd99cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLoansFromBank" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan</link:label>
    <link:label id="lab_us-gaap_LongTermLoansFromBank_label_en-US" xlink:label="lab_us-gaap_LongTermLoansFromBank" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable to Bank, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansFromBank" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansFromBank"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansFromBank" xlink:to="lab_us-gaap_LongTermLoansFromBank" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_753eec5e-99a1-4902-91a7-effb3c6acac8_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_84a597e6-0a26-4255-87e0-219f885d7af0_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_faa3bddd-dcd4-4c86-9b7e-5b43ddd2a059_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion of discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_701ba967-6db7-4504-8c3f-07949b6b8307_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_411b7711-2a65-4e48-97be-5529c55c6979_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b00a0920-f105-4ffd-9dc9-4e6f0d34c1d8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3b8d0f17-6050-4573-9108-441593b869c5_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_55849b0e-4a10-42d2-a47a-a19d7ab63fd5_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business and Financial Condition</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityCurrent_4a291db4-4daa-4493-8418-8c99ce9103ed_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current portion</link:label>
    <link:label id="lab_sera_LeaseLiabilityCurrent_label_en-US" xlink:label="lab_sera_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Current</link:label>
    <link:label id="lab_sera_LeaseLiabilityCurrent_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityCurrent" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityCurrent" xlink:to="lab_sera_LeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_21052a9e-0e57-4893-8c93-14425c8f8bbf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4df1c33c-d9c8-40cb-845e-775de6f4c191_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_b133eaaa-b787-4b81-873a-feacbba02aa1_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:to="lab_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_88796aa8-7157-482e-8050-c2bac810a97f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_32cb4ac1-844f-4060-99ef-67f7c408bc16_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_02ee591c-b0a5-4f01-bc80-1a3ed9498359_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_fbab7219-3206-46e8-a6b4-6c5d87918746_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b8a4682c-df7f-4f24-8da1-5b80b13eb774_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_d4408a3e-ff5c-4d01-b067-4d2770bd1f25_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_84838012-672b-4f7b-a7b9-87610735aa3d_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_f5255a27-bdeb-4e8a-9064-4ab072e39b11_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_23cabff9-7d53-4a6b-a1d6-bccb44b96910_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2dcd00ed-4218-445a-b1d1-f92103ffcb64_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_54561dc4-627a-4861-ad56-7724612436c9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_43ae8569-4cc6-4934-859e-bd2be063800e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6826648e-5d3e-4818-943a-56d3c3e8abba_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_f0478761-2dde-4585-b316-bdecf13fb37d_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Marketable Securities [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityUndiscountedExcessAmount_d367576c-e2f5-460e-a62c-1c7dae3453d6_negatedTerseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_sera_LeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label id="lab_sera_LeaseLiabilityUndiscountedExcessAmount_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_sera_LeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_0b2d33ef-e890-4fdb-ad82-b653f88f42e9_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_6825a2ff-7a25-4090-b48a-f0c2be135dad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest at the end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_932056fe-7f38-4ae3-9c27-309ba5c7bb35_terseLabel_en-US" xlink:label="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_label_en-US" xlink:label="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four and Thereafter</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_documentation_en-US" xlink:label="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:href="sera-20220930.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:to="lab_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_9c3f3e51-02aa-4ad4-a9b9-a7178ea790ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_2f829d77-b6f2-4dcd-a21d-b58968c119ba_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_07201cc5-4598-4361-ab4c-0f948604dadc_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Marketable Securities Classified by Contractual Maturities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5e0053a8-bfe0-4b3e-bd10-cf86dd697a97_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e389cb2b-a42a-45d9-9b93-95596183ed8b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares of common stock outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5e8396f1-f142-401f-a420-c5fce4a0ced2_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt1238SharePriceMember_36ddf633-4c50-42a5-ac2b-50d3c38d4f01_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12.38</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt1238SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 12.38 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt1238SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At 12.38 Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt1238SharePriceMember" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt1238SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt1238SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt1238SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_SeriesESeniorConvertiblePreferredStockMember_8235846e-4076-42c9-ae03-04e8585ad7d8_terseLabel_en-US" xlink:label="lab_sera_SeriesESeniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Senior Convertible Preferred Stock</link:label>
    <link:label id="lab_sera_SeriesESeniorConvertiblePreferredStockMember_label_en-US" xlink:label="lab_sera_SeriesESeniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series E Senior Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_sera_SeriesESeniorConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_sera_SeriesESeniorConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to Series E senior convertible preferred stock.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesESeniorConvertiblePreferredStockMember" xlink:href="sera-20220930.xsd#sera_SeriesESeniorConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_SeriesESeniorConvertiblePreferredStockMember" xlink:to="lab_sera_SeriesESeniorConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e60ac5e7-0bac-4474-910c-1429550ab278_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price per share, vested and exercisable at the end (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_9dc87ce0-d758-489f-9443-8ad430ba63d3_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total employee stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_4998ce8a-f6e0-4cd1-a04a-f5367c1d40de_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing information</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e690f4ba-f234-4419-9776-068a2560d727_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_PaycheckProtectionProgramLoanMember_a97d4b93-e83d-4641-bdd6-a59e60a11a35_terseLabel_en-US" xlink:label="lab_sera_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loan</link:label>
    <link:label id="lab_sera_PaycheckProtectionProgramLoanMember_label_en-US" xlink:label="lab_sera_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loan [Member]</link:label>
    <link:label id="lab_sera_PaycheckProtectionProgramLoanMember_documentation_en-US" xlink:label="lab_sera_PaycheckProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for Paycheck Protection Program Loan under the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PaycheckProtectionProgramLoanMember" xlink:href="sera-20220930.xsd#sera_PaycheckProtectionProgramLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_PaycheckProtectionProgramLoanMember" xlink:to="lab_sera_PaycheckProtectionProgramLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_544babe1-c599-41fb-b1a7-2f372dc201a4_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9dabffe9-6233-4f23-a63e-2d9ced1ffb8f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the beginning (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_49c326c6-21b7-40f3-896e-80662e3d68a6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding at the end (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_PlanEspp2021Member_902fbb22-42fe-48e3-b4cd-1f6d949bbc61_terseLabel_en-US" xlink:label="lab_sera_PlanEspp2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP</link:label>
    <link:label id="lab_sera_PlanEspp2021Member_label_en-US" xlink:label="lab_sera_PlanEspp2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Espp2021 [Member]</link:label>
    <link:label id="lab_sera_PlanEspp2021Member_documentation_en-US" xlink:label="lab_sera_PlanEspp2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents information pertaining to 2021 Employee Stock Purchase Plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PlanEspp2021Member" xlink:href="sera-20220930.xsd#sera_PlanEspp2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_PlanEspp2021Member" xlink:to="lab_sera_PlanEspp2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockWarrantAt9.03SharePriceMember_2dd39b35-7ab6-4b0e-bd62-9b5211d76ed5_terseLabel_en-US" xlink:label="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">9.03</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt9.03SharePriceMember_label_en-US" xlink:label="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrant At9.03 Share Price [Member]</link:label>
    <link:label id="lab_sera_CommonStockWarrantAt9.03SharePriceMember_documentation_en-US" xlink:label="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant issued by the company that allows the purchase of shares of common stock at a price of $9.03 per share.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt9.03SharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:to="lab_sera_CommonStockWarrantAt9.03SharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_6288b37a-ebac-4363-b4fd-ac069b9d5245_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_0bea8901-4774-431b-a88c-c24a9fdbd013_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3f0dd3ac-62cc-4ab4-94f2-7f02489fa8fa_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c24c459-9290-4a3a-9921-9c3fc1c92cb2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued from conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RightOfUseAssetTotal_45df4c82-97e7-4cae-b398-41abafafeccf_totalLabel_en-US" xlink:label="lab_sera_RightOfUseAssetTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total right-of-use assets</link:label>
    <link:label id="lab_sera_RightOfUseAssetTotal_label_en-US" xlink:label="lab_sera_RightOfUseAssetTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset, Total</link:label>
    <link:label id="lab_sera_RightOfUseAssetTotal_documentation_en-US" xlink:label="lab_sera_RightOfUseAssetTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetTotal" xlink:href="sera-20220930.xsd#sera_RightOfUseAssetTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RightOfUseAssetTotal" xlink:to="lab_sera_RightOfUseAssetTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_a54ec4ba-5e89-46ed-bc81-ff9d4bdf7d0b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3847de13-6ae8-4a27-ac82-6e9a59851397_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_9a78f1c2-230f-41e2-9e4c-a4f7a4dfe8bf_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d4b1c449-3eab-4a1c-acb2-63c7a93f7b14_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0834d456-8296-47ed-9475-886994c38e76_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_35b59aaa-d9ab-4739-8f53-f94acb8f493f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilitiesTotal_3f1deb32-3335-4ce0-a055-77afe2a8fe9f_totalLabel_en-US" xlink:label="lab_sera_LeaseLiabilitiesTotal" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesTotal_label_en-US" xlink:label="lab_sera_LeaseLiabilitiesTotal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Total</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesTotal_documentation_en-US" xlink:label="lab_sera_LeaseLiabilitiesTotal" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilitiesTotal" xlink:to="lab_sera_LeaseLiabilitiesTotal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_416c0a17-4425-4013-9f77-62cbcefa756f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_45b88c17-a744-483c-9f8c-afac09fa2948_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b120106c-c36a-418a-9d42-47bd55a39664_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_b512d364-3802-48b2-8932-f510a569b342_negatedLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_ec71db98-17e5-4731-8ff8-6a54460b5836_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_RepaymentOfAccruedInterestOnLongTermDebt_ccb48a69-1963-4ba8-ad55-aff975b37717_terseLabel_en-US" xlink:label="lab_sera_RepaymentOfAccruedInterestOnLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of accrued interest</link:label>
    <link:label id="lab_sera_RepaymentOfAccruedInterestOnLongTermDebt_label_en-US" xlink:label="lab_sera_RepaymentOfAccruedInterestOnLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of Accrued Interest On Long Term Debt</link:label>
    <link:label id="lab_sera_RepaymentOfAccruedInterestOnLongTermDebt_documentation_en-US" xlink:label="lab_sera_RepaymentOfAccruedInterestOnLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of cash outflow for repayment of accrued interest on long-term debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt" xlink:href="sera-20220930.xsd#sera_RepaymentOfAccruedInterestOnLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt" xlink:to="lab_sera_RepaymentOfAccruedInterestOnLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_a1467d89-fd94-4b5c-8e15-7a417c034f09_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ClassOfWarrantOrRightExpired_6c2aec40-84e3-4b3e-aaaf-9cd0ecc1c9a9_terseLabel_en-US" xlink:label="lab_sera_ClassOfWarrantOrRightExpired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant Or Right, Expired</link:label>
    <link:label id="lab_sera_ClassOfWarrantOrRightExpired_label_en-US" xlink:label="lab_sera_ClassOfWarrantOrRightExpired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant Or Right, Expired</link:label>
    <link:label id="lab_sera_ClassOfWarrantOrRightExpired_documentation_en-US" xlink:label="lab_sera_ClassOfWarrantOrRightExpired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant Or Right, Expired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ClassOfWarrantOrRightExpired" xlink:href="sera-20220930.xsd#sera_ClassOfWarrantOrRightExpired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ClassOfWarrantOrRightExpired" xlink:to="lab_sera_ClassOfWarrantOrRightExpired" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilitiesAbstract_6a6a8f1f-e8f6-40e5-9182-5a65fa0df63d_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities:</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesAbstract_label_en-US" xlink:label="lab_sera_LeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities [Abstract]</link:label>
    <link:label id="lab_sera_LeaseLiabilitiesAbstract_documentation_en-US" xlink:label="lab_sera_LeaseLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesAbstract" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilitiesAbstract" xlink:to="lab_sera_LeaseLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_eb643824-0086-48d0-8309-0169ce602014_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_762b6e9a-75bf-4782-8d29-0c0d42c43863_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_74efaebf-cbe8-4e2a-af68-9f48343291f2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d4a314af-2a8e-42a8-ac2f-3f6ece139036_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_3928498b-c295-45f7-94da-e3a8cbfe6e1c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued paid time off</link:label>
    <link:label id="lab_us-gaap_AccruedVacationCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedVacationCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Vacation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedVacationCurrent" xlink:to="lab_us-gaap_AccruedVacationCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommercialCollaborationAgreementMember_ca41812c-2794-40dd-a642-34b567a0930d_terseLabel_en-US" xlink:label="lab_sera_CommercialCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Collaboration Agreement</link:label>
    <link:label id="lab_sera_CommercialCollaborationAgreementMember_label_en-US" xlink:label="lab_sera_CommercialCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Collaboration Agreement [Member]</link:label>
    <link:label id="lab_sera_CommercialCollaborationAgreementMember_documentation_en-US" xlink:label="lab_sera_CommercialCollaborationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for the Commercial Collaboration Agreement with Anthem and its affiliates (the "Commercial Collaboration Agreement").</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommercialCollaborationAgreementMember" xlink:href="sera-20220930.xsd#sera_CommercialCollaborationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommercialCollaborationAgreementMember" xlink:to="lab_sera_CommercialCollaborationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_42099612-593c-4d4e-8945-bcac1a4550ae_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_b9da4305-c39d-4ce0-8764-414a50627399_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_04026f62-5285-4807-bae2-e456318ab590_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_StockIssuedDuringPeriodSharesStockWarrantExercised_d8749d15-ea75-4d54-a058-268762ecea33_terseLabel_en-US" xlink:label="lab_sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock warrant exercises (in shares)</link:label>
    <link:label id="lab_sera_StockIssuedDuringPeriodSharesStockWarrantExercised_label_en-US" xlink:label="lab_sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Warrant Exercised</link:label>
    <link:label id="lab_sera_StockIssuedDuringPeriodSharesStockWarrantExercised_documentation_en-US" xlink:label="lab_sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Stock Warrant Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:href="sera-20220930.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:to="lab_sera_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_eae4a8ab-be2e-4a2a-b89f-86bf9af4d681_terseLabel_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock available for future grants under the 2021 Equity Incentive Plan</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:href="sera-20220930.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:to="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_5289204d-2a19-4d92-a02e-2b7e8b7faed0_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_9e5e83d2-bacc-4bd5-b4af-b955d1080439_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Effects on Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Effects on Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:to="lab_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_222db4fd-72a3-41cf-94a6-d197fdad9c00_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_0d45646c-6613-4b3e-9e26-72c743af836c_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_136aa281-467f-41cf-9881-dd032ffb248d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_1111ca3d-1b01-4e69-ada8-93e57e0e1e81_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share &#8212; diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_fa9cf080-4d94-4739-ab5e-de63ca4d2be6_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_c9505278-a8ce-4d0e-b857-6007d77f8d26_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d32d5931-3ef5-4747-814c-994d9d294c9f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_dde9cd18-e7b5-4cfd-9c69-0ad4d8e7ec75_terseLabel_en-US" xlink:label="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Reserved for Future Issuance</link:label>
    <link:label id="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_label_en-US" xlink:label="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Reserved For Future Issuance [Table Text Block]</link:label>
    <link:label id="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_documentation_en-US" xlink:label="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The tabular disclosure of common stock reserved for future issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:href="sera-20220930.xsd#sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="lab_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5a2c7f7f-83ce-4fe5-9003-05aad72cd211_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b64eee3f-83e6-4741-8c99-fc877e40be2a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f73f6b11-2a5b-4993-b96a-0681dce75f23_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_7a6b75e9-460e-4659-bcab-6c794319310a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other losses, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingGainsLosses_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingGainsLosses" xlink:to="lab_us-gaap_OtherNonoperatingGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_71375e06-4446-43fd-bb9b-d5c8fe82cddc_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_cf16d6e2-4a55-4088-846b-856ed26f1981_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_a39c58e9-5925-40e3-b6d7-96351a31e1ce_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_f44f2b95-1467-4d9e-a59b-c754b2f5e44a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subject to options outstanding, vested and exercisable at the end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b13464bb-36e1-444c-8532-86269175c7d3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_c2fcc2e9-2603-4590-94de-26e4a04c6684_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_cf8f45d8-5c79-4ad0-9e3f-6c69d668c49f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_a57f491c-a061-43fb-810f-714676877b00_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_409a40db-399d-4b6b-9876-076bc545ea4b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_58b1647c-a4f1-4ce0-b4ce-70b150b1356c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_c66bbee4-93d5-42aa-8200-656721398868_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_34e6f7ff-b3a0-4581-a71c-117d9bf20385_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRentCreditCurrent_14905486-755d-4741-85bd-9770387b0f10_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent, current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRentCreditCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRentCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentCreditCurrent" xlink:to="lab_us-gaap_DeferredRentCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_760a14cd-922d-45fd-b3ba-72cb433ecd2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_59084795-fe4b-4215-9720-3254b8724013_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_958ece90-60cc-4a20-a3bc-f3433eada366_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_efb8f92d-ec1e-4493-ac2d-4b7424ba328e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_dc4b70ab-bdb6-433f-ad5e-f14eef6858df_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds allocated to issuance of common stock warrants in connection with Series E</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_31277378-7ddd-4506-8038-0be938315a58_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent_56deadf3-c7d3-431e-a3b9-61926504f83e_terseLabel_en-US" xlink:label="lab_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease-related liabilities removed from deferred rent</link:label>
    <link:label id="lab_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent_label_en-US" xlink:label="lab_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease-Related Liabilities Removed From Deferred Rent</link:label>
    <link:label id="lab_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent_documentation_en-US" xlink:label="lab_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease-Related Liabilities Removed From Deferred Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" xlink:href="sera-20220930.xsd#sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" xlink:to="lab_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d36908b9-3c79-4249-9803-f4b4f65ab4c2_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_c1445e73-0b49-4692-94ef-7ba26a24e23f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearFourAndThereafter_91611fb7-dcc4-4588-91a6-389ccd2af569_terseLabel_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026 and thereafter</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearFourAndThereafter_label_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Four and Thereafter</link:label>
    <link:label id="lab_sera_LeaseLiabilityToBePaidYearFourAndThereafter_documentation_en-US" xlink:label="lab_sera_LeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Liability, to be Paid, Year Four and Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearFourAndThereafter" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LeaseLiabilityToBePaidYearFourAndThereafter" xlink:to="lab_sera_LeaseLiabilityToBePaidYearFourAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_8b43c22b-3594-43d6-ab86-869a6309db6b_terseLabel_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_label_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Employee Stock [Member]</link:label>
    <link:label id="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_documentation_en-US" xlink:label="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Available For Future Issuance Under2021 Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:href="sera-20220930.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:to="lab_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_9977d765-a2f8-479b-869a-cdaad51024f7_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_7e0dc270-1fda-4d2a-ae28-73f84b6cf287_terseLabel_en-US" xlink:label="lab_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million (in shares)</link:label>
    <link:label id="lab_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of new stock classified as temporary equity issued during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="sera-20220930.xsd#sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_58d42070-a031-4754-894b-b4f3d24b47c5_terseLabel_en-US" xlink:label="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</link:label>
    <link:label id="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_documentation_en-US" xlink:label="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:href="sera-20220930.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:to="lab_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_7bdfa9d0-d6bd-4053-8085-a86a50fff6cc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_b64f6280-22a0-448e-97c3-ecffa7e7e12b_terseLabel_en-US" xlink:label="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of square feet under lease</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_label_en-US" xlink:label="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Area Of Leased Space Office And Laboratory</link:label>
    <link:label id="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_documentation_en-US" xlink:label="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The area of leased office and laboratory space.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:href="sera-20220930.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:to="lab_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_b294a592-5b0c-4394-bdd1-39c1bc7bda34_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_February2019ConvertibleNoteMember_3f15ae56-774c-4ba7-93ca-249b9053ab47_terseLabel_en-US" xlink:label="lab_sera_February2019ConvertibleNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2019 Convertible Note</link:label>
    <link:label id="lab_sera_February2019ConvertibleNoteMember_label_en-US" xlink:label="lab_sera_February2019ConvertibleNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February2019 Convertible Note [Member]</link:label>
    <link:label id="lab_sera_February2019ConvertibleNoteMember_documentation_en-US" xlink:label="lab_sera_February2019ConvertibleNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This member stands for February 2019 Convertible Note.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_February2019ConvertibleNoteMember" xlink:href="sera-20220930.xsd#sera_February2019ConvertibleNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_February2019ConvertibleNoteMember" xlink:to="lab_sera_February2019ConvertibleNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_36ef8b1f-b9a5-4e8c-8fd8-d93f1ac5ee64_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c84f8489-5b90-447b-b25c-7daa7f53b176_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_af3855d9-d917-42f1-be70-ae7c0fe01411_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_c4ae7bf2-e7b2-471b-8042-e6adac8ecfca_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_965c9418-2934-467d-9a62-ea97bf23b57a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_37d68f5e-2824-496c-92c4-7243aeeefe3a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_f64cca94-970a-414a-851b-4023b64d2101_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_352f872c-7e70-4fb8-b02e-604a8ca7678c_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f471adff-cb52-4fde-9454-15257f62ee59_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_530e2835-d671-493f-af12-0a329886da2c_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8b6ca48e-b7bb-4aaf-8512-3036e9b37351_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e5ac4e98-bec8-42d2-8e80-7028fb069805_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_aa6b5887-f257-4336-bc98-a85272ac098b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_b7b1e716-2961-44a8-9fcb-e461f9438f97_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3feeb027-ea57-47b7-8f75-97604690c200_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0f800b91-1107-4827-840c-b9bce92ca9d7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from initial public offering of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_3c2aa84e-e229-4c6e-893a-b675dc5ea51c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_7f9b6d8a-9c15-461a-be1d-8d06764838a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_10a6bbc2-6e87-4fe8-bef7-aad85a45c8a6_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_93e861ca-96e2-4402-aa23-26333859d629_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock_6eb675a6-b954-4152-a6f7-d3cb51d75224_terseLabel_en-US" xlink:label="lab_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of preferred stock to common stock (in shares)</link:label>
    <link:label id="lab_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock_label_en-US" xlink:label="lab_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares, Conversion Of Preferred Stock To Common Stock</link:label>
    <link:label id="lab_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock_documentation_en-US" xlink:label="lab_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares, Conversion Of Preferred Stock To Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock" xlink:href="sera-20220930.xsd#sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock" xlink:to="lab_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3c95ec37-82e8-43b5-b4ed-6c4cf1d2ecd9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_d2e519b3-1216-4720-86dc-49992c780bd6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_87d975e3-8469-422a-8376-82ea50aa59bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_46046674-f54d-47f8-8e21-4c1dc45ba7a3_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_5892098e-26f7-4af3-94ce-6effae7474ed_terseLabel_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_label_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</link:label>
    <link:label id="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_documentation_en-US" xlink:label="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:to="lab_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>sera-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:181dff8b-221c-4709-ab07-a5f181ab4d14,g:4b08700b-5ca3-4c7f-8934-f342ec818a3e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Cover" xlink:type="simple" xlink:href="sera-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_afde8272-7099-45aa-aa6b-7ab32739d74b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_00a5c90c-8292-4845-bf63-6d0320e2776b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_afde8272-7099-45aa-aa6b-7ab32739d74b" xlink:to="loc_dei_DocumentInformationTable_00a5c90c-8292-4845-bf63-6d0320e2776b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_bf925884-7677-4f46-ab06-21a99deb35b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_00a5c90c-8292-4845-bf63-6d0320e2776b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_bf925884-7677-4f46-ab06-21a99deb35b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_bf925884-7677-4f46-ab06-21a99deb35b5" xlink:to="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a9027035-f078-49a8-8c04-63c489eaf853" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:to="loc_us-gaap_CommonClassAMember_a9027035-f078-49a8-8c04-63c489eaf853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_e385a6ef-7780-43aa-b088-4e91e6d2023e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b1cafdca-ed4c-4102-9b9f-e9d830d1475d" xlink:to="loc_us-gaap_CommonClassBMember_e385a6ef-7780-43aa-b088-4e91e6d2023e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_00a5c90c-8292-4845-bf63-6d0320e2776b" xlink:to="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1698aade-b898-441a-8c02-06bc856920c7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentType_1698aade-b898-441a-8c02-06bc856920c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_74700370-a0eb-47ad-b96b-8915fdac534e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentQuarterlyReport_74700370-a0eb-47ad-b96b-8915fdac534e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4ac8ae04-4449-44f2-9fef-0f211d2f555f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentPeriodEndDate_4ac8ae04-4449-44f2-9fef-0f211d2f555f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_84bfcf99-134e-47d3-8ae1-befe12effdf2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentTransitionReport_84bfcf99-134e-47d3-8ae1-befe12effdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_74ac126e-b7ca-46b0-8645-79dd23de6431" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityFileNumber_74ac126e-b7ca-46b0-8645-79dd23de6431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3b8520e8-6067-437f-bd3a-ee8e920aeae5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityRegistrantName_3b8520e8-6067-437f-bd3a-ee8e920aeae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ae3f7ad9-684a-46ec-b5e6-5425c31bd933" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ae3f7ad9-684a-46ec-b5e6-5425c31bd933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_473e1b9d-5c49-4e98-9ce4-6e32d90387bb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityTaxIdentificationNumber_473e1b9d-5c49-4e98-9ce4-6e32d90387bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_868fc294-0a9f-4bb5-b2d7-086c7cd03397" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressAddressLine1_868fc294-0a9f-4bb5-b2d7-086c7cd03397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_23834d92-437f-45cb-a388-0e7457b5de87" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressAddressLine2_23834d92-437f-45cb-a388-0e7457b5de87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_34837305-f517-4d19-8180-6de530914589" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressCityOrTown_34837305-f517-4d19-8180-6de530914589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_08cdd5e0-7802-4732-ac0f-abe5c59f2866" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressStateOrProvince_08cdd5e0-7802-4732-ac0f-abe5c59f2866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_51f2b4d3-97ef-42c8-957b-59c71ddef7c3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityAddressPostalZipCode_51f2b4d3-97ef-42c8-957b-59c71ddef7c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b4d40523-e037-47e5-a618-26588798a1d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_CityAreaCode_b4d40523-e037-47e5-a618-26588798a1d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7939e62c-943e-4d55-b315-4e2e61a16ec5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_LocalPhoneNumber_7939e62c-943e-4d55-b315-4e2e61a16ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_948a8cdf-de8a-47f7-bf4f-d3ee063454a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_Security12bTitle_948a8cdf-de8a-47f7-bf4f-d3ee063454a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_798e12d2-4919-4f31-8e61-c3b9bf1ee7ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_TradingSymbol_798e12d2-4919-4f31-8e61-c3b9bf1ee7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_60bfe19a-45c4-42af-94f5-cffc558b3911" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_SecurityExchangeName_60bfe19a-45c4-42af-94f5-cffc558b3911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_c9525399-6b8c-4884-bf1d-24ab2fc0a519" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityCurrentReportingStatus_c9525399-6b8c-4884-bf1d-24ab2fc0a519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ce831c40-8c45-4573-903b-d42282ee649f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityInteractiveDataCurrent_ce831c40-8c45-4573-903b-d42282ee649f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_04cc9085-8537-4788-9520-fd8246ff9ea5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityFilerCategory_04cc9085-8537-4788-9520-fd8246ff9ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1f9d1398-b97c-4ca2-bb07-870508280e7f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntitySmallBusiness_1f9d1398-b97c-4ca2-bb07-870508280e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_adccb908-0484-4dac-8558-a60f55a94a05" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityEmergingGrowthCompany_adccb908-0484-4dac-8558-a60f55a94a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_85075639-6224-4d5f-97a1-9779c1976364" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityExTransitionPeriod_85075639-6224-4d5f-97a1-9779c1976364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2e3572d7-5618-477f-b9ce-ea89b811f55a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityShellCompany_2e3572d7-5618-477f-b9ce-ea89b811f55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_895076d1-6914-409b-a443-79abfe52c43b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_895076d1-6914-409b-a443-79abfe52c43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_186fcf23-f99c-4ab2-ac9e-57f83d85a4ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_EntityCentralIndexKey_186fcf23-f99c-4ab2-ac9e-57f83d85a4ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_02cb6d2b-f7f1-467e-87cf-2963f13fe1a8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_CurrentFiscalYearEndDate_02cb6d2b-f7f1-467e-87cf-2963f13fe1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f2141942-503e-409e-9be6-4c9882ad789b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentFiscalYearFocus_f2141942-503e-409e-9be6-4c9882ad789b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_e863def6-7b79-4e03-8a7a-43379195910e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_DocumentFiscalPeriodFocus_e863def6-7b79-4e03-8a7a-43379195910e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_b1454f18-86d2-4ea3-9afc-36d49b0f71eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_9e9721a3-5458-4059-9747-a4c05e8a4f8a" xlink:to="loc_dei_AmendmentFlag_b1454f18-86d2-4ea3-9afc-36d49b0f71eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedBalanceSheetsunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_43461a3a-af67-475b-b9ef-62ac1f9ce9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_195d1acb-bca6-4526-93b3-3ff8cb6d0af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43461a3a-af67-475b-b9ef-62ac1f9ce9d9" xlink:to="loc_us-gaap_AssetsAbstract_195d1acb-bca6-4526-93b3-3ff8cb6d0af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_195d1acb-bca6-4526-93b3-3ff8cb6d0af3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4fd494d8-eb04-4650-bbe4-cbf7e5a53578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4fd494d8-eb04-4650-bbe4-cbf7e5a53578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_e971b9c2-49a5-4ea1-b2b3-ab2d91f98646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_e971b9c2-49a5-4ea1-b2b3-ab2d91f98646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6cdb5c34-1282-49a1-83d7-8bbba557a25e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6cdb5c34-1282-49a1-83d7-8bbba557a25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_ab38e357-ae73-487f-89cd-b5d89d2da258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_ab38e357-ae73-487f-89cd-b5d89d2da258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0cad90c1-c56a-4b20-83d5-12297017882a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0cad90c1-c56a-4b20-83d5-12297017882a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cce83b12-0722-4739-b584-6105e007b10f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_267ea179-b023-4afb-8d43-991b79112492" xlink:to="loc_us-gaap_AssetsCurrent_cce83b12-0722-4739-b584-6105e007b10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1fa0789b-2fde-4f4c-9b2a-0fb14485a61d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_195d1acb-bca6-4526-93b3-3ff8cb6d0af3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_1fa0789b-2fde-4f4c-9b2a-0fb14485a61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_bf728175-fe1e-4a21-8b38-3c45e51285c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_195d1acb-bca6-4526-93b3-3ff8cb6d0af3" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_bf728175-fe1e-4a21-8b38-3c45e51285c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d0ac8edd-8f13-4673-adba-b978313eb5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_195d1acb-bca6-4526-93b3-3ff8cb6d0af3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d0ac8edd-8f13-4673-adba-b978313eb5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_bf1ed5c8-7bfb-47e7-9e7e-ea891b790f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_195d1acb-bca6-4526-93b3-3ff8cb6d0af3" xlink:to="loc_us-gaap_Assets_bf1ed5c8-7bfb-47e7-9e7e-ea891b790f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_43461a3a-af67-475b-b9ef-62ac1f9ce9d9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d07771d5-c97a-443a-857e-2e1e80a9d9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:to="loc_us-gaap_AccountsPayableCurrent_d07771d5-c97a-443a-857e-2e1e80a9d9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_42a58f1b-20ef-4675-b9cf-73d7c847933c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_42a58f1b-20ef-4675-b9cf-73d7c847933c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditCurrent_07d914bb-54df-4b31-9204-e1fd0b28c559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRentCreditCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:to="loc_us-gaap_DeferredRentCreditCurrent_07d914bb-54df-4b31-9204-e1fd0b28c559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_ce0aee27-023b-47f0-b4b4-84026b832dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_ce0aee27-023b-47f0-b4b4-84026b832dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3d22489b-296f-48ab-a675-e3de3d029dc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3d22489b-296f-48ab-a675-e3de3d029dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0491e949-b3a7-4deb-9621-95e70fb9c0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_794c563a-cf60-4b56-a12d-df84ae1be29f" xlink:to="loc_us-gaap_LiabilitiesCurrent_0491e949-b3a7-4deb-9621-95e70fb9c0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9abf7052-2998-404f-ab7f-f6ad23065f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_9abf7052-2998-404f-ab7f-f6ad23065f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c1499d6a-1f80-464a-8fc3-bb62c7391952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:to="loc_us-gaap_Liabilities_c1499d6a-1f80-464a-8fc3-bb62c7391952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8eb6e7ff-5062-4e57-bd6b-8fdd07ecb53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8eb6e7ff-5062-4e57-bd6b-8fdd07ecb53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f667fdc4-16c2-4d26-949c-80799f7d749b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f667fdc4-16c2-4d26-949c-80799f7d749b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_591336d2-6e0a-48b9-a112-93fddc6ed357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f667fdc4-16c2-4d26-949c-80799f7d749b" xlink:to="loc_us-gaap_CommonStockValue_591336d2-6e0a-48b9-a112-93fddc6ed357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a452d83e-a77c-4673-89a8-904f8f35e4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f667fdc4-16c2-4d26-949c-80799f7d749b" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a452d83e-a77c-4673-89a8-904f8f35e4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0e1af871-4aa4-4ee7-b8fa-3fb24ffbfef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f667fdc4-16c2-4d26-949c-80799f7d749b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0e1af871-4aa4-4ee7-b8fa-3fb24ffbfef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef9f91dc-da07-4d21-8c53-3df42bf51898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f667fdc4-16c2-4d26-949c-80799f7d749b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ef9f91dc-da07-4d21-8c53-3df42bf51898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_42a99ede-345a-492a-898e-fe3953b50334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f667fdc4-16c2-4d26-949c-80799f7d749b" xlink:to="loc_us-gaap_StockholdersEquity_42a99ede-345a-492a-898e-fe3953b50334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_177733ae-a0e3-44ce-8f40-88e71cfaa772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f31595ec-5c16-4d11-baca-45ea9edd4342" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_177733ae-a0e3-44ce-8f40-88e71cfaa772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedBalanceSheetsunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0c37aee7-fc5e-412d-979f-21955d2c4359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_baa9d13b-ac67-4cca-a359-5a4e004564ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0c37aee7-fc5e-412d-979f-21955d2c4359" xlink:to="loc_us-gaap_StatementTable_baa9d13b-ac67-4cca-a359-5a4e004564ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_828f14d6-79c4-4e1a-8043-10cb01ca4238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_baa9d13b-ac67-4cca-a359-5a4e004564ab" xlink:to="loc_us-gaap_StatementClassOfStockAxis_828f14d6-79c4-4e1a-8043-10cb01ca4238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_828f14d6-79c4-4e1a-8043-10cb01ca4238" xlink:to="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_66b5d742-90c2-4649-95c4-0e65c84b7ef4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:to="loc_us-gaap_CommonClassAMember_66b5d742-90c2-4649-95c4-0e65c84b7ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_5e8809fc-2249-427e-aebf-bc12c2b92b12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_daa3803d-57fd-4fde-a13f-6a72fae8ac3c" xlink:to="loc_us-gaap_CommonClassBMember_5e8809fc-2249-427e-aebf-bc12c2b92b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_baa9d13b-ac67-4cca-a359-5a4e004564ab" xlink:to="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1cc8d15-4624-4c4a-b240-868e6d31ceec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d1cc8d15-4624-4c4a-b240-868e6d31ceec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0eee3270-28e4-41d3-9376-41d0cf5d3b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0eee3270-28e4-41d3-9376-41d0cf5d3b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_86b81244-a4a9-4397-9019-a7ae33cf9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockSharesIssued_86b81244-a4a9-4397-9019-a7ae33cf9cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_62ceec29-b1fb-4ed0-9ba9-d1dcb4921bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c25fc102-c67e-4a78-b6e8-21c9514b0c1d" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_62ceec29-b1fb-4ed0-9ba9-d1dcb4921bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofOperationsandComprehensiveLossunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_444329be-deb6-4315-a2d5-11a09964fe14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_444329be-deb6-4315-a2d5-11a09964fe14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_be3d9479-0da0-4877-a194-1f3ddd7341f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_OperatingExpensesAbstract_be3d9479-0da0-4877-a194-1f3ddd7341f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_f9fd66c9-fa1b-4664-b974-2be03a79a566" xlink:href="sera-20220930.xsd#sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_be3d9479-0da0-4877-a194-1f3ddd7341f1" xlink:to="loc_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense_f9fd66c9-fa1b-4664-b974-2be03a79a566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bb8fa03b-6125-44e2-a7a2-8ce562f15e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_be3d9479-0da0-4877-a194-1f3ddd7341f1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bb8fa03b-6125-44e2-a7a2-8ce562f15e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_ade82f7f-8836-4912-abaf-1fb951ec47ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_be3d9479-0da0-4877-a194-1f3ddd7341f1" xlink:to="loc_us-gaap_SellingAndMarketingExpense_ade82f7f-8836-4912-abaf-1fb951ec47ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_61530244-1d51-487d-b3b7-93ca651a5b42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_be3d9479-0da0-4877-a194-1f3ddd7341f1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_61530244-1d51-487d-b3b7-93ca651a5b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7e7ae889-ef40-4b35-9cc3-da21b2393837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_be3d9479-0da0-4877-a194-1f3ddd7341f1" xlink:to="loc_us-gaap_OperatingExpenses_7e7ae889-ef40-4b35-9cc3-da21b2393837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6e841cfb-8243-438a-a724-59bb50898ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_OperatingIncomeLoss_6e841cfb-8243-438a-a724-59bb50898ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_16ad37c9-1ae7-4ab6-8f57-b5e7143394e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_InterestExpense_16ad37c9-1ae7-4ab6-8f57-b5e7143394e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_56b243de-a71a-44f0-af6f-699a9eb89148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_56b243de-a71a-44f0-af6f-699a9eb89148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4783d6d2-927a-4cae-89a4-75a21c6a56d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_NetIncomeLoss_4783d6d2-927a-4cae-89a4-75a21c6a56d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e94173e6-2815-42f3-ae17-553df7ce7ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_EarningsPerShareBasic_e94173e6-2815-42f3-ae17-553df7ce7ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_64877bfa-4ccf-4f16-8732-ebc1db9104ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_EarningsPerShareDiluted_64877bfa-4ccf-4f16-8732-ebc1db9104ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a0bab262-7deb-467e-94c4-c05b27e3d046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a0bab262-7deb-467e-94c4-c05b27e3d046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_86227860-6a67-4dce-8da9-37d22dadaabd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_86227860-6a67-4dce-8da9-37d22dadaabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_10663c2d-c1a1-4f73-8e5e-40822b6c61f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_10663c2d-c1a1-4f73-8e5e-40822b6c61f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7c3f6540-29b4-4b3c-b61f-784e351d8a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_10663c2d-c1a1-4f73-8e5e-40822b6c61f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_7c3f6540-29b4-4b3c-b61f-784e351d8a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9565e67f-0158-4618-a808-8ea206cc558b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_10663c2d-c1a1-4f73-8e5e-40822b6c61f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9565e67f-0158-4618-a808-8ea206cc558b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cfd040a1-af96-43e3-afd5-ff7db99786e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c77d8275-f30a-4878-9766-cedce94d5ea9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_cfd040a1-af96-43e3-afd5-ff7db99786e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_85d908e7-c448-40f7-86d5-c6bf275ab0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_85d908e7-c448-40f7-86d5-c6bf275ab0a1" xlink:to="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a0006441-84a3-4271-9b55-350f541c4d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a0006441-84a3-4271-9b55-350f541c4d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a0006441-84a3-4271-9b55-350f541c4d3a" xlink:to="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeniorConvertiblePreferredStockMember_8b48f533-0e38-4766-9a0f-3fe26cc6b498" xlink:href="sera-20220930.xsd#sera_SeniorConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:to="loc_sera_SeniorConvertiblePreferredStockMember_8b48f533-0e38-4766-9a0f-3fe26cc6b498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_JuniorConvertiblePreferredStockMember_2335cc82-443a-4aff-a37c-d98cf3a906ad" xlink:href="sera-20220930.xsd#sera_JuniorConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_241dbcd1-1d7b-448b-8779-4f61f5c146ff" xlink:to="loc_sera_JuniorConvertiblePreferredStockMember_2335cc82-443a-4aff-a37c-d98cf3a906ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7f003781-e431-4dd8-baea-e5dc179806a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7f003781-e431-4dd8-baea-e5dc179806a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7f003781-e431-4dd8-baea-e5dc179806a3" xlink:to="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3297f119-177f-4c56-a272-c012912d1b7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_CommonStockMember_3297f119-177f-4c56-a272-c012912d1b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_d4e02d21-1d81-456f-ae5c-9350f52f22ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_d4e02d21-1d81-456f-ae5c-9350f52f22ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_da1fd61d-50bd-4ade-9526-6d29a27fab8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_da1fd61d-50bd-4ade-9526-6d29a27fab8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_a27e5032-3880-4829-9b3c-7ab664da8f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a8325b52-c0ef-48bf-beee-090f43ebd6dd" xlink:to="loc_us-gaap_RetainedEarningsMember_a27e5032-3880-4829-9b3c-7ab664da8f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_79892b81-abb7-4060-8220-f0b180d3c817" xlink:to="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e3c5fe87-85c1-4a57-87d8-f697fee8cacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e3c5fe87-85c1-4a57-87d8-f697fee8cacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_388aed4d-3770-4bf3-8add-e92370bbf6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_388aed4d-3770-4bf3-8add-e92370bbf6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_64f03cae-ba84-498d-b57c-191154ce8358" xlink:href="sera-20220930.xsd#sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_64f03cae-ba84-498d-b57c-191154ce8358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b0c9fc39-586c-49fb-a882-dd64793b03ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_b0c9fc39-586c-49fb-a882-dd64793b03ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock_c1f0aa94-e3c8-49ab-b31f-f4a7dd44d044" xlink:href="sera-20220930.xsd#sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock_c1f0aa94-e3c8-49ab-b31f-f4a7dd44d044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock_19fa5fe1-3e9e-49c8-bea0-b083f9a0dfea" xlink:href="sera-20220930.xsd#sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock_19fa5fe1-3e9e-49c8-bea0-b083f9a0dfea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_17d38c30-23b0-4219-b2fd-77c60cc1d72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_17d38c30-23b0-4219-b2fd-77c60cc1d72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_033c9461-5b5a-41d5-acbe-9231f9996a39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_28c24a2e-0b4c-4a38-b136-6a960f35048d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_033c9461-5b5a-41d5-acbe-9231f9996a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b01e2cd7-17fc-4e93-b144-4920e9846ad2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_794de28e-4ba9-4b87-9dc3-31c44fc5edf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_CommonStockSharesIssued_794de28e-4ba9-4b87-9dc3-31c44fc5edf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5cfaa4c1-1252-4418-8ccb-bd96b91cb519" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockholdersEquity_5cfaa4c1-1252-4418-8ccb-bd96b91cb519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea8a35b9-3acd-4fe3-b6b6-b225f69f8eef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_ea8a35b9-3acd-4fe3-b6b6-b225f69f8eef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b14dc5e-6109-4109-b978-279a1306de31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6b14dc5e-6109-4109-b978-279a1306de31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a24857ce-8b27-4cbc-a282-2e2d14d0072c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_a24857ce-8b27-4cbc-a282-2e2d14d0072c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_9997a258-d74d-43fb-bfcc-c32bff0bd8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_9997a258-d74d-43fb-bfcc-c32bff0bd8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_e8f9a1d4-d347-444b-aa23-6d3a8da5a7c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfUnits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits_e8f9a1d4-d347-444b-aa23-6d3a8da5a7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment_1f310440-887c-4a43-806a-4089d1861a86" xlink:href="sera-20220930.xsd#sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment_1f310440-887c-4a43-806a-4089d1861a86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d86fa1ef-37bc-4798-8541-84c99493bd48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d86fa1ef-37bc-4798-8541-84c99493bd48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6a8ca979-766b-499a-988f-a8a4fa36c691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6a8ca979-766b-499a-988f-a8a4fa36c691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_StockIssuedDuringPeriodSharesStockWarrantExercised_e2ced1e4-0114-4be1-9a61-7f45c91f30dd" xlink:href="sera-20220930.xsd#sera_StockIssuedDuringPeriodSharesStockWarrantExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_sera_StockIssuedDuringPeriodSharesStockWarrantExercised_e2ced1e4-0114-4be1-9a61-7f45c91f30dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9f9b200d-a873-4b7f-9e67-bc497fbbbb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9f9b200d-a873-4b7f-9e67-bc497fbbbb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27e22ad4-e733-4097-8b44-11f036e86f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_27e22ad4-e733-4097-8b44-11f036e86f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b50a54a5-bc71-4219-9e56-edb3844e8f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_NetIncomeLoss_b50a54a5-bc71-4219-9e56-edb3844e8f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eebb91e9-8a38-44cd-b449-6b22431a9bf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_CommonStockSharesIssued_eebb91e9-8a38-44cd-b449-6b22431a9bf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_df38594e-e8e3-4ae6-a37f-ca94e43cb184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cf9361ea-b4fc-48dd-9083-493e4a2593ce" xlink:to="loc_us-gaap_StockholdersEquity_df38594e-e8e3-4ae6-a37f-ca94e43cb184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_247189ca-db09-4c97-b15f-1a839a736483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7c99fbcc-bcb5-48f4-9f4f-cf60a3d5c556" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_247189ca-db09-4c97-b15f-1a839a736483" xlink:to="loc_us-gaap_StatementTable_7c99fbcc-bcb5-48f4-9f4f-cf60a3d5c556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d96409c0-f9b7-470c-b0f2-3e504df0e7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c99fbcc-bcb5-48f4-9f4f-cf60a3d5c556" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d96409c0-f9b7-470c-b0f2-3e504df0e7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_9aa70d4e-b1bc-4b88-9d84-bfcd7d4dc4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d96409c0-f9b7-470c-b0f2-3e504df0e7ef" xlink:to="loc_us-gaap_ClassOfStockDomain_9aa70d4e-b1bc-4b88-9d84-bfcd7d4dc4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesESeniorConvertiblePreferredStockMember_8fd6127b-6c08-419c-8713-2e6eceafda52" xlink:href="sera-20220930.xsd#sera_SeriesESeniorConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_9aa70d4e-b1bc-4b88-9d84-bfcd7d4dc4e9" xlink:to="loc_sera_SeriesESeniorConvertiblePreferredStockMember_8fd6127b-6c08-419c-8713-2e6eceafda52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c99fbcc-bcb5-48f4-9f4f-cf60a3d5c556" xlink:to="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_e2f9f54c-efd9-4744-b377-d8adc0ca5696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_e2f9f54c-efd9-4744-b377-d8adc0ca5696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_TemporaryEquityStockIssuanceCosts_d5c774de-217d-499b-b968-ac5290f6112c" xlink:href="sera-20220930.xsd#sera_TemporaryEquityStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_622bb0c5-877f-4d2f-a03f-f0c4657a5bd2" xlink:to="loc_sera_TemporaryEquityStockIssuanceCosts_d5c774de-217d-499b-b968-ac5290f6112c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="simple" xlink:href="sera-20220930.xsd#CondensedStatementsofCashFlowsunaudited"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_1b9a4c8b-a387-4c47-82b4-6f71be7742d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9cc2118d-b876-4577-a4d1-4919463bf8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_1b9a4c8b-a387-4c47-82b4-6f71be7742d1" xlink:to="loc_us-gaap_StatementTable_9cc2118d-b876-4577-a4d1-4919463bf8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d2a110e3-d0d9-4818-b7b1-107f8d329bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cc2118d-b876-4577-a4d1-4919463bf8aa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d2a110e3-d0d9-4818-b7b1-107f8d329bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a1bda8c0-5d64-44c0-b145-1d78a2667fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2a110e3-d0d9-4818-b7b1-107f8d329bda" xlink:to="loc_us-gaap_ClassOfStockDomain_a1bda8c0-5d64-44c0-b145-1d78a2667fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesESeniorConvertiblePreferredStockMember_e7d7d49e-90aa-4b7f-b94e-506baec1abee" xlink:href="sera-20220930.xsd#sera_SeriesESeniorConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a1bda8c0-5d64-44c0-b145-1d78a2667fd8" xlink:to="loc_sera_SeriesESeniorConvertiblePreferredStockMember_e7d7d49e-90aa-4b7f-b94e-506baec1abee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9cc2118d-b876-4577-a4d1-4919463bf8aa" xlink:to="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f46555c6-0ae5-447a-ac00-d6f3bd5c347e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:to="loc_us-gaap_NetIncomeLoss_f46555c6-0ae5-447a-ac00-d6f3bd5c347e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5f7a90b7-846b-45a3-b978-5315679ca36f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5f7a90b7-846b-45a3-b978-5315679ca36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_04119257-cfc7-46e3-b356-ce3109ae91a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_04119257-cfc7-46e3-b356-ce3109ae91a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_dcb8e1ee-f5e7-4684-8e2e-707bef5418fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_ShareBasedCompensation_dcb8e1ee-f5e7-4684-8e2e-707bef5418fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_d9088433-9090-4c8e-84fa-343eb2934058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_PaidInKindInterest_d9088433-9090-4c8e-84fa-343eb2934058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dd57dad3-ded9-4e77-87a5-25d149cc8304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_dd57dad3-ded9-4e77-87a5-25d149cc8304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e2318389-3db8-4856-93f3-95a3904a32ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e2318389-3db8-4856-93f3-95a3904a32ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_6ae80806-575c-4861-bf92-d98f378ebe19" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_243a64a7-eef4-4440-afda-be13405cd4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_243a64a7-eef4-4440-afda-be13405cd4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_ddcca4d1-8e5f-4f1c-82fe-93931cf83743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_ddcca4d1-8e5f-4f1c-82fe-93931cf83743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_082e4b27-7e19-43b3-b3ce-41342301ddcf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_082e4b27-7e19-43b3-b3ce-41342301ddcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ced7bb99-9f0a-401c-bca1-e99182a1fb60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_ced7bb99-9f0a-401c-bca1-e99182a1fb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b1b19072-7919-44f1-9b69-e9b26d2bc383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b1b19072-7919-44f1-9b69-e9b26d2bc383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IncreaseDecreaseInDeferredRent_6a94fcce-aebb-47af-bc19-6ce63a6498d0" xlink:href="sera-20220930.xsd#sera_IncreaseDecreaseInDeferredRent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_sera_IncreaseDecreaseInDeferredRent_6a94fcce-aebb-47af-bc19-6ce63a6498d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d7e04610-b58f-4732-8117-cb81bb1aa5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_976b36bd-b23b-46f2-ad57-5fd04da03c73" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_d7e04610-b58f-4732-8117-cb81bb1aa5f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_800990af-6d47-41e0-ac9b-c05b7245ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fce06344-a781-4faf-b054-bb4ab4131aa0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_800990af-6d47-41e0-ac9b-c05b7245ce11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_879056a3-c97b-4e57-af19-28e8c15ee71b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_879056a3-c97b-4e57-af19-28e8c15ee71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bc1121d1-a542-4933-ac78-b3733bae3878" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_bc1121d1-a542-4933-ac78-b3733bae3878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_53054d8e-4925-49a6-9d9d-27858ac0c29d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_53054d8e-4925-49a6-9d9d-27858ac0c29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e7e51fa7-07bc-4f70-a9e5-589805196532" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e7e51fa7-07bc-4f70-a9e5-589805196532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21e65405-fa7f-4fcf-b88b-76cfe02f6217" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_b7125d12-6476-42ec-9b79-bec80c93acce" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_21e65405-fa7f-4fcf-b88b-76cfe02f6217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_af65d398-29dc-4564-b840-fd23ca1d1c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_af65d398-29dc-4564-b840-fd23ca1d1c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_347fe74e-658e-4716-802f-42f2cc630ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_347fe74e-658e-4716-802f-42f2cc630ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5d0ce548-89c7-4bef-918d-3f1dc80d3f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_5d0ce548-89c7-4bef-918d-3f1dc80d3f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c20dfae8-da52-49a7-a211-0e1b2208a585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c20dfae8-da52-49a7-a211-0e1b2208a585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_95effff5-913f-4f4f-8f94-1eb49f562811" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_95effff5-913f-4f4f-8f94-1eb49f562811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_c5ffcc23-7983-4aea-933b-ab8c83dfc116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_RepaymentsOfDebt_c5ffcc23-7983-4aea-933b-ab8c83dfc116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_63675a48-20bb-4b95-8973-ae26654510e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_63675a48-20bb-4b95-8973-ae26654510e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_83ff83f4-1e71-4d5a-b458-70122fff29c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_43ec70f5-4b25-4325-92b1-3ff240ecbf51" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_83ff83f4-1e71-4d5a-b458-70122fff29c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c3b867e-4494-4fe1-9995-6a0c45f59729" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_6c3b867e-4494-4fe1-9995-6a0c45f59729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8975bdaa-341a-4924-854a-c9bcf539cc38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8975bdaa-341a-4924-854a-c9bcf539cc38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99a0c14c-8753-4f90-9d00-f1cd1b47ae6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_99a0c14c-8753-4f90-9d00-f1cd1b47ae6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b516bf3d-1940-4b8a-b7f9-f0885133edeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b516bf3d-1940-4b8a-b7f9-f0885133edeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_43905b14-71f0-41e3-a3b1-ba2549300d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b516bf3d-1940-4b8a-b7f9-f0885133edeb" xlink:to="loc_us-gaap_InterestPaidNet_43905b14-71f0-41e3-a3b1-ba2549300d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_89bfc67e-694b-4282-8d79-c0e7f88491a9" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_855deb76-5c32-4369-a713-bdad8bb4617a" xlink:href="sera-20220930.xsd#sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:to="loc_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities_855deb76-5c32-4369-a713-bdad8bb4617a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock_a345839b-cf8d-42b6-9f04-629cd5ca6acf" xlink:href="sera-20220930.xsd#sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_05456230-d41e-40b6-b0bd-cb5f83473b0b" xlink:to="loc_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock_a345839b-cf8d-42b6-9f04-629cd5ca6acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition" xlink:type="simple" xlink:href="sera-20220930.xsd#DescriptionofBusinessandFinancialCondition"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_04ebd88c-3c40-4c49-8f97-772a96592c02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d9811b28-0d55-4451-bb36-1a33c61156e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_04ebd88c-3c40-4c49-8f97-772a96592c02" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_d9811b28-0d55-4451-bb36-1a33c61156e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="sera-20220930.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_005b4f19-18b8-41da-bac5-aa0904dce6d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_438566a3-25f3-4974-ae63-8deff986b482" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_005b4f19-18b8-41da-bac5-aa0904dce6d9" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_438566a3-25f3-4974-ae63-8deff986b482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecurities"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_a3226baf-55ae-40da-be08-5cecf733ce3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_b1f3c7da-4fc9-4933-9f79-338750cd7843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_a3226baf-55ae-40da-be08-5cecf733ce3f" xlink:to="loc_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock_b1f3c7da-4fc9-4933-9f79-338750cd7843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipment" xlink:type="simple" xlink:href="sera-20220930.xsd#PropertyandEquipment"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipment" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f6b73670-c556-4dd3-82bf-a124a59edd26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_11515419-00bb-45a4-a062-6e9f93c3bef1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_f6b73670-c556-4dd3-82bf-a124a59edd26" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_11515419-00bb-45a4-a062-6e9f93c3bef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities" xlink:type="simple" xlink:href="sera-20220930.xsd#AccruedandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_7529bc26-40c7-4f8d-bb9d-77f410dbb87d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_c471f85d-5365-4ae2-ad3c-6f7335e9f5cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_7529bc26-40c7-4f8d-bb9d-77f410dbb87d" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_c471f85d-5365-4ae2-ad3c-6f7335e9f5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenet" xlink:type="simple" xlink:href="sera-20220930.xsd#OtherIncomenet"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_c0f40a1d-4ab9-46a2-a364-47d21c0c49a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_8819b99e-b0a7-441a-afb6-930b4e7a54e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_c0f40a1d-4ab9-46a2-a364-47d21c0c49a2" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_8819b99e-b0a7-441a-afb6-930b4e7a54e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotes" xlink:type="simple" xlink:href="sera-20220930.xsd#LoansandConvertiblePromissoryNotes"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_40d83141-20a2-4bb9-af30-c0b8eac83481" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_cd788ebb-a1dc-481b-b99e-e48220fe715b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_40d83141-20a2-4bb9-af30-c0b8eac83481" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_cd788ebb-a1dc-481b-b99e-e48220fe715b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="sera-20220930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_18a6e6d1-40e7-404d-be1a-317568bc31cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_333e495c-952c-41be-bc1f-0cc697e0a64c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_18a6e6d1-40e7-404d-be1a-317568bc31cc" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_333e495c-952c-41be-bc1f-0cc697e0a64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="sera-20220930.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_828fcc67-5ad0-4300-9760-835fcb3a52c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4c33e1f9-26a2-4cca-a70a-9cc8d4fee678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_828fcc67-5ad0-4300-9760-835fcb3a52c9" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4c33e1f9-26a2-4cca-a70a-9cc8d4fee678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructure" xlink:type="simple" xlink:href="sera-20220930.xsd#CapitalStructure"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2ce77ff3-6d10-4d4a-9c73-f90d08b61dd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8230ccb0-4ea3-43c9-931b-c1d3fd564d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2ce77ff3-6d10-4d4a-9c73-f90d08b61dd1" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_8230ccb0-4ea3-43c9-931b-c1d3fd564d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="sera-20220930.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_222c3114-9057-4646-b169-7b76d961faa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_95374b9a-9729-412f-bed6-1adf015b37b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_222c3114-9057-4646-b169-7b76d961faa7" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_95374b9a-9729-412f-bed6-1adf015b37b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Warrants" xlink:type="simple" xlink:href="sera-20220930.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_39f55435-e629-4877-a7fd-faba52af72d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsTextBlock_c4e19420-e966-4bbd-8fda-8e07ee8dd58a" xlink:href="sera-20220930.xsd#sera_WarrantsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_39f55435-e629-4877-a7fd-faba52af72d9" xlink:to="loc_sera_WarrantsTextBlock_c4e19420-e966-4bbd-8fda-8e07ee8dd58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingences" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingences"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingences" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_114cd453-4f14-4efb-8d25-e9c2b55ab20d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d250176c-f7cc-4505-85c2-c28faf9d4c68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_114cd453-4f14-4efb-8d25-e9c2b55ab20d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d250176c-f7cc-4505-85c2-c28faf9d4c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/Netlosspershare" xlink:type="simple" xlink:href="sera-20220930.xsd#Netlosspershare"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/Netlosspershare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_333aeecf-6288-4f5d-9e79-a1696e7b5d88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_103231bf-633d-4646-8aac-d1af38a9e392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_333aeecf-6288-4f5d-9e79-a1696e7b5d88" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_103231bf-633d-4646-8aac-d1af38a9e392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SubsequentEvents" xlink:type="simple" xlink:href="sera-20220930.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_508a9365-b488-4902-8320-92d6b2d2971f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_edfb13a9-ec89-47dd-a4a6-f566d3b72c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_508a9365-b488-4902-8320-92d6b2d2971f" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_edfb13a9-ec89-47dd-a4a6-f566d3b72c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="sera-20220930.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9f4283d2-5c5e-4474-8694-af8f9254f73d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_72bfd6b2-ba01-46d1-815a-17925daf0049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f4283d2-5c5e-4474-8694-af8f9254f73d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_72bfd6b2-ba01-46d1-815a-17925daf0049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_c461165c-146f-4f19-85c1-c471b67a4c82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f4283d2-5c5e-4474-8694-af8f9254f73d" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_c461165c-146f-4f19-85c1-c471b67a4c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1e229e8b-5e9e-4fdf-a046-6604c5bee28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f4283d2-5c5e-4474-8694-af8f9254f73d" xlink:to="loc_us-gaap_UseOfEstimates_1e229e8b-5e9e-4fdf-a046-6604c5bee28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_681fce9b-5462-4765-a872-7e7d188b8f24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f4283d2-5c5e-4474-8694-af8f9254f73d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_681fce9b-5462-4765-a872-7e7d188b8f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_24e0b546-f370-4bfd-94f9-6da2c1da4255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_73b1cf21-50a5-45df-90d0-a0f6ed2d4da6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_24e0b546-f370-4bfd-94f9-6da2c1da4255" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_73b1cf21-50a5-45df-90d0-a0f6ed2d4da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0945692e-b100-488e-98f5-bc6244c41b52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_24e0b546-f370-4bfd-94f9-6da2c1da4255" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_0945692e-b100-488e-98f5-bc6244c41b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_ffa79508-02c8-449f-bc2e-cb252724f018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_24e0b546-f370-4bfd-94f9-6da2c1da4255" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_ffa79508-02c8-449f-bc2e-cb252724f018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentTables" xlink:type="simple" xlink:href="sera-20220930.xsd#PropertyandEquipmentTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d6aaa9fc-1926-48a2-bfe9-9b63da30a28b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_eddfac78-827c-480c-9780-e72e072795ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d6aaa9fc-1926-48a2-bfe9-9b63da30a28b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_eddfac78-827c-480c-9780-e72e072795ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="sera-20220930.xsd#AccruedandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_5000679b-ba2e-47ed-b3d8-a237c0eca586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_31c8ef62-b0fe-42a6-8db6-e2a434fb482f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_5000679b-ba2e-47ed-b3d8-a237c0eca586" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_31c8ef62-b0fe-42a6-8db6-e2a434fb482f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenetTables" xlink:type="simple" xlink:href="sera-20220930.xsd#OtherIncomenetTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_59358237-8524-4ae0-9b27-9ed171777020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_4a296e98-0492-4c65-abce-7992afca0b98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_59358237-8524-4ae0-9b27-9ed171777020" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_4a296e98-0492-4c65-abce-7992afca0b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="sera-20220930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b4759002-c336-4793-b747-87e3171d3f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_bb2879fa-2937-452e-9710-1bb73c4c4d45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b4759002-c336-4793-b747-87e3171d3f7e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_bb2879fa-2937-452e-9710-1bb73c4c4d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureTables" xlink:type="simple" xlink:href="sera-20220930.xsd#CapitalStructureTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_1ad9c552-14dd-47a2-85f9-db7761091559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_880c1f93-d53c-4c6e-b001-2e0c7cc26d51" xlink:href="sera-20220930.xsd#sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_1ad9c552-14dd-47a2-85f9-db7761091559" xlink:to="loc_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_880c1f93-d53c-4c6e-b001-2e0c7cc26d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="sera-20220930.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04bcc89a-b530-4c2d-8a55-bafb6e4d2a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3f2a7145-019f-45c1-88c3-cc069428661d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04bcc89a-b530-4c2d-8a55-bafb6e4d2a48" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3f2a7145-019f-45c1-88c3-cc069428661d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6273ca9b-3f64-4739-a1bd-866314800d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_04bcc89a-b530-4c2d-8a55-bafb6e4d2a48" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_6273ca9b-3f64-4739-a1bd-866314800d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsTables" xlink:type="simple" xlink:href="sera-20220930.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_0de83f14-830c-4e31-82a4-e209e6ac9ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_f60b013d-65bd-4332-84b5-7f810f94f287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_0de83f14-830c-4e31-82a4-e209e6ac9ea7" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_f60b013d-65bd-4332-84b5-7f810f94f287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_160ecb21-1b67-4c75-8f32-c6e64395e146" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_ae0fb4db-f9eb-4e43-af34-057a0a76510a" xlink:href="sera-20220930.xsd#sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_160ecb21-1b67-4c75-8f32-c6e64395e146" xlink:to="loc_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock_ae0fb4db-f9eb-4e43-af34-057a0a76510a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_072337ac-6954-4cb6-880d-df1f877a0087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_160ecb21-1b67-4c75-8f32-c6e64395e146" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_072337ac-6954-4cb6-880d-df1f877a0087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_569411d1-b062-4f1c-a012-a7ca38bd3c33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_160ecb21-1b67-4c75-8f32-c6e64395e146" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_569411d1-b062-4f1c-a012-a7ca38bd3c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cf0a0e4a-af3a-469f-99f9-b1f38458b165" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_160ecb21-1b67-4c75-8f32-c6e64395e146" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cf0a0e4a-af3a-469f-99f9-b1f38458b165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareTables" xlink:type="simple" xlink:href="sera-20220930.xsd#NetlosspershareTables"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_de619b03-bb43-41a2-b691-30e1698ac2ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_714d3909-9cf7-4aba-ac92-fb75b3dfbf6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_de619b03-bb43-41a2-b691-30e1698ac2ee" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_714d3909-9cf7-4aba-ac92-fb75b3dfbf6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d888449e-70c7-49dd-9b2c-f5922a5e02e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_de619b03-bb43-41a2-b691-30e1698ac2ee" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_d888449e-70c7-49dd-9b2c-f5922a5e02e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#DescriptionofBusinessandFinancialConditionDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8867a982-2610-4351-ade8-58b81880fdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cf5d59d8-6909-46c8-8c30-2b3b4cdd6c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8867a982-2610-4351-ade8-58b81880fdb0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cf5d59d8-6909-46c8-8c30-2b3b4cdd6c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_464654de-420b-42eb-ad57-6ac10dee73d0" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8867a982-2610-4351-ade8-58b81880fdb0" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_464654de-420b-42eb-ad57-6ac10dee73d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7dd8cf05-d15f-4bde-9f0c-707cbb0789a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3104b27f-0310-4502-9c63-e6fa15804422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dd8cf05-d15f-4bde-9f0c-707cbb0789a6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3104b27f-0310-4502-9c63-e6fa15804422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_20b73359-1311-4982-bdec-a4c97ef37598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3104b27f-0310-4502-9c63-e6fa15804422" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_20b73359-1311-4982-bdec-a4c97ef37598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_88c9fa8b-3a36-4c58-881a-e08d721351ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_20b73359-1311-4982-bdec-a4c97ef37598" xlink:to="loc_us-gaap_TypeOfAdoptionMember_88c9fa8b-3a36-4c58-881a-e08d721351ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member_59a50714-0abd-4e73-a59e-860e7c5ba4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_88c9fa8b-3a36-4c58-881a-e08d721351ca" xlink:to="loc_us-gaap_AccountingStandardsUpdate201602Member_59a50714-0abd-4e73-a59e-860e7c5ba4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3104b27f-0310-4502-9c63-e6fa15804422" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_634461ae-c271-45ea-8175-06023bae791f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_634461ae-c271-45ea-8175-06023bae791f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_7cd6bef5-e3a8-4dce-98eb-db66eb9721f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:to="loc_us-gaap_OperatingLeaseLiability_7cd6bef5-e3a8-4dce-98eb-db66eb9721f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent_4c88540d-21e9-4638-b64b-93275e1ea096" xlink:href="sera-20220930.xsd#sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e1faeca8-8597-49ac-8af9-ddd50d762e91" xlink:to="loc_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent_4c88540d-21e9-4638-b64b-93275e1ea096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_6d042a85-c0fc-40f9-99a6-2f9b30ac6cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_6d042a85-c0fc-40f9-99a6-2f9b30ac6cfa" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7a822bf3-d5ae-4bc9-b301-099b7a1feedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7a822bf3-d5ae-4bc9-b301-099b7a1feedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7a822bf3-d5ae-4bc9-b301-099b7a1feedc" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_1dcd129b-cb0c-4903-9f9c-a65e4f5fa9b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_1dcd129b-cb0c-4903-9f9c-a65e4f5fa9b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CurrentMarketableSecuritiesMember_b04c0028-28ac-474e-af2c-9c2ee97b957e" xlink:href="sera-20220930.xsd#sera_CurrentMarketableSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:to="loc_sera_CurrentMarketableSecuritiesMember_b04c0028-28ac-474e-af2c-9c2ee97b957e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NonCurrentMarketableSecuritiesMember_30567342-7a8b-4547-9a9c-8ee8ea1884c7" xlink:href="sera-20220930.xsd#sera_NonCurrentMarketableSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d29d0abb-b778-431c-af60-34495aa2e3f4" xlink:to="loc_sera_NonCurrentMarketableSecuritiesMember_30567342-7a8b-4547-9a9c-8ee8ea1884c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_302a1e6f-6fb6-476a-acff-7cce8cec4c7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_302a1e6f-6fb6-476a-acff-7cce8cec4c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_302a1e6f-6fb6-476a-acff-7cce8cec4c7a" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_3d93bce9-e8cc-48ee-886b-9934588282eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:to="loc_us-gaap_CashMember_3d93bce9-e8cc-48ee-886b-9934588282eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_b0c7eb2e-b7ab-4355-9ee5-2cdf105fa2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:to="loc_us-gaap_MoneyMarketFundsMember_b0c7eb2e-b7ab-4355-9ee5-2cdf105fa2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_b379d94b-a7b8-4f47-81d2-a19c12938d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_26c9f816-b19e-4976-8f92-d7aee67ac544" xlink:to="loc_us-gaap_CommercialPaperMember_b379d94b-a7b8-4f47-81d2-a19c12938d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b94163f5-df26-4ef3-83d8-660d5851febd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b94163f5-df26-4ef3-83d8-660d5851febd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b94163f5-df26-4ef3-83d8-660d5851febd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_ca831f9d-b0d2-48bb-9d80-d62e513381b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_CommercialPaperMember_ca831f9d-b0d2-48bb-9d80-d62e513381b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_065c59e2-c84e-4212-bd79-8508c05b066e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_065c59e2-c84e-4212-bd79-8508c05b066e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_db851b1a-7d67-4584-896a-33a79225ea87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_db851b1a-7d67-4584-896a-33a79225ea87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_201e99b2-72b5-4a06-8475-303f35e9c756" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_f920faf7-27cb-4f6b-a15e-45903805459d" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_201e99b2-72b5-4a06-8475-303f35e9c756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_991636bf-38aa-4d6a-a587-edf92adb2ae0" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAmortizedCost_7e8ff6fe-9894-430b-8063-268addd0cd0a" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsAmortizedCost_7e8ff6fe-9894-430b-8063-268addd0cd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_607f5688-2ec8-4717-b2ff-aa3571f3cc6a" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax_607f5688-2ec8-4717-b2ff-aa3571f3cc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_2c007fcb-6439-44c0-8d99-c4c2356c1b55" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax_2c007fcb-6439-44c0-8d99-c4c2356c1b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8a15104c-4ece-4489-b4e1-c0c9d27b67a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_8a15104c-4ece-4489-b4e1-c0c9d27b67a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fd9f6aa4-cbb9-4bb4-b0ec-12d7870bf14f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_fd9f6aa4-cbb9-4bb4-b0ec-12d7870bf14f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a59f29c3-5610-4edc-a2b6-6839162ef3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a59f29c3-5610-4edc-a2b6-6839162ef3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3645a992-1de8-49a5-8a6f-a4ed775df609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3645a992-1de8-49a5-8a6f-a4ed775df609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_435b2286-f0a3-4ebe-9675-7b2966032d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_435b2286-f0a3-4ebe-9675-7b2966032d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_9d09f5b8-2570-40d4-8bef-0598ad2b8ebe" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost_9d09f5b8-2570-40d4-8bef-0598ad2b8ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_2d8ee240-ee48-4c80-beeb-50a7b9f4a340" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax_2d8ee240-ee48-4c80-beeb-50a7b9f4a340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_d692d4e4-17f6-4b37-b3cd-8d48cc618bf5" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax_d692d4e4-17f6-4b37-b3cd-8d48cc618bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_cff4b63c-9803-4786-a395-66e386c9a0a1" xlink:href="sera-20220930.xsd#sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_fa9a8404-918d-4335-879c-6818519ec89f" xlink:to="loc_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue_cff4b63c-9803-4786-a395-66e386c9a0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_aaabaece-0b8c-4b8a-8743-1002f22127b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_5e9e613a-08e8-491c-ba3d-a18378ea58d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_aaabaece-0b8c-4b8a-8743-1002f22127b8" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_5e9e613a-08e8-491c-ba3d-a18378ea58d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_f552093f-2083-4eb9-822c-413e2dbe4cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_5e9e613a-08e8-491c-ba3d-a18378ea58d6" xlink:to="loc_us-gaap_FinancialInstrumentAxis_f552093f-2083-4eb9-822c-413e2dbe4cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_f552093f-2083-4eb9-822c-413e2dbe4cc7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8a221cdc-a0ec-467a-a30e-46b4275c5b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_CommercialPaperMember_8a221cdc-a0ec-467a-a30e-46b4275c5b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ee4ed24b-36c8-4ef3-a826-09c97a8a7c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ee4ed24b-36c8-4ef3-a826-09c97a8a7c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6d76c66-bf19-4bae-9e1d-f05d95d60f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f6d76c66-bf19-4bae-9e1d-f05d95d60f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_69ba28d0-bd04-4cc4-ac30-8d74f3243715" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_677d9db9-a3d7-4a4f-86d1-42c58c1659c0" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_69ba28d0-bd04-4cc4-ac30-8d74f3243715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_5e9e613a-08e8-491c-ba3d-a18378ea58d6" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_67cefc83-8071-44f5-ab39-a20aa54b0f60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_67cefc83-8071-44f5-ab39-a20aa54b0f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_15ee780b-c8ef-4676-b266-7277f24152c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_15ee780b-c8ef-4676-b266-7277f24152c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_db55df50-0b8f-4228-9c31-e154a682189d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_db55df50-0b8f-4228-9c31-e154a682189d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0461edb-dcbc-43fa-9c90-098da4db0d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_e0461edb-dcbc-43fa-9c90-098da4db0d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0402d5fb-e812-4cab-ae2f-59cc4596b0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0402d5fb-e812-4cab-ae2f-59cc4596b0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_046ce435-6703-4482-b502-eccd78c073db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_cc360e59-4288-4cc6-a69d-0748429ff341" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_046ce435-6703-4482-b502-eccd78c073db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_82affe62-ec91-480a-9a55-986f0f1687da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_65ae129b-f89a-41a4-bfa5-de847cf283ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_82affe62-ec91-480a-9a55-986f0f1687da" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_65ae129b-f89a-41a4-bfa5-de847cf283ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_80436fcb-1ebf-4502-ba05-258dc7e5cfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_82affe62-ec91-480a-9a55-986f0f1687da" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld_80436fcb-1ebf-4502-ba05-258dc7e5cfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAbstract_cbebec49-50db-43c6-8bdf-8fdd418ffafc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_ede841e7-c4ee-467c-ae05-441d60c709fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_cbebec49-50db-43c6-8bdf-8fdd418ffafc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_ede841e7-c4ee-467c-ae05-441d60c709fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f0ef8dee-c5e3-49c9-916f-6ea24541dd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_ede841e7-c4ee-467c-ae05-441d60c709fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_f0ef8dee-c5e3-49c9-916f-6ea24541dd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_87c5a9ae-da3c-4815-8811-ff39d3f4d884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_ede841e7-c4ee-467c-ae05-441d60c709fc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_87c5a9ae-da3c-4815-8811-ff39d3f4d884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_941d192a-3c5b-42f5-80f0-75c7cd357a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_ede841e7-c4ee-467c-ae05-441d60c709fc" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_941d192a-3c5b-42f5-80f0-75c7cd357a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_41f1b29e-b133-434b-aee8-fc83e2de26a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAbstract_cbebec49-50db-43c6-8bdf-8fdd418ffafc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_41f1b29e-b133-434b-aee8-fc83e2de26a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a6fcd632-c32b-4800-8cf2-c20fb132e6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_41f1b29e-b133-434b-aee8-fc83e2de26a1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_a6fcd632-c32b-4800-8cf2-c20fb132e6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cc9d3094-f822-47fc-9c75-a4b4db3c90cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_41f1b29e-b133-434b-aee8-fc83e2de26a1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cc9d3094-f822-47fc-9c75-a4b4db3c90cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_283dfbcb-5804-45ba-991d-866ca36c451e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_41f1b29e-b133-434b-aee8-fc83e2de26a1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_283dfbcb-5804-45ba-991d-866ca36c451e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3a8e8efb-b6ef-4220-bbcd-6b4d370cf0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df0640c6-062e-45c9-aded-791da5dcda28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3a8e8efb-b6ef-4220-bbcd-6b4d370cf0ac" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df0640c6-062e-45c9-aded-791da5dcda28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9f683ec0-6b05-4ada-9ca9-b172447d5686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df0640c6-062e-45c9-aded-791da5dcda28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9f683ec0-6b05-4ada-9ca9-b172447d5686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9f683ec0-6b05-4ada-9ca9-b172447d5686" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryEquipmentMember_8a3d2124-db1c-4eaa-be79-fc7f354e9369" xlink:href="sera-20220930.xsd#sera_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_sera_LaboratoryEquipmentMember_8a3d2124-db1c-4eaa-be79-fc7f354e9369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_1bb62440-e802-4eb5-813d-1834dc992702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_ComputerEquipmentMember_1bb62440-e802-4eb5-813d-1834dc992702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_31f76ae4-ae72-4749-8649-a99b2a9a58d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_31f76ae4-ae72-4749-8649-a99b2a9a58d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_e97d02cb-e5da-4d62-97db-fd53cab2c1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_e97d02cb-e5da-4d62-97db-fd53cab2c1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_396833e2-0e56-4e8e-90b7-8e4549d87ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb8ff98e-e056-4515-95d0-000190ef022c" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_396833e2-0e56-4e8e-90b7-8e4549d87ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_df0640c6-062e-45c9-aded-791da5dcda28" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_2c8fc50a-6bbc-4e43-ade7-06c898d08752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_2c8fc50a-6bbc-4e43-ade7-06c898d08752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c051f73f-cea6-4d35-a01f-cfc451bcfc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_c051f73f-cea6-4d35-a01f-cfc451bcfc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_790a001f-bb79-461c-a5b8-b14dd73ad13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b25093cb-6450-4aae-8bbf-10bc1cf3d9d4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_790a001f-bb79-461c-a5b8-b14dd73ad13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#PropertyandEquipmentNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0b70e37c-3576-4a91-85a2-fac9fa7927ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_048cc848-49e9-4add-a6c3-3e1fcdc572cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0b70e37c-3576-4a91-85a2-fac9fa7927ec" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_048cc848-49e9-4add-a6c3-3e1fcdc572cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_a9212d96-59b4-4641-8647-925d0a0424b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:to="loc_us-gaap_AccruedSalariesCurrent_a9212d96-59b4-4641-8647-925d0a0424b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedVacationCurrent_72368543-ba00-4f68-bf62-9a033c4b4eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedVacationCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:to="loc_us-gaap_AccruedVacationCurrent_72368543-ba00-4f68-bf62-9a033c4b4eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_AccruedClinicalStudyCostsCurrent_a98c6c79-5bd3-4542-9ee4-891f1169940c" xlink:href="sera-20220930.xsd#sera_AccruedClinicalStudyCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:to="loc_sera_AccruedClinicalStudyCostsCurrent_a98c6c79-5bd3-4542-9ee4-891f1169940c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_a9c6a5b8-f602-4875-86b3-b112cbffce28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_a9c6a5b8-f602-4875-86b3-b112cbffce28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d188830b-90e9-4adf-8d13-cedcc0cb5550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d188830b-90e9-4adf-8d13-cedcc0cb5550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b9f984f9-8a9c-4978-b8f1-9ad72ea36a2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_b9f984f9-8a9c-4978-b8f1-9ad72ea36a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_996f34a3-1315-4e20-99b7-dd383dcf75bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesAndOtherLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract_72f85f0e-610e-46d2-b81d-5d549791ff12" xlink:to="loc_us-gaap_AccruedLiabilitiesAndOtherLiabilities_996f34a3-1315-4e20-99b7-dd383dcf75bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#OtherIncomenetDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/OtherIncomenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_0b595c6f-da8a-4eaa-b36a-926fb14c76ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_73b56025-06c1-4eac-89b3-10d4e19ee9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0b595c6f-da8a-4eaa-b36a-926fb14c76ea" xlink:to="loc_us-gaap_InterestIncomeOther_73b56025-06c1-4eac-89b3-10d4e19ee9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_96db017f-bb6c-46a9-b4fb-a5d1a69744cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0b595c6f-da8a-4eaa-b36a-926fb14c76ea" xlink:to="loc_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium_96db017f-bb6c-46a9-b4fb-a5d1a69744cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_8a1c9445-04e4-45c4-94e6-441b7c0c318f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOptionChangesInFairValueGainLoss1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0b595c6f-da8a-4eaa-b36a-926fb14c76ea" xlink:to="loc_us-gaap_FairValueOptionChangesInFairValueGainLoss1_8a1c9445-04e4-45c4-94e6-441b7c0c318f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e97922a4-b992-482b-af5b-5ae33f1a1dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0b595c6f-da8a-4eaa-b36a-926fb14c76ea" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e97922a4-b992-482b-af5b-5ae33f1a1dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingGainsLosses_ce6c0c1f-1ef8-4535-a6c4-e25caded65d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0b595c6f-da8a-4eaa-b36a-926fb14c76ea" xlink:to="loc_us-gaap_OtherNonoperatingGainsLosses_ce6c0c1f-1ef8-4535-a6c4-e25caded65d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1b930578-131f-46fd-8fe3-a93615cd2193" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_0b595c6f-da8a-4eaa-b36a-926fb14c76ea" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1b930578-131f-46fd-8fe3-a93615cd2193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#LoansandConvertiblePromissoryNotesBankLoanDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2b271c12-63d0-4651-84fd-56cffece06f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_f9b79e0c-99ad-463b-b4d2-395f0fd3092a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2b271c12-63d0-4651-84fd-56cffece06f1" xlink:to="loc_us-gaap_DebtInstrumentTable_f9b79e0c-99ad-463b-b4d2-395f0fd3092a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d59d7433-2d2a-4ff1-8758-fd57e64f480d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f9b79e0c-99ad-463b-b4d2-395f0fd3092a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d59d7433-2d2a-4ff1-8758-fd57e64f480d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7953baf7-cd4c-492d-ae39-6ab0b3727cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d59d7433-2d2a-4ff1-8758-fd57e64f480d" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7953baf7-cd4c-492d-ae39-6ab0b3727cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LoanAndSecurityAgreementMember_a06d54d0-4e22-40e5-af91-74b5403506bb" xlink:href="sera-20220930.xsd#sera_LoanAndSecurityAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_7953baf7-cd4c-492d-ae39-6ab0b3727cfc" xlink:to="loc_sera_LoanAndSecurityAgreementMember_a06d54d0-4e22-40e5-af91-74b5403506bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_f9b79e0c-99ad-463b-b4d2-395f0fd3092a" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansFromBank_b0a0b142-201f-4604-9e75-e48888ee8575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermLoansFromBank"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_us-gaap_LongTermLoansFromBank_b0a0b142-201f-4604-9e75-e48888ee8575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_6f6b5c14-3f70-45df-a70a-8564618d1453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_6f6b5c14-3f70-45df-a70a-8564618d1453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_a05fa076-a06c-4057-af73-2aca98e7e067" xlink:href="sera-20220930.xsd#sera_RepaymentOfAccruedInterestOnLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_a05fa076-a06c-4057-af73-2aca98e7e067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_10ca8cfb-ece7-43d4-8037-f5781875979d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f1b2415a-3c36-459d-ac22-ac7e6db76898" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_10ca8cfb-ece7-43d4-8037-f5781875979d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e9277dda-386b-4072-a9a8-09042a40787d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e9277dda-386b-4072-a9a8-09042a40787d" xlink:to="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dd875b8e-dedc-453f-9e40-6ec1d565510e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dd875b8e-dedc-453f-9e40-6ec1d565510e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0f913c8a-c9fa-4508-9334-a1903c5e998f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd875b8e-dedc-453f-9e40-6ec1d565510e" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0f913c8a-c9fa-4508-9334-a1903c5e998f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_February2019ConvertibleNoteMember_6daaf99d-3f2c-4bc9-b122-efb162b7e8d1" xlink:href="sera-20220930.xsd#sera_February2019ConvertibleNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0f913c8a-c9fa-4508-9334-a1903c5e998f" xlink:to="loc_sera_February2019ConvertibleNoteMember_6daaf99d-3f2c-4bc9-b122-efb162b7e8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ae76dd6b-fa67-496a-876a-aeb48774cb16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ae76dd6b-fa67-496a-876a-aeb48774cb16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_83c01f06-e8ef-4e28-95e9-1ad6ba27c352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ae76dd6b-fa67-496a-876a-aeb48774cb16" xlink:to="loc_us-gaap_ClassOfStockDomain_83c01f06-e8ef-4e28-95e9-1ad6ba27c352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeriesDConvertiblePreferredStockMember_df853945-91fd-49cb-a570-77c386193934" xlink:href="sera-20220930.xsd#sera_SeriesDConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_83c01f06-e8ef-4e28-95e9-1ad6ba27c352" xlink:to="loc_sera_SeriesDConvertiblePreferredStockMember_df853945-91fd-49cb-a570-77c386193934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fac4348f-8c61-4fec-be4b-c9769d601033" xlink:to="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e0ea3a91-c58d-4e26-abee-027ea06c22e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e0ea3a91-c58d-4e26-abee-027ea06c22e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b7b22a43-a891-4120-be87-ed90fcdd4642" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_b7b22a43-a891-4120-be87-ed90fcdd4642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_379d185c-37f7-4056-bb1d-599f7552a964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_379d185c-37f7-4056-bb1d-599f7552a964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1cd2b815-b00a-4cf1-b4f7-87b673aa8581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_1cd2b815-b00a-4cf1-b4f7-87b673aa8581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionOriginalDebtAmount1_3a2435ae-df00-40b1-b7b5-06342fbec98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtConversionOriginalDebtAmount1_3a2435ae-df00-40b1-b7b5-06342fbec98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseLongTermDebt_0af9fee4-61e3-4a3a-b390-d36df57e5021" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_InterestExpenseLongTermDebt_0af9fee4-61e3-4a3a-b390-d36df57e5021" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fe2b6ba9-2818-4ccc-8106-03d4737d7ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_fe2b6ba9-2818-4ccc-8106-03d4737d7ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3b74710a-9bc8-4099-b367-45ef6f76917c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_3b74710a-9bc8-4099-b367-45ef6f76917c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_82293f47-5850-450f-b5e4-b2f151c29464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_82293f47-5850-450f-b5e4-b2f151c29464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_e8b7e4de-ab40-43d8-aec1-18438ed4894f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_e8b7e4de-ab40-43d8-aec1-18438ed4894f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_cda4eda7-cc81-4d48-9efc-66849072048c" xlink:href="sera-20220930.xsd#sera_RepaymentOfAccruedInterestOnLongTermDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_26c9c7ae-2ccb-478e-bd57-2292d3585fb7" xlink:to="loc_sera_RepaymentOfAccruedInterestOnLongTermDebt_cda4eda7-cc81-4d48-9efc-66849072048c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_99a92c87-4c3e-4c8b-886f-ff0a6e81a31b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7a046172-9b31-431e-94d2-23aa4d239cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_99a92c87-4c3e-4c8b-886f-ff0a6e81a31b" xlink:to="loc_us-gaap_DebtInstrumentTable_7a046172-9b31-431e-94d2-23aa4d239cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_59825725-2ffb-49a9-a3fd-094d3dfa70b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a046172-9b31-431e-94d2-23aa4d239cf5" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_59825725-2ffb-49a9-a3fd-094d3dfa70b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5efa3326-4ca6-42c5-a8a7-49fb0722fd29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_59825725-2ffb-49a9-a3fd-094d3dfa70b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5efa3326-4ca6-42c5-a8a7-49fb0722fd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PaycheckProtectionProgramLoanMember_14e82fb0-4827-4c7d-9336-150307d40836" xlink:href="sera-20220930.xsd#sera_PaycheckProtectionProgramLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5efa3326-4ca6-42c5-a8a7-49fb0722fd29" xlink:to="loc_sera_PaycheckProtectionProgramLoanMember_14e82fb0-4827-4c7d-9336-150307d40836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7a046172-9b31-431e-94d2-23aa4d239cf5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_b432b21e-ac89-4890-b2b8-529b78976393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_b432b21e-ac89-4890-b2b8-529b78976393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDecreaseForgiveness_76581833-b5d6-4551-b794-14209c024409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDecreaseForgiveness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:to="loc_us-gaap_DebtInstrumentDecreaseForgiveness_76581833-b5d6-4551-b794-14209c024409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_876b1b8d-7ab6-4767-a99e-0ac3f6a6b778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_17f13e98-29fc-4136-a383-5b5c4ceb1452" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_876b1b8d-7ab6-4767-a99e-0ac3f6a6b778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8f583822-fe75-45f0-be95-1328033ad6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8f583822-fe75-45f0-be95-1328033ad6b4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c52ee249-b102-4a76-9456-324ec8a1985b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c52ee249-b102-4a76-9456-324ec8a1985b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_c52ee249-b102-4a76-9456-324ec8a1985b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_739f57cf-7bc6-40a7-8df8-4523eb5af7d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_739f57cf-7bc6-40a7-8df8-4523eb5af7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_e8e42f37-ab13-431e-a7ad-40d7cc16bf5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_e8e42f37-ab13-431e-a7ad-40d7cc16bf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_885718aa-be59-4b9d-8d48-3dab0b3089b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2538fc12-e552-4834-8240-2cd9da9b87ce" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_885718aa-be59-4b9d-8d48-3dab0b3089b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_843417bc-6bad-4548-8153-f6da67d08cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_843417bc-6bad-4548-8153-f6da67d08cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c10d7dbd-0d52-4e48-8d9d-8e0f9f4e04a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_843417bc-6bad-4548-8153-f6da67d08cd2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c10d7dbd-0d52-4e48-8d9d-8e0f9f4e04a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_bb00b3b0-44a4-46ee-8e6b-e63b061962ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_c10d7dbd-0d52-4e48-8d9d-8e0f9f4e04a0" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_bb00b3b0-44a4-46ee-8e6b-e63b061962ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_304a56cb-aed6-4919-899b-fad7fb2ebab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_304a56cb-aed6-4919-899b-fad7fb2ebab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_304a56cb-aed6-4919-899b-fad7fb2ebab5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_4da15d33-bc32-431e-b2dc-1d38950a364d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:to="loc_us-gaap_MoneyMarketFundsMember_4da15d33-bc32-431e-b2dc-1d38950a364d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_954ecd06-d59f-4baa-8598-9c3d1130ad16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_09ff1775-db13-40b8-bf3e-0c01cf3313b5" xlink:to="loc_us-gaap_CommercialPaperMember_954ecd06-d59f-4baa-8598-9c3d1130ad16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_877d6cc8-2342-4fd9-9e80-65516e78e169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_FinancialInstrumentAxis_877d6cc8-2342-4fd9-9e80-65516e78e169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_877d6cc8-2342-4fd9-9e80-65516e78e169" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_cf594233-56cf-4e08-b743-9fc297c33692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_CommercialPaperMember_cf594233-56cf-4e08-b743-9fc297c33692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_ba5a376f-cf38-4f88-a3ba-3849ef90caf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_ba5a376f-cf38-4f88-a3ba-3849ef90caf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f9dfc2e1-f4f1-4718-81d9-3ede67f37784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f9dfc2e1-f4f1-4718-81d9-3ede67f37784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_c97281fb-2469-4851-b7cf-39049c595699" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_83921d9b-0439-4475-a5ad-d9a863447258" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_c97281fb-2469-4851-b7cf-39049c595699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62feb95a-b4ed-44eb-9e7e-88b5d69d1a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_594b5442-22f3-42d7-ba34-7f125e9b7349" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62feb95a-b4ed-44eb-9e7e-88b5d69d1a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_62feb95a-b4ed-44eb-9e7e-88b5d69d1a06" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_181169db-60b9-48e1-9955-3dceeb8bab69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_181169db-60b9-48e1-9955-3dceeb8bab69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3c587cfe-73a7-4776-8034-be43f96c62e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3c587cfe-73a7-4776-8034-be43f96c62e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_2897891d-a61d-463c-b12e-c73126a5c586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_59bdafd7-24af-41a8-a8ab-25f06a573312" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_2897891d-a61d-463c-b12e-c73126a5c586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_4dfd31e4-643a-4466-9e75-440232ae5d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_4dfd31e4-643a-4466-9e75-440232ae5d3e" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_677e39ca-4188-4ac5-a390-374b0def883a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_677e39ca-4188-4ac5-a390-374b0def883a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_677e39ca-4188-4ac5-a390-374b0def883a" xlink:to="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_HealthcoreIncMember_4a3d5c25-ec24-4a4c-be10-727683a6309d" xlink:href="sera-20220930.xsd#sera_HealthcoreIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:to="loc_sera_HealthcoreIncMember_4a3d5c25-ec24-4a4c-be10-727683a6309d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ElevanceHealthIncMember_285d5a9e-6845-4149-97d5-5afd539d44ae" xlink:href="sera-20220930.xsd#sera_ElevanceHealthIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_a14e2d82-eb4b-4d9f-85cb-29bcfca309ed" xlink:to="loc_sera_ElevanceHealthIncMember_285d5a9e-6845-4149-97d5-5afd539d44ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f4d4c911-0f7f-4bb0-b51e-6dcac3b14234" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_MasterServicesAgreementMember_903a8b0d-a8ef-4b76-9425-c8814ba4a274" xlink:href="sera-20220930.xsd#sera_MasterServicesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:to="loc_sera_MasterServicesAgreementMember_903a8b0d-a8ef-4b76-9425-c8814ba4a274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LaboratoryServicesAgreementMember_0f961c91-a6ee-4c0f-be25-0917f4d9b750" xlink:href="sera-20220930.xsd#sera_LaboratoryServicesAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:to="loc_sera_LaboratoryServicesAgreementMember_0f961c91-a6ee-4c0f-be25-0917f4d9b750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommercialCollaborationAgreementMember_5e4d5515-c706-423b-952d-a271efcab942" xlink:href="sera-20220930.xsd#sera_CommercialCollaborationAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30ca18a5-7769-4d74-a862-158c651be816" xlink:to="loc_sera_CommercialCollaborationAgreementMember_5e4d5515-c706-423b-952d-a271efcab942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_c18ea2fa-21da-4c83-9b0e-a1cfcf8cf06d" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_149ff056-2d0d-4f37-82fc-4bea949a4744" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_149ff056-2d0d-4f37-82fc-4bea949a4744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_36114340-be6c-45db-813e-9bcd79cbab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_us-gaap_RevenueFromRelatedParties_36114340-be6c-45db-813e-9bcd79cbab9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_7f1dca02-3ff8-47be-aa35-3d78c555ed23" xlink:href="sera-20220930.xsd#sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm_7f1dca02-3ff8-47be-aa35-3d78c555ed23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_427c0e1c-131a-4bc3-ab8a-2e44ce88c5fe" xlink:href="sera-20220930.xsd#sera_RelatedPartyTransactionCashReceivedFromRelatedParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_df308c81-3256-42d3-be7e-37fbe6736d39" xlink:to="loc_sera_RelatedPartyTransactionCashReceivedFromRelatedParty_427c0e1c-131a-4bc3-ab8a-2e44ce88c5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CapitalStructureNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_60e0bb83-a48f-4b6f-9ed5-a762ae3e950a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_60e0bb83-a48f-4b6f-9ed5-a762ae3e950a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_4e864e61-735c-48e4-b281-2b60959df7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_4e864e61-735c-48e4-b281-2b60959df7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_4e864e61-735c-48e4-b281-2b60959df7db" xlink:to="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5841fa3a-e037-487e-b5e7-bf14191ec2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:to="loc_us-gaap_CommonClassAMember_5841fa3a-e037-487e-b5e7-bf14191ec2a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_03eb3cdf-dceb-422f-baf7-1969ca3923d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:to="loc_us-gaap_CommonClassBMember_03eb3cdf-dceb-422f-baf7-1969ca3923d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_86b4ac64-5e40-46df-955f-11e7f0661d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_aec182f0-15db-46cc-84e3-6f5c611a50b0" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_86b4ac64-5e40-46df-955f-11e7f0661d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e70af6e8-44e9-4e43-828c-4f0b4e2e08ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_a2eaaad8-aa84-454f-b0be-595c7cf9d0b8" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e70af6e8-44e9-4e43-828c-4f0b4e2e08ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_518e2ddd-cb99-4c61-87a4-1fd6adc65843" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e70af6e8-44e9-4e43-828c-4f0b4e2e08ae" xlink:to="loc_us-gaap_IPOMember_518e2ddd-cb99-4c61-87a4-1fd6adc65843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_6cab56a8-1019-4437-885a-78717e008cfb" xlink:to="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2358a497-867c-49cc-ad07-788c8046821a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2358a497-867c-49cc-ad07-788c8046821a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_27038a17-9f00-4274-b025-49f33c2bc7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_27038a17-9f00-4274-b025-49f33c2bc7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_30304b3e-258c-42eb-9f39-821e61ffd6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_30304b3e-258c-42eb-9f39-821e61ffd6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d94db035-a5bd-4b76-8a40-458b1504c0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_d94db035-a5bd-4b76-8a40-458b1504c0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_4dcf1780-1243-4734-b63d-606dd0e831c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_us-gaap_PreferredStockSharesIssued_4dcf1780-1243-4734-b63d-606dd0e831c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfCommonStockClassesAuthorized_4d2fe2c0-c43d-4085-9c78-9e41fc5179d2" xlink:href="sera-20220930.xsd#sera_NumberOfCommonStockClassesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_sera_NumberOfCommonStockClassesAuthorized_4d2fe2c0-c43d-4085-9c78-9e41fc5179d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_NumberOfVotesPerShare_141eac93-c17c-46d3-a2ae-76120f9e1a55" xlink:href="sera-20220930.xsd#sera_NumberOfVotesPerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_sera_NumberOfVotesPerShare_141eac93-c17c-46d3-a2ae-76120f9e1a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockConversionRatio_ba05ae02-1f9e-4f4d-9e79-d1151b63f74c" xlink:href="sera-20220930.xsd#sera_CommonStockConversionRatio"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_67717f58-1aa7-4362-b8a8-bc528c844772" xlink:to="loc_sera_CommonStockConversionRatio_ba05ae02-1f9e-4f4d-9e79-d1151b63f74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CapitalStructureCommonStockDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_2d22cfae-6163-4e98-9ae5-2bb3f415055f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_2d22cfae-6163-4e98-9ae5-2bb3f415055f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7f6fc1a7-62fd-40b2-9722-4960db0a6408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7f6fc1a7-62fd-40b2-9722-4960db0a6408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_16a4fab1-95b4-43c3-9de3-8694bc8463e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7f6fc1a7-62fd-40b2-9722-4960db0a6408" xlink:to="loc_us-gaap_ClassOfStockDomain_16a4fab1-95b4-43c3-9de3-8694bc8463e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_3e44b810-4beb-4c88-8869-a0f33fde9b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_16a4fab1-95b4-43c3-9de3-8694bc8463e2" xlink:to="loc_us-gaap_CommonClassAMember_3e44b810-4beb-4c88-8869-a0f33fde9b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_dcea7dd3-da2a-41ed-aa4f-caf50b694996" xlink:href="sera-20220930.xsd#sera_CapitalSharesReservedForFutureIssuanceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_dcea7dd3-da2a-41ed-aa4f-caf50b694996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:href="sera-20220930.xsd#sera_CapitalSharesReservedForFutureIssuanceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceAxis_dcea7dd3-da2a-41ed-aa4f-caf50b694996" xlink:to="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_06413558-a7db-4ae2-9e39-0bd1f8de0224" xlink:href="sera-20220930.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_06413558-a7db-4ae2-9e39-0bd1f8de0224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_5e457629-4e58-4067-8266-b775388f4355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_us-gaap_EmployeeStockOptionMember_5e457629-4e58-4067-8266-b775388f4355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_f9f5e7fd-230c-4069-981f-c1452b1342cb" xlink:href="sera-20220930.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember_f9f5e7fd-230c-4069-981f-c1452b1342cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_44cd05fc-383a-4120-bb02-c882d051d86d" xlink:href="sera-20220930.xsd#sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CapitalSharesReservedForFutureIssuanceDomain_085bc40d-552d-45ff-b138-bdc5d34f8465" xlink:to="loc_sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember_44cd05fc-383a-4120-bb02-c882d051d86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8185f4f5-0c32-4c14-b70e-7bda06f7e887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_d66d2d4c-bcbe-44a5-9a7e-31c2d67efec1" xlink:to="loc_us-gaap_ClassOfStockLineItems_8185f4f5-0c32-4c14-b70e-7bda06f7e887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_074cef4a-ea3e-4009-818d-36c99f77eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8185f4f5-0c32-4c14-b70e-7bda06f7e887" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_074cef4a-ea3e-4009-818d-36c99f77eb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba777260-bfe6-4cc1-88e2-af1260e02fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba777260-bfe6-4cc1-88e2-af1260e02fc3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a9856b5d-13cd-419d-982d-727136c8f19f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:to="loc_us-gaap_PlanNameAxis_a9856b5d-13cd-419d-982d-727136c8f19f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_a9856b5d-13cd-419d-982d-727136c8f19f" xlink:to="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2011Member_668973b9-8316-45e8-ae91-be3e3a9e7b5e" xlink:href="sera-20220930.xsd#sera_Plan2011Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:to="loc_sera_Plan2011Member_668973b9-8316-45e8-ae91-be3e3a9e7b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_Plan2021Member_eed05322-413b-4a32-b264-8d739f433f7b" xlink:href="sera-20220930.xsd#sera_Plan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:to="loc_sera_Plan2021Member_eed05322-413b-4a32-b264-8d739f433f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_PlanEspp2021Member_07c91b95-d53d-442e-9585-86a2c7a5c5bd" xlink:href="sera-20220930.xsd#sera_PlanEspp2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1e2ebe2a-e36a-4162-8bf5-791b61312424" xlink:to="loc_sera_PlanEspp2021Member_07c91b95-d53d-442e-9585-86a2c7a5c5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_9651f2c5-54d0-4b1d-8108-44123dc2e4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_9651f2c5-54d0-4b1d-8108-44123dc2e4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6bbb5561-f5af-45c5-9981-6e3e5ac7d2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_9651f2c5-54d0-4b1d-8108-44123dc2e4ba" xlink:to="loc_us-gaap_ClassOfStockDomain_6bbb5561-f5af-45c5-9981-6e3e5ac7d2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d7f0b695-2f92-4e54-a438-e66d4e69efdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_6bbb5561-f5af-45c5-9981-6e3e5ac7d2b0" xlink:to="loc_us-gaap_CommonClassAMember_d7f0b695-2f92-4e54-a438-e66d4e69efdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8ffee6e3-e2c5-43c2-98f8-4543dd821c4a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e58d72f7-33a5-422b-a7a6-f9f73e5d26c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e58d72f7-33a5-422b-a7a6-f9f73e5d26c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c38d8e8e-f260-4751-b6c9-c7ec6e247f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c38d8e8e-f260-4751-b6c9-c7ec6e247f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b6e6856d-604d-4aa8-ab1d-7ae26e7bb8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b6e6856d-604d-4aa8-ab1d-7ae26e7bb8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1cc9adb1-1411-463f-8906-00247949a19c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_1cc9adb1-1411-463f-8906-00247949a19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ca8a5bca-14d3-49d5-b15f-1a1bf450bbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ca8a5bca-14d3-49d5-b15f-1a1bf450bbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df05fa83-3c82-4e86-9620-e1c3e94bc1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_11117acc-ba2a-4575-9810-7b641268aca7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_df05fa83-3c82-4e86-9620-e1c3e94bc1f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#StockBasedCompensationStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c0cbfa74-0c31-4d8c-bc82-8104de2d3248" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c0cbfa74-0c31-4d8c-bc82-8104de2d3248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d22f3e29-481c-4044-b451-6a3d9f853a61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d22f3e29-481c-4044-b451-6a3d9f853a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_331b4140-d61f-4dfc-b4d7-f415333c558b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_331b4140-d61f-4dfc-b4d7-f415333c558b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7915dc4f-c7cb-41b2-a78c-14a90d1a0140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7915dc4f-c7cb-41b2-a78c-14a90d1a0140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_abec7f84-167c-457c-9aba-b130e09a510c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_abec7f84-167c-457c-9aba-b130e09a510c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_95a317a1-3f70-414c-b2d2-a9f9aca6464e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ac1ff10a-7f3c-4be5-a879-eaec0f781857" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_95a317a1-3f70-414c-b2d2-a9f9aca6464e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3617f98e-5527-49ed-abe8-aa5b314bc4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_3617f98e-5527-49ed-abe8-aa5b314bc4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7da2b426-2af2-45c8-a00c-4f2e9790d4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7da2b426-2af2-45c8-a00c-4f2e9790d4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9864727d-d535-40a0-be26-3f91de7735ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9864727d-d535-40a0-be26-3f91de7735ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ded08985-a4f2-49e8-b450-f92537a0d16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ded08985-a4f2-49e8-b450-f92537a0d16a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_f85a1dcd-ac2f-4d94-a0a7-49f1f1972860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_f85a1dcd-ac2f-4d94-a0a7-49f1f1972860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7ad74a5f-0abd-4699-82d0-cf9f895dfc28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_7ad74a5f-0abd-4699-82d0-cf9f895dfc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f059fe1d-b5aa-4de9-a5ad-f33301b5822e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f059fe1d-b5aa-4de9-a5ad-f33301b5822e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5745ae30-74b7-4885-a491-8ef2e5339f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_b0bb1dfc-5f0a-49e8-a330-9ee7e2d7b775" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5745ae30-74b7-4885-a491-8ef2e5339f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1674d6c0-57e6-4906-bde9-56c32468f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1674d6c0-57e6-4906-bde9-56c32468f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_b2709a9b-345d-4139-81a1-c47a3a2895b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_b2709a9b-345d-4139-81a1-c47a3a2895b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39071350-4a2a-4a05-86ad-b7e37af7c989" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2fb63465-4192-4754-84f0-f44a58edc3ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2fb63465-4192-4754-84f0-f44a58edc3ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_2d6add1c-6595-4352-bb6a-723eb75a4a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_2d6add1c-6595-4352-bb6a-723eb75a4a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8d78fe4c-4ff8-44d4-94d9-0eb4c3afde47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_8d78fe4c-4ff8-44d4-94d9-0eb4c3afde47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_83b9803a-5ed1-4a40-a457-61c598be76e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_83b9803a-5ed1-4a40-a457-61c598be76e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_9cf31689-440d-4da7-9e12-7f1952bff1ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_9cf31689-440d-4da7-9e12-7f1952bff1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_28ce796c-b455-4868-9ef0-da558b45893c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8c4d45b7-41cd-426f-ac03-327469a2a71d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_28ce796c-b455-4868-9ef0-da558b45893c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#StockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6be80e21-9568-4fca-b99b-3133bcde479c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3af0a185-cf44-46bc-9b84-2685796b7c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6be80e21-9568-4fca-b99b-3133bcde479c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3af0a185-cf44-46bc-9b84-2685796b7c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ed30e7ac-999e-44db-8405-fd87186d666a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3af0a185-cf44-46bc-9b84-2685796b7c6c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ed30e7ac-999e-44db-8405-fd87186d666a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ed30e7ac-999e-44db-8405-fd87186d666a" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a778c5d-1940-414b-b2b5-3ab866d79558" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a778c5d-1940-414b-b2b5-3ab866d79558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_49788c27-fad6-4b79-8651-b46e32773840" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_49788c27-fad6-4b79-8651-b46e32773840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_306e04b9-93c7-4e2f-a3f4-afd67342c064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fc3d7303-22f0-4dfb-bf6b-3d305588c965" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_306e04b9-93c7-4e2f-a3f4-afd67342c064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_fa794871-49c6-4b1f-8c5e-d9b0da9eee67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_3af0a185-cf44-46bc-9b84-2685796b7c6c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_fa794871-49c6-4b1f-8c5e-d9b0da9eee67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_fe5ec377-67d1-4859-ba20-77276f5b7c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_fa794871-49c6-4b1f-8c5e-d9b0da9eee67" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_fe5ec377-67d1-4859-ba20-77276f5b7c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#WarrantsCommonStockWarrantsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_4d80eeb5-bd6b-476a-9fd7-69d57e240d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_11be537b-8b35-4be4-9ce3-8c8cf75ba590" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_4d80eeb5-bd6b-476a-9fd7-69d57e240d4b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_11be537b-8b35-4be4-9ce3-8c8cf75ba590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a72e5990-6b56-4967-9e5c-d5f8b2262bb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_11be537b-8b35-4be4-9ce3-8c8cf75ba590" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a72e5990-6b56-4967-9e5c-d5f8b2262bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a72e5990-6b56-4967-9e5c-d5f8b2262bb7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember_da78f565-7bfa-488b-9203-df9cc6dbf39f" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt520SharePriceMember_da78f565-7bfa-488b-9203-df9cc6dbf39f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt9.03SharePriceMember_e4838ddf-f24f-4eee-9e26-53719385b535" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt9.03SharePriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt9.03SharePriceMember_e4838ddf-f24f-4eee-9e26-53719385b535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt10.84SharePriceMember_2c0fb133-4c15-4d25-ad8f-3165f487b20a" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt10.84SharePriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt10.84SharePriceMember_2c0fb133-4c15-4d25-ad8f-3165f487b20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt1238SharePriceMember_2cacad70-01ac-4b62-831b-0ecdbcbbe7a9" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt1238SharePriceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt1238SharePriceMember_2cacad70-01ac-4b62-831b-0ecdbcbbe7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt2077SharePriceMember_b5a2e661-6a43-4fad-82c6-0fad5e6fdaa6" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt2077SharePriceMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4d6b3c6b-130f-4769-9af5-0c2119464fae" xlink:to="loc_sera_CommonStockWarrantAt2077SharePriceMember_b5a2e661-6a43-4fad-82c6-0fad5e6fdaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_11be537b-8b35-4be4-9ce3-8c8cf75ba590" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_77c3c54d-e7a8-4d73-854b-b6bd5fbd1f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_77c3c54d-e7a8-4d73-854b-b6bd5fbd1f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_3e99afc7-be74-4658-91e4-66fff63d4ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_21f6b302-984e-43cd-a4c1-79f68c39c4aa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_3e99afc7-be74-4658-91e4-66fff63d4ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#WarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1cf24bf2-ee87-47ab-8d2d-4d0eb3fc5dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_91c681d4-0ebc-4690-9f57-7481cd84ccd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1cf24bf2-ee87-47ab-8d2d-4d0eb3fc5dfc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_91c681d4-0ebc-4690-9f57-7481cd84ccd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a8f9d73d-5481-4d47-ab7c-d4194078f717" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_91c681d4-0ebc-4690-9f57-7481cd84ccd7" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a8f9d73d-5481-4d47-ab7c-d4194078f717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cc0f227-6575-490d-ad40-79a1d88c6e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a8f9d73d-5481-4d47-ab7c-d4194078f717" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cc0f227-6575-490d-ad40-79a1d88c6e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommonStockWarrantAt520SharePriceMember_d9c18707-cbe5-4bef-8c81-70908aa66c9f" xlink:href="sera-20220930.xsd#sera_CommonStockWarrantAt520SharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7cc0f227-6575-490d-ad40-79a1d88c6e87" xlink:to="loc_sera_CommonStockWarrantAt520SharePriceMember_d9c18707-cbe5-4bef-8c81-70908aa66c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_dc7e57d6-6fdd-4fef-8fa0-fb20e1d3157a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_91c681d4-0ebc-4690-9f57-7481cd84ccd7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_dc7e57d6-6fdd-4fef-8fa0-fb20e1d3157a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_ClassOfWarrantOrRightExpired_9798404c-a417-4ce4-86f9-1b9266b36fbd" xlink:href="sera-20220930.xsd#sera_ClassOfWarrantOrRightExpired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_dc7e57d6-6fdd-4fef-8fa0-fb20e1d3157a" xlink:to="loc_sera_ClassOfWarrantOrRightExpired_9798404c-a417-4ce4-86f9-1b9266b36fbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesLeasesinFinancialStatementDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe9bb2b0-92e4-4dac-9056-060822c06386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetAbstract_b94a5147-e4da-43c3-ac76-da37925fa2f0" xlink:href="sera-20220930.xsd#sera_RightOfUseAssetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe9bb2b0-92e4-4dac-9056-060822c06386" xlink:to="loc_sera_RightOfUseAssetAbstract_b94a5147-e4da-43c3-ac76-da37925fa2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_43f7661a-590e-41aa-a176-a24c5307387a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_RightOfUseAssetAbstract_b94a5147-e4da-43c3-ac76-da37925fa2f0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_43f7661a-590e-41aa-a176-a24c5307387a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_8197ef90-38e5-43f3-801d-1d68c232f98b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_RightOfUseAssetAbstract_b94a5147-e4da-43c3-ac76-da37925fa2f0" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_8197ef90-38e5-43f3-801d-1d68c232f98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_RightOfUseAssetTotal_33086d50-b593-4b74-9526-89b46b6caeea" xlink:href="sera-20220930.xsd#sera_RightOfUseAssetTotal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_RightOfUseAssetAbstract_b94a5147-e4da-43c3-ac76-da37925fa2f0" xlink:to="loc_sera_RightOfUseAssetTotal_33086d50-b593-4b74-9526-89b46b6caeea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesAbstract_436eb079-f64f-436f-9b40-8444e2aeafe1" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe9bb2b0-92e4-4dac-9056-060822c06386" xlink:to="loc_sera_LeaseLiabilitiesAbstract_436eb079-f64f-436f-9b40-8444e2aeafe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_667ef98a-b7cd-44d0-b3e8-ab39dd469042" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_436eb079-f64f-436f-9b40-8444e2aeafe1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_667ef98a-b7cd-44d0-b3e8-ab39dd469042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_63d0d2b8-12c5-4e87-8f74-4938563535e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_436eb079-f64f-436f-9b40-8444e2aeafe1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_63d0d2b8-12c5-4e87-8f74-4938563535e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b7a9a0e8-7e5a-48ec-9ab0-c3a2ea3ae064" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_436eb079-f64f-436f-9b40-8444e2aeafe1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b7a9a0e8-7e5a-48ec-9ab0-c3a2ea3ae064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_6acc06bb-27ac-422e-9fa7-45d89aceb014" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilitiesAbstract_436eb079-f64f-436f-9b40-8444e2aeafe1" xlink:to="loc_sera_LeaseLiabilitiesTotal_6acc06bb-27ac-422e-9fa7-45d89aceb014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_20c54243-08e8-4b0e-9bfb-270f6f036db7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe9bb2b0-92e4-4dac-9056-060822c06386" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_20c54243-08e8-4b0e-9bfb-270f6f036db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d0e9713f-3acb-47cb-bdb8-9638ae548901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe9bb2b0-92e4-4dac-9056-060822c06386" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d0e9713f-3acb-47cb-bdb8-9638ae548901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9f488655-232c-40e9-a51b-bf5524cbda66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fe9bb2b0-92e4-4dac-9056-060822c06386" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_9f488655-232c-40e9-a51b-bf5524cbda66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesLeaseCostandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fb4a08d7-ea66-4e4c-8c09-8cb69cdac751" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_e7fc3f81-111b-4101-a1ad-642b56e72703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fb4a08d7-ea66-4e4c-8c09-8cb69cdac751" xlink:to="loc_us-gaap_LeaseCostAbstract_e7fc3f81-111b-4101-a1ad-642b56e72703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6ab589ef-afb6-477f-a30e-da0e3d47256e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e7fc3f81-111b-4101-a1ad-642b56e72703" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_6ab589ef-afb6-477f-a30e-da0e3d47256e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_7670a2fe-9e96-46b6-9b72-3a52c56a2c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e7fc3f81-111b-4101-a1ad-642b56e72703" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_7670a2fe-9e96-46b6-9b72-3a52c56a2c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_df178472-b943-41da-9d70-6e847f8b04eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e7fc3f81-111b-4101-a1ad-642b56e72703" xlink:to="loc_us-gaap_OperatingLeaseCost_df178472-b943-41da-9d70-6e847f8b04eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_40ceb392-c806-4938-9993-cd860f7ed98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_e7fc3f81-111b-4101-a1ad-642b56e72703" xlink:to="loc_us-gaap_LeaseCost_40ceb392-c806-4938-9993-cd860f7ed98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseOtherInformationAbstract_0aae53b2-ef65-4d47-bff2-0e37807c28ef" xlink:href="sera-20220930.xsd#sera_LeaseOtherInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fb4a08d7-ea66-4e4c-8c09-8cb69cdac751" xlink:to="loc_sera_LeaseOtherInformationAbstract_0aae53b2-ef65-4d47-bff2-0e37807c28ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeasesOtherInformationAbstract_b9322747-0ed7-42bb-84ef-a28e317d0754" xlink:href="sera-20220930.xsd#sera_FinanceLeasesOtherInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseOtherInformationAbstract_0aae53b2-ef65-4d47-bff2-0e37807c28ef" xlink:to="loc_sera_FinanceLeasesOtherInformationAbstract_b9322747-0ed7-42bb-84ef-a28e317d0754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_21003896-496b-4ec8-a823-526b76a74655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_b9322747-0ed7-42bb-84ef-a28e317d0754" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_21003896-496b-4ec8-a823-526b76a74655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_b1711202-1a6d-4b31-b812-264a54864a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_b9322747-0ed7-42bb-84ef-a28e317d0754" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_b1711202-1a6d-4b31-b812-264a54864a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_55b2f544-9c05-496b-96bc-4d9b9a9be2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_b9322747-0ed7-42bb-84ef-a28e317d0754" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_55b2f544-9c05-496b-96bc-4d9b9a9be2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_85bf429c-6559-405f-912b-6a3eb5d053d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_b9322747-0ed7-42bb-84ef-a28e317d0754" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_85bf429c-6559-405f-912b-6a3eb5d053d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5a90d424-0f41-4e52-aebc-75c24252e1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_FinanceLeasesOtherInformationAbstract_b9322747-0ed7-42bb-84ef-a28e317d0754" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_5a90d424-0f41-4e52-aebc-75c24252e1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OperatingLeasesOtherInformationAbstract_cf6c37c9-c3cf-4bc7-97d3-3bf309a441bc" xlink:href="sera-20220930.xsd#sera_OperatingLeasesOtherInformationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseOtherInformationAbstract_0aae53b2-ef65-4d47-bff2-0e37807c28ef" xlink:to="loc_sera_OperatingLeasesOtherInformationAbstract_cf6c37c9-c3cf-4bc7-97d3-3bf309a441bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_c14655b2-022b-4003-b854-c6651582721d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_cf6c37c9-c3cf-4bc7-97d3-3bf309a441bc" xlink:to="loc_us-gaap_OperatingLeasePayments_c14655b2-022b-4003-b854-c6651582721d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_80c9d108-41d8-462d-852f-03857bc78201" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_cf6c37c9-c3cf-4bc7-97d3-3bf309a441bc" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_80c9d108-41d8-462d-852f-03857bc78201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fe08548c-4ad1-478d-9fae-356c0100cfc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_cf6c37c9-c3cf-4bc7-97d3-3bf309a441bc" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fe08548c-4ad1-478d-9fae-356c0100cfc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_acf8f39a-cb64-4af2-9be6-da3f82375707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_OperatingLeasesOtherInformationAbstract_cf6c37c9-c3cf-4bc7-97d3-3bf309a441bc" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_acf8f39a-cb64-4af2-9be6-da3f82375707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cba8753-a323-4fc1-95d4-b97eb7e3ac8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cba8753-a323-4fc1-95d4-b97eb7e3ac8b" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b8d10a92-c507-4408-bd4d-2165a8e89713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_b8d10a92-c507-4408-bd4d-2165a8e89713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b8730d34-66c6-40d3-aa1b-aeb561c17a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b8730d34-66c6-40d3-aa1b-aeb561c17a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6679705b-0c16-4ee3-843c-7c8506e9916c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6679705b-0c16-4ee3-843c-7c8506e9916c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7fcdc993-7316-4fb1-9367-c1ef37916beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7fcdc993-7316-4fb1-9367-c1ef37916beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_4567f233-65ec-4f4e-b1fd-10ed8b911b08" xlink:href="sera-20220930.xsd#sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_4567f233-65ec-4f4e-b1fd-10ed8b911b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eb84f246-74fe-419c-8aee-318703654b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eb84f246-74fe-419c-8aee-318703654b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0596db92-3bbd-4821-9a92-e06ba8f9b7be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0596db92-3bbd-4821-9a92-e06ba8f9b7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9e4b2b04-e30e-4c89-91c2-23f64da00f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_OperatingLeaseLiability_9e4b2b04-e30e-4c89-91c2-23f64da00f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5994eeb9-4f50-4538-a3bc-e146423e53ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5994eeb9-4f50-4538-a3bc-e146423e53ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7be96306-4c17-494d-86bd-7e9811de667f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_181e33d7-a50e-420a-b8c6-fbc669b8dc52" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7be96306-4c17-494d-86bd-7e9811de667f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cba8753-a323-4fc1-95d4-b97eb7e3ac8b" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_c44a7de1-7ad9-4ad3-9001-14645213e05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_c44a7de1-7ad9-4ad3-9001-14645213e05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0740dac2-6d10-4ffa-8d21-e7fa2df5f036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0740dac2-6d10-4ffa-8d21-e7fa2df5f036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_cb042085-37ea-4f5d-8197-6fa2751e3b47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_cb042085-37ea-4f5d-8197-6fa2751e3b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b4b8553f-b0ba-4452-860b-cff171417657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_b4b8553f-b0ba-4452-860b-cff171417657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter_198d1bcc-bcf1-4599-a9db-007b54aba413" xlink:href="sera-20220930.xsd#sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter_198d1bcc-bcf1-4599-a9db-007b54aba413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_51ef1b2e-473d-455f-b062-8c148a3a8c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_51ef1b2e-473d-455f-b062-8c148a3a8c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_8048cba1-53b6-4559-bc94-8fdeefec546d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_8048cba1-53b6-4559-bc94-8fdeefec546d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_95714b2c-35a8-48d9-9a79-1e9bc726fd72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiability_95714b2c-35a8-48d9-9a79-1e9bc726fd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_bfb2d77e-cde7-4c3c-a9d1-662ed374a9aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_bfb2d77e-cde7-4c3c-a9d1-662ed374a9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_dc16afff-f2f1-4985-80bf-c7748a27215b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_65871797-5140-4b2c-a0cd-1aee3c7ab604" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_dc16afff-f2f1-4985-80bf-c7748a27215b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityPaymentDueAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cba8753-a323-4fc1-95d4-b97eb7e3ac8b" xlink:to="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_2fe3c627-a324-434e-a504-bb65c5ee8bcb" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear_2fe3c627-a324-434e-a504-bb65c5ee8bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearOne_8c79575d-2886-4338-903b-02f61c60115f" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityToBePaidYearOne_8c79575d-2886-4338-903b-02f61c60115f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearTwo_fccdcd6b-6737-43d5-8c69-2ebe4a76e573" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityToBePaidYearTwo_fccdcd6b-6737-43d5-8c69-2ebe4a76e573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearThree_26d1026d-04f3-4b95-9914-659d7d4356a7" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityToBePaidYearThree_26d1026d-04f3-4b95-9914-659d7d4356a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityToBePaidYearFourAndThereafter_141bb72f-ef9d-4ec9-a40b-6f5f6a0fb724" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityToBePaidYearFourAndThereafter_141bb72f-ef9d-4ec9-a40b-6f5f6a0fb724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityPaymentDue_e7fa873f-393f-45c1-a41f-3951639c9ae3" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityPaymentDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityPaymentDue_e7fa873f-393f-45c1-a41f-3951639c9ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityUndiscountedExcessAmount_ee299fcc-9f3b-47ca-946c-cd36c2a9d6ba" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityUndiscountedExcessAmount_ee299fcc-9f3b-47ca-946c-cd36c2a9d6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilitiesTotal_457d22dc-52d4-4917-a349-cd7348f58a50" xlink:href="sera-20220930.xsd#sera_LeaseLiabilitiesTotal"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilitiesTotal_457d22dc-52d4-4917-a349-cd7348f58a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityCurrent_70de6fbb-ae7e-4bd8-bfc4-5ba84c5b722a" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityCurrent_70de6fbb-ae7e-4bd8-bfc4-5ba84c5b722a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LeaseLiabilityNoncurrent_879f3ce7-f23d-4c95-bccd-69a3ab2f7a36" xlink:href="sera-20220930.xsd#sera_LeaseLiabilityNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_LeaseLiabilityPaymentDueAbstract_c00e0d16-9202-452b-ae48-f1e1490ad356" xlink:to="loc_sera_LeaseLiabilityNoncurrent_879f3ce7-f23d-4c95-bccd-69a3ab2f7a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#CommitmentsandContingencesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f392009-133f-40a5-b735-b0605d17d5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesTable_027b8635-28fc-42e3-8efe-34d33c52aef4" xlink:href="sera-20220930.xsd#sera_CommitmentsAndContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9f392009-133f-40a5-b735-b0605d17d5f6" xlink:to="loc_sera_CommitmentsAndContingenciesTable_027b8635-28fc-42e3-8efe-34d33c52aef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b54b2ab6-ae55-4311-a088-425c25bae34d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesTable_027b8635-28fc-42e3-8efe-34d33c52aef4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b54b2ab6-ae55-4311-a088-425c25bae34d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_113e4e22-156e-4e13-881a-c3afbf39399e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b54b2ab6-ae55-4311-a088-425c25bae34d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_113e4e22-156e-4e13-881a-c3afbf39399e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_OfficeAndLaboratorySpaceMember_7e29b83d-799e-486c-9661-382cb827634a" xlink:href="sera-20220930.xsd#sera_OfficeAndLaboratorySpaceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_113e4e22-156e-4e13-881a-c3afbf39399e" xlink:to="loc_sera_OfficeAndLaboratorySpaceMember_7e29b83d-799e-486c-9661-382cb827634a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:href="sera-20220930.xsd#sera_CommitmentsAndContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesTable_027b8635-28fc-42e3-8efe-34d33c52aef4" xlink:to="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_a64e73b1-b474-4eb8-96f5-87d633730845" xlink:href="sera-20220930.xsd#sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:to="loc_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory_a64e73b1-b474-4eb8-96f5-87d633730845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7335f842-703b-4b07-9c26-d718901602c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_7335f842-703b-4b07-9c26-d718901602c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_IndemnificationLiability_18dc7ca4-2301-46ab-a93d-8d9b3a306e95" xlink:href="sera-20220930.xsd#sera_IndemnificationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sera_CommitmentsAndContingenciesLineItems_12d2d04f-8396-47d4-848d-79bd6099bc8e" xlink:to="loc_sera_IndemnificationLiability_18dc7ca4-2301-46ab-a93d-8d9b3a306e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f96b5101-d93d-4cc2-9eb3-cfb934e30557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_9510d661-b340-4b51-8d2c-981081893c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f96b5101-d93d-4cc2-9eb3-cfb934e30557" xlink:to="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_9510d661-b340-4b51-8d2c-981081893c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_9510d661-b340-4b51-8d2c-981081893c78" xlink:to="loc_us-gaap_StatementClassOfStockAxis_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_c03e0f43-e5d2-4ee8-9d2b-8e6adbfe3712" xlink:to="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_02e5d40c-f354-4b17-b787-a11e9dd75888" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:to="loc_us-gaap_CommonClassAMember_02e5d40c-f354-4b17-b787-a11e9dd75888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_6f9ce91d-b84c-43af-bff8-ebdeec7a10d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f4f22687-a762-4857-be08-0b4662b282bd" xlink:to="loc_us-gaap_CommonClassBMember_6f9ce91d-b84c-43af-bff8-ebdeec7a10d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareTable_9510d661-b340-4b51-8d2c-981081893c78" xlink:to="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_eaae04a2-065b-4bb0-b78e-10260eedf219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_NetIncomeLoss_eaae04a2-065b-4bb0-b78e-10260eedf219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f5e91bc-c1f4-43c6-bb8f-296da39e8a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5f5e91bc-c1f4-43c6-bb8f-296da39e8a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d46c231c-fe68-4a1f-a933-811d024a0380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d46c231c-fe68-4a1f-a933-811d024a0380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_416dbff5-f2cc-4d55-9df6-f5e2eca72480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_EarningsPerShareBasic_416dbff5-f2cc-4d55-9df6-f5e2eca72480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_d4bbfb30-0c02-4a85-bab7-fc0fc6a2b8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems_ab84c42a-955e-4a74-8bc2-7600e4bae83a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_d4bbfb30-0c02-4a85-bab7-fc0fc6a2b8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_deba2f6e-5cbb-4939-9907-449121c35ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f50f43e2-6a74-4e20-867d-e909226bb96f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_deba2f6e-5cbb-4939-9907-449121c35ecd" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f50f43e2-6a74-4e20-867d-e909226bb96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea60385c-a263-4111-9954-31c1eb57b39d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f50f43e2-6a74-4e20-867d-e909226bb96f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea60385c-a263-4111-9954-31c1eb57b39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ea60385c-a263-4111-9954-31c1eb57b39d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_JuniorConvertiblePreferredStockMember_64b552cb-2c30-4b7d-9576-0c0efd919554" xlink:href="sera-20220930.xsd#sera_JuniorConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_sera_JuniorConvertiblePreferredStockMember_64b552cb-2c30-4b7d-9576-0c0efd919554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_SeniorConvertiblePreferredStockMember_8734bb21-1557-403d-8f68-f2ff805b6d8a" xlink:href="sera-20220930.xsd#sera_SeniorConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_sera_SeniorConvertiblePreferredStockMember_8734bb21-1557-403d-8f68-f2ff805b6d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_WarrantsToPurchaseCommonStockMember_0406caa7-ad2f-42a4-8014-8074f8776fbf" xlink:href="sera-20220930.xsd#sera_WarrantsToPurchaseCommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_sera_WarrantsToPurchaseCommonStockMember_0406caa7-ad2f-42a4-8014-8074f8776fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fd79ceb8-4828-4dd6-8c94-a1f9f7a0c439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_89c46f77-e46d-44df-86e4-a5429d529d00" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fd79ceb8-4828-4dd6-8c94-a1f9f7a0c439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_efadb867-98df-4100-af77-485106ab6931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f50f43e2-6a74-4e20-867d-e909226bb96f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_efadb867-98df-4100-af77-485106ab6931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8f4357c8-93d7-4fbf-82cf-8bf9aaeb4c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_efadb867-98df-4100-af77-485106ab6931" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8f4357c8-93d7-4fbf-82cf-8bf9aaeb4c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.seraprognostics.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="sera-20220930.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.seraprognostics.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_85a72f9f-0f48-4815-923a-6f7831c7a515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_77de4fe4-6aca-4138-bfe3-fa5bbe940de5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_85a72f9f-0f48-4815-923a-6f7831c7a515" xlink:to="loc_us-gaap_SubsequentEventTable_77de4fe4-6aca-4138-bfe3-fa5bbe940de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e88637b5-0b5e-478d-a26f-07ad20a7e937" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_77de4fe4-6aca-4138-bfe3-fa5bbe940de5" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e88637b5-0b5e-478d-a26f-07ad20a7e937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7888262d-cf66-446c-bdc7-2c3a34d3dbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e88637b5-0b5e-478d-a26f-07ad20a7e937" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7888262d-cf66-446c-bdc7-2c3a34d3dbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cc8d66f2-bf84-431e-9ceb-ff50f32925f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7888262d-cf66-446c-bdc7-2c3a34d3dbda" xlink:to="loc_us-gaap_SubsequentEventMember_cc8d66f2-bf84-431e-9ceb-ff50f32925f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_77de4fe4-6aca-4138-bfe3-fa5bbe940de5" xlink:to="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fbc3006b-4239-4e0b-9bbf-f883bed0d912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_fbc3006b-4239-4e0b-9bbf-f883bed0d912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sera_AdditionalMinimumOperatingLeasePaymentsDue_ce476ce5-17b0-4658-9957-64cd7631668d" xlink:href="sera-20220930.xsd#sera_AdditionalMinimumOperatingLeasePaymentsDue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a24f0196-efae-4b11-a226-cb26dc17859e" xlink:to="loc_sera_AdditionalMinimumOperatingLeasePaymentsDue_ce476ce5-17b0-4658-9957-64cd7631668d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>image_1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1a.jpg
M_]C_X  02D9)1@ ! 0$#_ 4H  #_X0 Z17AI9@  34T *@    @  U$0  $
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M_P#*+J'_ ,8H ^@**^?_ /AZ1\"?^AZ_\HNH?_&*/^'I'P)_Z'K_ ,HNH?\
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M'P)_Z'K_ ,HNH?\ QB@#Z HKY_\ ^'I'P)_Z'K_RBZA_\8H_X>D? G_H>O\
MRBZA_P#&* /H"BOG_P#X>D? G_H>O_*+J'_QBC_AZ1\"?^AZ_P#*+J'_ ,8H
M ^@**^?_ /AZ1\"?^AZ_\HNH?_&*/^'I'P)_Z'K_ ,HNH?\ QB@#Z HKY_\
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MY_\ ^'I'P)_Z'K_RBZA_\8H_X>D? G_H>O\ RBZA_P#&* /H"BOG_P#X>D?
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M_P#*+J'_ ,8H ^@**^?_ /AZ1\"?^AZ_\HNH?_&*/^'I'P)_Z'K_ ,HNH?\
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M W[5/P__ &G8M8;P+XFL_$#>'YHX-2BCBEAFLGD3?&'CD577<N2#C!P<'@T
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M .-4?\,B_M$?]'<>(/\ PW>@_P#QJ@#Z@HKY?_X9%_:(_P"CN/$'_AN]!_\
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M/^&1?VB/^CN/$'_AN]!_^-4 ?4%%?+__  R+^T1_T=QX@_\ #=Z#_P#&J/\
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MPR+^T1_T=QX@_P##=Z#_ /&J /J"BOE__AD7]HC_ *.X\0?^&[T'_P"-4?\
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MZIKUUX%T6?6(].N_ &B107IB&[RG9(@RJW0E2#Z5ZQ^RY_RD;_:G_P"Y3_\
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MMJ-XBL1U#)&CMN/1Y))7P X4 &5I/PCN_@CI5N/ ?F3Z=:QJEQH-]=NT=V
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M444 %%%% !1110 4444 %%%% !1110 4444 ?,O_  6:_P"45/Q\_P"Q,O\
M_P!%T?LN?\I&_P!J?_N4_P#TUR4?\%FO^45/Q\_[$R__ /1='[+G_*1O]J?_
M +E/_P!-<E 'TU1110 4444 ?,OBK_E,CX#_ .R,^)/_ $^:#7TU7S+XJ_Y3
M(^ _^R,^)/\ T^:#7TU0 4444 %%%% !1110!\R_L[?\I0OVF/\ L7?!/_HO
M5Z^FJ^9?V=O^4H7[3'_8N^"?_1>KU]-4 %%%% !1110 4444 %%%% !1110
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M/)&#7KGQ)D\9_LT?M/\ BSXC:3X)U[Q9X#\1:3 _B2VT.".[U+S;2!Q#<VL
MF$TTRA?):W2%C*DT;K(K6WDS]I\+OVQ(/C=X5CUSP?X'\4>)=)D=HOM6G:MH
M%Q&DBDJ\;[=2.R1&!5D;#*P((!!% '@7P%_8N^(?@7]M']G[QAJ6CP0^'_ ?
MP/@\%ZU<+?0.UKJB>7NA"!MSC@_.H*<=:B_X*>S_ /&7WP+FAF\NST@P77B
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M"?X7^$[2[U+Q='+>OIMK_9PU!VL[G<TZVY03,P5 3(&)"*#D*,?5E>,_M?\
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MV%FVI(_]E"T6>6TV2SL/+O\ +29,@8!SB*,5A_ 7]O\ ^*/[8'[1?@>P\??
MG]JWP9)IWB#/AN34?A*8]#TJ:2.2#^U=1O)I(40I#-*!&(W6+<[!II&B\KZD
M_;G^)FI?LTZ;\+;SQ9\0+AK/Q1\0])\.6DZ:':QQ6-S<"=DGF9I%"PH(W+'G
M [&@"?XE:_X"_P""97A_XO>-/#/@"QT[PWX(\ P>)+K1?#.G16C:A*EQJ#R.
MP10#(Y ,DSY. SL3@UY-^R;^VY\4O%_[9W@OPSJ_QK^ WQBLO'L-[=ZKX8^&
ML)U)/ EG#:2RQWQOTDW?9FN!;6V^Y0&5[I-BK@@>G?MO^"_B%;?L:?$GQEX
M\2^(/''B3Q%H&FVD$WA.PMFU-M$%X)+Z;2T#;+B\-A<7;VZJP+R"((2Q6ODO
M]E']DGX>_';XT?"F^^ /[*7Q3_9;/PN\26^M>(?&_CCP[+X9U34=/BW-)I=N
MGVAYK]KTOY4KS9BC@$P8EC$C 'Z5_LQW/CB[^%UP_P 1$:/Q'_PD6O+$"L*_
M\2U=8O1IAQ#\G.GBT.3\QSE_GW5\M?MS?M:_$[X;_&V]T\?&;]G[]GCPGHL<
M<^FP^+M0@U3Q'XS VL\RV.]#';.PE@CCB9KB1HV/R%E1?;_VM?\ @GCX'_;.
M\3:3JWBK5O'NGW.C6K6D"Z!XEN=+B=&?>2Z1, S9_B/..*\/_:1^,_A7X/?'
MV'P=JW[&/Q1^+GB:QTVWTCPQXQT[P98^(-/U2R2V1H4NM7F8&RQ<//$ZW'W2
MC3'*2JS '=_%#Q]^T=XNT3X-ZUX3T$:&VN^$[?4/&FF1"TG32]4EUGPN7MP]
MP-Y$>G2>(E!7@A,G]X(:U_\ @H!^Q#\(OC)\&O'GB3Q)\/O#-YXD;1)UDUJ.
MU%KJ<BK&VT-=1;)F5<G +D#)QC)KM_V#_@WXL^ /[*'A/PKXZU'2=1\56*W4
M]\-)C,>FZ?\ :+N:XCL;12 1:VL<J6T0VK^[MTPJCY1YC_P7!2X'_!*CXT3P
M>);_ ,*QV6B"ZN[RTT]-0>:U2:-I[8P/)&'2>(/"P\Q>)#DD95@#SW]@O5]!
MUKX_?'B3X2^ _"OA'PI9^$=$O/!=_8:3;1ZAXK%W_:B#4I[ED\V6"5K"'[,)
M)&1H%27I*JQ_8/P"G\3W/P)\%2>-E*>,Y-!L6U]2L:E=0-O&;D8C_=C][OX3
MY?3C%?'?_!.[]G'X\>"?VYOB)XP\<?'#0OB?X(NO#.EZ,EWH_@ZRTJSU>[M+
MK4X3;H\,TGEM8/YZ2(N"SW*JVWRBI]O^,G_!-?P#\<OVA+7XEZQK'Q$M=?M9
MK29+?3O%-W9Z>6MMOEYMT8)@[1N&/FYSU- 'QK_P42_X**?&/Q-\#=3\6^%]
M)_9YT;X&:UXB?PAIEC\18KO5/$7CZ:'4%LY&MM.B5H5A>9)SY4RM*D4!E=8L
MD)M>"?\ @FIH\O\ P5M\96.H?![P=<?!>WTZQ:ST^XTVSFTN.T&GK]GVVK9
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MO8!]!T %%%% !1110!PGQH_9?^'/[1:6G_"=>"/#'BJ;3]WV*XU'3HYKFQW
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MC>I(2UO)+((%%R!)(61EP%D!N_\ !4SP!\3CX@^)'B+P/X?\<:EINI?#K2-
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M$>&?&'P"\#ZM<>-OCA:SZIX?L+R2"P^*&O6=K"TEM&Y6*&.Z6.*,$X5$4*H
M    KL/^'<WA3_H?OV@/_#M^(_\ Y,KT#]D__DUGX:_]BKI?_I)%7H% 'S__
M ,.YO"G_ $/W[0'_ (=OQ'_\F4?\.YO"G_0_?M ?^';\1_\ R97T!10!\_\
M_#N;PI_T/W[0'_AV_$?_ ,F4?\.YO"G_ $/W[0'_ (=OQ'_\F5] 44 ?/_\
MP[F\*?\ 0_?M ?\ AV_$?_R97P;_ ,%J?^"7FDZSXR_9OBO_ (D?%K6/A[XJ
M^+&@^$]9\+:QXUUG54O'NWGS=K+<WDB1,D2R1KLA#YE)\T ;#^N5>$_MT? ?
M1_CM_P *=_M>XU*W_P"$-^)^B^*++['(B>;<VWG^6DFY&S&?,.X+M8X&&% &
M3H7_  3.\*:'8"W_ .%D?M&7F&+>9=?&#Q')(<]L_:QQ5S_AW-X4_P"A^_:
M_P##M^(__DROH"B@#Y__ .'<WA3_ *'[]H#_ ,.WXC_^3*/^'<WA3_H?OV@/
M_#M^(_\ Y,KZ HH ^?\ _AW-X4_Z'[]H#_P[?B/_ .3*^-?^"['_  3;M] _
MX)O_ !1\5>'_ (N?'*Q@\.Z'/>:GI>I?$+7-7L]9@1&VVYAGO#"H:5HB[213
M!HT=%5&998_U*KQ/_@H]\']-^/W["7Q5\&ZQ/?6VEZ_X=N;:XELW5)T7;NRA
M964'('530!R/PX_X)2?#_P"%'@72O#>A^-/CW8Z)H=K'8Z?9Q?%?Q!%#96\:
MA(H(D2Z54C1 JJB@!54   5M?\.YO"G_ $/W[0'_ (=OQ'_\F5] 44 ?/_\
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MG4?%UUJ=[JD6C_$76-*M+BXBU&YM1-Y%M<1QB1H8(59MN6\M<]!7ZHU\7_\
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M-\1/V0_V1_B)\3E\/_#75V\#Z'<:LMFGB.Y9K@QKD+C[*N>>V1GU'6OG$?\
M!03]MI+?PK<S> _V2[>P\86\,UE>2>/-0\B)IXDFMXYF$),33(X\MF'ELVU
M^^2)9)E.,5>1M0P]6M+DI1<GY>2;_)/[C]+J*_-VS_;F_;@NO'-[X=D\"_LB
MV>I6\"W<!N/'VH+#J$!P&D@<0E7V.=CID.A*%E"2Q/)1T_\ X*!_MPZKX/U'
M5;?X<?LJ27&C2/#?Z2/'-_\ VC;2)]]/*\K#G:0ZF,N)4(:(R!T+3[:'?O\
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M#\?/@L-W3_BM],Y_\C4 >TT5XO\ \/(?V=_^B]?!?_PMM,_^/4?\/(?V=_\
MHO7P7_\ "VTS_P"/4 >T5\7_ /!O7_RB ^$7_<9_]/=_7M'_  \B_9W!_P"2
M]?!?_P +?3/_ (]7S[_P2R^._P %_P!B7]@_P+\,?%/[0GP#O->\,_VA]JFT
M[QYI\MJ_GZC=7*;&>1&.$F4'*CD'J.2 ?=5%>+_\/(?V=_\ HO7P7_\ "VTS
M_P"/4?\ #R+]G?./^%]?!?\ \+?3/_CU 'M%%>+_ /#R']G?_HO7P7_\+;3/
M_CU'_#R']G?_ *+U\%__  MM,_\ CU 'M%>?_LI_\FU>!?\ L"6O_HL5R<W_
M  4J_9SMBGF?'[X)Q^8P1-WCC3!N8]A^_P"3[5Q7[,O_  4-^ .B_L]>"[.\
M^.7P>M+JVT>VCFAF\9Z=')$PC *LIFR"/0T ?4-%>+_\/(?V=_\ HO7P7_\
M"VTS_P"/4G_#R/\ 9V#;?^%^?!;=UQ_PF^F?_'J /::*\7_X>0_L[_\ 1>O@
MO_X6VF?_ !ZC_AY#^SO_ -%Z^"__ (6VF?\ QZ@#VBBO%_\ AY%^SN#_ ,EZ
M^"__ (6^F?\ QZC_ (>0_L[_ /1>O@O_ .%MIG_QZ@#VBOG[]FS_ )*)H/\
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M:MXF\,Z3-9^)[.2-?&W@EIEW7[;=J7=L[;4,Y1/W4_RQW,<?E2^6\:M;=W\
M],\-Z;\.+<^#[V:X\*W$CR:9:-D1:/&#L:RB1E$D,<4BR*+>3FW.Z%5CCB2&
M/?!VY].WIIY+LGT>L'I\+1X_$7,\*W*_Q)N]F^9K>36U1Q2?M(_N\3!*H[5(
M._:4445ZA\*%%%% !1110!\R_P#!9K_E%3\?/^Q,O_\ T71^RY_RD;_:G_[E
M/_TUR4?\%FO^45/Q\_[$R_\ _1='[+G_ "D;_:G_ .Y3_P#37)0!]-4444 %
M%%% 'S+XJ_Y3(^ _^R,^)/\ T^:#7TU7S+XJ_P"4R/@/_LC/B3_T^:#7TU0
M4444 %%%% !1110!\R_L[?\ *4+]IC_L7?!/_HO5Z^FJ^9?V=O\ E*%^TQ_V
M+O@G_P!%ZO7TU0 4444 %%%% !1110 4444 %%%% 'SEJ?A[3_%GQNDTW5+&
MSU+3[KXF2^=:W<*S0S;?":LNY&!4X8 C(X(![5ZS_P ,X?#S_H0_!?\ X)+;
M_P"(KS*R_P"3AX_^RFS_ /J(BOH&@#XG_P""VOP)\#^'O^"2G[05]I_@WPK8
MWEKX+OI(;BWTFWCEB8)PRLJ @^XKY(T7P?H7Q!_:*L=-L5U6U\#^)+.VBU[3
M+.R=KBS=-#AFN6,"LK.JR^:TL2Y)&]HPY.U_N+_@N;_RB!_:*_[$B_\ _0*^
M5/@1JGB";_@HAX1OK'2[&W\;V.GV@N=*DNL6VJP)X9C 9)/X?,16,;L,HSA9
M!P17#C.GS_KS\X]5>VJ/J.&W_%OM[M];+?1OK'6W+56E.5E+W9,]6U#_ ()P
MZ+8:CI-CK'Q!UR[\+Z^\4GA7Q=;7$DWV6ZF!6&"63SBBNXD"V\YW)<;S!)^\
M:,71;_\ !-N74/$MYH\_BZ[T?XE:9;-/9&1[E--\66$;8#H_G,ZQAI%65 'E
MLY95.)8I(WN?HBUNM)T[PEJFJZ3I<FN?#'7&GM_%7A2XL_-N/#\SY%TZVN"2
MN68W%J <[C+$&+,LTFHZ;:Q:5HOAWQ%K5YJ7A74KB"Y\"^.K:\$U]I-VX*VT
M,MRV\-*RR%(+E]Z7:2FVN!)))_IW#_P.OW:]OY9=-F?66=[.][O[.M_M)PVY
MK?Q:6TU^\IZGS"/^";VF:S;2^)M#UCQ'<2:7<26OBWPG-;DZG9R,F96C F;?
M+M</L1BEU&RO&S;D\RU>?\$\/#.E:3I=Q<^.]6U3X::X(WTW7899C_84VX>4
MLI\[Y(MV DW6)P$? PU?3;)K>M>-DAF?3-!^,6@V1-O<!7BTCQOIB.,\?.XA
M#R#<F7FL)I@0989E:\BTS4U,>M>)/#>BW4]I/.]OXZ\"W$2O=6]PR@RS11 E
M&G*,&9%)CNXV62,LS*TI_P 'I]^G_I4?^WH@GLU_=:M+_P  :GT:VHUG_P!>
MJNA\ZM_P310^,4\.:SXZU;2?%T<<C>&M=*3/;:Y" 'DB9?/7$@" S6X(W*HE
MB8;3Y'#^)_V"ETCQ)9ZIIFJ:Y_PG']LVNG^)/"+7 2293;W#)<VMR\J";S$M
MV%M.YCCEV-#,8'C<6OUQ-#H>E>!K+3]0O6USX1ZX8I=#UR*Y;[1X5FW P*TX
M.](DDQY-QD/ X".<;6'-_'&RUN^\>_#?0]8N;>P^(>D^(,^&O%OV 26^LVQM
MIVDBFC4J S&.+[1;*R!PJS0LA4&W-;_=UUOTUVO;2,GI->[+4EQCR\KM:TD[
MQ?+RIWFG!>\H*6M6DO?P\_W]#W;H\2NO^">_A/2?!5GKEKXPUG5_A/J 9+UA
M%<PS>$Y(I-C-+ TJR1PQ2HZS(P66REC.Y0BR?9]&\_X)IV=GXJL_#^O>/M<M
M[B\);PGXH3S'2\<IN-O)^^"I<;024^[/&"R$%72/Z/TC5]4G\3:QXD\-Z.=/
M\=:<85\;^"&NDV:XNS9#=VLS[(S.8XBMM=MLCN8X?LMSY+PJVGYJMX:T#X:R
M7%O&-<^!VN!Q<VQCEAF\#RQRD.0A"S6]M#-&0\9"3:=-$>$B0BT-+>7S2LG]
MZ2>_VJ<O[II[[GUYK^4I<THZ:_#*I*.S_A8VEVK)H^<M"_X)HS7FOZ[]F\57
M^F_$C3D2:[T:626*SUVV7*I)'<"3>\3DG;*P9H'.QUQD.?\ #O?07\(7&M:7
MKGB;5?"$DLUGXJ\.R6TS:AH,A!-PWV59F\PC?NF@7=YB/YL)D+!9_I[5M)N)
M-1T?PSXFUB>+5XI3+X(\;Q*GF7,FPG[//C"&X,8(>,XCNHU+J%972)UO<:QK
M?C"YU#3[:QT+XL:%;(FJZ4\K)IOBVQ5B$97P28R2WE38,EM(S(X96=)#6_\
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M%OW=RB\C>"#5_9CT^YU7PQI.L:+'#HOQ:T?1H[>^T^XN'CTSQ=I<<\S1X^\
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M_P#;GP5US8^GZ@DTD<_@N9) 8P9 5EAMXI5'ERY66QEC )6-08-+5=*U._\
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MED(V02GE6!W+Y,REP_,<@SM>=T?[!_[-]X)]-N[33=-\6:>SOIES_P (+/\
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MVL96 (BAD.<<8S0![E7G_P 0_P#DO'PZ^FI_^B$KT"O/_B'_ ,EX^'7TU/\
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MS\7:7%I2VOA_Q7?7%YX/U:]CF\)^++>55N_#MZ[8M[:68 A6R^RVN2"LRO\
M9IPTC(UZVYM]8UKQA;6-]<V.A?%C0K9VTK55B9--\76*L"Z,F23&25\V')DM
MI&5T+(RM(VY&G:1;>)-4\/::WB;P+J5Y=V7CCP:;$W$^GW+Y^U75O:%27:02
M&2XLU4B[247-N'FD=-0K75KIMOX;T71=:UJ?7/A_KDMM<^"?&UM?"XNM&N)
M/LD4EWEMY;S MM>,66X606\^^1U:]\66_P#P?NU[=I;Q>CT/TNE?E6]]?LZW
M:][W-N9K^)2^&K'WH>\6-&UFX6_UCQ-X9T>XCU".81^-_ \A4S/*5YN;<<(9
MR@RKC$=U& "0X5ESYH/#?A[X<0V]Q,-:^".M!)+.\CEDBF\#RI(#&1("LL-K
M%*@*2 K+I\L8!*PJ#:Z=Q;ZQK/C&VL;ZXL=#^+&AVSMI6JK$R:;XNL58%T9
M23&25\V')DMI&#H61E:1NC:S<)?ZQXF\,Z/<1ZA'-Y7C?P1(5,SRE1FYMQPA
MG* %7&([J, $APK*>3\^GWZ?^E1Z_%'4M2MJO[KTE;;2#4WJK/2C6>L'^YK7
MBQVJZ5J5]XETGPWXDU;^R_'VE^<_@OQHEJOEZVFT/-;7$*[$:4QQ W-F"B3I
M$+FW,3PD6/#?LN7=[<> (=:\,6<=CX^T=2/%/A9YO+A\0VYFE$,\,CA5+E49
M8+O 5_*>WFV-$?LW33P>&_#WPXAM[B8:U\$=:"26=Y'+)%-X'E20&,B0%98;
M6*5 4D!673Y8P"5A4&UYKX"6-WK'P\\(>']:OCH/CC3_ +;)X*\7)"KQ:POF
MR//:SQ+L5G*Q9N+/*K-'$MQ T<D)-D:_EU^[7OTC)Z27N3U)<8\MG:UI+6+2
MLG>:<%JH)ZUZ"]ZA+_:,/>#:.H@GT'1? -W>6=H=;^#NMF6+5](EMV6?PA,&
M(F(A(#QP)(#YL. ]LZEU 0$1V]6TEE?1O#?B36;IU>99_ WCF%U>XBG*GRX)
MI,%6F*$J"V8[N,LK N2'ETS4]5U'Q3JFNZ%I<>D?$;1TA7Q;X2:Z'V?Q!#@K
M#<V\S!59F6-A;W9"AQ&UO.(GB(M<^"?0-&\ W5Y9VIUOX.ZV9(M7TB6!UG\(
M3!R)B(2!)' D@/FPX#VKJ74! RQFEOZM;\TD]UO3?D:>\Y]>:ZZIRYFM-?AE
M4E'X9?P\73T=JB.?\2Z=XHTGXJW?BSP_9V>G?%C2K*-/$6@H633?'FG1-MCN
M83\S'9N(5L/-:NX7$J-Y=YL>"_&VA^*O!NK>,/!NFS>(? 6N7%S:^./!,MF+
MB]T:\;/VR2.T7?F;+EKJR7<MTK_:+??,[+?VO%SVWAS3-/TGQEXADM[&U;[;
MX-\?K*AFMI-A*PSR'*&8QDKELQW<996!<LK^=>)/#'B_]H+QU_:6AZ;IOPU^
M*FBZ>TDM]-<7NGMXTLP&CCW0($D^R[RC*TSO-9R,%:)D<BX-;^?XW_SMNMIK
M5:F?N\O3ELNKY>6^FOQ*"EL_CP\_=E[IY!_P5$COM$;]C^RL[Z/Q=X U#]H3
MP;J/AS7EO5NY;>%A=%+:63<3<(4<-#<@L6C4K*=ZK+<?H=X-T73/#GA33[#1
M4ACTFSMTBLUBD,B+$!A0&).1CODU^7G[='P\U'PYJ7[+NJV?CS7-4TF]_:8\
M,+KWA76-+M;:XT36G,TDKCR?]2[?.\D:EXK@W2W2.WFM+<?<?PF^.6D?"+X!
M?"6PU&UUJ\NO$NE)#91:;8/>2,T5MYKY1,M]Q2?E!/![ FO3PG\/^OP\O75;
M'Q'$&F,EWZZ6=^O,MN;NX^[+XENSW*BN:\$?&#PW\0[R:UTO4XWU"W023:?<
M126E] A. SV\RK*BD\ LH!(/I72UTGB!1110 4444 %?!/AGQS'\1O\ @X!\
M'ZM%;O:QR_L_:]!Y;MN(,/BJSA)S[F,G\:^]J_._XK0ZI\%O^"Z?A,^ ?"8\
M7:A%\"=55=%.JK8L8I_$EO--<">8,F$EV+L)R?/!'"-@ _1"N!T&7_A:?Q0A
MUZ%_,\.^&89K;3I5;]WJ-Y*0LTZ^J1(IB1P2&,\_958^16_Q2^)7Q<\:'0]<
MT'0]!MY(RP\,OK-QI]UJ"A?G5[E[1A<Q 'D6NT#D.S E:^A?!#Z@WAJW74]*
ML-%NHQY8L[*Z^TP0HO"A7\N/^$#C:,=.: -:O/\ XA_\EX^'7TU/_P!$)2MX
MO^)08X\#^%R,\'_A*I.?_)*L*[U7Q%JOQO\  +>(-%TW1I4.I"%+/4VOA*OV
M=<DDPQ;<>F#F@#UROG?_ ()0V=K8?L _#^&S6-;=5O\ 8$.Y>=0N2>?KFO4]
M>\3^/K36+B/3O!_AZ]L4<B">;Q&]O)*O8M&+1@I]MQ^M<)^P=\$_$G[,?P*T
M+X>:EI=A%I?AZ*Y,%^FL?;)YWENI)]K1BWC50/-;Y@Q^Z..<@ ]PHKE?&7B#
MQEINL>7H7AG1=6L?+!\^ZUU[.3?SE=@MI!@<<[N<]!63_P )?\2O^A%\+_\
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MV ?:(,X0W!C7*2C$=U&H1RK*K19S#PUX=^&B03NNN? S7 IM[@220S>!I8Y
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M &+O@G_T7J]?35?,O[.W_*4+]IC_ +%WP3_Z+U>OIJ@ HHHH **** "BBB@
MHHHH **** /GZR_Y.'C_ .RFS_\ J(BOH&OGZR_Y.'C_ .RFS_\ J(BOH&@#
MY2_X+F_\H@?VBO\ L2+_ /\ 0*^5/@'XFU:+_@H3X4UK2_#UPWB*SL[0:IX:
M-[$CW:KX8C4RP.?W9D=$=H7?RUF 2.4PD%H/JO\ X+F_\H@?VBO^Q(O_ /T"
MOE;X):3XAU#_ (*&>!]-DU:UTWQI:6$#Z;K*V0>VO8U\,PL(Y8B1N#HB+-&K
M(?F9HFC(5H^/&7]VW?\ 'R?1]KZ/6+W/IN&^6]52M:VM[M<N[YHK65/1.3C^
M\IVC5A\#3^U,>&?#?PS:2-5UKX$ZT#YL6V2";P'+')R0/EFM[2&:,[E^2;3)
MHC]R!"++3UC1[R75](\+^)]7FMO$-M(\G@CQO'&F^^;86:VG4;4-P8U_>P_+
M'=1H9(PC(Z6YHVLZD_B/5_$OAK2'L/&5@T2^-O!+7"8U8;-D5W:RML0SF./$
M%T=D=S'%]GG\IXE:RS/^*9\.?#-I(U76O@5K0/FQ;9()O <L<GS$+\LUO:0S
M1G<OR3:9-$?N0(19>?I;RMYI63^]13_[>IR_NGV'ON=M7)O^[*3E*/\ X#*K
M*.S_ (6-I=JR-.SO-8U/Q?>:GIEG:Z+\4M%@C77=":;;8>*[,9$<L4A'(/(A
MG(W1-F*48R!4M+O2;#PEJFK:3I<FN?#/7'GM_%?A2XL_-N/#\[Y^U.MK@DJ2
MS&XM0#NW&:(,699[>KZ1>2:QI'A?Q1J\UOX@MY'D\$>-XXTWWS;"S6TZC"&X
M,:_O8?ECNHT,D81D=+<L[S6-3\7WFIZ99VNB_%+18(UUW0FFVV/BNS&1'+%(
M1R#R(9R-T39BE&,@&M_ZO?KIM?NMIKWHZF:<>6ZM:R>C?+RWM%J3U4$]*=1^
M_AY_NJOND&HZ=:Q:5HOAWQ%K5YJ7A74KB"Y\"^.K:\$U]I-VX*VT,MRV\-*R
MR%(+E]Z7:2FVN!)))_IV!\1O&7B32?B3X3LPNCZ-\7DO!IXN622+2?&FDB.:
M0E0"S",2^7N0^9-82S<>;%.KW>W:7>DV'A+5-6TG2Y-<^&>N//;^*_"EQ9^;
M<>'YWS]J=;7!)4EF-Q:@'=N,T09F99^2^-.G20_\*Q\.ZIKU[J'A+4_%-I<>
M#_&UMJ"27NGRO:W*VT$L[[A-*?,407#"1+I&,-P'<[KP_P"!U^[7M_++ILRM
M;V>]Y?9UO]I..W-;^+2VFOWE/4[/2]44QZUXC\.:+=36LT[V_CKP+<1*]U;W
M#*#+-%$"4:<HP9D4F.[C99(RS,K2U9H=#TKP-9:?J%ZVN?"/7#%+H>N17+?:
M/"LVX&!6G!WI$DF/)N,AX' 1SC:PONFMZWXVCAFDTS0?C%H-D3;W 5XM(\;Z
M:CC/'SN(0\@W)EYK":8$&6&96O(M+U13'K7B/PYHMU-:S3O;^.O MQ$KW5O<
M,H,LT40)1IRC!F128[N-EDC+,RM*?\'I]^G_ *5'_MZ()]5_=:M+_P  :GT:
MVHUG_P!>JNA-J6FZIJ?BG3-#US4X]'^)&CI,_A/Q8EL/L_B"# ::WGA4JK%E
MC4W%H"H<1K<0&-XE:V32-8U.X\3:QXD\-Z.=.\=:<85\;>"6NDV:XNS9#=VL
MS[(S.8XBMM=MLCN8X?LMSY+PJUA0FAT/2O UEI^H7K:Y\(]<,4NAZY%<M]H\
M*S;@8%:<'>D228\FXR'@<!'.-K#0U+3=4U/Q3IFAZYJ<>C_$C1TF?PGXL2V'
MV?Q!!@--;SPJ55BRQJ;BT!4.(UN(#&\2M;&M[KRZZWZ:[7MI&3TFO=EJ2U'E
ML[6M).\7R\J=YIP7O*"EK5I+W\//]_0]VZ,M6\-^'_AM)<6\8USX&ZX'%S;&
M.6&?P/+'*0YV$+-;VT,R$/&0DVG31'A(D(M/ _A#=WVF_%[PKX;U*]\K4]6B
M@M?#7BV)"TUNJW'B&8"8X6,S.\6QH3F.XB#, &!$?T?I&KZG<>)M8\2>&]'.
MG>.M.,*^-O!+72;-<79LAN[69]D9G,<1%M=G9'<QP_9;GR7A5K#Y,\!Q^&]&
M\3^#Y[L?VA\*=2EADNXIEDAD\+E7\4(%2-462W@AD261RY62RD0D;$3$"TMY
M?-*R?WI)[_:IR_NFGON?7FOY2ES26FOPRJ2CL_X6-I=JR:/K2WN-8UOQA<ZA
MI]M8Z%\6-"MD35=*>5DTWQ;8JQ",KX),9);RIL&2VD9D<,K.DE.QOM,L_#.L
MZMI.C3:U\.]:DN+7QGX,NK$3W6@W$@/VMTM/F#!A(6N+10RS+)Y\&]G9;JUJ
M^D7+ZEI'ACQ/J\\.KPRF7P1XWB5/,N9-A/V>? "&X,8(>,XCNHU+J%972)UO
M<:QK?C"YU#3[:QT+XL:%;(FJZ4\K)IOBVQ5B$97P28R2WE38,EM(S(X96=)'
MK?S_ !OUTVO;=;36JU,TX\O3ELNKY>6]HM2?O*FI:0F_?P\_W=3W2KJ.G6<&
MC:'H.O:Y>:IX-U2XM[GP)X[MKT3WVBW<@VVL$UTV\/(XE\NWNY-Z7:2FUN1)
M+(&U"TZ:UK_C..VN9--\/_&#P_9L]I=HCQZ3XSTY7&[Y<LWD[W4/&2\UC-*I
M!EBE1[JG97NF6?AC6-6TC1IM:^'>M27%KXS\&75B)[K0;B0'[4Z6OS;@WF%K
MBT4,LRR>?!O9V6Z=J.G6<&C:'H.O:Y>:IX-U2XM[GP)X[MKT3WVBW<@VVL,U
MTV\/(XE\NWNY-Z7:2FUN1)+(#J"_X'7[M>W\LMT]&4T[V=[W?36]O>3CMS6_
MB4_AJ1_>4]2;2]49I-9\2^&M&N69IC!XY\#3JC7"S%!OGA3.PSE"&^4F.[C*
MD$L58TI(_#^C_#^ULKVZ.N?!O7#&^E:JD[I<>#YE<&)6E!$D4,<JCRILK):R
M(%8A0K1Z+IK6O^,X[:YDTWP_\8/#]FSVEVB/'I/C/3E<;OERS>3O=0\9+S6,
MTJD&6*5'NH]+U1FDUGQ+X:T:Y9FF,'CGP-.J-<+,4&^>%,[#.4(;Y28[N,J0
M2Q5B_P#@]/OT_P#2H_\ ;T=11E;5?W7I*VWP-3Z6VHUGM_"JWBQ^IZ9JM[XJ
MTO0=>U1-)^(FDK,WA#Q>MJOD>((=H>:UN(5**S,D:FXM 4618EN+<Q/$#:>=
M_M(_$6\T+P#XJU[1=*71_&]S ='\:^$Y;H&'44EM)DAOH9"JB1]D)%O=A46>
M.)K>=8Y( +/M)(_#^C_#^ULKVZ.N?!O7#&^E:JD[I<>#YE<&)6E!$D4,<JCR
MILK):R(%8A0K1^9?MUVFHO\ #W3]%\33+#XVTF>4^&_%D=JJQZ[:F"1IH)E4
M!5E(CC,]L-J2"-9X-AC*VIK?3RZZWZ:][:1EM->[+44E'EL[6M):Q:C9.\TX
M+503UK45[]"?[^A[ET3_ +.MYH>E?#GQM<)90ZQ\&]5UH0ZE:"&2.X\*S+8V
M1DE*'$D<,<H*R1@))9/#N "*WD^J:KI4K76C^&?$VL7 NA+YW@?QQ#L,SRE#
MM@F;&PW!3(*D>7=Q[N-VY5\^_9CU+6KG6/'GB+0+7[/XTTO5[9/$_@N34(WC
MU6V_LVT6*>W=BJ),WERFWN6$:3JA@N!&R*UGV22>'=#^'<]W:P?VY\%=<WIJ
M&GO#)'/X+F20B0B,A98;>*92)(B%EL98R0%C5E@-+>7S2M?[TD]U\5-_W33W
MW/KS775.7,UIK\,JDH_#+^'C*?:JC1@GUK5O&=Q>6=O8:'\6=#M5&IZ89&CT
MSQC8*Q"NC')V;F/ERX:2UD<HX>-R):UE>Z=;>'=9US0]&N-:\ ZU+<6WC7P5
M<V(GNM&N) 3=RQVGS;F;S"US9J&6X63[1!OD=EO9]5TJ5KK1_#/B;6+@70E\
M[P/XXAV&9Y2AVP3-C8;@ID%2/+NX]W&[<JN@GUK5O&=Q>6=O8:'\6=#M5&IZ
M89&CTSQC8*Q"NC')V;F/ERX:2UD<HX>-R)36_P#5[_E>VZVFM5J9^ZXW5K67
M5\O+?37=03TC)^_AY^Y/W2I?6.GVV@Z)HFM:W=:QX%UB:WN? _CBVOA/>:)=
M2#%I%+=G>'9A)LMKM]Z7*2_9KCS))%:^Y+]IV*_USX7^++36)K70?BEH/AZZ
M:WO[:,QZ?XPTQ1\^$)),89QOA):2TF=6!>.17N.OLKW3K;P[K.MZ)HUQK7@'
M6I;BV\:^"KFQ$]UHUQ(";N6.T^;<S>86N;-0RW"R?:(-\CLM[P_[44-CI7[,
M.KZ7K6HR>)? NI:=]M\$^,([S[3<:5</$1;03W66+[UDV6]XQ9;E)3;W!>61
M7OC^O\M>W9[Q>CT*UO9WO=]%>]O>3CLY-?Q*?PU8^_#WCOM'UB1+C6/$OAK1
M[KS?.,/CCP/,JM<),5&^X@3[C3E,-\O[N[CP0=^UC1N+?P]H/P]M[6ZN/[:^
M"^M>7+IFIQ3.D_@N57!B_>@B2*WCD4>7+E9+.1 K$1 &#2EBUG7?&4-I=S:?
MH/Q>T&T9K&^6-H]+\9:>K#<"N6;RMSKYD66ELY9 RF2.1'N(]'UB1+C6/$OA
MK1[KS/.,/CCP/,JM<+,5&^X@3[AG*8;Y?W=W'@@[]K$\GY]/OT_]*CU^*.H1
ME;5?W7I*VWP-3Z6VHUG\+_<UKQ9Q?[2=MJ,EKX5T+Q)=6MK\0=)\2:4/!_BY
M[4_9]9C?4K3S8IX8GB#28CC>XLPR)-Y"7$/EM$/LG'?LAWFM2^-M2U[PQH[6
M/B;2?"ND+XF\-2HL,?B,&ZU-5F@N65%DE\J.,6]R2(W"-;SB%T8VG2_'>#3-
M ^"NAVT-_P#VG\'M:\0Z)+I^J17C6\_@W&IVYV^=E7CMDPPCD!$EHZA#^[V^
M3RG[,^CW>L_$?3-+U;5[;P_X^L?"-B?!WB.*$R)JD0N]3DF@N(1L219%7$]F
M''FK;BXA:&2%'M36_P!W7KTU[VTC)Z27N3U)<8\MG:UI+6+2LG>:<%JH)ZUJ
M,??H3_VC#W@VGZ]!/X>T'X>W%U:V_P#;GP6USS(]2TV2!TF\&2JY$O[H@216
M\<JL)(2%DLI$) 6-2(+NL:/)'<Z/X;\2:Q<^=YPE\#^.(BK7"S%?EMIV^ZTQ
M3Y?F_=W<>01OR#)I6JZI?^)]6\0>'])72?B%I(A7QEX-:[4PZY%M*0W5M,P1
M'=DB86UX0BS+"UM<"&2$BRSH)_#V@_#VXNK6W_MSX+:YYD>HZ=) Z3>#)5<B
M7]T0)(K>.56$D)"R64B$@+&K+ :6\OFE9/[TD]UO3?\ =-/?<^O-==4Y<S6F
MOPRJ2CK&7\/&4^U5&C#/K.L^,KB\L[>PT+XM:%:JNI::TC1Z9XQL%8A65L$^
M7N8^7+AI+61RCAXW99JMG>:=;^'=:UK1=%N-:\ ZU+<6WC;P3<V(GN]%N9 3
M=RQV@W;RWF%KFS4,MPLGVBWWR.RWLVL:/)'<Z/X;\2:Q<^=YPE\#^.(BK7"S
M%?EMIV^ZTQ3Y?F_=W<>01OR#)!/K.L>,KB\L[>QT/XM:':JNI::TC1Z9XQL%
M8A65B"?+W,?+EPTEK(Y1PZ.RS&M_/\;_ )7MNMIK5:F:Y>6ZM:RZM1Y;Z:[J
M">D9/W\//W)^Z5;VRT^#0=%T+7=:N=:\"ZU-;W'@?QQ;WPGO-'N9!BTAENSO
MWNWF!+:\<LMTLGV:XWRR*U_:FAUG6O&4%G>3Z?H/Q;T&U9M.U%8VCTSQCIZL
M-RLN2WE[F'F19:6TE<.I>-U:>I9WFFP>'-:UK1=%N-;\ ZW+<6WC;P3<V(N+
MK1KB0$W<L=H-V\MYA:YLU#+<+)]H@WR.RWJWEG80Z%HF@Z[K5UK7@?6IK>X\
M#>.;>^%Q>:/=2#%I#+=G?O=O,"6UXY=;I9/LUQOED5K\TM]W_ U[=GO%Z,K6
M_6]WT5[V][W=G)K^)3^&K'WX:DVE:K*]WK'B;PSH]P+P2^3XX\#S;#,\I0;I
MX5SL-P4P58'R[N/;SN"LM"6+P[HGP[M[6ZN#K7P7UHH^G:BDKQW'@J9'!C!D
MXEAMXI5'ERY62RD0*Q6-08-.:'6-;\906=Y/I^@_%S0;5FT[45C:/3/&&GJP
MW KDMY6YE\R++2VDKAE+QNC3LTK597NM8\3>&='N%O%E\GQQX'FV&9Y2@W3P
MKG8;@I@JP/EW4>T9#!64W_'I]^G_ *5'K\4=0C*UFO[K34K;:0:F]K;4:SUB
M_P!S6O%C]5TK5-1\3Z3X?\0:LND_$+21,_@WQDEJIAUR+:&FMKB%2B.S)$IN
M;,%%F6);FW,,D*M9;'PM:/Q/\3M0U2-9/!_C*T6.'QGX<WBYMM1RA2UOHVPG
MF*PA*PWJ*IDBC>":,36PBM.3EB\.Z)\/+>UNK@ZU\%]:*/IVHI*\=QX*F1P8
MP9.)8;>*51Y<N5DLI$"MMC4&#K?"US_9_P 3M#T;QU''<>+-+2Y3PSXD1?LP
M\06SQ@SP-Y>U5N L:236I'E2FWCN(D'DE+72G\:;[KK]VO>VD9?:7N2UL<N.
MB_JU2,$_AFK**6BUFE!Z**E[U6B]:$[5Z+]FY(_%OX,>,=-T^[_:.\$W&IZ[
M)J'BCQU8?\(OJGAKP3J'B2$2:!X[UKQ"_P!IMF:R9RT]X;8I#,0%@9Q(<A:Z
MW_@G+HVG0?\ !4G]GRWT/5-5NO"VCZ9!I2ZGK?AF^T>ZU75M/T/Q<6@BA FM
MXDDAUB><>9=%PMDR@.6S57QG\'/BW_P49_:(\7:)X3T;]C+2K[0?'6JW$3:3
M-I5KKUNUK=W,<$EY/97%Y>RM(F)98W@MW:7ABJ!@WN7_  2U_P""2_Q=^#O[
M67@GQMX]\(^$/ NG_#ZVLXY6T>WLK--=DL=%U/2+79;VL]QYCNNLWL]Q>3R1
M22/#"JVR*2P]@_-3[]U"YU#7OB1?WFCV=MX9^*&BPGSM,N;DMI_B_2ED/EYE
M" LH+X68)YEI-(0RO%*5N,ZRO;&/0M<U[0=#NM9\$ZS/<6_CKP+<6(N+S2+J
M09NYX;0;P\C"0O<V:;UNUD^TVWF32,NH:'C.QN+S7['P_P"+=0DMKJ:\-QX+
M\96D:136]RP.+:4 >6LVTLNTCRKF,LA7=N0P12ZUK/C2:ZM8=/T+XNZ%:*M]
M8EVCTKQIIR,=K*V&;R]SG9)AI;.60JPDCD9;CQ97YOG\[^FU[;K:2U6I^G4N
M7V4=K<JZOEY4]/>?O<B>D9/WZ$_=E[I5N[73;?PWHNBZUK4^N?#_ %R6VN?!
M7C:VOA<76C7$@'V2*2[RV\MY@6VO&++<+(+>??(ZM>V[FWUC6?&%M8WUS8Z'
M\6-#MG;2M56)DTWQ=8JP+HR D^7DKYD.3);2,'0LC*TE6RO;&+0M<U[0=#NM
M9\$ZS/<6_CKP+<6(N+S2+J09NYX;0;P\C"0O<V:;UNUD^TVWF32,NH)=VNFV
M_AO1=%UK6I]<^'^N2VUSX*\:VU\+BZT:XD ^R127>6WEO,"VUXQ9;A9!;S[Y
M'5KV/Z_RU[=GO%Z/0VUOUO=]$W=KWO=V<FOXE/X:T??A[Q9T;6;A;_6/$WAG
M1[B/4(YO*\;^")"IF>4J,W, ^X9R@!5QB.ZC !(<*R^>? 6/2-"_9<T6'6'&
ML?!W6C(\%[&[0S^"IDNW,;^8NV2*V25%9)@5EL94!)$(#6OHMQ;ZQK'C&VL;
MZXL=#^+&AVSMI6J+$R:;XOL58%T9 2?+R5\R')DMI&#H61E:3A?V6=1FLOA0
MOB/PM8S7%Y#+-%XT\&LRF:9S(^+B 'Y?M'EXP1^[N8U"DAU5E?D_/I]^G_I4
M>OQ1U"+M[T?[KTE;;2#4WJK/2A7>L'^YK7BSNM5TK4K[Q+I/AOQ)JW]E^/=+
M\Y_!GC-+5?+UM-H>:VN(5V(TICB!N;,%$G2(7-N8GA(L33=3U74/%.J:[H6E
MQZ3\1M(6%?%OA)KD?9_$$."L-S;S,$5F98V%O=D()!&UO.(GB(M<R:'PWX>^
M&\,$\PUKX(:T$DL[R.62*;P/*D@,9$@*RPVL4J I("LNGRQ@$K"H-J?$J^U'
MP[9_8O$VI-9>._"]E>7W@WQA';HJ:_''"99K2>)=D9E:.$&YM!L2=(A<V_E/
M"19&M_NZ_=KWZ1D])+W)ZDN,5&SM:TDTXM*R=YIP6J@GK7H+WJ$O]HP]X-HY
M+1TT7Q-;ZAKBZ=?:E\"(+J>SFT28/&V@W8VBXNS;;1(EO!,)(S V&M94EE50
MH0Q=YJNE-OT;PWXDUFY?=,L_@;QS ZM<),5.R"9\%&G*$KELQW<996!8LK>
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M2\13_%8WGA[PSX@TOP;'XGA,DOA'QH/$\\?VB7YC]EDVZ=LDG,* RQ%8X[E
MSQJIC80=SHVLZD_B/5_$WAG2'L/&5@T2^-O!+7"8U8;-D5W:RML0SF./$%T=
MD=S'%]GG\IXE:RS/^*9\.?#-I(E76_@5K8/FQ;9()O DL<F&(7Y9K>TAFC.Y
M?DFTR:(_<A0BR-+>5O-*R?WJ*?\ V]2E_=-/?<^O,WY2ES27_@,JLH[/^%C:
M7:LB/P=J_C77?'>M:C-H/A[PO\2M!BA74=%M-7EN+/QE9#($P:2"()R"(9P7
M:-BT4N!E:\Q^+6J:A!=:/J6G^&=!U3X1:IXI\G6?#=Q=3SWVF7#V]R+S=8_9
M2(EV/,\UJK2AV"O&,R/YGLFKZ1>2:OI'A?Q1J\UOX@MY'D\$>-XXTWWK;"S6
MTZC"&X,:GS8?ECNHT,D81D=+?B/BSJ6H7_Q(\(:A:Z;;Z5\4])UZVCU?1?M)
MCL?$MLMM=>7/$Y'S*0&6*8C=$S-'(,#%&M_ZO?KIM?NMIKWHZF=X\MU:UD]&
M^7E3M%J3U4$]*=1^_AY_NJONFS\1HM4TSPIH.@BXM/$VAZG>V\_@?QI<Z\]K
M<:1.Z,MO')>K!<[YSY@CM[B1&CO(YFM[@O(X%_F2:Q\7-:^)MC:S>'/AUH/Q
M2T.QB8WP\27D.G>,=-4KYX2+["Y:%)92-AD,UG+(K?-%.#==/:W6DZ?X3U35
MM)TN37/AGKCSV_BOPI<6?FW'A^=\_:G2UP25)9C<6H!W;C-$&9F6>34=.M8M
M*T7P[XBUJ\U+PKJ5Q!<^!?'5M>":^TF[<%;6&6Z;>&E99"D%R^]+M)3;7 DD
MD_TX_P"!U^[7M_++ILRM;V=[WE]G6_VDX[<UOXM+::_>4]3B]!\8_$:0>)/$
M6A_#OPFUG(\L'C'P-+XDGFNDNR%+RI%_9^P2M&V]PA>.ZC97CWLP:2G-K'BW
M2OAC966H:#X)USX8ZY/$^AZO%XTO-_A5L@P;KH:?YB(DN!#-M#0, CL!M(]'
M=-:UOQK'#-)IF@_&'0;(M;W"J\6D>-]-1QGCYW$(>0;DR\UA-,"#+#,K7D6E
MZHI36O$?AS1;J:UFG>W\=>!;B)7NK>X9099HH@2C3%&#,BDQW<;+)&69E:4\
MO7I]^G_I4?\ MZ()]5_=>DO_  !J?1K:C6?_ %ZJZ'&Z]>?%W4/%&AZ'JFC^
M ]+^)&DV\LGASQ6?$-S';:VGWI[62)-/"RAHXXS<6V8]^P3P>4T*O;_*VEZ/
MKWB/Q^OB"W\"^&6\2Z??26^H>'YM4$9U]OLFL-!,C/9@2O\ N&6*XWA)/*2W
MF ,:FS^T9H=#TKP-9:?J%ZVN?"/7#%+H>N17+?:/"LVX&!6G!WI$DF/)N,AX
M' 1SC:P^8?#_ ((F^(?QK\ ^&_$"Z2OBNT91H&LW>F)?6NIVZOXCDF6XA90@
M621(EFMU92XA$L31LBM ^OW==;]-=KVTC)Z37NRU):CRV=K6DFG%\O*G>:<%
M[R@I:U:4??P\_P!_0]VZ.L_9MUKQCX7_ &0[::[\+^%/$7PEU:>YCFM[S6[J
MPN/"#I>W ED9$L3);VT,T:_*N9;.13)F.)2+;TCQ#/\ %+SO#WAKQ!I?@U=?
M1GF\(>-%\4SHTDN&(MI&73MLDYA4>9&RI'<H&**"K"/K?!-K)X<O]1U3P/X9
MM/#GBO1?*3QCX MY(H;;5T*E8KJT<B.+SF2-A;W9$<=RD1MKGR7A5K"!'\-:
M!\-9+BWC&N? W7 RW-LT<D$W@:6.4A_D(6:WMH9D(>,A)M-FB/"1(1:3I;R^
M:5D_O23W^U3E_=-/?<^O-?\ NRES26FOPRJ2CL_X6-I=JR9AVWB+XKZW\4)K
MNQ\(^ =!^(FAP1IJ]DWBJZ2U\6:>,[71?L!#)N+>5-O+V[L4?*LZ2:7@;5Y/
M^%>ZIK4WAFSNO!VN2W5KXW\"Q[M3;P_/)G[3)'"\*&3>K[[FT$9642&>#S&=
MA=[FKZ1<OJ6D>&/$^KSPZO#*9?!'C>)4\RXDV$_9Y\ (;@Q@AXSB.ZC4LH5E
M=(G6]QK&M^,+G4-/MK'0OBQH5LB:KI3RLFF^+;%6(1E?!)C)+>5-@R6TC,CA
ME9TD>M_ZO?KIM>VZVFM5J9IQY;Z<MD]WR\M[1:D_>5-2TA-^_AY_NZGNG'Z/
M)XDDTSPSH'CC^Q9?!6L7:7'@WQ[I/BJ74[_0+AT1;")[J6T432RF62*&ZE)C
MN8W%M<&>6<?;M+Q9>_$+5/B7IMGINF>#]/\ BAH=H6.HW>J7&GZ?XLTU95#F
M.%+><R0YD&^)I/.LIY%P9(I4DNM*RO=+M/#&LZMI.C3:U\/-:DN+7QGX,NK$
M3W6A7$@/VITM?FW!O,+7%HH99ED\^#>SLMT[4=.LX-&T/0=>UR\U7P=JMQ;W
M/@3QW;7HGOM&NY!MM89KIMX>1Q+Y=O=R;TNTE-K<B260'4%_P/\ @:]OY9;I
MZ,IIWL[WN^FM_M)QVYK?Q*?PU(_O*>IQ^A>,?B1+=^(O$GA_X>^$@NZ2'QCX
M(D\33R7+W)49E2/[ $69HR&)0O'=1E2NYBK'R;]JO4?$^G_LOVMO?Z3X1U+X
M5ZM?QRZ->V?B6ZNIO#3"*;9$SO91NL22#]VQP]NR;&(4+Y?TFZ:UK_C..VN9
M--\/_&#P_9L]I=HCQZ3XSTY7&[Y<LWD[W4/&2\UC-*I!EBE1[KQW]L*[COOA
M%JWB#P_8W5G-+J?D>,?!UP%\R"[-M+FX1<E?.*<[D)CNHRC D[6+_P"#T^_3
M_P!*C_V]'4496U7]UZ2MM\#4^EMJ-9[?PJMXLQ?@W/\ $RY\3:AHKZ?X-L?B
M'8ZFTWA_Q5<:U/;V^IG^SK(S6+Q1V16<-!#!)<6Y,/F8,T C:W$EOZ7I?B_X
MIWWQ"\0>(/#?@3P;IGBO2?D\5^$W\7S;_$$8C=;2ZB+6"1"618@L%WO"21QO
M;S[7@ L^9_9\E\/Z=X \3V.H'^U/A+JVN6YLM8BN9%N/"]T+&P:(M+D/#%&^
MP1S J]K)& Q"X:/U?5-+U6^\4Z7H.O:I'I/Q$TE9F\(^+EM5\CQ!#M#S6MQ"
MI169EC4W%H"BR+$MQ;F)X@;1ZWNO+KK?IKWMI&3TDO=EJ)QCRV=K6DG>+4;)
MWFG!:J">M:BO?H3_ ']#W+H\TM?$7BC1?A3?7L/@WP/K/P@UIBESI?\ PDM\
MK>#Y%D83L5.G+-;P0S)AX=GF6<JL1Y<:$0W]?N?B?L\.^&_$&F>#VU1I&F\'
M^-4\5SJZS8/EP22#3BLD[1<,K*L=U'N !(8#O-*U74[[Q-JWB3PWI/\ 9?C[
M2_)3QGX,>Z7R];3:4AN;>9@B-*T<1%M>$(DZ1&VN!$\/^@YL;^'=#^'<]U:P
M_P!N?!37-Z:AI[PR1S^"YDD(D(C(66&WBF4B2(A9;&6,D!8U86ZTMY?.UK_>
MDGNMZ;_NFGON?7FNNJ<N9K37X95)1^&7\/&4^U5'/V_B'XLZM\4I+BS\)^ -
M#^(NBVT2ZM:'Q3=1VGB_3U_Y:1H; @H'9A'(7,EL[;7RDA67@_BSXE\=']G3
MXD:UI7@OPK_PA6L6-Y!XI\*+K\]Q>Z%?2$?:IX[=[%%5MLCR7%L&9)]RSPY>
M1S=^UZMI,K76C^&?$VL7 NQ-YW@?QQ#L,S2E#M@F;&PW!3(*D>7=Q[N-VY5X
MC]I%M0UWX8>.KG;:^&_B?H_A^5-8LE)_L[Q;IRA@LL>>60%B8WYDMI&,;[D<
M^::W_J]_\[;K::U6IG[KC=6M9=7R\M]'?=03TC)^_AY^Y/W3<\2QW-A\.=&T
MF\O;;Q!H&KM:W?@3Q<NN,6T6]E 6V@EU'RI6;<)2EM>O$ZW:2?9KE7DE#7LO
MARX\=>)_'7V/Q+8^%?"/Q8\/Z=')IFH:??SW&F^-;,8-PCH\",MNLCJ"FZ2:
MVDD#@>7(AN;]G>:=;^'=:UO1-%N-;\ ZW+<6WC7P5<V(GNM&N) 3=RQVGS;F
M;S"US9J&6X63[1!OD=EO4OK"PM]!T/1-;URZUCP/K$]O<^!O'-M?"XO-%NI!
MMM(9;L[P[.)-EM=OO2Z27[-<>9)(K7Q_7^6O;L]XO1Z%:WL[WN^BO>WO)QV<
MFOXE/X:L??A[QY3\=_$GBQK?4M>\,^$]$CTN+Q+HX\4>$KK5Y3J$]^+ZT966
MV6U:..21L*9$DD2XB99 &? /S!\1+#P[X/\ %7C*2STW0[SPS>:,+S3'T_7[
MEH?"EQNOF0I(=.CEQ%*BF,?(8'$8:78&,/V1^T*^I:HVAVVIKI^D_%K0M:T;
M[!>1[[?2_&%B-6M0&(^9O)65T,D.6EM)7!4O'*DEQY;^R_X.T+7O&6I>)M,\
M$:/KDUGX?TZ7Q=X;O-,AGO3=/=:AON8"X(^T>6D3X7Y;E"#G?M-'KY]/OT_]
M*CU^*.H)VU7]UZ2MM\#4^EMJ-9_#_!K7BSU+Q%=?%V^\1:#X?U?2? NF_$?2
MX)I/"WC!O$-PD&L#[TUI+$FGA9MT4437-KF(2B,3V_DO CVD^F^+_BI>_$?Q
M!KGAWP)X-TOQ=H_R>*O"C^+YMWB*$(ZV=W"6L$BWRK"%@O-X1TC>WG"26^VS
MW[BW\/:#\/;>UNKC^VO@OK7ERZ9J<4SI/X+E5P8OWH(DBMXY%'ERY62SD0*Q
M$0!@TM4TO5-2\3Z5X?\ $&JKI'Q$T@3/X.\8I:J8=<BVAIK:XA4HKLR1*;FS
M#(LJQ+<VYADA5K,UO]W7KTU[VTC)Z37N3U):BHV=K6DM8M*R=YIP6J@GK6HQ
M]^A/_:,/>#:?FMEXE\4:'\*[^]A\&^!M9^$.M,8KO26\27H;PBX=EN"RMIJR
MP6\4JX>'9YEI(K$;(T*PWO$,WQ.@B\/>'=>TWP>]^TQE\'>-%\67'F0S$?N[
M:67^SBLDS1Y!WJL=RF5(+YSWFE:KJE[XHU;Q!X?TE=)^(6DB%?&?@QKM3#KL
M>TI#=6TS!$=V2)A;7A"),D+6UR(9(2+'/AF\/:#\/;B[M+<:Y\%=<$D>HZ=)
M Z3>#95<K+^Z($D5O'*K"2$A9+*1"0%C5E@-+>7S2LG]Z2>ZWIO^Z:>^Y]>:
MZZIRYFM-?AE4E'6,OX>,I]JJ:.=M_$/Q8U?XHR7%GX2^'^A_$;1+:)=6M#XI
MNH[3Q?IZ]'1#8$% [,(I2YDMG8J^4D99<W2/%7CA/"7B37--^'7@W5_ ^L>?
M;^+? \NNW-W<:9>2,/MCBV_LX_>2222YM4647.X30*SRO]K] UC1Y([G1_#?
MB36+GSO.$O@?QQ$5:=9BORVT[?=:8I\OS?N[J/((WY!C^('[3_AG]F;X:^*O
M&WQ,MK#P7K6BQV]EJFIK874UEJI9BEI+&\$4DLD!DD(V[6> R.K#!#/I3I\T
MN5Z?Y_E?OTDM5J<.+Q2H4/;17,DEHF[.-[*S?O<J?P/^)0G^[E=-'&PWOC#^
MPO">@^*;7PSJ7@?7M1@E\)^.;'QG<7MYH!D$8LU-VUCB>X<2R);7$N([I2EM
M</)-.&O>N\3:?X^UGQ!9G3M+T.U^)_AHI&=6N+F>PT?Q+IA8D@;(9RP9@=UN
MQ$EM*=ZN\;*\_P"0L_\ P=B:Q'\3F\$S?"KPG+'>>%;S2K[18]W]AWWB.:_1
MCJ1G9!/_ &7)9O<3/ UN;@R,4(8GS#^OUY\2M5_;+_85UK4OACK5O%JGCSP1
MJ,.@>([!YK:&RU9H);='07$<<ZJEQ\R.T8.(B2%^7=U1P=MWV_KY/9[K8\.I
MQ$Y)^SAK[SN[6UW=K6]]752'PR=I))E7X??$OPG<_$;Q9<1^./A;IMYHY8_$
M;PS8>)X=4M].#HZP7<^Y86M)W:/8_FQJLJ*P.YD5A'^SIXE\:S>&;B7P1_PJ
M?QA\/WDQH9L?'4]Y'IBC.^V2XCT]U>%?EV1GF(90,R>6L?XL?!O]EG7?C7J\
M?PK\._"SQAX9\5:IK+?VS%=:?JN[2H1(L.FQ7JW-JEA!;Z+;WFHW(F61S>WT
M5I.@FDD9E^W_ /@WR_9V^)'@#XF?$+QQJ7P_\<?"GX>^*K(I!H/B^6Y_M::Y
M%VSVJR"Y1+B:2UMC+')=SQJTIN$C1I8K:.2NB-""ES):_P">_P GO;OKN>+4
MS;$U*;HU)7BTD[I:\OPN^_-%/E4MU'W+\NA\%_M'Z%?_ +8/Q1^(VF_!/X8C
M2UL?$MS V@7%OJ'Q >/5K?5=3_M*]LS)I5[;Z1'/<2+(8Y'M0^0X"^9E?M;_
M ()2?LJ_MF_"+Q1X$U3Q'H%_X7T71[F]E\0Z=XC^)5TVG^(;.2QEBMH(M*5]
M42RFCN6BF,L<L *Q;# I)-?>WB'_ (*@_LT>$=?OM)U;]HCX%Z7JFEW$EI>6
M=WX\TJ&XM)HV*2121M.&1U8%2K $$$$9K6^%7_!03X"_';QS9^%_ _QN^$/C
M+Q+J D:UTG0_&.G:C?7(C1I'*0PS,[;45F. <*I)X!K8\T\RU;Q)XRT'P=X@
MN[CPMX$\3?"_5[N6'4['_A+;RX/AB<2N+J0M_9XDCMXYER\84O;.&<%(E(A7
MQ!/\3HK?P_X;\0:9X1DO'G,W@_QHGBVX$MO/@B*"27^S2LD[1D@[U6.ZC)4A
MF+ ^B'4+J[\>:]KWA'3YK'QMHLD<?BGPG=2)"/$-M\R6UW$Y/E^8\<3?9[K(
M201/;7'EO PL\6WN/#V@_#VXNK6W_MKX+ZUYD6I:;+ Z3^#)5<B7]T0)(K>.
M12)(B%DLY$+ "-2(/$E;Y?A:_P!]D]UO3?\ =/U*ES-+?FNNW-S..G]UU)1U
MC+^'BZ>CM51S]OK_ ,6=:^*?G6WA7X?:#\2-#M8EU.$^*+N.R\8::IY9$^P-
MNC61W$<A<RVLC[7W1RLD^?HWBOQXOAGQ-KVE?#GPCJG@_5FG@\8> Y-=N;NZ
MTV^E93>2):_V<?F:.626YM8Q*MV&6>W5Y9G^W=]K&CR+/H_AGQ-K%UYGGB;P
M/XXA96N$G*G9!,^-AG*$K\P\N[C+*1NW*9(9M:UKQG-=6L.GZ#\7=!M%6^L6
M=H]+\9Z>K':P;#-Y6YSLDPTMG+(5821R,MPM;^?XW_*]MUM-:K4+QY;JUK+J
M^7EOIKNH)_#+X\//W9>Z>=W^I^.+;P-H&D:QIW@W7?!NNW4-QX.\86_CFYFE
MT.214^PH]_\ V>YD=S(R6]TZE9E98)VEDE4W>;^S'=>-O$.G^'=.OM/\,^%_
M&^BZ?<RZ1K<>IS20^++<7#&6W>W^SJ&@#L0Z^:9;=RDBJ5D&_P!,L[RQBT+7
M->T'0[K6?!.LSW%OXZ\"W%B+B\TBZD&Z[GAM!O#R,)"]S9IO6[63[3;>9-(R
MZAQ/P$ALU_9]\(Z-XBU"2^\$:U/YWA#Q?9W.ZYT.\>>1;:*6X);YG+XM[HY2
M<2?9Y@SNAO#^O\M>W9[Q>CT*UOUO=]$W=KWO=V<FOXE/X:T??A[QO7OBGQA9
M>(]8\2?#_P (:1=-'&5\;>#=1UE[6\>]VG$D$:VTD9D:,*PF#[+F/C;N56$6
MJ_8=!^!$<;VNE>(/A3KEK'+:9U*>"'P1=JP*I]J6+SX;**9?DG$2S6$D8RJ0
MJ/LG37%OK.K^,;>QOKBQT/XLZ';.VEZHL;1Z;XPL%8%T= 2=F2/,AR9+:1@Z
M%D96E31M9G6_U?Q/X8TBXCOXYO*\;^")2IF>7:,W$ SL-P4 *L/W=U& "0P5
ME/)^?3[]/_2H]?BCJ"E;WE_=>DK;:0:F]59Z4*[U@_W-:\6<1X@G^+<^N^'O
M#>M:3X&T_P"(&FPS2>%/&)\0SQ0ZJ1N:6SEB33PDCF&*-KFU_=+.J&>W$309
MLY].\7?%2]^)&N:SH/@;P7I7C'1P%\3^&6\73C_A)( CK:W4.ZP6/?((ML%U
MO"LJ/;SA7AVVV]/!X;\._#B&">8:U\#]:"26=Y'+)%-X&E20&,B0%98;6*5
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MA\3Q%?ZX^:][*][-ZJZ;DO=G=6:J+2I&TWK)HN?\)'\5/^A.^'__ (6-Y_\
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M9W+\DVF31'[D*$66!\<M*U<^*OAKX9U[49EUJW\2I)X3\;QVZ,UTOV6X)@N
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M]NSZ7KGCW4O$*_:XM!U33':R&K2_;FFNWU=I9@D*6\$>F1*))6EROC?QXO\
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MXM(\;::CC/&7<0AY!N3+S6$TH(,L,RM=\/\ '7SM6^ _Q'U_PCH\S.UC=?\
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M776_37O;2,GI)>[+4EQCRVE:UI+6+4;)WFG!:J">M:BO?H3_ ']#W;H^3U\
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M1\%? WPW\/\ Q&VKZ;;Z@=2:V:S\^\U6[OF6)F1V1?.E<*"R(3C!.T5UU%%
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M=2\!_$OP<\<'BCP7K$T+ZAH[NH9)4>)FCN;24?-%<Q$I(O4(X>-0#V&BBB@
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MG>ZAXR7FL9I5(,L4J/=4[.\TRV\,ZSJ^D:--K7P]UJ2XM?&?@RZL1/=:%<2
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M1110!\R^*O\ E,CX#_[(SXD_]/F@U]-5\R^*O^4R/@/_ +(SXD_]/F@U]-4
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MG>3:<WA?QU#\5=)A\4Z*MQYL,S8VVU[&VU1/#(L;K%=JB-(D1AE5);9H+?\
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M2[4QAVF_LW6K>/PU'@$A=\:R)CD>:UI).>)UQY_U;_P7-_Y1 _M%?]B1?_\
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MM!\*:@5N[>)ETWQII21/O*H6+&,-(-T99IK&>4$&6&97N_(_@?\ M1Z;X0^
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M?:(-\CLM[\V:G^U;%>?M#Z/H'B+0/B=_PD%KI)3P;JT5A:#6F9W62)I8_/\
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MZ//'H^KR)=:QXD\-Z/<^=YQB\<>!Y0K3B8K\US OW6F*?-E?W=W'@@[\$O\
MX/3[]/\ TJ/7XHZB7=?W7I*VWP-3Z6VHUGK%_N:UXL_/[_@X#;7--\0_LLZ-
MXL@&I:EI/Q3LAI7B5(4C&L6KE-RRJ@ ANE*1^;&H6*7$<L04;X+;],_V4_\
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M+-;1PRPD&)MLEC+&R@1I&$MUI;I:WFE9/[U%/_MZE+^Z:>^Y]>:_E*7-*/\
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M'>T ?I]116/X_P#&MI\./!&K:_?)<26>CVLEW,D"AI'5%+$*"0-QQQD@>XH
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M?_IKDH ^FJ*** "BBB@#YE\5?\ID? ?_ &1GQ)_Z?-!KZ:KYE\5?\ID? ?\
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MCHBPV=MX8\2W-M=>#O'FD&(7MA=D,MG#/<X97E*S,EO<R;X[N.9K:X$DDO\
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M5I^BZ[X5"1331RVEK.&?Y21YIG>\^Z2DZNC9W<GT'Q]9Z-<FYU);JXU'X/\
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M.?\ L"W/_HLT >@4444 >?\ [,7_ "24?]AK6/\ TZ7=>?\ _!3S_DSO5/\
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M /GZR_Y.'C_[*;/_ .HB*^@:^?K+_DX>/_LIL_\ ZB(KZ!H ^4?^"YW_ "B
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MTS1/#OB+6[S4/#.H7$%SX$\=VUVLM[I5VZE;:*2Y8.K3,LA2&X</'>1RM;W
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MB&3&86_=2+MR#T^@6?A_POX%U*\\.:"NI?"W5FGM?%7@U]/#3>'9FR+EH[0
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M_AFZ^)6G06-UI]]INI7$.C>,K**+9(P\F3=Y;%HA(%:26SE:,;IHBIN-&/\
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M<ZAI]M8Z%\6-"MD35=*>5DTWQ;8JQ",KX),9);RIL&2VD9D<,K.DG%ZK\(?
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MK'1;7XIZ?XQTRWMKEU>+2?%^G[Y/FV_.?*$KH)(6\R2TDF.TO',DEQY)X_\
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M+T;6?$OA_3M'OKV74KN2[U&&&&=;15=(BS':<SR0/MSDB,]LUO\ _#5?PO\
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MM^_L$_#GXOZQH]CX?U+QM9SW,^GV<K2P6QCNYH %9OF.1$#SW)KWZ@ HHHH
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MQ#*9/!'C>-4\V>383]GGP AN"@(>,XCNHU+*%972)=)U;4[OQ-JWB3PWI/\
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MX<V=]J&I>./[4A>>PU#R/&^NQP_:[::2WN/+5KUCY?FQ/M))RN#WKXI\<?\
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M/[*_@&^\ ^&=4U'^SM7N?#^HN;C3()9/*N79=44'="BN2%4')PHZ5\\^%/\
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M(O#>CW5WIUQFV\<^![B!7NK:X:-3--%#RIF9&#O&N8[N)UEC+,ZM-QO[1_\
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M^4F.[C*L"6*L3_@]/OT_]*C_ -O1U",K:K^Z])6V^!J?2VU&L]OX56\6<?\
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MSP 3ST]: /4M2M8_@SXGL;K3X_)\-:_>I9WUG&,0Z?=S,%BN8E ^19)"L<B
MA2\B2 *QE,G?5\(^*/C%\>OB1X.2&\;PNN@ZE<6ZQ:F-!O8[?=]H3R9%D*X
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M HHHH \__9B_Y)*/^PUK'_ITNZ\__P""GG_)G>J?]C%X9_\ 4@TZO0/V8O\
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M* "BBB@ HHHH **** /F7_@LU_RBI^/G_8F7_P#Z+H_9<_Y2-_M3_P#<I_\
MIKDH_P""S7_**GX^?]B9?_\ HNC]ES_E(W^U/_W*?_IKDH ^FJ*** "BBB@#
MYE\5?\ID? ?_ &1GQ)_Z?-!KZ:KYE\5?\ID? ?\ V1GQ)_Z?-!KZ:H ****
M"BBB@ HHHH ^9?V=O^4H7[3'_8N^"?\ T7J]?35?,O[.W_*4+]IC_L7?!/\
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MI<3:=,ZCSKJ&#.V6<QMN\M28KQ&5U8L093R]>GWZ?^E1_P"WH@GU7]UZ2_\
M &I].U&L]OX570\S_:'^+FL>!_VC_ N@Z@NO:E\1- TW5/[#U;P[817;:S')
M]D<+=6?F1!@8X'%Q;AE!&R>!HF"-;Y?B?_@HI9_#KQX^NI\-?B3X6\8&UM[K
MQIX9NK"%;34K;Y(1>1R-*A\Z/ 2&Z,:K<)$+>8(4B>SN>(/!W@_X>?%3X6Z?
M>:TNK?"W7-,U>?2-;,Q6]TBY9].VR2W2[2H25(O*G.'A;"-A44CSS]O"74/B
M1X^OM#U#6M);Q9\.?"E]=:=K<:Q>7XC1C TL$D9&U9ELW>:6!.ICBFB,>!Y)
MK?[NNM^FO>VD9;37NRU):BHV=K6DG>+Y>6]YIP7O*"EK5I+WZ$_W]#W;H=!^
MV9\/]!^+5U9?\(1\1+[X:W?AVZMVT*;38H[SPH\5T))?*43AX;6![>1MI9'L
M9(F"[(D5;;J]#_;YTGXBQZ3H-YX=^*E]K]NYN_!/BFSTBU:_N8R7C'FH)PDC
MEH98I$4^7<"%SM1@5C\MT?4_$7B7]M-/B=H^DM8>-K/PFOC'6M!F5S_:%I'=
M>5&EI,P16>32TC2.?;MD)>&18I WV>W^QOK/A#X6KX=O?$ M[SX:_$SPT]O.
M@F9SX4N;:=$+R-N\R&#=:F;Y<-92;F_=QH3 :6\K>:5D_O23_P"WJ<O[II[[
MGUYK^4I<TEIK\,JDH[/^%C:7:LCVSX3?&?6OBE^U%J^HQZ)J7@#XH6OA?34E
M\-Z]";*T\7PQ7%^TA0G<=I5E,4W,D+)(I$D:RA_4;6ZTR'PSK6L:/HMQK7P_
MUJ6XMO&G@NYLO.N]$N9.;J6.U&[<6WEKBT4,LZO]H@WR.RWGFNM^ ['QS^U#
MJGA/Q=XB\[5?^$;TH^#/%]J=MTDT=UJ4D:RR+A!=XW912%G2$R*$8%8_0/!+
M>+K[Q#>37$>EZ;\7O#,*1:A;B0Q:?XYTU2?*E;Y?E.2P2903!(2"-DCPEZW_
M *O?KIM>VZVFM5J91<>6ZM:R>C?+RWM%J3]Y4U+2$W[^'G^[J>Z7+VRLO[%T
M/0=>UR[U;PAJT]O=> _'EK>K/>Z3=2+MM8I;IMX>1EDV6]T^]+Q)3;7 DDD!
MOK3IK6O^,X[:YDTWP_\ &#P_9L]I=HCQZ3XSTY7&[Y<LWD[W4/&2\UC-*I!E
MBE1[JG:W.FQ>&M:UC1]%N-;^'^M2W%MXT\%W-EYUWHES)S=2QVHW;BV\M<6B
MAEG5_M$&^1V6\=>V-E_8FAZ#KVNW6K>$-6GM[KP'X\M;U9[S2;J1=MK%+=-O
M#R,LNRWNGWI>)*;:X$DD@-\O^!U^[7\I;IZ,MIWZWN^BO>WO)QVO;^)3^&I'
M]Y3U.2^-ERNH?"_Q-X@\/V<UCYE_:P^-O!UR@::*Z^T0'SHD!V^<PV_,I,5S
M$RN"6VLW2S0Z!H_@&TL[R[;6O@[K1CDTC5XYW6X\'3!QY0,O$D<,<@'ES9#V
MKJ$?" &/G?VB&O-9\,W=OK0M-%^*N@QVOV>YMMT.F^,=.%[ -ZJ=S&%9)$+P
MDM+9S.,,\4R2778:5JK-)K/B3PWHURQ:9H/'/@:=$:X68H-\\*9*&<H0WRDQ
MW<95@2Q5C73[^GWZ?^E1Z_%$SC)JHWKM"WO)+1OD:GO=;4JS^'^%5NFR34M-
MU34_%.F:%KNIQZ/\1]'29_"7BQ+4?9]?AP&FMYX5*JQ98U-S: J'$:W$!C>)
M6M32M5U.^\3:MXD\-Z3_ &7X^TOR4\9^#'NE\O6TVE(;FWF8(C2M'$1;7A")
M.D1MK@1/#_H.;-#H&C^ ;2SO+MM:^#NM&.72-7BG=;CP=.''E R\21PQR >7
M-D/:NH1\( 8]+4M-U34O%.F:%KNIQZ/\1]'29_"?BQ+4?9]?AP&FMYX5*JQ9
M8U-S: J'$:W$!C>)6M5K?[NO7IKWM\,MI+W9:E2C'EL[6M):Q:5D[S3@O>4$
M]:U%>_0G^_H>[='G/Q5A\-:3X2\&W5O<0WWP6U/Q#FYL)XY89_"4R0W231*F
M!)!;QL)"\3[)+&2%@-L8V6]SX$6+W?PE\(>&_$E]-8W?GSS>"?&5N5,HN/-E
M_P!'E.-OGE=P*-^[N8LC&X,HE^)6LRW?CWP[XBTG1;G3_B!I_B.TC\5>#TO8
MUBU9A9W0@NXI)%1)&:*&1+>[_=+,J>1<>6]OMM*OP)M=/\%?LTV?]I6KZM\)
M=4-U#JEC/"T5SX)F2ZD#DIA9(K:.1,R*0LMC*A;B(-]F';E6UK>=K7^])/?K
M3?\ ="/M'5E?FYN9?RN7,XZ6:]V524?A?\/&4[[54=]!/K6K>,[B\L[>PT/X
MLZ':J-3TPR-'IGC&P5B%=&.3LW,?+EPTEK(Y1P\;D2U;2[TV#PYK6M:+HL^N
M> -<EN;;QMX)N;$7%UHUQ(";N6.TPV\MYA:YLU#+<+)]H@WR.RWMG6-'F%YI
M'A?Q1J]RMXLWF^"/&\6TSM-M.()CC8;@ID%2/+NH]W&[<JK!/K6K>,[B\L[>
MPT/XLZ':J-3TPR-'IGC&P5B%=&.3LW,?+EPTEK(Y1P\;D2K6_P#5[_E>VZVF
MM5J"<7&ZM:RZOEY;Z-/=03TC)^_AY^Y/W3&UC7O#FEV.C>%_$GBZ'4O"6JR0
M7O@CQI%JT<VH:+.Z$VL<URQ;<S*^VVO7WI=)(;:Y\R616OW/XZCUSQ8D=QX@
M\+Z'\6/#UJ?LFH+<K'I'C'3PV2K#<S",LWSQY:6SE?<IDBD#7'$^+/@%H/B>
M^UWQQX<CU!O"NOW4L?C?PE_PCNF7U_H]R8U6>6.WGM9V9AEI+BU3=]H$S3P&
M1V$=UGS_ +)FAZ?:^'])U;QMJ&I^ -::Q?P?XNM-/T6::TN"$%M!<W9LV=VG
M) @NRY2Z$QMILR/&;Y?U_EKV[/>+T96M[.][OHKWM[RY=G)K^)3^&I'WX:GQ
MM_P7>\1^&_&^O?LU:SX>G?3=0N?C'IR^(_#QF23[#?C;F8JI*AG7_EJA*3J(
MW!.-Q_96OQ9_X+3?#F\^%WB[]G'3/$,S2>*%^*.F*UY;Z18V%CK=HCGRYX3;
M01D[6<AX)6=K=W."R2I+-^TU>GA?@^?]771][:=>I\/Q!?ZTGTY5;JK=.66\
MHVTBY>\E:+UB%0:G_P @VX_ZY-_(U/4&I_\ (-N/^N3?R-=1X9\2_P#!/[]S
M^U;\OR^?X LS(!QYA2QT';GUV[WQGIN/J:^X:^'OV O^3KHO^R?VW_I#X?K[
M'\:^/]+\ 6$<VHW 66Z8Q6EK&-]S?RXSY4,8^:1R 3A1P 2< $@ XSX[^&--
M^)WCOP%X7U+3[35;3^T+C6[RUN8UEB:WM[66(%D8$$>?=08SWJ[_ ,,H?##_
M *)[X+_\$UO_ /$5J?#_ ,)WT>LZCXDUQ436M85(5MDD\R/3+6/)C@5NA8EF
M>1A]YVQDJB&NLH \K'[(7AI_#D.@S:AXFN?#,+1[=$FU$O8&-'#I"4(R8P5'
MRD]!R36I_P ,H?##_HGO@O\ \$UO_P#$5Z!10!R/A/X >!? >NQZIHG@[PSI
M.I0JRQW5GID,,R!AA@'501D'!P>16YH_A'3/#^J:A?6=C;V]YJTHFO)E7]Y<
M, %&3UP .!T&2<9)SI44 >5_$[]CCP+\0T>ZM='L?#7B(7\>J0Z[I%E;P:C%
M<QR"42>88VR2PRV0<Y.:Z;X!>*;SQG\%?"^HZE,T^K3:;"FHN5"DW:*$N 0H
M !$JN"   1T%==7G\DR_ O6M3NKCY?!NKW3W\LRCC0[F3+3,X _X]Y7W2,Y/
MR22.6^1LQ@%?]K;XFZI\'?V?M=\1:*T"ZE8/:+$9H_,0"2ZAB;([_*[?C7P3
MXX_Y'_\ X)I_]C9J_P#Z8[VOM']ON^AU/]CGQ-<6TT5Q;S/I[QRQ.'1P;^VP
M01P1]*^+O''_ "/_ /P33_[&S5__ $QWM 'Z?5Y_^S)_R2ZX_P"QBU[_ -/%
MY7H%>?\ [,G_ "2ZX_[&+7O_ $\7E 'H%%%% 'G_ .S%_P DE'_8:UC_ -.E
MW7G_ /P4\_Y,[U3_ +&+PS_ZD&G5Z!^S%_R24?\ 8:UC_P!.EW7G_P#P4\_Y
M,[U3_L8O#/\ ZD&G4 ?0%%%% !1110 4444 %%%% !1110 4444 ?E!_P;'_
M /)5/VX/^RU:C_Z.N:^6/^"1?P]U_P"&O_!JO^V18^(M#UCP_?3:AXFG2WU*
MRDM97C.@:6H<+( 2I*L,XQE2.QKUSXF_\%5?V^_@?\<OB!H_P]_86TF;P[%X
MCOHK75;+P?JD9UR&.XD2&[D>*55D:2,*^_'.[(X->#?'S_@ZS_:X_9]FFTGX
MD?L[_"_PO<R$PRZ;K4%]#</V*F![K>1Z_+@9YH _4/\ X-O/^4)7P#_[!5[_
M .G.\K[@KYS_ ."2O[5FI?MO?\$[OAE\5-8T/0_#>I>,+*XN)]-T>-H[&U,=
MY/"!&K,S $1@G)/)-?1E !1110 4444 %%%% !1110!\R_\ !9K_ )14_'S_
M +$R_P#_ $71^RY_RD;_ &I_^Y3_ /37)1_P6:_Y14_'S_L3+_\ ]%T?LN?\
MI&_VI_\ N4__ $UR4 ?35%%% !1110!\R^*O^4R/@/\ [(SXD_\ 3YH-?35?
M,OBK_E,CX#_[(SXD_P#3YH-?35 !1110 4444 %%%% 'S+^SM_RE"_:8_P"Q
M=\$_^B]7KZ:KYE_9V_Y2A?M,?]B[X)_]%ZO7TU0 4444 %%%% !1110 4444
M %%%% 'S]9?\G#Q_]E-G_P#41%?0-?/UE_R</'_V4V?_ -1$5] T ?*7_!<W
M_E$#^T5_V)%__P"@5\J_!;P[K4__  4'\"Z+=^('L_$4-G;OH_B1;),2X\,0
MND,T6=KL46-)D4QB9=SQ>2W$/U5_P7-_Y1 _M%?]B1?_ /H%?&WP7_X0FQ_:
M^\'K?31WGPKFL[8O.TL^[P](OAZ+GS ?-M8[:8 AAY9T\P9S$D.8.'&[*_Y^
MF_5+^\M8NSVN?4\,)\\^5.^B5HIN[4M(MZ2DU=>QE[M://"ZGR'Z$6%_JNK>
M*]0UG1M/@T7XF:+%$GB7PT]QBT\1VW*Q312D ,&"M]GNL#[K0S!"C+#1@GT7
M3O!FH:EIFG2:Y\*]<::'Q)X;FM2UQX:G)/VATM\;E0,29[8#*G,L8)+*]W6M
M%U%O$6D>&?$VKR6/C"Q:5O!/C9;=/^)I\FZ2TNHUV(9S''F>V&R.YCB\^#RG
MB9;-=/U#5=6\5ZAK&CZ?!HOQ-T6*)/$OAI[C%IXCMN5BFBE( 8,%;R+K (VM
M#,$*,L7%K?SUZ:WZZ;7M\4=IKWHZGU*<>52BURVBTU)\O+>T6I/WE!2TI57[
M^'G^YK>[9D.I:;"UEHOASQ'K5Y>:/>7$5UX$\=VMPLEY87+*5@BDG(96G*.4
MCE<-'>1R-#,KM(RW,O\ Q/-;\<;E_LG0/C-H%C@@^9#HOCO2XY/^!N(1)+P?
MWD^FSS_\MX+@B_I03Z+I_@S4=2TS3I-<^%>N--#XD\-S6I:X\-3DG[0Z6^-P
M0,29[8#*G,L8)++)/J6FPM9:+X<\1ZU>7FC7EQ%=>!/'=K<+)>6%TRE8(I)R
M&5IRCE(Y7#17D<C03*[2,MRO^!U^[7_TF7_;LBO)_P!ZZ<=;_;3AW_Y^TMFO
MWM(--U.W.GZUXC\.:+>7V@WUQ-:^._ EU:K)>Z;=,H:XDCMU+JTY20/+ A>.
M\CE6X@:1I%:[X7XR66GV6C?#;3;K66U;X6ZQXEM;CP]XDAO_ /2M!=K:X$$1
MGR690S*8+@DE=OERY.UI._\ ^)YK?CC<O]DZ!\9M L<$'S(=%\=Z7')_P-Q"
M))>#^\GTV>?_ );P7!%_P7Q3O=/DNO#_ (CT/2M1N-%O/%QM_&G@2XLDFN["
M^:SN&N'6W5F7SFCD+R0Q^9'>))'/ 7,H>Y/^#T^_3_TJ/3=!=[K^[]K6_P!A
MJ??_ )]5=I+]W4._OK'5M6\66.DZM?6^B_%#189&\.^(E@VV?B:U&#)#+&"
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M6O@?QQ_R/_\ P33_ .QLU?\ ],=[7Z>O]P_2OS"\<?\ (_\ _!-/_L;-7_\
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M .FN2@#Z:HHHH **** /F7Q5_P ID? ?_9&?$G_I\T&OIJOF7Q5_RF1\!_\
M9&?$G_I\T&OIJ@ HHHH **** "BBB@#YE_9V_P"4H7[3'_8N^"?_ $7J]?35
M?,O[.W_*4+]IC_L7?!/_ *+U>OIJ@ HHHH **** "BBB@ HHHH **** /GZR
M_P"3AX_^RFS_ /J(BOH&OGZR_P"3AX_^RFS_ /J(BOH&@#Y2_P""YO\ RB!_
M:*_[$B__ /0*^5/@)XDU&/\ X*!^%=<TGP[=2:Q;V=JNJ^&FN(XY+D+X8B5Y
M(2?D:1D5VB9BBSC8KM']Z+ZK_P""YO\ RB!_:*_[$B__ /0*^5?@CIWB*\_X
M*'>"+/\ M#3[#QO9Z?;M8:I]E+6>HQ+X9A81RIG.'15$J*04+EHR,*1QXR_N
M_P!:^3Z/M?1ZI[GTW#?+>JI6M97O=KEW?-%:RALY./OTVHU(? S[5SX9\,_#
M)4D*ZU\"=:4;'S)!-X"ECDX!/RS6]G#-'P?DFTN:+^"! ;'3UK1=1;Q%I'AG
MQ-J\ECXNL7E;P3XV6W3_ (FGR;I+2ZC78AG,<>9[8;([F.+SX/*>)ELS1]8O
M9-9U;Q1X7TB:U\26LB1^-_!$DJ!K]M@5;FW9MJ?:/+3]U/\ +'=1H(I2C(CV
MV8#X9\-?#)4=EUKX$:THV/F2";P%+')P"?EFM[.&:/@_)-I<T7\$"9L?.TMT
MM;S2LG]ZBG_V]2E_=/L/?<^O-S>4I.4E_P" RJRCT_A8ZEVK(U+"_P!6U;Q7
MJ&LZ/I\&B_$W18HD\2^&GN,6GB2VY6*:*4@!@P5O(NL @JT,P4HRQ48)]&T[
MP;J.J:9ITFN?"O7&FA\2>&YK4M<^&IR3]H=+?!8(&),]L!E3F6,$EEDNZSHV
MHGQ%I'AGQ-J\ECXNL7E;P3XV6W3_ (FGR;I+2ZC78AG,<>9[8;([F.+SX/*>
M)ELUL+_5M6\5ZAK&CZ?!HOQ-T6*)/$OAI[C%IXCMN5BFBE( 8,%;R+K (*M#
M,%*,L5:WL]]>FM^NFU[?%'::]Z.IFG'E4HM<MDTU)\O+>T6I/WE!2TIU'[^'
MG^YK>[9D&I:;"UEHOAWQ'K5Y>:->7$5UX$\=VMRLEY873*5@BDG(96G*2%(Y
M7#17D<C03*[2,MSC>./"GB#XA_$;P_+'#X?T3XQ^"9TOI/.DGMM(\;Z3$LJ
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MS/B/X1Z=\3?&MYJDGA?0].^+FBQK)K&F[C!;>++4?(LT4XPX!QB.?[\+_NY
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M*VD$_FLUP;K2)XHVR844?O$1<9R3*N!@' !]F?L^.L?[/O@=F(55\/6!))X
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MOO\ P47G_P :H_X:A\$_]!*^_P#!1>?_ !J@ _9B_P"22C_L-:Q_Z=+NO/\
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M$OAWPO\ #GP'K5CX>F?5H7%FEMK<$1\X20!E98GE*K'&[9GC,C1N@ ;+UO\
MU>_73:_=;36JU,TX\MU:UEU:CRIVBU)ZJ">D)OW\//\ =U/=#PU;?#[0/VG?
MMWBC6[.[\(Z_X+EUKPEJ%LT4EWHCBX8Z?;O,5=&O#;PH TZM]H:X,$XG>5OM
M/N'A/X<6_@3XM:#IGB&U\'^"_B-H?A6:[-Q?+"NB^,-]XDDF69<[&:5PR8,U
MI)@KYL)1KGXD\0:EX/G^*UC-8^'_  V/#6I6$:ZY9I>M-;65SYWFSS_=.PD+
MLD@2(J0S&*-BRB3WCP#9_#O2/^$,TCQE;^#O%7A_6O#B'3/$&BFP75M#O?/5
MH1<M)^YFF4+M260 7*-Y$L4TDFVZ7_ Z_=KV_EETV96M^M[OIK?[2<=KV_BT
MMIK]Y3U/HWX3^)-(O_CEXX\1> O#UC<:+-H.G1>-?"-O#%++]H:?45FDA5"8
MI)0BJQ1,I<QR;U)=E+]%/\2OA[I/AFST'4/%^BZY\+]::)]$U2/6$%[X4G!#
M0HTF[S(XT<#RI^'@8!'( 5AX_P# G5#XJ_:Z:/X:CP3H&O:;X9M6NFTN-;/2
MO$D$<U\6>2SW>?"'9[5)$D1I[21E(,L11[GW+3O#FBRRZOXFT#P;:W$?FFW\
M;^![FPADNK:8J"\\$>"K3%"&*IF.[C8.A+D&0\O7I]^G_I4?^WH@GU7]UZ2_
M\ :G^%&L]OX570KWGQ-T?7/$-EH^L^._#.E?$/P_'++X8\7Q7$#6NMVYVF6"
MXB5U4[PB?:+3<@?8D\#1O&K6QIGQUT6XUK4O%GAW4O#NE^-+)XX?&/@^37+8
M0:\%0+'<6L[LD;3>6@%O=G8D\<?V:Y$+Q V+7\ ^!]'\%VMG?6FFZU\)_$.Q
M]&UZ)0+GPO,6'E(\X'F+$KX$4Y(:%@$<XVL+VH_#"WU+Q#IWAW7(=%T7XA:2
M))O"OBE-*B^R^(8@N9()X%VJY**/M%IE0P03P-&\:M;&M_NZZWZ:][:1D])K
MW9:DN,>6SM:TEK%\O*G>:<%JH*6M6DO?H3_?T/=NCSGXO_$WP3I?P N;3P_X
M@T/6?A3XBEM=FGF^2WO/!;K=Q,T8B9EECM%9&4PX66QE7:%$'RV?=:E\1/#M
MSJ>G^%_$GC[15U>Q9KCP=XWAO[9I78+S!<X8)Y^WAXSB*ZC!90K!DBYGXV>%
M]-U7P=X@\0:/X=T_P[XVTF;3X/&'A+RHI(]44W$:V]S;R,(U+-L(@O %6>)'
MMYT22$"RZ"'PCX!\.> 9KR/1=+UGX)ZYYBW226)ANO DRR%9 P*K-!:12JP=
M#METV6,_=MU(LGHH+MKZ65NFZ2>_6G+^Z)*3KMZ\WN]$YN4D[>]\$ZDH_#;]
MWC*>KM6)K?XS:7K?B.YUC3]?\'Z%\4-"A2#5=/?5XTTKQ;:*3LVR9.4.6,4V
M#);.S(X9&=)*8^,W@&P\,ZIK6EWVBZM\/_$;3Q^,/!=W)#+=Z3-)G[5/#:[F
MWEBS-<6J!EN QN+??([+>;&K?"G38;[3/"?B:.QM]464R>#/&D5C")+J0*3]
MFN %"&XV AXR!'=1@LH5E=8B+P5'KWBF:ZL?#OAO0_BIX=MU&IZ.\*KIGBNR
M!(5T8J3Y9.?+GP9+>0E'#*S)(FG?^KWZZ;7MNMIK5:A&4>6ZM:R>C?+RW]UJ
M7Q*FI:0F_?P\_<G[IY'^TU\6CINF^!/#.C^,=%\4Z//K*ZGX5\51>)K<W^GL
MEK.(+:>>1F260M*BP7,I9+A3Y=R&;=)=Y/[&GQM\2?%+5O"^CQP>'/#_ (^T
M_2+^YLKN.X8P>(+2*Z4F&X5"X\EWEE^7<9[5U$@#1RJ;G2_:>^$VC>(M!T3Q
M#X)M[73]%U+7[BQ\1>&;OPTFI3:)>RV<XN9%LU8$L$+22VJB1)VV30J[2O\
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M@U/XV>#3IMQ_Q5OAD_NFX&J0>A_VJU?^%=>'_P#H Z-_X!1__$T?\*Z\/_\
M0!T;_P  H_\ XFNH\,^#O _QK\-VGA?28SK&F^(&71]+4K)JVI6G]ELFG6T3
MVH6%UC.)(W<D#K*0>16Q_P +R\-_\^NC_P#A1ZQ_\>KZNUC]D?X7Z]=+-=>
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MQ+_P:W?M?:]J7AO0=0US3=4\2+::C<Z?%+=VH70=+91'*REUPS,1@C!8GJ:
M/WE_8=_:S\+_ +<_[*?@WXK>"M.UG2?"WB^UDFTZSU6WBM[RWCBFD@*ND,DD
M:_-$V KL,8Z=!ZO7P_\ \&WG_*$KX!_]@J]_].=Y7W!0 4444 %%%% !1110
M 4444 ?,O_!9K_E%3\?/^Q,O_P#T71^RY_RD;_:G_P"Y3_\ 37)1_P %FO\
ME%3\?/\ L3+_ /\ 1='[+G_*1O\ :G_[E/\ ]-<E 'TU1110 4444 ?,OBK_
M )3(^ _^R,^)/_3YH-?35?,OBK_E,CX#_P"R,^)/_3YH-?35 !1110 4444
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M,<<;7(G(5>3%%<E<W$-P8)8V<LUTO^!U^[7_ -)ETV96M[/?WMXZW^VG#O\
M\_:6TE^\IC?#7PET74_@5X@^*GA;2]'O$T^\FC\3^%+SP]H%X\#($ :(1V0"
MG:09(H]HG5C+$[,5,_IGQ[^"7P]\!?LZ:Q+:^'/#6K> -:M!=>'?$ME90F\\
M.SLP:)'N%7?Y); BG)W(2(Y,@JQ\G\.?$F&P^#'_  @]KX?\1:'\4;>SGA%]
MY5C#H^O:<]RWRS*MRSF(%Q(0@EFLYYR0TJ3-]J]8^,7Q^\+^(/A+XJNO!INI
M?^$G!LO$W@>>RD:ZM[^<J#+;HJE#.[.IDB1C'=*XEC)D;_2#_@]/OT_]*C_V
M]$$^JW]UZ2_\ :GW_P"?57K_  JI[1?V&K:KXKT_1]8U"#1?B9HL4K^&O$J6
M^+3Q);##2PS1*0&#!5,]J""-JS0E2BM$:1J^HW'B+5O%'A?27L?&EBT2>-O!
M+W**-9 39%=6\K[(_M'EQXM[H[([F.(6]QY31(]CGW5KHND>"M/T_4-0;6OA
M/K30S^'O$,%T6N/"TQ(-N#<9W+$&($-P3F,XCD)4JQT+^PU;5?%>GZ/K&H0:
M+\3-%BE;PUXE6WQ:>)+88:6&:)2 VX*IGM01C:LT)4HK1/6_W==;]-=KV^&6
MTU[LM29*/+9VM:2UB^7EO>:<%[R@I:U:2]_#SM6HOE,I'\,^&OABTD:KK7P)
MUI666)DD@F\!2QR$,"I"S6]G#-&0R$)-I<T1X2!"+'YQ\2? WQ%^R[^S5K/@
M?Q'I=C=7^H"\U3P]XLTK4?+2&1K2..6R*R(NXM%;[VA9L31Y*9>$F/ZCTC5]
M2N/$>K>*/"^DO8^-+%HD\;>"7N44:R FR*ZMY7V1_:/+CQ;W1V1W,<0M[CRF
MB1['SKX_MH_AW]D+Q8^C0_\ "0?!O6]*N%BM?(=)_ ]S&Q'E^4P66*TBGC*M
M$RK+ILT97:L"E;$4DHM:6_"R?WJ*?3>F^\;$U*,IUXU;RYTVMTY.4X[-?!.K
M**34K>SQM-:.-;F3B^ T7C34OCI\3/$#6</AOXCQOIUWJ'A6>]5[75K3[(D9
M3S%+*#N0M%.A;RFD*/D,ZGO+.\TG3_">JZII>E2:U\,]:>>V\6>$[FS\VY\.
MSOG[2RVV&RIW$SVH!#!O.AW%F6?@]3O;'X=_&WQ!H_C;Q)?Z;XA"V5SX.\9?
MV>S27(6%U,4H1=DC%5"2Q_+'.(V=1&Z@1:D?[2>BZAJLGB/3KRST/XD:;&L&
MLZ08Y_[/\4VR$A&63R\@'DPSLH>(DI(NTLM7.,F[V?Y]-?*_=;26JU.7"U*,
M:?*I1MZN*M=\NKU4;_!4:YZ,[PJ+D:*OPSLM+&M^+?#NM:IJ5[X;U#Q=;3^#
MO'<.H+<7>FW[Z58+:QM<%6'F-'*L<-Q+YB7BO)!<;WF"WG?NNMZSXV2*9]+T
M'XQ:#9$P3A7AT?QQIB/SQ\[B(/(-R_/-833 CSH9@;SQCX8?'3P;X;U+XB7"
M6J7OPU\8:^XUCPQ=:0YFTT2Z?9K<7"Q["LB&3S5G@RV0OF1;CE)NON/C;X)G
ML[/POKWB[4-2\/>9'?>#O&<(F?4]%N<;(8I9GC8O,%D*Q7#!TNHGD@N0[,3>
MSROM_737_P!)ENMF='UBGNY+KT5]?B]W:_\ S]I[37[RGJ<I\%?$_C/P[XA^
M)FL:-X)U#Q-H>K^)=2D\2^&9+FS)TYRB!X_+#L[7/#%EC66*XC="C;@-]?X<
M_ :Q\._$N?QQXB:V?X:^-[ 6^F7UGJTE[-X9N"UD+5GNBJ-$D?V15BF',3;$
M<C&X]E\!!>^)M1U6\L;NUTOXI07]]?65U-9S6.E>.=,%Q\XV-O?[.)7/0R36
M,DRM^\CGQ==IIFJ*T6M>)/#>BW5Q97$\EMXZ\"W,*O=6UPR@RS11 E&G*,'9
M$+1W<;K)&69E::I2U:?FM=?73_TJ*]484:"M"49-6<6N5\JOJHOF\[_NJLKZ
M_NZBZDVI:;JFJ>*=-T/7-2BT?XD:.DK^%/%:6P^S>((,!I;>>)2JMN5%-Q:
MJ&$:SP&-HU:V-(U?4Y_$VL>)/#>CMI_CG3S"OC;P2UT@36UV;(;NUF?9&9S'
M$5MKMMD=S'#]EN?)>%6L*$T6AZ5X'L=/U"^;7/A)KC12Z%KL5RWVCPM-N!@5
MIP=Z1J^/)N,AH6 C<XVM5_4M-U34_%.FZ'KFI1Z/\2-'29_"GBM+8?9O$$&
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MSAF0AD(273)8S]RW0BRT]:T6Z75-)\+^*-6N(-8@E:3P3XVC1?-GDVD_9I\
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M4 %?F#XX_P"1_P#^":?_ &-FK_\ ICO:_3ZOS!\<?\C_ /\ !-/_ +&S5_\
MTQWM 'Z?5P/[4UQ):_LX>.)(I)(I%T6YPZ,58?NST(KOJ\__ &K?^3:O'/\
MV!;G_P!%F@ _X96^'7_0GZ+_ -^?_KT?\,K?#K_H3]%_[\__ %Z] HH \_\
M^&5OAU_T)^B_]^?_ *]>'_\ !13X >"_!?[*>I:AI/AO2[&]CU[P]"LT46&"
M2:Y812+]&1V4^S&OK"OG_P#X*>?\F=ZI_P!C%X9_]2#3J -;XI?!+PG\-W\*
MZIH.A6.DZ@OB?3(1<6RF.38]PJ.N0>C*2".X)%>U5\/_ +='[3>I>$/C1<>'
MX?CE\,?#MOH^K:9=1Z!J'@&_OM0T@A(9OM$]VFHQQSQ@GSC&D,9*,$W!@7.I
M^S5^UYJWQ/\ VCO">@W/[2'PS\;V]^;LOX>\._"S4=+N-3V6LKC=>S:C<I;B
M,KYG*#?L* Y88 /8O%WP8\=?"3Q/?>(/A!?:'-8ZM<->:KX)\13RP:3<W#L6
MEN;&ZB2233YI6.Z51%-;R.#((8II9YY<5OVE/CI-JDFGP_LUWR7"PHRZA<^/
M-*CTEI3G<OF(7N@JX!W?9<D-PN017T)10!Y'X(^"'B?QMXQL?%GQ5U+2=1U'
M29?/T3PYHOF_V)H,F7Q.SR;7OKK:P GE2-(]H,4,3&1Y/7*** "BBB@ HHHH
M **** /RP_X)Z_\ !03X8W__  5T^(WP)_9L^!MY!X)N-9U+4_B;\18;F[N+
M2?68TG.Y5.^.*-[A'C61I%$I+;$ 4,WB'[27_!R+X'\*>,/BG\._AW^R%=?$
M[]G;PA>RZ-X]U[38?LNEW ?-O+))#%9O;I&_E,$-Q(IF6,#Y!R/(?^"7'_!6
M#X<?\$0_@A^UI\(OBLNJ:%\;-$\>:QJNAV@TB>?_ (2.5K6*"VB$JQLD:++!
MYH>9E1H[H,I;)!S_ -DGX_\ AW_@EC_P:]^(K[QIHNJ:MXL_:VN?$EKH-O\
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MV?\ ]1$5] U\_67_ "</'_V4V?\ ]1$5] T ?*7_  7-_P"40/[17_8D7_\
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M\.>(X+HM<>&)R1]G5KC)81AB!#<$Y0XBDR"K-=_XGFM^./\ F$Z!\9= L?\
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MTT\,(+*TS*X>2)-T=W&ZS1%G8&X/^#T^_3_TJ/\ V]$$W>Z_NO27_@#4^_\
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M>OV6K>%_"?P]T'4O+OM/EV^#?&WV6.V;3%!E5[>ZB540W>V&5/("B*\1?-7
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M !U_P4N^*?A[]HC]INWU@> _#K>?\+/AQK<QN6@M\DP:AJ>[)GE\LJ$$I=W
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M10 4444 %%%% 'S+_P %FO\ E%3\?/\ L3+_ /\ 1='[+G_*1O\ :G_[E/\
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M[.K7&2PC#$"&X)RAQ')D%6:[_P 3S6_'&/\ B4Z!\9M L>#^\AT7QWI4<G_
MW$(DE_Z:3Z;//_RW@N/]/CTS5(5L]:\2>&]%O+O1KNXEMO'7@6YMUDO=/NF4
M-/+' I93.5D#R0H6CO(Y%GA9VD5KD_X/3[]/_2H_]O1"[W7]W[7_ ( U/O\
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MM[&":/I\DVDS1?P6R?\ $O6ENEK>:5D_O44_^WJ4O[II[[G]IR<O*4G*2_\
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M;EE#33PP@LK3,KAY(DW1W<;K-$6=P;BO=6VB:1X)T_3]0U!M:^$^M-#/X?\
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M_P#<I_\ IKDH ^FJ*** "BBB@#YE\5?\ID? ?_9&?$G_ *?-!KZ:KYE\5?\
M*9'P'_V1GQ)_Z?-!KZ:H **** "BBB@ HHHH ^9?V=O^4H7[3'_8N^"?_1>K
MU]-5\R_L[?\ *4+]IC_L7?!/_HO5Z^FJ "BBB@ HHHH **** "BBB@ HHHH
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MO@?5HUCD\7?#W6IYH-=TB\^'FIJOAE_F^T@1(0%C#$F:'/[L@NB\L#Y;\5_
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M[>D88@17&[*'$;X!4G3O/AU\0]1^(EGIVL?$:+1_B%I,,Q\.:V-!@6U\16N
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M_/-833 CSH9@;SSJU\'Z[8^ -3O]+\43:Q\/=7GN+?Q;X9N/#%O+<:!+(/\
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M_:B$?[S]J;P\S=ROPGM5'Y?;30![#_PTSX7_ .?;QI_X1FL?_(M'_#3/A?\
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M5':$T^N_0]JHKX]_8N_X+E_ 7]O?XWV_P]^'NH>)[CQ'<6<]\B7VCO:P^7"
M7^<DC.",#O6E^U!_P6B^!_[(7[3MC\(O&5]XDA\9:A]C\F.TTE[BW/VI@L69
M <#)//I4U/#GBB&8O*)X"JL0H>T=/DES\E[<_+:_+?KL/ZY0</:*2M>U[]3Z
MPHHHKXLZ HHHH **** /F7_@LU_RBI^/G_8F7_\ Z+H_9<_Y2-_M3_\ <I_^
MFN2C_@LU_P HJ?CY_P!B9?\ _HNC]ES_ )2-_M3_ /<I_P#IKDH ^FJ*** "
MBBB@#YE\5?\ *9'P'_V1GQ)_Z?-!KZ:KYE\5?\ID? ?_ &1GQ)_Z?-!KZ:H
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MT/EO&RVJV-]JVK^++[5M)L;?1?BAHL,:>(O#KSXL_$MJ,B.6*0@;E(5O(N<
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MTA1'1F57E!9?+*L4XMO=I^BO?_/O;22U08JM3C%>ZI1=G92ERN-K*S:^!/\
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MC@;.)S:S0LT(^2YB963+D&3/_@]/OT_]*C_V]$[D]FO[KTE_X U/HUM1K/\
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M/+9VL,-M:6>N:U;V\$2!(X(DU:[1$11PJJH"@#@  #B@#XM^%/[+/P[^(_\
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MTZWL[.WAM;2UC6&""%!''"B@!551PJ@   < "I(XUAC5$5551A5 P /04Z@
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MX8?]%"\&_P#@X@_^*H_X4IKG_14OB!_W[TG_ .0:/^%*:Y_T5+X@?]^])_\
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M^L$OBSPI#X>>3[+<72NTTT,:/(H)4QLT<FT7*.9!^\SYU<CVM^'??3_TJ/\
MV]$Q^L07O*79Z2_ETBU/NMJ57K_"JGOU_8:MJ7BW3])U;4+?1OB;H\4C>'/$
M:P;;/Q-:C#2031J0#D*IGM@005$T)7:#&NC:SJ$GB#5O%'A?29++Q=9/&GC;
MP2\Z ZH0FV.ZMY&VQ_:/+CQ!<G;'<QQB"8QM&CV?$W?Q4\$Z)\-]$@U75;[5
M/A5XH5[OPSJT23OJ?AB:!P F55I?+CD($4P!:,D1ON4JQI^+?V@K?["TE]>:
MIIOQ*\,6\_\ PC6OMX9U&*U\40B,R/!<0+ &\MMB^?$!A2%FA92J^6<LK];_
M (WZ:[7[2VDO=EJ3[:@XV<HVLUJO=Y6[M.*U4+ZU*2]^A.U:B^4ZU'\+^%OA
MA_RSUCX"ZPI!!$EO+\/I(Y,$$?++;V,,T>"#LFTF:+^"V3_B7_"7_!4CXJ?M
M+6/_  4E^!7P)^&_Q$T+P[JFNZ-?:EI/BB]TM;BXG$<@0"X5=FR1DS'*$S%+
MY<<@1"QCC]@\&_\ !1#7-%\$7WQ$72--M/&%UJ?V3Q/X8L;*\6SO(#;[;6]W
M."BWH,3*K^:@G@1(I-I2.2U^<?%'BCP_XM_X+O?LA77A74OM&AQ^&=6@72TC
MD6W\-3JZ>=I]OYB)(MO&YRD3!A#N:)"L*111:8>G>:36GW*W31]$^GQ0EHO=
M9QYMC'##SJ0G[]]V[OF=D[N.GM''1U%^ZQ5+WVE6@T_2[;]@7_@HY8^,;K7K
M?]I+X7VVI7T*P7DD7AEE6\5/N&1=V&9!D*Q&X XSCBN6\2_\$EOV[/&NC_V7
MK?QQ^$6K:.MY)J,.GS>'9TM[6XDSYCQ+'(I3>69F4':69FV[F8G]?**])4X)
MW2_I[_>?$RQV(E#DE-M-)6OTC\/_ (#LNRT6A^-Q_P""+'[9QBC7_A;7P=_<
M,6A;^R-0S"2",K_I. 0&(^A/7)I;C_@BQ^V9=2,\GQ8^#;,ZA')T?4#YBC)"
MG-SR 23CU_&OV0HK2QS^TD?C+#_P0_\ VP+>0M'\3O@FFX$8&AWXZ]?^7GO5
MH_\ !%K]LYH$C;XM?!UDC(:,'2-0Q&1TV_Z3QCM7[(446#G:V/QMNO\ @BM^
MV9>;6E^+'P;D=5V;GT?4&)4D$KS<]#@9'M5>'_@A_P#MA6MPLL/Q0^"<++W3
M0[\>G_3QG\J_9JB@.9GXVK_P12_;)6T^S_\ "UO@S]G7&V+^QM0V(!C  ^T]
MB,CTJ.3_ ((C?MA7,_F7'Q.^"=U(P 9I=$U L^.F3]IK]EJ*+ YR>Y^1_P .
M/^"6?[>WP9U>XO/!OQV^$WA=KY EY%9Z#=21WN.5,@FE?++D[2,$9;'#-G0L
MO^"<?_!0RQ\-:OH8_:%^$LN@ZXTQN]*F\*&6R?SL^<HB8E0DA9BR ;2S,V,L
MQ/ZP45G[*#U:_I[G3''8B*Y8S:6G7^5WC]SV>ZZ'Y0ZC_P $[O\ @HSK/A_2
MM/O/VF/AS=_V#/'<Z==S:!+)>V<T8*I*L[,9"^QFC9F),B/(LA=9'#6Y_P!@
M7_@HY-XSA\0+^TE\+X=8BMOL3W,7AED:YM]Q98I0&Q(JLS,FX$H7?:5WON_5
M.BCV,.W;\-BGF.*>\W]KK_-\7R?5'PC_ ,$@/^":GQ2_8E^*_P 9/&WQ6\7>
M%_%GB/XL7]OJ5S<:+:/:QF=$"R,8V) +;=Q(/)8\"ONZBBM#CE)MW>X4444"
M"BBB@ HHHH ^?_V&_P#CTE_[%3P]_P"BKJOH"OG_ /8;_P"/27_L5/#W_HJZ
MKT[XW?$/4/AOX8@O+"UA999Q%/>3PS3V^GIM8^8\<(:5@6"H-H !?)8 8(!V
M5>*_%_\ :\B^%_Q-O?#?D^$H6L;6"X>;6_$3Z:TWF[SB-%M9MRJ%Y)(Y.,=Z
MZ3X7_%^Z\0>%-8U/4I[755TUEPFC:/?)+@CH(I07D;_<!KPSQC9^ _BK\;/'
MFK:YX7^(TUTEA8K;FTT_6K-XR(I>9$@V>BX+CH#CC- '6C]O6$A?W_PG_>?=
M_P"*ZF^;OQ_Q+Z/^&](OF_??"?Y?O?\ %<S<?7_B7UY#HG@;X>W'A?X0S3>'
M_BE)<:Y+$-;D4Z_MU$'2+N9A$0^&S<)%)^Y_A1B/D#5<;X?_  W!^)?_ !3?
MQ4_XE+@:3SX@_P!!']GPR?O/G^7]ZSO^]_A8'[N* /4O^&](OE_??"?YON_\
M5S-S]/\ B7U'=?MW0W%I,GVCX3K\I5C_ ,)S-\G'?_B7^^:\S3X?_#<WGPX7
M_A&_BIMU5'.JC/B'_32+)W'E_/\ -^\ ;]WV&?NYJCJ_@;X>P>#/BU<1>'_B
ME'=Z++<KHLK'7]NG!=+MI4$I+[5Q,TCGSOX6!/R;: .D\"_'[_A'HOAW;1:M
M\*;R3P)HS:7A/&$X:^!@AA\S'V$[/]5G'S?>QGC)-<^-<VJ_#;X@:&=2^%L2
M^,+FZG:Y/BVX(L/.B1-I'V#YMNW/5<Y[4V'0/"'@/XG>"[SPEIOQ2T#5);&\
M9[F73];OO,D"0E?W$Y82Q$Y#JH'RL/F5MC+)?_M$:?J/P%^+^DWVF>(;?Q%?
M2WUU=6D6B7K1V8>%8PS.T2[4+1L0SA3CJ%(( !T.K?M07&H_%70O$'F_#"-M
M)TR_L1:GQA<%IQ<26CEPW]G\;/LP&,'/F#D8YY[6OC'J1^"'BZWAB\#ZK877
MB&.ZO9M*\2RW-Q8_;M3C"#R6M$#!7?:277@$XS\M>F>)/CYILW[17A"[&A^.
M%2WT'6(BC>%[\2L7GTT@JGE;F4;#D@84E<XW#/SG\3?BA9WEM\0]NF^)$^U:
MI9.OF:+=)L \3M+A\I\I(^4!L$O\@^;B@#[$OO\ DZG3/^Q4O/\ TLM:C_9N
MG%K\)KR1ND>OZ^Q_#5[TUQ5Y\?--;]I/3KS^P_''EKX9NH2A\+W_ )I)NK<Y
M">5N*\<MC ) ZD5VO[/]C=6/P7F-Y9WFGR7FI:Q>I!=PM#,L4^HW4T19& 92
M8Y$;! (SR : /A/]@O\ :+U#]H3_ (*W?M$>+O"?A^RDO+[P3X4M9['4-4-O
M':)&;_9(94AD+;G9U*A,KY><G(%?;GC_ ,!>)_&/@/6I/%>N6]O8QV$T@TG0
MQ);QR$1,=LURS>;*N>2JK$K#Y6#+D'\Z_P#@@Y_RDB_:*_[$WPS_ .E.IU^I
MWQ(_Y)WKW_8.N/\ T4U %'X'Q+!\%?!\<:JD::)9*JJ,!0($P *ZBN9^"G_)
M&O"/_8%L_P#T0E=-0 5\O_"G_E'#HW_7RO\ Z>:^H*^7_A3_ ,HX=&_Z^5_]
M/- 'U!1110 4444 >?\ [,7_ "24?]AK6/\ TZ7=>?\ _!3S_DSO5/\ L8O#
M/_J0:=7H'[,7_))1_P!AK6/_ $Z7=>?_ /!3S_DSO5/^QB\,_P#J0:=0!YO_
M ,%U/B?K_A;_ ()\^+O#OP[^(&F^!OBYXB?3I?"^[QA:>&=0NH[?5;&6_-O<
M7$\ VI:>=YF''R,5.=X!^Q;:YCO+>.:&1)895#HZ-N5U/(((X(([U\(? ?X;
M^$[O_@JI^T#HGQI\-Z#KOCKQE'8WO@+4?$5K#=Q:OX82V*RV&FI,6"+:S!C=
M11I'O>997$F?,&Y\&;!?V$/^"D^D_ SP-OF^$WQ2\,ZCXNLO"T;-)'\.KRTF
MC6>2T!8_9],NFF0+; "**XW>5L5S&0#[6HHHH **** "BBB@ K^03_@D)_RE
M&^ 7_8\Z7_Z4)7]?=?G#^SC_ ,'"W[*W[0OQZ\(>!O"OA7QA:^)/%FJV^EZ;
M-<>&;2"**XE<*A9UF+* 2.0"1Z5_2G@/Q?G&2Y/GN'RO*YXR->E!5)0ERJBE
M&NE*2Y9734I/=? ^^GCYIAZ=2I2<YJ-GIY['Z/4445_-9[ 4444 %%%% !7\
M@GQ._P"4N'B'_LKUS_Z>6K^ONOSAUWX'?\$TIOVBKR^U"^^#_P#PLAO$;SW*
MOXLG6\_M;[268&+[1@2?:,_)MQNXQVK^E/HZ>(E'A6KF4JV#KXCVU*,5[&"G
MRV<M9W:LM=]>IX^;81UU"TDK/J['Z/4445_-9[ 4444 %%%% 'S+_P %FO\
ME%3\?/\ L3+_ /\ 1='[+G_*1O\ :G_[E/\ ]-<E'_!9K_E%3\?/^Q,O_P#T
M71^RY_RD;_:G_P"Y3_\ 37)0!]-4444 %%%% 'S+XJ_Y3(^ _P#LC/B3_P!/
MF@U]-5\R^*O^4R/@/_LC/B3_ -/F@U]-4 %%%% !1110 4444 ?,O[.W_*4+
M]IC_ +%WP3_Z+U>OIJOF7]G;_E*%^TQ_V+O@G_T7J]?35 !1110 4444 >8_
MM!?\C?\ #G_L,WW_ *9=2KF?V(O^*:\*_P!@GY8[C1-%\16J]ECNK%(9 /\
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M0,H>$(RRV4L:+"3"8DLCV,]K=N]O+S2[?:IO:\2WF6'NYNIK>3>L7*Z5I/\
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M,Z=XZ\8:E)I-^R^(;2TACCC\R7R#'%(IW,D14_ZP?=)Z&@#VSPI_R('[-/\
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MX^!8I$62.3PW8*ZL,A@;6,$$4 =C8WL.I64-Q;R++!<(LD;KT=2,@CZ@U+7
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M?/$@7$C@!%/4@#+,.@.*_3:OG#1_^4HNI?\ 8E2?^CK.G83E)Z-_TMON+_\
MPWM'_P!$W^('_@''_P#%T?\ #>T?_1-_B!_X!Q__ !=?0%%!)\__ /#>T?\
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M=:M1J6YH3G*496:>L6[.S2;CTMS1.C"Y+@,/4C6P]*,91M9Q:35W>-I]+O\
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M7,W&^&21,C! <D$$ U]^_LQ?\DE'_8:UC_TZ7=>?_P#!3S_DSO5/^QB\,_\
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M "BBB@ K^03_ ()"?\I1O@%_V/.E_P#I0E?U]U_()_P2$_Y2C? +_L>=+_\
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M7S+XJ_Y3(^ _^R,^)/\ T^:#7TU0 4444 %%%% !1110!\R_L[?\I0OVF/\
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M_:@_[+5XM_\ 1DM 'ZU4444 %%%% !7G_P <_P#D.?#O_L:X?_22[KT"O/\
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M?$6M7U]X:OKJ&X\">.[>[66_T:\=2EM#+<L'5I664QPW$@>.\CE:VN1(\O\
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MQ.2Y:XM%!$@8SP[G9EN;>M:+=#5=)\+^*-6N+?6K>5I/!/C:-$\VXDV$FVG
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ML'5I664QPW$@>.\CE:VN1(\O^G+_ ('7[M>W\LNFS*UO9[^]]G6_VTX?S?\
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MJ:O:/S,*\_\ VCO^15\/_P#8UZ)_Z<8*] KS_P#:._Y%7P__ -C7HG_IQ@H
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M8&77-;CTZX\Q22L;03R$K@C#;HUY.1C/%>+_ +%7B_2O%?BF!=+U*QU!M/\
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MW\:-2\+_  __ &AX8=7\8ZEK7V/2-(UN2.""YNYC;,-L*$QM$@6-V1=R1#
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M,KU;N:Y4[I:Z?@?:E%%%?Q0?1A1110 4444 ?,O_  6:_P"45/Q\_P"Q,O\
M_P!%T?LN?\I&_P!J?_N4_P#TUR4?\%FO^45/Q\_[$R__ /1='[+G_*1O]J?_
M +E/_P!-<E 'TU1110 4444 ?,OBK_E,CX#_ .R,^)/_ $^:#7TU7S+XJ_Y3
M(^ _^R,^)/\ T^:#7TU0 4444 %%%% !1110!\R_L[?\I0OVF/\ L7?!/_HO
M5Z^FJ^9?V=O^4H7[3'_8N^"?_1>KU]-4 %%%% !1110!YC^T%_R-_P .?^PS
M??\ IEU*MK]G#_DWCP'_ -B[I_\ Z31UB_M!?\C?\.?^PS??^F74JVOV</\
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MGX;^'TET^@^']#T-[T@W#:?8Q6QG(SC?L4;L9/7U-<W\<_\ D.?#O_L:X?\
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MVGT\Q>8<[?,($Q7=R0),?Q5] ?$S3+G6_AOX@LK-9&O+S3;F"!8R QD:)E4
MD@9R1U(^HKX1T[0=)TF72]'N_P!DN&;5KBS:50^I7"RW*P^6LLFW[*>C2)GG
M@N* .XU?Q3\%6^!7C:./4?A;_:DGB*\:R5;BP^T- ;\%#&,[MGE\C;QMZ<5V
M5WXO^ 9_:%L)%U3X0?V0/#MRLCBYT[[,)_M-N5!.=N_:'QWQN[9KQ*6X\,0:
M+>:BW[)MBMCI]P]K<3'5;C9#*C^6R,?LO!#_ "X]:MMI6B1Z_'IA_9%MQJ$E
MNUTL']IW'F-$K*I<#[+T#,HSZD4 >G?L]?LV6?Q7\0WVLWFBZ)8^$=+U[5WT
M6>QMXXY=5BDU*XFBFCE0 B/88U21#Q&H6,JKR;O7_C!\<?"'P7\4+I,>J^"_
M#_B_Q+$)WN-5N8+.*"!"5^U7)+(TH4L1'$&#RMD H@EEB^9D^+I@\/MJ"_LX
MZDFG0W9T[S1XEO1&DZW!M3%_Q[?>$P\O']X8JGJ7]G:[XLFM;S]D[[9K+0+=
M2"?6+J2=HLE%<EK4G&5VCZ8H [BW^+?PSOOV<_"MOJ7C'P3JFLVOC&UU"8WF
MIV;W2[]=66XG*9 C5HV=WV*J;68X"U1^%VG_  -\)?'3Q)I=_P"*/A[?>&X=
M$L/[&NVUZ (BBXO=T#R>;AY8U:-<C),:Q%LN69N"2X\,2:%;ZFO[)MB;"ZN4
MLX9_[5N-DDSS"!4!^R_>,I" >IQ5N+2M#GUZ?2U_9%MVU"UMX[J6 :G<;TBD
M:14<C[+T9HI #ZH?2@#T[P1\/?!,W[%>E^*/#\.FRZQI\-L1J%C=EWM[A;B/
M(W*V%<9Y'49KZTKY&^%&F9_9!\<:Q:^$X_ ^AZ_J-K<Z9H\=RUQ'%&HM(VE5
MF1#AV0]5'W>XP3]<T %?,/\ P2;_ .3;=6_[&2Z_]%05]/5\P_\ !)O_ )-M
MU;_L9+K_ -%04 ?3U%%% &':_##PU8^*$UR#P_HD.M1JRK?QV,2W0####S N
M[!'49YK:DC65"K*K*>H(R#3J* "O"?\ @I)_R:)K_P#U^Z;_ .E]O7NU>$_\
M%)/^31-?_P"OW3?_ $OMZ /7?AU_R3[0?^P=;_\ HM:V:QOAU_R3[0?^P=;_
M /HM:V: "OSL_9UT+7+O_@JI\;I_"NH6UCKNG1W5U%!>_-::LGVFVWVMPVUI
M(XV\P[98ANB<1MME16@D_1.OS=^#NE:#KO\ P54^+UGK6HW.AWEQ=2IH6KVQ
MV7&F:D9;<0O'(59$=E,D>V4&.82M ZR+,8GQK_PW_G;\3T,J5\7!>?\ +S]-
M;QZKO;5*[6J/JS2M5ABL];\0^'M$O+S0[RXEM_'?@2XMEEO=-NG4-/-% I96
ME99!)+"A:.\CD6> N[_Z7#=VFC:7X-TW3=2U*36OA;K30W'AKQ+;W9>X\,SL
M1]G5KC)(C#$"&X).W(BDR"K/>/\ ;7B#QK_S"_#_ ,9/#]E_TTBT?QOIB2?\
M#?R/,E_Z:3Z=/-_RVAG_ -.KZ5JL,=GK?B'P]HEY>:)>7$MOX[\"7%LLMYIM
MTZAIYHH%+*TK*X>6%"T=Y'(L\!=W_P!*\G_@]/OT_P#2H]/BB?HBO>ZW]W[6
MM_L-3[_\^JNTE^[JEB]LM6U?Q98Z3JU];Z)\4-%AD?P]XA2#%GXFM1@R12Q@
MC<IPOGVV04(6:(C:K(:/K&H2>(-6\4>%])DLO%UD\:>-O!+SH/[4PFV.ZMY&
MVQ_:/+CQ!<G;'<QQB";RVC1[.C=VFC:9X-TW3=2U*36OA9K30W'AKQ+;W9>X
M\,SL1]G4W&21&&($%R2=N1%)D%6>]>V6K:OXLL=)U:^M]$^*&BPR/X>\0I!B
MS\36HP9(I8P1N4X7S[;(*$+-$5VJR/6_GIUUOTUVO;9[37NRU)<8\MG;ELTT
MT^7EO>2<5[R@I:U*:]_#SM6HOE,I'\+^%OAAD;-8^ NLJ001);R_#^2.3!!'
MRS6]E#-'@@[)M*FB_@MD_P")?JZWHE\NNZ3X9\3:M-9^)K.21O!/C985W7S;
M=SVERB[4,Y1/WL'RQW,:>;%Y;QLML:/K&H2>(-6\4>%])DL?%UB\:>-O!+SH
M/[4PFV.ZMY&VQ_:/+CQ!<G9'<QQB";RVC1[/)5_"_A;X8;ALUGX"ZRI#*1);
MR_#^2.3!!'RS6]E#-'@@[)M*FB_@MD_XE\Z)=+6\TK+\5%/_ +>I2_NFGORG
MU<F_*4G*2_\  9591_[A8ZEVKK7S3]KV^N-;_L^^AL;;0/B7I[W]OK^DO.WV
M+6+7^P-7VW<1P/-4QK*L$Q *$M%* 5*KUWP*FTO0/V;=%OK*V7Q1\,=7TB*T
M\5:!+;FXDT*=H%%U(D!!+0L69I[?!X8RQ@AF63F/VV-)U:VT?PMX=\375T^I
MZ=<:M+X>\90P1K)?VXT'4V>TN2%VQSMLC66,!4N4'F1;&5TM^R^ -Y>:KX"\
M.ZIX<LUT?XB:'X>TY-8T&YE$=OXIL1 HAF5^AW*#Y-P.8V#0R@895O\ ._SO
MUTVO;=;27O1U.5-735N7E35G[MKVBU-^\H)Z4ZC]ZA/]U5]W4Z#5M)M[;3M%
M\.^(M:OK[PS?74%SX$\=VUVLM_HUXZE+:&6Y8.K2LLIC@N9 \=Y'*UM<B1Y?
M].L,NM>(/&JQR-I?A_XR>'[$M%*JR1:/XWTQ)!D@9=_(\R4!D)DGTZ>8<S0S
MH]]2LKW1]*\'ZEJ6FZ8VM_"W6VGMO$_ABYL_,G\-S-D7)%L03Y>6;S[;!QN,
ML8(9EDEU;2;>VT[1?#OB+6KZ^\,WUU!<^!/'=M=K+?Z->.I2VAEN6#JTK+*8
MX+F0/'>1RM;7(D>7_3I_X'7[M>W\LNFS.BSO9[^]]G6_VTX?S?\ /VEM)?O*
M8[2=62.'6O$7AW1;RXTZXN)(/'7@6>%9+NQN64&:>&$%E:9E8.\:%H[N-UEB
M+.P-Q7N+;0]'\#V.GZA?'7/A'KAAFT+78;IC/X6EW P S@[UB5]ODW&=T+ (
MYQM87F76O$'C58Y&TOP_\9/#]B6BE59(M'\;Z8D@R0,N_D>9* R$R3Z=/,.9
MH9T>^ATG5DCAUKQ%X=T6\N-.N+B2#QUX%GA62[L;EE!FGAA!96F96#O&A:.[
MC=98BSL#<'_!Z??I_P"E1_[>B";O=?W7I+_P!J?1_P#/FM_W"JGC?[9=KKEQ
MXCTO1_$-]_9_BW2/#.MG1/$4*I';^)H=UBS0RP@@&38K^=  %X$T10@"'VK2
M-7U*Y\1ZMXG\,:2VG^-M/:)/&W@E[E%76@$V175O*^R/[1Y<6+>[.R.YCB^S
M7'E-$CV'@W[7-EH^B>&M&MY=07Q%\,]6\-:I-X<U&-VEFT%S-I[1JTV<B%7$
M8AE)W1E@C' 5J[VV_:%\/^+O$%QIVJ>+(M!^('@6\N-,TKQA=:7/9V&J[ &G
MM+M72-/NJGVB#<J'$<\+1L%,%)-O2_Z^3OWM\,GI)>[+4SJ2IQC[]DK-:IJ-
MKWDG!:J'-9U:4??H3M6H>[='412^&?#/PS:6)5UKX$ZT&6:%HY()O 4L<A5P
M4(6:WM(9HR&0A)M+FB/"0(18Z>M:+=+JND^%_%&K7%OK5O*TG@GQM&B^;<2;
M23;7 &$-P44B2(XCNHU+H%966*+PSXGNM?U;4O&'@[3XX?%UN(?^$R\'+>1M
M%KR;-D-W:SL4B:X,46+:[.R*YCB%M<>4T2/848I?#/AGX9M+$JZU\"=:#+-"
MT<D$W@*6.0JX*$+-;VD,T9#(0DVES1'A($(L8TMTM;S2LG]ZBG_V]2E_=-O?
M<^O-?RE)RDO_  &564=G_"QM+M631J6MWK&K>,+O4=.M+/1/BIHENBZSHS3%
M-/\ %EDI(22-R.5/S>5/@O"Y,<@*EE-*TO-)T_PIJVJ:7I,FM?#36GGMO%OA
M*YL_-N?#T[Y^U.MKALJ=Y-Q:@$.&\Z'<699[>M:+=#5=)\+^*-6N+?6K>5I/
M!/C:-%\VXDVDFVN ,(;@HI$D1Q'=1J70*RLL3K2[UC5O%]WJ.G6EGHGQ4T2W
M1=:T9IBFG^++)20DD;D<J?F\J?!>%R8Y 5+*7K?S_&_73:]MUM-:K4S3CRW5
MK63T;Y>6]HM2>J@GI";]_#S_ '=3W2KJ>F6L6EZ'X?\ $&N7NH>%]0N8+KP'
MX\M;Q9K[1[MU*VT,MRP=7E993'!<R!X[R.5K:Y$CR_Z=:8:UK_C589FTOP_\
M9/#]D6AF57BT?QOIB.,D#+N(-\HW(3)/I\\PYFAF1[VE9W>DV'A/5M4TO29-
M:^&NM//;>+?"5S9^;<^'IWS]J=;7#94[R;BU (<,9H=Q9EG?J6FVL6EZ'X?\
M0:Y>ZCX7U&Y@NO ?CRUO%FOM'NW4K;0RW+!U>5EE,<%S('CO(Y6MKD2/+_IQ
M_P #K]VO;^6739E:WL]_>Z:W^TG':]OXM+::_>4]232]45X]:\2>&]%NIK6:
M=[?QUX%N(E>ZM[AE!EFBB!*&<HP9D4F.[C99(RS,K2U9H=#TKP-9:?J%ZVN?
M"/7#%+H>N17#?:/"LVX&!6GSO2-),>3/D/ X".0 K#0*ZUKWC58IFTOP_P#&
M3P_9%H9E5XM'\;Z8CC) R[B#?(-R9DGT^>8<S0S(][%IFIJT>M>)/#>BW4]I
M/.]OXZ\"W$2O=6]PR RS11 E#.48,R*3'=QLLD99F5I3_@]/OT_]*C_V]$$[
M:K^Z])?^ -3Z-?\ +FL_^O570EU'3=6U#Q7INBZUJ4.D?$C1XY6\+>*EM@+;
MQ';X#2V\\2E58LJ*;BU!4,$6> QM&#;FD:OJ5SXDU?Q-X9TAM/\ &^GF%/&W
M@E[E NM*$V175M*^R,W!CBQ;W9V1W,<7V:X\IH4>PSYH=#TKP-9:?J%ZVN?"
M/7#%+H>N17+?:/"LVX&!6GSO2)),>3/D/ X".<;6&AJ6FZMJ'BO3=%UK4H='
M^)&CQRMX5\5+;#[+XBM\!I;>>)2JL65%-Q:@J&"+/ 8VC!MWK>Z\NNM^FNU[
M?#)Z37NRU)<8\MG:UI)IQ:CRIWFG!>\H*6M6DO?P\[5Z#Y;HRXY/#/ASX9M-
M"JZW\"]:#+/ T<D$W@26.0J_R$+-;VL,T9#H0DVF31'A(4(LM/6-'NCJ>D^%
M_%&K7$.L0RM)X(\;QHGFW$FPG[//@!/M'E@AXSB.ZC4LH5E=(ETC5]2N?$FK
M^)O#.D-I_C?3S"GC;P2]R@76U";(KJVE?9&;@QQ8M[L[([F.+[-<>4T*/89<
M<GAGPY\-&FA1=;^!>MAEG@:.2";P)+'(0_R$+-;VL,T9#QD)-IDT1X2%"+):
M6\OFE9?BHI_]O4Y?W33WW/KS7\I2YI+_ ,!E5E'9_P +&TNU9-&G:W6L:IXQ
MNM0T^UL]%^*NBVZ#6-',I33_ !=9*2$DC<C.W)/E38+P.3'("I(:I:7>EV?A
M;5]8T?2)M<^'&N27%MXP\'W-EYUSH4[Y^U2):X;<#O)N+0!A(',\(9V9;FWK
M&CW1U/2?"_BC5KB'6(96E\$>-XD3S;B383]GGP AN#&"'C.([J-2RA65TB\U
M_:-\<:CI6L:3>1K<>&/B-:W$J>(K"PU*6RMO$VFVVFWUVLT4B\NI^S%8Y&!:
M%Y"D@(X:E%MV_J_Y7[K:2U1SSJ1A3YTDU9/1NW+>R:;][D3^"?\ $H3O3FFK
M'H.H6%G%H^AZ!X@UR\U3PCJEQ;W/@3QW;7@FO=(NY!MM89;IMX>1A)Y=O=2;
MTNTE-M<"220&_M2)K6M^-8X)I--T'XP:#9EK:Y57BTCQMIJ.,\99_)#R#<F7
MFL)I0098IE:[^=?#'@[QAXI^#5]XBTBQM]:^'FM6TB:UX6C\7:A<364D[A[I
MI+?[%R-DLDD\"I*9MPDB#ESYVAJGPG^(PT;0;/Q%KMKK&DZY?BY\'^,+'XA:
MAY>D32J$LHWN&M)<SRK,\<-R5$-P'\B0%YD2Z)126_;^K^3^%[K9Z$TJTYRM
MRO[5[KKHVN32[<7>K37NS2<X>\>[:1J^S^V/$GAO1[N2WDG>#QSX&GC5[JVN
M&4&2>&,$JTY1@S*I,=W&RR(2S RT[FVT'1/ =G9WEX=:^#VM&*;1M9AN&$_A
M"8,##^^!WI C@>5-D-;, CG9@Q^0I\'?BUJ?Q/@TZ;4-.T7XC:;8P.=1;QKJ
M4=KXIT]2IG\I/LK,\,<LK*4,GFVTLB,08YT-Q7T;X=?$272M>US0=-NC'#)-
M%XN\&-XXO6O5NV +RB,6>TR,C;V"F1+F,JT99F4R#C;?S_X.G_I4?^WHFE.L
MI6<;[1>[7^!J;6C6U*J]5_"K*S/=M1T[5-4\4Z;H>N:E'H_Q(T=)G\*>*TMA
M]G\008#36\\*E5;<L:FYM RAQ&L\!C>-6MC2=6U*[\3:MXD\-Z3_ &;X\TWR
M5\:^"FND\O7$V;(;JVF?8C3&.(BVNR$2X2$VUQY+P@V/S/\ $3PKXN^%GP-A
MUK4&D\5?#2::VFTF;2O'U\S^',,!"RRO:*55)-HB8*&A8;6.-H'5ZI\%_BI<
M>+=-T/5-4ATWXA6=K,?#OB>3QK?BWU>,D/-;%%L_G^6*)I[?='O"":+88PT!
MRO?TZ]>FNU[?#)Z27NSU)C4IRYJ>FB::<6DHWO*\%[RI\RO5I1]ZA->WH/EN
MCH?!-]X3T+QCX\DM;+^U_@OJUAIR7\+"2*3P8ZO=!@86"RV]O!,D@D0[9+"1
M!\J11M]F_+[]MC^S[/\ X)??M'V.O+)=7D>EV\GA_5SD&67[79[X'9>!(8=Y
MP?ED52P&Y,#]!_"'A#XC:W\9O'=UX9\.ZCH_C+PVMJWB[2)/']R#XI1H9EM&
MMY_LJH9@D*^5-(RH8W$4H1E!M?SS_:A:^T7_ ()+_M.#3;<ZKX3U#1+6"6(8
M670IUU*R96*.%<Q!E$13&^%]OR!-_DNFK22_3I?MO:_3>F_[K,\94YJ%25]=
M;MR5^9Q>\U[OM'%:37[O%TT]JT;'[]:=_P @^#_KFO\ *IJAT[_D'P?]<U_E
M4U>R?FH5Y_\ M'?\BKX?_P"QKT3_ -.,%>@5Y_\ M'?\BKX?_P"QKT3_ -.,
M% !^S%_R24?]AK6/_3I=UY__ ,%//^3.]4_[&+PS_P"I!IU>@?LQ?\DE'_8:
MUC_TZ7=>?_\ !3S_ ),[U3_L8O#/_J0:=0!] 5XKK_[#N@^(?VK+7XMR:_K<
M>L6KQ.NG)INC-:,8X1",S/8M>C(&>+D$'@87Y:]JHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#YE_P""S7_**GX^?]B9
M?_\ HNC]ES_E(W^U/_W*?_IKDH_X+-?\HJ?CY_V)E_\ ^BZ/V7/^4C?[4_\
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MDU^&?[+$Z6O[3G[6$LC+''%\?]6=W8X5%&KQ$DGL .] 'Z^?!CQG:> /V0_
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MMU;_ +&2Z_\ 14%?3U?,/_!)O_DVW5O^QDNO_14% 'T]1110 4444 %>$_\
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MFCWEQ%=>!/'=K<+)>6-RRD0123D,K3E'*1RN&CO(Y&AF5V=EN?(_X'7[M?\
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MO-."]Y04M:M)>_AY_OZ#Y;HHQOX9\._#1YH576_@7K899X&CD@F\"RQR$/\
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MV36W<VQ) ?9%?^8R@$A+>0].: /NNBBB@ HHHH **** "BBB@ HHHH ^9?\
M@LU_RBI^/G_8F7__ *+H_9<_Y2-_M3_]RG_Z:Y*/^"S7_**GX^?]B9?_ /HN
MC]ES_E(W^U/_ -RG_P"FN2@#Z:HHHH **** /F7Q5_RF1\!_]D9\2?\ I\T&
MOIJOF7Q5_P ID? ?_9&?$G_I\T&OIJ@ HHHH **** "BBB@#YE_9V_Y2A?M,
M?]B[X)_]%ZO7TU7S+^SM_P I0OVF/^Q=\$_^B]7KZ:H **** "BBB@#S']H+
M_D;_ (<_]AF^_P#3+J58L.NW.A?L(:#]AD\O4M0\+:;I5@_]VZNX8;: _A+*
MAQ6U^T%_R-_PY_[#-]_Z9=2KF? W_%1^"?@)X?'S1_V5;:_=+_>AL[&-4_*Y
MN;5O^ 4 >T>']#MO#&@V.FV<?EV>GV\=M G]R-%"J/P %7*** "BBB@##^(O
M@>'XB>#[S2III;.28+);7<0'FV-PC!X9TSQOCD57&<@E<$$$BJWPK\<3>-O#
M<G]H0Q6>N:3.VGZO:QD[;>Z158[<\^6Z/'*A/)CEC)Y-=+7G_P 1?^+8>-+7
MQI'\FEW*QZ;XC4?=2#)\B\^L,C;7/'[F5V)/DJ* ./\ VK_B)XN\.>/O OA_
MPGK4>AR^)/M*23/:17"[UN+")"0ZM\H%Q(<+@DXYXQ7P[_P1O_9A\7WGQD_:
M;\;Q^(O#][JEG\<_%FDWT.HZ8TEO>RJ82TVV-TVY,S$+T'IP*_03]H/]GB?X
MV:KH-_9Z[_8=]H23QQ2&VDF_ULEM+N4QS1.CJULF"&(P6&.A'YK? /\ X)Q?
MM.^&OB9XT7X:?M+Z1X3T3XF:UJ?Q#GM;KPW>7,D-S<W0@E1G%\N\_NE.\\D#
MF@#[KU3XE7^CZG<6=Q/X#6>UE:&0)X$U:10RD@X92589'4$@]C4'_"V[K_GX
M\#?^$#K%?/'_  [F_;B_Z/$\-_\ A'WW_P L:/\ AW-^W%_T>)X;_P#"/OO_
M )8T ?0__"V[K_GX\#?^$#K%2VGQGO["X6:WO?!<,R?=>/P'K*LOT(KYS_X=
MS?MQ?]'B>&__  C[[_Y8T?\ #N;]N+_H\3PW_P"$???_ "QH ]J^&OP:\;>*
MIH;CPK\2+;2FT73(M)E,/AVYM#-&)IIE+?:E.XYD<?)@  9KF?BUIWC[3?'7
MA;1KWXM:A=:C'XABACQX=E$=M*T$P$@D$&Q^#C 8_>)[$CYM_;0_9P_;<_9%
M_9-^(GQ0N/VL="UF'P'H%WK;V,'A>]MY+L01E]BR-?L%)QP2I ]#7HUGXP\2
M>-OVG?A1HMYXM\6MI/B"/2]4FM_[9N6\B:73;:5S&S.67+7,@'.0#C/7(!Z1
M\7O$?QJ^#FOZY:W_ ,0IFM=(TDZK'=Q6*3^?E)O+0Q) 2N7@=2S$*HP2><5]
M)Z7^U'X1FTVW>6ZUGS7B5GQH&H8R0,](,5XA^UM^S3X?\!I'KEA=>(?[7U:R
MU>*\NYM5FEFN4CT>\E5&9CDKNB4$'@KD'@FOJKP]_P @"Q_Z]X__ $$4 <7_
M ,-/^#O^?K6O_"?U#_XQ1_PT_P"#O^?K6O\ PG]0_P#C%>@44 >9>)/VIO#-
MIX>OY;&;6I;Z.VD>W0>'+^3?(%)4;3&@;)QP74'^\.H^%/%'[?7Q6T7Q=I.O
M:QI/B#3]0L+*ZM+5KCP\L"/%*T#S?*PYP8(N>WXU^G%5=4T.RUL0_;;.UO/L
M\@FB\^)9/*<=&7(X8>HYH _,VY_:?^+UWX1U;0W\)^-/L.M7LNH7('AD[C+)
M-YS8.W@;^WIQ6I)^V=\:I?&L.OMX5\8?VA!92:>A_P"$6^3RGD21N-O7=&O-
M?I110!^8;?M/_%YO!TVA?\(GXT_L^;5GUIA_PC)W?:'OS?DYV_=\\DX_N\5T
M5A^U1\?+_P 6-XDMO OCZXNYK)=/\V/P>[Q&)9&? PF,[F/-?HU7.^,OB_X3
M^'4PCU_Q-H.BS,I=8[V_B@D90,DA68$@ $\#H* /SKTW]H_XR7GA33_#=KX-
M\=7%II^H1:I!%'X6+R>=%="[4G"Y($J@D>G%:]Q^UQ\=?#OC>ZUVX\%^.;74
MM2L8+"3SO"3(K0P23.F%*]0UQ)D]\CTK]$O#OB.P\7:':ZEI=Y;ZAI]Z@EM[
MF!Q)',AZ,K#@CW%7: /S7\%?MG_&KP!X4L-%T_PKXP6QTV(0PB3PMN8*.F3M
MYK4_X;^^.W_0K^+/_"4_^QK]%** /SK_ .&_OCM_T*_BS_PE/_L:N?L?_M;:
MU^S%\,[[P_<?"7XD:LUUJLVH)-'ISQX5TC4*04ZC8>1P<]J_0BB@#Y,_X>A:
MC_T1'XF_^ ;?_$4?\/0M1_Z(C\3?_ -O_B*^LZ* /DS_ (>A:C_T1'XF_P#@
M&W_Q%'_#T+4?^B(_$W_P#;_XBOK.B@#Y9G_X*.>(K:S^T2? +XM1VX 8RMI<
MH3!Z'/EXKS7]IW]M+6OV@O@EJ7AR'X1_$#18[FZLGEU&]M"EK:A+J)QYCLH5
M VS:"S 9/6OO"H[RSAU&TDM[B&.>"92DD<BADD4\$$'@@^AH \C^%7[5?A&[
M^'FDK+)K5O<6D/V*>(:1<W(CEA)AD D@22)P'1OF1V!]:Z#_ (:?\'?\_6M?
M^$_J'_QBNZL+"WTJSCM[6&&VMX5VQQ1($1!Z #@#Z5-0!Y__ ,-/^#O^?K6O
M_"?U#_XQ7YB_LT_'_0]?_P""SW[0^BW6OZIX9DTJ**\\+ZK%874TTU]=.9VB
MEMPF94\F*0&%PN8@^"KHLB?KU7Y)_LY+X=\._P#!<+]KZ3Q=9WE[X5UC1],_
MM:\0[(] 5+IS'?22(RRP1Q211-]IC):V?9.3''%)-%CB?X;O;Y[?>MO7IOT/
M4R6_UVFHIMMV2C9RNTTK1EI/_KV_XGP77-<^Q8/VF=+N-?N/$&EPW^C_ !&L
M(D7Q!X=_LN^-GXFME)2.:-_(&"0I\BX8*1@Q2@ ?NX(_V@OA_I>BWTFFV^K:
MU\,_$#RP^(?#D_AZ],GAR=B?/D2/R<",,29K<'*MF2/)+*_H&LZ-J#^(-)\+
M^*-6DLO%ED\C^"?&R0(#J9";I+6XC7:GVCRX\SVPVQW,<9GA$;1NEHEC?:MJ
M/BW4-7TC3[?1_B;H\4:^(_#C3[;/Q/:C*QSPR, #D*P@N2 05,,P7:1'Y5G?
M[^FM^NFU[;QVFO>CJ??1<>5-6M:+NF^7E3M%J3U4%+2G4?OX>?[FM[MF<%=?
M'3PA>:?I_AWQ!XB\27>DB6*\\$^.+?2[QK_3[A@4AB>5H&#S[9"B2LKQW<3O
M%.KEV%Q,_P"T5I^N^(8[PW+>'_B[H5LT(9=#U*/2?&NG1L#\RB%Y5M]\W!8/
M-83RM@SPRG[;U4$^BZ=X,U#4],TZ37/A7KC30^(_#<UJ6N/#4Y)^T.EOC<J!
MB3/; 94YEC!)97L:EIL+6>B^'?$>M7EYH]Y<177@3QW:W"R7EC<LI6"*2<AE
M:<HY2.5PT=Y'(T,RNSLMRO\ @=?NU_\ 29?]NR*]?[R^'6_VTX=_^?M+9K]Y
M3.-T7]HOPH]W>:IX;TOQ!>Z7KUQ]F\9^!;CP_=27%A=3JIEFBC$;1><1(&FA
M5C'<H_G1%I&/VK7\8^)/"_P\\ Z9:^(-5N]8^%.N-%<>&/$EB9;J[\-S\&!3
M-&'?8"1Y%QR5_P!5)D$,_0D:UK_C7_F%^'_C)X?L>#^\BT?QQIB2?\#<0"27
M_II/IT\W_+:&?_3LF]\>:/X,\/Z]XOL[5;;PO<7,MMX]\&:H(EN-+NG7=/-%
M$24:9E?S)84+1WD;K/ 7=\W1_P 'I]^G_I4>GQ1!7O=;^Z_BUO\ 8:GW_P"?
M579K]U5/)/VH?%<GQ+T#PO!>326?C327UE=+\2#27MX]?L%T+4VG0QRH"A8K
M&DT6!M+"2(CY2FO\$OVC-!\+^ -%U[PM!KD?B;3](L(/%_A Z5<_\3H);K%'
M=P.(_*6Z,<7[F<LL=Q$BPS%#''):<[^U->P^-_ACI^@>"]0T?XD>#]+U036-
MS'K:+<>&7N+"]M+>&XG+<1K+<(T,LC#_ %9BD)RK/VGACQGJW@KPGX-T/QOH
MNK?#_P")7A?2Q;:)KT=JNH:=JEM$B+)#.+:1RT3!%,T1QLVK.K1$*T>G*_G?
MOK?9:[7[/:2]V1Q^TINST<)1:V?(XWYI)Q7O*G?6I!/FH3M5I.UD.7X]?#/P
MMX-ET]9]1UKX(ZHKAD_L;48&\!R0L20C>4KQ644L7RA2LVFS1@+BW4"PNZE\
M<-#NKZQT'Q'K^N6OB'29"W@WQJOAV[$MZ64EK:XB$*AIBD>)H0!%<(HEC\MU
M*V_7^"_&K^*;J^\<>!;6%M?41-XO\)0WL4D6MKLVQ7EI-E8FG,<>(+K*Q74<
M8@F,;1(]G45_#'A;X8;EV:S\!=94AE(DMY?A_)')@\?+-;V4,T>"#LFTJ:+^
M"V3_ (E^>ENEK>:5D_O44_\ MZE+^Z=WON?VG)ORE)RDO_ 9591_[A8ZEVK+
M7G(?VF-*O=>FU[3(K[1?B5IL*)KN@_V5?&S\36JDJDB/Y&1G#>1<,H9#F.10
M-P6"T_:(\ Z/I%_)IMKJFM?#7Q TUMXE\,W7AR\D;P[+(#]H98C"5\HEF\^V
M!(&3)'G++)WVM:+?#7=)\,^)M6FL_$UG([>"?&RPINOFV;GM;E%VH9S&G[V#
MY8[F-/-BV/&RVRV5[JVK>+;[5=*L;71?BAHL,:^(/#[3[;+Q/:#(CEBD(&Y3
MAO)N,;D8-%*!AE5ZW\_QOUT[VW6TU[T=3)./+=6Y;)Z-\O+>T6I/504M*=1^
M_AY_NJONV9\F_MK?&?PTNE:'I.I:AK7BOPX^C:D/!_B/R)8]3T^6;[)Y:2RW
M003[8U=%G#2&YAF:&X20EY+KTOX(^//#/@;0+6VTJ\DT'XGZ6+F\@G3PY>6V
MD^-M/>83']U# 3';!KA%"X:6PF?"F>&0-></^WW!HJ>!;35-!M7O/!NH07AU
M/0;N$++X5NO[3TH7)2$@LA9F"R0#@;VD3(=@_P!+ZKI5O;:=HOAWQ%K=]?>&
M;ZY@N? GCNVNUEO]'O'4I;0RW+!U:5EE,<%S('CO(Y6MKD2/+_IRTMI^?W:]
MOY9=-F*,:G.U/SM[NM[>^G';FZU:2TDOWE/75\;IW[3'A.TEU#7/#^GZ]-I^
MJ3&+QKX(N- NI)[*XE4&6>)!$T?G%7#2Q!C'<HWFH3(?W_E'Q>\*>#_B+.]Y
MH]ZWB[PCJ&CP6VB7&I:&6315BG>2&W^V742M#$S3LL=PLJE#Y:.0JJX^D676
MO$'C58Y&TOP_\9/#]B6BE59(M'\;Z8D@R0,N_D>9* R$R3Z=/,.9H9T>^ATG
M5DCAUKQ%X=T6\N-.N+B2#QUX%GA62[L;EE!FGAA!96F96#O&A:.[C=98BSL#
M<'_!Z??I_P"E1_[>B:+>Z_NO27_@#4^C_P"?-;_N%5T/C_XE:/)X1\1V^E^*
MO %_H/C:QN[@^'+G3/ &C7=KJMN%;8+A$*I,S1@F:%&90R&2,H50QS1:>'UQ
MM>TKX8:]!KD-M8-XIT1_ 6CR6IMGW;;B(% RRJ#+Y<XA47*P>3)MV1O:_65Q
M;:'H_@>QT_4+XZY\(]<,,VA:[#=,9_"TNX& &<'>L2OM\FXSNA8!'.-K"YJM
MCJEUXHT_2-<U2#1?B-HL4S^&/%7V<+:>(K8 /+;W$2E58E44W%J"H(03P%#&
M#;Z<RO>W;KUZ:]VMI;27NR.25"3BTYZ6FOALN5N\DXK50C+6I27O4)?OJ5U<
M^*? &H_#S5Y]?T^[TB;3_ACY;F_N+_P%9->^&YWEN1,088G>*SBD@9"1(DEG
M*,*HA1C:]W>_"KP/_:EMX>U[7+2SE@F27PMXFB^&$*_;9-K$6]P@M%WS!5.^
M,YCG0;QM8,L?N?P8U?6/$7B+Q9\2/#MK&/%FI7-M/XB\%^8(_P"T]/6UCBM9
M;>:9(A]H*Q2R6]RVR&X5GMYO*:-9;+6BE\,^&?AFTL2KK7P)UH,LT+1R03>
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M]I/.]OXZ\"W$2O=6]PR@RS11 E#.48,R*3'=QLLD99F5I3_@]/OT_P#2H_\
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M?^%+CXE?$_2?AXOB/Q%X8\,W6H6%MJ?A/Q/_ &3-J%Y<R2IYCV<LHGMXUG,
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M?W7I+_P!J?1]*-9_]>JNA-J6FZKJ7BK3=#US4HM'^)&CI*WA7Q4ML/LWB&#
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M\2!74C]XD/ZU?\%KS_QJ._:-_P"Q U;_ -)GK\_]<&@Z/XP^%:KJC77P[O\
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M(PQ @N225)$4F<JSWKZQU;5_%=AI&KW]OHOQ.T6*5_#OB)+?%GXEM1@RPRQ
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M"?QQJ$,,/AGXBZ3ID<7B31]Y:S\0V>\+'<1L0-Z\$PSX#(0T,@&"JUK?SO\
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M,<;?:(%C@FC4QQ267LNE^(?!]IX$U5=/==?^"LEU+8ZI9-%-;W'@"ZBD^?\
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M=R;TM-)\5?&'XD6MUKMKIWA'XC>&+)+G3+"=6BL/'=I#.KBXN K2;84D92L
M:6;3IYUD8RI+&+B7X366B^'/@M'JFBZ3#X@^'>N62VGC+PP;'S9](N#"JW,T
M=M@EE(),]J =ZMYT(9F9;CH]0T^T32=#\/\ B#7+S4O"NI7$%SX$\=VMXLU[
MI-VZE;6*6Z;>K2LLAC@N9-\=Y'*UM<"1Y/\ 3AV6WY_=K^4NFS+BIR2<]]=.
M7K;WTX]_^?E+137[R&H[2]35H]:\2>&]%NI[.>=[?QUX%N(E>ZMKAE!EFBB!
M*&<HP9D4F.[C99(RS,K2Y/B?0-!O/A9'H6HZI<:G\(?$HB.B^(+:96NO"DN\
M&)&E=6VPA@%BG8;H6_=O@;6&VRZWK?C9(9GTO0/C%H-D3!.%>'1_'&F(XSQ\
M[B$/(-R9DGT^>8$&:&96O8M+U16CUKQ)X;T6ZGLYYWM_'7@6XA5[JVN&4&6:
M*($H9RC!F128[N-EDC+,RM+*=G]_3[]/_2H_]O1+E%25GL^7[7RA:?1]*59_
M]>JNAY/?06_['MC#X?UR&ZT76M%-_JWA?QUIUC]HAUG>?.N;.^MU92WF!$$D
M(8*RQ))&T$D,4D?<?!N7Q'-K'B;QU8:7<6/Q'O+N.X\9^ [B=%-W9[/+L3;2
MOL07"V\.8;G*PW#">WG,31K)8X_[0AT_0?V6==L]Z^*OA?K&FM/X=U,,9Y?#
MMP!F"&1_O>2' 6*4_-$V(GXVFN^U+3=4U/Q3INAZYJ4>C_$C1TF;PIXK2V'V
M;Q!!@-+;SPJ55BRHIN+0%0PC6> QM&K6VCDW[RW;6W?I9[7_ )7M)>[(Y84H
M1_=2LXQB]TVK7?.G!>^H)J]6FG[2C-NO1;5[^4^ -<\%Z;\0_B-'8V1U?X.7
MUAI0U)2LD,G@UP]WC$1"S6]O;S1R"1#LETZ6/&V.*)OLOYD_MKMIUK_P2_\
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MJW%NTC2@WD-U:Z/IWA#3-+U34Y-<^%^N-!<>%_%%O>>9<>')VQ]F1KG).S+
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M7EUI=U<1W/@3QW;3K)>6-RRD00RSD,K3%'*1RN&CO(W:&4.SD7$_\#K]VO\
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MECN8XS-#Y;1NEH6-]JVI^+;_ %;2;"WT;XG:-%&OB/PXT^VS\3VHRL<T,C
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MF[%_P4K_ &.;7PYI_BS2O OCKPGK<'B#PEK6HW#6]K#?1JZF&1U^95>-G^9
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M-3[V_A5=I+]W4)O@)9WFK:-!I=S>KH?Q*T75]>;0=?>$"S\3P#5;IKB&2-2
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M(![-13+>YCO+>.:&1)8I5#HZ-N5U/(((Z@^M/H **** "BBB@ KY=_X*W?\
M!,SP/_P52_9ET[P+\0?%.N^#_#_AG7HO%;:CI<MO$Z/!:74!$C3HZ+$$NI&)
MP,;!R!G/U%7Y0?\ !W#\:_%7AG]BKX<_#'PSK$GAV'XT>-K?0-9OQ(8XVL5C
M9F@D8<B-Y6A=\$96%E.59@0#\U/B;_P3P_X)4_"?QO+H&H_MC?$Z^O+:5H;B
M?1]'.JV<)&>1<6VG212*2,9B9_RYK]$/^"+O_!"/]ECX8_';P7^TI\!?CMXH
M^*D7A-[V*!#=V,MJ)+FQGM'BN8XX$FAD6.Y+A'V,#L)&#S]0? #_ (-WOV0_
M@/\ "+3O"LGP9\)^,+BUMEBO-:\1V@U#4M1EVX>9I'SY98Y.V((BY^4#%?"/
MPB_9_P!'_P"",W_!SWX!^&/P>O;NP^%O[0GA2:[U;PH;Z2XCTMUCOVCVAR25
M2:R#QNY+JDUP@(7J ?N11110 4444 %%%% !1110 4444 ?,O_!9K_E%3\?/
M^Q,O_P#T71^RY_RD;_:G_P"Y3_\ 37)1_P %FO\ E%3\?/\ L3+_ /\ 1='[
M+G_*1O\ :G_[E/\ ]-<E 'TU1110 4444 ?,OBK_ )3(^ _^R,^)/_3YH-?3
M5?,OBK_E,CX#_P"R,^)/_3YH-?35 !1110 4444 %%%% 'S+^SM_RE"_:8_[
M%WP3_P"B]7KZ:KYE_9V_Y2A?M,?]B[X)_P#1>KU]-4 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !17#:IXQ\?6^IW$=KX(TBZM8Y66&9_$7EM*@)VL5
M^SG:2,'&3C.,FH/^$W^(O_0@Z+_X4_\ ]S4 >@45Y_\ \)O\1?\ H0=%_P#"
MG_\ N:C_ (3?XB_]"#HO_A3_ /W-0!X__P %KO\ E$?^T;_V(&K?^DSU^?>M
M?\(W:>.OAA-:E;[P+=Z?I2:A9NKG^RI!9Z>+H;3\ZHLF\-'@&(J=H"\+]S?\
M%==:\0ZQ_P $BOVECKV@V>AM'X!U3R1;ZE]M\X&VDW9/EIMQQZYSVQ7QIX*T
M:R\7ZAX7U[1])LF\1>&M&T!]6@O?'D4+:H!82!9(9G SD0P^5(C#RP@BE57R
ML'%C.GSZ?U?SCNUJM4?4<-MKVC>WNMZI).^C;W@[M*-5>[";C&?NS9^B^KZ1
MM&C^&?$VL7DMK+<)/X&\<P2JUU:W!4B*&64@J9RC%%=P8[N-FCD#,S+*]'UO
M6O&SS0IIF@_&+0;("XMRSQ:1XXTQ'..?G<0AY#M?#S6$TQ!$T,S+>?"%S\6(
MO#WPWO/["\9ZWXE\+SZ+82W7AV\U"XAAT34)&)ND6!EQ-#%*JJ\ (93*67*J
MVSU#Q!\8?CS+H'AW1=:T2Q95GCD\*>+QI-TU[#<L"(E\XS;&E9&*#>K)<QLR
M2"0NPDX/^!U^[7_TF7_;LCZRUM'_ 'EK'_P-.'1K>M17_7VEH?2]A?V:Z1KG
MB#P_H=YJGA/5+B>V\=^!+FS6:]TJZ==UU+%:KO#2LLF^>V3?'=QRBYMS)))_
MIS+FVTJU\*Z3I&KZM-KGPXUR2WN/"'B^WO?-NM"N'Q]ECDNLL3DN%M[MB1(&
M$$VYV5KGYZF^//[1&H_%:.\A\%>'-&^(>GV+":V31;Z.U\4Z<C$*) 9V+Q1R
MRAE< RVLDI7)CG=;BGH7QU^. LO%5]I'PYT?4M!U2XEM_%?A&7PU>3C3[IU+
MW3BU\]CYLJ3))- I*7"N)XU=YF:Y/ZV^_3_TJ/3=!K>^M[QZZW^RU+;FM_"J
M[37[NIJ>Y_&_6M:TZQCL+R^7P_\ %RW,&D^']>M(_+M?$UM=7,5N<H<CY&F6
M22$Y:!P)$)0@MN> [<>$[.XU3P/H<UC=Z.L5EXO\",Z>9+LC"+/;DD(;CRU&
MR48CNHU"L594>+Y+^(OQ)^*'BSX,:)H?BK1-'U;X?:C/'=>'/$C07Q?3Y75_
MLH^U"Z^<!),0S2%]_"R%W*M+YZ^@^(I]3BTN;0?#VG^)+-5DM[W[;JOE:W G
MWD9C?':"<>8B;70X93M(SI%*RWO\KWMIKW[/:2T>IQ5)24I*T>6R6K:7+S/G
M3@E=03UE!/GHU/?IM11]X21^&?#GPS6&9EUKX%:T%:"=9)()O DL<@*$."LU
MO:0S1@JX*3:9-$.4A0&RU-7TG4KGQ'I/ACQ/JS6'C:P:5_!/C9+9%76@$WRV
MMQ$FR/[1Y<6;BT&R.YCB-S;^4T3I8?GAJ<.MSZ5JFJ:?X9TO39K""6/6-(CO
MM3$R.5!-S&6OCOE55S&23%(O!&<%?=?V6_'^H:1^S_XBT\V*?$7X(KJMM:6N
MJW_B:XANO"#1VEG*K>=Y*R6]K!-Y;QR1I"^GRH6+!$,L$226VUO16_-13V?Q
M4W_=9UTI59N\K\W,]FI2YFK=E&564%[T?X6,IZ75:*;^FM.U'5K_ ,6:EK6B
MZ;#I'Q(TB.)?%/A9K@"U\1V^"L5Q!*P56)5&$%T0H(0P3A&C(MZ$,VAZ5X&O
M=0T^R;7/A'KC2Q:YH<MLWVCPK-N(G98,;TC23/G08#PN"Z#&Y1RWB'6?B=-J
M_A_PWXA\/Z7:>/+,3OX0\9?VRD:ZH5!>2UGC2W6-YC!&K7%J/+2Y2)[BW6(P
M,++KO"VM>(-:U_4==L=#MO#OQ.TE8U\4>$A?"2U\16HRL%S#,RHI=D0B&YP
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M3_+'<QIY4OEO&K6WG=UXD\2:9\.]-L=2\-Z7K7PXUJ:"?PQXAM_%WF2^''8
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M-O/M:"-K+$L_&NK>'?A'=7"^!]&U;X)ZM\IM6UZ2%_!#QRLLH.;=9K:U@GC
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MJ?CY_P!B9?\ _HNC]ES_ )2-_M3_ /<I_P#IKDH ^FJ*** "BBB@#YE\5?\
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MDLVH-J'@&ZT;1FBN?MLD<GA^06VF>8//#K)#'#("JX*O:,F,HL8\KAQNRO\
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M*Y69;J%G9V^VQI^S%\*M!T*VTZ_T'P_J?P]\6B(^&_%]G%$UQI4DQ!@MY[@
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MT;QSI:2?\#<0"27D?O)].GG_ .6\$X-]7TS4X19ZWXB\.Z+>7>C7EQ+;>._
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M7UZ*3TDO=EJ:TZL:E-2LN5Q?3W7&]Y)Q3O[.]I5*<?>H3_?T7RZ'%?'S5H_
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M=\57/CR*YNK3P1:I'')Y/F0I.TBW$@C@C\^Y@B6*+<TDUPBPQ.68CQWXG?\
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MW-Q\L=S&@AE*-&CVN5_Q2_A7X8?\L]8^ NL+_P!-+>7X?21R?\!EM[&&:/\
MV)M*FB_@MD_XE^6ENEK>:5D_O44_^WJ4O[IV^^Y]7)R\I2<I+_P&564?^X6.
MI=JZUU;&^U;5/%M]JVDV-OHOQ.T6&-?$7AUI]MGXFM1E8YHI" &!"L(+D@%2
M&AE"[66.C!/H]AX.U+5-+TV37/A=KCS0^)O#,UH6N?#DY)^T.EO@L%#$F>V
MR"3+$"2RRWM:T74#K^D^&/$^K2V?BJS>1O!/C98$W:B=FY[6Y1=J&X,:?OK?
MY8[F.,S0^6\;+:EC?:MJGBV^U;2;&WT7XG:+#&OB+PZT^VS\36HRL<T4A #
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ML5EJ,22*JO\ ,K%'C>13M.Y3M<!BFT@'YU_\%TOV?$_8S_8C_9&_8+^#^O\
MB"WT7XI^,I=+GFN9Q+>W\+7T;N+@QJJF-KS5!+L"@?N%'1#1^S_^Q[I?_!"W
M_@X5^!_PI^#_ (T\5:MX!^._A:[_ .$FT#6KV.>57AAO#%<'RT1.);971C'N
M7%R@;:Y"];^PG_P1K^-EQ_P40\"_'7]KG]I'X>_%"3X3V@B\,VFF:Y)?2S2H
MKB$RM-!;K&L;R&8L \DDB+N.,D^__L%?\$>;'X5_\%.?&W[2_P 2OC9%\7/B
M%J]WJ,7@VP%X9E\-V%PTH"!I)'>1H[5VA1$"1QHTF VX% #])**** "BBB@
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MM=_RB/\ VC?^Q U;_P!)GKX(\3Z1';?%#X-V-UKES?>']0TW0)]'UQ;E7NK
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M>]OZ/Y,\NK?ZY.,;\W(]%;FO=\R=)^[??VE/9ZU(:6/E7_@X#\=^'[GXJ3>
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MM]BRO=7U3Q?>ZII=E:Z+\4-%@C77M!:;;8^*;096.:*0CD'#"&X(W1MF*4
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M9C'&_FVK;EFAC6XA.^"067._MOG^WOV8OB)K&D ^&=6WV47C;PO<?O%:<W,
MBNXB,#>VQ0MPHV3P@AU\R-?*ZK]BN.XT3]G?P+'>6(\9?#_7+B-K:/[$+J?P
MM?QWQ:%C&%+/:BXC1P^#)9S+N)\CYK/HC_"7:_RMZ;I7^<'_ '4>7B/]^FW\
M;AO>TW)WW:_=SFX[_8Q-.[TK31\__P#!83Q-I=S^UEX7T'XLZI!??!.'PJ-0
MMM T/5_"]IKJZVUU.AN;J/6)(YVLFMT58FM&QYT<HD4@(1L?\$M/&VGW?PQ^
M-FE7%]9^(/@#I-SIJ^%_#TUYH6K>(=#M9ED6^DO4T5WB2T,JB6#S"UP$@N&8
MG" =!_P5D\,?!?XG^.[7P7\>OC5XJ^&7@3Q9X?&F+IEKI"Z5INK7$KW7,OB"
M2TD3S%1&;["MQ'@1>9*CQR8/?_\ !./]F3P-\*+[QQ\0/ ?Q<T_XSZQ\04T6
MPU'6K>?3/L$5AIRS):Q1)IL:Q!Q%<W#%SDR.5)V@5Z52-XM?\'\#XG"5/9UX
M5'?1IZ/E>CZ2UL^SMIN=[JNEIY.B^&_$VM7=QI]Q<1W'@;QU;3(UW:7+*1#%
M+,0R&<HY1)'#17<;M%*K,[+-:LAJWB#XAQM*VG^&_B]H-HJW&Q772?&^DI+S
M@$L_DJ\I*G+SZ=<3X_?07#"^Q? OQ#^$>N>*/BMX*TGQUX1UKP_X/BD/C#P:
M\JRR^%)"&DD?9G?%;NH9MFPH'#&-EY6K7PE\8?#_ ./OP,\/:UIWQ,T?QOX=
M;65_X0WQ=I^H))=6\P_=Q1-= E7N0S2V[!QF>-_*E20R2A_+]A-:M?CV\_\
MTE[]&?<+-L+/W*<KM]H_S;OEVU_Y>T[\M_?IOH?EE_P7#\2V7@;_ (*7?VC\
M8-.UC6O"UA;0ZSX!M;C6M/TC3YI;>QADMXX+K4)HX(%74X+LWS6[I>-%<6 0
M,@97\(^'_@OXF0?M5?#_ %3P2WQ2U_XW>)FCUS3]?.G1QV_B"P662TAU"6ZD
M"7YBNM1L]1N)TNV%G'I=U$J1"1H%K[!_X*K?'OXA?$K]O_6?A?J7Q(\8?"'P
M)X=%L]IJFAV6MW0L[<V-I>1:I-;:/<6U[<?:;Y[NR28SK;6ITMPRM+<H1Y;X
M3\%6NF>,]"N+K_@HG\6E@BU6S9TE\*_$>%+C_2(_W+/=:Y);J)/]63+&Z#?R
MIZ5ZQ^?G[+?%RX^&NA:YH.M>/'\#6>I:8TPT2_U\VL<]HS>69OLTDV&0G9%N
MV$9VIGH*@_X:P^%G_12OA_\ ^%#:?_'*\U_;N_X)D?#_ /X*$:[X.U+QI?\
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MY2A?M,?]B[X)_P#1>KU]-4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$=OM,;SPY,-U',+J%V9V-[S$7[3W@A_"Z:-J/_"<:K\/91#?^&?$::3=_;M
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M6VNVTBIXW\$/(IDNGVX%U;$X0SE%S'*-L=U&FQ]CHK0T?#OQQT?]I?\ 9?\
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M/X7\1:PUQI_PX\#:5\0O"L"IJ_A:73;;^S==M&)VRV[-&% <JQAN0H*L&BF
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MTU1110 4444 ?,OBK_E,CX#_ .R,^)/_ $^:#7TU7S+XJ_Y3(^ _^R,^)/\
MT^:#7TU0 4444 %%?A_^W]_P60^.'_!._P#X)%?LF^,/ ^LZ=JOB7X@6]U!K
M6H^)+=]5N+D0HK(=[N#NRW)))( Z5R_@[]NK_@L=X_\ ".EZ]H_P<\*WVDZU
M9Q7]E<+INFJMQ!*@DC<!KT$!E8'! /- '[T45^;O_!'3X[_\% OB=^TCK^G_
M +5WPXT/PG\/(O#4UQIU]:6UG#,^J"ZM5BB_<W,C%6@:Z8Y3&8U^8=&_2*@#
MYE_9V_Y2A?M,?]B[X)_]%ZO7TU7S+^SM_P I0OVF/^Q=\$_^B]7KZ:H ****
M "BBB@ HHHH **** "BBB@ HHHH **** .&U3X;^++W4[B:W^(NKV<$TK/'
MFE6+K I)(0%HBQ '&223CFH/^%7>,?\ HIVM?^"C3_\ XS7H%% 'G_\ PJ[Q
MC_T4[6O_  4:?_\ &:/^%7>,?^BG:U_X*-/_ /C->@44 ?(/_!77PSK'AO\
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M4?#/[77BGP;HL\40@TF/X?>'KY;8B-58B6:W,C;F!;D\;L#@"O'_ !K^Q?\
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M]QK%C!B:2U2)YH$=HK@V\C&)Y;2W8KOBC=/TD_9B_P"22C_L-:Q_Z=+NO/\
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M\::5<>$=%M_%6M7?A+1-0DQ<>'O#K7+-9V\P9F\K:HD=4+MY<;QKE<;$[?\
MX)EV<MK^P5\+YI(9+>+4M&74[6%X_+:&UN7>XMT*%5*E898QM*@KC! (Q6=X
ML\;G]O+1)_"'A&#5HOA=JRM!XD\6R6YM8=;LSO673M,\P"2838"2W:IY(@D<
M02M,0\/T#8V,.F64-M;0Q6]O;HL4442!$B11@*H'     '2@"6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /F7_@LU_P HJ?CY_P!B9?\
M_HNC]ES_ )2-_M3_ /<I_P#IKDH_X+-?\HJ?CY_V)E__ .BZ/V7/^4C?[4__
M '*?_IKDH ^FJ*** "BBB@#YE\5?\ID? ?\ V1GQ)_Z?-!KZ:KYE\5?\ID?
M?_9&?$G_ *?-!KZ:H **** /YT/^"PH^&,G_  1*_8IC^(]UXXMMT5\VG?\
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MZ"%@=_K'YV==\;OV+?C]X6^+&O\ Q$^"?[1FO1WVJ7+7[> /B#90ZQX2N#@
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MGKX.\5Z/J$?QF^#FDZGJ\K2M8:$VB:]&J>=$SZ?IQC1P05:1%(7+ K,O49+
M\>,O9?UZ:]'V>W1[GTW#?+SU$[;>;=M;^[M.-OCBO>2]^&L&?HS97MC%H6N:
M]H.AW6L^"=9GN+?QUX%N+$7%YI%U(-UW/#:#>'D82%[FS3>MVLGVFV\R:1EU
M!MW::;;>&]%T76M:FUSX?ZY);W/@KQK;7PN+K1;B0#[)')=Y;>6\P+;7C%EN
M%D^SS[Y'5KRW%+K6L>-)KJUAT[0OB[H5HHOK$NT6E>--.1CM96^9O+W.=DF'
MELY9"K"2*0BXK65[8Q:%KFO:#H=UK/@G69[BW\=>!;BQ%Q>:1=2#==SPV@WA
MY&$A>YLTWK=K)]IMO,FD9=0\_P#K_/3MWCNGJCZ[6]U>]UU5[V]WWMN:W\.I
M\-2/N3U+-Q;ZSJ_C*WL[RXL=#^+.AVKG3-3$;1Z9XQL%8%D= 2=F6'F19:2U
MD<.A='!E31]8F-[J_BCPOI%PE\DWE>-_!$NSSGEV#,\(SL-P4P58'R[J/:"0
MP1UJW=IIMMX;T71=:UJ;7/A_KDEO<^"O&MM?"XNM%N) /LD<EWEMY;S MM>,
M66X63[//OD=6O+=Q;ZSJ_C*WL[RXL=#^+.AVKG3-3$;1Z9XQL%8%D= 2=F6'
MF19:2UD<.A='!E-;_P!7OZ[7ML]IK1ZDVCRV=K6?1\O+?5-;J"EK**]_#S]^
M'NF;+%X;\/?#B&WN)AK7P1UL(]E>I+)%-X(E20&/]X"LL-M%,@*2 K+I\L8!
M*Q*#:Z>K:3J5[XETGPWXDU;^S/'FF><_@OQHEJGEZVFP/-;7$*[$:4QQ W-H
M"B3I$+FW\IX2+%NCZQ,;W5_%'A?2+A+Y)O*\;^")=GG/+L&9X1G8;@I@JP/E
MW4>T$A@CKGRQ>&_#_P .(;>XF&M?!'6@CV5ZDLD4W@B5) 8_W@*RPVT4R I(
M"LNGRQ@$K$H-J:6\OFE:_P!Z2>SWIO\ NFGON?7FOV3ES-:Z?#*I*/Q1_AXV
MGVJHJ^-;S4M8T3QIK&CV,'A_X@:;I;Q^,?"\MQNM=;MS"Z17D$NU0[%(V^SW
M6U1(L36TZQO%BTX']F;4-'TGX=>-+B'3;/6OA%J&I6]KK5DD#M/H<_\ 9&FM
M<7#*26,23%TEC #6QA#* JN$] ^+^FWEQX?N?#OBW4I+/QII6G7TGA#QA!"D
M8U^$0,\]I.B@1^<T40-Q:@+'.D0N;?RGA(LN1_9<U'7KG4_&6N:*OD^,M(N=
M,76?!TVJ12)JNG_V-IZ0S0G?M@D=HYWMYF""128IPA :VT5[-?IKYW6U_P":
M*TDO>CJ<%1Q]K!Z6LK/F:C974'&;][E3TI59>]0E>C6]U)GH6KZ05;1?#GB/
M6KJ2*2=9_ WCF"17N8)V4B.":0Y5IF0E0S9CNXR4<%R1)-')K6O^,Y+BWCTW
MP_\ &'P_9JMU:L[QZ3XTTU'.WYL,_D[Y&V28>:QFE((EBE=+O/AFT'1/ 5U?
M6-K_ &[\&]=\V/5](DMW6;PE*'(F(A($D<*2!A+ 0'M74LH"AECM:MI!4Z+X
M;\1ZU=21R3K/X&\<P2*]S!.RD1P32'*M,4)4,V8[N,E'!<D29_\  Z_=K_Z3
M+_MV1VVZ/^\M8V_QIPZ-;UJ*V_BTM"/3=2L[;1]<U[0=#O-4\&ZI<7%OX[\"
M7%D)[[1;N0;KJ>&U7>'D<2^9<6D>]+M)1=6QDED9=0;?6.EV7AC1])U;6)M:
M^'>M26]WX-\96E\)[G09Y /LJ-=?,&#"0+;W;%EF63R)][.K75R.36M?\9R7
M%O'IOA_XP^'[-5NK5G>/2?&FFHYV_-AG\G?(VR3#S6,TI!$L4KI=U=-U*SMM
M'US7M!T.\U3P;JEQ<6_COP)<60GOM%NY!NNIX;5=X>1Q+YEQ:1[TNTE%U;&2
M61EU _K;[].W\T=T]4&M[J][KKK?[+4MN:W\.IM47[NIJ?'?[0OCF[^*OQW^
MQ_#2)=-^*OAIKFQUKQ'X>O6TJ+Q.%D555+; DDG9R X!8*=P+2Q(LJ>5^$?V
M1?B793ZO-I-Z+7Q%HNHR:7=:;9RW7V]9WBFR T<9CV21+* _F;&!*YRVT^Y?
ML"Z5X0O_ !)\1O[1CNCH-]XD2VT'QE9WWG'1[HR2?97%PQ;8TVY0DYW1RM^Z
MD)\Y$E]5_9\G\2_$/4I)+'6/#/AWQMI>M:E)I-W'H;6MGXJTZ.:5+F,^7,5D
M5[G;)(,&2'<'4?O%=N[VSC[J=]O77]>SV>VY\M'+*=5^WG%Q<N9V2M%<KU=D
M](])Q3YJ?Q)..B^8/!?[-^NZ/X#:XU+Q-I*^&M6M[3?XEM_[6E_X1>SCO)#N
M*8ACV_:(V5D<.T4BJQ6$%IES=1_9^^+.FW=KIU]JUKH\'DZA!I\9CF@AO2@E
M^VVL,4<&78QP&5H]F)4PZ[_+?9]M>'[?Q^(M8\0>'[S25\00I;0^-O"#Z1A[
MFY5R9KJ%#/L,LEN%6-@P2=5^9BRIY67K=A<>%/A%#:W7BWPY?_!GQ&9K?3[R
M33YH6\&W37"G3QO\])H(;:9 %966:SG1<&&.-3;3]:D_ZT[=KV[]8O>Z-Y9'
M2CH[JVCV;U3DU\7*YVUIJZA7@O<<9W1^>'QC^&_B7PQJFK7/BFY_XG=O<)#<
MPR1LDTH+2JLOS*NY3Y0(89!#@$JP*CI/#WP9\>:IX3URZTFZ7_A'6UU;752U
MC+"EK<IYY26>(0G8(T\UCM!\D.0=I;![S]O'Q'>>-?B;-I>M^./"_C>;3],L
M1H>MZ4MJ);Z$S,DD<_EE5^TEG>1TAS&PC5Q'&,K'ZW^Q-\7Y+?PSKWBC3?&7
M@_1?$DGB63[7X2O+Z"U&N6SR&9D225DWW!,A2"X*IG:8Y"5"&'HJ3?+HO\_N
MZ^G5;'CX3#4_;6<NJ::=DW?3WF[Q3Z3:]R5E-+5KR?PG\#-<GT&UT?QQJEC#
MH^MZ;:S^&_$1T6_U"33'_M$CR(56-"#.&NF,<BE9,J<C>&.7XP_8@\7S_'OQ
M%X?AO]"LM8CNIXX(OLM]&NI0>2)7GA(@D!BVOM;+L4=PA)\R-I/LB#2M7TCX
M)74UCJFC:U\/M:CD@URQET*3;X4N?M&9W%F9/-C@10R2V^\-;R9E0! 47;\6
M>%_$,FK>'?#^K>+H1I,E\+KP;XR^SBXO(I&@=8+9YPP47!W##N'CO(C)$X+.
M5DY?K$KW5NGIKYVV?1[='9GM?V+2473?-O):KWERZOW;_%'3VE/65K5(-QV_
M.CPA\!?B)IWA?Q9K'AX720Z?HFSQ-;P03V]W9VTX0S6TL+QJ[D1,LDGE!T:,
M[@SJZ[OIK]A'Q[\/9?#\O@'7--_LK5+R:.^7Q%"RO?V%Z6C6"X-^B[&BE>9#
M;3@A"9C ZMNCEO/4-$D^)FI_MN7"7B^';+QEH'@]I("+;R;#Q/:B[A5HGF!>
M012DEU?9YEI,,;9HMZW7E'P3O-+\-?\ !17XGMH?PZNO^$5G\-.FO>%Y;#9=
MV-O+]A^VA+,*Z7169F+11,R31&1K<SYACF*DN=-2[=GKZKMW73=#P=)4)QG2
M5^:5K*<;P;5URR>G,[)QDFU)7A)'U-=6NL:IXQM=/U"ZL]%^*FBV[G1M9$13
M3_%UDI!>*1 ?N]/-AR7@<B2,E2"R:1JURVI:QXG\,:1/#K$,HB\;^")63S+F
M38!]H@SA#<&, I(,1W4:A&*LJ/%5NK72K7PKI.D:OJTVN?#C7)+>X\(>+[>]
M\ZZT*X?'V6-[K+$Y+A;>[8D2!A!-N=E:YMW5KK&J>,;73]0NK/1?BIHMNYT;
M61$4T_Q=9*07BD0'[O3S8<EX'(DC)4@MRZW_ *O?IKM?L]IK1ZGNVCRV=K6:
MV:CRWO).*]Y03UG!>_AY_O*?NF8R^&O#_P -8[>XD77/@;K@4VUR))8)O TL
M<H*?."LUO;0S1@I("DVFS1#E(D!M-35])U*Y\1Z3X8\3ZLUAXVL&E?P3XV2V
M15UH!-\MK<1)LC^T>7%FXM!LCN8XC<V_E-$Z6#=(U:Y;4M8\3^&-(GAUB&41
M>-_!$K)YES)L ^T09PAN#& 4D&([J-0C%65'BSF7PUH'PUCM[B1=<^!NN!3;
M7(DE@F\#RQR@I\X*S6]M#-&"D@*3:;-$.4B0&T6B72UO-*R?WJ*?_;U.7>+-
M/?<^O-?RE+F:UT^&564=U_"QM+M65SR_]NMO^$E_9S^(&H,O_")^-M/BT^+Q
M;H:-YUKK4)NX4M[N)CMWKN0>5<A0Q1'@E4/'M@ZW]A5+[0_@+X-N]+5O$OA'
M6)S#?Z:=KS^'+P73;9XE;_ED'"-)$?FC;]ZG!85R?_!121M'_9KU;0?'C+>>
M)-/,*^$?%6T6PU^-KF#SK:81[8TO!$F^:WP(9U@%U"B^3+#9;W[ ;P^)/A=X
M9U+PS<)HOBFS2./Q-I-Y&\<&M6+7$BQW:C'S.J*XBN$!#&%X)/N P],?A7?F
M]'MK=;7[I:27O+='BUU>M)_8]DK.SE"W-:+C/XU"]E"<O?I2M0J:1DSD?^"@
M7QP_9AT+]I>^T7XQ_#>Q\4:UX-\ MXPUWQ#J%G9FUT#0TDO! N9IDGN))KJ.
M6*.&VBE;?,"VP')W/^"4GQ<^ _CK5OB/HOP?^#^H_!?7M+31]7\3:/?Z58V-
MU=1:A;S36%S*+.XG3>\:2YCE99X\8DC3*YT/^"F__!-*7]MWPW=>(/#NOVNF
M?$KP[HTD/@W^V-)TF^T?3]1!D>*YE:YTZZN(\LZAS"P^5%PN<DZG[$_[,OC[
M]DSXR_%6X\8>.(/$7@3Q8F@W.BSWRV$%\VM/]JCU22<VUI;*YGFDLEC9][MM
MQP>#ZA\)&+D[+<_.W_@H%I4?['W_  42F^,5Y^R7\9-=T&/XBV-]HS6OQ1L[
M7P?XF\43JEK::M_9+1.T=X[;%$A*C<@9NIS]/?\ !'_QQ\-_$_[/7Q#\(WWP
M>U[X)WG@OXHO9Z[;:SXF;6M3D\17,5O/]OFU",*4F<RQ0A@VT_)'G#[#](?M
M)?"[2?VS/#;> ?%6CI8^*O!FO67C/1-.FU.2&TUAM/NUFM+A+F.,L82^R.;$
M3-;R.-T<B&(S\W^SS\*M%^!,GQ<\<>&;'Q!XEB^)GC.;7/'_ (8U*"-]7\-W
M#65O!+;Q6\083^7''%(809#<0SB6WDG5H$N.2IB*<HM?FOOT\NJWL?08+*,9
M2KPJ6:LUK&23U5XM2U5I;1E\+>E[GRK_ ,%A/V'OBKK_ .W%H'QD\/?#%?CQ
MX+70K;2;WPT=2DM7M&M_MQ,4J0R1RM;2-=),#$LX:6,B6W8+!)'X+X*_86^,
M'[7W[17PUNO"O[,^E_LSZ'X6UVUUC5-<TV^U"RM%%O-%(DBV]XEK*9T6)Q$L
M%EDO+\]PD+2I-^LT?BS_ (1_1H;.\\1W6H_#WQ@$;PYXNL+P&;27G(,%O-,N
M5:-F91;W#;E?*PS;G*/<S7&M^*-5NK?PKJ&K0Z'\0-'+7VCZ@(B-+\5P("K[
MX\YP58":$'?$VR1"5V,5]<7;^NWSZ/9[;EOANI>[FK:ZV>RW;5K^Z]*D;<T/
MBLXZGQ!_P<,_%;Q?IOC/X3> %\6>*O!/P[\;1W*ZC=>'8KV:\U*Y%_IL$B&.
MS*3W!MK"YO+J.SCD_P!):-BR3"W\F3X3^+'[6'CA]1T_6[[X_?$KP3I'AG4-
M'\,:#'/JFHVDUE$;J2W=+E+>[ALXKZVT.W@U.X2\AN)I+G54M2AP(U_6'_@J
M%^V!H/P6\(^ ?"GQ ^ =K\7K'X@65[J%]I-^UE=:5I,UG]C!BE:YC:*21FO2
M$PH+"&4@8!Q\C_%[_@I;'\1O@[X;^&OPZ^#=E\!YF\2Z):Z+XBLKS1/+\*)+
MJUH+EK*!K=XDN)H#-#'B,YDF3@FNQ.ZN?.RBXR<7T^?XK1_(_0#]G3Q]\3OB
ME^R?\)O'VL69TSXF7WA'3=4\5>#K@BV2]DGMT>9 CX-I<"3S#'NPH.Z*7H)(
MI89M#TKP-?:AI]BVN?"/7#+%KNA2VS?:/"LVXB=E@(WI$KY\ZWP&A8%T&-RC
MEOV5/'$W[1'[$_[-'B+Q1XBN-/\ BSXP^'ND:[IOB5[, 7NHS:5;7-["P0)%
M(LPW2R6>4,L<4DD04VIE@[C3M1U:_P#%FI:UHNFPZ1\2-(CB7Q3X6:X M?$=
MO@K%<02L%5B51A!=$+G88)PC(1;^5B/XC_X?IKIWMO'[2U6MS[[)],'%O31/
M7W-.9J+<OY5*ZIUUK2J7IU/W;BSY=\4Z9;W/BRPTF^U.2:%O$?\ Q1WBB-Q>
M7<5PWB.R42-(RNAF\KS2)'S',LI1@2Q#_42MK6O^-6DC72_#_P 9/#]B%EB9
MI(M'\;Z8DAP"<._D>9*2K@23Z=/,>)H9W2^^6O$TVEVKZE="QFNO .KZQ(NJ
M:5<0&%_#L \3:>9/W&-ZKQ&KP !HV9F'<5]/ZII:F/1?#?B36KJ>RN)TN/ O
MCJWF5[JUN&4B*&64@HTY1BBNX:.[C9HY S,RS9U-_N_X&O\ Z3+_ +=9U86_
M)K?[6ZOT7.N7KWJTM_\ E[3T&Z7J=M%INM^(O#NB7U_X9O[F>V\=^!+FT66^
MTB\=0]S+%;*75I664236\9>.\CE6YMS(\O\ IL-[9Z3IOA+2],U35)-:^&.M
M/!<^%?%5M>>9<>')VQ]F5KG))0E@(+DD@AO)EW;E::\IUKQ!XU:6-=+\/_&3
MP_9!98F:2+1_&^F)(< G#N(/,E)5P))].GF/$T,[I?5]+U2VBTW6_$/AW1+Z
M_P##5_<SVWCOP)=6BRWVD7;J'N98K92ZM,RRB2:WC+QWD<JW-NTCRYO8_P"#
MT^_3_P!*CTW1U)N]UO[OVM;_ &6I;7M_"J[37[NH6+NSU;6?%MGI>J7EKH?Q
M3T."1]"UU(2MCXHM 09(Y(P?F0_+YUOG=$VV6,XV/7@_[1.DZEXV_:5\ >(/
M!?@^XN/&_AF6]UWQ5X0;5$MMTEN;&(3H6_=OYJRJ%N$7,R1J"-T11?:KRSTG
M3?".EZ9J>J2:U\,=:>"Y\*^*K:\\RX\-SMC[,K7.2=F6 @N22"&\F7=N5IN5
M^* ^(0^.GA-(+6/_ (3GP_I&I0V>I6\L5K9^)XFELG0O&[*'0+%.)K8,&B:1
M98SC8XTIRY9\W_!UM9:][;2VDM'K8X\;057#NDGRIK=7BE%23E[J3?(GK4I6
M<J,_?A>FVCQF?1?&/Q*TGPUJ.L>$Y_"/P,L=>TW5DW>*4N(/"%O;F[AN4C:W
M5;JTC5K@#G8+#[-@M!#$/L_HWCSX8:EI/[8'PWT*]O-/T?75M]8O-#\7VUK;
M1RZ[/Y<++]LMEV"2Y5$=)U4*DT;^9$T+,8[;JM!^)GC-?'VLZUX;^&][9ZE;
MR*GC/PNVL6I%VYC^2[A!*_OBJX295V7*(8V^>-6A\R\0^'YY)?#OC*;PG->?
M!/2;.ZMX+!]3BCD\*^>\0+).CK+:6UK/;HR[@CZ<Z.=\4,*+:US:=$DFM'96
M7Y+\8/NFS%T_>;O.4I3C+WH\\N:5M%HE*HU=ZMT\33=WRU(I'O=A?ZMJ_BO4
M-8T?3[?1?B=HL42>)/#;W&+/Q);#*Q312D ,&"MY%U@$%6AF"E66+/L)M#T3
MP/J%]INFG6/A/K!FM_$/AN:T)G\*S$G[01;X++$&),UN!F,DR1Y!93C'5O&6
MI^)?"WAGQAH]YH?BR.>X7PIXW-U:LTX5-[07,496.25XT'G6RE%N%A>>%8C"
M1:W=4\8^+3\26U#PSX.\GX@:;#$GBK1QJ<,-GK5O\RQ31M(5,BD*WD707*[6
MAE4,C)'GRN]NORWZW6U[?%':2]Z.IV*I3Y/:*W*DMG)+E3M%J37-[/F5J55K
MGH3_ '-6\;,XWXE^$=G[2?PHTO6O%4W]DW%CJ7_"(>+[;4,:DLCBU^S1S2D-
M',R,^Q))=Z72W(BE21F<S^G?\3KQ!XU_YA?A_P",GA^R_P"FD6C^-],23_@;
M^1YDO_32?3IYO^6T,_\ IWB>I1WVH>);/QI:?#O4-2^&.FVNK6.L^')[RVD_
ML66Y,2W(%O\ ZV--T0:2#;B/YG4 ,17?V&L:YJ5MX<\.>,=-U2TT:^OXY/!G
MCJ/6;:YO=)G:)OLRR3J7625@QB260%+M)O)E65I'^T.2NEZ=_/37_P!)?R9C
M3DHU)IIW<G]BVO*N>\4M7_S^I[?;IO0Z+0+NTTW2=6UOPOH%S-X=FFDL_&_@
M"6T1[K2;AD!GEAMEW(TA1P\D$>Z.[CD6> N[C[7Y_P"*?"'A.R^-/@4ZMK"Z
MQX UCP[?MX7UV">1[K0V-SIQMV:[4G$432[8)V.X&Y\M\_>?I_%?BOQL_P 4
M[6'3_"MO#\5M#T]6GNH+Z.UTGQCIBS$,HCE8R-"&D!'+S:?//C,L,Q^V\C:Z
MYKMQ\4]2\::'\*]4O-%L[/5](\8>%9=3M97LKJX>TFN)(K,!F:6984D=$S'<
MHZ31!VG+SJ$;]NN_XZ?^E1Z/5%XBIRK3FO>#]UW>C7*U-JU[?PZN\HWIS5['
MJ-_8:MJ7BZPTG5K^WT?XG:/#(WAWQ$L&VS\3VHPTD$T:D Y"J9K<$%2!-"5V
M@QL\.7]U::KJ7B+PAHITSQ)IABA\9>!1*B"_"H$CN+5CMC\_RXP(+CY8[F.,
M03>6T:/:<CX8\0S77A'3=+\3:-=?\*JUJ6&;P[XF76H;J;PW(PW6W^D1,S;!
M)M6&X8@IN6-RV06O?$+6O&MCX\T?1FT9)OB)I<$K:#XG@N(;:U\0VP(:6WFA
M<J&W*%,UNK J5\Z(IM4H6=[^G57OLM=K]GM)>[+4OF@XN+2M:2=XR4>5:R3B
MM?9IZU*:]ZA/][1?+='GE_H_PZ\-_M!:7>R+<:M\)]4\%W2QCR3%'X$CBU&
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MNRBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^SM_RE"_:8_[%WP3_P"B]7KZ:KYE_9V_Y2A?M,?]B[X)_P#1>KU]-4 %%%%
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M9H?Q*;4/#$UA(+GP/\0Q=1W<,$C)\D;WJ_(Y*_+F=8UNXE99(\\R^6_"&_\
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MJ Z*N7 Z/]IW39K[_@M?H][X1\!ZIX^\9>'?A/;76L6%]?Z7'I$NEW.I:A#
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MW!4B*&64@J9RC%%=P8[N-FCD#,S++X__  .OW:_^DR_[=D?I+C;1_P![[/\
MX&G#HU_R^H_]Q:5TR'3M1M$TK7-?T#0[S4?"^HW$]KX\\!W5FLU]I%VZAKF6
M*U4NKRLLHDGMHR\=Y'*MS;&1Y?\ 3H[RUTJP\)Z3I>K:M-K?PUUIX+GPEXNM
MKWS;KP].^/LJ/=9;*G>!!=,6#AO)FW%E:XO*VM>(/&K2Q+I?A_XR>'[(++$S
M21:/XWTQ)#@$X=_(\R4E7 DGTZ>8\30SNE]6TS4[6'3-<\0>']#OM0\+ZA<S
MVOCSP'=6:S7VCW;J'N9HK92ZO*RRB2>VC+QWD<JW-L9'E_TY?\'I]^G_ *5'
MIN@N[W6_N]=;_9:EM>W\*KM-?NZFIY5_P5+_ &EOVD?V1_!/@G6?A/HOPY\1
M>'[>TOSXW\0>*C8V<.F2(UHMDP%UK6EQ1K*'NR["63#11@*@:OS-^*O_  5H
M_:0_X*->"IO@Z=.^!]]=>*KNQN--MM+O=(TO4+R[M+N"]M'L9O\ A-@TCK<6
M\+ P[\[2,'D5]2?\%YOA5JWB?1?@]XPT_1?$WQ ^ _@_2Q*UKX<N[FZDBG^U
M6+BY,T*3SH\NG17,$%_M;R'E?,L!G$Z^>?\ !1[X#_!73/AA\#M'^&?P+^)$
MWC/XV6EGXH,&F76HWTDVEQ/8RWEA?QM+*MQ=3171BCDGVBWE)N3<0F(.WMP^
M%?\ #_B?F.(3562?=].7KV6B]%ML?H+\'?"C_!3]@/X,^"?B9X,M-#\/Z+X&
MT31_$Z66IO(O@B^M+.U",)ED>18+>>(XOH[AI+9X89MVP27,/5:OI.I7/B/2
M?#'B?5FL/&U@TK^"?&R6R*NM )OEM;B)-D?VCRXLW%H-D=S'$;FW\IHG2P@^
M"WAOXK?"+]EKX5Q^)]27QKXS\+^%-/L/&VG*8WDUNY6VC6YN+>9L%K@2I(5W
MD1S L"(V972E+'X9\-?#)8Y&76O@3K05H9EDD@F\!2QR!D(<%9K>TAFC!5P4
MFTN:(<I @-CY>*_B._XZ:?+HG]KXH2U^%GW61ZX2FH;W=N7WGS.^BC+3VCCH
MZ3_=8JFN16JP3/G?5;S4F^)FK:AI]E:VOC33]<67Q#HL#DPZT/\ A)[ 1B":
M3RUY?Y8[EE&X0F*0+M/E?1L,VAZ5X&OM0T^Q;7/A'KAEBUW0I;9OM'A6;<1.
MRP$;TB5\^=;X#0L"Z#&Y1\Y>-+&ZC^(=KH.L:PUKXCL_$DD?A?Q'=21YUJY_
MX22RWB:WB\E))@B322VRJL3H@EBV&-EMOIS3M1U:_P#%FI:UHNFPZ1\2-(CB
M7Q3X6:X M?$=O@K%<02L%5B51A!=$+G88)PC(1;S4O?_ ('WZ=_YH[27O1U.
MC!N/L[IKH])-*U[1?,]5%2TI5?BH3_=5ER-,AU32U\K1?#?B36KJXLKB=+CP
M+XZMYE>ZM;AE(BAEE(*M.48HKN#'=QLT<@9F99I@=:U_QJTL2Z7X?^,GA^R"
MRQ,TD6C^-],20X!.'?R/,E)5P))].GF/$T,[I?4()]#TKP-?:AI]BVN?"/7#
M+%KNA2VS?:/"LVXB=E@(WI$K[O.M\!H6!=!C<M6=4TM?*T7PWXDUJZN+&XGC
MN/ OCJWF5[JUN&4B*&64@JTY1BBNX:.[C=HY S,5FS_X'7[M?_29?]NR.QKH
M_P"\M8_^!IP[_P#/ZC_W%I:#=,U2VBTW6_$7AW1+Z_\ #=]<SVWCOP)=6BRW
MVD7;J&N98K92ZM,RRB2:WC+QWD<JW-NTCR@WL-Y9Z1IWA'2],U/5)-:^&.M/
M!<^%?%5M>>9<>&YVQ]F5KGD[,L!!<DG.[R9=VY6EO ZUK_C5I8ETOP_\9/#]
MD%EB9I(M'\;Z8DAP"<._D>9*2K@23Z=/,>)H9W2^KZ7J=O%INM^(O#NB7U_X
M;O[F:V\=^!+JT66^TB[=0US+%;*75IF60236\9>.\CE6YMVD>4&]/^#T^_3_
M -*CTW07=[K?W?M:W^PU/:]OX57:2_=U"Q>6FK:SXML]+U2\M=#^*>AP2/H6
MNI 5L?%%H"#)')&#\RG"^=;YW1-MEC.-CANB:W>IK6K^)O#.D36OB"UD1?&W
M@EY5WW;[<+=6S':AG*)^[F^6.ZC3RY-CHK04[RST?3O".EZ9J>J2:U\,=:>"
MY\*^*K:\\RX\-SMC[,K7/)V98""Y).=WDR[MRM+>N[/5M9\6V>EZI>6NA_%+
M0X)'T+74@VV/BBT!!DCDC!^93A?.M\[HVVRQG&QP:W\_QOTUVO;9[37NRU):
MCRV=N6S6J?+RWO).*]Y03UJ4U[^'G^]I>[H9;)X9\+?#((QCUKX#ZTH*.&D@
ME\ R1R9'(VRP64,T8(8;)=+EB'W+= ;#4UG1M0?Q#I/ACQ/JTECXOL7E;P3X
MV6W0?VK\FZ2UN8UVH;@QQYGMALCN8X_/@\MXG2S;HNMWR:UJWB;PSI$UKXAM
M9$7QMX):5=]XVW"W5LQVH9RB?NIOECNHT\N38Z*T&:Z^&?"_PQ"L8]:^ ^M*
M"CAI()? ,D<F0<C;+;V4,T8(8;)=+EB'W+= ;!:6Z6MYI63^]13_ .WJ4O[I
MI[[GU<F_*4G*2_\  9591W7\+'4NU9:ZEC?:MJWBN_UC1["WT7XG:+%$GB/P
MX]QBS\26PRL4T4I #!@K>1<X!!5H90I5ECH6EWHND^"]0U#3].?6OA3K336_
MB/PY<6I:X\+3$G[01;X+"(,29K<#*$F2/(+*U_6=&U!_$.D^&/$^K26/BZQ>
M5O!/C9;=!_:OR;I+6YC78AN#''F>V&R.YCC\^#RWB=+,L+_5M7\5W^L:/86^
MB_$[18HD\1^''N,6?B2V&1%-%*0 P8*WD7. 5*M#*%*LL;UOYZ]-;]=-KV^*
M.TU[T=3.,H\MU;EM%Z2?+RWM%J3]Y04M*=1^_AYWHUERD.JZ5%':Z+X=\1:U
M>76CW5Q%<>!?'5O<+)>:==,I6"&6=@RM,RN4CF<-'>1R-!,'=R+J;_B=>(/&
MO_,+\/\ QD\/V7_32+1_&^F))_P-_(\R7_II/IT\W_+:&?\ TZA:76BZ3X+U
M'4-/TY]:^%.M--;^(_#EQ:EKCPO,2?M!%O@L(@Q)FMP,H29(\@LK6-5TJ**U
MT7PYXCUJ\NM&NKB*X\"^.K>X62\TZZ92L$,L[!E:9E<I',X:.\CD:"8.[D71
M_P #K]VO_I,O^W9%.+O9_P![[.M_MIP[_P#/VELU^\IB:5JL,=EK?B'P]HEY
M>:'>7$MMX[\"7-LLM[IETZAKB:*W4LK2LL@DEAC+1WD<BSP%WD!NX;JUT;3/
M!NG:9J>HMKGPKUQH)_#?B2"[+W'AJ9B#;JUP"6$88KY%SG*DB.0G*L][_B=>
M(/&O_,+\/_&3P_8_]-(M'\;Z8DG_  -_(\R7_II/IT\W_+:&?_3J^E:K#'9:
MWXA\/:)>7FAWEQ+;>._ ES;++>Z9=.H:XFBMU+*TK+())88RT=Y'(L\!=Y ;
ML_X/3[]/_2H]/BB&M[K?W7I+6_V&I]_^?57:2_=U">^L=6U+Q;8:3JU_;Z/\
M3M'BD;PYXC6#;9^)[48:2":-2 <A5,UL""I FA*[08UT;6=0?7]6\4>%])EL
M_%EF\:>-O!+SH#J9";4NK=VVI]H\M,0W!VQW,<8AF,;1H]I2N;;1M+\&Z=IF
MIZBVN?"O7&@G\-^)(+LO<>&YF(-NK7 )81ABOD7.<J2(Y"<JSW;^QU;4O%MA
MI.K7]OH_Q-T>*1O#GB-8-MGXGM1AI()HU(!R%4S6X(*D":$KM!C>M_NZZWZ:
M[7_E>TU[LM2;1Y;.UK-.Z?+RWO).*U4$]:E->_AY_OJ/NW1E*WA?PK\,/^6>
ML? 76%P01);R_#Z2.3D$?++;V,,T?3Y)M*FB_@MD_P")?JZWHFH+KVD^&?$V
MK36?BBSDD;P3XV6%=U^VW<]I<HNU#.43]]!\L=S''YL7EO&RVQHVLZA)K^K>
M*/"^DRV7BRR>-/&W@EYT!U,A-J75N[;4^T>7'B&X.V.YCC$,QC:-'M,M6\+^
M%?AA_P L]8^ NL+@@B2WE^'TD<G((^66WL89H^GR3:5-%_!;)_Q+UHETM;S2
MLG]ZBG_V]2E_=-/?<^KDWY2DY27_ (#*K*/_ '"QU+M66NI97NK:OXLOM6TF
MQMM%^*&BPQIXA\///MLO$UJ,B.6*0@;E.&\BYP"A#12@894I6]QI%CX1U35=
M*TN37/ACKCSP>*?"T]H9+GP].Q/VF1+;!.W<Q,]J <Y,T0+%EFNZWHE^NO:3
MX9\3:M-9^*+.21O!/C985W7[;=SVERB[4,Y1/WT'RQW,<?FQ>6\;+;%E>ZMJ
M_BR^U;2;&VT7XH:+#&GB'P\\^++Q-:C(CECD(&Y3AO(N< H0T4H&&5'K>SW_
M !OUTVO;=;37O1U,HN/*I1MRV3NF^7EO:+4G[RIJ6E.H_?P\_P!U5]VS/)=2
MO_[ ^*&M:3=#Q!XRTO4'T7_A#?&&FZA:+?:1=-#<M:[KNX?RWE9)S%'-)N2[
M24P3+,9G6X_,G]K$1^*_^"6W[3&H2WTFD^([?PW;R2+;86#7+1=3L8Y$>)LD
MHCR1R##;X7D4"1DDD6;]4/ >IZ3;>,?B5?Z;X>_M7X::L;>'Q/X>EL6-WH[O
M$_VB1;;G<%D,OGVX!)W&2+<04E_*K]JN_P!(U+_@E/\ 'S0;_3QJ.J7FF6\^
M@2QP_:)H+Q;RW!V[07B9K<SH).%=6DB8@R*DF]&,7KIT[_+7KV3^3/(S"M6B
MN6/,K^TOI&ZLK27+IRM[U(:K:<=]/W]T[_D'P?\ 7-?Y5-7,Z?\ %CPL+"'_
M (J7P_\ ZM?^8C#Z?[U3?\+9\*_]#-X?_P#!C#_\57J'PIT%>?\ [1W_ "*O
MA_\ [&O1/_3C!70?\+9\*_\ 0S>'_P#P8P__ !5<%^T-\3_#5WX8T%8O$6AR
M,OBG178)?Q-A5U" DGYN@ ))[ 4 ;O[,7_))1_V&M8_].EW7G_\ P4\_Y,[U
M3_L8O#/_ *D&G5WG[+%W%??!R.:&2.:&76-89)$8,K@ZI=8((X(K@_\ @IY_
MR9WJG_8Q>&?_ %(-.H ],_:$^/'@G]F?X0ZMXU^(FMV/AWP?I#01W^H7B,\$
M!GGCMX@P56/S32QH.#RP[<UP][\)?$5I^U%I>NZ?\+_@F?#FFYC@\3274L?B
MBR26';.(8EL"B[FRN!= ,G)P?EKR7_@JQJ'PS_:J^ /CC]G[QHOQRTN'6I-,
MDO-4\*?"3Q-K\,?V>[M-1C\F[M=.GM)<F%$;9(VPEU.'4@>P?#3]NKPA\6_B
M-I/AC1O#7QFBO-6\[%WK/PI\3:#IMH(XFE)FN[^Q@ACW!"J@OEG*J.6&0#V:
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^9
M?^"S7_**GX^?]B9?_P#HNC]ES_E(W^U/_P!RG_Z:Y*/^"S7_ "BI^/G_ &)E
M_P#^BZ/V7/\ E(W^U/\ ]RG_ .FN2@#Z:HHHH **** /F7Q5_P ID? ?_9&?
M$G_I\T&OIJOF7Q5_RF1\!_\ 9&?$G_I\T&OIJ@ HHHH _,OX)_\ !)7X1_\
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MJ?=?\NZO5?NZIZ#?V&K:CXMT_2=6U"WT?XFZ/%(WASQ&L&VS\3VHPTD$T:D
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MX7^&;3PQH+0^'="C9O%.BH2EA$I*MJ$ (^[T()!'<&O7J\__ &CO^15\/_\
M8UZ)_P"G&"@"/]E>UBL?@Y'#!''##%K&L*D:*%5 -4NL  < 5P?_  4\_P"3
M.]4_[&+PS_ZD&G5Z!^S%_P DE'_8:UC_ -.EW7G_ /P4\_Y,[U3_ +&+PS_Z
MD&G4 ?0%?//B;X.?&6^_;8L_%%CXF\GX6QR0M-I7_"5&/<JVX1Q]@_LI@<RY
M./MPS][*_<KZ&HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#YE_X+-?\ **GX^?\ 8F7_ /Z+H_9<_P"4C?[4_P#W*?\
MZ:Y*/^"S7_**GX^?]B9?_P#HNC]ES_E(W^U/_P!RG_Z:Y* /IJBBB@ HHHH
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MQ>VB^8YP 1W-?:% 'S+^SM_RE"_:8_[%WP3_ .B]7KZ:KYE_9V_Y2A?M,?\
M8N^"?_1>KU]-4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ?+_P#P6N_Y1'_M&_\ 8@:M_P"DSU\&WNI+-\8_AQJNCZ/?K)'INBKKWA\Q
MA992MCI@=UCSM9I.&5L[9E*'.<$?>7_!:[_E$?\ M&_]B!JW_I,]?"^KWVMO
M\=/A9#<0V%AXRM]%T..TN(]_V#5H!9Z88MYQNVD %XQEH7;*EU*O)QXS[/\
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M6_\ R*O@W_L>?#__ *<8: +G[)&I_P!L?!.&X">7YFM:U\N<XQJMV/Z5Q/\
MP4\_Y,[U3_L8O#/_ *D&G5U7[%G_ ";]:_\ 8:UO_P!.]Y7*_P#!3S_DSO5/
M^QB\,_\ J0:=0!] 4444 %%>/?$G]H/Q5JWC+4/"7PI\'VOBS7M)D6'5M8UG
M4#I?AW0I&0.(I)ECEGN;G8ROY%O"R@$"6:WWH6Q[GP?^TY#&MY#\0_@7<2@!
MGTI_A_JD,;?*OR"\&L,5.[?^\-NPP5_=@J2P![S17E?PO_: U>Y\9P^#_B)X
M97P7XMNP[:;);WIO]%\0A [,+.Z*1GSEC1I&MI8XY0@=E$B1O(OJE !1110
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MCZU\+KXUM=#FU#49X?#>KPZHVF"XMDD#ZAJ4 E>+SI+;]UYQRVUMORDC]%:
M/F7]G;_E*%^TQ_V+O@G_ -%ZO7TU7S+^SM_RE"_:8_[%WP3_ .B]7KZ:H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BN&U3]FCP#K6IW%Y=>%=(N+J
M[E:::5XLM([$EF/N22:@_P"&5OAU_P!"?HO_ 'Y_^O0!Z!17G_\ PRM\.O\
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M(G&U4FVS8/\ P4.\$^"O"GQBTJ3X?Q-9>']4T5;UK J8_P"S+C[7<PS6_E.
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M]XB^SQ^$O"NA_%?PY;^;)9.CQZ-XTT\, 64_.ZQ%G&'&^:QF<!A-#)B[9:?
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MDSE?CI\'+&3P-K-]X;TJ\\._$JRGL],\1^'+C7[V:TUA+N1;6WN$E,R%XG;
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M .Y3_P#37)1_P6:_Y14_'S_L3+__ -%T?LN?\I&_VI_^Y3_]-<E 'TU1110
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M^Q=\$_\ HO5Z^FJ^9?V=O^4H7[3'_8N^"?\ T7J]?35 !1110 4444 %%%%
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M@;QS;RJ]U;7#*1%#+*04,Y1BJNP,=W&S1R!F9EED1];UKQL\T*:9H/QBT&R
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M$/%]O>^;<Z#.^/LL;W66)!W@6]VQ(D#"&;<S*US;1];UKQL\T*:9H/QBT&R
MN+<L\6D>.-,1SCGYW$(>0[7P\UA-,01-#,RWE>PO[./2-<\0>']#O-4\)ZI<
M3VWCOP)<V8FO=)NG7==316J[PTK+)OGM4WI=I*+FW,DDG^G'_!Z??IV_FCTW
M0:WNKWNNNM_LM2VYK?PJNTU^[J:EBZM=8U7QC::?J%W9Z+\5-%MW.C:RL133
M_%MDI!>.1 >5Z>;#DO"Y$D9*D%FZ+K-Q'J6L>)?#6CW$6IQ2B/QOX(D96EED
M*X^TV_1&F*#*N,1W48"DJZ@I6NK72K3PKI.DZMJTVN?#?7'M[CPCXNM[WSKG
M09WQ]EC>ZRV0=X%O=L6$@80S;F96N;=U:ZQJOC"TT_4+NST3XJ:);NVC:RL1
M33_%MDI!>.1 >5/'FPY+PN1)&2I!8UO_ %>_37:]MGM-:/4EJ/+9VM9]&H\J
M=Y)Q6J@GK."]_#S_ 'E/W;HSI8O#?AOX;1V]Q(NN? S7%1K:Y662&;P/(D@:
M/]XI66"UAF12DH*2Z=+$O*0H&M)-<\%7EW\0]$TOQ%K$VD_$+3XYH?!WCF&W
M14\1P;#))97D*[(FN%2,R2VHV),D;7-MY12:*SMZ+K5RFI:QXE\,Z/<0ZI#*
M(_&_@B1E,LLA7'VFWZ(TQ095QB.ZC 4E74%*$D?AOP[\-8[>XD77/@9KBH]M
M<K+)#-X'D20-&?,4K+!:PS(I20%)=-EB7E(4#6A&7+JK?I9/[^5/YTWWBPK4
MG5O3GS-R?2SGS26ZM:+JRCNKJGC*:NG&LDSEXOBAX^T/QKJFLIX%MX/&V@K$
MOB[2]+U:$6>MV8W+'>JEP8FQY<;F"XC,A81O!* \;);R?"SXK>&_&7P]\0:A
MI>@:I<?"&XNY+#7-"U*WC:;PU(T<<SSPQQ/)_HG[T&2($/;N&95"AE7K?%_A
M.^\2W]EX-\6:Q+I_C*.*YB\&^-XK=%_MN-HBT]I<1+LC^T&*/=<6@V1W,</V
MJV\IX72P^>_&W[%7C#XWV]TR^)M)\/\ Q'\(:?:V>IZ!IVF36O\ :T<:B*"Y
M6>2\*3I)%$RPS^7$&,?E2B!XY$ATBHNZEH]>G7JFEI=K=+22]Z/EQU9U:?+.
MDE*%HWM*RY;VA*,Y6?)&6E.I*TZ$KT*RM92]N^*FJOX&\.:'I/B"ZU+6+6XU
M6PC\#^-+.96O+*>YGCMT6:;:RM*L<S$.X,=W$'BE!9F\W>5M;USQLTT*Z7H'
MQCT"R"SP,SQ:/XWTQ'..<.XA#R':^))]/GF((FAF9;SXF^)O[!4_A+X-Z?XG
MLOB3=:QX/DU2WT[6XY=&>UN/#[27<4#&6V,[-F&1SYD?#J5& 02R]=JW_!,S
M4],\;:/9ZI\7+B/1=96/^P=?CTHS6\]TX($#M]J'DNZD>4VYEFRR[@Y5'KV=
M/^;MWZ[:_E+_ +==S%XK&)6=#6T]+K=/WUR^:UJ4O^XD%%'L7B/]H-O#7B37
M(_"/PQ\7^(-'UQ[Z#Q5X.U&S@ACBOUMDN;QK>/?(SR.DV)HHHI+>[:030.S-
M(]U@M\8_&</PGL;75_AEJVK^"=4N[67PEKL?BZSDNM(,HS:D7P+AL,0L-Q(1
MO$D<3F5GW2\[\!/!][\+_CU8^"M+D\,#XO>";O4/M4Q2X6#Q5I9M8);47LV&
M96*321QLN]K5OF$<J&2.?Z"T[4;6/2=<\0>']#O-2\*ZE<3VWCOP)<V:S7VD
M7;J&NI8K52ZM*RR"2>VCWQWD<JW-N9'D_P!.*D5#1KIY]=].W5QZ;HK"U)U^
M:I&H])+1.-TULN:S][[,*M[32Y)6NCQOXC^.OB=XSUOP?INM?"^YTGXE:7/;
MW>GZZFJP+!J4$-U&\B2PQ$F9, /)#&Y9,[U"J<'VK1=:NUU;5_$_AC29[?6[
M>58_&_@B1U\RY?;@7-N3A#<%%S'*,1W4:A'*NJM#5NK;2;'PII6DZMJTFN?#
M37'M[CPGXMM[WS;C0)WQ]E1[K))!+*+>[)._<(9BS,K7%N\M-8U/QA9Z;J5Y
M::+\4M%@D.AZX(2EAXLLU(+Q2H#R#P98 =T38EB.,&LY2;>G_!O;N^O9[27N
MO4ZJ=%1B^=\R::=TU'E4FVN56M!-^_!+VE"252#<3,DC\,^&_AFL4K+K7P)U
MH*T,RR203> Y8Y R$."LUO:0S1@JX*3:9-$.4@0&RU-7TG4KGQ'I/ACQ/JS6
M'C:P:5_!/C9+9%76@$WRVMQ$FR/[1Y<6;BT&R.YCB-S;^4T3I8-T76KM=6U?
MQ/X8TB>WUNWE5/&_@AW7S+E]N!<VY.$,Y1<QRC$=U&H1RKJK0YLD?AGPW\,U
MBE9=:^!.M!6AF622";P'+'(&0AP5FM[2&:,%7!2;3)HARD" V4:6Z6MYI63^
M]13_ .WJ4O[IU>^Y]>:_E*7-)?\ @,JLH[K^%C:7:LDS4T[4=6O_ !9J6M:+
MIL.D?$C2(XE\4^%FN +7Q';X*Q7$$K!58E48071"@A#!.$:,BWHP3Z'I/@>^
MU#3[%M<^$>N&:+7="FMF\_PM-N(G98"-ZQ*^[SK? :%@708W+5[5])U*Y\1Z
M3X8\3ZLUAXVL&E?P3XV2V15UH!-\MK<1)LC^T>7%FXM!LCN8XC<V_E-$Z6":
M=J.K7_BS4M:T738=(^)&D1Q+XI\+-< 6OB.WP5BN()6"JS%48071"A@A@G"-
M&1;UK?[^FM^NFU[?%'::]Z.IFI1Y;JUK1::DU'E3M!J;U4%+2E5?OX>=Z%=<
MMF1:MI2I%HOAWQ%K5W<:?<3QW'@7QU;S+)=6=RRD0P33$%6F96*)(X:.[C=H
MI0SL1/,K:UX@\:M+$NE^'_C)X?L@LL3-)%H_C?3$D. 3AW\CS)25<"2?3IYC
MQ-#.Z7U&WGT/2/ ]]J&GV+:Y\(]<,T.NZ%-;-Y_A:;<1.P@(WK$K[O.M\!H6
M!=!C<M6-6TI4BT7P[XBUJ[N-/N)X[CP+XZMYEDN[.Y92(8)IB&5IF5BB2.&C
MNXW:*4,[$3K_ ('7[M?_ $F7_;LBO)_WEK'_ ,#3AW_Y_4?^XM+0;I>IV\>G
M:UXB\.Z+?7WAV^N9K7QWX$NK59+[2;MU#7,L=LI=6F99!)-;QEX[R.5;FW:1
MI0;R&\L]'TWP?I>FZEJDFM?"_6G@N?"_BBWN_,N/#4[8^S*USR?+RP$%R2?O
M"*7=N5I;RMK7B#QJTL2Z7X?^,GA^R"RQ,TD6C^-],20X!.'?R/,E)5P))].G
MF/$T,[I?0:7JEO'IVM>(O#NBWU]X=OKF:U\=^!+JU62^TF[=0US+';*75IF6
M0236\9>.\CE6YMVD:4&\/^#T^_3_ -*CTW07=[K?W?M:W^PU/:]OX57:2_=U
M">]LM6UCQ99:7JE[:Z'\4M#AD?0-?2#;8^)[08,D4D8(W*<+YUOG=&VV6(C"
M.J:)K=\FN:MXF\,Z3-9^)+21%\;>"6E7=>MMPMW;,=J&<HG[J?Y8[F-/*DV/
M&K6]*\M-'TWPAI>FZEJDFM?"_6G@N?"_BBWN_,N/#4[8^S*USR?+RP$%R2?O
M"*7=N5I+UY9ZMK'BRRTK5;VUT3XHZ)#(^@:^D&VQ\3V@P9(I(P1N4X7SK?.Z
M-@LL1&%936_G^-^FNU[;/::]V6I+4>6SMRV:U3Y>6]Y)Q6J@GK4IKW\//][2
M]VZ,MT\+^%OAAM;R]9^ NLJ"K!I()? $D<F001MEM[*&:,$$;)M*FB_@MD_X
ME^IK&CZA)X@TGPOXHU:2Q\76+R/X)\;) @_M3";I+6XC7;']H\N/,]L-D=S'
M&9X/+:)TLVZ)K=\FNZMXF\,Z3-9^)+.1%\;>"6F7=>MMVI=VSG:AG*)^ZG^6
M.YC3RI-CQJUOF.GACPK\,=K>7K/P%UE058&2"7X?R1R9!!&V6WLH9HP01LFT
MJ:+^"V3_ (EYI;I:WFE9/[U%/_MZE+^Z:>^Y]7)ORE)RDO\ P&564?\ N%CJ
M7:LM=6QOM6U?Q9?:MI-C;Z+\3]%AC3Q%X=>?%GXEM1D1RQ2$ ,I"MY%S@%2&
MAE"[65*-I=Z+I?@S4M0T[37UKX5ZTTUOXD\-W%H6N/#$Q)^T$6^"1&&),UN
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MZ^3O3>K,40AEVDU\#_L4^-_V#?V;?%7BKQ)XX^)O[0?Q*\3:MX>U#0=&O(O
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MA\'=-U"^M;;Q':Z;HIT?6EM<V]VIT_32BRPAUW,$5?.B5D5]OF1F,X$/W?\
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M&NLDE2646]T2=VX12EF96G=XE\-WWC/6%\.^()[/3?B-9V4\.DZR82NG^+[
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M\$T9[?P]H7P^MK6ZN/[:^"^M>7)IFIQ3ND_@R97!B_>@B2*WCD4>7+E9+.1
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M7PNUIH+CPQXGM[O?<>&IVQ]G5KG)/EY8""Y).,B*7.5:3YYM/B9X\^+'[?\
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M?_M'?\BKX?\ ^QKT3_TXP4 '[,7_ "24?]AK6/\ TZ7=>?\ _!3S_DSO5/\
ML8O#/_J0:=7H'[,7_))1_P!AK6/_ $Z7=>?_ /!3S_DSO5/^QB\,_P#J0:=0
M!5_:^\"?$_X\Z=X@\"S?!/X&_$GX7ZDUJWE^*_B-J.ES:@8FAN!YUG%H5U&G
MEW,8*XN'W"-&.TDHNA\.OC3\:M2^-&CZ#XT\)_ 7POH\AE_M$:1\3[_6M:YA
M9H1!:3:-9J<R;-Q:480L0"0 ?>J\.\0?L&>&?$?[6UK\8IM8U2/7[22*1;)=
M)T5K<F. 0C,[V+7PRHSQ= @\#"_+0![C1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?,O_!9K_E%3\?/^Q,O_P#T71^RY_RD
M;_:G_P"Y3_\ 37)1_P %FO\ E%3\?/\ L3+_ /\ 1='[+G_*1O\ :G_[E/\
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M"?\ T7J]?35 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTEUZ:WMM!^(%K:20RZ7'X)U$6OB2T4N(#*PNF=HT9LK*(P\+LR9*2,)<"?\
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M]YJMI>16=I*Z+]ICMH+4QO+QR8N,L0O]!E-AB6WB6.-5CCC 5548"@= !3J
M/F7]G;_E*%^TQ_V+O@G_ -%ZO7TU7S+^SM_RE"_:8_[%WP3_ .B]7KZ:H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^9_P!I[]AGQ=\?
MOV2?B3\([+XB:/H^B^/M.U:P2:;PRUQ-9B^>:0Y87:AMK3$9VC('2OCO7?\
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M6KJ:UFG2X\"^.K>57NK>X92(H992"AG*,55V!CNXV:.0,S,LN/\ P.OW:_\
MI,O^W9'I6Z/^\G>/_@:<.C6]:BO^OM+0;IVHVL.E:UXA\/:+>:EX4U*XGMO'
M7@6YLQ-?:1=N-UU-%:KO#2LLGF3VL>]+M)1<VYDDD(OH[RSTFP\*:3I6JZM+
MK7PUUIX+GPEXMMKWS;GP].^/LJ-=9;*G>!;W1)#AA#-N+*T]M'UO6O&SS0II
MF@_&+0;("XMRSQ:1XXTQ'..?G<0AY#M?#S6$TQ!$T,S+>0:=J-K#I6M>(?#V
MBWFI>%=2N)[;QUX%N;,37VD7;C==316J[PTK"3S)[6/>EVDHN;<R22'[<O\
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MM4T=/#_BR/0M?BUFVCE\R*4K:6"Q3Q28 EA=0=DA57VKL=4>-HT_1#X)>*_
M]G\+=)BO_C%JVBWD:.)K&/6X(EM6\QOD"M&2N/0DU^??_!76V\1:+_P5&^#&
ME^(KA=:N-/T/Q&MKK8CCA;58#::?M,T2 +'<J !)Y:K#(<21K&'-O!^G?[.N
MO?$:W^"N@)IOA7P5=V"PL()KKQ5=6\TB^8V"T:Z?(%/L';ZUZ^'O[-7\]U9[
M]>E^[6CW6C/SW.)1>+DX6M:-K2<HVY5;E;]Y1M\,9>]!6A+WHLX+XC^+? DO
MCSX?M#\9]7NH8]9G:>9M<MV-DG]FW@$@(C^4EBJ9.>)".I!KE/&&K:'JG[7_
M (,DT/QA=>,+99[!6NY[V.Z:-]FJ_N@R*H  PV,9^;->R_%+7_B2_P 1OAJU
MQX3\#QS)KMP;9(_%EU(LS_V5? J['3@44(7.X!R655P Q9?GK]OB7Q!KGQL\
M.Q^)-+TG2;IY]%14TK69[L>7]HU'YQ,8('20-G&T<8!#9X&QY9]A_LO_ /)M
M/P[_ .Q9TW_TEBKNJ\9_9)\7:OX<^$'@?P[XMMK"RN;C2+=-$O+.=I;;48%A
M!CA9F1"EVL*AGCQM<*SQE@LJQ>S4 >8_M5?LI^&_VO?AT_A?Q09FTF=)X;B%
M8HI4N89H7AEC99$88*.<$ ,IP001FOSG\#?\&V'P+UWP!8:MX<^&_@76)[FZ
MOH+N/Q+=:A&D0ANI(HS$;613DJAW!\CIC%?K-7G_ .R__P D;M/^PAJ7_IPN
M* /Q?_X)??LL?MJ>,/V%K[PK\+?B'\+='^$UKXLU[3]-T?4] ^T7&FO;:M.&
M,%QYBS1[+B,RPN&\V)MK*X95(^E-7_90_P""EVO7N@WUU\:O@[)K'AQB;/4E
M\)0QW0# +*CE7"O'*%7?&5V%D1MH>.-E]R_X( ?\F 7G_91/&/\ Z?[VOL[7
M]>L_"VBW6I:A<1V=C8Q--/-(<+&@&236<J4&[M?TM5]SV[=#JIX[$4XJ-.;2
M5[);>\N67_@4=)?S)).Y^:/P@_9N_;\\3_&;Q9=:A^T-\)_"VN:?;V<-^;7X
M=K=V^J^8KF,R*)U7S8D50'QOVNJD[0!75:=_P3S_ &U-.\):MX?7]IWX1S>'
M=8:1IM*F^%"R6D0DYD6-#=_NT9B6V+A5))4+DU]O?!?0[VVT74-:U2W:SU;Q
M5>MJEQ;R(%DM$*)%! ^/XT@CB5N2-^_!P:[*CV,.RZ_CO]_4I9CBDK*H_L]7
M]GX?_ =HO=+161^=/BG_ ()U?ML>-_">BZ3K'[5/POU3_A&[RWU'2KZZ^%HE
MOK"ZMV#03K,UV6:1<8+/N\Q2RR>8'<-Y#XG_ ."0?[4G[;'[-]UH7B+]ICX?
MZ=X=\9:8^AZO%8?#DQW%]8I>O,L4C"["R&.8-)&Q >/S)55E6:99/UTKS_\
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M)LV.3P[H?P[GN[2#^W/@KKGF)J&GO#)'/X,E60B4B(@2PV\4JL)(B%ELI4)
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M$N-'\-^)-8NO,\X2^!_'$3*UPDQ4[+>=_NM,4ROS?N[N/((WY!7IY=?NU_\
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M:'=WDZ7MHY>'4K<Z=(0Y^1-LR>9&'^148N&0 %DCO_L]_P#)1/!G_8$\5?\
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MLMMGQ2Z%I7@6]U#3[)M<^$>N&6+7-#EMV^T>%)MQ$[+!C>D22 ^=!@/ X+H
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M9EO*$4NAZ7X%O=0T^R;7/A'KAEBUS0Y;=OM'A6;<1.RP8WI&D@/G08#P."Z
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M_(J^'_\ L:]$_P#3C!0 ?LQ?\DE'_8:UC_TZ7=>?_P#!3S_DSO5/^QB\,_\
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M_LC/B3_T^:#7TU7S+XJ_Y3(^ _\ LC/B3_T^:#7TU0!^8/P&^*_BC1?VH_\
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M#:ZKH-G;_M0:'J'@NZ:1)['^R]6671F="4=5-BH\D,  JJSPL5*#828M0_\
M!1+]F_4-=_LW4/VKM*9M,3[3HWB"/3-28H3\IAE7^S]_F 8W<>7*I'(;*A^S
MG?9_UMK_ .DRZKW9:D?7L,XW]I&UF]DE9O6\$]$W_%HKX7^^H-Q9^FUEX?\
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MGXZ:7\0?V?SX,T^S\:6S?$3Q#H7@^[DN_"FJV,*V.I:M:6=Z#--:B-2;2:X
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MR4?\%FO^45/Q\_[$R_\ _1='[+G_ "D;_:G_ .Y3_P#37)0!]-4444 %%%%
M'S+XJ_Y3(^ _^R,^)/\ T^:#7TU7S+XJ_P"4R/@/_LC/B3_T^:#7TU0 4444
M %%%% !1110!\R_L[?\ *4+]IC_L7?!/_HO5Z^FJ^9?V=O\ E*%^TQ_V+O@G
M_P!%ZO7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MY_\ '/\ Y#GP[_[&N'_TDNZ] KS_ ..?_(<^'?\ V-</_I)=T >@4444 %%%
M% !7G_[0?_'CX1_[&O3?_1M>@5Y_^T'_ ,>/A'_L:]-_]&T >@4444 %%%%
M!1110 4444 %%%% !1110 4444 %9?C?_D2]8_Z\IO\ T6U:E9?C?_D2]8_Z
M\IO_ $6U &/\!/\ DA?@O_L V/\ Z3QUUE<G\!/^2%^"_P#L V/_ *3QUUE
M!1110 4444 %%%% !1110 4444 %%%% !1110!PW[1&J76C_  YMYK2XGM9F
MU_1(B\,A1BCZK:(ZY'.&1F4CH0Q!X-=S7G_[3/\ R3&V_P"QCT'_ -/%E7H%
M !1110 4444 %%%% !1110 45QWQO\47WA+PKI=QI]P;>:X\0Z/92,$5MT,^
MHV\,J_,#]Z-V7/49R"#@UV- !1110 4444 %>?\ [+__ "1NT_["&I?^G"XK
MT"O/_P!E_P#Y(W:?]A#4O_3A<4 >@4444 %%%% !7G_[+7_)"-#_ .WC_P!*
M):] KS_]EK_DA&A_]O'_ *42T >@4444 %%%% !1110 4444 >4?%O\ 9AD\
M5^-I/&7@OQ9J_P .?'$T44%W?V,,5W8ZW%%N\N*_LI08YU0,0LB&*=1\JS*N
M5/'MX1_:NN==FLV\?_ "UTC[-$J:I'X%U:2\:;+"5OLK:L(U!&PIF9]I+ A@
MHW?0]% 'FOP<_9PA^'/B6X\4:_XBUSQ]XZO;<VDFNZP(4-G;,XD-K9V\*)!:
MP;@F0B>;*(H3/+.T:./2J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /F7_ (+-?\HJ?CY_V)E__P"BZ/V7/^4C?[4__<I_^FN2C_@L
MU_RBI^/G_8F7_P#Z+H_9<_Y2-_M3_P#<I_\ IKDH ^FJ*** "BBB@#YE\5?\
MID? ?_9&?$G_ *?-!KZ:KYE\5?\ *9'P'_V1GQ)_Z?-!KZ:H _*__@L?\>/B
M-X<_;STWPIX<^(_CCP?X?M/ -AJPL]!U,V*2W4^HZE%)+(4&YR4MX5 )(&TX
M RV?FUOC;\4=-T^6^U#X[_&2WL;=2\CMXMECR%&6^8\* .2QX _*OIC_ (*C
M?L^?$3X^_P#!5.PT[P'X)U+Q))-\--)CDOI6-EHVGD:KJ^3=7K*RQ@!@=D:R
MS,,E(GP<>[?LI_\ !&'P;\-]0L?$WQ8NK/XJ>,+5DGM;.>S\OPWHDBG<AM[%
MRXFD0X(N+DR.'021K 25H _.7PG^T=\0/'.E?VEIO[17Q4O=/9RF^Q\82W.&
M#%63Y20K*>JNRL*[K]GC]I+XI:!^UE\';?\ X6W\4-8L=8\9Z=I6H6>L:\]]
M;7MO,S1RHT3#;AE/&064@$-D C]*/VRO^"8?PV_;&NYM>NH+KPA\0/)6*'Q9
MH02&^D5  D=TC*8[R$8 "3*Q12WEM$QW#\_X/^"?/QJ_9T_;6^#%KKGA>3Q=
MX?M/'FFW:^+O#%I))IQ@BD9G>[MR7ET]@HR?,:2')55N'<[: /V,HHHH ^9?
MV=O^4H7[3'_8N^"?_1>KU]-5\R_L[?\ *4+]IC_L7?!/_HO5Z^FJ "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O!_P!MKXFWWPX\6_ 6
M&SAM9E\3?%"RT:Y,RL3'%)INI2%DP1ALQ*,G(P3QZ>\5\R_\%&_^1X_9B_[+
M/IW_ *:=7H ^FJ^??C9_P58_9U_9R_:!TWX6>-OBYX1\.^/-4EB@CTNYG<FV
MDE"M&EQ*JF*V9E>-@L[H2LB-]UU)^@BVT9/ '4U^)^B>$/VG#^Q%\3]6^'-O
M\+KC]D[5M2UOQI=Z[XA^U:%\1_B'H$MS<7MU.]T4N81Y\.^..\N(TN)(!#*/
M++*5 /V-T7XKZ'XA^*/B#P;:W3R>(/#%C8ZCJ-N87588+QKE;=@Y&UMQM)^%
M)(VC.,C+?&7Q@\-_#[QIX1\.ZQJD=EK7CR^GTW0;5HW9M0N(;2>]E0%5(7;;
MVTSY<J/DP"6(!\:\4_%74/#_ ,"[/X\?"WX+^(/'?CCXF:)H3W/A^75XM*U(
M6(CFG@2<S,\,<EO]LF#*F2S2$;F"@CA?$WQ5\9?&7Q?^R+KGCOX<WWPK\13?
M%W5(I= N]5@U*2%%\%>*PDGG0@(0XYQC(H ]^^"/[5O@?]HC7]8TOPGJDVH7
MFA6L5Y>H]G+ (HI;W4+)""Z@-FXTR\7 R0(P>C*3Y=_P4O\ CMJWP*TOX%MI
M5KI]T?%_QE\+^&+O[6CMY5M=7#B1X]K+B0;1M)ROJIKUOX0?LR>!O@+K>J:E
MX2T&/1[W6K>.TO9%N9YO/BCN[Z\1<2.P&+C4;U\@ _OR/NJ@7YO_ ."S7_((
M_9A_[.(\%?\ I3+0!]F4444 %%%% '@7QA_X*E_L\_ +XP67@'Q=\7/!VC^+
MKV[6P.GM=&5K*=AN"73QAH[4[?F_TAHP%PQP"#7;?%+]K3P!\&XO'7]OZ\+:
M;X;^%9/&OB"&.UFFDL=)19V-P JD/Q;381"7.S[O(SY9^UG\+O /@/X!^//A
MGX/\)^'?^$W^/EKJNFQ:3;0(EQKEU?K-]JO[QOOFV@^T2S2RN<*N(TS(\43\
M[H7[.GAS5OVK_%'PDUZ.Z\1>$;GX!:/X0U&.\N)%FU2Q:\U2TE$DJ,KAI(BP
M9U8-EB00>: /KRO'/B9_P4)^"/P>^+.G> _$7Q0\&Z?XVU74K/1[?01J"3ZC
M]KNY4BMHG@CW/&9'DC +A0 P8D+S7*:S^U7\9[?]JW_A!;;]G+7YOA^^HQV?
M_"?KXJL%MXX&12UU]C*^;A&)&S.3MSWQ7PGX@_8H^+GP7\-_!W2?$7@/X3^#
M?#WPY^*'@M->\;6TB:]XJ^,%[)XETU!>O<2Q+-8I+/-/=SB1WE\SRH48Q&0T
M ?K1XP\6Z=X!\):IKVL72V.DZ+9RW][<,I9;>")"\CD*"2%52< $\5A77QZ\
M(V7P?TWQ]-K5O'X1UBWLKFQU!HY MTEZT26FU-N\M*\\2JFW<6D5<9.*G^-W
M_)&/%W_8%O/_ $0]?)OP.$GQK\/?LA?#F-EDT7PCX$TCXD^)H]NY7^S6,-MH
M]N_/&^]DENT./O:-U'1@#US4?^"I_P"SOI?[1]G\(YOB[X-_X6#?71L(M+2Z
M,BK="01?9GG4&".<RE8A"\@D,C*@4L0I[BZ_:M\#V7Q\A^&4FJ3+XRN)(XDL
M_L<I0L]I/>*/,V[.8;:9NO50.I /AO[6_P"RY\-]3_9LN/V8_ ?@_P /Z3)\
M3$@BGT_2;.*$:1I\=S UUK5P1@^9"!NBD<M)+=&$9.7=/?+C]F3P/=?&J'XB
M2:$C^,X'25-2-S-N#);36JGR]_E\07$R?=_CSU ( .\HHHH *XG]ICQA<?#W
M]G#X@:_9QPS7>A^&]1U"!)@3&[Q6LDBA@"#M)49P0<=Q7;5YG^VI_P F;_%K
M_L3-8_\ 2&:@"A^P%\0+SXL?L(_!3Q5J$5M!J'B;P%H6JW,=NK+#'+/I\$KJ
M@8DA0SD $DXQDGK7K=>#_P#!++_E&+^SE_V2_P ,_P#IIMJ]XH **** "L/X
ME_$[PY\&? NI>)_%VO:1X9\.Z/&);W4]4NTM;6U4L%!>1R%7+,JC)Y+ #)(%
M;E<O\6/@IX1^.^A6>E^,_#ND^*-+L;Z+4H;+4K<7%M]HBSY<C1ME7*EB0&!
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M_<I_^FN2C_@LU_RBI^/G_8F7_P#Z+H_9<_Y2-_M3_P#<I_\ IKDH ^FJ***
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M;/1;72KU8WC66VM[6W0#:LDJKYS3/B5@SOP0 :@_:W^*#1;9/V5_C$V1AO\
MB?>$,'UX_MJOC?P'_P $\;+P9XFLVO?V??VQ?%O@O2;I9]-\ ^(OBGX9U#PC
MIT<4@DM;:.P;60K6]MM1(HI"ZA(U5@XSG[2?0OBO^S';-J$7B;5/C5X-M 9+
M^PU:QMX?%5C"-[-)9RV4,4-\4&U1;20),X!(N)),1R>R^"_&FD_$;PCINOZ#
MJ5GK&B:S;1WEC?6DHF@NX9%#)(CKPRLI!!% 'B7_  UU\4/^C5_C)_X4'A#_
M .75<[XW^,GC3XB>)O!^L:M^R9\:+B_\!ZO)KNBR+XE\)QBVNWL+S3V<A=;
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MP59:/\'_ (N>-M!T_2R[6VB>)H[?Q%HDF^7S7$B,D5VN6:0Y@NXN96)#84
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M';<@!N?"IS\-_P!OWXG>%;5MNC^,O#NE>.([<'Y8-1\VXT^]91GY5DBMM.;
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MX!'<2-?7$A@M-N-L0CMI6'+E\E53T3X"_P#!+[X)?L^^(9?$5EX-@\4>.+Q
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M-=6-W<:EI5S$9$O;RU'EM':2_,K,<@#'4C4_X>)^-/\ HT7]J#_OSX6_^7E
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M%%?E_P#\(9XB_P"B<_\ !4#_ ,./H?\ \O*/^$,\1?\ 1.?^"H'_ (<?0_\
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MJ!_X<?0__EY1_P (9XB_Z)S_ ,%0/_#CZ'_\O* /U HK\O\ _A#/$7_1.?\
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MNZO-13(/ESZQ-';R)$0,,EO;0R$$CSL9!^-_^$,\1?\ 1.?^"H'_ (<?0_\
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M?_R\H_X0SQ%_T3G_ (*@?^''T/\ ^7E 'Z@45^7_ /PAGB+_ *)S_P %0/\
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M\O\ _A#/$7_1.?\ @J!_X<?0_P#Y>4?\(9XB_P"B<_\ !4#_ ,./H?\ \O*
M/U HK\O_ /A#/$7_ $3G_@J!_P"''T/_ .7E'_"&>(O^B<_\%0/_  X^A_\
MR\H _4"BOR__ .$,\1?]$Y_X*@?^''T/_P"7E'_"&>(O^B<_\%0/_#CZ'_\
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M/_#CZ'_\O* /U HK\O\ _A#/$7_1.?\ @J!_X<?0_P#Y>4?\(9XB_P"B<_\
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M#_P_\)>'=:D?6? TWB.YU.XU2XU>-OF74;01+&NFI@;6W&0\C'(!]9T5\O\
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M_P#"AOVN/^CD/@__ .&5N?\ Y?T ?4%%?+__  H;]KC_ *.0^#__ (96Y_\
ME_1_PH;]KC_HY#X/_P#AE;G_ .7] 'U!17R__P *&_:X_P"CD/@__P"&5N?_
M )?T?\*&_:X_Z.0^#_\ X96Y_P#E_0!]045\O_\ "AOVN/\ HY#X/_\ AE;G
M_P"7]'_"AOVN/^CD/@__ .&5N?\ Y?T ?4%%?+__  H;]KC_ *.0^#__ (96
MY_\ E_1_PH;]KC_HY#X/_P#AE;G_ .7] 'U!17R__P *&_:X_P"CD/@__P"&
M5N?_ )?T?\*&_:X_Z.0^#_\ X96Y_P#E_0!]045\O_\ "AOVN/\ HY#X/_\
MAE;G_P"7]'_"AOVN/^CD/@__ .&5N?\ Y?T ?4%%?+__  H;]KC_ *.0^#__
M (96Y_\ E_1_PH;]KC_HY#X/_P#AE;G_ .7] 'U!17R__P *&_:X_P"CD/@_
M_P"&5N?_ )?T?\*&_:X_Z.0^#_\ X96Y_P#E_0!]045\O_\ "AOVN/\ HY#X
M/_\ AE;G_P"7]'_"AOVN/^CD/@__ .&5N?\ Y?T ?4%%?+__  H;]KC_ *.0
M^#__ (96Y_\ E_1_PH;]KC_HY#X/_P#AE;G_ .7] 'U!17R__P *&_:X_P"C
MD/@__P"&5N?_ )?T?\*&_:X_Z.0^#_\ X96Y_P#E_0!]045\O_\ "AOVN/\
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M&_:X_P"CD/@__P"&5N?_ )?T?\*&_:X_Z.0^#_\ X96Y_P#E_0!]045\O_\
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M$GB#X9^/I_"D>K:)HDFC6^H6ZZ;IUZKM;/<7!1PUZZG$I!"*>#F@#Z$HHHH
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M^*)-;O/"D%_%$Z7-[:RV-J3;1M,BR26[S.H.[RRH./!M.^%?QW\(_P#!-?\
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M%%% !1110 4444 %%%% 'S+_ ,%&?^1X_9C_ .RS:=_Z:=7KZ:KYE_X*,_\
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M* /F7Q5_RF1\!_\ 9&?$G_I\T&OPE_X.\?CKXW^'/_!5G3]/\/>,O%6@V#>
M],F-MIVK7%K"7-Q>@ML1P-QP.<9X%?NUXJ_Y3(^ _P#LC/B3_P!/F@U^)_\
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MIH&J^%_%&BZ;=QW^EZE;M;W5HS:A=.H=& *DJRMSV85T7P0_Y2T_M$?]D[\
M?^EGBJ@#Z:KYE^"'_*6G]HC_ +)WX _]+/%5?35?,OP0_P"4M/[1'_9._ '_
M *6>*J /IJBOD72OVO+[X9_&_5+[XL^,/'/AGRI;FUM_ NG?#N\OM)A@$FVW
MNAJD%E,]V[Q*LA:*=(U,K1M$KQL![3\%OVR/ /[07BN;1?"]YX@N-0M[5KQU
MOO"^J:7&(E9$)$MU;QQELNORABQ&2!@$@ ^6_#?PM\,?$VR^(T&J_L^^&OCQ
MX@_X6OXEBTE->TW3I-/T(,;4RRW%W>(YMHG*Q@B"*:5RHQ$X1BOEUS_P39T'
MX=>!_CIX5\2_LS_##7/B#\4[NXO? FJ^#? =K)H?AW[1HMG8PV_VN6,/8_9K
MRWFF>5A&K"3SXU#R-"G::SK?PST#PG\5KCQ;XW\0^$/'2_$GQ8W@Z+PYXBU"
MQUK4IP+4R+#963[[] _V?=')#-&I=,J"P)F_9J^,'[8VK>#?!;^']$USQDEW
MIEG)K\OQ?\.V?A06UTT*&>*"XLY8[Q520N!YNCRD@+^]8@D@'T%XD\&7_C"?
MX:_$+X:WG@OXD:Y\+;/4?#=Q97.L>3:W9G2VBNC'=1I-]GO8I+1%P\9^22XC
M;87WKB_$3X2?M%?'C1?$6M1^)O#/PUFU'0FT.U\!7)3Q#HM[N^T>;=W5XEO;
MW4%S(LL4:>0TD4(@WNER7\N/T3XE?L1>!?B7XJD\66]G?^ _B!<HOG>*?"%\
MVDZI,P^ZMQ)&!'?1J2<1WD<T7.?+S7/_ -I_'[]G[_C\LM&^/7AJ'I/IP@\.
M^+84']Z&1QIU])U)=)+  8 B8Y) /5/@+\/KCX2? SP7X5NIXKJZ\,Z%8Z3-
M-$"(YG@MTB9E!YP2A(SV-=97@_QC_:VNM,^ 7A?QEX8TO5--FUKQUX:\+W5C
MXET2YTZ\M(K[7K+3KM6@F$;AQ'/(8Y!NC;Y)$,D94MYK8?MB?M#?&7]HSXQ>
M$?A?\-O@[=:'\)?$4'AV:^\6>-=2TN\OY9=.M+[S%AM]+N4";;M5!,F3M)QC
M% 'V%7S+_P $JO\ DA_Q&_[+-\1/_4LU2J?PN_:N^-FA_MD^#?A3\6_ WPIT
M6/QUX<UK7M.OO"'BZ_UB2'^S9=/CD2:.YT^UVA_[00JREO\ 5OD#C-S_ ()5
M?\D/^(W_ &6;XB?^I9JE 'TU7S-_P2K_ .2(_$;_ ++-\1/_ %+-4KZ9KYF_
MX)5_\D1^(W_99OB)_P"I9JE 'TS1110 4444 %%%% !1110 4444 -FF6WB:
M21ECCC!9F8X"@=237._#GXR>$/C%;7LWA'Q5X;\50Z;.;:[?2-3AOEM91UCD
M,3,$;_9.#725\/\ _!!1 O[-'Q8( &[XU^-B<#J?[5D% 'U-XG_:A^&?@CQA
M+X=UKXB>!=(\001B633+W7K6WO(T/1C$\@<+[D8K=^'?Q0\,_%[PXNL>$_$6
MA>*-(:5X1?:1?Q7ML9%.&3S(F9=RGJ,Y%?"'C/Q#XK3_ (.)KJ^\ Z+X2\47
M%U^S9I['^U_$,VE6_P!G;Q->L)(YH;.[+DG;\NQ00<[N #[Q)\7?$/[/O[&G
MB3Q1K7A?P[H?Q8U?4)DGT/0TDU"UFUV\NOL=CA8T6:>-\VS-((UD>-6D**2P
M !]#Z!XDT[Q58R76EW]EJ5M%<SV;S6LZS1I/!,\$\1920'CFCDC=>JNC*0""
M!QFL?M8_"OP]\0O^$1U#XE_#^Q\5_:XK#^Q;CQ#:1:A]HEV"*'R&D$GF/YD>
MU-N6\Q< [AGXS_X)?:O8_L;_ +;WQ,_9OM[GQ5/X/\6:?%\3/ EWXBTZ]LKN
MXE81VNNV[&ZBB9Y/M@CN\1@KB]D/&"!P7Q3N/$'_  3JM_$%UX^T?P_\9/V.
M/BQ\0%\86_BS3F4:_P##K4=6U6&ZM[BY1MR7MHE]+$8IXR9D^7<" B$ _0K7
M?VK_ (6^%_%E]H.I_$KP!IVN:6,WNG77B&TAN[3H?WD32!TZC[P'45TO@?XD
M>'?B;X.M_$7AO7M%\0>'[P.T&IZ9?17=G.$=D<K-&Q1MKHRG!X*D'D&O@GP'
MK7C_ $?_ (+K?M--X"\-^#_$5U)\/_!_VA-?\27.BQPX^W[-C0V-V9,G.00F
MT 8W9P/LK]DO3K[2?V=O"D.N:/HOAWQ?<:?%J/BK2M*V_9['6[Q!>ZBH"]VN
MKB:0D\MYF[^+- #_  U^UU\*/&?B6UT71_B=\/-6UB^G>UMK&S\1V<]S<3)C
M?&D:R%F=<C*@$C(S6[X:^-/@WQIXTU3PWH_BSPSJWB+0\?VEI=GJD$][I^>G
MG0JQ>//^T!7Y.?LX_LL>-OV]O^":/QQ^#GAS1?#NGP>)/CEXGE'C#5[\C_A&
MS#K_ )S7=K;Q(99+N-8R(AOB7<^3(%!#?87[$E@EA_P5=_;04$R2%? HDF8#
MS)B-%E&YB ,GCTH ^QZS-&\:Z/XB\'VWB+3]6TR^\/WEHNH6^IV]TDMG/;,F
M]9TE4E&C*$,'!VD<YQ7DO[;OQ3CT?X._\(SIEUJ+:O\ $#58_""2Z/;37MYI
MR31O)?7");J\@E@L([F9/E/[Q8@1ALUX%_P1K\;P?!O7OBQ^S#+_ &M!:_!W
M6#JW@<:I8W%C<W7A+5))+BS7R[B..5OLL_VFU9BN,11X^4KD ^R/"GQ>\)^/
M/ :^*M#\4>'=:\,,'8:Q8ZE#<6!",5<^>C&/Y64@_-P00>E7?!7CK0_B3X:M
M=:\.ZQI6OZ/>KOM[[3;N.ZMIU]4DC)5A[@U^6'[.RZG_ ,$==,\*_&:Q_M&^
M_9E^,@AD^)=@I:?_ (5[KDTGE1^(85Y;[%.=D=TB_<8K(N0%C'WQ^P!K%KIG
M_!.7X)Z@/,FL[?X;Z%<#[)"]R\D:Z9 W[N.,,TA('"H"6X !) H ]LK@?B1^
MU9\+O@WXD_L?Q?\ $CP#X5UCR%N?L.L>(+2QN?*;<%D\N616VG8^&Q@[&]#3
MO@=^T;X?_:%M=1FT'3_'FGII;QI,/$W@C6O##.7#$>4NI6MN9@-IR8@P7C=C
M<,_"_P"VAX?\<_L7?$+X\?&[3_#OASX_?LS_ !0@$WQ5\(/(L>O>'%T^Q73;
MRXLW<^5=6R06I,MM(59"K;"HW, #[L\7_M-_#;X?>*8=#U[XA>!]#UNX@%S%
MI^H:[:VUU)$02)%B=PQ4@$A@,<&M'P1\;/!OQ-\,:AK?AOQ=X8\0:+I,TEO?
M7^FZI!=VME+&BO(DLD;%49$968,00&!. 17P!X_\8ZAK?_!9?]G/6_A7I^@^
M+;74O@'JEUI9UW6)M'AFL9+W3VCF\V.TN'\PH4^3RAG<<E<8.+_P4?U+Q-<_
M"_X!^'/B?H/ACP5;_&#]H>QL_BIIVB79N[#6-/%S>6^EQ74S+"TUM=VVFZ<C
MR2QQEQ"JE!@QT ?>W@3]LWX/_%+7K72O#/Q6^&OB/5+X[;:STOQ/97EQ<'GA
M$CE+-T/0'H?2M#QU^U#\,_A?XBGT?Q-\1/ OAW5K6..6:RU/7K6TN(4D.V-F
MCDD#!7) 4D8)/&:C^-WP'T#XJZ/X?NKK1;6^UCP%J,7B#PR0%C:ROH$81A&_
MA5U9HG (!21AD<$?*O\ P;\65M\4O^"1_A/6O%$47B#Q+\1KO7-0\=3:G&)Y
M]8U*74KJ&Z%XKCYF"(D)C<?*D:IC  H ^Q_$GQ<\*>#=<T72]8\3>'M*U+Q+
M+Y.D6EYJ,,$^JR<?);HS!I6Y'" GD4[Q)\5O"_@[Q/INB:OXDT#2M:UH,=/L
M+S4(8+J_"@EO*C9@TF "3M!QBOR._9D_9KTW]O[_ ()I?!GX6^)M6UO_ (0N
MQ^.7BG1_ 'B"RNY$O].T[3M-\2-I-W;3'#$VTL*"/)*[;=%/RC ]Z_9*_:_\
M8>-_VL_AG\"OC?#;V/[0'PAO]2&IW,,?EVGC;27TNY2UU^RX ,4^T+*J_P"J
MG#*0A(10#[.L/VQ_A#JNH)9VOQ4^&]S=27AT]88O$UD\C7(Y, 429\S@_)][
MCI7H[N(T+,0JJ,DGH!7P1_P1_P# .@_%/X2_M>^'?%&D:9KWAW6/VC/']KJ&
MGZC;I<6MW"UZFY)$<%64^XKH/^"!7C35O%?["FHV<VJ7^O>$?"?COQ'X<\"Z
MO>3FXDU3P[::A)%8R"4DF1$4/$IR?EA4 X H ^C'_;3^#D<=\S?%GX9JNER/
M#>$^*+'%HZ?>63][\C+W#8(KH/"7QZ\"^/O%MUX?T+QIX3UK7K&)9[G3;#5[
M>YN[>-@"KO$CEU4@@@D8((K\Y_\ @G/XB^,FC_#3]L"/X:^"/ 'B*WD_:(\=
MEI]7\0W$-X2;^-9E2Q6QDBG80Y**]R@=L*VT<GW;]C#POI_A#_@KQ^UCINF6
M<%E8Z?X-^'%K;Q1+A8HDM];1%'? 5%'T4>E 'USXV\=:'\-?#%UK?B/6-*\/
MZ+8J'N;_ %*[CM;6W4D#+R2$*HR0,DCK6=\.OC3X-^,'V_\ X1'Q9X9\4_V6
MZ1WO]D:I!??8V<;D63RF;864$@-C(Y%?'/[7/B-_&_\ P6Z_99\&:Y=--X+T
MW1/$WB#3['<'M+SQ);6\!B\Y=P!FMK.=IX\@LGG;P!NWKE_\%.M8UCX6?\%-
MOV5?$/PYA1_B1XETWQGH=Y9PQ9?7M*@T<WB1W&"-\<%ZEN\88X628X^^00#[
M%\8?M1_#+X>^)I]%\0?$7P)H>LVIB$UAJ&OVEK=0F4XBW1O(&&\\+D?-VS5_
MXA?'KP+\)+W3[?Q7XT\)^&;C5\_88M6U>WLGO<=?*$CJ7QD?=SUKY/\ ^"%?
MAK0OBC_P1L^'=SKL-IXG;XCZ=J.H^,I]2Q=MK]_=7=PNH->,^?-=G#QN'S@(
M$X"@#X/_ &:/B-XQUGX#_P#!.S4-.MSXVNM#^)'C;3O""ZEJ36AUK2K2TU2#
M3U:X:-RH\B-(T<J052,DX)8 '[9> /B1X=^*_AF'6O"VO:+XET>X)6*_TJ^B
MO+64C@A9(V93CO@UM5\)_P#!%>9/C+XF^/GQTFN;+P[KGQ;\4VL.O?#FU216
M^'NI:7:_8Y[>[,BQL]]-A9)I!$B/B-EW@[C]V4 %%%% !1110 4444 %%%%
M!1110!\R_P#!1G_D>/V8_P#LLVG?^FG5Z^FJ^9?^"C/_ "/'[,?_ &6;3O\
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MK+XYT_PM\7/#<<WV1KW5M).G7C,J[O*6ZM!'%Y@4@DR12,1@GDDG]%OV7_\
M@\U_9V^*AM[7XE^$_'/PIOI /-N%B&O:9">_[V +<''M;<^W2OQC_P"";O\
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M@_P/\'/%7A'6=&NO&#7O@NTU*TL3?^(;J^6?^T;K[7>S7'G.QGGEFVDS2$R
M(JA@N09O&'[#7@GQE^U3!\:))_$]A\0K7P\_A:'4+#69K>---=S(;<PJ?+9?
M-/FC>K$. PQ@5Y[_ ,%5?VM]<_8\^$7@?Q1:7&L:)X(U#Q?:Z=XX\5:3I:ZI
M=>$M&>WN7:^6%XI8POVA+:-Y7CD6-)6.PL5P[X9:3\5?CGX%%YX2_: T[7O
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MY-/\.0,% L[9W&2H8$@(D<2ER(XH8E6-0#Z"_9S_ &\OC_XK_:E^&/A?Q?\
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M"*>SM,?,92\BJ\=I<;$^/=K'8_MR_LXPPQQPPPQ>)$CC10JHHT^(  #@ #C
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M+Q+K/C6[TVYB$5QI:ZE?37-O:S*.DT-L]O%)DG]Y&_08  .+_8-^'%I\8_\
M@E3X8\(ZA=7UE8^*O"]]H]S<6;(MS!'<-<1.\9=70.JN2I967(&5(XKT;X"?
MLH:?^SEI,EW:ZQKWCSQ9%I,6CV^M^*;FW%Y]C@!,%F&M;>*&" /\S>5 "Q.Y
M_,*KCQ7]G'6;SP[_ ,$2Y-0T^[NM/U"Q^'^LW%M=6TK0S6TJ17;)(CJ0RLK
M$,""" 16_P#!7X&_$+X0_!KPKXK\ _$#QEXR-QHMK?ZCX0\::NVM1:P7@61U
MM=1N6-W:W+,3M:6::WYVM$H(D0 Z'_@G_K=Q_P (YXFT_P 965YHOQGO-1_M
MWQWIUVNU?M,Z"*&6Q822+-I@BME@MI5<G9:E9 DZ31I]"5X'\8)H_P!H_P"
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M 5\R_P#!/#_DJ?[57_99KG_U'M!KZ:KYE_X)X?\ )4_VJO\ LLUS_P"H]H-
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M/:?@]K7Q4CT[7/@_X_T/PA-/Y0UI+^VN[J%"P DDM %  !)8),[ #Y0YXKX
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M$;UFQ^*'Q4\.^#KR>Z1[J&72]1\[?-;/%(H$F$C9)#O3!/RG((^GJ "BBB@
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M32(N!M5G#$# P#T%;%%% !7S+_P2J_Y(?\1O^RS?$3_U+-4KZ:KYE_X)5?\
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MA_\ ^$[:?_&ZZ'QG\*?"_P 1K*UMO$/AO0->M[$DVT6HZ?#=);D@ [!(I"\
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M2VHZ"7QKJXC'YQ8JNWP?\4+#YGE6NWK@?$"_W?ELS7ZV?\.//V9O^A%\0?\
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MKI,+W\BZ7<PA#J$4<08S+%A6P@+8DW#@,:W1_P $0?V:!&4_X0?Q#M8@E?\
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M#?LDZKKWB+1[SPS/\3/%^J^-++0KM$CGT2SO'3R;=E0!1A8]X SQ(.37'_\
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M\.7OV7_^B0>'_P#P)NO_ ([0!]045\O_ /#E[]E__HD'A_\ \";K_P".T?\
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MB0>'_P#P)NO_ ([0!]045\O_ /#E[]E__HD'A_\ \";K_P".T?\ #E[]E_\
MZ)!X?_\  FZ_^.T ?4%%?+__  Y>_9?_ .B0>'__  )NO_CM'_#E[]E__HD'
MA_\ \";K_P".T ?4%%?+_P#PY>_9?_Z)!X?_ / FZ_\ CM'_  Y>_9?_ .B0
M>'__  )NO_CM 'U!17R__P .7OV7_P#HD'A__P ";K_X[1_PY>_9?_Z)!X?_
M / FZ_\ CM 'U!17R_\ \.7OV7_^B0>'_P#P)NO_ ([1_P .7OV7_P#HD'A_
M_P ";K_X[0!]045\O_\ #E[]E_\ Z)!X?_\  FZ_^.T?\.7OV7_^B0>'_P#P
M)NO_ ([0!]045\O_ /#E[]E__HD'A_\ \";K_P".T?\ #E[]E_\ Z)!X?_\
M FZ_^.T ?4%%?+__  Y>_9?_ .B0>'__  )NO_CM'_#E[]E__HD'A_\ \";K
M_P".T ?4%%?+_P#PY>_9?_Z)!X?_ / FZ_\ CM'_  Y>_9?_ .B0>'__  )N
MO_CM 'U!17R__P .7OV7_P#HD'A__P ";K_X[1_PY>_9?_Z)!X?_ / FZ_\
MCM 'U!17R_\ \.7OV7_^B0>'_P#P)NO_ ([1_P .7OV7_P#HD'A__P ";K_X
M[0!]045\O_\ #E[]E_\ Z)!X?_\  FZ_^.T?\.7OV7_^B0>'_P#P)NO_ ([0
M!]045\O_ /#E[]E__HD'A_\ \";K_P".T?\ #E[]E_\ Z)!X?_\  FZ_^.T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>image_2a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2a.jpg
M_]C_X  02D9)1@ ! 0$#_ 4H  #_X0 Z17AI9@  34T *@    @  U$0  $
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M_P#*+J'_ ,8H ^@**^?_ /AZ1\"?^AZ_\HNH?_&*/^'I'P)_Z'K_ ,HNH?\
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M'P)_Z'K_ ,HNH?\ QB@#Z HKY_\ ^'I'P)_Z'K_RBZA_\8H_X>D? G_H>O\
MRBZA_P#&* /H"BOG_P#X>D? G_H>O_*+J'_QBC_AZ1\"?^AZ_P#*+J'_ ,8H
M ^@**^?_ /AZ1\"?^AZ_\HNH?_&*/^'I'P)_Z'K_ ,HNH?\ QB@#Z HKY_\
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MY_\ ^'I'P)_Z'K_RBZA_\8H_X>D? G_H>O\ RBZA_P#&* /H"BOG_P#X>D?
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M_P#*+J'_ ,8H ^@**^?_ /AZ1\"?^AZ_\HNH?_&*/^'I'P)_Z'K_ ,HNH?\
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M W[5/P__ &G8M8;P+XFL_$#>'YHX-2BCBEAFLGD3?&'CD577<N2#C!P<'@T
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M .-4?\,B_M$?]'<>(/\ PW>@_P#QJ@#Z@HKY?_X9%_:(_P"CN/$'_AN]!_\
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MZ.X\0?\ AN]!_P#C5'_#(O[1'_1W'B#_ ,-WH/\ \:H ^H**^7_^&1?VB/\
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MPR+^T1_T=QX@_P##=Z#_ /&J /J"BOE__AD7]HC_ *.X\0?^&[T'_P"-4?\
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M_P#&J /J"BOE_P#X9%_:(_Z.X\0?^&[T'_XU1_PR+^T1_P!'<>(/_#=Z#_\
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M3'_8N^"?_1>KU]-4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZY./"['_ (+1_':7X5Z3XLN/A#\)(].U'XNQ_"AA'XXU!IDNFF*&41G30OE
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M"?&%A\0O!NDZ_I<WVC2]<LH=0LY<8\V&5%D1OQ5@:U* "BBB@ HHHH ****
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MFGE[J@ KPC]DAE\&_&SX\>#;IBFI6_BZ/Q5;QN?FGTW4[.$PW &XG8;JUU"
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M0OVF/^Q=\$_^B]7KZ:KYE_9V_P"4H7[3'_8N^"?_ $7J]?35 !1110 4444
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M^*K)-&UO1-;UF74H8+ZQCOOM%E/&XMITD7R[D+NAN(8V9HX #Z.\&_L[W/\
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MU;_@J;^R?KNE75C>?M'_ +/=U9WD303PR?$'2&26-@596'VCD$$@CWK\@/\
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MI8[D7*0,LK!(EW>6\B/@_P#!,W0/"O[5/[.7QC^$/A%O&?PCT6'Q)IFKZ#X
M\<_VC>>)?"NGQ36TKW$\=[*2L=Y=6EP1%;S2PQ,68OYKRQK'^V;^T[\/Y?VE
M/A_\5?V=_P!J#]A6RUKPGX?U+PS)I'Q!\8V\FEV$-Y/;SR7EBMC=(T5TY@6*
M1C@-&<9XP?2_V2_VP?@'\/\ QSXD^)OQ5_:X_9H\6?%KQE8VNDWD^C^-=)L]
M(T+3;62XE@TZQ1[@S&)9;J>1Y9F:21G&<!$4 'UM^RW\#&_9N^"&E^#FU-=8
M;3;B]G^UBW^S^9]HO)[G&S<V-OG;>ISMSQG ]!KY_P#^'L7[+/\ T<M^S_\
M^'#TC_Y(H_X>Q?LL_P#1RW[/_P#X</2/_DB@#Z HKY__ .'L7[+/_1RW[/\
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MP/\ &GX6_M!_'%O"ME9ZQX$\._##4'70]'TZ2UM\W6I_8;F.ZM;UK[[2K2W
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M\LLCL3DL[&ON^OC/]AK_ )2S_MR_]A#P1_ZCR5]F4 %%%% !1110!Y_\(?\
MDIWQ5_[&.V_],^G5Z!7G_P (?^2G?%7_ +&.V_\ 3/IU>@4 %%%% !1110 4
M444 ?"/_  3B^%FB?![_ (*R?MN:3H-JUM:W'_"%ZI<-)*\TMU=W5GJ5S<3.
M[$EFDFE=CS@9"J%4*H^[J\O^&'A+2M(_:@^*FK6FF:?:ZIK%MHHO[R&V1+B^
M$4,ZQ>:X&Y]BDA=Q.T$@8KU"@ HHHH **** /DG]@_P'I?PW_;O_ &M-+T>U
M6UM?[:\.W<GS%GGGGTA)IIG8\M))+([LQY+,37UM7S#^R3_RD0_:T_["7A;_
M -,45?3U !1110 4444 %%%% !1110 4444 %%%% !39F9(6:-0[@$JI.W<>
MPSVIU-F5GA94;RV8$*V,[3ZXH&MSP>POM,LO#&L:MI.CS:U\.]:DN+7QEX,N
MK$3W6@SR _:G2T^8,&$A:XM%#+,LGGP;V=ENG:A86-KHFBZ#K^M7>L>"=7GM
M[CP/XXM[T3WNC74@VVD$UVV_?(WF!+:\?>MTLGV:Y\R616O[5O<:QK?C"YO[
M"VL=!^+&A6R+JNE/*R:;XML58A&5\$F,DMY4V#);2,R.&5G22G87VFV7AK6-
M6TC1IM:^'FM27%KXS\&75B)[K0;B0'[4Z6OS!@PD+7%HH99ED\^#>SLMUX6G
M]?CIV[K>+U6A^J>]S75[W75-WM[K4MG)K^'4^&M'W)^\7)H=9USQC#9WDVGZ
M#\7-!M6;3]06-H]+\8:>K#<"N2WE;F7S(LM+:2N&4O&Z//'I&KR+<ZQXD\-Z
M/<?:/.,7CCP/,%:?SBHW7$"_<,Y3# K^[NX\$'?M:H=0L+&TT31=!U[6KO5_
M!.KSV]QX'\<6]Z)[W1KJ0;;2&:[;?O=O,"6UX^];I9/LUQYDLBM?VIH=8UWQ
MC#9WDVGZ#\7-!M6;3]06-H]+\8:>K#<"N2WE;F7S(LM+:2NK*7C='G>M_/\
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M110 4444 ?,O[.W_ "E"_:8_[%WP3_Z+U>OIJOF7]G;_ )2A?M,?]B[X)_\
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MR/1?&=Q>Z596\5U'#IBNT),8V[@),@, 2,@9% 'T=17AW_#>WAG_ *%GQ_\
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MX_\ _!-_]G0![C17@MG_ ,%$/!NH7UU:V^A^-IKFQ*BXB32@SP%AE=P$F5R
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M^,.JZ=XJ'@'Q\8H?%T*%M/U!5$=MXF@4$^9'@!5N%4$R1  $*SH HDCA]5H
M\%^ _P#R?/\ 'K_KGH'_ *0FO>J\%^ __)\_QZ_ZYZ!_Z0FO>J /E7_@H_\
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MC9_R1GQ=_P!@6\_]$/7B7[%W_)QGQB_Z\_#7_IO>@#Z4HHHH \._96_Y+/\
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MO^P7+_2@#:^ G_)"_!?_ & ;'_TGCKK*Y/X"?\D+\%_]@&Q_])XZZR@#Q_\
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M4H7[3'_8N^"?_1>KU]-5\R_L[?\ *4+]IC_L7?!/_HO5Z^FJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH \+\.?\I#_$/_ &)L7_I1'7NE?+OC
M[XBZI\-OV\]7NM)\*ZIXLFG\*11/;V+8>%?/0[SP>,@#\:['_AJKQE_T1GQC
M_P!_!_\ $4 >B_&'X/:5\:/"ITW4A+!/ XN+&^MV,=SI\ZD,DL3J0RLK!2""
M#E0000".6^#WQAU;3O%0\ ^/O*A\70HS:?J"H([;Q- H),D> %6X503)$  0
MK.@"B2.'#_X:J\9?]$9\8_\ ?P?_ !%?/W_!4O\ :6\7?\,!_%C6X?A9XN\/
M:WX5\+:CK&C:]YH670+R"W>2&[1@H*M$ZJX(/5 >H! ![Q\!_P#D^?X]?]<]
M _\ 2$U[U7\WO[*'AS]I;XT^#&\;:?\ M/?&:T\:>+](T_5;VWM[BT0WL1MH
MWB)D=PS*BRA,A#L)4-]X9]1;P'^U)=:0=2LOVJOVCKNTLI7AU.!19?;+(JN6
M'E*Y9W4[24'+(VY"_P JOS_6J?\ 7X_=U['LQR'&-I66]MUU5XZ[6GM![2>B
M=S]:?VO_ !3:^!_VB/@YK5]YGV/1UUV]G\M=S^7%9QNVT<9.%.!7T):7*WMI
M%,F=DR!USUP1FOYY?B?\!?V@O%7BGPM-KW[4?QHU31=4BE@TO4Y9K*52;F,1
MM&K*Y0+,C(%<MA]VT8.W?V%I\*?VK+>^ET63]JSX_P!KK$<+RV,+360@O85.
MT,C;^V5#J QC+#[P9&8^M0O;^O+[^G<7]AXKEYFE:R>_3:3[^X])K>.[5M3]
M[J\.^+O_ "?'\(/^P?K/_HA:_("'X>_M5:A83R6G[4W[14UYI<HCU*P,EB+B
MWXR=@W_.<<KP!(.AKF?%/PN_:&/CGPKXDN?VJOCI<V8@G6TU@FT:6PW@*_(?
M:D9Z.SD;<<@ $@^M4][_ /#=_D]'VZV*_P!7\;?E4=;M6NK\VZBN[E'WH?SK
MX.9Z']"U%?@O_P *M_:IM/$7]DWW[6'[0EG=7A<Z;)YEBT=X%7<5_P!8 )5^
M8F/))12P) <)7L?AK^UAJ=M=6T/[4W[00\0:7Y37VFM=6*X5\X>*0N-\;!7\
MN3:%9HV1O+99!&?6H;>O3JMUZVUMU6JNB?[#Q37,K6T=[JW+)VC*^RBY>ZY/
M2$_=J.,FD?K5\5O%UE\/_P!MRWU[4FDCT[1/A_=W]TR(798HI9I'( Y)VJ>.
M]?0U?SJ^-?A+\<O%7B5+^_\ VIOC?J-O?Z3<:5?RSBU^V6]NWF":&2/=Q&O[
MP2JQ5TPQ*[0Q7T"?X9_M3:;K,%O>?M9?M!0VNI,J:==K+8M'<.1GRV_>85C_
M  _,=XZ<\4?6J??M^.S]'T>U]-P>0XQ+6.NNG6\7[\;;\T=Y1MS*/O6<=3]Z
MJ\)TG_E)%JG_ &(*?^EJ5^0UO\,OVL+J2\TT?M5?'^/Q%:1&=;.6YLEBN8\X
M5TDW9*'@$A248X(/&[E8/A3^T=-\2[KQ!9?M-_M 7&IV=BUEJLBI;?VK90(P
M9HS&&(?#[&V*=S*V]-X*!SZU3W_KS^[KV*_U?QG-RI+>VZMJKQ=]K3V@]I/1
M.Y_0S17X(W'@#]I^RGL;F7]K;X_2:%K A6QU*&XL)(7DE^XK$2;563*>7)NV
MNSA.&*>8Y?A?^U<FJ3:3-^U;^T!;ZRT;SV2/-9"&^C4XW*V_@C(#J Q3<#\P
M*ECZU#;^O+[^G<G^P\5;FLK6OOTVD^_N/XUO'=JVI^O?PT_Y/L^)/_8(T_\
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MVL/VB)]%C+I?2YLUGT]E.UM\6_(VD$.#@IC)!&<8'P@^#'[1W@CPEI.EZ?\
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M,U;2;[]ISXY3316RG4K&YCTIHGA8')!6,,R'!PP!!*,O!!VG.M@^K3M?IO\
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M_P#!9K_E%3\?/^Q,O_\ T71^RY_RD;_:G_[E/_TUR4?\%FO^45/Q\_[$R_\
M_1='[+G_ "D;_:G_ .Y3_P#37)0!]-4444 %%%% 'S+XJ_Y3(^ _^R,^)/\
MT^:#7TU7S+XJ_P"4R/@/_LC/B3_T^:#7TU0 4444 %%%% !1110!\R_L[?\
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M)$+* @98KFJZ4QDT;PWXDUFY8M,L_@;QS ZM<),5.R"9\;#.4)7Y@8[N,LK
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M,RNSLMQ,#KFN>-RRC2O#_P 9= L0'0F2'1O'>EI)P#]]Q"))3@_O)]-GG/\
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MFWUFU[LY-6?M(:58\M1^_*1^B=%%%=9\^%%-FG2W3=(ZQJ6"@L< DD #ZDD
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M0#[AG* %6'[NZC !(8*RT)(O#F@_#J&UNIO[;^">N;'L;Y)I(I_!4J2 QCS
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MW4:A6*LJM%G,OAOP_P##:.WN)!KGP.UP(;6Z$DD,W@>6.0% 7!6:"VAF0%)
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M>]$XXTX>WYT]+)IJ4N6VD8-3>L8)Z4IM<U&?[JLK*YK^+O %SK'B'POI.O\
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M]B9?_P#HNC]ES_E(W^U/_P!RG_Z:Y*/^"S7_ "BI^/G_ &)E_P#^BZ/V7/\
ME(W^U/\ ]RG_ .FN2@#Z:HHHH **** /F7Q5_P ID? ?_9&?$G_I\T&OIJOF
M7Q5_RF1\!_\ 9&?$G_I\T&OIJ@ HHHH **** "BBB@#YE_9V_P"4H7[3'_8N
M^"?_ $7J]?35?,O[.W_*4+]IC_L7?!/_ *+U>OIJ@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /"_#G_*0_P 0_P#8FQ?^E$=>Z5\K_$K]GKP?
M^T9^WAJVE^,M'_MBQL?"L5U!%]JGM]DGG(N[,3H3\K$8)(YKJ/\ AUO\"?\
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M?_1>KU]-5\R_L[?\I0OVF/\ L7?!/_HO5Z^FJ "BBB@ HHHH **** "BBB@
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M%5UH]LVO?"/7-+O8[K3&MV6X\'7*JZOB%@)([>.92)(2%DLI$) 6-66#S?\
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MQ\%^-KBS7Q?:I./"7BN?3XYK7Q#$5#S6EU;C9&\C1Q*;FS!1)TA%S;F%X?\
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MR)<K$\L2QM%BW[:RO=6U;Q9?:MI-C;:+\4-%AC7Q#X>>?;9>)K49$<L4A W
MX;R+G *$-#*!M94N5[^?WN]M=-KVWCM):QU.7#\OL[JW+OHW&/+S-1:D_>Y.
M;2G5?OT9WIU?=:9XO_P4'630_P!DN^TG6&;Q9X?9K>^\(>*2_P!JFASP+>XF
M&29#"[B.ZSB>-F20^;AKG@_^#6C(_P""/7A'=@M_PD?B#) _ZBEQ7<?MLB.'
M]D#Q3J'@]B_@O5KE4U+0KE?)N?#&H"96DV1G_5@OD2P'A682(<,V_A_^#6;
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MK.[*L<S2( SL0%P68\D [BBBB@ HHHH **** /F7_@LU_P HJ?CY_P!B9?\
M_HNC]ES_ )2-_M3_ /<I_P#IKDH_X+-?\HJ?CY_V)E__ .BZ/V7/^4C?[4__
M '*?_IKDH ^FJ*** "BBB@#YE\5?\ID? ?\ V1GQ)_Z?-!KZ:KYE\5?\ID?
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MYCR*U[<EBUK6O&<-K=3:?H/Q=T&T9K&^5&CTOQEIZL-P*Y9O*W.-\>6ELY9
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MBR1V^G?&CPR(;_1+VV*V]CXOM(+B-R5$A*E5)R\#DM;3,I#-%('F^7-,73_
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MJ.T?F*T4T,L9,<UO,CPS(<,I*HR_;%?/_P#P2G_Y1K_ S_L2M,_])TH \/\
MVFOASXSFM? 7A_\ :6^*&E^)O .FZQ!K)M/ 7PBUF34?%=Q8,KPK?RV\M_':
M0^8T,KI%%$TS*51XXU=&^[+*\34+.&XCW^7,@D3>A1L$9&58 @^Q (KA?CG^
MR[X!_:6CTQ?'7AFQ\1KHQE-D+AY%^SF39OQL8==B=?[M3_%OXW^%?V=/#&GM
MK$]PLE\_V'1M(T^UDO=2UB98RPM[2VC#2S.$1F.T$(BL[E45F !V]%>#I\>/
MCGXD1[O1?@+ING:?D^7#XJ\>V^GZE(N5P3#96U["N5+'!GS\H!P3QL> OVM5
MF\2Z;X=^(7@_Q%\+?$FL3+:Z<FK/!=:7K$[;R(;74+=W@:4B-BL$QAG< E8B
M%8@ ]@HHHH **** "BBB@ K\R/\ @U)_9"^)G[%G_!/#QEX6^*G@W6/ _B'4
M/B+>ZK;V.I(JRRVKZ9I<2R@*2-I>&5?JAK]-Z_E^_80\._M]?M]_L)?$?X^>
M&_VN_%FC>&_AI<:G;7VG:GXGU+[==-8Z?!?R&+RT9,-'.JKN8?,#G P: /Z@
M:*_EETO5?V\]5_X)'ZE^V$G[6WC)? ^F7(MI-%;Q/J/]JNQU6/3,@;?*QYLH
M?[_W0>_%?T7?\$U?&VK_ !*_X)S? 'Q'X@U*\UC7O$'PW\.ZEJ5_=RF6XOKF
M;3+>26:1SRSN[,Q)Y))- 'ME%%% !1110 4444 ?,O\ P6:_Y14_'S_L3+__
M -%T?LN?\I&_VI_^Y3_]-<E'_!9K_E%3\?/^Q,O_ /T71^RY_P I&_VI_P#N
M4_\ TUR4 ?35%%% !1110!\R^*O^4R/@/_LC/B3_ -/F@U]-5\R^*O\ E,CX
M#_[(SXD_]/F@U]-4 %%%% !1110 4444 ?,O[.W_ "E"_:8_[%WP3_Z+U>OI
MJOF7]G;_ )2A?M,?]B[X)_\ 1>KU]-4 %%%% !1110 4444 %%%% !1110 4
M4RYA^TV\D>Z2/S%*[D.&7(Z@^M<%_P *!_ZG;X@?^#C_ .PH ] HKS__ (4#
M_P!3M\0/_!Q_]A1_PH'_ *G;X@?^#C_["@#T"BO/_P#A0/\ U.WQ _\ !Q_]
MA1_PH'_J=OB!_P"#C_["@#B_#G_*0_Q#_P!B;%_Z41U[I7QWXB_92TCXI_MM
MZMH>L>(?&-Q!9^&(KQ+@:D/M!;SD7:7V'*X8\8ZUW'_#LCP+_P!#!X^_\'"_
M_&Z /HROFW_@L=_RB=_:0_[)OKW_ *035J:/_P $X/ >DF3?J/C&]\S&/M&K
M$[,9Z;5'7/?TKYY_X*T_L >#/"/_  3:_: \066J>+EN-+\ ZS=PV[ZGOMRT
M=E*0&4IDJ2.1GG)H ^;_ /@AT;*X\ _#VQUW6%\,:A)X,M)?#.O(RQB"\-EI
M9%N58[6_=AE,;G;,A(X;I^BMOXY.M^*;G5+"\T#0OBIH4"1:KICWP33/%MDI
M.PK)R2A);RIL&2W=F1PRLZ2?EI_P24^$FB^/_@#X17Q!J%_-X)D\%VHU6]L5
M@NI-$9;?3C)<2-(K_N%F<AW0;[<C<2(E<Q?<6H_\$\M*L/%%CH.O^-M=MVNI
M-_A#Q-%96#1SR%"1:S_N1^^VC.TMLN4!*X8,J^++?[NOW:_^DRZ_#+4_3Z=O
M9I:;27PNVFLTX;I)ZUJ*U@_WU&\6=E\0OVEOAK\)/#4UW<3)??#OQT]Y8>*/
M!T]L9KC1)W %Y(L*;@JMYV9[?.R42^? 69F%S9\ _&OP+\3/"]AH<GBZYU+P
M;_:$<?@WQF;@QZIX<O\ 9BWMIYY@2SE9?+M[N0.ETDC6MUYDK@ZA\[_'K]F'
MQ-\-+75KSPVNJ2^-M/\ #VHVGB>T::VM;2]TYD3;<Q&*%&FMV438)&Z*10CX
M!(DO_![]DZ3QYX1U[Q?J6G:YI7A>YOWLO$7AA(K35-0TW_1H1-<B.2W+298N
M\ML$#/'+YD7FG N)TM_7ST[=UO%ZK0V][FNKWNNJ;NU[KYMG)K^'4^&M'W)^
M\>U?M0_$&&[^%'BQ=4UC2-"^*&AZ%+:B]L9"NG^,-*D;RGV*&9_+S+EHLM-9
M3."K/%*DESC6'[=G@V&]DUSP1X6\::Q:ZL1'XO\ "%OH$CI&[H-T\>X"-9]N
M-P_U=PA!R&PQQKO_ ()_>&=,N=$L-7\=:_?^"=<>T?PEXLM!83-9W+A5@M[B
MX,#;FF+ 0718QW/FFVE'FO$;UUM_P3Z74_$-QH]YXKO-(^*.DVCS6$KV-G'I
M/BFR5US+&! 6"995DC/F2V<LJG][')%)<FM_/\;_ )7ML]IK1ZD>[R].6SZ/
MEY;ZZ?$H*7Q1^/#S]Z/NE?Q)^UN_A_X/7(A^'>K^(/A+=M#)H]S?Z_;V5]X:
ME\P")$:%I9PJ3!/)=1YL$@5,D!-GJ/P=^)^H?':STNQ\0-=>#OBUX;DN++1M
M<N+1?+U"5$5[FPN$0K%,2J(T]LC*LJHMQ#Y$L++9>=>'/V+;73H[SQ/X2USQ
MC;ZII\[V_BWPS]FT]-3M&:+;(8 L.PR&-BV%^2ZB8%6)(+<[/X"A^"4%E8ZM
MXG\7:[\$]8?[=9:CIVI/&VB,LH=+N([<Q-!(-SH-LD;*9$.5*4:6_JUOS23V
M>]-_W33WG+KS7?1.7,UKI\,JDH_%'^'BZ>JM41].:3JVI7WB75O$GAO2?[+\
M>Z7Y*>-/!;W2^7K:;2D-S;S-L1I3'$1;7A").D1MK@1/"#8YD,WAOP]\.)IX
M(1K7P0UH/'>6<D4D4W@>5)") 8R%EAM8I4(>,A9=/EC) 6%2+7ES\#K_ %;Q
M-8:7JOQ"\8:?XZCMYW\&^+!>;K77;=E$KV\L:A<OMC1I[4.HE6);B$H8R+7I
M_AUINI^'KS5-8\-Q:I_PGNE/'_PFGA+4]129M<0KLAN+>X81HTACB(MKLA$G
M2(VUQY3P@V)K?[^GWZ;7ZRBM)+WX:F:<5%-6M:+34FE9.T&IO513TH5W[U"7
M^SXB\&F:6L:/.M]I'A?Q1J]RE\DWF^"/&\6WSVFVG%O.<;#<%,AE(\NZCW<!
M@Z*L$^M:KXSN+VRM['0_BQH=JHU/3#(T>F>,;!6(5T8Y.S+'RY<-);2.4<.C
MD2\-H7PY\-^"?"UOJ\.M^)O$GP2OHY(+W3+NYD1?!\JLR/YD!59(K:&0$.F$
MET^6'<0(E;[-O>/_ (:3^)=;\/\ AWQ1XL\1Z;>6KN?!7C+3;E(9+F5TX@N3
MMVFY" C'"7,>X@!MZJ;Z^G7[M?\ TF77X9:E-6NG_>33C;;6:<%JK/6O06L'
M^^HWBS2L;[3[3P]K&N:'H]QK7@'6I;BW\:>"[BQ\^ZT6XDR;N6.T^;<6\PM<
MV:AEN%D^T0;Y'9;UNH:?I]GH&BZ+K6M7.K^!-7FM[GP1XWMKT3WFAW,@Q:Q2
M71WARPD"6]V^]+E)/LUQYCR*U[R-E\&-:U#Q%?26?B?Q5H_Q8TFWC.I6#ZR8
M['Q98HQ"R12;"WEDLP20AGMI'*.&1OWM>+X/:>/"&H:MHNK_ ! UCP'J4MU:
M^-/"$LXEOM)GE^:ZD6U",)&)D9KBU56^T+*9X3([;+LZ?U\].W=;Q>JT#7FN
MKWNNJO>WN^]LY-?PZGPU8^Y/WCT*:'6M:\9PVMU-I^@_%W0;1FL;Y4:/2O&>
MGJPW KEF\K<XWQY:6SED#*9(Y%:XCT?6)%GUCQ-X9T>Z\SSS#XX\#S*K7"3E
M1OGA3.PSE"&^4^7=QE6!W;6/#ZC\$+"UCT.SUKXB>.M7\"ZQ-;77@SQA:Z^)
MY='NI$V6\4MP5<$R"3;;W>2DZS?9YLNZ->21_ S6M1\6/8W7C3Q/HOQ;TJS)
ML;XZD\>F>+M/1P3C"EQ'N<"2++R6DLH8>;'(C7!K?S_&_P"5[;/::T>I/N\M
MM.6SZ-1Y4]4UNH)ZRBO?P\_>C[ITT\'AW0/AY;VEW<?VY\%=<\N33M1CG=)O
M!DJN#%^]!$D5O'*JF.8%9+*1 "5C56@TM5TK5+WQ1I/A_P 0:LND_$+21,W@
MSQFMHIAUV/:'FM;F%2B.[)$IN;,%$F2%;FV,,D -CP>F?"B1[35->\-:Q\0O
M,CN6C\;>#9=33[:LS(-\L2A=CS%<-QE+J,J5;)4FK>?!30-$\&:>MSXT\9ZQ
M\&=46%]/U"'6&1O",T;@PEVVAH[>.15V2C:]G)& V$ :$TMY?A:_WI)[/>F_
M[II[[GUYKOHG+F:UT^&524=)1?[O&4^U5)GHVE:KJE[XHU;Q!X?TE=)^(6DB
M%?&?@QKM3#KL>TI#=6TS!$=V2)A;7A"),D+6UR(9(2+'.@G\.Z#\/+B[M+<:
MY\%=<$D>HZ=) Z3>#95<K+^Z($D5O'*K"2$A9+*1"0%C5E@YJ_\ @#J4WC&S
MT'7OB!XTTOQY:QW(\&>+?M8>WU>)E$DMK-$ F9-L*-<6@=%G2!;B!HVB(LV:
M1\)M4O=4UC5M UGQOI?Q!TF2!_&/A%M?7_B=1E#'%<VUPR1I(72$BVNW54F6
M!K:<021.+,UO;UZ:WZZ=[:RBM)+WX:F:<>6ZM:T7I)I63M!J;U4$_=HUI>_0
MG_L^(O!IG;:QH\BSZ/X9\3:Q=;_/$W@?QQ"RM<).5.R"9\;#.4)7Y@8[N,LK
M L64NBEUK6?&DUU:PZ?H7Q=T*T47UBSM'I7C33D8[65L,WE[G.R3#2V<LA5A
M)'(RW'/KHWA_1/@O-!9W&H:Q\%]:@:UU")E9-0\&RHVV5]C*'CA25&\V)E$E
MG*K$*L:LL"Z=\+6\*:W9Z'XE\8>*-0:\F6;P/XRN+Y;A[6?:=L#L5VBX925^
M;,5W&2I7=N4GIY=?NU_])EU^&6H]M'_>6L;;?&G#I;>M16L7^^HW1K65[8PZ
M#KFNZ%H=UK/@?69[BV\<^!KBQ%Q>:/=2#-W-%:#>'=A(7N;--ZW2R?:;?S)9
M&6_X?X#1V#? OP[H^N:@]YX'UC5;B?P9XRL;OS+K0[QKV=+9);EBX+2%\073
M;H[@3&VG#,Z?;-K7_AOK7CSX@ZGJ%MK>K^%/BYI]I#]MTVUU)K71_%=A$=JO
M$=K.L9+MM<[Y+2:8AED23$_G/P/^%4>J? VXUK3]6\=:UX/OK_5;'QMX,6Z%
MS>:6[W,OG21VJJXD<H^^XLU#?:4F\^#?*?*O5_7^>G;NMXO5%:WNKWNNJO>W
MN^]LY-?PZGPU8^Y/4]NFAUG6_&4-G>3Z?H/Q<T&U9M/U!8VCTOQCIZL-P*Y+
M>5N9?,BRTMI*X92\;JT_DFF?%9?&OQPU;5+/PIJ=CHN@ZJD/B#PK<[6_M+63
M;N)9$3.WSTCE5XU(\J]P'5O.C2MV^^">GQ0:'::S\1?'6L^ ]:EMKKP7XQM/
M$"SR:1<RIMMHY+@JX)D$FVWN\E)UE^SRY=T:\I>)_P!DG6/B'=:G8W?BKQ#I
M/Q2L+#[-'JEQ(TVB>+]/#DA)$P6,>XG="SM):R/N7S(W5YZ5[Z;_ (_Y7ML]
MIK1ZF4N11]ZW+:VJ:C:^JMNH*7Q17OT)^]#W3@_CQ^T1\+?!?C/P3X3U+Q$N
ML?#"PU@:K&\8N5NO"9;3+M8(XI4 <1QRSP/$ZLLMFZ 9"JGD^[:/JDWQ&C\*
MV]]KGV/Q9):'4/ 'CE;(+'XAMI8EF>WN8!Y:F1XD1KFR_=K.D0N;?R9(?]!^
M-KKX3>//@M\0K4Z+X/\ %6JZ?-X@E:^T.WOH]--U=G1IDD\B%8YE$@1;DF52
MZW,:@*H+!JZ3PM_P3NM_#GP;\*W'B;7H8O!.O:7;27=V^D!KCPE=LB-Y<SB5
M76%),J)P0UNZC<%C&Z)6T\OFE;IYI)[/>F_[IHIMSLFW)M_RN7,U:6GPRJ..
MDX_P\93[54F?6VEZIJE_XHU77]!TI=)^(FDK"OC#P>UTOD:]%M*0W-O,P179
MDB86UX0BRK$UM<")X2+/.AF\/Z'\/[F\L[;^V_@SK?F1ZII<D#I/X.F5R)2(
MB!)%!'(I\R'"R6DB%E 0,(?EZ3_@DL8?B%_PCNO?$B^TK7KII9?"^N)I"_9=
M879YDMNR+,@6=0A:2V! EBC$T+ QRK:U-'_X)9W6L6^K3:=XJU&U^(&@>4=?
M\+/$J_;HVR$GMKAI%65)$C?[/<,J+(8FAF\B2.5;8UO]_36_73:]M916DU[\
M-24X\MU:UHO232Y4[0:F]5!/W:-9^_0G^XK^Y9GUSJVDR"?1_#?B36+DN9A-
MX&\<PLK7"S%3LMYW^XTY3*_-^[NXR01OW*?,_P!M33-4\>?LV?%J*-;;PW\5
M[#P1J-KJ5I$"=/\ %VG&WE570,<L@:0F-R?-M97*,6CD83^%W?\ P2^T"R\$
MV^O67CS5M4^'5X9(=64Z2R7/AF1&*NTMN9 ZQQR!EF0[9+=E)*[0_E[DG_!,
M >'SH7A'5/&V@P64\ZW/A?Q@GA6.:XO+ABSBVGF^T8\PAOD5MR3HH'WAMH7?
MTZ_=K_Z3+K\,M0E'1Q>GQ+X;6_G3ATMO6H_9?[ZC>+/@O_@F%_P5 \=?\$X?
MV2]%^#?BW]E#]HKQ98Z?9WNF^(-(N?"C?97NW9)7\E95WHC6]U&)H)%9)!+;
MR*(B\AN?8+?_ (.&;F]^& TW5/V5?VG-3\/QW,-YX7U@V'_$PT<,%%N4O6#>
M>ZLY6.5AF2.18Y?/+2/+]>?L^:_XDU_]J6;2$UNRO?C/\.=+UJSUQKR)TM?$
MUA]LTTVD+RE7=(6#3F-T+/;2\LCH[13^A/\ "FSO-"UC7-!U#X@7W@_4;N\@
M\<^!VF$E_HUS,?,NI(K1%=9'/FM)/:H'%W'.+FW:61PE]M*I%ZN/?O\ EY=5
MTW1Y]'!UZ:4856K>ST2CNNTK6O-?PZFTU[DG?0^#=<_X.*/$VH7?AV]D_9/_
M &BK'XAZ=!Y2:G!X<,<>K0*RF:&6U)R\)R&VB3,3L&5ER0;FG?\ !Q;J>F_$
MS4-1T7]C[]H^WM]1!/B/1#HGG0W<K)A+@+M'DS$ !FP5E0 ,NX*Z_<U_\$=-
MM+/0[75OB%XXUGX>ZU);77@_Q9::^L[Z-<2*!;(]QM8$2"3%O= E91+Y$N6=
M&N9_^%%:QJ7BO^S;[QMXJT;XK:7:.=*U0Z@RZ?XHLE8%A@ OLR5\V'<SV[LK
MJ71D:052-[\O5=>MN_=]'M):,)82LZ;C[;3EFOA5K.5]K748/XH+WJ$OWD4U
MJ?GWI7_!PE%9?#C6=%OOV0?VCM1^&\H2;3;9].:)O#IB?=B"\3#1QPRI') R
ME9+5X_W<@5(EAE\0?\'#GBF_\.>'TU+]EG]I)?'VC2SPZ#XF/AM(9[G.7\FX
MMT"QW"RPQ)]IAC\M)3"9HEMGCA-O]]:3\*;@IJFN>&]8^($>H6]SM\;>#7U9
M?M3R,@!G@^4(\Q0!E?[ES& ,JP!6K=?!7P[H/@2Q$WC+QEK'P3U1(6M;J/5F
MC;P=-%*&B9CM#Q6T4L:%)!LDL)8E)VQKNMIYH<OPK;NTK7NGW23TOO3?2VIT
M?5\4ZO-[65^>]N6#;DX6E&WPRG..K5^3&0WESI1/SK^+7_!<;5/B3\8X/$VA
M_LQ_M9>"?%"6<4&M1Z+IB1MJ%JQ8!V!BW+(S1(HE;<"EL$VG:"G(V_\ P5_U
M!?#=]I:_ O\ ;2D\"1P20W&F&SMS#:RK(6DR?LYC2-<?ZO8NQE)W=A^J6H_
M#4F\96?A_P 1?$'QMIWC:W6Y'@GQ?]K#0ZM&5\R2TGC4(//"0JUQ:AD2YC@%
MS 8VB=+%FE_"/5=0U;5M4T/7/&FE?$;2#"WBOPN^O+LUR':4BGMYRB*^]8R+
M>Z955Q$T$PA>-Q;:>V5[./?U\U;OU:^TO>BWL>?'+)J*E&MTBT[KET=H2YFD
MU!_#&HTG1J?NJL8:2?Y-?%+_ (+E>)O 7A:S\4:Q\.?VM]#C\.ZBE]I.N^(-
M/@EM;"(IM"NTBH'=P2K.7"2(Q5HR"<_KA^SY\2M3^//@#PGXRTU8=&^*\GAJ
MRO[FVO6$5CXWTUD5U9RB8V[I25D1#)932LI5X92ES\1?\%Z_A?'X3_X(Z_$K
M5O!_B3Q-K7@"^2VAFT;4+PH_AR\6_B#IY#*I51(&1X"%>&49 VEE3Z5_8E^&
ML@_9N^#</BCQ)XDLY;[PYIUSX+UZ"[!M]/NGLTQ:LC*528 LJJQ,=S$60@G<
MC%22E34DNOW]FI?D]NC*PM&5'%RHN7,E%Z/>*O[T94O*S]I!7EI[2#:2;]LL
M+^SAT;6_$'A_1+S5O!VK7%Q;^.O MQ9">]TBZD&ZZFBM5WAY&$F^XM$WI=I*
M+FW\R60B_;=VFEV?A?2-'UC5Y=<^'.N/;W/@_P 86U[YUSH<\F/LL;W66W [
MP+>[)82AQ#,6=E:ZH>*?"&M?$CQ7<R6^HW'@_P"+VBV,:75I97KV>E^,+"*0
ME9%<*S^63(ZJY\R2SEF(994?_2&6^C6;?#?6KCP_:^(-2\'ZIYVG^.O"4T0F
MUG2+IU!NKF*!0X>=Q)YES;('2[67[3;^9+(1?\^EOOZ??IV_F71ZH]:,I<VM
M]XV?,KWM[K4MN;I2J;5%[D]3)\&Z3JNH?M!^,+.^UC3]+^*FEFVDTG4DB:.Q
M\0VRVL?F12QYY1E\II8@2T+D/&2 &/8Z1J]TVIZQXD\-Z/-#K$,BQ^./ \KH
M9+ERF/M-OG"&<HN4D&([J-0CE756B\<\,?#'P_)\1]:L]0\:>,M2\#ZA=:5-
MX=\66NN)/]AN9;1#:>9<;3]\2!+>YY5LB)R6D3SNR'P/U:\\6-I>H^-/%&D?
M%"QM)/[%UAKYA8>)+-6#,N -X4';YL&XM$Q$B[E*L=))<VC_ ,[VTU[]GM):
M,Y:4Y^SM**M9Z-67+S-R7*M?9IZR@O?HSM4A97.A9?#?A_X;1V]Q(-<^!VN!
M#:W0DDAF\#RQR H"X*S06T,R I("DVG31#E(D!M+FMZ/?7WC/1?#/B35O[/^
M(.CB:?P-XW^QKLUN/;NGM+F)/+C:8QQ@W5FIC2XCC6ZMO(>$K8<=IGPNNI[?
M5-8\.:IX\AUFTN1_PFO@]]6075PS)M,T#;51Y6108Y"-ES&@0E& ,>9=_"71
M=%T'2?-\4>+M7^!NH10FSOX=7:"3P9=02_N_-78KPVR2(JK(NR2QEBPP6,;K
M?*7*EY?.UK_>DGL]Z<O[IVTY574V?-=]8N7,X[V^&=2<-)1_AXVGT]JDSTK2
MM5U2\\4ZMX@\/Z2NE?$+2A"OC+P:UTODZ]%M*0W=M,X1&=DB86UX0BS+$UM<
MB&2'_0F0:AX#\'_ [7-7DFN-2^%.K.L<VD269V^&6,KQ72-&Q6:&-)MH:WV>
M9;2)( J@!(I-4TK5-0\3:3X>\0ZLND_$'21,_@WQDEJOE:Y'M#S6UQ"I1&=D
MB4W-F"BS+$MS;F%X0;+C/C)\-;_X[^$?&1T&UU#PW\3X4L?^$C\+PZKY5KJA
MC9O)NHY"$CF6:.,K#>,B[UM5@E$4EN\=OK35Y6?GOWMKIM?^:.TE[\>IQ8R?
M+A^>GT4'[K=N522@U)^][-.ZI57^\HROAZUTXLX;4?V_/!7[&O@?Q]J<^O77
MQ"U+6/%EAIOAFW,ZP7.N2SZ?8Q6Z27,@$:)&JGS+B0_<A=R&8X;@=&_X+M:O
M'^S:^L:E\*[6;XR:Q<KJ/A;X<V>JZBMUXD\-LZC^W8C)IHNS;+$EY+C[%YCI
M92%$(Y'(:+_P3SF_;'\ R>%X;KQEI>A:-XHL&NKM-=C@NM"NH(+&26>")HMT
M5Y"ZN%#*0NU8G4A6S^9G[./@C]GCXG^)K[PS\5O$WQ"\#7NZ"YTS4]*N;#6M
M*TB!+<R1_P!H:8VF1':+.YWF2V%Q!9I,09+59&63U*=N1<NUO7\3X''>T^L5
M/:IJ7,[IKE=[ZWBM$[[I;;'[92?M5:?_ ,%1?^"2WQJU+PGX5UNXU?5O!NN^
M'I_#%K?Q&\N;NXT?SK>&VNE5XV%U;7EI-#+L/R7499 P:,?A/X[_ &3YO@7X
MPC\&^+;?6M)\1ZKH,EE-H*6=O!J$5F]C+9BZN!9:&DRI%%,6^T3,(RT:-(SA
M<5^]/P8_8D\$_!+_ ()V>.O#/PG^+FJ:?H_CCPOJ<MO\07U>WN(;&XN+-XQK
M4<EKY$*B%1&R^2T<<<=O&B&-47'X+?M'GP1XB\=0Z79^-/#<>A^&I;:YN)_#
MWAMM(TV^G3+Q:M>6^H^+8;R>:1")%NYX2\B.A1B"HK0Y3]@/^"$6AP^"/!/Q
M6\,^!?#_ (!N=/TV+2KBQ^(6ARZKJ&C^,KQA>Q/:K=W4%NDT=G';VX46 -K$
MMZ BAMZGZPT76KQ=7U?Q-X9TB:WURWE5/&_@AY%,ER^W NK8G"&<HN8Y1B.Z
MC4(^QT5H?DO_ ((M>'-3^+OP2\=:UJG[3GB#Q]I6K)HUI:6%J=2TB^\$RQQW
M,F&34+N[=?M4=W:E3&?(E2VB9#(K9/T&/@AJUYXL;2=2\:^*-'^*%A:R?V)K
M)OF^P^([,,&9< ;PH.WS8-Y:)MLBEEVL>'%_$OZUZ6[/M?1ZI[GU7#\E[*HF
MD^][ZQTOS)?%!:-N/OTVHU([,WY(_#/AOX9K%*RZU\"=:"M#,LDD$W@.6.0,
MA#@K-;VD,T8*N"DVF31#E($!LN?_ &CH=1M+3PKX=\4W5O\ \)G9>)-+3P5X
MREM!Y>KA[^V\R*XBB,:?:T5!)-:@I%<K +F )Y4D5C'I/PPO&CU36O#>K>/+
M?7+*Z!\:>$&U=!=7#%-OGP/M5'E**#'*1LN40(QC9<Q8GC'X&Z3:?"VQ;3_B
M!XT3X/W:V[V>HVVH,C^!Y[:<,C2QE5,=G')&J' C>P>+Y\0AFM../*K.^GX6
MO]]D]NM-_P!UGT=;V\U*,8MS;=M4Y.;CIJERNI..DM/9XRGLO;),WOV8KFYN
M?AQI.K^%;7[#X\T;3;=?$'ARXD$,/B6T^80SQN<+O*JPAN1QE'@EVE#Y/2V]
MQH>E>![[4-/L6UOX2:X98=>T&:V;[1X5FW$3LL&-ZQ*^?.M\;H6!D08W+7D=
MS^ROX^\#>*-*\++\1Y[76M/AG3P/JURDT%OJ:F(22V1E21C#,OE%I;4HXN((
MEGA;=#,MITVA>"[_ %/Q3JD>FZUXRT#XK:;%#=^(/#%SKBJOB2S V+<6MQM5
M9!@;(YV&%9/)F6/@QW*%VVN[Z=>NG=KXEM)>]'4YJ6*Y80C)6O&+5Y:63M'W
M^D5+2G4;YJ$[T:MXK3T#5-*41:+X<\1ZU=W%C/.EQX%\=6\RR75I<,I$4,TI
M!5IBC%$=PT=W&S12!G8B:96UKQ!XU:6)=+\/_&3P_9!98F:2+1_&^F)(< G#
MOY'F2DJX$D^G3S'B:&=TOO/9/A'HMKX"-]I^O>-M6^%-\);?7=&:Y(N?#DH<
M^<S6Y3B-'W>=!M#Q,"ZY&0-#4?@FD>OZ3IOB+Q]XVN-/O)UG\$^+X-761K>>
M2,JD$DA4@3,CLJ29V7*.T;#<=LL67?M_P-?_ $F7_;K.J4JB33AK[VENJ^).
M'=[U:7_<6GH=7I>J6\>G:UXB\.:+?7WAV^N9K;QWX$NK59+[2KMU#7,L=LI=
M6F99!)-;QEX[R.5;FW:1I0;REKDN@^%?A]9V^M:L^K?";4A%>^'?%-O=&2X\
M,2=;<-<#+>6"0(+G)(R(I-VY6DYZQ^#&M:KX@OH8_%?B'1?C%I-E&)!-JKQ:
M9XOTZ*4E2L@1I%@W32 '$LMA-<$E)XY,7=+Q7X)O)/@!XND\!PZ[K5G?O/!X
MN\'ZSMDU72M0)6>:5$C# SD.KR0Q[X[N.6.XMVD:13>+3K^7WZ?^E1Z;HIRJ
M:N.C5K/FZV]Q\W?I2J[27[NH2:!\7?"OBWQTMNOBK0M)^*UK+'%I/B2&)EL_
M%,;A$2&>+@8D"QK) 2"&"20MD*R][HFMWZZ]JWB?PQI,UGXFLY(U\;>"6F7=
M?MMVI=VSMM0SE$_=3_+'<QQ^5+Y;QJUM\9>%?@1KU]KOAY+G7=:D\(Z?JN@2
M#7O^$ACN+/3P;:+8ZM&I" J<6\OW8\I$Q)8,?K;QIX$U;Q[XLL])U;Q%?>%?
MB;H]E/'H&O6!^SV7B>URK.LB+@DC:AFMPP*D"2/C:5UG&*:Y6_7SZ:][:)O2
M2]V5SBP]6K.G+VM-)6:M9I63O-..[IJ7O3A%\]&;56DDKH\I_;<6'PK^Q3JX
M\)R0ZU\*=;,(TZW_ -7/X0N$G ^RI'( WV,2(T8MR!+8S+Y00VY"6/$_\&LW
M_*'CPA\V[_BHO$'S>O\ Q-+BM']LOX8QO^S?XPUBQUKQ+IFO6-Y;-XP\,:K?
M"YCEG;:D5VA55#DB-?+N0")8XRC!7CVP_/7_  01_8<'[5'_  2+^']TOQ@^
M.GPW73O$7B/$/@;Q5_8T5R&U*4?O5\I]V-F1TP7;UKLP=O9Z;?A\NJ7D_A>F
MR1\UQ%*3Q5YKWK:WUDV]G)KW92:L_:1LJJM4?O2D?L-17Q?_ ,.:/^KK?VT/
M_#F__<U'_#FC_JZW]M#_ ,.;_P#<U=1X)]E7NHV^FK&UQ/#;K-(L*&1PN]V.
M%49ZL3P!U)KP'_@DY>0ZA_P3.^!4UO+'-"_@K3-KQL&5L6ZC@BO&_B!_P0ET
M'XL>#-0\.>*/VDOVNO$7A_5HO(O=-U+XA1W5I=QY!VR1O:E6&0#@CJ :\T_X
M(1?\$X?%OPS_ &0?A[XL\3?';XNZU9ZUX8M)]'T&V\32QZ+I%M/#$Y@%HZ,-
M\3JVR5'4%)=IB4H7D /TS)P*^8_@+\8M LO@;KO[4/Q#U3[+I/BBT?5=)NG@
M>YC\.^%F=/L,5O'$';_28TAO)F0,\DMP%):.WMUC].\2_LU-K_AS4+%?'7Q
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MU^3PW>:E+L$VK6YMX+RQNY O'FR65W;B4@!3,DQ"J,*/8:\!_90D/BK]IO\
M:*\36^6TF3Q1I_A^UE'W+J6PTFU%S(OJ$N)Y+<^CVL@[9/OU !1110 4444
M%?E9_P $)/\ @ES\5/V9?^"-7QI^#?CZUT/0?%'Q/U379]'F@U6#4K)K:_T2
MRLX;AI;9I%V^;%)D#+;5S@Y&?U3K^:#]H/\ 8E_:,_X(S_\ !37X;? ']DOX
M]^-]0G^*&E2Z]HNCZQ<16^GH\;W1,%Q#(7LYF*VSGS6ACR9,8')H _077_\
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M]B9?_P#HNC]ES_E(W^U/_P!RG_Z:Y*/^"S7_ "BI^/G_ &)E_P#^BZ/V7/\
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MCE5A)"0LEE(C$!8U98.4^!M@+GX7^'_#GB*_N+4MJU_+X)\9V\BM<17/VNX
MAE<C;Y[#<,,#%=1LR$%MRLO^!U^[7_TF77X9:CVT?]Y:QMM\:<.EMZU%?"_W
MU&Z.QLKRQBT+7->T'0[K6O!&LSW%OXZ\"W%B+B\T>ZD&;N:&T&\/(PD+W-FF
M];M9/M-MYDLC+J'$_MF_M/:I^Q%^Q)#XD\&ZW:^-&\1ZQIFB^#]4OR=1ALK?
M4)8TAFFE64&_6)&<Q'>KS_Z.DDK,SW#=_%+K6L>-)KJUAT_0OB[H5HHOK$NT
M>E>--.1CM96^9O+W.=DF&ELY9"K"2*0BX\3_ ."D/CSPG!_P3W\2VNC^#M"U
M*'XA>-]&\,ZQX?\ $QNH[?1-3U/5K*":6:&VE62":*65;L-:R)OF874;NTOG
M2=&%M[3[_+UM^L7L]4>-G_-]4=K[QOM+I[KD^NGP58_''W9:H^ I_P#@JA^T
MMXA\,?#/38/B5\*?$'B;^TQXK/B6\N;%+/28=0T+4[FWTZYN4@M[2)K.QMKJ
M6Y/D2,'O;.(/DF1OT-_X)B?\%!O&'[;?[&>J^*O$G@^SU7Q'X;U.#3=4MM-B
M-HFKVEQIMCJ22Q6\CRJMRMMJ$<<MJ9F GAE4. 5%?C!9M>WO@SPW_;'P=N?$
MTOBJ'1]0T+3?$=QJUUJFM:/KEKJDMI-82+XAVV\;MI;O(YFM[EC;P;VD"[:_
M7C_@BU\:=4^/'["NK0>#]'\$^!_^$/\ $$$6APZ5:W0T_6+:]T;2]<1[M;F6
M:Y$THU9EED\UY/,3?N?E6]"I?D=OP_X.A\?@>7ZQ#GM:ZOS-I?-QU2\UJCW)
MT\.Z)\.X+2[G_MSX*ZYL;3]06:2.?P9,D@,8,H*RPP13*#'*"LMC+& 2J*K0
M:.K:3JE[XGTGP[XBU;^R_'^E^<W@OQHMJOE:Y'M#S6MS"I1&D9(E-S9@HDZ0
MBYMS"\/^@LTK596NM8\3>&='N!=>;Y/CCP/,$,S2E!NGA7.PW!3!##]W=Q[>
M=VUA1DC\.Z)\.X+2[G_MSX*ZYY;Z?J"321S^#)ED!B!E!66&"*908Y05ELI8
MP"515:#Q]+?\.E9?BDGL_BIR_NGZ9[SEUYKOHG+F:UT^&524?BC_  \93[54
M:6EZIJFH>*-5U_0-*72?B)I*PKXP\'M=+Y.O1;2D-S;S,$5V9(F%M>$(LJQ-
M;7 B>$BSS89O#^A?#^YO+2V_MOX,ZWYD>J:7) Z3^#9E<B4B(@216\<BGS(<
M+)9R(64",$0Z6JZ5JEYXGTGP[XBU8:7X_P!+$S>"_&BVJ^5KD>T/-:W,*E$:
M1DB4W-F"B3I"+FV,,D/^@FEZIJFH>*-5U_0-*72?B)I*PKXP\'M=+Y.NQ;2D
M-S;S,$5V9(F%M>$(LJQ-;7 B>$BS-;V?GTUOUTVOUE%:37OPU,TXJ-U:UHO2
M32LG:#4WJH)^[1K2]^A/_9\1[MF?)?P+\.V;_P#!27QAHVK>)KJ*[_L^8>%/
M%"R!KD7/VJ/R@[_<DD>/>A#?)<*Q4@L^#]:12ZQX@\8S75K#IWA_XP>'[14O
M;)Y'CTKQCIRN=OS89O)W.QCEPTME+(RD21R21W/R#^SUJ?A72?VY_B=*-%FO
M_AGJ6B7<6HV36S1-X9B^WQ;F: @20QPR* Z ![8@L J1G9]=:OI$BSZ-X;\2
M:Q<^9YPF\#>.865KA9BIV6\[_<:8IE?F_=W<>01OR">GEU^[7_TF77X9:CDN
MC_O+6-MOC3ATMO6HKX?XU&\60Z?J%E;Z+KFO:#H=YJW@S5KBXM_'7@6XLA/?
M:-=R#==SPVB[P\CB3S+FTCWI=I*+JV\R61EU!M[9:99^&M&T?5]9FUKX=ZU)
M;W7@SQG:WPGN="N) /LB/=_,&#>8%M[MBRS+)Y$^]G5KNY')K&O^,9KNTAT_
MP_\ %_P_:*E[9/(\>E^,=/5SM^;#-Y.YV,<N&ELY9&4B2.1TN:NGZA96^BZY
MKV@Z'>:MX+U:XN+?QUX%N+(3WNC7<@W7<\-HN\/(XD\RYM(]Z7:2_:K;S)9&
M74#^MOOT[?S1W3U0TW>ZO>ZZJ]_LM2VYK?PJGPU(^Y/4M7%OK&L^,+:QOKBQ
MT/XL:%;.VE:JL3)IOBZQ5@71D!)\LDKYL.3);2,'0LC*TC=&UFX6_P!8\3>&
M='N([^.;RO&_@B0J9GE*C-S /N&<H 588CNHP 2'"LM6\LM-M/#6C:/K&LS:
MU\/=:DM[KP7XSM;X3W6AW$@'V2-[OY@V[S MM=L6699/(GWNZM=W+FWUC6?&
M-O8WUQ8Z'\6-#MG;2]46-H]-\7V*L"Z,@)/EY(\R')DMI&#H61E:4UO_ %>_
M37:_9[36CU)M'EL[<MGT?+RWNTTO>4%+6<%[^'G[\/=,V6+PWX=^&\=O<2+K
MGP/UP(]I=I+)%-X(E20-'^\4K+#:Q3(ICE!673Y8QRD2 VNEJVD:G=^)M)\-
M^)-7_LWQYIOG-X*\:K:ILUQ-@>:UN84V(TQCB!N;0%$N$A%S;>2\)%@W1M9G
M6^UCQ-X9T>XCOHYO*\;^")2IF:4J,W$ ^X9R@!5A^[NHP 2&"LN=-#X;\._#
MB*WN)5UOX'ZV$>SO$EDBF\#RI(&C_> K+#:Q3(I20%9=/EC'*PH#:K1+R^Y6
M3^]13V>].7]TT]]SZ\U_)RYFM=/AE4E'XH_P\;3[54F?%W_!Q/(OB;_@E/\
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M?=7TWQ@BP>.-%A4:5K=LOD0^)+$RIYJX'&X?(TMN<A75)$^7!7A/^#6@D_\
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M_@7\-=+\*Z&MS_9^EH_[VZF,US>32.TLUS/(>9)YIGDEDD/+R2.QY-=-110
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M7TU7S+^SM_RE"_:8_P"Q=\$_^B]7KZ:H **** "BBB@ HHHH **** "BBB@
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M['G6YA+1L3PV2W3A/CT[=[^GJOY9;VT>J/$X@26%M+=2:UBXM._O))?!)/\
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M<C1O R1?$7BC]GO]M[XC16;>)OA5JFM36:-Y0OM+TJ\6V+[=XC,GC[C)5<D
M$A1GTK]!?&?A?QA\1?@M\1)-;\87?@R33_!.I6/A/X@WEK!8G3A<PW"G6;B-
M)5,-U D=M(XVP1E09$$1EDM[7\1?B!^W1\0O .JWUK:_M3?$+Q%::7 MQ)J/
MF7VBK/"V/*G6#5/%]E<F.4%6C<0!9%=2N017H8=-05_RL_G;2_=K1O5:,^/S
M:I&>*DX6MHE:3DK))+E<K24?Y8R]Z$;1EJF?8/\ P1L_8*^&7Q3^)/QJT_5M
M'DM/&7]AVLOB6:-4LKS2?$+>+_'5K=J\$-[>0 Q):6L48:>=6A@A?)\PD_8
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MA34[B>V\=>!;FS$U[I-VXW74T5JN\-*PDWSVJ;TNTE%S;F220B^Y/:2>K?\
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M,N9-H N;<G"&X**#'*,1W4:A'*LJM#FR1^&?#7PS6*5EUKX$ZT%:&99)()O
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M_P #/^Q*TS_TG2OH"OG_ /X)3_\ *-?X&?\ 8E:9_P"DZ4 ?0%%%% !1110
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M?_1>KU]-5\R_L[?\I0OVF/\ L7?!/_HO5Z^FJ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \+\.?\ *0_Q#_V)L7_I1'7NE?+/Q&^#4?QJ_;QU
M:PD\2>+/#(M?"D5P)] U#[%/+^^1=CMM;*\YQCJ!75_\,$6O_16/C;_X5 _^
M-4 >]U\V_P#!8[_E$[^TA_V3?7O_ $@FK7_X8(M?^BL?&W_PJ!_\:KY^_P""
MK_[%=OX/_P""9'Q_U9?B7\7M1;3? &M7(M;[Q$)K6XV64K;)$\L;D.,$9&03
M0!\Z?\$$;+4-<\)>#3H=Q!H/C+3?A]:7-D+C+66MVJVVE 6\SA<LA#?,4&^"
M1E<!E8++^B>D:L8FUGQ)X;T:ZDBDG:'QSX&FC5[F"=E!DN((QE6F9"&*KF.[
MC(="7(,GYL_\$-/#NFW'@SP#9^*M0U+3XM0\&Z?'X?URW<13:)JC6^F^3M;R
MS'!*?-,,;2 Q3B06LBOYHCN/TL=-:U[QG';W$FFZ!\8/#]FS6EVJ/'I/C334
M<;OERS>3O==\>7FL9I0098I4>Z\65^;SO\[_ )7M\I+1ZGZ=2Y?9+;EY?-QY
M;Z_WO9I[KXZ$_>7NG"_'R+1]!_95\36KNOB;X3ZQHEQ/H.HHS2S>%K@1.8$+
M_?%NL@41R?>MV 1_DP8^PM-.U/5KWP_H>MZE%HGQ&TBU9_"7BM+8&WUZ#8K2
MVT\2E5<LL:FXM-RAQ&MQ T;Q*UKS/Q@U"63X(_$SQ!X6TZ:W\_2=0M_&W@VZ
M*K-97+6K[[J( E?-VD.VTF.ZC(D0ER#)K:=;Z'HGPJTFSU"\;6OA#K45O-I.
ML17#"X\(3@@Q S [XX$D \J;(>V<!&(0 QSI;R_"WYI)[/>F_(Z/><NO-=]$
MY<S6NGPRJ2C\4?X>+IZJU1&SH^KZG<>)M8\2>&]'.G>.M.,*^-O!+72;-<79
MLAN[69]D;3F.(K;7;;([F.'[+<^2\*M89T<GAOP[\.)+JUC77?@?KH=;NT:*
M2*;P3(DA63]VP66"VBF1A)$0DNGRQMPD2,MKI:GIFJ:GXITS0]<U./1_B/HZ
M3/X3\6):C[/K\. TUO/"I56++&IN;0%0XC6X@,;Q*UJFD:OJEQXFUCQ)X;T<
MZ=XZTXPKXV\$M=)LUQ=FR&[M9GV1F<QQ%;:[8)'<QP_9;GR7A5K UO\ ?T^_
M3OUE%:27OPU,XN-KJUK1>DFE9.T&IO513TH5W[U"7^SXB\&FFZSH]PFH:/X;
M\2:Q<1ZA'*9/ _CB,*TTDA7(MK@\(TQ089#B.ZC!( <$+\T?\%2M1;5/AYH5
M[=:;'H_Q,T?7[2/5;&&9EL]>LTM[QH[F,_\ +2,8<)(07@,DD;?>(?VSQ#\2
M? WPU\%+#&X\2?"7Q-;SROH4,$G]H^$C"["9EMR%F@M(9HV21'$;Z?.F/DC4
MK;><_M(:?\2OB5I'@WPR?#M]9WT.IW#^%O%NJZC917%S%+I]U!]EN3#(Z><X
ME7*[@+E$SM#!E4\_3K]VO_I,NOPRU&UT?]Y:QMMK-.&ZL]:]!:P?[ZC>+/4/
MAA?Z3:_!J/6-'TM_$/PXURS-KXQ\(W%E]HN-%GDB'VJ5+4AMZN)"UQ:@,LRR
M>?#O9V6ZVM1TZSMM&T/0=>UR\U7P;JMQ;W'@3QW;WHGOM%NY!MM8)KIMX>1Q
M+Y=M=R;TNTE-K<B2616U"/P;::U]HMWL[:QT+XM^%],M[;6-):8KIWBVRC&U
M'5\$F,MN\J?!>WD9D<,K.DCK*]TNR\,:QJVDZ/-K7PZUJ2XM?&7@VZL1/<Z#
M/(#]J=+7YMP;S"UQ:*&699//@WL[+='3^OGIV[K>+U6A6M[J][KJF[M>[[VS
MDU_#J?#6C[D_>+DD>LZ_XRCMKF33?#_Q@\/V;/:7:(\>D^,].5QN^7+-Y.]U
M#QDO-8S2@@R12H]U'I6JL9-9\2>&]&N6W3-!XY\#3HK7"3%1OGA3.QIRA#?+
MF.[C*LI+%6:'4=.L[;1M#T'7M<O-5\&ZK<6]QX$\=V]Z)[[1;N0;;6":Z;>'
MD<2^7;7<F]+M)3:W(DED5M0M21ZSK_C*.VN9--\/_&#P_9L]I=HCQZ3XSTY7
M&[Y<LWD[W4/&2\UC-*I!DBE1[HUOY_C?\KVV>TUH]2/=Y>G+9]'R\M]=/B5-
M2W7QX>?O1]TSY8O#^C^ +6QOKHZY\'-<,<FDZM'.ZW'A"8.#"IF!$D4,<@'E
M39$EK(H5B%"M'>U33-5O?%6EZ#KVJ1Z3\1-)69O"'B];5?L_B"':'FM;B%2B
ML[)&IN+0%%D6);BW,3Q?Z(W2M59I-:\2>&]&N6+3-!XY\#3HK7"3%1OGA3)1
MIRA#?+F.[C*LI+%6:G+%X?T?P!:V-]='7/@YKACDTG5HYW6X\(3!P85,P(DB
MACD \J;(DM9%"L0H5HS2W_#VM^:2>SWIO^Z:>]S=>:[Z)RYFM=/AE4E'XH_P
M\73U5JB-#2=6U*]\2ZMXD\-Z3_9GCW3/)3QIX+>Z3R];384AN;>9MB-*8XB+
M:\(1)TB-M<")X0;'+AF\-^'?AQ+<6\0UKX'ZT'2\LWBDBF\#2I(1(#&0LL-K
M%*A#QD++I\L9("PJ1::6J:7JM[XJTO0M>U2/2?B)I*S-X0\7K:K]G\00[0\U
MK<0J45G9(U-Q: HLBQBXMS$\7^B.TG5M2O?$NK>)/#>D_P!F>/=,\E/&G@M[
MI/+UM-A2&YMYFV(TICB(MKPA$G2(VUP(GA!L36_W]/OT[]916DE[\-3-.*BF
MFK6BTU)I63M!J;U4$]*%>7O4)?[/B+P:8W6-'G%]I'A?Q1J]RE\DWF^"/&\6
MWSVEVG%O.<;#<%,AE(\NZCW<!@RJMO<:SJWC*XO+.WL=#^+&AVJC4],,C1Z;
MXQL%8A71CD[,L?+EPTEM(Y1PZ.1+F0S>&_#OPXEN+>(:U\#]:#I>6;Q213>!
MI4D(D!C(66&UBE0AXR%ET^6,D!85(M-+6-'G%]I'A?Q1J]RE\DWF^"/&\6WS
MVEVG%O.<;#<%,AE(\NZCW<!@RJ;Z^G7[M?\ TF77X9:C:MH_[RLXVV^-."U5
MGK7H+6#_ 'U&\65[*]T^S\/:QKFAZ/<:UX UJ6XM_&G@NXL?/NM%N),F[ECM
M/FW%O,+7-FH99UD^T0;Y'9;QNH:?I]IH&BZ+K6M76K^!=7FM[KP1XWM;T3WF
MAW,@Q:Q279WARPDV6]V^]+E)/LUQYCR*U[;M[C6=6\97%Y96]CH?Q8T.U0:G
MIAD:/3?&-@K$(Z,<G9ECY<N&DMI'*.'1R):UE>Z=9^'M8US0]'N-:\ :U+<6
M_C3P7<6/GW6BW$F3=RQVGS;BV\M<V:AEG60W$&^1V6\/Z_ST[=UO%ZK0>M[J
M][KJKWM[OO;.37\.I\-6/N3]XT+*WU+7OB+96>JW5KX;^*6B0?N=1@MR=.\8
M:6L@\S$1;+("^6B+F6SFD!#/%*&N,'QM^T%\)?@G\79UD^(WABPD\0>)].\%
M^(/"\9_M R:]J@46*-##N>UN)U92S2((Y$^9]I4R5UG@2VFTNYT726FE\9>#
M=2C^W>#_ !3$5U.XTHM Y2.>9A)O'DNY@OCN$B$Q3,9=DMW^%'_!2+_@B-^T
MY^U-^U$_BVQN_B%<:?#XXTOP-%XHUZTTYM=UN-KH1?\ "0RPZ/;0F/3;0*KK
M+<.\H3:P$:[MO=AJ491O+>_]>NG5;K<^7SK,*U&HJ=)I1<6ME9IMZ)-7C9JZ
M@]:<[\C2LS]MO#>H_#/5/A+XDLXO&VB^*OA?INJKI43:?=FZ;P=?0RKN@^V6
M[L;=;:7RGC=C&]F5'[P(L8B\U\6_M#_#C]C/]E_P1XP^)6O:NWB'2-6U>WT2
M?2K42:UK>+NXENX/)C41M;O!!YER9 EM%Y*3DP-##)'YY_P17_9P^*G[#W[%
M_B3P?X^\,^*9[WPGJ::0/#,G]CR:3=6D:[IK_1Y+.V@:=+E9][)=@S-)"R,0
MY9CPO_!5W]D33-0_8<^&WBK1_&_@'P]8>!;V[2T3Q'JJZ;INHVM_J5MJ,$$+
MW*,OVB.YT^QQ;21@2QI<V^8@^Y:C1IJIR65K>?>Z]4GM_+TW.>MF.*GA%B7*
M7,YN[]VS;ARRO:SC*<=)WNJRNY7<'?UK3/\ @LY^S3I.L^'?&UAJOCJ.X^)&
MDZ??:E::5X8OM2BMOM%LD]F^H):Q2HE\+4+^[A9K@P>69$>*.%D](_:>U3Q%
MX9_80O-6_9M\-Z#\4E\4SZ=/HVDS1P:OI!TN\N81<S6L$EU:Q31+;R231P-=
M1Q9"@,D8P/QG\;HOQ6T74M>O?B]\"F\3^*M=8:K;:U/=><UK-<M>7=^L\.G2
MI9S226VD6R0VR.T5IIRJ+@R2%T_6SX7_ +3/PK_X)A_\$D_ WC:\\67'C[P!
MI5O:0C7]'ABCCU:YU"]VM-$DTD<<%O\ :;A\*\@6&)0"QV9/0J<$[I=_QW^_
MKYZGBU,=B)P=.<VTU%6?:.D?_ 5I'M'W5IH?G'X7_P""!'QCG^*/POU"YF@^
M&+7$EMX?9=0\4M="Z-MI=TY>73=*2'9&T=NR^4NKR*-[+@J[&OU2_8U_8:U;
M]@GX(^,M+\)ZOX:U[Q%XN\52^,+R"+P_%X=T1IY+>TMY;2UM;9F%G&\=H"'S
M*5EE>1A+DJ? =1_X.4/V>3X:TWQ%=Z+XL_L>2^FMM/U.:]\.?9GNXHD\Z.*4
MZIM,J17*;E4[E6=<X#C/T?\ L[?MC>$?^"AGP6UO5_"MQXL\#S:)K\6B)-JD
M,%O=VU^;2TO[=T\N66&:&6"\MR!O*RI*5Z-R5?@=O\AX&WUB'-:UU>Z;5O-+
M5KO;6VVI;T_4-/M/#^M:UHNBW.L> ]8FN+7QOX(NK(3WFAW,@S=RQV@WARPD
M+W%HF];A9/M-OYCR,MZ:AI^GVF@:+HNM:U=:OX%U>:WN?!'C>VO1/>:'<R#%
MI%)=G>'+"39;W;[TN4D^S7'F/(K7MR&;6-<\8S7EG#I^@_%S0;55U#3WD:/2
M_&&GJQVD-@MY6YF\N7#2VDKE6#QNZ3T]/U#3[3P_K6M:+HMSK'@/6)KBU\;^
M"+JR$]YH=S(,W<L=H-X<L)"]Q:)O6X63[3;^8\C+>^-_7^>G;NMXO5:'Z7K>
MZO>ZZJ][>[[VSDU_#J?#5C[D_>+DL6LZ[XRAL[R;3]!^+N@VC-87ZQM'I?C'
M3U8;@5RS>5N9?,BRTMI+(K*7CD1YX])U:4W6L>)O#.CW'VGS?)\<>!Y@C3F4
MH-UQ N=AG*8((_=W<>.=VUA7U#3]/M- T71=:UJZU?P+J\UO<^"/&]M>B>\T
M.YD&+2*2[.\.6$FRWNWWI<I)]FN/,>16O;DL6LZ[XRAL[R;3]!^+N@VC-87Z
MQM'I?C'3U8;@5RS>5N9?,BRTMI+(K*7CD1YWK?S_ !O^5[;/::T>IE[O+TY;
M/H^7EOJFOB4$]917OX>?OP]TS9(_#NB?#N"TNY_[<^"NN>6^GZ@DTD<_@R59
M 8@905EAMXI54QS K+92H 2L:JT%OQ/X8O/$FL:?X3\6:A!:^-K6*XC\(^+I
M+%)+;Q% R;KBRN[<;(Y&>.(?:K+*)<)$+FW,+P_Z#YAXB_;1\.^"/B?J,?AG
MPSXLUC7I9GB\>>!;+31<M ZA5DNXR2(S*-R*60F.Y1ER5;:XYNV_;-\*Z?X#
MNM-O/A[\5-6^#]Y&LVG71TQ8[CPO-'*"B1SK<!DABD4-%*'26TDC"@[0GDFE
MO^'2LG]Z2>S^*G+^Z:^\Y]>:[Z)RYFM=/AE4E'XH_P /&4^U5'H/PZU_7/!W
MQ>U2QTNP.G^,+.UBGU'PM<7RNNMVT:^6%BG<()75$!L[]@OGQ(]K<B.6T<VO
M3V\_A_0OA]<75K;_ -M?!C6O,BU/3)8'2?P9,KD2_NB!)%;QR*?,APLEG(A9
M0(P1#X?XM_:1U?XE^*OAWHMYX9\<>'_B-HOB:.+PKXUU3PU"D-Y:2KLNEO(T
ME4 M!O-S;Q,J2K;>?&;<J!:^[:9XTEU#Q)JGB+0+>QT?XA:2(H_&'A!]0C^S
MZ]'M*Q7-O.VQ'9DC(MKPA%E6-K>X$,D)6S-;_?TU\]-K]916DU[\-3-./+=6
MM:+TDTK)V@U-^\H)^[1K2]^A/_9\1[C3+&KZ/(EQH_AOQ)K%SYGG"7P/XXB9
M6N%F*G;;SM]UIBGR_-^[NX\@C?D&2*76->\8S7EG#I^@_%[0+14O[!Y&CTOQ
MAIZL=I#89O)W,WERX:6SED96#QR.EQAP>)/".A> IKBUDM=:^#>O;X]1TJ4%
M+CP=*'(DQ"<21VZ2 ^9%@/9NI90(P1#=U::U%UI/AKQ%XF4S)+YW@CQQ#/&]
MQ'*5^6WN&^Z9BGR_-^[NH\@C?D$]/+K]VO\ Z3+K\,M2FK:/^\M8VV^-.'2V
M]:BOA?[ZC>+);&^L8M#US7M!T.ZUCP3K$]Q;^.O MQ8BXO='NI!NNYX;1=X>
M1Q(7N;--Z7:2_:;;S)9&74&W=IIMMX;T71=9UJ;6_A_KDEM<^"O&MM?">ZT6
MXD ^R1R7>6W%O,"VUVQ99UD^SS[Y'5KPA\2W6O>+9KZSGT/0?BUH%JL>H6+7
M7EZ5XPL%8[</\S>5N9C'+AI;25V5@\<CI<5;7Q;H5MH.M:]H=B-7\$:Y-<0>
M./ MS;I/>:3<R9-W/#: N)'?S"]S9IO2[63[3;>9-(RZ@?U_GIV_FCO%ZH%>
M_6]UU5[V]WWMN:W\.I\-2/N3U/C'_@Y!=KO_ ()7_%"S\6(FG_$#1[&T2WU*
MS4PVOBO3OMT&YE4DYV.RL\#$O!(P*L8Y TOT;^P!=_V9^Q]\/]?\&VTVH26O
MAG3+?QAX3= DMV?L<0%W C8 N&B"LIX2YCP"0P5E^;/^#B36(=)_X(W?$+21
MJ%OXX\&W\6GW_A+Q%'=KJ$]B#<1%+>XF!9I%,+L(+S)\V-C%,QE*2W?TI^P]
M]L\1?LP_"&WA^S^%_B3I'@K3Y-$NY"6L/%.FB"-C#(0,NBE@)$QYEO(PD3*.
M#+K]B_6_SV[[-]GM):/5GG_\Q+3^'D_[<MS.]X?'&*>LDO>HS]^/NQ1Z'+#X
M;\._#B*WN)1K7P0UH(]G>)+)%-X'E20&/]X"LL-K%,@*2 K+I\L8!*PJ#:Z>
MK:3J5[XETGPWXDU;^S/'NF><_@OQHEJGEZVFP/-:W$*[$:4QQ W-F"B3I$+F
MW,3PD6+='UB?[=J_B?POI%PE_'-Y7C?P1*4\YY=HS<0#.PW!0 JX/EW484$A
M@K+FRQ>&_#WPXBM[B8:U\#]:"/9WB2R13>!Y4D!C_> K+#:Q3("D@*RZ?+&
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MF^G8I=#TOP->ZAI]DVN?"/7&EBUS0Y;9OM'A6;<1.RP8WI&DF?.@P'@<%T
M91\M?\$.?V,/B]\$M,^*7C/Q9HMU\*/^%@06Z:/X8U&X_M4V-Q%>:C<+<S*9
MVED2.WN[.R7SI5N)8K!2QA'E)']9Z=J.K7_BS4M:T738=(^)&D1Q+XI\+-<
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M>G;NMXO5:%^\Y75[W75-W:]WWMG)K^'4^&M'W)^\7)(]9\0>,H[:YDTWP_\
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M1+>T\<>"I+'[1<Z9<O:QF[N(+3#%V<2&2YLU#+=I+]IMP\TC)J&G_+NWF_\
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MGPT2&9EUKX%:V%:"=9)()O DL<H*8<%9K>UAFC!1P4FTR:(<I"@-E+E=:O\
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M:W4P1ZQ;-/I2S0L2,2A0()6B))C?:R\%L_LM\'?^21>%?^P/:?\ HE*_'?\
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M?_\ HNC]ES_E(W^U/_W*?_IKDH_X+-?\HJ?CY_V)E_\ ^BZ/V7/^4C?[4_\
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MWR#_ (:(\>:CX\_M2#2K70_B1IMLT=U8#P=XD6U\6Z?&<*S*+5G\H22'RY6
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M.K?MG?\ #3'Q C_LN[6U_P"$/_TL^;G68M+W?;OMO'^M\W'D'[NWON']*O\
MP2TU:ZU__@F/^SG?7UU<7M]>_"_PS/<7$\ADEGD;2K9F=V;)9F))))R2<U\8
M^)/^"/-KX7_X(&^(?V-_"_QH\#ZYKNHW<5U;>)=50:7:'&NP:FZO#'+<.N$C
M9 0S9;!.T$X^]OV(O@[=?L[_ +%_PA^']]J&GZM?>!?!6C>'KB]L&+6MY):6
M,-NTL18 F-C&64D D$<"@#U"BBB@ HHHH **** /F7_@LU_RBI^/G_8F7_\
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M]3^%?P_M_!EOX9\2WFN:MKMIXVM]6TS583X=O--&F:>A>-KJW:2:&\,UJMS
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M9_V)6F?^DZ5] 5\__P#!*?\ Y1K_  ,_[$K3/_2=* /H"BBB@ HHHH ****
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MBBB@#YE\5?\ *9'P'_V1GQ)_Z?-!KZ:KYE\5?\ID? ?_ &1GQ)_Z?-!KZ:H
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M^(7C'2_"_C;P3H4EWX5\2-:.\.O"YEV.+F",!>8[8I- "H.\S0F)@ODXVF?
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M$+=M%2Y::*T<XG?375?/A+AGX/U#_P $L/@5\+?V=_\ @F<LD/C#3/BAX/\
M%MW'>Z[K>EP2KIUA]FMK32HHXU8_:(8K&#3K6)Y92)HWMY)Y/*(;9\#>"O\
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M"8MDT;MCKAXP3SA1P #\VO\ @H[_ ,H)/VL/^N?AO_T9I-?K5\'?^21>%?\
ML#VG_HE*_)C_ (*20-:_\$*_VM(Y,"2-?#BL <C(ETH&OUG^#O\ R2+PK_V!
M[3_T2E '24444 %%%% !7S__ ,$I_P#E&O\  S_L2M,_])TKZ KY_P#^"4__
M "C7^!G_ &)6F?\ I.E 'T!1110 4444 %%%% !1110 4444 %?A#_P\&_X*
MC?\ 1B_P?_\ "*O/_EI7[D>/?&5K\.O VM>(+_S/L.A6$^H7'EKN;RX8VD;
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M(_'WAK3]>-IDM]C>XMTE>') SL9F3/0[<C@T >D4444 %%%% !1110!\R_\
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M)'"D@'E39#VKJ$8A K1SI;^K6_-)/9[TWY&GO.77FN^B<N9K73X95)1^*/\
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M?=,V6+P[H7P\M[6ZN/[<^"NN>7)IVHI,\<_@N57!B!E!$D-O'*H,<H*R64B
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M3U!&:\%_X4#\1/\ HBNC?]^O"O\ \BU]Q44 ?#O_  H'XB?]$5T;_OUX5_\
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MI)1#EW;E0>HJJ/V0C^SK;G5_@A+-X<>Q4R/X*FOI6\,ZTBAC]GCA=F73I6R
MMQ;!50A3)%.B^60#WJBN5^"OQ?TGX\?#73_%&BK=16MZTUO-:W2JEUIUU;S/
M;W5I.JLRK/;W$4T,BAF"R1. 3C)ZJ@ HHHH **** ,SQKX2L_'W@W5M!U%7;
M3]:LIK"Y5&VLT4J%' /8[6/-?SH:I\"?^"B7[#/[(OQ$_8A\'_!>;QU\/_%N
MH7MCI/C?3;1IQ_9=X^)XTG$H@@6<;MWVD*T0GF!ZHR?TA5_,;^Q%XS_X*1?M
M[?L2?$+X]>#_ -J:/3?!_P -;C4K;4[/6=6GAU*=K&PAOI3"D5E)&P,4Z*NZ
M1<N&!VC#$ ^T/VS/^"6O[5VE_P#!,C]G;]C'X)Z;X<_X0O4M%9?BIXAGN(H8
M=/N_M<5ZZ"1Y/,:W:ZFG<B"%Y)!$HX4LI_6C]F'X#:;^RU^S?X"^&NCS276E
M^ ?#]CH%M<2($DN4MH$A$K@<!GV;CCNQK^;#3/C1_P %&-5_X)5ZA^U]'^U%
M(OPUTVX%M+IK:K-_;C,=3CTW*Q?8_(QYTBMS./D!/WOE/]$/_!.#Q_K/Q7_X
M)X? 7Q3XCU"XU?Q#XE^'7A[5=4OIR#+>W4^F6\LTKD<;G=F8^YH ]HHHHH *
M*** "BBB@#YE_P""S7_**GX^?]B9?_\ HNC]ES_E(W^U/_W*?_IKDH_X+-?\
MHJ?CY_V)E_\ ^BZ/V7/^4C?[4_\ W*?_ *:Y* /IJBBB@ HHHH ^9?%7_*9'
MP'_V1GQ)_P"GS0:^FJ^9?%7_ "F1\!_]D9\2?^GS0:^FJ "BBB@ HHHH ***
M* /F7]G;_E*%^TQ_V+O@G_T7J]?35?,O[.W_ "E"_:8_[%WP3_Z+U>OIJ@ H
MHHH **** "BBB@ HHHH **** &7,QM[>218Y)FC4L$3&Y\#H,D#)]R*X+_A=
MVK?]$S^('_?.G?\ R97H%% 'G_\ PN[5O^B9_$#_ +YT[_Y,H_X7=JW_ $3/
MX@?]\Z=_\F5Z!10!Y_\ \+NU;_HF?Q _[YT[_P"3*/\ A=VK?]$S^('_ 'SI
MW_R97H%% 'Q-\3]>^(/C;]L[4IO!B^,O VJ+X;B%PHT72]4N)8?-7@I-="-5
M+;3N5RV1C&"36S_8O[1G_10/B!_X0'AW_P"3Z],\.?\ *0_Q#_V)L7_I1'7N
ME 'R_P"!?A?^T%XR:Z%U\9/$/AW[/MVG4_ &C?Z1G.=GDW,G3'.['WAC/./G
M?_@K5X/^.?AC_@GY\?;75/B1XH\2:%;^!=7^V21>"=&MK*\A-C(77S1="9%P
M2I98RPP2 >,_I17S;_P6../^"3W[2/\ V3?7O_2":@#\\O\ @@UX@\1^"/"'
MA77O"MC>^*+JV\#Z=!J_AB-(8;F[M3!IH%U"SS+''-LVE&;*S"#RG*$B6W^Y
M[/XOZ;H/PTO)%^'?C35/@;J4+L]O*EG%+X-ECF"NB 70D@M8958LK>7)ILD#
M %8E"VGQ;_P0=L;CQ%X0\!6MOJ:^%_%EOX$M[C0+[!:UU "STIC:2QE@9XS&
MI\V'(; $L;(Z*\?Z-Z-K.I/XCU?Q-X9TA['QE8M$OC;P2UPF-6&S9'=VTC;$
M,YCCQ!='9'<QQ?9Y_*>)6LO$EO\ ?T^_3_TJ/VE[\=3]0I/W$_*#^*VBT@^?
MHD]*%=ZT97P]>]-IGS7^UY\6_'&C)X=T[5&\8>%;_0['5M1\,>)Y%L$N]7,,
M,#K#<&.X #!-ZRJC%9UVNL18;(M/]F+XP^/)M=\07,>C>)M<^)6CRVS:A9>?
M9?8]:T][>)E1W:XW?*S.T4X#M$7V.-K-'72?M/\ PF\$Z]^S;JFL+ILWBCX5
M6^E:A-I<4$EU;7'@.[",&3RD*2"Q2XA57MY5WZ?+$046!2MGUGPL^ VC_!S1
M])\'M+/HNIW5P=1\(>-$E>XDO+AHEW6UQYC$><8T"O!E8KF)-\81T985YKRZ
M_=K_ .DRZ_#+4II;/^\M8M;.\TZ:U5GK7H+6F_W]"\&4;#XQ1V>CZ]>:7\+?
M'&L?#/5&N[?Q5X9NK*QEDT:X()N#%;?:6.U]Q,UJ5VMYGG1\LZSI>_$ZY_X1
MC2='\0>&?B+?>&[N\M9_ ?C2WNM.EU/3+J566V1[IKEXWDP_E0W$A9;R.X-M
M<)*TC&\]!M;O6-8\7W>I:;:6>A_%30[=%UK16F*Z?XKLP2$D20CE#\WDSXWP
MN6CD!!932M+S2;'PGJVJZ7I,NM?#76GGMO%OA*YL_-N?#T[Y^U.MK\V5.\FX
MM0&#AO.AW%F6=:6_KYZ=K[K>+U6AI[W-UO==4W=KW?>V<VOX=3X*\/=E[YRE
M[\7_ !;J_BFS$GP_\2:+\9-'T]Y(WA2SBTKQ=IT<Q4JRM=L_D[G1F13++I\M
MRGS31R@W?A_[:'Q-\/2:5'XDE^'?BK3;%M<N+'Q7X=U"WLLKJ4NEWB1RQA)V
M=9295F( $=RBI(IW$&7Z>U+3;6/2M#\/^(-<O=1\+ZC<P77@/QY:WBS7VD7;
MJ5MH9;E@ZM*RRF."YD#QWD<K6UR)'E_T[YP_X*GZA<:AX'\)6NO6>G:7\5=*
MU^VBCNH!)#I_BK35BN3Y\(+,3&LCJ'B<R2V4LY&YXKB.:ZK6_G^-_P KV^4U
MYF7N\O3EMY\O+?73XE33W7QX>>J]T[_P7\4X-(^!>C6&J^#/'&M?"G4+.SDT
M76$GLUN?#D_R^4%G%UNCBCD ,4[,KP, C<!2OHVA:AKGCC4-)T_Q''?>#?B9
MI0G_ .$6\07MM"%\06XPTL%Q%#(8VWJBF>U#KN"+/ 8VC!MJ_P +=12'P)_P
MD'AG2;B[LWMX[;QQX)FA#7$4YA3S+B&+E3,R,'9%S'=QLLB$NP,MR>#0M(\"
MV=A?7C:Y\(=<,4NB:W%<,+CPG-N!A4S [TA20#RI\AX' 1R%"LLZ6_JUOS23
MV>\'Y&OO.77FN^B<N9K73X93E'XX?P\53U5JB,CPK\6O$&M?$V_U7PY\._%&
MB^,+=8?^$W\,W-Q8K9ZL!!B*Y@E,ZG[3LA,=O=F-(KE8A;7!B\I);"+Q1XOT
M/X=_#AKC3_#NL>-O@?KT$KW-K91+#-X(FBF"NFR:2*6W@CE5]T;!)-.EMW^X
MB;+;J]2TW5M0\5Z;HFMZE%H_Q(T=)6\*^*EMA]F\108#2V\\2E58LJ*;BU!4
M,$6X@,;1@VRZ1J^I7/B75_$WAG2&T_QQIYA7QMX):Y0+K:A-D5U;2OLC-P8X
ML6]V=D=S'%]FN?*:%'L'Y/SZ??IWZRBM)+WX:F::235K6BTU)I63M!J;U44]
M*%=^]0E_L^(O!IKA=7^).N,FCZ#XF\*_$"/6(KECX)\7Q)IOVJ5_+W"*?_2A
M$TS("KQYV74:LP56!5)!\9?%6H^,_M^G?#?Q3I'Q4TNTB_MG2P]DFF^)K(,0
MIW-<[BH)/ESJK- [&-MZLROTB/X;\/\ PVDN;>-=<^!VN!UNK5HI(9O!$J2%
M9/W9"S06T,R,'B(2;3IHFX2)&6UT-8TBX.HZ/X9\3:Q/%JD<IE\$>-XE0RS2
M%"?L\^,(9R@P\9Q'=1@LH5E98S_@=?NU_P#29=?AEJ-JRL_[R:<;;:S3@M59
MZUZ"U@_WU&\6<%8?&);73=?OM)^%?CC6?AOJSW=MXN\+75C8S2:3<,K&X:*U
M^TL3YF_,]J5VR"7SX_F9UN67?Q0G_P"$4TK2-?\ #/Q$U+PI?7=I-X#\9P7>
MG3:EIES,K+;(]TUTZ._SB*"ZD9A>)<?9KA97D+7OH5M<ZQK'C"ZU#3[6RT/X
MK:';(NKZ0TI33O%MBI(1T<@DH26\J;!>W=C&X9697IV=WI=GX7UC5M)T>;6_
MASK<EQ;>,?!US9>=<Z#/)G[4Z6OS;@V\M<6BAA*'\^'>SLMT:6_KYZ=NZWB]
M5H5[W-UO==4W=KW?>V<FOX=3X:T?<G[QR=[\7?%FK>)[%)O /B;1_C%H]B\E
MO-#'9Q:9XLT^.7:RNK79;RBSHS(K226,LZD-(D@-R[2_C3J*Z_K6L>&_A;XZ
MDMY)W@\;^$IHK!V28IE[B&/[229F4@D!?+NHV5@=Q#-UFH:?9PZ/H>@:_KEY
MJG@_5+BWN? GCNVO1/?:/=R#;:PRW3;P\C"7R[>ZDWI=I*;:Y$DD@-_:=-:U
M[QG';W$FF^'_ (P>'[-FM;I4>/2?&FFHXW?+EF\G>Z[X\O-8S2@@RQ2H]T:W
M\_QO^5[?*:T>I'N\O3EMY\O+?73XE!/=?'AY^]'W3S=?BS9Z;\.5M;[P/XXU
M;X0ZH(IM&U)9[);KPO,)!Y2K.MWNCACD ,<Q97MG4(3M"F/0UCXF^*+S5]&T
MK7/"/C32_B1IIN!X4\31VFG;-:@"J\L%S"+M(W\Q4!N+1' <0BXA,+QJ;;M-
M*U5@VL^)/#>C74BO,T'CGP-.BM<13E1YD\,>2C3E"&(4F.[C*LI+%6>G-#H&
MC^ ;6RO;HZY\'=<,<FD:O'.ZW'A"8.#"#,")(X4D \J;(>U=0C$(%:,TM_5K
M?FDGL]Z;\C3WG+KS7?1.7,UKI\,JDH_%'^'BZ>JM41)HGBO5KZ]U#QAX=\.7
MFD>/K)+8^-_ ,EQ$7U9&0)%<P2DK$TXCC(M[L%8[A(#;3^6\*FQYCP1X[TF]
M\"W\G_"(^((_@CJBNMY;:G%#&_A&996679'%,\L-O#,C"2)@DEA+&2 L:,MM
MV>IZ9JM_XJTO0M=U2/2/B-I"3-X2\6K;#[/X@AP&FMKB%2BLS+&IN+0%!((U
MN+<Q/$#:FDZMJ=WXFU;Q)X;TG^S?'FF^2OC7P4UTGEZXFS9#=6TS[$:8QQ$6
MUV0B7"0FVN/)>$&Q-?SZ??IWZRBM)+WX:F::2335K1::DTK)V@U-ZJ">E"N_
M>H2_V?$7@TSR/]K'QAXD\,:/HOA6]'BJ/4%UJTA\'?$73Q:[YHY0N^"5C/&#
M,4)1E;9'<JA;Y2I*^-_L5_$OQS8>/5O-&M?$VL>,H=+O)M3T7%M'IVMP1ZB5
M!\Q[C<5!>7;.%WPRN5VR1EP_TQXP\$^"?$GPC:.[LYO$?P)UB;SKS3U>YL[C
MP7<12D/\B&.>*UBF1EE@;:]E(C941*RV_GG[*W[/7AGP)H^FK*;_ $7Q!J%Y
M>Q>$/&T>HSW(F=+J51;31NYA$S+'R@4)<Q X(<,%/^!U^[7_ -)EU^&6I371
M_P!Y:QMMK-."U5GK6HK6#_?4;Q9UMA\8UL].\07FD_"OQQK'PWU5[RV\7^%;
MNQL)Y-)N&4FY:*U^TL2)=^9[4KME$OGQY9W%S'>?$^9?"FE:3KWAGXB:EX2O
MKRTF\!^,X+S3YM2TJYF5EMHY+MKITD;YUB@NI687B7 MKA9I)"U]Z%;7.L:W
MXONM0T^ULM"^+&A6R)JVDO*4T[Q98J2$=7P28R2WE3X,EO(S(X96=)*=E>Z7
M9>&-8U;2='FUKX=:U)<6OC+P;=6(GN=!GD!^U.EK\VX-O+7%HH995D\^#>SL
MMT:6_KYZ=NZWB]5H.\F^M[KJF[M>[[VSDU_#J?#6C[D_>.4OOB[XLUGQ+8Q7
M'@'Q-HOQBT>QDEMKB"*SCTWQ38)+M961KLL82S(7C#2264LZ$-(DBM<+I?QI
MU)?$.LZQX<^%OCIHWF:'QQX1FCL'Q*T>6N((_M.3,RX. OEW2$,,-ACUFHZ=
M9P:-H>@Z]KEYJG@[5+BWN? GCNVO1/?:+=R#;:PS73;P\CB7R[>[DWI=I*;6
MY$DL@.H6I(]8\1>,8[6ZDTWP_P#&#P_9L]G>(CQZ5XQTY7&XA<LWD;W421$O
M-932*09(Y(Y+HUOY_C?\KVV>TUH]2/=Y>G+9]'R\M]=/B5-2^*/QX>?O1]W?
MS=/BS9Z=\-_LM_X'\<:M\']4$4NCZB)[-;KPO,)!Y2B=;O='#%( 8YBR/:N@
M4G:%,=_6/B9XHNM7T72=<\(^-=,^)&FM<+X3\4)::=MUN *KRV]U"+M(W,BH
M#<6B.!((!<0&%XE-KV>DZLPEUKQ'X<T6X9FF,/CGP-,JO<+,RC?<0)]QIF0[
MOE_=W<9!!WX+5)8?#^C> +6RO;K^W/@WKGER:3JT<[K/X0F#@P@S B2.&.0#
MRILB2UD4*Q"!6C6EO^'M;\TD]GO3?]TT][FZ\UWT3ES-:Z?#*I*/Q1_AXNGJ
MK5$8&C_&CQ'J/Q NM8\.?#'QAI/CBV^R)XU\+R7%A]DU.-T"1W44K7"9D5(V
M6"\V*DZ6[6\P1HE-G=\0>(M!^'GPBNM1L-'O_&7P6UC?'=Z1;0B*\\&2HY$F
M(Y6B:"UBE1@\;%)+"6,X"Q*5MNBU/2]4OO%6EZ#KVJ)I/Q$TE9F\(>+UM5\C
MQ!#M#S6MQ"I169DC4W%H"BR+$MQ;F)X@;1=)U74K_P 3:MXC\.:3_9?C[2_)
M3QGX,>Z7R];3:4AN;>9@B-(T<1%M>$(DZ1&VN!$\/^A/K;UZ??IWZRBM)+WX
M:F:<5&ZM:T6FI-*R=H-3>J@GI1K/WJ$O]GQ%X-,\!\:_MJ1V6I6_A#6-$\4I
MK^BWTH\*>+=0NK#39E>-%W1R3/*;>:50ZI(H;9<(V2H8D"A)_P %$;^\\91Z
MO8>"[+2OB!IL$4.LP)XHTY=,\2VH)P,M+GC+&.52[V[,4;>C,LGH>L?!7PK:
M^%+S5M*UKQ"OP3\1322ZGI=HL<7_  AMT'VS.89H6DAMXY(]LD6$DL9(R<")
M6%MYKXQ^"OQNTGQ+X?T?Q)X@TO6+AXHE\(^*=-O8K!!<*C@Q3,ULV^>1,$JQ
M"3H" 68,%/\ @=?NU_\ 29=?AEJ-JWNO^\M8VVUFG!:JSUK45K!_OJ-XLP/%
M?[:FE^(IX=0TWP5CP#/K+7OBCPW=ZIIUX;9F\R.^DM[3S=S>?#-.)K7:4G:4
M31X=Y?M7I-S^V#X/31K/PWKMQK6J^&9KF&?P;XHA\0Z1/JVBW!20Q)+<F]<,
M47Y(;N5B+A)?L]P)'8O><M8_#/XW:A\0;S[+9PZ7\0M+M8O[2M7\0V\=OXAL
M@>)(Q]DPR[BP23+- S%7R&*O0\":'XIB\4+9:IIVN2> _$Z:HWBKP[97%MJ5
M]I<L?E"\?[$UIC!-PK3VRJWGB;SH1(\FVY-/Z_'3MW6\7JM!ZWZWNNJ;O;W?
M>V<FOX=3X:L?<G[QWEU^VS8:SJ]M-+##I?Q4T&U(@U"#4]*CTKQ-9"1L13 W
MIPC'YFB#/):2.&5G1\S267[=/A>SUK4/$7A[0[R.&\F:+QCX7N-5TC;-)MP]
MS;K]L^:?;W5?+NDQR&VN-R]_9[TVVCT+3]:^(7C#5O FL2VEQX,\7VNH6D\N
MFW+J%MX9[DP/N:7?BWNRQ2X$QMILR/&;V1/V>-6U/Q6VGWGC37='^+&DV;MI
MUZ?L\>E^*[%7!8A1 7V;F DB)>2TDD##S(W1YS6_]7O^5[;/::T>I'N\MG:U
MGT?+RWUNMU!/645[^'G[\/=.1B_;&^'VE>#O[%O+/4-6^%.KB%]*;^VM,CO_
M  K.)%,2(ZWHDB@B<*\<I9)+-XP,A I@M:A^V3I>KWFFZ;K-U<V7C[0?M#^%
MO%\-YHK)J-OB,R0WL*WT<3>:%07%HKHLP@6X@,$D2&SZ#3?@F\MKJFO>&]7\
M;_;(;DQ^-?!TSV)O!(4&Z2%?(\MIBN&! V74>W# [6JI>? 'P[H_@BQ6X\;>
M+-6^#6K)$;+48;BWCF\*3I)F,R/Y >*!)%4)*NQ[.2,!MJ#="M+>7SM:_P!Z
M2>SWIO\ NFOON?7FN^B<N9K73X95)1^*/\/&4^U5'(>,?VK]/^)WBW1=2\*^
M&]2L_'T.OZ0?%'ABUU;3+JVUUHVB=)+=Q<J99%5=D5X(U61(VAG"-"!:[/[*
M/Q$L5_9PT*WG\,Z]J_P;U+21%JL]UY$D/AJXC(65T\N9IUMQ(&9T9%>T="XV
MQ@B'J[K]G74U\<V>BZU\0?%6B^/+-;H^"O%:16GV;58V3=);31+$FZ0)&K3V
MGF*LZ0+<0&-HB+.C^R-X4OOAGI'B:Q\+64=CXY\"ZO):^*O!SZG'.NLVLO[Z
MUGCF81CSFA;%O=ND2SK$8)UB,8-H];V]>GWZ;7ZRBM)KWX:F:<>5-6M:+TDT
MK)V@U-ZJ"?NT:TO?H3_V?$7@TSJ/B;KM]X1?0_#.O6?BCQ!)).LW@GQMH[6A
MN8)BK!(9WFEC0W!3*X.8[N-B&4DNI\;_ &M_'7A;]J/]E_Q]HUUKFB^'_B1J
MWAIM#UK2;'5K81^+=/N%*;(B'D4NOFN8V!>2TE9E)DBD/VCW)9/#^C?#BZN+
M.%M8^#&N"2+4=/>!DN/!4RN1*1$P#Q6\<JGS(B ]G(A8 1*1!\\_LB_!C[7X
M13P5XJ\2>*/#]_X4\1W>F>&/$>G7%JT#7J_O N6A9D>5)=RJ[;+F-F7GD,>?
MIU^[7_TF77X9:C:MH_[RLXVV^-.'2V]:BOA_C4;Q9\/_ /!&?]H/Q;^S#>_$
MO]FCQ1J7C31_'GPC4W.A6EM;6]G_ &YI*S )<R*UP4W1B15:./S05D4AWV2/
M7[4?\+NU;_HF?Q _[YT[_P"3*_$G_@K]\.(_@Q^VG^S[K3&?2?B?9_%;2?#E
M[J%D4MUU/3+V!%G,;Q1H6AF4LK1L6:,2NC%@_F2?OM7K8>HY0N_Z^71]T?GV
M;86.'Q+A!-)V:5[Z/722TE'M+JM]3S__ (7=JW_1,_B!_P!\Z=_\F4?\+NU;
M_HF?Q _[YT[_ .3*] HK8\T\3^+7[<&D_ O2K6^\6>#?'&C6UY(88&DBL7,K
M!2Q 5+HG@#DXQT]14UC^UIJWBG3IGT'X0_%*YN4&8UU.QM]*A<^[S3;L?[J-
M].]8?[>\*S>&(]ZJVWP[XA89&<$6'!KZ"H \7\'^,_$%MK#:YX@^'_CK5-?D
MB\J/R8=.2UTR,X+16ZF\+ ,0"\C$M(57.U52-.H_X7=JW_1,_B!_WSIW_P F
M5-XU_:@^&?PV\1S:/XB^(G@70-7MMOG6.I:]:VMS%N4,NZ.20,,J01D<@@]*
M[#0M=L?%&B6>I:;>6NHZ;J$"7-K=6LJS07,3J&21'4E65E((8$@@@B@#QOXP
M>.I/%MOX6;4_"WB+0;>U\0QETU'[,K72&QOMPC,,TG("\[MOWAC/./+?"FH?
M%>#P]HT.A^'_ (A-H+V5L;&>/Q7I7DQV[1(8\[]/W_*I .03E3UZGVS]JO\
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MF;Y(XXT5G=BB(I8A2 <E^R]+_8?[3G[0OA^VQ_9L/B/3=:C0-E8)[S2;7ST
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M7TU7S+^SM_RE"_:8_P"Q=\$_^B]7KZ:H **** "BBB@ HHHH **** "BBB@
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M=-^YB:>JM41@?&6^OM3^%?Q,U[P[8QZ+XNM]#N8?'/A"XN/W6H*;21([Z"3
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M='\,^)M8N(]4CE,O@CQO$J&6:0H3]FGQA#.4&'0XCNHP64*RLL9_P.OW:_\
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M %%%% !1110 4444 %%%% 'A?AS_ )2'^(?^Q-B_]*(Z]TKPOPY_RD/\0_\
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M)V-EJ6K:5JBWGV:YN/(66,P3PMACQD>:#@D< ]^#3^&WQ U_X8?#[0])\2>
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MI^/G_8F7_P#Z+H_9<_Y2-_M3_P#<I_\ IKDH ^FJ*** "BBB@#YE\5?\ID?
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MIXM3TS3O-CFDGCA4KY5F$*C>F1@8V'EMV  >N?\ #R'X1_\ 0>U3_P $-_\
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M_P!$#\2?^#/2_P#Y/H =_P (C^T-_P!#!X/_ / \?_*RC_A$?VAO^A@\'_\
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MY2A?M,?]B[X)_P#1>KU]-4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!X7X<_Y2'^(?^Q-B_\ 2B.O=*\+\.?\I#_$/_8FQ?\ I1'7NE !7S;_
M ,%CO^43O[2'_9-]>_\ 2":OI*OFW_@L=S_P2>_:1_[)OKW_ *034 ?!G_!
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MLV"?P]H'P]N+JUM_[:^"VM>9'J6FR0ND_@N57(E_=$"2*VCD4B2(A9+*1"P
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MRLL?O5% &7X*\%Z3\./"&E^'] TVST?0]%M8[*PL;2(106D$:A4C11PJJH
M'I6I110 4444 %%%% !1110 4444 %%%% !1110 4444 ?,O_!9K_E%3\?/^
MQ,O_ /T71^RY_P I&_VI_P#N4_\ TUR4?\%FO^45/Q\_[$R__P#1='[+G_*1
MO]J?_N4__37)0!]-4444 %%%% 'S+XJ_Y3(^ _\ LC/B3_T^:#7TU7S+XJ_Y
M3(^ _P#LC/B3_P!/F@U]-4 %%%% !1110 4444 ?,O[.W_*4+]IC_L7?!/\
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M\UWT3ES-:Z?#*<H_%'^'BJ>JM41H:1J^IS^)M8\2>&]';3_'.GF%?&W@EKI
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MTC5M!\1VNO\ B)=6UR"TN+&V7Q"+E5BA9@SD012W,KG"0P1;F_UBD 'F=O\
MM%_M$1^/+O4([[Q+_;DUA!;SD:#9%_LR23-%E/LV -[RX; SR,G&!EZ1\>/C
MA8^%_#=K'<:W-HNF7]O<:;%)H]KY+S))N0;U@#/EL\!LGI7U1IW_  4Q_9VM
M_C]K&N2?'+X3IHMUX?L;&&^/BFR%O+<17-X\D2OYFTNJ2Q,5!R!(I/45Q^B?
M\%!O@39_!3X?Z/-\8OAG'JVA:S97>HV;>([03V,,<[/))*F_**JD$E@  <T
M?3_AWQ/JWC3]F;^U=<M?L.K7VA2RW4/DM#L<Q-_ Q++G@X)XS7-?\$Y/^4>G
MP'_[)WX?_P#3;;UQ_C[_ (*I_LSWO@76H8?C_P#!V6::PG1$7Q=8EG8QL  /
M-Y)KM?\ @GC93:9^P#\#;:YAEM[BW^'V@1RQ2H4>-UTZW!5@>001@@]* +_[
M:@N&_9>\7"S:%;K[-'Y9ESL!\Z/KCFOAG_@UI_Y-@_:*_P"S@/$O_I)IE?=W
M[8/_ ";;XI_ZX1_^CHZ^$?\ @UJ_Y-@_:*_[+_XE_P#233* /TXHHHH \_\
MAI_R6SXE?]?.G_\ I&E>@5Y_\-/^2V?$K_KYT_\ ](TKT"@ HHHH **** "O
MAG]F3]LGPS^S#_P3/_9MT.]TOQ5XN\8^/?".GV&@>%O"U@M_K.IA;:/SYUB9
MXT2W@1P\LTLB(BX^;<54_<U?F?\ L\_"3QA\,/@;^R1^TAX)T'5/&T7@_P"%
MZ>%O&7A?3(UFU;4='N((YX[C3T>2-'N+>X0.T1W/-&2D>' #@'L'_!&?7O!O
MP!_9R\/?LVKJ'BS3?B!\-;*ZNY]&\8Z!_P (_K&H6,VH7$@O[> 3317%J))?
M+\ZVGF16VJY1V"5]H5^>'[:7[2?A/]N?Q#\'--^!L/BK5_C=X8\<VVHZ7>-X
M8U329?!=G'(T&K2ZG)<PP_9K4P;X9;>;+3N8T6&5P OZ'T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 ?,O\ P6:_Y14_'S_L3+__ -%T
M?LN?\I&_VI_^Y3_]-<E'_!9K_E%3\?/^Q,O_ /T71^RY_P I&_VI_P#N4_\
MTUR4 ?35%%% !1110!\R^*O^4R/@/_LC/B3_ -/F@U]-5\R^*O\ E,CX#_[(
MSXD_]/F@U]-4 %%%% !1110 4444 ?,O[.W_ "E"_:8_[%WP3_Z+U>OIJOF7
M]G;_ )2A?M,?]B[X)_\ 1>KU]-4 %%%% !1110 4444 %%%% !1110 44RYN
M%M+>25]VV-2[;4+M@#/ &23[ 9-<%_PTSX7_ .?;QI_X1FL?_(M 'H%%>?\
M_#3/A?\ Y]O&G_A&:Q_\BT?\-,^%_P#GV\:?^$9K'_R+0!Z!17G_ /PTSX7_
M .?;QI_X1FL?_(M<G\;_ -LO2_ /PWNM3T>T\0MJ"7-I!&=0\):K';H)KJ*%
MW8O#&&*I(S!-ZEV 4'+"@"OX<_Y2'^(?^Q-B_P#2B.O=*_'']H7]I_\ ;#\;
M?\%1(?#7P7;X=Z!JVH?!F'QW=?VWH<LAET_^U'MB$B$TLGF;DB(0#>?F^4Y%
M=%X)\:?\%2OB#J,MKI_B;X*QRPQ^:QO_  7?Z?'MR!P]PB*QY'R@DXR<8!H
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M_CU<_P#%?]I/XL?$SX::[X?F\(W2Q:U92V;F/P3JT; .I4X8R,%//4J<>AH
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M%Y<-]XE[IR3DX'NU !1110 4444 %%%% !1110 4444 %%%% !1110!\R_\
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M>@8*QFN 8]XSU$:%Y6_V(G/:NLT72+?P]HUII]JGEVMC"EO"G]U$4*H_  4
M?!/_  Z)TC_HW7]C_P#\(C3/_E91_P .B=(_Z-U_8_\ _"(TS_Y65^@%% 'Y
M_P#_  Z)TC_HW7]C_P#\(C3/_E91_P .B=(_Z-U_8_\ _"(TS_Y65^@%% 'Y
M_P#_  Z)TC_HW7]C_P#\(C3/_E95G1_^"4-GX=U>UU#3_@!^R18W]C,EQ;7-
MOX,TV*:WE0AD='73 596 (((((!K[WHH \7_ &<O@[XV\*_%3Q7XL\;3:))J
M'B*VMH,:=<M,I,0*YP88]HVA1_%DY/%>T444 %>3_MO^$_\ A/?V:=<T/[0;
M/^VKO3;'SQ'YGD^;J%LF[;D9QNSC(SZUO2_%Z^\4SM%X+T%_$$2EE.J75S]A
MTK<!T2;:\DP_VH8GCR""X((KR/QS\5_%WB+6/&7A+Q/!X=C7P]?>&+NW?2UF
MY^T:K"2K-(WS8"+R$7G/X &UX/\ !'C[XH:1XL\/:WX^L[JWT35?[*9TT!8&
MN46"VN WR3 J09<8!Z+UY(K<^'7[.7B3X3Z%_9GA_P :V>GV&[>(?[#\U5.
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MP!_P3B\+?%NXNO$OAW]GG]E[^TK#3HI;CP]<>"]+C;4K*59)K*YABDL%A47
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M]H>VDO?@!XZAACDFFF\/WZ(B*69V-M(  !R23VKI= 4IH5DK AA!&"#V^44
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MK_B*^_8W_P"AN\3?^"*3_P"*H_XBOOV-_P#H;O$W_@BD_P#BJ /TEHK\VO\
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M-4U#2].B^V6MG?13S6F20/,16+)G!^\!7K= 'S__ ,)I\1/^?GX@?^$A8_\
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M_#W3-=/#NA?#N&TNYO[<^"FN;&L+]9I(Y_!DJ2 Q@R K+#;Q3(ICE!66QEC
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M0OVF/^Q=\$_^B]7KZ:KYE_9V_P"4H7[3'_8N^"?_ $7J]?35 !1110 4444
M%%%% !1110 4444 %%%% !1110 5F^+_  =I?C[P_-I6L64.H:=<,C202C*L
M4=9$/U5U5@>Q K2HH _%_P#;D^&'AWX:_P#!Q?X-TW1='M;#39O@A:W4MM%D
M1RR?\)!>\GG_ *9I_P!\BONS]F[XQ^)?V@0R'PS\,-&FDBCGLS-I,K1WH,$,
MTB(P?[\0GBW @9#J5SAMOQC_ ,%'O^5DCP5_V0BU_P#4@OZ^U_V"_ R^._V7
M)88K@Z?JECJ=I>Z9?*FYK&Z72;$+(!D;E(9D=<C?&[H3AC0!ZE_PK+QG_P!
MWX3?^">?_P"+H_X5EXS_ .@;\)O_  3S_P#Q==Q\-?'+>.-!D:ZMQI^L:;*;
M+5;'?O\ L5TJJS*#@;D965T; WQR(V!NP-N_OX-*L9KJZFAMK6VC:6::5PD<
M2*,LS,>   22> !0!X/\6%\5?"OPE)J$NC_"N\NIF,%C9Q:/-YEY-L9]B_/T
M"([LW\*1NQX4USO@:^75OB%H5\MG9V#:CXLTF\D@M(]D,;R>&978*/3+'KS7
MI1LYO&_A7Q%XYU2&:!+C1KF'0K.9"CV%DT98RNIY6:?"LP(!1%B0A6$F[PS]
MG#QQJ'Q,\;^#Y-+\)^*FT.;4=.U,:W+8F/3_ "[?0WLY!YAXSYQ*C'7!H ^F
M?VA+V;3O@'XXN+>62WN+?P_?R12QL5>-A;R$,I'((/((Z5TN@.TFA63,2S-
MA)/4G:*Y;]I#_DW?Q[_V+FH?^DTE=1X>_P"0!8_]>\?_ *"* */CGQO;^ ].
MLKFYAFF6^U&TTU!$!E7N)TA1CDCY0S@GO@'K1X \;V_Q#\-_VG:PS0P_:KJT
MVR@;MT%Q) QX)&"T9(]B.G2N9_:._P"15\/_ /8UZ)_Z<8*YWX7^,=8^%GAB
MXT2\\"^,KV:WU74IQ/916LD$R37T\R,I:=3RDB]0.<T ;G[6GCWQM\,/V?\
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MI,=W&RR1EF96EJ30Z%I/@6RT_4+UM<^$.N&*70]<BN&%QX4FW P*TX.](DD
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MNC]ES_E(W^U/_P!RG_Z:Y*/^"S7_ "BI^/G_ &)E_P#^BZ/V7/\ E(W^U/\
M]RG_ .FN2@#Z:HHHH **** /F7Q5_P ID? ?_9&?$G_I\T&OIJOF7Q5_RF1\
M!_\ 9&?$G_I\T&OIJ@ HHHH **** "BBB@#YE_9V_P"4H7[3'_8N^"?_ $7J
M]?35?,O[.W_*4+]IC_L7?!/_ *+U>OIJ@ HHHH **** "BBB@ HHHH ****
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M3_L%W/\ Z*:O,?\ @G,P;]BKP#CG_0Y1_P"3$M>I?$I=_P .?$ /0Z;< _\
M?IJ\)_X):V<>G?LVWUM"OEP6_B._CC3).Q04P* /7/VD/^3=_'O_ &+FH?\
MI-)74>'O^0!8_P#7O'_Z"*Y?]I#_ )-W\>_]BYJ'_I-)74>'O^0!8_\ 7O'_
M .@B@"'Q7X0TOQUH<VF:Q8VNI:?.5,D$Z!T8J0RG'J" 0?45R/\ PRM\.O\
MH3]%_P"_/_UZ] HH \/_ &R/V?\ 3?%G[$WC;P-HO@>[\3VNHV6VW\.:3'I'
MG7\OG)(JK_:Z26"_.H8M.CA0I959P@/PS_P1M_X)/Z]\!?C-XDUWXH?#_P")
MWA^UU;2I(K#0=5U;PW<^%]&S+ WE@:7<![N\^1MES]BM8UC,J>6&92WZK44
M?//[4NN?#O\ 9=^'>DV?EV?AUM8\2:1?K%;VTC?:([+4[.>=_E!^Y$"V#R>@
MR>*\LU#]IG]G/Q)^T!KFN:I)9W>GZAI%HHFDTBZ8R78GNFE)7R\YV-#SC!_
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M28[N-EDC+,RM+4FAT+2? MEI^H7K:Y\(M<,4NAZY%<M]H\*3;@8%:<'>D22
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M*+F;P]?K'%]MB\QR;:0 !=V3D\#%=%H'Q;\*IH5DK>)O#ZLL$8(.HP\?*/\
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M$:N9KQM;OI-3\/[DDGP=GG)'SY<DG+8YVR[0,C<"/1O^#77_ )05_ WZZ_\
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MF7Q5_P ID? ?_9&?$G_I\T&OIJOF7Q5_RF1\!_\ 9&?$G_I\T&OIJ@ HHHH
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M2>J6]M)/JYK2?Q[R9N_\$2[#6/A[^WSXO\.^"?#>FKH/AGPKJB^'['6].O\
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M[VDVO@FM*\?<E[USVCQ#/XKU3Q=96]M;Z'IOQCT*-=MS+/)9Z3XOT=9!YLB
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MK?O_ %?J?"YAI%*WVI?94?Y>W_I'V'?N>Q_\+R_:U_Z-U^#G_AZ;O_YGZ/\
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MH7[3'_8N^"?_ $7J]?35?,O[.W_*4+]IC_L7?!/_ *+U>OIJ@ HHHH ****
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M\2M\:_A6]JMU=:1J$EKXFLKEHK::VDF5F6.1GV^?:P+TP#(*ZC_AZW^S./\
MFO7PGZ9_Y&:TZ?\ ?= 'T!17S^?^"K?[,X_YKU\)^!G_ )&:T_\ BZ#_ ,%6
M_P!F=0<_'KX3_+R?^*FM./\ Q^@#Z HKY_/_  5;_9G7_FO7PGXZ_P#%36G'
M_C]'_#UO]F<$_P#%^OA/\O7_ (J:TX_\?H ^@**^?S_P5:_9G&?^+]?"?CK_
M ,5-:<?^/T'_ (*M_LSK_P UZ^$_'7_BIK3C_P ?H ^@**^=9O\ @KE^S'!J
M'V4_';X9O-Y?F?N]<AD7;G'WE)&?;.>GK3O^'MG[,O\ T7+X;_\ @YB_QH ^
MB**^>?#_ /P5K_9>\37$D5K^T)\'5DA&6%QXLLK;O@X\R1<X/'%:W_#S?]FW
M_HX3X'_^%WI?_P ?H ]PHKP76?\ @J=^S-H&ES7EQ^T)\%?)MUW/Y7C33IGQ
M[(DQ9C[ $UB_\/C?V5O^C@/A7_X/X/\ XJ@#Z4HKYK_X?&_LK?\ 1P'PK_\
M!_!_\51_P^-_96_Z. ^%?_@_@_\ BJ /I2BOFO\ X?&_LK?]' ?"O_P?P?\
MQ5'_  ^-_96_Z. ^%?\ X/X/_BJ /I2BOFO_ (?&_LK?]' ?"O\ \'\'_P 5
M1_P^-_96_P"C@/A7_P"#^#_XJ@#Z4HKYK_X?&_LK?]' ?"O_ ,'\'_Q5'_#X
MW]E;_HX#X5_^#^#_ .*H ^;?^"N<&@W7_!9+_@GQ'XFO'TW1Y)/B&KWB3- ]
MG*=%M/(F61>8V2;RV#]%*AB0 37UQJ&GZMJOBK3M%UK4(=%^)FBQROX8\3I;
MC[+XCM\!I8)HE*AMP13<6H*_<6>$HR*T/YB?\%.?^"A?@GX]?\%C/V,)OA7X
MZ\%^,M+\-VGBZ"\O-(V:VUDVHZ<+:<2VX;;)B"/='&<;VW@Y'%?5.K:Q?6_A
M?0_#\GQXM]0^'\J++9:NGA!FET.='#088N)8T'2.9)"T9 0A5P:X,53O*_DN
M_?K;[U+>+UV;/K,AQ2A1Y-?B;7PM*\=>52:NVE:5-WC6B^7244SVCQO;7EYJ
MUY\0_"]J?#OQ \$2+>>,?"DDN^/5H1$4:6)P ':6"(B&Y"A)U@CCF1)K:,V>
MI:W7A71/A8MU:M!XA^ ?B",LP3?&W@=D?D@?+)#912H<K\DNFRQG[D"$67BE
MYXF\3>)_B,J:Y\=+/3]<T=)8]"U1/!"^7K-K+&/.A<J5/)4&2W=&4%(I4+,@
M:/K?A#\<-%^%_@C2=0T;4))/%VBZ?::?XR\,M Z+XB,$*P+>VSE1&MT4B!AF
M8HMQ$JP7'E-&CVG/*%EWU?1^5]-M?M17Q?%'4]FCBE*=[\JM#3GBDFK\B52[
MDN7:E6E=T7:A6O!MGJ6LZ+>+J^D>&?$VKS6^O6\C/X(\;I&OF73[<FUN ,(9
MRB_O(N([J-3(FQT9876MUJ^L^+KS4],L[30_BIH<$::WHCS%;#Q39@D1R)(1
MRA^;R;C&^%RT<@QO0\"/CC\,?#/AQM*CU*/6_@WK@*FT^R7,,O@J1&+?N_D6
M2.S21/E5=LMA*B[,0 "SL7GQN\-:A=6F@^(/%TT>M:.YF\(>-HK"3SIR1S!<
MQA%#2[5 ECP(KA '78X*PQRROM_737_TF75>[+4Z/;T;:R5K/=65K^]>"U2O
M_&H+6$OWU!N#.HL[S2=/\)ZMJFEZ3)K7PSUIY[;Q9X3N;/S;GP[.^?M++;?-
ME#O)GM0"&#>=#N+,L\NIZ9:Q:7H?A_Q!KE]J'A?4+F"Z\!^/+6[6:^T>[=2M
MM#+<L'5Y664QP7,@>.\CE:VN1(\O^G<FG[2>BZCJTGB+3[VST/XD:7$L&L:2
M8Y_[/\4VR$A"K^7D _,89F4/$Q*.I4LIW/"_BOP[J?@35->\.V+>(_A7KCSV
MWBKPO/9^;/X?GD&;ETML'<A\S=/;*&#!S-#N+,LT\KMMIZ:6].W=;Q>JT-%7
MBYI*7O-_S)R<K:6>SG;X)_#7A[L[3-DC6O$'C589FTOP_P#&3P_9%HI562+1
M_&^F)(,D#+OY'F2@,A,D^GSS#F:&='OH=,U-3'K7B3PWHMU/:3SO;^.O MQ$
MKW5O<,H,LT40)0SE&#,BDQW<;+)&69E:5FJ:7:Q:7H?A_P 0:Y?:AX8U"Y@N
MO ?CRUNUFOM'NW4I;12W+!U:5EE,<%S('CO(Y6MKD2/+_IU#QMX]F\-^(8[C
M7KK3_"?Q8T&W$4-VEK<?V)XVT\,2!\HD=82S'*,7GL)Y#@SPRJ]ZU=O2]_Q_
MRO;Y27F*4J<87DTHVMK=1M?;NH<W3XZ$]5[I8FAT+2O MEI^H7K:Y\(]<,4N
MAZY%<M]H\*3;@8%:<'>D228\F?(>!P$<@;6%_4M-U;4/%>FZ)K>I1:/\2-'2
M5O"OBI;8?9O$4& TMO/$I56+*BFXM05#!%N(#&T8-MG>"?&VG^+_  ]?^-_!
M&GR:IHNJ,R^,_!CQI)/'*Z R3PQ E3.48,R*3'=QLKH69E:5TT.A:5X%LM/U
M"];7/A'KABET/7(KEOM'A2;<# K3@[TB23'DSY#P. CD#:P6EOZM;\TD]GO!
M^1M[W-UO=]$Y<S6NGPRG*/QP_AXJGJK5$:&D:OJ5SXDU?Q-X9TAM/\<:>84\
M;>"6N4"ZVH39%=6TK[(S<&.+%O=G9'<QQ?9KGRFA1[#-5O#>@_#:2XMXQKGP
M.UP.+FV,<L,W@B6.4AR$(6:WMH9HR'C(2;3IHCPD2,+72U'3M6U#Q7INB:WJ
M46C_ !(T=)6\*^*EMA]F\108#2V\\2E58LJ*;BU!4,$6X@,;1@VYI&KZE<>)
M-7\3>&=(;3_'&GF%/&W@EKE NMJ$V175M*^R,W!CBQ;W9V1W,<7V:X\IH4>P
M/)^?3[]._645I)>_#4S322::M:+34FE9.T&IO513TH5W[U"7^SXB\&FN+^!-
MO<ZO\#/A9H/B>Y71M8?0K"Z\$>*[*+:J2-9HWV*16)'G+&"K1,=EU$A9<,KK
M%VEM<:QK/C"ZU#3[6QT+XL:';(NK:2TI33O%MBI(1U?!)C)+>5-@R6\C,CAE
M9EDX'X"?V9X>_9#\'W&H74?B_P"$NN:#:+J[B[-S+X2O(T03RB56+BVCN8W+
MX826,T98%8E/V7OM1TJ9]6T7PSXJU:X35(9C+X)\;0!!-=/MR;>8@;/M!C!#
MQD>7=1@NH#*Z15+XON_X&O\ Z3+K\,M3&C;V,;6M9K9VTLYKDWLGK6H[P?[^
MC>+*=I=Z7;^%-6UC2-(FUOX<:X\\'B_PA<V7FW6@W#Y^U2):X8G)<M<6B@B0
M,9X=SLRW,E_86:Z1H?A_Q!KEWJGA35)X+GP)X[MKQ9KW2KIUVVL4MTV\-*RR
M;(+E]Z7:2FVN!)))_ILUC<ZUJGBVYU"QM;'1OBOHEM&NM:/YACT[Q=9J2$EC
M<Y.TG/E3'+P.3')E20U6VN]*LO"NKZQI.DRZW\-]:DN(/%_A&YLO-N=!G?/V
MJ1+7#9R7+7%H 1(&,\.YV9;F>G]?/3MW6\7JM#IUYM+WNNJ;NU[OO;.37\.I
M\->'NRM([+P1XGCT_P 2ZDWC73]-T?Q=H6G8N-;CC^SV.LZ:C,PN8I6)VQJQ
M8R6\CLUL[MR\<D4\_AOP"_X+7_!C]H[XM>-?"N@KXKMU\#^'!XJN-6U&QBM;
M.^LB5V&&-IOM2O(CK)&LT$1EC(>/>I!/K^F> U\;_"WQ%X,U[4%\7_"WQ5H,
MT6GZ]_:0DN&TVYA*/:W$V[,V(I,PWBLS21_ZX^;'Y]U^'_A+]BC2?VY->\5?
M!W0?VB+63P/X$MI?BBFKW/A34WTS61%;+8_VQ!9RI#NF=#M>Y@NYH6WRR6D4
M3%7C]3#7Y-?Z_P _7J? 9W;ZTU&UK+9NWR3UC_@?PNZVL?L;^P+_ ,%3_A1_
MP4<TN>3P#=:W:W\%C'JG]G:Q9"WN)[*1VC6YB='DAFC$BM&_ER,T4BE) C_+
M7\_/[45OX8TOQE\;/#,EYJ]GH.J^.?%,EW/J6C6EGY4D]WJ%LA-K)XOMK7_1
M6NKEK61[%"#,6P5DVG]4/^#?CP=X/\>^/?'7Q4C^+0^(OCS5M.1;BVDT34M)
MNUMKR82OJ4XU#;+=?:C9V\:2PQI JV14;I&E8_)/_!5J_P#&GB+QSXJ\'_%;
M6-:\5^/-/\37=_;-H/BD>(;70-'DN+AM.CC\/6VE7$>G2_96M&^UW"-=%XRR
MS*' '0>2>D?\$CK_ ,-W7_!0/X<^.O'$?Q-\9>*OB]-K4WP\UK5M>\/75GI]
MK!:ZB^Y[>SU6]O"EO:"ZL89-L5K&)W584DG9V_4#Q%)H_AOPWJEQ<31^*O@[
MKEQ.FIJ96FD\(7*3LL[[@=ZVL=PC[UR)+"6-B-L*D6OYK_\ !!;P]\2K+]H?
M3#X3U7P1-X)MA<-\0EU*XT^;QE>(UG(+-KDM90ZJ7:Y%LP>Z;RVC1PN>*_3,
M:G<'QWXA\1>#-.NK?Q9I<R)XN\'7,D<#>(8 ICM[V!BPB6Y:&+%O<EA%<)$;
M6X:-X$>PXL9T^?GZZ=5;>.[5VM4CZ?AMM2J/HN5[J*3OHW+>G*[2A6^&$VHU
M/<J2:K:SHUPFH:/X:\2ZQ<1ZE'*9/!'C>,*9I)"O_'M<=$:<H,,AQ'=1@D .
M&5/(/C;J&N:M\=8;V33H])\=Z*GA];W3(YQ%8>)PNN1")TE96/DL[1%9=IDA
M(:-LC<&]/CD\-^'/AO)<6\:ZY\#=<#K=6K120S>")$D*R?NV"RP6L,R,)(F"
M2Z=+$W"1(RVGE?[0&B7MA\:_#^AZWK"WFK+)H2^#_$Y@\V;+:PNWSP,(\ZQF
M0D?<F6+?A6RJ\E/?3RZ_=KU_NRZ_#+4^AQL5[.TE_,M8M;?&N5:P:>M:EO!_
MO:-XL]:L;[2[+PQK&K:3H\VM?#K6I+BU\9>#;JQ$]SH,\@/VMUM/FW!O,+7%
MHH99ED\^#>SLMT[4M-L[?1M#T'7M<O-4\&ZI<6]QX$\=V]Z)[[1;N0;;6":Z
M;>'D<2^7;W<F]+M)3:W(DED5M0M6]QK&M>,+G4-/MK'0OBQH5LBZMI+2E-.\
M6V*DA'5\$F,DMY4V#);R,R.&5F62G8WVEV7AC6-6TG1YM:^'6M27%KXR\&W5
MB)[G09Y ?M;K:?-N#>86N+10RS+)Y\&]G9;K+2W]?/3MW6\7JM#M][FNKWNN
MJ;NU[OO;.37\.I\-:/N3]XN.FM:]XSCM[B33?#_Q@\/V;-:W2H\>D^---1QN
M^7+/Y.^1=\>7FL9I0098I4>[CTG5F,FL>)O#.CW3,TS0>./ \Z*UPDY4;YX4
MR4-P4(;Y28[N,JRDL59H=2TVSM]&T/0=>UR\U3P;JEQ;W'@3QW;WHGOM%NY!
MMM8)KIMX>1Q+Y=O=R;TNTE-K<B2616U"TZ:UKWC..WN)--\/_&#P_9LUK=*C
MQZ3XTTU'&[Y<L_D[Y%WQY>:QFE!!EBE1[MZW\_QO^5[;/::T>IG[O+TY;/H^
M7EOK=?$J:>Z^/#S]Z/NF;/#X?T3X?6UG>7)UOX,ZWY<FEZI'.Z3^#IE<&(&4
M$2101R*/+FR)+210K$( T6EJFEZIJ'BG2M U_55TGXB:2LS>#_&"VJ^1KT6T
M/-;7$*E%=F2)3<V8*+*L2W-N8GA!LX])U9C+K'B;PSH]TS-,T'CCP/.BM<).
M5&^>%,E#<%"&^4F.[C*LI+%6:C-#X?T3X?6UG>7/]M_!G6O+DTO5(YW2?P;,
MK@Q R@B2*".11Y<V1):2(%8B,!H5I;R^=K?FDGL]Z;_NFOO.77FN^B<N9K73
MX95)1^*+_=XNGJK54:.DZMJEWXGU;Q%X=TG^R_'^E^2OC3P6UTOE:Y'M*0W=
MM,X1&D:.)A;7A").D)MKD0R0_P"@Y\,WAW0?AW-=6L(USX)ZX)([^P>%XYO!
MDJN5E_=$"6&WBE5A)"0LEC(C$!8U9;?1U32]4U#Q1I7A_7]572/B)I"S/X/\
M8+:KY.O1;0TUM<0J45V9(E-S9@HLJQ+<VYB>%6LTTG5M4O/%&K>(O#ND_P!E
M_$#2_)7QIX+:Z7RM<CVE(;NVF<(C2-'$PMKPA$G2$VUR(9(/]!>M]?/IK?KI
MM?K**TDO?AJ9IKENK6M%Z2:5D[0:F]5!/W:-:7OT)_[/B+P:8S6-'FCNM'\-
M>)=8N1<"82^!_'$15IQ,5.VWG;[C3E,J0W[NZCR"-^14D,VLZYXRGO+.'3]!
M^+F@VJKJ.G-(T>E^,-/5CM(;!;RMS-Y<N&EM)7*L'C=TGSH9O#N@?#N:ZM(1
MKGP3UP2)?Z?)"\<W@R57*R_NF DAMXY5820D+)8R(Q 6-66WNZQI$L=UH_AO
MQ+K%R)Q,)? _CB(JTXF*_+;SM]QIBGRX;]W=QY!&_(H_X'7[M?\ TF77X9:C
M:Z/^\M8VV^-.'2V]:BM8O]]1O%GQ/X?U#3V_;RU35+[PO?77A[5-9U-=7\/R
M6"7-Q!$^S[4DEJF_SF&]O,B3?YBAC&)2RK)Z9_P:Z_\ *"OX&_77_P#U(=3K
MA=%O/%&G?\%(&1K'1;;QQ9ZQ=22V\I>"TU;<$D1%=@7CCE4LT;X<IO5BL@!5
M^Z_X-=?^4%?P.^NO_P#J0ZG7K4K]>RZ>O]6Z'Y_F%K>[;XI?:O\ R].W:7VE
MOJF??U%%%;'F!1110 5\_P#_  2G_P"4:_P,_P"Q*TS_ -)TKZ KY_\ ^"4_
M_*-?X&?]B5IG_I.E 'T!6/X^^'^@_%7P;J'AWQ1HND^(O#^KPFWOM-U.TCN[
M2\C/5)(I 5=>!P01Q6Q10!\\WW_!./0;6YT]?#GQ,^.W@[2K"X:X&E:9X^OI
MK.0&-H_)Q=M.\<(W!ECB=%0HNT*!@]_\$_V3_ _P!U:\U;0]/U"\\2:E +:]
M\0:YJMWK>M7D(;>(7O;R26?R0V66$.(E/W47I7H]% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 ?,O_!9K_E%3\?/^Q,O_ /T71^RY_P I&_VI
M_P#N4_\ TUR4?\%FO^45/Q\_[$R__P#1='[+G_*1O]J?_N4__37)0!]-4444
M %%%% 'S+XJ_Y3(^ _\ LC/B3_T^:#7TU7S+XJ_Y3(^ _P#LC/B3_P!/F@U]
M-4 %%%% !1110 4444 ?,O[.W_*4+]IC_L7?!/\ Z+U>OIJOF7]G;_E*%^TQ
M_P!B[X)_]%ZO7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% '\S?[-7[$OP?^*7[+.I^-M2\&^'?$'C"'X@^)K/6H+E<W
M$ME'J5HML4&Y1&P\VX56^XX$B$Y0-'^@GP._X(A?L=Q?!OPSXZ\1?!_PSXD\
M"^*M-AGU#5EO[V&7PI=;!',TWESK_H9D5O,<@26<N\R$P%C9_(_[(L]MJ'[!
MEU:^3/INM6GQ%\8RV-\RX@U&-M3T_=!D']YL*EFC/*Y1QSR/UL_9'U":V^!^
M@>(/"%A,=;L=(LH_&/@Z5EC?55\A5CO+?<0GVAHD_=39$=RB>3*4>-6MO)J3
MDINSZ^OKIUT^*/5>]'4_0<%A:,L-#GBOAC>]HNS>EYI62YOX5;_EW.]"NG3:
M9X+I?_! ;]E7P5*O@75O@_X1L=?O)/-\*^+;B"6[AUQHE9_L]S \OE_:EC#^
M= GEK<1!YK<Q-&Z6>BO_  14_9A\47;R:?\ LZ?#?3?'GA-%&M^$IXBUGK-L
MY.V6VE8CY7VN8+@!065XIE1E=8?I/_BF?#?PR6.1EUKX$ZTH\N3=)!-X"ECD
MX!/RS6]I#-&,-\DVES1#[D" V.GK.C:BWB/2/#/B;5Y+'QA8M*W@GQLMNG_$
MV^3?):7,:[$,YCCS/;#9'<QQ?:(/*>)EL\^>71OIU^[7S^S+:7PSU.R6%HWO
M*$?M/6%MM)W@M4E_R_HKWJ+_ '^';IMH^2M;_P""*/['NIZ7)XJL?@/X7U+P
M+>2;-:L8;6XM]6\+7$?RR2*J.)=B'(FMCDIC?&#@JU,?\$ _V.]&4:!K'PE\
M.MH_BSY?"OC.QO)RT<DWS0V\Q\QH#*"1Y$C(8K@;4=3)CS_L+3]0U;5?%>H:
MQHVGPZ+\3-&CB7Q-X9>XQ:^([;E8IX96"AMP5A!=$#[K03!"C+#1@GT73O!>
MH:EINGOKGPIUQIH?$7AR:U+7'AF<D_:'2WQN5 Y)GM@-R',D8^\KGM);W[]_
MGYV[K>#\A+!T;\O)K[J^RW>UX*_PN5M:<_X>(AH[5$?)9_X($?LLZ_(- _X4
M7X#T/XF>' =02SDN]0CT3QG9+B-WC8S22Q0N70.4WSV,YAWBY@9!>B_\$+_V
M/]35O%VA_L\Z7?Z;IK?V;XK\'SR7AU?0KA ':2)([AB\Z)(C-"K21W,#136S
M/N3[5]=ZGIL)L]%\.>(]:O+O1[RXBN? GCNUN%DO+"Z92L$4DY#*TY1RD<KA
MHKR.1H9E=G*W,W_$\UOQQN7^RO#_ ,9M L<$'S(=%\=Z7')_P-Q"))>#^\GT
MV>?_ );P7!%^>TG?=_K?\KV^4EYD_5</R_!&UGT]WE;U_O*%]_MT)[^Z?'Q_
MX(._L7^'XENKSX0^%]4^'OC *^C>)[34+HOHCS8\N*5Q,4:%F8>5.P(#$1RY
M)5G#_P &_/[*<[_\(;J7P9\'Z+XYMQ]JT75]]ZVG>)XHN6#Q>?\ *VWB>%"K
MJ#YD3!<%?KO2]4@2PUKQ'X;T6]O-!O+F:V\=^!+FV62^TR[90UQ+';J65IF6
M022P1EX[R.1;B!I&D!NX+NUT;3?!NFZ;J6I2:W\+-::&X\->);>[+7'AF=B/
MLZM<9+",,0(+DDE21%+G*LY[25M_Q=K>N]K[/>#T>AI]5I<WP:W_ )8N7,E_
M+\+G;XH?!7A[T;3/DL?\$(_V3?$+MJVC_LZ^'5U[POBW\4>")M1NC+,C\K-:
M3-,H+X5F@D)6&==\<@BD!>W;+_P0V_8I\-P2>+V^"_AG7/A3X@!:XOOM6H0W
M/@R5?W<K3#SED%F'1A,9 )K&82&3_1]YL?L2^L=6U;Q98Z3JU];Z+\3]%AD;
MP[XB2#%GXFM1AI(98P0&!"KY]MD%2%FB*[5:--$UK4!X@U;Q-X8TF2R\563Q
MKXV\$M.F=1.W:EW;.VU#.4C_ '-Q\L=S''Y,WEO&K6K]I.^[_P"#UT[V^*/5
M>]"S,_JN'Y?@C:RZV5F_=M-JZCS?PJ[UIR_<8A.#N?'4O_!O1^R;I=W_ ,(3
MX@^$V@Z?K.H CPMXKCEN?)UEHP9/)N(1,L8O%16\V)=B3Q*\L'E%98[7)\;?
M\$&/V5;_ ,%ZRVF_ ?PIH'Q!\%V,MWJ6@3:G?R6>L0;&VSV\K3;C&Q4M%*,!
M7!CF3(8+]CLOAGPQ\,-RA=:^ ^LKRH\R";P!)')U'W9K>S@FCZ?)-I4T7\%N
MG^@5_C-I=S_PB-UX:\7:E-'X@L["\E\&>,XD2-]3Q;NSVLX4!!<F-#YL&!'<
MQH98@C(Z6R]I+:_;K]VOG]F6TOAEJ7+"T4^9P6\F[PMJE:=X+56_Y?T5[U)_
MOJ#=-V/Q/_X-]O\ @FU\#?VI_A'\*=4^(/PWT3Q1?>(?%OB[3=0DO&F_TBWL
M[*SEMHRJN /+>:0@@ G=@D@ #]<?^(>_]C'_ *-]\$_]]7/_ ,=K\_\ _@UX
MS_PH3X'[OO?\)YX[SC_L&Z?7[@:UK=GX;TBYU#4;NVL+&SC::XN;B4110(HR
M69F("@#DD\5[1^9'P3\:O^" O['D2^&-)T_X#^#[6ZU[7;>V=H9KJ.0V\8>X
MN ")@0#%"ZDC!&_@@XK<_P"(;#]B+_H@NB_^#O5?_DJOJWP;IMUXX\;-XNU"
MWDM+.WMVL] M)X]DR0R;&ENI5(S&\Q1 L;?,D<8W;7EDC3MZ /AO_B&P_8B_
MZ(+HO_@[U7_Y*H_XAL/V(O\ H@NB_P#@[U7_ .2J^Y** /AO_B&P_8B_Z(+H
MO_@[U7_Y*H_XAL/V(O\ H@NB_P#@[U7_ .2J^Y** /AO_B&P_8B_Z(+HO_@[
MU7_Y*H_XAL/V(O\ H@NB_P#@[U7_ .2J^Y** /AO_B&P_8B_Z(+HO_@[U7_Y
M*H_XAL/V(O\ H@NB_P#@[U7_ .2J^Y** /PE_;@_X)P?"?\ 85_X+=_L::'\
M#? NF^#6\5'5Y[J"+6;^%;Z=(BD0:Y\R2: 88KYD663<6"L1@_IE!\&/#]]H
M]YK7AVU^(,VD6\L]IXU\#R>*M574+2YD_>3S!([H^=<%9 [(6DCNH722%FW(
M9_CS_@LIIK:S_P %[/V#[./4KS1YKK^V(8;ZT,?VBSD90$DC\Q7C+JQ! D1T
M) #*P)4_?A&N:WXW$<C:5H'QDT"Q)CD DAT;QUI:2<\?.XA$DHRN9)].GG',
M\$X-]PXMM25K_P!=O/R>CVW/K.'84Y4I\RCH[ZWVM:\E_+_?C[]-VE\-SAKG
MX*>#=&L]/N[[6O%FM?"_6'@N= UJ'Q?JA3PI.,"W#+]H\M85;;Y4Y7,3_+)D
M$,)3^SG;G6T\.:MX@\7:3\1K>V=/#OBE_%&K2P^(+572:2!E-T"C-Y2?:+>-
MD+*OFQ,H'[GK]*U5%@UGQ+X:T:\N--N+B2W\=>!;B!7O+*Y909I8H064SE'#
MO&A:.[C=9HF=G5IZMS;:'I'@>QL+^^;6_A'K9BFT'7H;EOM'A2;<# #.#O6%
M7QY,^=T+ 1N=NUAQ\SM>_P"+M]^]NSW@]'H?2+#PO91UO;X8N5TMN7X7.WQ0
M_AXF'O1M41S.F_!RTNI[[5?#=OXXT_Q3HMQYOC/P6/'.J)-JYDCCC2Z@NC<H
M99?+ME%M.[+#,D;P2B&12]I5/P8\ ^'/"=GJ\=UXJUKX(W4<"?9_^$GU>!/
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MWIDNO"MWYFZ-FN02WDB3!BN=VZ!\*QV89./&?"K[?A\^J_Q+6+L]KGTW#/\
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M!OEUJ>UTSQ&\T<UT[PB)+0R9&R1E547YAME#8ZL17>?\&NO_ "@K^!WUU_\
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M,CX#_P"R,^)/_3YH-?35?,OBK_E,CX#_ .R,^)/_ $^:#7TU0 4444 %%%%
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MY55X/5(ND:YK?C=8Y&TO0/C)H-B3'(!)#HWCK2TDYX^=Q"))1E<R3Z=/./\
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M^5MI!&:^XK*Z^VV<,WER1^<@?9(NUTR,X8=B.XKY;_X)<> I?V'?^">'P_\
M 'Q,\;>#Y_$GA2&[CU._AUQ9K5C-?W$T>)I=C'Y)HUY YX&>,_5% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'S+_P %FO\ E%3\?/\
ML3+_ /\ 1='[+G_*1O\ :G_[E/\ ]-<E'_!9K_E%3\?/^Q,O_P#T71^RY_RD
M;_:G_P"Y3_\ 37)0!]-4444 %%%% 'S+XJ_Y3(^ _P#LC/B3_P!/F@U]-5\R
M^*O^4R/@/_LC/B3_ -/F@U]-4 %%%% !1110 4444 ?,O[.W_*4+]IC_ +%W
MP3_Z+U>OIJOF7]G;_E*%^TQ_V+O@G_T7J]?35 !1110 4444 %%%% !1110
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MNN:WXW6.1M+T#XQZ#9$PS /#H_CG3$?GCYW$(>4;ES)/I\\P(,T,ZM>UK?\
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MR4?\%FO^45/Q\_[$R_\ _1='[+G_ "D;_:G_ .Y3_P#37)0!]-4444 %%%%
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M4H=!$-UH5QIE\+B]L$=Y )I9S!(\S& S6\<['<\>_>9G\YI?W4KY_P#V)?\
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M0OVF/^Q=\$_^B]7KZ:KYE_9V_P"4H7[3'_8N^"?_ $7J]?35 !1110 4444
M%%%% !1110 4444 %%,N8VFMY$21H792%D4 E"1U .1Q[C%<%_PJ;Q9_T5+Q
M1_X+-+_^1: /0**\_P#^%3>+/^BI>*/_  6:7_\ (M'_  J;Q9_T5+Q1_P""
MS2__ )%H ] HKS__ (5-XL_Z*EXH_P#!9I?_ ,BT?\*F\6?]%2\4?^"S2_\
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MY7_"2\S&<H1IN;MRI=+VY4_+WN1/;[=">GPG077QD^&NG:58^&=5^(/AS6_
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M  E/Q"^-7C*'7-+T/4;>R/AEO#=]%J$/F6?G371U$+:K/O6,J(MKD-+M4(&
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MCP?H>HP>.M>\0:;(MGJ&BOI.DQQ&6#3)+0K'<+*OF;)"N-[+E<,VYR"?/?\
M@@I\#/B)\9?^"&'[.K> OC=XF^#ZZ?\ \)*+U=)\/Z1JPU7?XAO]A?[?;3&/
MR]K8\O;GS#NSA< 'ZL45\G?\,/?M$?\ 1ZWQ)_\ #?\ A+_Y74?\,/?M$?\
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M\+!U?./^N5I7ZH5ZQ^?A1110 4444 %%%% !1110 4444 ?D-_P6Z\7K\/\
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MRYHUU^SW^R59_P#"80MHS:''J6J7Z,1,]K UU<7.6$1;+")P2JEN<@9-9_\
MP3M\!:M\-OV5-!TO5-5M]36&2?[$D%HMNEA;B0J(!M^_AE=MQ /[S;C"@GW
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MEOXBU/?QZF,BK'_!KM_R@L^!WUU__P!2'4Z /OZBBB@ HHHH *^?_P#@E/\
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M:W>IZ/;W<]LVUDW(\B%E.UF7((X8CH3756MK'8VL<,,<<,,*A(XT4*J*!@
M<  <8% ')_ 7X,:?\ ?A9IOAFQN;K4GMC+<W^IW8076LWT\C3W=]/L54\ZXN
M))97V*J!I"%55 4=A110 4444 %%%% !1110 4444 %%%% !1110 4444 ?,
MO_!9K_E%3\?/^Q,O_P#T71^RY_RD;_:G_P"Y3_\ 37)1_P %FO\ E%3\?/\
ML3+_ /\ 1='[+G_*1O\ :G_[E/\ ]-<E 'TU1110 4444 ?,OBK_ )3(^ _^
MR,^)/_3YH-?35?,OBK_E,CX#_P"R,^)/_3YH-?35 !1110 4444 %%%% 'S+
M^SM_RE"_:8_[%WP3_P"B]7KZ:KYE_9V_Y2A?M,?]B[X)_P#1>KU]-4 %%%%
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M[*8\*LENT0A+0J0Z*J2+L9%8<MXUU*^OO"OC?Q)X9T[^R_%5MI\L7C?P;/.
MNH?Z.R)=P/@+]H$:?N;G"QW,48@FV-&CVGDXC^(_^'Z:Z>GQ0ZKWH^\C] R?
M3!P;TV?\FTGR-RZ-2;5+$?\ +N;=*JG2DCXY_P"#/L;?^"3FI#)./B#J_)[_
M +JTK]4*_*[_ (,^L?\ #IO4=HPO_"P-7P,8Q^ZM*_5&O6/S\**** "BBB@
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MV*.]M.LRJPX()4G!X/%86D? CP/H&IP7MCX-\*6-Y:N)(9[?2+>.6%AT965
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M&</AY_T(?@O_ ,$EM_\ $4?\,X?#S_H0_!?_ ()+;_XB@#&_X:83_H2_&?\
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M[%WP3_Z+U>OIJOF7]G;_ )2A?M,?]B[X)_\ 1>KU]-4 %%%% !1110 4444
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MY;\U+_EY"W.HM3C&5/WS]6/^%V>#/^AN\,?^#2#_ .*H_P"%V>#/^AN\,?\
M@T@_^*K\GH/^#6_]ES7]-N+&S\'^++/QYX99)M5\.W'BZX\G5K8Y'F6EP0O[
MN3:3%*PVAU:.548,8UNO^#8[]CPZ=:^+M-\,_$#5?!J[[;7+,:_=+JWA^9#A
MY&B'S,(SD30E?,4?.A8#8Q]<I^?];OY/1]5U5M1_ZMXO:\;[6OU>L5>UGSQ]
MZF[\LUI&3E[I^L'_  NSP9_T-WAC_P &D'_Q5'_"[/!G_0W>&/\ P:0?_%5^
M4\?_  :V?L@:)XBCL-8TWQA)X?\ %97_ (1CQ+9>*)6@+RJ/+MIS\T8E8G,,
MH_=S A,+(%$U:R_X-8/V8-4M+SPQ)X>\0:7\3-'B%]##<>)KQ-(\46J.JM/
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M@#Z HKY__P"&X?\ IP\&_P#A6?\ W+1_PW#_ -.'@W_PK/\ [EH ^@**^?\
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M* "BBB@ HHHH **** /F7_@LU_RBI^/G_8F7_P#Z+H_9<_Y2-_M3_P#<I_\
MIKDH_P""S7_**GX^?]B9?_\ HNC]ES_E(W^U/_W*?_IKDH ^FJ*** "BBB@#
MYE\5?\ID? ?_ &1GQ)_Z?-!KZ:KYE\5?\ID? ?\ V1GQ)_Z?-!KZ:H ****
M"BBB@ HHHH ^9?V=O^4H7[3'_8N^"?\ T7J]?35?,O[.W_*4+]IC_L7?!/\
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M;MU#7,L=LI=6F99!)-;QEX[R.5;FW:1Y0;U=5TI(X=%\.^(M:O+C3;BXCN/
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M\UI):GSG$7+]6C:VZM:ZTU^%/>-[^[+WJ4KQV:/V HHHKTCXP**** "BBB@
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M'_TUO7V#7QK^UCJ]N/CAXJL-S?:C9F?;L;;L_LQUSNQMZ]LY]J^RJ "BBB@
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MCOK4@E=4YOWZ:YJ52]H'ZA?\,I?#7_H1?"__ (+X_P#"C_AE+X:_]"+X7_\
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MPU_Z$7PO_P""^/\ PKY^_:P_Y*QXK_ZX'_TUO7V#0!Y__P ,I?#7_H1?"_\
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MX)^")C_ITVHW]M<>+=5B^8&"W6SFEM].5_D)N3/+<!"Z+%;2E+B( 7]D&/\
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M-F1BL_;6%_JVK>*]0UK1=/@T7XF:+%$GB;PR]QBT\1VW*Q312L%#!@K?9[K
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M9\3:M)8^,+%I6\$^-EMT_P")K\F^2TN8UV(;@QQYGMALCN8XO/@\IXF6S/\
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MYTW7/$7AW0[R^\/WUQ-:^// =U:K+>Z9=NH:XECMU+JTS+())8(R\=Y'*MQ
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MVB@L%<*V=A^TZF<'TX(/T(H ^WJ*** "BBB@ HHHH **** "BBB@#\[? ?\
MRE6O?^QBO_\ VG6I_P &NW_*"SX'?77_ /U(=3K"\%O=#_@K!=^6L)B_X26]
MSN)!VX7<?J#LP,<Y/(K=_P"#7;_E!9\#OKK_ /ZD.IT ??U%%% !1110 5\_
M_P#!*?\ Y1K_  ,_[$K3/_2=*^@*^?\ _@E/_P HU_@9_P!B5IG_ *3I0!]
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?,O_!9K
M_E%3\?/^Q,O_ /T71^RY_P I&_VI_P#N4_\ TUR4?\%FO^45/Q\_[$R__P#1
M='[+G_*1O]J?_N4__37)0!]-4444 %%%% 'S+XJ_Y3(^ _\ LC/B3_T^:#7T
MU7S+XJ_Y3(^ _P#LC/B3_P!/F@U]-4 %%%% '\[G_!6[]D;XI?M7_P#!$O\
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MOB5'>>"; W7]C:II=F]@5MXM@87US 'W[FQL8XV'.,C(!WM[^W5XBCMR;?\
M9S^/LTV0%1K#2(U.2 <M_:!Q@9/3M7T)7YY_\%2/B5\7?VD_V8;;PQH/[,_Q
MTTG58_%&BZDTKW7ARZC\FWOHI9,?8M7GD^ZIZH!ZE1S7Z&4 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 ?,O_  6:_P"45/Q\_P"Q,O\
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MBZF2W@BCU6!GFD=@B(JALEF8@ #DD@4 =51110 4444 %%%% !1110 4444
M%%%% !1110!Y_P#LF_\ )K'PS_[%32__ $DBKT"O/_V3?^36/AG_ -BII?\
MZ215Z!0 4444 %%%% !1110 4444 %?$G_!&S_D$^,_^O:P_]*M3KZN\6_'3
MPIX*U=M-O-7CFU5 &;3K&&2_OE!Z$V\"O* ><';S@U\U?\$E/AOXF\!Z)XPD
M\1>&=>\.+.MG! -4LGM7N&2:^D<HCX8J%GC&2 ,D@9P: /L*BBB@ HHHH **
M** "BBB@ HHHH _.SP)_RE8O/^QBO_\ VG6K_P &NW_*"SX'?77_ /U(=3K)
M\,6,\O\ P51\R&_CC3_A)+\R0K NX %<@MU.[*\]MO'6M;_@UV_Y06? [ZZ_
M_P"I#J= 'W]1110 4444 %?/_P#P2G_Y1K_ S_L2M,_])TKZ KY__P""4_\
MRC7^!G_8E:9_Z3I0!T7[5G['&A_M<0Z&FM:YK^BC06G:$Z9#I\GG>;Y>[?\
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M\=7<LL;7$B!V ()"Y(!%>I?\/8OV6?\ HY;]G_\ \.'I'_R10!\*_P#!*/\
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MB/;\K\1/[ \-_LYZW'#&OB'X):UIL_V;".LW@:>/=L7;@2PV<4\8QPLNF31
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M*^#]+\#Z2MCH^GVNG6JG/EP1A=S="S'JS''+')/<FM*O/_\ AK+X5_\ 12O
M/_A06G_QRNN\*>,=)\>:'#JFAZIIVLZ;<%A%=V-REQ!(5)5L.A*G# @X/!!%
M &E1110 4444 %%%% !1110 4444 ?GKX,T]K;_@J/)<%@5N?$6HX']W:8Q5
MS_@UV_Y06? [ZZ__ .I#J=9_@F]DG_X*FW$+-F.#Q%J.P8Z9\LFM#_@UV_Y0
M6? [ZZ__ .I#J= 'W]1110 4444 %?/_ /P2G_Y1K_ S_L2M,_\ 2=*^@*^?
M_P#@E/\ \HU_@9_V)6F?^DZ4 ?0%%%>-_$'XC>*OC%X[U/P-\--4MM 707$'
MB?Q;-9?:O[(E>-9$L[&*1?)GO"CJ[M(6CMU:/='*TFQ0#V2BO!T_X)U^!M5C
M,OB+Q!\6/%FJR,7DU'4/B'K4$Q8E3E([6YA@@^Z/E@BC49; &YLM3X.^.?V7
M8?[4\$>*/%OQ#\+V*F2^\'>)]1.J:B\*ABQTW4I\W+76,;8KV:6*4H$\RW+M
M, #WJBL7X<_$/1_BSX%TOQ)X?O5U#1=:MUNK2<1O&S(W9D<!XW4Y5D=5=&#*
MP# @;5 !1110 4444 %%%% !1110 4444 %%%% !1110!\R_\%FO^45/Q\_[
M$R__ /1='[+G_*1O]J?_ +E/_P!-<E'_  6:_P"45/Q\_P"Q,O\ _P!%T?LN
M?\I&_P!J?_N4_P#TUR4 ?35%%% !1110!\R^*O\ E,CX#_[(SXD_]/F@U]-5
M\R^*O^4R/@/_ +(SXD_]/F@U]-4 %%%% 'YE?!__ ()+_"K_ (*P?\$B_P!F
MW0_BE)XHAMO"&DM?:?)HFH):2AY=R.'+QR*RD*O;((Z]:_%#_@H%_P $\_@7
M_P $P_\ @LQ??#OXK:3\7E_9QDT^VOM*O-*FMIM;U&.73H\S12R*D3QIJ(GC
M<!0P6,@ G!/WE_P4-_X*6?&K_@F]_P $6_V.=2^"_C%?!NH>*K:[MM3G_LBQ
MU%KB*) R)MNH957#.3E0">.<<5YYXL^"?_!7S]MGX4^'K[Q7H7P_^(_A/5+:
M'6=*A\2>'_A]J$&R:(-'*L-S;ML8QN.JA@#@^E $'_!H/\/+#5?^"LWQV\:?
M#O0_%<?P=L/">IZ1HU_K4:&YM8KC6+":PMKIXR8_M36MM(S!"1F)R#C!/]'E
M?E?_ ,$$_@O^WO\  SXT:QH7[2&E^$_#?P7L_#-P-#TC0M-\+Z?;PZNUW:E&
M2+1XD91Y NL[L(2PX+8(_5"@#YE_9V_Y2A?M,?\ 8N^"?_1>KU]-5\R_L[?\
MI0OVF/\ L7?!/_HO5Z^FJ "BBB@ HHHH **** "BBB@ HHHH 9<W"VEO)*^[
M9&I=MJEC@#)P!R?H.:X+_AISPG_U-'_A*ZI_\CUZ!10!Y_\ \-.>$_\ J:/_
M  E=4_\ D>C_ (:<\)_]31_X2NJ?_(]>@44 >?\ _#3GA/\ ZFC_ ,)75/\
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M]YCTKH/^&G/"?_4T?^$KJG_R/7H%% 'G_P#PTYX3_P"IH_\ "5U3_P"1Z/\
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M-'_A*ZI_\CUZ!10!Y_\ \-.>$_\ J:/_  E=4_\ D>M3PC\;=!\<:TNGZ?\
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M?J/BFX\4:'X2MK74;>V\%:Y-9V\MLJPS(MX+/[-(5<8.R1N<XS@U^A5?,O\
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M/0W,\,0FN[2Y,[7,RQ'*_9 NP0G/F$[AMPWZY4 ?,O[.W_*4+]IC_L7?!/\
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MX?\ AOP!%8R:SI.M_!'7A&;8I?&"Y\"RK(&CVD,LT%I%,BLCJ4FTR:-2"D"
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M4 %%%% !1110 4444 %%%% !1110!Y_^R;_R:Q\,_P#L5-+_ /22*O0*\_\
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MFHVS=L7.,9VC/05U%M;1V5O'##&D,,*A$1%VJB@8  '  ':@!]%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?,O_!9K_E%3\?/^Q,O_ /T7
M1^RY_P I&_VI_P#N4_\ TUR4?\%FO^45/Q\_[$R__P#1='[+G_*1O]J?_N4_
M_37)0!]-4444 %%%% 'S+XJ_Y3(^ _\ LC/B3_T^:#7TU7S+XJ_Y3(^ _P#L
MC/B3_P!/F@U]-4 %%%% 'XI_M(_L4:-^VI_P17_91TW7OVDO"?[.=CH=O+<"
MZ\0WZ6EKKDCHRB-2]S &DC 9@,L<.W3G/XY_MC_LFP_LM_MG>!_A;H?[4GA/
MXF^'?&$>GRW/C7P_K8FTK0A<WLMJZW+)<NBM"D0F<&082122 <U^C7_!6V?X
M>VG_  0^_8PD^('@/XB>-K?%VMG_ ,(KXGM]!>R<Q9;SI)M.OE<. -JA$/R,
M=Q&0?RP_MS]FW_HA/[1__AW-+_\ F7H _>S_ (-Z_P#@FIX7_8R_:X\6^)?#
M_P"V3\/?V@Y-0\(3:9-X9\.:I%=26@:]LY!?2*E[/A8_*\H$H.;G[PSAOV!K
M^=__ (-'KSX2WO\ P43\<MX!^&/Q<\'ZLGPYO!/J'BCQQ9Z[9/ =3TS,*Q0Z
M-8E)68(P<RL-L;C8<[E_H@H ^9?V=O\ E*%^TQ_V+O@G_P!%ZO7TU7S+^SM_
MRE"_:8_[%WP3_P"B]7KZ:H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3PVJ[P\CB7S+BTCWI=I*+JV,DLC+J'YR_P#!+.TTVS_X.;?VH!H>KOKVAR^
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MPWHFM7FL1['\C4++0H(A&Q89+1ZF[#.T@?+@X/I6!_PL#]JW_H1(O_ W2?\
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M[</D)R 54?[7&#^NE?F+_P '6_\ RC2O/^PCI_\ Z=]-H ^D/V2?^2\>!_\
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M(OA?_P *N3_Y"H_X2_XE?]"+X7_\*N3_ .0J /0**\__ .$O^)7_ $(OA?\
M\*N3_P"0J/\ A+_B5_T(OA?_ ,*N3_Y"H ] HKS_ /X2_P")7_0B^%__  JY
M/_D*C_A+_B5_T(OA?_PJY/\ Y"H ] HKS_\ X2_XE?\ 0B^%_P#PJY/_ )"K
ME?C?\3_BAX6^$?B#4+?PSX<T6:VLG9+^+Q UV]F>@D$36BK(5SG:6 ..M 'J
MW@7P?9_#SP3H_A_3O-&GZ'8P:?:B1MS^5%&L:;CW.U1D]ZQO&?Q%:/5)/#OA
MUK2^\5R1AO*?+P:4C [;BZV\JG]U,AI2,+@!W3Y@_8XMOB5\5?V<O#-_=7&I
M:_IHMS:1(?%IT=3%'F-4(M[,S<*H&XSLQ(W9&<#WKPFOC;P+HZV&C_#?P?I]
MHK%S'#XHD&]CC+L?L668X&68DGN: .[\"^#+7P!X6MM+LVEDCA+R232G=+=3
M2.TDLSGN\DCN['NS'I6O7G__  E_Q*_Z$7PO_P"%7)_\A4?\)?\ $K_H1?"_
M_A5R?_(5 'H%%>?_ /"7_$K_ *$7PO\ ^%7)_P#(5'_"7_$K_H1?"_\ X5<G
M_P A4 >@45Y__P )?\2O^A%\+_\ A5R?_(5'_"7_ !*_Z$7PO_X5<G_R%0!Z
M!7YB_P#!UO\ \HTKS_L(Z?\ ^G?3:^^O^$O^)7_0B^%__"KD_P#D*OSS_P"#
MJJ/4K[_@F7'=7'E6-PEW8-=V44GG1F1M5TSY1(54D*V<-M&?0=* /T,_90_Y
M-A^'O_8N6'_I.E>@5^9?[$?PLT/XVP6>C^)M6&@W<L?EZ?+#'ILGV]UY$7ER
M6A=7"<Y:0[\-C)# >W>+O^"=.I:=K3Q:+Y>J6 52MQ=7&FV<C''(\L:9(!@]
M]W/M0!]C5^8GC?\ ;U\?>#?&7_"+^*/%'Q'\(ZQX9U:6_BOY/ FK-9^(89-:
MCC:[N2=/"0Z7;VDJ6L<4>[S)KA6>8%$N)/3?'G[#7B;P=X&UK5VT_3E72[&>
M\).HZ=(!Y<;/RO\ 9*[NG3<N?4=:Q_@?)KWQ&^ L^AZAK/A2ST#4I(9I](N]
M;TZTA=C#;S[Q!+82%0TF),*P4,3@<9(!\+>(_P!E2\\6?\%E--\96OBSQ-JD
M7A_X@QZI<ZMXD\&:S=:3"4U/S#!IAFM[B0W$97:LRBVM,$.L\B@"OWB\2?\
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MT;XF:-'$OB;PRUQBU\1V_*Q3PRL%#;@C"WNB!]UH)@A1EA_-G_@EC<:/=?\
M!SI^U1+H-G)INF2^"[9TLI(# ]DY?3O,A:(\QLDF]2G12"!P!75@[<_R_7IY
M7WB]8O39GB<1\WU;6_Q*^J>KBVG)K=N.L:L?=KPM)VG!G[*4445Z1\0%%%%
M!1110 4444 %%%% !1110 4444 %><_M<VZ7?[-'C6&1=T<NERHPSU!P#7HU
M>>_M8?\ )N'C'_L&R?TH \__ ."7<2P?L5>$U48&;AOQ,[D_J:^@J^?_ /@F
M!_R99X3_ .V__HYZ^@* "BBB@ HHHH **** "OS%_P"#K8X_X)I7G_81T_\
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M]?35?,O[.W_*4+]IC_L7?!/_ *+U>OIJ@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .+_:0_Y-W\>_]BYJ'_I-)74>'O\
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M>DFMG:FU-ZJSTH5WK3?[BO>#':OI.I7/B/2?#'B?5FL/&U@TK^"?&R6R*NM
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M_P#DJ_B+_L8_!_\ Z6"O(?V2_P#E.E^V!_V*'@3_ -$:C7KWQ/\ ^2K^(O\
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M_&?P>\6:/8(LE]JVC7EG;(S!0TDD#HH)/ RQ')K=T>W:STFUAD&)(H41AZ$
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M6O%UGINI7EGH?Q4T.WD?1=:2$K8>*K,$&2-XP>4/R^=;YWPN5DC.-CG\T_\
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MR4?\%FO^45/Q\_[$R_\ _1='[+G_ "D;_:G_ .Y3_P#37)0!]-4444 %%%%
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MI#_DW?Q[_P!BYJ'_ *325U'A[_D 6/\ U[Q_^@B@"Y1110 5\+_\'+/_ "A
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M_E^'ZKMUCJF>'Q)?ZLKW^+6Z6]G>]OAF].:WNU/=FM4S]HJ***](^)"BBB@
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M51ZDG@4 >/\ QK\<3:WK\NAM!''%H7B;PQ)'*"=TOGWT;'(]M@_.O!/V2_\
ME.E^V!_V*'@3_P!$:C7J/Q%\1:??_%K7E@OK.9IO$?A#RPDRL7Q>#.,'G'M7
MEW[)?_*=+]L#_L4/ G_HC4: /M^BBB@ HHHH S=*325UW5&L_L/]I,\?]H^2
M5\[=L'E^;CD'9C&[MC'%:5>?_#3_ )+9\2O^OG3_ /TC2O0* "BBB@ HHHH
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MPF^">GZ';S/I%S#IC:G+JLDB,)8Q;QJTI"!$)=1M7< >76OQJUC]GG]FT_\
M!1#3/ 6D_'?5KKX"W+QQW7Q&N/#-Q;S6Y-J9'(LF42E1<;8LE1P2WW>:_IR^
M&O\ P1L^''[4O_!/OX#^ /VDO +ZUJOPPTR3;I?]M3VHL[B;B0-+93(7^54X
M#E<CG.*Z&?\ X-[?V-9O@G=?#]?@/X6AT"\O$U"2:.YNUU3SD4JA&H>=]K"@
M%OW?G;/F;*G<<@'X]_\ !I#X4\-^!O\ @MU\<-%\&>()/%O@_1_ NN66BZXU
MNUN=8LH]=TI+>Z,9Y0RQJK[3R-V*_I0KY_\ V$_^"7?P+_X)KZ)JUG\'? EG
MX7EU]D;4[Z2[GOKZ^V?<5Y[AW<1KDD1J50$D[<DD_0% 'S+^SM_RE"_:8_[%
MWP3_ .B]7KZ:KYE_9V_Y2A?M,?\ 8N^"?_1>KU]-4 %%%% !1110 4444 %%
M%% !1110 RY,BV\GDJC3;3L#DJI;MD@' SWP:X+^U?BI_P! 'X?_ /@^O/\
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MOVM?$EAX!U*WL]6^$.M?#_6+E[?4M'?0M=,?A=B,S 1E \<*OR\:EC"QRBA
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M6J5[<RAU@_CI2TU@>S?$7]I+Q5-X \*^']:\5> ?$/@J36-.U'2/$>GP:O\
M;=%9+R%[<"\FB<X"/B.X*2L\:LDA>1T\_H/@=^T1K$WAOP_%>>-O!?A3QMX;
MMG32+H>%-3NH?$5EDNT$TB3*&3>?G3R@T38>,D')\"M_@O\ M$V?BZZN(_\
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M$RQLO_#LR4;@1D?M!Z "/_(% 'U])^W1XT\2.;[0_$7P@CTJXYMUN-*\032
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M)-*M7=W.YG)A4DD]R:\L_P""G?\ RC6_:&_[)GXD_P#37<UZA\(?^23>%_\
ML$6G_HE* /"_VHOVZ_&/@;XGWWP^^"/PANOCM\0/#]I;ZCXCL4\36GAW3?#<
M%P6^SI<7LZN/M4JHTB6Z(S^4HD?8KQE]'X2?MSS?&#1_@C?6WA.?2Q\4]0U;
M2]5M;B\2XD\.W6G6]X;B+S(MT<V+FS>(." P(;@_+7P-^WEH'P1_:(_X*'?&
MB3XM?'WQ%^S+;>#]/T_PE-:>#_$DFAZ[X_M_L$=Z;Z^S')'-9I]NDMH46-V<
MP3;FP%C'V5_P2S\,>/H/V [GP_-JTFE:=9W>IZ5\+]8O= CM+^/PVA,6CWEY
M8A((_-V 2"/RH=T7E!T#EV(![;^U_P#'N?\ 99_9<\??$BWT,>)'\"Z'<ZXV
MF&]%G]LCMXS(ZB4H^P[%8@[&Y&,<UPFM?MGZMI7[;NG_  G7PNDFFWFI6UBV
MK^>^4671M3U$OLV[>'L$B^]_RVSU !\&_:0^ /QX^#/_  3?_:@F^,/[05G\
M;+34/AMJZ:9;P?#^S\,'2I%LK@R.7MYY#-O!4;6 V[,CJ:^^Z /'_P#@H5K-
MYX<_8$^.&H:?=7-AJ%A\/]>N+:YMY6BFMY4TZX9'1U(*LK $$$$$ BG?\$^]
M8O/$7[!7P1U#4+JYOK^^\ Z%<7-S<2M+-<2OIT#.[NQ)9F8DDDDDDFJG_!2/
M_E';\?/^R<^(?_39<4__ ()Q_P#*//X#_P#9._#_ /Z;;>@#V:BBB@ KYW_:
MI_;(^(/PL^)*>"?A3\"?%'QB\4+IBZK=S'5[?P_H=@CF58HI+^X# SN86_=I
M&Q *DD9KZ(KYB_;9_P""LWPC_8B\;VO@?7M>LI?B1JUE'>Z=HEQ,;&U6&1WC
M2XN[Z1?(MK=61V?EYRB,8H)WVQL 2_"__@HY!\3_  Y\-+F/P7?:7JGBWQ[?
M_#;Q-I5YJ4)N/!VLV-K?S7,1:(/'=('L&5'1E#QS1R#&=E>K?LQ?&B[^/GPN
MN/$%[I:Z/-#XBU[1!;AR^Y-.UB]T^.7) /[U+59<8P/,P"0 3\K^%U\'2_#_
M /9:O?!GC#1_B!!K/QGOM7UCQ)IB>7:ZSJ]UI'B*YOYHT+.8X_M$LBQQ%W,4
M2QQ;V$8)]J_;*_9^^/GQF\0Z)<?!W]H>Q^"FGV-O)'J-I/\ #VS\3G4Y2P*2
M"2>>,Q;5!&U00<YS0!@_M2?\%))O@SX]U[PC\/OA1X[^,_B;PE!'+XACT%8K
M;3_#[2P"XBAN;N8B-9GA*R^6NYECDC9L"1,^S?LR?&;_ (:._9M^'OQ#&F-H
MH\>>&M-\1#3FN!<-8?:[6.X\DR  .4\S;N  ;&<#.*^:?V@O^"6+?$R3Q9?Z
MO\6O&T?@WQE:1ZIX^\'Z=#!9Z;XSU.WL;>U>X=U!GMX9X;*W2:VCD,;JI VE
MF8^S?\$X$6+_ ()X_ 55555?AUX?  & !_9EO0!H_"?]J>S\;>%_BAK7B"PA
M\)Z9\+O$>IZ+?7,M[]HCDM;**.8WK$(OEAHI Q3YBF"-S5XAJ/\ P4?^,7C*
MVT&V^&O[*_B_QEK%QI>G:IKXU/Q/9^'],T WEO%="T%W.A^TW44,\1ECBCVJ
MS;0[8+#@[R$?%8_$+X+Q[G_X6_\ ''4K+6D1BI3P_9V=C>:H7QSY4\44=@2/
MXM3C[9(],_;&_P""O?PE_9P^)VI?"F/QUX=TOXK1QPK*NM1RPZ7X<6=$D6[N
MY3L24)%()1;12>;+\J9B#F5 #/\ B#_P5DMV_9S^'/Q)\#^#[_6-+\>Z=JET
M]GJ>^SO-(N+!EBFM)D56Q*DXFB;!(W1':6!!K[&KS']C/2/!.@_LO>"[/X=:
MU#XF\'V]@%L=8CE$W]KMO;SKIW'#22S>;([#J[L:].H **** "OD3_@DQXQU
M?Q?JW[4XU;5-2U0:5\??$>GV7VNY>?[';);:>4@CW$[(UW-A%PHW' YKZ[KX
MS_X([?\ (7_:V_[.(\3?^DVG4 ?9E%%% !1110!G^*_$UIX+\+:EK&H-(ECI
M-K+>W+1QM(RQQH78A5!+':#P 2>U?(?@S_@J%\1I_%GA?5_&_P"S-X^^&?PA
M\9:W8>'M.\3:[JUK_;%I=:A-';6)OM'C#36<<ES+' S22$QO(F1M(-?7GBKQ
M3I_@?POJ6M:O>0Z?I.CVLM]>W4QVQVT$2%Y)&/95522?05\,V7_!3O\ 9_\
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M% !1110 4444 %%%% !1110 4444 %%%% !1110!\R_\%FO^45/Q\_[$R_\
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M]%^-/P_T?3+7=Y-G8_"J.W@AW,6;:B:@%&68DX'))/>M#_A2'[1'_1?/!_\
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M""$$DD*BZ@%49)/ ZFOHVB@#Y_\ ^%(?M$?]%\\'_P#ALQ_\L:/^%(?M$?\
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M"VUI&)+J_GDD6*"U@0D!YYII(XHU) 9Y%&1G->8Z;^QY8_'.\M?$WQRL]/\
M&^N2'[1:>%[O_2O#/A=2<I!#:/F*ZN(P5#WTZ-(\@=XEM8G2WC /C'_@EUXO
M\1>,/^"I7QT\1>,?CQ\/]4U.:XTZP7PUHUQ"L.O1-I\:Q3*D5X8C=1+#;K*
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MQ_V+O@G_ -%ZO7TU0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>!?LC.-:_:0_::U.Z&[4K7Q[8:(I;&Z&S@\-:-<01#C.WS+V
MXE .>;E_7%>^UX'XV _96_:9UKXB7A$/PW^(6FV\/BJ].?+\-:I9#R[?49NR
MVL]JYAGG8A;?[!:,V(WFDB /D7X#?&N;]F?P]^W5\0/%N@Z#XD^-G@OQG>:I
M/9ZAO6\G\+B&$Z.LDC*V+<0BX9%B^0#' R*Z[X:^-+?]BG]I?]G^Z^']C9:/
M\'/VJK5FO_!EO(T=GX3U9K-+N&]TR(#RHXYVEV3PIY2Y_>@.Y*U[]^W#_P $
MQ_AQ^WC:7-[K5QXE\)>++O0I_#3^*/"NI'3]2N=)G;?+I]SPT5W:,WS>3<1R
M*C,SQ^6YWUT>F?L<_#GX:O\ #'Q!J;W5Q#\!/#<FD>&[G6+\?9M'@%K';RWT
MG"Q_:/LT6PSL/E1Y0NT.^0#)^-LG]B?\% _@3>6@"WFK:-XGT>\V@9DLO+L;
MK+<9(6>V@ ]/-;^\:]]KPKX-:5<?'W]H^[^,%Q;W%MX7T71)/"_@>.XB>&:^
MAGGCGU+4RC@,L5P]K9109 )CLWE!9+E,>ZT %> _L2'^UOB-^T+K%UAM5O?B
M;/:3DXW10VNE:9;VT8]%\E$D"]-TSMU<D^_5X#KTZ_LD_M*>)/%^I21VOPS^
M*ALYM8U"239#X;UV"!;1;FX8G:EK=VL-G!YAP(IK2,-D7 ,8!Y_^W3^SEXH^
M'7[+OQC\=:+\>OCAI^IZ#X6UK7K"UAU/3EM;::&TGGCC4"R\P1JR@##[@!][
M/-?*_P"R3\0?B=IG[2__  3^;5/C3\5/%&G_ !D\ :AX@\3:7J^IP2V=Y<)H
M2W"C:D",RB5]P\QG;*CYLY)_5S7-#L?$^B7FFZE9VNH:;J$#VUU:W,2S07,3
MJ5>-T8%65E)!4@@@D&N9O_AQX ^'VGZ3KUUH/@_0[7X>Z=,FF:C+8VUM'X9L
MEAVRB&4J!;0B%<,%*J$7!X% 'F?Q3D_L3_@I%\'9K0!;C7/!?BJPOU4#]];0
MW&C31NW&3Y4K%5YP/M3_ -ZO?*\-^!^@WOQG_:(UCXPZA9W=AHMKI!\*^";:
M[A>"XDL7ECN+_4'B<!H_M<\-LB(PSY5A#(<>=M3W*@ HHHH **** "BBB@ H
MHHH **** "O OV@'_M?]N[]GO2[OYM/LX/$VOVX894:A!9V]G$1Q]X6VHWP!
M'."_;->^UY+^UE\*=;\8Z9X3\6^$;:.]\:_#'6U\0:59/,L"ZQ$T$UK>V!=B
M$4SVEQ.L9<B-9UMW8@1Y !\SZ5^SGH_Q1_X+G?$S4_%W@/3?$6@_\*VL([6[
MUC1$O+/SA<0?*CRH4W@;^ <XW>]?''[8'[%^FG]FC_@H)_9/PGL?[17QEH/_
M  C/V3PPOG"#[9:&7['MBW;-FXMY7&,YXS7[*_"GXM:#\:_!=OKWAR^-Y8S$
MQR)+"]O=64R\26US!(%EM[B-OED@E5)(W!5U5@163\</AYXP^(6GZ?%X0^(5
MY\/Y[:1FN9K?1[34C>*0 %(N%8+@Y.5Y.: /(?\ @H%81^&/^"5'Q!N+>W2U
MNO"'@@ZWI$*((_L]_IT*7=B$7'RLMS;P;<#A@,=!7TQ7SG\7;"Y_:3N/#WP;
MM=7'B>S\/WVFWGQ+UY8EBB"V;172:<1&/*%W>S1PM+;H?W-I)(SB/S[7SOHR
M@ HHHH **** "BBB@ HHHH **** "BBB@#P'X.G^VO\ @HI\;[R\PUUI/AGP
MKI-D&QF*T)U2Y++Z>9/-*&/\7D(#G8,?+?P$_8T^%'Q _P""MG[5'A_XO_"[
MP7XI\2>(#HWC#PQ-XAT&UOQJ&DM;FWGFM7D5FVQ7&R&4%5 ?:!O R/J[XWZ7
M=_ C]H73_C%:P377AJ^T5/#'CF*$%I;6SAG>>PU-5'WH[22XO5F4#(AO&ESB
M J^U^T#^RS\._P!MKP=X?OM8^T37&EAM2\+>+/#>KRZ?JVBM/%M^TV&H6SK(
MBR1E<A6,4JA0ZNO% 'Q/_P %3/V(/A%^RIXH_9?^(7PW^%?P[\'ZWHWQR\-V
MEW)H_A^VLY[RQG:831JT48RZE$D4L0!Y9Y!(KZV_;+?^QOC#^SGJUL NJ1_$
M8Z=&0!NFM[G0]66XB/&=NU%E(&/FMT/\.#%X2_X)[Z7'\1/!_B;QY\1?B9\8
M+[X?7$E]X;@\7W&G?8]*O'C$0O1!8V=JDURD>]8Y9Q(T7FR,FUF+5)X:V?M9
M?M+^'/'%BWVCX;_#&"YE\.WXSY/B/6KN%[:6]MR1A[:VLY)H8YT)2=M0GV_+
M"K2 'OM%%% !1110 4444 %%%% !1110 4444 > _P#!1W_3O@EX5TF;;_9O
MB#XC>$-,U(-C;):R:_8EX6SQMEVK"P[K,1U(KP'_ (+N^ -)^(^H?LGZ7X@L
MK&^\/WWQUT"SOH;UU2"=)?-4Q'<0&+KO 4<MS@&OL#]IGX+?\-"? W7_  G'
MJ#:1J%]'%<Z7J*H7.F:A;S)<V5UM!&[R;F&&3;D9V8R,YKC],3PE^W?\"M8\
M _%#PK8OJBV\-MXQ\(WK-OTVYW$I+$XVR&%I87DMKN/;N\H.C*Z,$ /B_P"/
M'_!.[X*>!O\ @LI\!](7X8>&H_#/CWP=K]@]D+,_9Y[FS N=Y&?O*C*,]MRC
M^(9](_X-P/#MOIW_  1S\!^%+F#[5:Z'J'B'2)DN(28[A3K%Z[J0PPZ_O2IZ
MC@CJ"*]NT3_@F=\/KS1H[?QUJ'C+XMWUE:?V?I>K>,M8:]U30K;<K,EG<Q+%
M)!(Y2/S;A"+B;RHQ)*X1 MGXHI8_ ;X.:;\$?@GIVF^'_%5]I0TSPYI^G08M
MO"=F^Z-M6N OW(8<2R+O*FYGC$2L7=F4 G_X)B:K<:M_P3\^$AGFDN19^';>
MPMYY#N:XM[<&""0G^(O#'&V[ONSWKW:N>^$GPPT?X(_"KPSX+\/P-:Z#X1TJ
MUT7386;<T5M;0K#$I/<A$49[UT- '@/[:W_$T^+'[-NBW&#I.M?%$-?(Q&V4
MV?A[6]1M0?I>6=K(/]J->^*\U_X+M>$K*/\ X)U^.?'5J+G2O''@*TCN?#?B
M33+J6PUC09)KRUCF-M=PLLT0D4*'56"N%7<#M&/>OVMO@YJGQC^$RKX;DL[?
MQIX6U*T\2^&9;MVCMSJ-G*)8X)F4%E@N$$EM*R@LL5S(5!8"O/?BQ^S[\)O^
M"K'P\L=/\?6OBB^TCP]+);:]X&DUZ]TA;:^;R)?(U6UM9HS,\6Q'A\PM"Z3"
M:/S(Y8Y" ?,NG?\ !2[7/V?9-%\*_#KX@M^V!XDCL;-]0\%66E2WGB?1]^U)
M/.UK38'L(O*.1Y>HPQ2MM'F7)8ES]>>(]1U/]HW]@SQE_P +.\"W'PYN?$OA
MW6K#6/#FH:C;:E)86Q6Y@!DF@+0.9( LI",RKYFW<VW)]+^%'P?\)_ CP+9>
M&/!/AO0_"7AW35VVNF:18QV=K /]F.,!<G')QD]Z\J_:_P!3;X^:-J7P+\,W
M32:QXSL_L?BJ[MF;'A;0IQLNI9)%!$5S<0L\-K&2)'>1IE5H[:9D .W_ &2_
M%^J?$']E7X9Z_K;2-K6N>%-+U"_,GWC<2V<4DF??>S5Z#4.GV$&DV$-K:PQ6
M]K;1K%#%&H5(D4855 X     Z5-0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!\R_\%FO^45/Q\_[$R__ /1='[+G
M_*1O]J?_ +E/_P!-<E'_  6:_P"45/Q\_P"Q,O\ _P!%T?LN?\I&_P!J?_N4
M_P#TUR4 ?35%%% !1110!\R^*O\ E,CX#_[(SXD_]/F@U]-5\E_M47_C;X+?
M\%!? ?Q0T7X2_$#XH^&X?AYK?A:[3PBVF-=6-W<:EI5S$9$O;RU'EM':2_,K
M,<@#'4C4_P"'B?C3_HT7]J#_ +\^%O\ Y>4 ?4%%?+__  \3\:?]&B_M0?\
M?GPM_P#+RC_AXGXT_P"C1?VH/^_/A;_Y>4 ?4%%?+_\ P\3\:?\ 1HO[4'_?
MGPM_\O*/^'B?C3_HT7]J#_OSX6_^7E 'U!17R_\ \/$_&G_1HO[4'_?GPM_\
MO*/^'B?C3_HT7]J#_OSX6_\ EY0!-^SM_P I0OVF/^Q=\$_^B]7KZ:K\W/C+
M;WGQ@^-^L?$"']GW]OSP3X@\06-GI^IGPEXH\/:/;WT=IYOD&2./7,,R":0
MG^\:PO\ A#/$7_1.?^"H'_AQ]#_^7E 'Z@45^7__  AGB+_HG/\ P5 _\./H
M?_R\H_X0SQ%_T3G_ (*@?^''T/\ ^7E 'Z@45^7_ /PAGB+_ *)S_P %0/\
MPX^A_P#R\H_X0SQ%_P!$Y_X*@?\ AQ]#_P#EY0!^H%%?E_\ \(9XB_Z)S_P5
M _\ #CZ'_P#+RC_A#/$7_1.?^"H'_AQ]#_\ EY0!^H%%?E__ ,(9XB_Z)S_P
M5 _\./H?_P O*/\ A#/$7_1.?^"H'_AQ]#_^7E 'Z@45^7__  AGB+_HG/\
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M6DJSPVWBR\M$TU)%SM=M/T^VM;.5ADD&6%RIP1@@$?&/_"&>(O\ HG/_  5
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MH'_AQ]#_ /EY1_PAGB+_ *)S_P %0/\ PX^A_P#R\H _4"BOR_\ ^$,\1?\
M1.?^"H'_ (<?0_\ Y>4?\(9XB_Z)S_P5 _\ #CZ'_P#+R@#]0**_+_\ X0SQ
M%_T3G_@J!_X<?0__ )>4?\(9XB_Z)S_P5 _\./H?_P O* /U HK\O_\ A#/$
M7_1.?^"H'_AQ]#_^7E'_  AGB+_HG/\ P5 _\./H?_R\H _4"BOR_P#^$,\1
M?]$Y_P""H'_AQ]#_ /EY1_PAGB+_ *)S_P %0/\ PX^A_P#R\H _4"BOR_\
M^$,\1?\ 1.?^"H'_ (<?0_\ Y>4?\(9XB_Z)S_P5 _\ #CZ'_P#+R@#]0**_
M+_\ X0SQ%_T3G_@J!_X<?0__ )>4?\(9XB_Z)S_P5 _\./H?_P O* /NSXI?
MLA^&_B-XSF\5:;J7B;P+XQND2.YUWPMJ)L+F^5-H07,1#V]UM"*JFXAD*J-J
ME5)!Y6Q_8A\1:O%-:^,/VA/CEXSTF9_^/%KK2- S%M*F-KC2-/L[KG)RRS*>
M!C:1D_'O_"&>(O\ HG/_  5 _P##CZ'_ /+RC_A#/$7_ $3G_@J!_P"''T/_
M .7E 'Z2?#;X9>'_ (.^"K'PYX5T?3]!T/30PM[*RA$4499B[M@=7=V9V8Y9
MF9F8DDD[E?E__P (9XB_Z)S_ ,%0/_#CZ'_\O*/^$,\1?]$Y_P""H'_AQ]#_
M /EY0!^H%%?E_P#\(9XB_P"B<_\ !4#_ ,./H?\ \O*/^$,\1?\ 1.?^"H'_
M (<?0_\ Y>4 ?J!17Y?_ /"&>(O^B<_\%0/_  X^A_\ R\H_X0SQ%_T3G_@J
M!_X<?0__ )>4 ?J!17Y?_P#"&>(O^B<_\%0/_#CZ'_\ +RC_ (0SQ%_T3G_@
MJ!_X<?0__EY0!^H%%?E__P (9XB_Z)S_ ,%0/_#CZ'_\O*/^$,\1?]$Y_P""
MH'_AQ]#_ /EY0!^H%%?E_P#\(9XB_P"B<_\ !4#_ ,./H?\ \O*/^$,\1?\
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MX*@?^''T/_Y>4 ?J!17Y?_\ "&>(O^B<_P#!4#_PX^A__+RC_A#/$7_1.?\
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MR:;XAT349])UG35;EDCN[=DD\IC@M"Q:*3 #HXXKX!_X0SQ%_P!$Y_X*@?\
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M5 _\./H?_P O*/\ A#/$7_1.?^"H'_AQ]#_^7E 'Z@45^7__  AGB+_HG/\
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MY0!^H%%?E_\ \(9XB_Z)S_P5 _\ #CZ'_P#+RC_A#/$7_1.?^"H'_AQ]#_\
MEY0!^H%%?E__ ,(9XB_Z)S_P5 _\./H?_P O*/\ A#/$7_1.?^"H'_AQ]#_^
M7E 'Z@45^7__  AGB+_HG/\ P5 _\./H?_R\H_X0SQ%_T3G_ (*@?^''T/\
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MZ/\ A0W[7'_1R'P?_P##*W/_ ,OZ /J"BOE__A0W[7'_ $<A\'__  RMS_\
M+^C_ (4-^UQ_T<A\'_\ PRMS_P#+^@#Z@HKY?_X4-^UQ_P!'(?!__P ,K<__
M "_H_P"%#?M<?]'(?!__ ,,K<_\ R_H ^H**^7_^%#?M<?\ 1R'P?_\ #*W/
M_P OZ/\ A0W[7'_1R'P?_P##*W/_ ,OZ /J"BOE__A0W[7'_ $<A\'__  RM
MS_\ +^NJ_P""=?QL\9?'3X ZI>>/KW1-4\4>&?&GB;PC=W^DZ:^FVNH#2M:O
M-/CN%MWFF,1D2W5BGFO@DC)H ]VHHKXI^"'B/]J#]K(>.O$GA[XR?"KP3H.C
M^/\ Q/X5TW2;KX77.KW$-MI6LW>G1/)<C6(!([I;*[$1* 6( Q0!]K45\O\
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M] 'U!17R_P#\*&_:X_Z.0^#_ /X96Y_^7]'_  H;]KC_ *.0^#__ (96Y_\
ME_0!]045\O\ _"AOVN/^CD/@_P#^&5N?_E_1_P *&_:X_P"CD/@__P"&5N?_
M )?T ?4%%?+_ /PH;]KC_HY#X/\ _AE;G_Y?T?\ "AOVN/\ HY#X/_\ AE;G
M_P"7] 'U!17R_P#\*&_:X_Z.0^#_ /X96Y_^7]'_  H;]KC_ *.0^#__ (96
MY_\ E_0!]045\O\ _"AOVN/^CD/@_P#^&5N?_E_1_P *&_:X_P"CD/@__P"&
M5N?_ )?T ?4%%?+_ /PH;]KC_HY#X/\ _AE;G_Y?T?\ "AOVN/\ HY#X/_\
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MD/@__P"&5N?_ )?T ?4%%?+_ /PH;]KC_HY#X/\ _AE;G_Y?T?\ "AOVN/\
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M&_:X_P"CD/@__P"&5N?_ )?T ?4%%?+_ /PH;]KC_HY#X/\ _AE;G_Y?T?\
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M[ _P*T.35&LO@K\);-M:TY]'U%H/"&GQF_L7=)'M9L0_O(6>.-C&V5+(I(R
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MC5G/^DSW862V?3_D=/,8DQ,I(!^LE%%% !1110 4444 %%%% !1110 4444
M?,O_  49_P"1X_9C_P"RS:=_Z:=7KZ:KYE_X*,_\CQ^S'_V6;3O_ $TZO7TU
M0!\R_M1_\I'/V6?^YM_]-D5?35?,O[4?_*1S]EG_ +FW_P!-D5?35 !1110
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MR'A(84>1SPJD\5Y;\.)E_9D_::A^&4'[GP+X]T^[USPC;Y'EZ%>6K1?;],B
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M[J5S=P7'VJU^T;6$\$1!12AW@G<9&7:OE[I,U?\ E*:W_9*E_P#3N:/V:O\
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M#S7]G;XJ&WM?B7X3\<_"F^D \VX6(:]ID)[_ +V +<''M;<^W2OQC_X)N_\
M!83X\?L<_#/Q;\*_@WX-\*^)9/B)>Q7$EK<>'9];NHECC,:06UL',;+\Q8^9
M'(68Y))+%O9? ?\ P0<_;A_X*/\ CC_A)/%WPB\'^ ;/52#+?:WH^F>"4A).
M-QM-/MTN0X&>7MG!ZD,<4 ?U%_ ?X\>$?VG/A'H?CSP'KEKXD\(^)(#<:;J5
MNKK'=('9"0'"L,,K*0P!!4C%>)_!#_E+3^T1_P!D[\ ?^EGBJMS_ ();_L@:
MG^P/^P/\./A%K.J6.LZIX+LI[>XN[+?]GE:6ZFGPA=58A1*%W%5SMSM&<##^
M"'_*6G]HC_LG?@#_ -+/%5 'TU7S+\$/^4M/[1'_ &3OP!_Z6>*J^FJ^9?@A
M_P I:?VB/^R=^ /_ $L\54 </H][\.OB[XIUZU_: ^(^I>&_B/;W4[3>#I?B
M!>^&+#1K%+AQ:2VEO;W,"W,<D(A=KIFG)DDE0/& 8$Z[]FOQ-;P?M.MH7PD\
M<:E\0_A-#IET_BEM2UJX\06_AK5 \'V&#3]2F9WD:9&NS<6IGG$ @M2J6OF$
M7'D__!3KPGI/A[X&?$WQ5'^T=XDDUS08[G4;#PS>W'AF\L=.G\S_ (]T@FT]
MYMJ9V@-(7PHRQ.37T9^RE\/M'\!ZQ=0Z/\<O$WQ.MX[(1)I-_?Z+-;Z<@<8E
MC2PLX&4_P_,2N&Z9P: /F?4_C;\4?@9X"^*>I_#+5O@#HD[?%;Q*=2NOBCKM
MSI=ND:FUV?9_* $C99MPDEC ^3YN3CR+P+_P4I\=?%_Q##I?B?QE\>O$'G,!
M)=_L_P#A#P]X@\.29X/^E1-J5ZB=]P,9''S]17KA_9>7]HG2OB9=3>!?@/XL
MM?#GQ0\43RWOQ%TR2XDT96-HQDM)XUW6^1&3(P9>$3G@UY!X.^&7QI^)WB:&
MS_9[U"-=)W;9?%FA>/O%">"[, _\N_\ :4UQ:WG&<&PM9XLC:\B=@#]!OVOX
MK7P]\/K'6M4^/7B3X$Z+HK,EUJMB^@K'J#.%"),^K6%VNX%3L$01F+L#O^4#
MY7U]/AO^T=<:3X7U3]NSXN3W-UJ-M<:.MU9^#M(GDO4=6@>SN&\/1-YQ9E"F
M%]S"3;R'(/T9\1[23X[^(O"GQ ^$?B#X?>/=?^&%SJ>E2:9JFJXT^:XF5(;A
M)+FUBG>QOX6A\O?]GD9$ENHFB'F93%^*VF_'C]I?X9Z]X!UCX8?"WPKHGBS3
MIM(U35+WQK=:S]EAFC\N22"SBT^ W#*&<J'N+8Y5&R#D  T?^"AMK-8_L_\
M@2&XN9+V>'XH?#])+AT5&G8>*M)!<A0%!8\X4 #/  KYU_;\\*^(/@C^T^OC
MB/PC\0M!_P"%FZU8^%[/Q%\'O'L-MKGB"=;61K9=2T;5($TR26)8)D2?S9':
M/9&> J5[S^V]X,B^''[*7PP\.P7FIZE!H/Q%^'6G1W>I73W5Y=+#XGTB,233
M.2TDK!<L[$EF))Y->2_MBZ5^SU\4?C_J&G_'7]I35IK3PWJMOJ%C\/U\20^'
M=/T&=(!L=GLDAOI9")'?,MRRXD "@"@#HOV"6^"__#2>L74>N?&#6?CY=:.]
MM=_\+6M;^UUZRTH2QR-;VD<L,-FMKYGENQLE*.V"S,5^7MO^"57_ "0_XC?]
MEF^(G_J6:I7"_LJ?M%_LY^!/VL/!OPB_9YT/X836GC#P[KFNZ[JGACR5NK1[
M"734A6X9$WSM/]ME/F2N6!M_XL\=U_P2J_Y(?\1O^RS?$3_U+-4H ^FJ^9O^
M"5?_ "1'XC?]EF^(G_J6:I7TS7S-_P $J_\ DB/Q&_[+-\1/_4LU2@#Z9HHH
MH **** "BBB@ HHHH **** "BBB@#YI\=?L0>,M5_P""D-C^T)X?^(/AG2VL
M_A_-\/CH.H>$I[\/;R7Z7[7'VA-0AQ()8HU \LC;N')(9>5_:A_X)W_%+]KG
MX;V.D^+/C1X774M.^(&C^,[66S\!SQZ?9VVF-%+!816S:HSAGG2626X>9V<2
MA51!&F/L"O&_VI/CS\2OA7&T/PS^$$WQ3U"QLO[3OXY_$,>A0B'<ZK!;2O%+
M]HO'\MRL6U$  WRQ[T# #?%/PB^,WB/Q*U]#\5/!NCPVNE7<5C!8^!KA2=1D
MC,=O<W3/J;?:+> /*PM@(PTC(QD^0 ^4_M _\$A_!OQJ_8/_ .%1Z>WAGPMX
MNAT[3X;3Q[:>&4;5+2_LY(9H]17;,DWGM-"'8FX)8L^YFW'.]H'[>GCCX]_!
MGX<>//@G\&;OX@>'?'WAR#Q%)<:OXFM_#PTP3_ZNU^:.;SIEVR>9MPB;4(9Q
M(,=;^S[^V8WQ6_8TT?XN>)/"TOA5M:$GV31+74%U26\+7;VMFMO*$C68W9\E
MHL  BXCYZF@!&^#WQLT+XAS:]I_Q.\'ZM9ZAX8LM+O\ 0]4\+7"V;ZO ;GS-
M4MVCO2T"3++ KVI$@(M@1*I8FO%=!_X) 7_PV_9N_9U^'/@WXC:1H]K\ _'#
M>/FN;WPFUVFMWTC:B\T,<,=["MI;EM3N=J R% L0W':Q;N/A+_P4OM_C5\-?
MV=[S1?":Q^+_ -HS0;GQ)I.C7FK>5:Z79VMI%<7+SW2PLS;#<6T8"0DLTX.%
M568>I_LG_M06/[4G@K7[R+3I=$USP;XCO_"/B/2WF\\:=J=E($E1)0JB6)T:
M*6.3:I:.:,LJ,610"?P9\-_B-;_&K_A(O$WCWP_J7AVWTB6PM]!T?PQ+IGF7
M,DL+_:KB>2]N#*8UC=(T5(PHN)22Y*[>'O?V*]8N?^"FME^T,OC+34L[/X>3
M?#X^&SH+M(\,FHQ7[7/VS[4 '#Q*H7R"-I/.<$<?\%?V^?B;^T-X_P#C!H?A
MGX5^ X4^#7B>7PMJESJ_Q"N;1;V=+>*X\R$)I,@$?ES)DR%<-D=!N/L/B3]H
MVZ^'O['X^)_B?PEJNCZS#X:@UBZ\)1R"ZU"/4)8$9=)C9!B6Y:X=;9-J_/(R
M@#D"@#A/VS/V)?$G[37Q]^"'CSP_XZT/PG/\%M;N];AL]0\,RZLFJR7%H]HR
M,R7ML8U$<C$8#'=@] 5-KXH?LV?&3XN^'O&VFZE\8O#.G6OB31'T'3(M(\%W
M5JFEQ3N/M<\N[5':>Y:)5CBD5HA!EV"N7(KIO@O^V=X1^-7[$VC?'>Q>XC\(
M:IX6/BJ:-%\ZXLXD@,L\#*OWIHF22-E'\<9%>>_!#]N[QM\7_"GPS\6+\*]-
MG\#?%?3I-2TC5=!\6?VO-IZ_V=/?117L(M(UCDD$/D_N9)D64E2^=F\ J_M>
M_P#!+KP[\=O"'@7_ (5VW@WX0^-?AWXKTWQ9H_B+3O"4=P\,UFQS T44UN7A
MFC>2-T:0J5?D$@&O7?!GP4UW1?VB/%WCC5_$.C:I8^*- TK04TN#1'MFM5L9
M;^7>TS7,@D\QM0EROEK@(HR>2?!K;_@H;\7O^&GO!?PAOO@EX-TGQGXV\&W/
MC6"&Z^(L_DZ?;V\L,,MM<.FDMBY#SJ-L8>/Y6_>=,^S>*?VD=?\ !7[$FL?%
M;5O \FD^(- \+W/B/4/"M[J1C>V>WA>::U-R(6RP$;!7$6&.W@ Y !S_ .PK
M_P $]O"?_!/R[^)=CX%FGM_"?CSQ*?$=CHC ^1X<,D$:2VMOSA;<RK)(B  )
MYI4< &N^_P"&3OA9_P +V_X6E_PK3X?_ /"S?^AN_P"$>M/[>_X]_LO_ !^^
M7Y__ ![_ +G[_P#J_D^[Q7S_ /"__@JA?:CIG[/>M>/?APGA/PG^TQ#8+X2U
MC2O$']L)97M]8&_M;+4(WMK=X9)(E95:'STWK@LJY8>F_'?]O7PK^S_^UC\)
M_A/K%K>M?_%6:XM8=308L]'N!#++9PW#8P'O#;7B0KD%FM)< XH [K]IKX1W
MGQ__ &=O'/@6QU:VT&X\::#>Z&-0GL6O4LUN8'A:3R1+$7*AR0/,7)'6O)O^
M&#M8_P"'4_\ PS/_ ,)MIOG_ /"MO^%:_P#"3?\ "/OL^S?V9_9WVG[']KSY
MGE_-CS]N[VXK4_;%_;"\2?LU?%+X1^%?#_@?2?%EU\7==F\.V5Q?>(WTF'3[
MJ.SGO,R[;2X8QF*WE^902& &W!S5'X+_ +?%Q\6=<^-G@VX\%C0/BG\"1:-K
MNAW&KB;3;N.\M7NK.XMKZ.$LT,T4<G+VZ2(R%6C% '*_M#?\$T=>^.__  3P
M^'_P'7XB:3I,_@D^'O-UX^%I+A+\:/+;RQ;;7[:AB\QK9=V9GP&..QKM'_8\
M\6'_ (*#-\=%\=Z"(O\ A7O_  @@T$^%Y3@_;OMOVO[3]M_O_+Y?E_=_CSS6
M]_P3^_:PF_;F_9#\%_%J3P[%X5MO'%G_ &C9Z:NHF_D@@+%5\R3RHAO)4Y55
M(''S'MYWX _;L^)'QC_:Q^-7PI\*_"WP7)>?!&]TJUU+4-7\=W-G%J*ZC9"]
MMVA2+2IR"(B X<C:QPI<?-0!Y[H'_!&.^TC]C;P;X#'Q4BL/B=\+/%6I^+O
MOQ&TCPQ]CNM NK_4;B^N8I+1[N5;BVE^TR0RPF5$EC"!AN4-7I7Q9_8:^('Q
M)_;*^%OQHM_B5X/T[6_AKX9U30/L$G@FYN+749=0$/FS\:FC1JK0(5CRQ +
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M 8F,;1GY638_83_;R\+?M[^"_%FL>&[6\TUO"/B6[\/W-I>?+-)$FV6SO0I
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MH'X[WWQIFAFB\,Q:&?#?@-+B#RII["::.XOM2P?F6.]DM[$1JV"8K&*3'[T
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M_!(K7/VC-2^&_@?X ^"]#UFYT:XT'PG91,T\T7EB&%!'%#Y]Q*901E0!NRS
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MUR.&TD?P_)=PWEM/I%GB1O,L]C1S,%V3 @Y4UZ)_P2J_Y(?\1O\ LLWQ$_\
M4LU2O9+;]G7P;9^-_!?B.+15CUCX=Z-=^'O#TZW,P&G6-U]D\^$)OV/N^PVO
MS2*S+Y7RD;FW>-_\$JO^2'_$;_LLWQ$_]2S5* /IJOF;_@E7_P D1^(W_99O
MB)_ZEFJ5],U\S?\ !*O_ )(C\1O^RS?$3_U+-4H ^F:*** "BBB@ HHHH **
M** "BBB@ HHJCXE\3Z;X+\/WFK:QJ%CI.E:?$T]U>7DZP6]M&HRSO(Q"JH')
M)( H O5\V_M[?MC>&_@K';?#_5+KX@:+>>--.F:?7O#O@G6?$']BV9;RG:-K
M"UG"7C@N(?,&V,HTKA@B13>W_#KXP^$?B_I[7?A+Q3X<\46JHDK3:1J4-]&$
M<NJL6B9AAC'( >A*,.QK;CU:UFU6:Q2ZMVOK>*.>6W$@,L4<A=8W9>H5C'(
M2,$QL!]TX /E[XD_$>ST/_@F$EI\#]!U_P -QZQIMKX"\ VESHMQIUUIC74Z
M:39W1M9U2>&&#S!<'SE1A%"68**V_'_[.'Q(\$^)OAW:_"IOAO'X)^&OA^/2
MM&TCQ(MYFQN$C-LMPIM_E9EM (4) *"6?KYGR^WM\5O"Z>,_^$;;Q)H"^(L
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M7V_A^\\1Z#:Z]>8^SZ;-J$4=Y/GIMB+;VS@]!0!^8'P.\!^ ?'?Q!_;<\/\
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MKU8Q3@W.G)RO"Z<6H6MIR[W:N>$_"IOLGQR\"VJ[<M'KMQ*1W9O#.K[1D'!
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M?B#0FA+W4(.X6]W;3I);W<().!+&7C#N8I(6<M7DO[17[7?Q+\=?';4/@_\
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M@ KYE_X)X?\ )4_VJO\ LLUS_P"H]H-?35?,O_!/#_DJ?[57_99KG_U'M!H
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MVMY=FU=)8F\Q8L1,)8HY-T*QD,@"[5)4@'SWJ42G_@Y,T5MJ[A^S5?8..?\
MD:+/_$_F:^N=?^%7A7Q?\5=#\4:CIFG7_BGPC8W5KIEQ,JR3:=#>20-*4!^Z
M7:RBP_7]TP!^\*\B\1_\$Y=!\2_M'67Q:D\??$ZU^(&G^&!X.BU2UU.UA/\
M9GG).\+1BV\MB\Z"5G92Q;H0H"CM_A3^RY8_!_PEXML--\6>.;S5?&E^VI:A
MK^J:FM_JB2F"*!1$\L9CBC2.%0D:QA$+.P4,Q) /D[_@W=^%N@>*O^"0'[,?
MB2^TNUFU[POIVIOIM_L"W%N);V_ADCWCDQLLA)0G:65&QE%(WOVFHE/_  7J
M_9;;:NX?#_QI@XYZZ?\ XG\S7T?^QK^R+X9_88^ .C?#+P7=ZW-X1\."1-*M
MM3GCN)+&.21I6C6145W4R.[9D+,-V 0H &!\;?V"?#OQS_:/\,_%:\\4^.]%
M\8>#=.NM+T6?1]0AMXK"WN@@N5"-"P?S/+0DR;L%1MVXH ]'^,_QATGX(?##
MQ-XHU3S;BW\,::^I36=J!)=W  ;RXHH\Y:25U\N-?XW(4<U\$?L'^,]2_9%_
MX*5:EX!\27GB&XTW]I_0?^$W6XU32-0T^WC\;64:KK-K:"ZAC)AFM3#,BCA%
MM-H"\ _45Q_P3N\/ZA-=W-]XY^)^I:GJ&NZ5K]U?WNLQ7$T\NES?:+" AH3&
MMM#<;IA B*AD=F8,370_M3?L6^&?VM]=^'^I^(-4\1Z7J'PQUY/$V@7&CW$-
MO+;:@B-&DK,\3LRA'=3$3Y3A_G1\+M /SV^-/[1^H?LL_P#!4#]JG5KW2M1T
M?X2^(-5\#:=\2O'&C-_Q,O"UA)H5Q%!*$0>:L3SM''+=(2]M&Q9%WLLD7KG_
M  7:\$^$O /_  06\7:+\/\ 3?#]GX-T]O"2:!:Z7L73A:GQ%I1B\IHP5\ME
M(.]=V0Q/.>?I_P (_L)>&?!_Q?\ BMXVCUSQ3J&K?&>TALO$]OJ,EI=V%S'!
M;M;6P2W>W,:B*%V0+@K(#^]64\UYA:?\$7OAC:?L:7'[/_\ PE'Q0E^$\UY;
MWJ:+-KL<GV4P7*W4<<,S0F:*$7"1RB)'"!HQ@ %@P!Z%X/LO'OB[]J'0[SXA
M_"_X?Z#I_AW0[F?1?$&B^()M9G2]DDC@>U+RV5HT*F!W;9MD60G.5,-> _M@
M7*_&#_@N-^SK\,?&D4=U\.=.\%ZWXVTK2[O#6.N>(K>5(8S+$V5FDM+=FGC!
M!\MG\P8(!'TQH?['5E:?%#POXKUCQY\2/%EYX-GGN]+L]6U:-K&*>:VDMFF>
M&&&-9'$,TJJ7W;/,8C!)K3_:3_9&\$_M5VGA]O%%G?PZQX/O_P"U?#NN:5?2
MZ?JV@76W:9;:XB(9=R_*Z'='(ORNK+Q0!5^,?[.O@^[\9:S\4_[&M(_'%GX)
MU7PN=2CB59;G3[AH+AH96QND"R6D90,<)OEP/G-?&G_!,CX1^&M5_P""!WPW
M\7W6BV%SXDTOX.ZII]E?RQ!Y;.&1)Y)%C)^[O=$+$<G8O/%?9UK^RO"?"NI6
M>H^./B!KFK:E8/IAUN^OX&O+:WD(WK#$D*VD;,HVF58!(0?OY"D9/P<_87\+
M_ C]CH? WP[K7BJW\$V^GRZ19M-<037UA92C#V\<K0\J0T@W2*[CS&PPPFT
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M''$3&5B7"+'%"BHVY42%%4 #%>"7/_!&?X87?[,_BCX/R>(/B&?A]XR\1_\
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MQ1HNKVK3:7X1OGTF&.SN(GAWF[LVT[3S<I.2OVJ53&/)#($Z;_@B/\:/A?\
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M3H.J7GBJ7QG:6\FC>08KZWN+">V:[BECDVF%H%28R^;L$7E.7*A21^R>J?\
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MG:3Q8_@S08-#D\<^(;OQ5KKI-+*VHZG=,&GN&,C,06('RKA% PJ@<4 ?.?\
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M";K_ ..T?\.7OV7_ /HD'A__ ,";K_X[0!]045\O_P##E[]E_P#Z)!X?_P#
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M *)!X?\ _ FZ_P#CM'_#E[]E_P#Z)!X?_P# FZ_^.T ?4%%?+_\ PY>_9?\
M^B0>'_\ P)NO_CM'_#E[]E__ *)!X?\ _ FZ_P#CM 'U!17R_P#\.7OV7_\
MHD'A_P#\";K_ ..T?\.7OV7_ /HD'A__ ,";K_X[0!]045\O_P##E[]E_P#Z
M)!X?_P# FZ_^.T?\.7OV7_\ HD'A_P#\";K_ ..T ?4%%?+_ /PY>_9?_P"B
M0>'_ /P)NO\ X[1_PY>_9?\ ^B0>'_\ P)NO_CM 'U!17R__ ,.7OV7_ /HD
M'A__ ,";K_X[1_PY>_9?_P"B0>'_ /P)NO\ X[0!]045\O\ _#E[]E__ *)!
MX?\ _ FZ_P#CM'_#E[]E_P#Z)!X?_P# FZ_^.T ?4%%?+_\ PY>_9?\ ^B0>
M'_\ P)NO_CM'_#E[]E__ *)!X?\ _ FZ_P#CM 'U!17R_P#\.7OV7_\ HD'A
M_P#\";K_ ..T?\.7OV7_ /HD'A__ ,";K_X[0!]045\O_P##E[]E_P#Z)!X?
M_P# FZ_^.T?\.7OV7_\ HD'A_P#\";K_ ..T ?4%%?+_ /PY>_9?_P"B0>'_
M /P)NO\ X[1_PY>_9?\ ^B0>'_\ P)NO_CM 'U!17R__ ,.7OV7_ /HD'A__
M ,";K_X[1_PY>_9?_P"B0>'_ /P)NO\ X[0!]045\O\ _#E[]E__ *)!X?\
M_ FZ_P#CM'_#E[]E_P#Z)!X?_P# FZ_^.T ?4%%?+_\ PY>_9?\ ^B0>'_\
MP)NO_CM'_#E[]E__ *)!X?\ _ FZ_P#CM 'U!17R_P#\.7OV7_\ HD'A_P#\
M";K_ ..T?\.7OV7_ /HD'A__ ,";K_X[0!]045\O_P##E[]E_P#Z)!X?_P#
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21110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175120000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Nov. 04, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SERA PROGNOSTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-1911522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2749 East Parleys Way<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Salt Lake City<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">990-0520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SERA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001534969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,611,720<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175358752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 38,810<span></span>
</td>
<td class="nump">$ 58,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">49,968<span></span>
</td>
<td class="nump">46,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,954<span></span>
</td>
<td class="nump">1,993<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">90,839<span></span>
</td>
<td class="nump">110,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">3,107<span></span>
</td>
<td class="nump">1,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term marketable securities</a></td>
<td class="nump">22,378<span></span>
</td>
<td class="nump">34,848<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">116,561<span></span>
</td>
<td class="nump">147,029<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,088<span></span>
</td>
<td class="nump">1,197<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="nump">4,016<span></span>
</td>
<td class="nump">3,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRentCreditCurrent', window );">Deferred rent, current portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligation, current portion</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">3,091<span></span>
</td>
<td class="nump">3,116<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,667<span></span>
</td>
<td class="nump">8,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligation, net of current portion</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">9,402<span></span>
</td>
<td class="nump">8,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 150,000,000 Class A shares authorized as of September&#160;30, 2022 and December&#160;31, 2021; 29,611,720 and 29,368,867 Class A shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021, respectively; 1,500,000 Class B shares authorized as of September&#160;30, 2022 and December&#160;31, 2021; 1,405,259 Class B shares issued and outstanding as of September&#160;30, 2022 and December&#160;31, 2021.</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">309,233<span></span>
</td>
<td class="nump">305,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,169)<span></span>
</td>
<td class="num">(183)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(200,908)<span></span>
</td>
<td class="num">(166,468)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">107,159<span></span>
</td>
<td class="nump">138,564<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 116,561<span></span>
</td>
<td class="nump">$ 147,029<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of rental payment required by lease over rental income recognized, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 30<br> -Section 25<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123408481&amp;loc=SL77919140-209958<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123415192&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175334736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (unaudited) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in shares)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">29,611,720<span></span>
</td>
<td class="nump">29,368,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">29,611,720<span></span>
</td>
<td class="nump">29,368,867<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in shares)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">1,405,259<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">1,405,259<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175392400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations and Comprehensive Loss (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense', window );">Cost of revenue</a></td>
<td class="nump">58<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,176<span></span>
</td>
<td class="nump">2,724<span></span>
</td>
<td class="nump">10,759<span></span>
</td>
<td class="nump">7,944<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">2,967<span></span>
</td>
<td class="nump">2,690<span></span>
</td>
<td class="nump">11,644<span></span>
</td>
<td class="nump">5,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">4,074<span></span>
</td>
<td class="nump">4,041<span></span>
</td>
<td class="nump">12,900<span></span>
</td>
<td class="nump">9,157<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">11,275<span></span>
</td>
<td class="nump">9,465<span></span>
</td>
<td class="nump">35,437<span></span>
</td>
<td class="nump">22,904<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(11,188)<span></span>
</td>
<td class="num">(9,442)<span></span>
</td>
<td class="num">(35,234)<span></span>
</td>
<td class="num">(22,848)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(439)<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="num">(744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">837<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,712)<span></span>
</td>
<td class="num">$ (9,859)<span></span>
</td>
<td class="num">$ (34,440)<span></span>
</td>
<td class="num">$ (22,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares of common stock outstanding, basic (in shares)</a></td>
<td class="nump">31,005,978<span></span>
</td>
<td class="nump">25,085,013<span></span>
</td>
<td class="nump">30,918,473<span></span>
</td>
<td class="nump">9,707,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares of common stock outstanding, diluted (In shares)</a></td>
<td class="nump">31,005,978<span></span>
</td>
<td class="nump">25,085,013<span></span>
</td>
<td class="nump">30,918,473<span></span>
</td>
<td class="nump">9,707,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized loss on available-for-sale debt securities</a></td>
<td class="num">$ (351)<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
<td class="num">$ (986)<span></span>
</td>
<td class="num">$ (25)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive loss</a></td>
<td class="num">(351)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(986)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (11,063)<span></span>
</td>
<td class="num">$ (9,884)<span></span>
</td>
<td class="num">$ (35,426)<span></span>
</td>
<td class="num">$ (22,550)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822103516400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock (Class A and B)</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Senior Convertible Preferred Stock</div></th>
<th class="th"><div>Junior Convertible Preferred Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,737,440<span></span>
</td>
<td class="nump">9,819,480<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,192<span></span>
</td>
<td class="nump">$ 77,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,938,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,675,922<span></span>
</td>
<td class="nump">9,819,480<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,499<span></span>
</td>
<td class="nump">$ 77,844<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="num">$ (125,570)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 5,889<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (131,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Fair value of warrants to purchase common stock issued to Series E investor</a></td>
<td class="nump">1,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,982,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Mar. 31, 2021</a></td>
<td class="num">(130,390)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,428<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(137,818)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,737,440<span></span>
</td>
<td class="nump">9,819,480<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,192<span></span>
</td>
<td class="nump">$ 77,844<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2020</a></td>
<td class="num">(125,570)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">5,889<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(131,459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(22,525)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,699,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Sep. 30, 2021</a></td>
<td class="nump">150,038<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">304,044<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(153,984)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,675,922<span></span>
</td>
<td class="nump">9,819,480<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,499<span></span>
</td>
<td class="nump">$ 77,844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,115,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,791,579<span></span>
</td>
<td class="nump">9,819,480<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,144<span></span>
</td>
<td class="nump">$ 77,844<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,982,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2021</a></td>
<td class="num">(130,390)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">7,428<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(137,818)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,307)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,004,955<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Jun. 30, 2021</a></td>
<td class="num">(135,798)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">8,327<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(144,125)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,791,579)<span></span>
</td>
<td class="num">(9,819,480)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock', window );">Conversion of preferred stock to common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (149,144)<span></span>
</td>
<td class="num">$ (77,844)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,687,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issuance for initial public offering, net of issuance costs</a></td>
<td class="nump">66,612<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">66,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of preferred stock to common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,839,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits', window );">Conversion of preferred stock to common stock</a></td>
<td class="nump">226,992<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">226,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment', window );">Conversion of preferred stock warrants to common stock warrants</a></td>
<td class="nump">929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">144,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Stock warrant exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(9,859)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,859)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,699,090<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Sep. 30, 2021</a></td>
<td class="nump">150,038<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">304,044<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(153,984)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,774,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="nump">138,564<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">305,212<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="num">(166,468)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(473)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(12,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,897,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Mar. 31, 2022</a></td>
<td class="nump">127,203<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">306,532<span></span>
</td>
<td class="num">(656)<span></span>
</td>
<td class="num">(178,676)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,774,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Dec. 31, 2021</a></td>
<td class="nump">$ 138,564<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">305,212<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="num">(166,468)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="nump">242,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">$ (986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(34,440)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,016,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Sep. 30, 2022</a></td>
<td class="nump">107,159<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">309,233<span></span>
</td>
<td class="num">(1,169)<span></span>
</td>
<td class="num">(200,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the beginning (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the beginning at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the beginning (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,897,593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the beginning at Mar. 31, 2022</a></td>
<td class="nump">127,203<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">306,532<span></span>
</td>
<td class="num">(656)<span></span>
</td>
<td class="num">(178,676)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(162)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,520)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,991,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Jun. 30, 2022</a></td>
<td class="nump">116,905<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">307,916<span></span>
</td>
<td class="num">(818)<span></span>
</td>
<td class="num">(190,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Balance at the ending (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Balance at the ending at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,712)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,712)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Balance at the ending (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,016,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at the ending at Sep. 30, 2022</a></td>
<td class="nump">$ 107,159<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 309,233<span></span>
</td>
<td class="num">$ (1,169)<span></span>
</td>
<td class="num">$ (200,908)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of Preferred Stock Warrants to Common Stock Warrants, Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_StockIssuedDuringPeriodSharesStockWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Stock Warrant Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_StockIssuedDuringPeriodSharesStockWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares, Conversion Of Preferred Stock To Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Value, Conversion Of Preferred Stock To Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123466302&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175118000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (unaudited) (Parenthetical) - Series E Senior Convertible Preferred Stock<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Issue price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 12.46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_TemporaryEquityStockIssuanceCosts', window );">Stock issuance costs | $</a></td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_TemporaryEquityStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Issuance costs of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_TemporaryEquityStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sera_SeriesESeniorConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sera_SeriesESeniorConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822174900208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (34,440)<span></span>
</td>
<td class="num">$ (22,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Operating Lease, Right-of-Use Asset, Amortization Expense</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,714<span></span>
</td>
<td class="nump">2,017<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">588<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="num">(26)<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(80)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="nump">3,116<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">205<span></span>
</td>
<td class="num">(2,085)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(204)<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="num">(534)<span></span>
</td>
<td class="num">(365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_IncreaseDecreaseInDeferredRent', window );">Deferred rent</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(25)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(27,372)<span></span>
</td>
<td class="num">(22,484)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(41,588)<span></span>
</td>
<td class="num">(67,572)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from maturities and sales of marketable securities</a></td>
<td class="nump">49,299<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(598)<span></span>
</td>
<td class="num">(555)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from disposal of property and equipment</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">7,129<span></span>
</td>
<td class="num">(68,127)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds allocated to issuance of common stock warrants in connection with Series E</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering of common stock, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">66,611<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">307<span></span>
</td>
<td class="nump">537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payment of convertible note payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment of loan payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Finance lease principal payments</a></td>
<td class="num">(186)<span></span>
</td>
<td class="num">(51)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">121<span></span>
</td>
<td class="nump">159,557<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(20,122)<span></span>
</td>
<td class="nump">68,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">58,932<span></span>
</td>
<td class="nump">13,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">38,810<span></span>
</td>
<td class="nump">82,479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">1,273<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities', window );">Purchases of property and equipment in accounts payable and accruals</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock', window );">Series E senior convertible preferred stock offering costs prepaid and deferred in prior period and reclassified to Series E senior convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=sera_SeriesESeniorConvertiblePreferredStockMember', window );">Series E Senior Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of Series E senior convertible preferred stock, net of issuance costs</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 98,983<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_IncreaseDecreaseInDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred rent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_IncreaseDecreaseInDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of senior convertible preferred stock offering costs prepaid and deferred in prior period and reclassified to Series E senior convertible preferred stock in the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sera_SeriesESeniorConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sera_SeriesESeniorConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822183018224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Financial Condition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of Business and Financial Condition</a></td>
<td class="text">Description of Business and Financial Condition<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sera Prognostics, Inc. (the &#8220;Company&#8221;) is a women&#8217;s health company utilizing its proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests with an initial focus on improving pregnancy outcomes. The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments (&#8220;CLIA&#8221;)-certified laboratory.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since its inception, the Company&#8217;s activities have consisted of performing research and development, conducting clinical studies, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of $200.9&#160;million as of September&#160;30, 2022. The Company&#8217;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#8217;s commercialization activities for the PreTRM test, and to support additional clinical and preclinical trials and anticipated research and development activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its diagnostic products and could be required to delay, scale back, or abandon some or all of its development programs and other operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all. Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#8217;s future operations are highly dependent on a combination of factors, including (i) the successful commercial launch and market acceptance of the PreTRM test; (ii) the success of clinical trials and other research and development programs; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#8217;s ability to manage growth of the organization; (v) the Company&#8217;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal sources of the Company&#8217;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#8220;IPO&#8221;), which was completed in July 2021. See Note 10&#8212;Capital Structure for additional details about the IPO. As of September&#160;30, 2022, the Company had aggregate cash, cash equivalents, and available-for-sale securities of $111.2 million. See Note 3&#8212;Cash, Cash Equivalents and Marketable Securities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these unaudited condensed financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182937888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021. The unaudited interim condensed financial statements have been </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2021, and, in the opinion of the Company&#8217;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial results. The balance sheet as of December&#160;31, 2021 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2022, or any other period.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Topic 842&#8221;) and its subsequent updates effective January 1, 2022. The Company adopted Topic 842 using a modified retrospective method. As such, comparative periods ending prior to January 1, 2022 are presented in accordance with ASC 840, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and periods ending after January 1, 2022 are presented in accordance with Topic 842. There was no impact to the Company&#8217;s accumulated deficit as a result of adopting Topic 842. The Company used the package of practical expedients permitted under Topic 842. As a result, the Company did not reassess its lease population, classifications of existing leases, or initial direct costs of existing leases as of the adoption date. The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. The Company also elected not to separate lease components from non-lease components for all classes of leased assets except for building leases. </span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of Topic 842 resulted in a right-of-use asset of $0.5&#160;million related to the Company&#8217;s operating lease being recognized in other assets on the condensed balance sheets as of January 1, 2022. A corresponding lease liability of $0.6&#160;million related to the Company&#8217;s operating lease was recognized in accrued and other liabilities on the condensed balance sheets as of January 1, 2022. In addition, at January 1, 2022, approximately $0.1&#160;million of lease-related liabilities were removed from deferred rent, current portion as a reduction to the initial operating lease right-of-use asset. </span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of adopting Topic 842, leases classified as capital leases under ASC 840 are now called finance leases. Accordingly, the condensed balance sheet items formerly captioned &#8220;Capital lease obligation, current portion&#8221; and &#8220;Capital lease obligation, net of current portion&#8221; will now be captioned &#8220;Finance lease obligation, current portion&#8221; and &#8220;Finance lease obligation, net of current portion&#8221;, respectively, beginning in the current period. Amounts in these balance sheet items were capital leases under ASC 840 in periods ending prior to January 1, 2022, while amounts in these balance sheet items are finance leases under ASC 842 in periods ending subsequent to January 1, 2022. The Company&#8217;s finance lease right-of-use asset and liability balances were not materially affected by the adoption of Topic 842. </span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of the condensed financial statements.</span></div><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The objective of the standard is to provide information about expected credit losses on financial instruments at each reporting date and to change how other-than-temporary impairments on investment securities are recorded. The Company is currently an emerging growth company and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. As such, the guidance is effective for the Company beginning on January 1, 2023. The Company is currently evaluating the impact the standard may have on its financial statements and related disclosures but does not currently expect the standard will have a material impact.</span></div>Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) and the SEC did not, or are not believed by the Company&#8217;s management to, have a material impact on the Company&#8217;s financial position, results of operations or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822194154432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock', window );">Cash, Cash Equivalents and Marketable Securities</a></td>
<td class="text">Cash, Cash Equivalents and Marketable Securities<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has classified its marketable securities as available-for-sale. The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of September&#160;30, 2022 and December&#160;31, 2021 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,170)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,848&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of September&#160;30, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(390)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,054&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,170)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, the Company had no available-for-sale debt securities that had been in a continuous unrealized loss position for a period greater than 12 months. The Company determined that no available-for-sale securities were other-than-temporarily impaired as of September&#160;30, 2022 and December&#160;31, 2021. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities classified by contractual maturities as of September&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.719%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822176167728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text">Property and Equipment<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net, as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,740&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,052)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,107&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Depreciation and amortization expense was $0.2&#160;million and $0.1 million for the three months ended September&#160;30, 2022 and 2021, respectively. Depreciation and amortization expense was $0.6 million and $0.5 million for the nine months ended September 30, 2022 and 2021, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822194154432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued and Other Current Liabilities</a></td>
<td class="text">Accrued and Other Current Liabilities<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of accrued and other current liabilities as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued paid time off</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued clinical study costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued 401(k) matching contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,016&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,885&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822179253040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other Income, net</a></td>
<td class="text">Other Income, net<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of other income, net, for the three and nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">128</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">272</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investment income (loss), net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">369</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">565</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Fair value remeasurements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gain on extinguishment of PPP loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other losses, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(20)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">497</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">837</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,067</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI https://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI https://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822192946848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans and Convertible Promissory Notes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Loans and Convertible Promissory Notes</a></td>
<td class="text">Loans and Convertible Promissory Notes<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bank Loan</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2014, through a Loan and Security Agreement with a bank, the Company obtained a term loan for $10.0&#160;million. In March 2021, the Company repaid the outstanding principal of $2.0&#160;million, accrued interest of $6&#160;thousand, and the final payment fee of $0.1&#160;million related to this loan.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Convertible Promissory Note</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2019, the Company authorized the issuance of a $6.4&#160;million subordinated convertible promissory note (the &#8220;Note&#8221;) to a stockholder of the Company, bearing 12% interest and a maturity date of February 26, 2021, to provide liquidity and additional working capital. On February&#160;15, 2021, the maturity date was extended to March 28, 2021. The Note was convertible at the option of the holder into shares of Series D Convertible Preferred Stock at a conversion price equal to 80% of the issuance price of the Series D Convertible Preferred Stock of $9.03 per share. In July 2019, $1.9&#160;million of the $6.4&#160;million Note&#8217;s principal and $0.1&#160;million of accrued interest were converted into 277,507 shares of the Company&#8217;s Series D Preferred Stock. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion feature of the Note met the requirements for separate accounting and was recognized as a liability at the measurement date fair value of $2.4&#160;million, subject to remeasurement to fair value, with any changes in estimated fair value recognized as a component of other income, net. A corresponding discount, which reduced the carrying value of the Note, was also recorded. The unamortized discount was written off in proportion to the partial conversion, with the remaining discount accreted to interest expense until maturity. The Company recognized additional interest expense of $0.1&#160;million from accretion of the discount during the nine months ended September&#160;30, 2021.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March&#160;24, 2021, the Company repaid the outstanding principal of $4.5&#160;million and accrued interest of $1.1&#160;million related to the Note.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Paycheck Protection Loan</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the Company obtained a $1.1&#160;million loan through a bank under the Paycheck Protection Program (&#8220;PPP&#8221;) under the Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;), as amended. The loan&#8217;s purpose was to maintain payroll and make rent and utilities payments as specified under the terms of the PPP. Under the PPP, borrowers may apply for loan forgiveness if the funds are used for payroll costs, mortgage interest, rent, and utilities payments over a specified term following receipt of the loan funds. During the term of the agreement, the Company utilized the loan funds for forgivable purposes and applied for forgiveness. In June 2021, the outstanding $1.1&#160;million PPP loan was forgiven and removed from the Company&#8217;s balance sheet. As a result of the forgiveness of the PPP loan, a $1.1&#160;million gain on extinguishment was recorded in other income, net for the nine months ended September 30, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822179253040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022 and December&#160;31, 2021, the carrying amounts of the Company&#8217;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of September&#160;30, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,510&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">109,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">54,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">135,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822183731360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, the Company entered into a master services agreement with Healthcore Inc. (&#8220;Healthcore&#8221;), a subsidiary of Elevance Health, Inc. (formerly known as Anthem, Inc., &#8220;Elevance Health&#8221;). This agreement covers a range of research projects, including Healthcore&#8217;s role as a contract research organization for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rematurity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">isk Assessment Combined With Clinical </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterventions for Improving Neonatal outco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ME</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s (&#8220;PRIME&#8221;) study. The Company paid fees related to this agreement of $0.6&#160;million and $0.4&#160;million for the three months ended September&#160;30, 2022 and 2021, respectively, and $1.7&#160;million and $1.1 million for the nine months ended September 30, 2022 and 2021, respectively. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. The Company recognized revenues related to this agreement of $17&#160;thousand for the three months ended September&#160;30, 2022 and 2021, and $59&#160;thousand and $41&#160;thousand for the nine months ended September 30, 2022 and 2021, respectively.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#8220;Commercial Collaboration Agreement&#8221;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#8217;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first three years of the term of the Commercial Collaboration Agreement. The Company received $3.1&#160;million during the nine months ended September 30, 2022, which amount related to the minimum payments for the year ended December&#160;31, 2021. Such minimum payments were initially recorded as deferred revenue at December&#160;31, 2021. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. There were no cash receipts related to the Commercial Collaboration Agreement for the nine months ended September 30, 2021. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elevance Health has been participating in the Company&#8217;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#8217;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#8220;ASC 808&#8221;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to </span></div>occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the three and nine months ended September&#160;30, 2022 and 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI https://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822178383952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Structure</a></td>
<td class="text">Capital Structure<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July&#160;19, 2021, the Company completed its IPO and issued 4,687,500 shares of its Class A common stock at a price of $16.00 per share for net proceeds of approximately $66.6&#160;million, after deducting underwriting discounts and commissions and offering expenses payable by the Company. In connection with the IPO, all shares of convertible preferred stock converted into 22,434,130 shares of Class A common stock and 1,405,259 shares of Class B common stock and no new shares of convertible preferred stock have since been issued.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to one share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#8217;s amended and restated certificate of incorporation. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares of Class A common stock were reserved for future issuance:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,532,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,287,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,822,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,136,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">598,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">305,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,730,519&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,517,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182837872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#8220;2011 Plan&#8221;) and reserved shares of the Company&#8217;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a four-year period and generally expire ten years from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors, and consultants of the Company. Options generally vest over a four-year period and options generally expire ten years from the date of grant. Options are exercisable only to the extent vested. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of September&#160;30, 2022, there were 1,822,815 shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 Plan. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Employee Stock Purchase Plan (the &#8220;2021 ESPP&#8221;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of September&#160;30, 2022, no shares had been granted under the 2021 ESPP and there were 598,777 shares of the Company&#8217;s Class A common stock that were available for future grants under the 2021 ESPP. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, references to &#8220;options&#8221; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. The following table summarizes information about these options granted and outstanding:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,287,126&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.36&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,095&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,185,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,924)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(694,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(242,853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,532,949&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,133,642&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and exercisable at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,800,098&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">453&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">283&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">717&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Sales and marketing expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total employee stock-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September&#160;30, 2022, there was $12.0&#160;million of unrecognized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 2.6 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182775632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_WarrantsTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warrants to purchase Class A common stock</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. The Company&#8217;s common stock warrants outstanding were as follows:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of Warrants Outstanding as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>During the nine months ended September 30, 2022, 12,506 common stock warrants expired unexercised.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182804528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingences<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingences</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#8217;s leases, the Company&#8217;s incremental borrowing rate or the Company&#8217;s intent to exercise or not exercise options available in lease contracts. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of September&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease-Related Assets and Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Statement Line Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_0049bb1e-6361-4f5b-bc41-972d98f2f6a3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_7e1627ae-b748-46d6-9015-15e5ad4fd6be">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_5469c87e-2e2e-466c-9319-75c619518553"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_a4928ad8-769b-47ab-8011-2c8705edcb02">Property and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_67f2aafd-7934-4f80-a929-ab372ba3fe4d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_b288df54-e98f-412a-96c5-369a8ce12b19">Accrued and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of September&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases a total of approximately 24,100 square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2022. The terms of the lease agreement included an option to renew the lease for one additional five-year rental period, which the Company did not exercise. Instead, in October 2022, the Company entered into an amendment for its operating lease. See Note 15&#8212;Subsequent Events</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company includes lease extension options in the right-of-use asset and lease liability when the Company is reasonably certain it will exercise the options. The rate implicit in the Company&#8217;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance Leases</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#8217;s current finance leases include bargain purchase options that the Company is reasonably certain to exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#8217;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#8217;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#8217;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has no liabilities recorded for these agreements as of September&#160;30, 2022 and December&#160;31, 2021. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Agreements</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#8217;s future results of operations, cash flows, or financial position.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822179252752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net loss per share</a></td>
<td class="text">Net loss per share<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the three and nine months ended September&#160;30, 2022 and 2021, the Company reported net losses and as such, basic and diluted net loss per share are the same. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of the Company&#8217;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the three and nine months ended September&#160;30, 2022 and 2021. </span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A and Class B common stock during the three and nine months ended September&#160;30, 2022 and 2021 (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,227)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(485)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,875)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,565)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common stock outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29,600,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,405,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29,513,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,405,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9,415)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(444)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(884)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common stock outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23,954,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,130,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,326,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">380,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,532,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,018,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,308,927&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,806,834&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182828288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent EventsLease AmendmentOn October 10, 2022, the Company entered into the Second Amendment to the Lease (the &#8220;Second Amendment&#8221;) with Eastland Regency, L.C. for its headquarters located in Salt Lake City, Utah. The Second Amendment modified the lease agreements, dated August 1, 2017 and amended on June 7, 2021 (the &#8220;Lease&#8221;), to extend the term of the Lease an additional <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfMTA5OTUxMTYyODQyNA_df1e695d-5bfe-4eae-921e-ce6dee848024">three</span> years to expire on December 31, 2025 (the &#8220;Extended Term&#8221;), and provide the Company with an early termination right which termination would occur under certain circumstances as provided in the Second Amendment after July 1, 2024 if exercised. Subject to adjustment as set forth in the Second Amendment, the rent payable to Eastland Regency, L.C. during the Extended Term is an amount equal to approximately $1.9 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822174868880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021. The unaudited interim condensed financial statements have been </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2021, and, in the opinion of the Company&#8217;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#8217;s financial results. The balance sheet as of December&#160;31, 2021 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2022, or any other period.</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adopted ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;Topic 842&#8221;) and its subsequent updates effective January 1, 2022. The Company adopted Topic 842 using a modified retrospective method. As such, comparative periods ending prior to January 1, 2022 are presented in accordance with ASC 840, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and periods ending after January 1, 2022 are presented in accordance with Topic 842. There was no impact to the Company&#8217;s accumulated deficit as a result of adopting Topic 842. The Company used the package of practical expedients permitted under Topic 842. As a result, the Company did not reassess its lease population, classifications of existing leases, or initial direct costs of existing leases as of the adoption date. The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. The Company also elected not to separate lease components from non-lease components for all classes of leased assets except for building leases. </span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of Topic 842 resulted in a right-of-use asset of $0.5&#160;million related to the Company&#8217;s operating lease being recognized in other assets on the condensed balance sheets as of January 1, 2022. A corresponding lease liability of $0.6&#160;million related to the Company&#8217;s operating lease was recognized in accrued and other liabilities on the condensed balance sheets as of January 1, 2022. In addition, at January 1, 2022, approximately $0.1&#160;million of lease-related liabilities were removed from deferred rent, current portion as a reduction to the initial operating lease right-of-use asset. </span></div>As a result of adopting Topic 842, leases classified as capital leases under ASC 840 are now called finance leases. Accordingly, the condensed balance sheet items formerly captioned &#8220;Capital lease obligation, current portion&#8221; and &#8220;Capital lease obligation, net of current portion&#8221; will now be captioned &#8220;Finance lease obligation, current portion&#8221; and &#8220;Finance lease obligation, net of current portion&#8221;, respectively, beginning in the current period. Amounts in these balance sheet items were capital leases under ASC 840 in periods ending prior to January 1, 2022, while amounts in these balance sheet items are finance leases under ASC 842 in periods ending subsequent to January 1, 2022. The Company&#8217;s finance lease right-of-use asset and liability balances were not materially affected by the adoption of Topic 842.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#8217;s assets or liabilities as of the date of the condensed financial statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-top:11pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-top:11pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The objective of the standard is to provide information about expected credit losses on financial instruments at each reporting date and to change how other-than-temporary impairments on investment securities are recorded. The Company is currently an emerging growth company and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. As such, the guidance is effective for the Company beginning on January 1, 2023. The Company is currently evaluating the impact the standard may have on its financial statements and related disclosures but does not currently expect the standard will have a material impact.</span></div>Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) and the SEC did not, or are not believed by the Company&#8217;s management to, have a material impact on the Company&#8217;s financial position, results of operations or cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822181113904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type</a></td>
<td class="text">The Company&#8217;s cash, cash equivalents and marketable securities by major security type as of September&#160;30, 2022 and December&#160;31, 2021 were as follows (in thousands):<div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,692&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,502&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,830&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,752&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112,325&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,170)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.475%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,672&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,656&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,848&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,146&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,963&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Marketable Securities Classified by Contractual Maturities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities classified by contractual maturities as of September&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.719%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,509&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,346&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Schedule of Marketable Securities and Cash Equivalents in Unrealized Loss Positions</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s available-for-sale debt securities and cash equivalents with unrealized losses as of September&#160;30, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less than 12 months</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or greater</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,689&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(390)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(113)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(377)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,054&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(657)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,206&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,170)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822179244128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Components of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of property and equipment, net, as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Computer equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">320&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total property and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,740&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(6,052)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(5,967)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,107&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,773&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182802528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Components of Accrued and Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of accrued and other current liabilities as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,498&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued paid time off</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">504&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued clinical study costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Accrued 401(k) matching contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Operating lease liability, current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,016&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,885&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182802528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Components of Other Income, Net</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the components of other income, net, for the three and nine months ended September&#160;30, 2022 and 2021 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Interest income</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">128</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">32</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">272</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">53</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Investment income (loss), net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">369</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">565</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Fair value remeasurements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Gain on extinguishment of PPP loan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other losses, net</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(20)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Other income, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">497</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">22</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">837</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,067</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822179252752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of September&#160;30, 2022:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,510&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">36,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">37,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">19,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,510&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">109,242&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the Company&#8217;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2021:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,021&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">54,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">39,672&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">25,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,656&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">135,872&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182820928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following shares of Class A common stock were reserved for future issuance:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,532,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,287,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,822,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,136,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">598,777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">305,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">13,730,519&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12,517,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tabular disclosure of common stock reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822179246640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Options Granted and Outstanding</a></td>
<td class="text">The following table summarizes information about these options granted and outstanding:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of<br/>Shares<br/>Subject to<br/>Options<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Exercise Price<br/>Per Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Remaining<br/>Contractual<br/>Life (In Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic Value<br/>(In Thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,287,126&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.36&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,095&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,185,510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Expired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,924)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Cancelled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(694,910)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(242,853)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Outstanding &#8212; September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,532,949&#160;</span></td><td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and expected to vest at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,133,642&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">7.9</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Vested and exercisable at September&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,800,098&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Impact of Stock-based Compensation Expense in the Statements of Operations</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">453&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">283&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">717&#160;</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Sales and marketing expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">General and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">452&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Total employee stock-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">914&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822181176064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Warrants or Rights</a></td>
<td class="text">The Company&#8217;s common stock warrants outstanding were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.832%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Number of Warrants Outstanding as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">December 31, 2021</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">5.20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">3,473&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">15,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,032,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">10.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,009,795&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">12.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">20.77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">722,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175167168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock', window );">Schedule of Leases in Financial Statement</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of September&#160;30, 2022 (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.324%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.354%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease-Related Assets and Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial Statement Line Items</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_0049bb1e-6361-4f5b-bc41-972d98f2f6a3"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_7e1627ae-b748-46d6-9015-15e5ad4fd6be">Other assets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_5469c87e-2e2e-466c-9319-75c619518553"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_a4928ad8-769b-47ab-8011-2c8705edcb02">Property and equipment, net</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,517&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_67f2aafd-7934-4f80-a929-ab372ba3fe4d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_b288df54-e98f-412a-96c5-369a8ce12b19">Accrued and other current liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation, net of current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost and Other Information</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease costs and other information consisted of the following (in thousands, except terms and rates):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.687%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.901%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease cost</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of September&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for the Company&#8217;s leases as of September&#160;30, 2022 were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.860%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.902%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026 and thereafter</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total minimum lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,306&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,457&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future lease payments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,357&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leases In Statement Of Financial Position</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182999536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of basic and diluted net loss per share of Class A and Class B common stock during the three and nine months ended September&#160;30, 2022 and 2021 (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(10,227)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(485)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(32,875)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1,565)</span></td><td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common stock outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29,600,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,405,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">29,513,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,405,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.35)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(1.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Three Months Ended<br/>September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Nine Months Ended<br/>September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(9,415)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(444)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(21,641)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(884)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Weighted average common stock outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">23,954,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1,130,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">9,326,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">380,913&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Net loss per share &#8212; basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(0.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">(2.32)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Warrants to purchase Class A common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,775,978&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2,788,484&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">Options to purchase Class A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,532,949&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">6,018,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">11,308,927&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8,806,834&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822182036480">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of Business and Financial Condition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">$ (200,908)<span></span>
</td>
<td class="num">$ (166,468)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue', window );">Fair Value</a></td>
<td class="nump">$ 111,156<span></span>
</td>
<td class="nump">$ 139,963<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175038592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member', window );">Accounting Standards Update 2016-02</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent', window );">Lease-related liabilities removed from deferred rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Lease-Related Liabilities Removed From Deferred Rent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201602Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822178247232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 73,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">72,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">112,325<span></span>
</td>
<td class="nump">$ 140,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,170)<span></span>
</td>
<td class="num">(183)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue', window );">Fair Value</a></td>
<td class="nump">111,156<span></span>
</td>
<td class="nump">139,963<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">38,816<span></span>
</td>
<td class="nump">58,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">38,810<span></span>
</td>
<td class="nump">58,932<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">404<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">1,510<span></span>
</td>
<td class="nump">4,021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">1,510<span></span>
</td>
<td class="nump">4,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents: | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAmortizedCost', window );">Amortized Cost</a></td>
<td class="nump">36,902<span></span>
</td>
<td class="nump">54,843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value</a></td>
<td class="nump">36,896<span></span>
</td>
<td class="nump">54,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">50,757<span></span>
</td>
<td class="nump">46,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(789)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">49,968<span></span>
</td>
<td class="nump">46,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">15,861<span></span>
</td>
<td class="nump">39,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(68)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">15,793<span></span>
</td>
<td class="nump">39,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">506<span></span>
</td>
<td class="nump">6,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">6,511<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">25,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(515)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">25,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember', window );">Current marketable securities: | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">8,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">22,752<span></span>
</td>
<td class="nump">35,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(153)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">22,378<span></span>
</td>
<td class="nump">34,848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">12,024<span></span>
</td>
<td class="nump">25,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(194)<span></span>
</td>
<td class="num">(112)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">11,830<span></span>
</td>
<td class="nump">25,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember', window );">Long-term marketable securities: | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">10,728<span></span>
</td>
<td class="nump">8,694<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(181)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 10,548<span></span>
</td>
<td class="nump">$ 8,656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=sera_CurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=sera_NonCurrentMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822178543264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">$ 85,054,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">657,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">23,206,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">513,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">108,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">1,170,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">52,689,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">52,689,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">496,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">496,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">17,882,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">319,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">19,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">390,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">37,007,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">709,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract', window );"><strong>Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Fair Value</a></td>
<td class="nump">14,483,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">264,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">3,585,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">113,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Fair Value</a></td>
<td class="nump">18,068,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Unrealized Losses</a></td>
<td class="nump">$ 377,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822181113648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAbstract', window );"><strong>Cash and Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">Fair Value</a></td>
<td class="nump">$ 23,206,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld', window );">Debt securities, available-for-sale, other than temporary impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of credit losses recognized in earnings related to debt securities held for which a portion of an other than temporary impairment (OTTI) was recognized in other comprehensive income (a component of shareholders' equity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL6284393-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=SL6284393-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822180988880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 50,757<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">22,752<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">73,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">49,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">22,378<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 72,346<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822178156432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Components of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">$ 9,159<span></span>
</td>
<td class="nump">$ 7,740<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(6,052)<span></span>
</td>
<td class="num">(5,967)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">3,107<span></span>
</td>
<td class="nump">1,773<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">5,910<span></span>
</td>
<td class="nump">5,033<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">1,227<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">992<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822103446448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 553<span></span>
</td>
<td class="nump">$ 514<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822178399408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract', window );"><strong>Accounts Payable and Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 2,033<span></span>
</td>
<td class="nump">$ 2,498<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedVacationCurrent', window );">Accrued paid time off</a></td>
<td class="nump">504<span></span>
</td>
<td class="nump">460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_AccruedClinicalStudyCostsCurrent', window );">Accrued clinical study costs</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued 401(k) matching contributions</a></td>
<td class="nump">482<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current portion</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">315<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities', window );">Total accrued and other current liabilities</a></td>
<td class="nump">$ 4,016<span></span>
</td>
<td class="nump">$ 3,885<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_AccruedClinicalStudyCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Clinical Study Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_AccruedClinicalStudyCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesAndOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesAndOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedVacationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 25<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6409733&amp;loc=d3e19396-108361<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedVacationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822176196880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Income, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other Income and Expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 272<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium', window );">Investment income (loss), net</a></td>
<td class="nump">369<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1', window );">Fair value remeasurements</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingGainsLosses', window );">Other losses, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">$ 497<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">$ 837<span></span>
</td>
<td class="nump">$ 1,067<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionChangesInFairValueGainLoss1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14172-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionChangesInFairValueGainLoss1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7,9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822103475792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans and Convertible Promissory Notes - Bank Loan (Details) - Loan and Security Agreement - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermLoansFromBank', window );">Term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Repayment of outstanding principal</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RepaymentOfAccruedInterestOnLongTermDebt', window );">Repayment of accrued interest</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Final payment fee</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RepaymentOfAccruedInterestOnLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for repayment of accrued interest on long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RepaymentOfAccruedInterestOnLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansFromBank">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansFromBank</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=sera_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=sera_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822103328032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans and Convertible Promissory Notes - Convertible Promissory Notes (Details) - February 2019 Convertible Note<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 24, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt instrument, convertible, conversion price (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Liability at the measurement date fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Accretion of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Repayment of outstanding principal</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RepaymentOfAccruedInterestOnLongTermDebt', window );">Repayment of accrued interest</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=sera_February2019ConvertibleNoteMember', window );">Series D Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Debt instrument, conversion price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionOriginalDebtAmount1', window );">Amount of original debt converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseLongTermDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt conversion, converted instrument, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RepaymentOfAccruedInterestOnLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for repayment of accrued interest on long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RepaymentOfAccruedInterestOnLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionOriginalDebtAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionOriginalDebtAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest paid or due on all long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=sera_February2019ConvertibleNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=sera_February2019ConvertibleNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=sera_SeriesDConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=sera_SeriesDConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822178215312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans and Convertible Promissory Notes - Paycheck Protection Loan (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=sera_PaycheckProtectionProgramLoanMember', window );">Paycheck Protection Program Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDecreaseForgiveness', window );">Amount of debt outstanding</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDecreaseForgiveness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDecreaseForgiveness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=sera_PaycheckProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=sera_PaycheckProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822104136192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">$ 72,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">1,510<span></span>
</td>
<td class="nump">$ 4,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">1,510<span></span>
</td>
<td class="nump">4,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">109,242<span></span>
</td>
<td class="nump">135,872<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">15,793<span></span>
</td>
<td class="nump">39,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">496<span></span>
</td>
<td class="nump">7,028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">37,007<span></span>
</td>
<td class="nump">25,675<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">19,050<span></span>
</td>
<td class="nump">8,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">36,896<span></span>
</td>
<td class="nump">54,841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | U.S. federal agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | U.S. government securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Marketable securities:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Recurring | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822176116880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sera_HealthcoreIncMember', window );">Healthcore Inc | Master services agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Fees paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sera_ElevanceHealthIncMember', window );">Elevance Health, Inc | Laboratory Services Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Recognized revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">$ 17,000<span></span>
</td>
<td class="nump">59,000<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sera_ElevanceHealthIncMember', window );">Elevance Health, Inc | Commercial Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm', window );">Term of agreement</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RelatedPartyTransactionCashReceivedFromRelatedParty', window );">Cash receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RelatedPartyTransactionCashReceivedFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Cash Received From Related Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RelatedPartyTransactionCashReceivedFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sera_HealthcoreIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sera_HealthcoreIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_MasterServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sera_ElevanceHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=sera_ElevanceHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_LaboratoryServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sera_CommercialCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822104071776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Structure - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 19, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>vote </div>
<div>common_stock_class </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering of common stock, net of issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 66,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_NumberOfCommonStockClassesAuthorized', window );">Number of common stock classes authorized | common_stock_class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommonStockConversionRatio', window );">Common stock, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Issue price per share (in usd per share) | $ / shares</a></td>
<td class="nump">$ 16.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering of common stock, net of issuance costs | $</a></td>
<td class="nump">$ 66,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock issued from conversion of convertible securities (in shares)</a></td>
<td class="nump">22,434,130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_NumberOfVotesPerShare', window );">Number of votes per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock | Initial Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of shares of common stock issued (in shares)</a></td>
<td class="nump">4,687,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock issued from conversion of convertible securities (in shares)</a></td>
<td class="nump">1,405,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CommonStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CommonStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_NumberOfCommonStockClassesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Common Stock Classes Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_NumberOfCommonStockClassesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_NumberOfVotesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Votes Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_NumberOfVotesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175020832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Capital Structure - Common Stock (Details) - Class A common stock - shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">13,730,519<span></span>
</td>
<td class="nump">12,517,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Warrants to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,775,978<span></span>
</td>
<td class="nump">2,788,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Options to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">8,532,949<span></span>
</td>
<td class="nump">6,287,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock available for future grants under the 2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">1,822,815<span></span>
</td>
<td class="nump">3,136,737<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">598,777<span></span>
</td>
<td class="nump">305,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CapitalSharesReservedForFutureIssuanceAxis=sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822180863008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2011</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized stock-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized stock-based compensation cost expected to be recognized over a weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,730,519<span></span>
</td>
<td class="nump">12,517,436<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2011Member', window );">2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_Plan2021Member', window );">2021 Plan | Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,822,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_PlanEspp2021Member', window );">2021 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Shares granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=sera_PlanEspp2021Member', window );">2021 ESPP | Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_Plan2011Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_Plan2011Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_Plan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_Plan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=sera_PlanEspp2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=sera_PlanEspp2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822180822496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Options (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares Subject to Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the beginning (in shares) | shares</a></td>
<td class="nump">6,287,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">3,185,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares) | shares</a></td>
<td class="num">(1,924)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled (in shares) | shares</a></td>
<td class="num">(694,910)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(242,853)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at the end (in shares) | shares</a></td>
<td class="nump">8,532,949<span></span>
</td>
<td class="nump">6,287,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares subject to options outstanding, vested and expected to vest at the end (in shares) | shares</a></td>
<td class="nump">8,133,642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of shares subject to options outstanding, vested and exercisable at the end | shares</a></td>
<td class="nump">3,800,098<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted- Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the beginning (in usd per share) | $ / shares</a></td>
<td class="nump">$ 4.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in usd per share) | $ / shares</a></td>
<td class="nump">3.26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Expired (in usd per share) | $ / shares</a></td>
<td class="nump">0.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Cancelled (in usd per share) | $ / shares</a></td>
<td class="nump">7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in usd per share) | $ / shares</a></td>
<td class="nump">1.27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at the end (in usd per share) | $ / shares</a></td>
<td class="nump">3.78<span></span>
</td>
<td class="nump">$ 4.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price per share, vested and expected to vest at the end (in usd per share) | $ / shares</a></td>
<td class="nump">3.73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price per share, vested and exercisable at the end (in usd per share) | $ / shares</a></td>
<td class="nump">$ 2.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual life, outstanding</a></td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, vested and expected to vest at the end</a></td>
<td class="text">7 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual life, vested and exercisable at the end</a></td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding | $</a></td>
<td class="nump">$ 444<span></span>
</td>
<td class="nump">$ 20,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at the end | $</a></td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, vested and exercisable at the end | $</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822104211712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">$ 1,278<span></span>
</td>
<td class="nump">$ 914<span></span>
</td>
<td class="nump">$ 3,714<span></span>
</td>
<td class="nump">$ 2,017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">453<span></span>
</td>
<td class="nump">283<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">179<span></span>
</td>
<td class="nump">420<span></span>
</td>
<td class="nump">358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total employee stock-based compensation</a></td>
<td class="nump">$ 794<span></span>
</td>
<td class="nump">$ 452<span></span>
</td>
<td class="nump">$ 2,007<span></span>
</td>
<td class="nump">$ 942<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822176081808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Common Stock Warrants Outstanding (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">2,775,978<span></span>
</td>
<td class="nump">2,788,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember', window );">5.20</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 5.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">3,473<span></span>
</td>
<td class="nump">15,979<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember', window );">9.03</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 9.03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,032,404<span></span>
</td>
<td class="nump">1,032,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember', window );">10.84</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 10.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,009,795<span></span>
</td>
<td class="nump">1,009,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember', window );">12.38</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 12.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">8,083<span></span>
</td>
<td class="nump">8,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt2077SharePriceMember', window );">20.77</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in usd per share)</a></td>
<td class="nump">$ 20.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">722,223<span></span>
</td>
<td class="nump">722,223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt9.03SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt10.84SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt1238SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt2077SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt2077SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822103442080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember', window );">5.20</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_ClassOfWarrantOrRightExpired', window );">Class of Warrant Or Right, Expired</a></td>
<td class="nump">12,506<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_ClassOfWarrantOrRightExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Expired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_ClassOfWarrantOrRightExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=sera_CommonStockWarrantAt520SharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822175023200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingences - Leases in Financial Statement (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RightOfUseAssetAbstract', window );"><strong>Right-of-use assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">$ 116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance leases</a></td>
<td class="nump">1,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_RightOfUseAssetTotal', window );">Total right-of-use assets</a></td>
<td class="nump">1,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesAbstract', window );"><strong>Lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligation, current portion</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligation, net of current portion</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesTotal', window );">Total lease liabilities</a></td>
<td class="nump">$ 1,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other assets<span></span>
</td>
<td class="text">Other assets<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">Property and equipment, net<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
<td class="text">Accrued Liabilities and Other Liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RightOfUseAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RightOfUseAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_RightOfUseAssetTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_RightOfUseAssetTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822103339760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingences - Lease Cost and Other Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">116<span></span>
</td>
<td class="nump">349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_FinanceLeasesOtherInformationAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash outflows</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash outflows</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">186<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_OperatingLeasesOtherInformationAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">3 months 18 days<span></span>
</td>
<td class="text">3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_FinanceLeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Leases, Other Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_FinanceLeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_OperatingLeasesOtherInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Leases, Other Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_OperatingLeasesOtherInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822174941216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingences - Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">$ 151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">151<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(99)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">1,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">472<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">735<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityPaymentDueAbstract', window );"><strong>Total</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear', window );">2022</a></td>
<td class="nump">286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearOne', window );">2023</a></td>
<td class="nump">518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearTwo', window );">2024</a></td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearThree', window );">2025</a></td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityToBePaidYearFourAndThereafter', window );">2026 and thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityPaymentDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilitiesTotal', window );">Total lease liabilities</a></td>
<td class="nump">1,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityCurrent', window );">Less: current portion</a></td>
<td class="nump">622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">$ 735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, Year Four and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilitiesTotal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Total</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilitiesTotal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityPaymentDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityPaymentDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityPaymentDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Payment, Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityPaymentDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Remainder of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearFourAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year Four and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearFourAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityToBePaidYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, to be Paid, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityToBePaidYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease, Liability, Undiscounted Excess Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, Year Four and Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822178171984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingences - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal period of lease</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_IndemnificationLiability', window );">Indemnification liability | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember', window );">Office and laboratory space</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_CommitmentsAndContingenciesLineItems', window );"><strong>Commitments And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory', window );">Number of square feet under lease | ft&#178;</a></td>
<td class="nump">24,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_CommitmentsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments And Contingencies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_CommitmentsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_IndemnificationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of indemnification liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_IndemnificationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The area of leased office and laboratory space.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sera_OfficeAndLaboratorySpaceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822180768608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share - Computation of the Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,712)<span></span>
</td>
<td class="num">$ (11,520)<span></span>
</td>
<td class="num">$ (12,208)<span></span>
</td>
<td class="num">$ (9,859)<span></span>
</td>
<td class="num">$ (6,307)<span></span>
</td>
<td class="num">$ (6,359)<span></span>
</td>
<td class="num">$ (34,440)<span></span>
</td>
<td class="num">$ (22,525)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common stock outstanding, basic (in shares)</a></td>
<td class="nump">31,005,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,085,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,918,473<span></span>
</td>
<td class="nump">9,707,254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common stock outstanding, diluted (in shares)</a></td>
<td class="nump">31,005,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,085,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,918,473<span></span>
</td>
<td class="nump">9,707,254<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share &#8212; basic (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share &#8212; diluted (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (9,415)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (32,875)<span></span>
</td>
<td class="num">$ (21,641)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common stock outstanding, basic (in shares)</a></td>
<td class="nump">29,600,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,954,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,513,214<span></span>
</td>
<td class="nump">9,326,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common stock outstanding, diluted (in shares)</a></td>
<td class="nump">29,600,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,954,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,513,214<span></span>
</td>
<td class="nump">9,326,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share &#8212; basic (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share &#8212; diluted (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems', window );"><strong>Impairment Effects on Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (485)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (444)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,565)<span></span>
</td>
<td class="num">$ (884)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common stock outstanding, basic (in shares)</a></td>
<td class="nump">1,405,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,130,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
<td class="nump">380,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common stock outstanding, diluted (in shares)</a></td>
<td class="nump">1,405,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,130,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,405,259<span></span>
</td>
<td class="nump">380,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share &#8212; basic (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share &#8212; diluted (in usd per share)</a></td>
<td class="num">$ (0.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.11)<span></span>
</td>
<td class="num">$ (2.32)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822180924480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">11,308,927<span></span>
</td>
<td class="nump">8,806,834<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember', window );">Warrants to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">2,775,978<span></span>
</td>
<td class="nump">2,788,484<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive securities excluded from the computation of earnings per share (in shares)</a></td>
<td class="nump">8,532,949<span></span>
</td>
<td class="nump">6,018,350<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=sera_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm139822181893104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Oct. 10, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal period of lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal period of lease</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sera_AdditionalMinimumOperatingLeasePaymentsDue', window );">Additional Minimum Operating Lease Payments Due</a></td>
<td class="nump">$ 1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sera_AdditionalMinimumOperatingLeasePaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Minimum Operating Lease Payments Due</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sera_AdditionalMinimumOperatingLeasePaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sera_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>sera-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sera="http://www.seraprognostics.com/20220930"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sera-20220930.xsd" xlink:type="simple"/>
    <context id="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i16957592c4d844449723ff11f81ecd36_I20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-04</instant>
        </period>
    </context>
    <context id="i93397e1b4eb84bd58369f6538fc60773_I20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-04</instant>
        </period>
    </context>
    <context id="i9527d69fa6764ba3bde674ace51bd382_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i70d0004071444462988600b21699ae89_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07dcbd5c00ff43149d052ff104148f12_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib7006217670f4919bc1f54ae58aca198_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i92dcff96f0bf4fa39bb22e90238470f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic51ec012d9294cf09bca3ce7057820b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id7d6832636f54cfb879106d568c3e932_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4568d701d67140978621ef6467b28490_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2ccbd1105a654fee862dae8d937f27b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d0d1d5bdbc7440ebc3c7e39076b89a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie2e001b0b3e94072999336b8b75218c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i46d6b66dc7804d95bad33599f8d253ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i890f658cedbc4a9488358a5cbd47a54f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if4c5d93068fb4cf5875603027219c407_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i17b2a2ad4e524d0eaa981607c6fbfc69_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ideecafdbfb2e400892c41acad085d37c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i675d2ddbd30b48f6aa38beea1d995af9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ibe5ac4edad344a23add99975ad28e041_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9acc8d4b939d44c7b49a30479bd930a8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib11ad9b4bb684f7f9f452c732964d9cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d38ca8b46774d8587bad81a1ff3a877_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie1632c22e5a9407d8bfd8a93f29344c7_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i55bfa45f9f4a4292bcf081e5d15c70c5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i810fc88333fd484d9c7c13ec52d5a637_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i63fb294666b2488e821ae0202b6a42af_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6b62659d21af4f5a9bfbc2ab6c0f6007_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id8fbca8e790a49b79263a594d6204f6e_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i92608e502e7d418c9ee082d453136131_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i58ea917c84dd4e53aea6ee8957e300ae_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1201920f9ebb4530acebcd6bea512aed_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i371f184bfcdc4926af9860e292313519_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if6649d2bf6df4035a225617e298f96cd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i26b85ca758534fa690d547a94d0fd16b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id7f27b7b00714ca6b49f201a81cb6811_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iefdecb634e6746a9bdf022491041a261_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iac27b6b2000c4669a337bc703245dd6f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie67812bd33894a75b67f8c3afd3db12f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i407cbb66b130405f954523a0479a7435_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i37848c02dbe348d3ba5b833c88ca1596_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaf5a14cabce742aeb6dc76b5d7e721f2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i233963b046f2403f9798a7e30959afe5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2ea1a93ebbe64e8697b8dc87ea3b8db5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i26bb98874bf94130aec2131d39b66870_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia159ea90af2444349d3a5b6dc4fb041c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i22c04c1aa9cc4ed1a3a5746977b13f78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i330c66d4416e4935ac95cf6c4b6c1b96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7144665eb1004d61979f59d59cd79ecb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5bee12794c5b43c48f79eadf2318e23e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8286f00ec99f411cbde3e81b53bacd01_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i66b9001f71b5420d9369d32a719c09c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i744e357934604565b8a1ba77622b5d45_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9de38b8fb9704048bc0348159dc7fec2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaaad9d062dd346ed999353e204d90789_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib44a2f2d0ad7493db173717bcd13180b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3acb9c650472454d93eaf5d1391c9c14_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i12055f8d1ea64059813056f3f8ec3acd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ied768dae55ea4525bbb0c49d70717a85_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7b5e4c15c48145beb18f34a8858062fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iccbc303ef6e74469bc7cc9ef0cc54b9b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8766f56549a44835bf6be9b33f3eae25_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if214de55f4ee4b85877312f75285700c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4792be6cc7d049b68b1601a03021fcbb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i143503177ddd45eebbeb3dfa4a241265_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4d1a20885eed4e00b8ec295d3a1a6126_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i368e83cd85ae4b37a1726dba858c0347_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iacd7efb6e7484abdb0dd404594377877_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i80965f98a9d044e49c5b70117ce9946b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9417167952f443a098281a8844ff48bf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if287f4a4ec254420821d8eb16d49742f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icfa9c03858414b669711a350682a6c36_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if84aa7b043f54e55b61863de27a42471_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i916da6c7f85d44858c10f7222fefaebe_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idb22c494aa524d09ba6a6867b74fdb09_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i919c74b4f87b42dfa028394b09d3d6ac_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic28dedecba064022874b838744cc8acc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i44be0a10165d42f2911e8707f403fd1b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1496266b4fc3412b98a1edf4db2a6612_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0211f8c70f4546fab653439ef8421171_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib73f2e6d58834f169b6677f9ed409235_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i581a92110a4843f6a5589fbed073bada_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i793efebda0234678845dfb4d311cf810_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:JuniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ice3e926ca9454ee092de309e776c0053_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i982fe00fe53a4a749b3fe8ea6ceb21a7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i349bc20944944c1e90a30491176f1186_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i2a7b24ecb628442489324a85e9888015_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ifef247b0e8bf4cdf83aa0c89d64ed53f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ice5c668015774084978a3b33807344f8_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i100ed6658c0743798fcbfcfe1fc0bb18_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesESeniorConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idef209848fc148788ca3494cf8345024_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201602Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i426c150219944b5e9da3b86ec1649f1d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i41585eff29234897a3b80b9a1807b068_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i308ca8df8a3c450db8268afabcd6b278_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8e8252a2c5ce48f2be393976df7df3e2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia94d6e17beb54943aec8dffc01b527b9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i27b735bee6644b40a873590cf5490f25_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5dfdc3fff2444683ab97d33895e30f14_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i892e66ef1e914f91954762a487029ccd_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i02965420c7c14abd9839a8d8b42176d5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i295341f5241643588814e697d1be3629_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0fa9319e62f84c96a99782f165bbd352_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89f3e16ed78043789e8e75c2ef6e3598_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic362baeed4fd478d809c38fe093e5c6f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3211865e368e427c97e8b1ed624dbcf0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:CurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f65666786e8428dabc37121eed3caa2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3de9e5774c374348827a38ac65ce15c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia5ff086cec454294bcec367c74433793_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">sera:NonCurrentMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ee644e2f79d4b719b22c7db29592acb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1dfe35561df44ad7a3daf4a423c867c5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i14b38fa83e74416baa59ee3c628b9614_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i673eefc904b445ec8b3f3be9c96ef633_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic496e34f317b4d5b8d382d221926650f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3172f410a08245ccaa4689e1ebcfe8fd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic107f77e19a641f2b66165932a7230ef_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i80780d051c164ea99d2de7902f458fa1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i223dbecf860e4e39a728901fdebb9f9f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic33a6f973d8841edaae5debeec90e7b3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9a394203b40c4fd299a9d183b56e5da5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie2896517d8854cdbb4a8622839fa7044_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i76721169755b495daf0275e4edcb974e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1ea98596ebc94fb597a9a7ecb322370a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i669added0b444346a5f738058ceb934b_I20141231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-12-31</instant>
        </period>
    </context>
    <context id="i9e9ca69a921249c6a78aa32baee42b33_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib88c7314479a44d4bad72460fdabc6d9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i60a0864fc6dd4e8fbe07647b8d79a429_D20190201-20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">sera:SeriesDConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="i600787d311a2404994266e049f220010_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb4eddf3f2864ba99d2b3f2c498583d7_D20210324-20210324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:February2019ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-24</startDate>
            <endDate>2021-03-24</endDate>
        </period>
    </context>
    <context id="i4e0ee74c3ff34aefb683e6d0f0a83a2c_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="id9bcf6ae0b3e42c2bef96302713690d0_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1602ad9e54b945c9bc70c8e1b2cb0cef_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">sera:PaycheckProtectionProgramLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib74370533b2343e5948c7c3132692fee_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icf7511108faf4cd0906efe6af85f04d8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9d63d790f8f54a508f078691f2d26768_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i612e8b546ca046b0bfda86066a454cca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i42d2faf58839437f8edcd20d96b207ca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1458e22a9c914fb9ae75771117d8fd05_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9902d71bf4ff4310af77e9ffa184e4b1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i63a5647d5c0340be84f03046f561d36e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i414b0aaf127042bd88523a0bb531c307_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib2a43bb4ef084888b75d6e3a33541d4f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if96032a7e83741c18f2e92eaa33744cb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8eda479567124bc7814e222145ebc019_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i656a95c6ee6440fc959d2f83704886e6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i918d3cc73cc24feb9a410f56da474f96_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i57d6bf244c40409a995f2c8c55e870cb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6e9ad3bbced74f1286c9edbd11d60a94_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifd27872ed39d473cabd931c1687ec88d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic9f7d318c031453095ba85b0e5175e30_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie045a5e26f014139838acb18403afe93_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib8f2c42715c1443cb59e29a781e6c0e7_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i395ae800742b4df1825940da3494ba86_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idbac569dd2004b2d99ae63842688565b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f27774bd30241ee8942a4cef573525d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib01e4104a4cb425bad5c8fe30243f72a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9132b6cdf5cd402dabd2fca792c7249d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i44df0ed744444847a688f0b9b2610c86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84f85bd632c0444084e27b6374b41155_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i71c26cad06b949fb97802e9a0a40f61c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab4c468c851148af9a6507c50ac2acc0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icafec0a54060431fa19e8c1658de99f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0319da007e0a4472971df069b87d62c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iea0875504fe4402ab5ef06f8708cb41d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i664717ae0afe4dc8864dc9d40f13dcea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7738521c4b514f00a138be71f2fa2aa8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4bf0489931cb444190182c5a4a0920c2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie44f5ba7c5664328b22fafcd4e4e4729_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i625bf249a07e4f79916f01e5b3ae9a49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ac1738373464afaa4f620044f28dc23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14a569c6473f4caba47df2fbed2a5e31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icacf2d98943d4579b2ae6dce4e1d872e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf16684d7e4b4069b71370834c076b72_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7696d66e3a844c518b0767e034d8b610_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97f06024a3634a4a848d749268fa8321_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3f9decf253d24e629dc8d16e78c681cf_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i07d69dbf6533445b9b4296a542908776_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i92b6834e9fa046c889b80dd680ca97ec_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:HealthcoreIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:MasterServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id5a4a33f19a4405284072607fbcb712f_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ife1874e670534eb286f346549f8030e4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if953534ebfe5400a9f6434aa8ae8fe2c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7171c7eb9dbe490681930536b5adb751_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:LaboratoryServicesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia4dfe18e2ba344628fb42a44cbb4c082_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i8faa0127d92747c19730bff7fe96a67d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9cbb3338066a4c86bb22691782cdfd99_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">sera:ElevanceHealthIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sera:CommercialCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if40be873cb3b4110921324e4559ce26b_D20210719-20210719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-19</startDate>
            <endDate>2021-07-19</endDate>
        </period>
    </context>
    <context id="i9f4d8885752a4f3f92312b675720aa76_I20210719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-19</instant>
        </period>
    </context>
    <context id="ibe8b830e52ae447d8c81bd371da3cbc6_D20210719-20210719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-19</startDate>
            <endDate>2021-07-19</endDate>
        </period>
    </context>
    <context id="id6cc8adcb35049f99e17c68122feee4f_D20210719-20210719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-19</startDate>
            <endDate>2021-07-19</endDate>
        </period>
    </context>
    <context id="ied62654e4491444e97d0acab99397010_D20210719-20210719">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-19</startDate>
            <endDate>2021-07-19</endDate>
        </period>
    </context>
    <context id="i59217ebe2e3b446297d6e7d10cdd6508_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia28bd723960742d0bc535d70294b0cec_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i795da5fab0804282a9b140098d707bf3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82559b67f9e148dab9ad2b1eed66b0c6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i36bc42d96e4e433984ab7a8838c57a60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2e079d863e01425487bf0a16e4109cb1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0ebe18a147e84a0e88b4ba20920b22e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i600edf893f194531ba73533739a7ffe3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i5d186423a55d4d4eb1d92c41476d9b48_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sera:CapitalSharesReservedForFutureIssuanceAxis">sera:CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5924a4c2b8a04efd9f8a9b105681d3ac_D20111101-20111130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2011Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-11-01</startDate>
            <endDate>2011-11-30</endDate>
        </period>
    </context>
    <context id="i370eabad665347dea0833447376cc361_D20111101-20111130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2011-11-01</startDate>
            <endDate>2011-11-30</endDate>
        </period>
    </context>
    <context id="i5105b69dd15f4d468202f02b3beddfd8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:Plan2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8b50f0c0967540a28d5b66bd6ed16b1a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if5143f467fec4136b943ecc3bf4ebd64_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">sera:PlanEspp2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib8612108452442a088e51138f3c2554f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia1ed6221f242409f8a9dbaaaee40c814_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i52f60d8b08f641c0b0ced84d1a9fb159_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ae79d05fb1b4c4ea6d13b1014a59490_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifc7ffa070afa4b67be9eacf9bbc4f4a5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i04312bc62a9c45d6b4ffb2e70999f7ce_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0c3b67e645ef427c8250de0d5e967256_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2708055ad45048f9b3a01fd826029750_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idc13b0c45ef84ef9ba43c43526394594_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i029f08fa15fd4befac391e8926338ac0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0b51209f01d949d29b662db2c64c7f22_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i75437e864838472e87ecd3c91bc6d984_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i727bda5c34a14d11b2577e2b1119b092_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iee09ca5ea08d408baf262d9aee778543_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ida49535190ff4a67a90335be92a43202_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iec090a0935104562aa028436a6704741_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib365f1c968bf458f93bb750efed2e461_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt9.03SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04ebe87305d04e299c0f999d0935e08a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i67ed818fbfe34672a57403d2698eb3a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt10.84SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic24f885b56b948b4b07a19510189e079_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id1f25f3dbc48464aacede203398c9efb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt1238SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0530edb52e204249ab51018f35efa2ff_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i84190d49c208410092379bb47e971ccc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt2077SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6bde4ed70d0494f837109a7f9176ae6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">sera:CommonStockWarrantAt520SharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if3480fe1ee8e4d4a882ed4f4391d52f4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sera:OfficeAndLaboratorySpaceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3f3d450f7a124081a7088d0b95d3115c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5fd78f55213f40769bb6407a882dcb00_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">sera:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1fec57d1a2df4384aef09573ccdf6570_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i78569680632f4aa9bc2c2383b785be95_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i287e032d20624fe0a98f6658b3eb78b3_I20221010">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001534969</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-10</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="common_stock_class">
        <measure>sera:common_stock_class</measure>
    </unit>
    <unit id="vote">
        <measure>sera:vote</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8wLTEtMS0xLTM3MDYy_37ec3da8-89aa-450e-97da-0576822f54b0">0001534969</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8xLTEtMS0xLTM3MDYy_79beeba9-b328-499a-baee-161e80d4b88b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8yLTEtMS0xLTM3MDYy_373749e9-1363-4885-bfb4-3870aca195a6">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF8zLTEtMS0xLTM3MDYy_febd4e3d-1e94-4514-ad4d-5309b726cd4c">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80L2ZyYWc6MDg0ZTNkZjY0YjIxNGUxZGIyMmJkYjg3MTBmMjQ2MjIvdGFibGU6YTU1OTkwOGNmYWFmNDMwY2EzNmYzNDc4NzZhZGY0ZTAvdGFibGVyYW5nZTphNTU5OTA4Y2ZhYWY0MzBjYTM2ZjM0Nzg3NmFkZjRlMF80LTEtMS0xLTM3MDYy_3599d630-dd4b-4824-a7bb-add29c163bab">false</dei:AmendmentFlag>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_0049bb1e-6361-4f5b-bc41-972d98f2f6a3">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_7e1627ae-b748-46d6-9015-15e5ad4fd6be">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_5469c87e-2e2e-466c-9319-75c619518553">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_a4928ad8-769b-47ab-8011-2c8705edcb02">http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_67f2aafd-7934-4f80-a929-ab372ba3fe4d">http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_b288df54-e98f-412a-96c5-369a8ce12b19">http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i287e032d20624fe0a98f6658b3eb78b3_I20221010"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfMTA5OTUxMTYyODQyNA_df1e695d-5bfe-4eae-921e-ce6dee848024">P3Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <dei:DocumentType
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY4_b295b859-af0e-4154-9403-b24ebc9759a5">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NWIzNDJkNjc5NzMwNDM1YTg2NmQ0MGM0Y2U3NDZiNmEvdGFibGVyYW5nZTo1YjM0MmQ2Nzk3MzA0MzVhODY2ZDQwYzRjZTc0NmI2YV8wLTAtMS0xLTM3MDYy_438857ec-f66a-44e3-842f-72d99a0160f9">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8xODc_583730d4-c224-4bf5-971e-74186596ab51">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6ZmMzODZkMWFkOTU0NGFkMjhlNWYxNjlmMDE4YmVkODMvdGFibGVyYW5nZTpmYzM4NmQxYWQ5NTQ0YWQyOGU1ZjE2OWYwMThiZWQ4M18wLTAtMS0xLTM3MDYy_9118d399-8ac0-41a3-a40f-92ace4d9c087">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDYz_cd6224e8-ac2e-45b9-9161-b93368757d93">001-40606</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY0_7bc5f095-f834-416b-a9a5-3f5c1499730d">SERA PROGNOSTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8wLTAtMS0xLTM3MDYy_547e848e-f35d-41c8-ac5f-6fe6f4f86d46">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8wLTItMS0xLTM3MDYy_7d463571-7201-4503-ace2-3643b8e72d14">26-1911522</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfNQ_c4f24fd7-e94d-4ba0-a53d-9eed4df3aac7">2749 East Parleys Way</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfOQ_dacb312b-bcca-46d9-a7ff-fc03630952e2">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfMTI_1c5f5b02-ba5c-489f-a58c-0c18e8f5725a">Salt Lake City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTAtMS0xLTM3MDYyL3RleHRyZWdpb246NDM2YWIzOTZiYTMzNGQwNGExZGY4NjY3ZDUwZDZiNDJfMTY_5bb91dfd-ca77-49e5-b4f7-779e6306e5a5">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6OTg5MmEwNDI0OTJkNGQ5NGE0MTMzMzQ3MzI5ZDY5MDgvdGFibGVyYW5nZTo5ODkyYTA0MjQ5MmQ0ZDk0YTQxMzMzNDczMjlkNjkwOF8yLTItMS0xLTM3MDYy_19a5c20c-79e5-48e6-93ae-a795fe03bdc3">84109</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY5_c67aba1a-47a7-4591-bb69-01b24c1efc34">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY1_d47469a4-85c6-42a0-a55f-adef8589059f">990-0520</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NjQ0ZDNlOGFkNjQ2NDhmOGFlMTdjZDlmNzM4ZGYxNTIvdGFibGVyYW5nZTo2NDRkM2U4YWQ2NDY0OGY4YWUxN2NkOWY3MzhkZjE1Ml8xLTAtMS0xLTM3MDYy_65118ae1-c0b3-4145-969d-ab0e534f71f0">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NjQ0ZDNlOGFkNjQ2NDhmOGFlMTdjZDlmNzM4ZGYxNTIvdGFibGVyYW5nZTo2NDRkM2U4YWQ2NDY0OGY4YWUxN2NkOWY3MzhkZjE1Ml8xLTItMS0xLTM3MDYy_5fd1bde7-efcc-4d79-a74f-0d0a571cc94e">SERA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6NjQ0ZDNlOGFkNjQ2NDhmOGFlMTdjZDlmNzM4ZGYxNTIvdGFibGVyYW5nZTo2NDRkM2U4YWQ2NDY0OGY4YWUxN2NkOWY3MzhkZjE1Ml8xLTQtMS0xLTM3MDYyL3RleHRyZWdpb246MDYyNDU0Y2NmYTM1NDFjYmI5OGM0NzM0NmYxZGI1NTBfOA_37dbb85a-7ccf-411c-a8d3-337bf7d84dc3">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY2_45ad4baf-7c53-4966-a4a9-c04405131722">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDcw_d26eeae8-f723-49d4-bd30-af6b3614a811">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6MmM0ODc4NzNhMTdmNGQwN2JhMDJhNjhmNDdhN2JkNGMvdGFibGVyYW5nZToyYzQ4Nzg3M2ExN2Y0ZDA3YmEwMmE2OGY0N2E3YmQ0Y18xLTAtMS0xLTM3MDYy_c6f027a3-b1d1-471e-a9d8-7ff8af318c6d">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6MmM0ODc4NzNhMTdmNGQwN2JhMDJhNjhmNDdhN2JkNGMvdGFibGVyYW5nZToyYzQ4Nzg3M2ExN2Y0ZDA3YmEwMmE2OGY0N2E3YmQ0Y18xLTMtMS0xLTM3MDYy_d99c4c98-d987-4bea-9500-17308eb8fe9c">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGFibGU6MmM0ODc4NzNhMTdmNGQwN2JhMDJhNjhmNDdhN2JkNGMvdGFibGVyYW5nZToyYzQ4Nzg3M2ExN2Y0ZDA3YmEwMmE2OGY0N2E3YmQ0Y18yLTMtMS0xLTM5ODM3_571f0de6-cd74-4aab-9d3b-d85e4582e375">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDcx_ba08659b-65fc-4d8e-b0da-27b653e43fb4">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8yMDY3_13216d7b-8ff3-4e2a-a671-96a892c3c060">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i16957592c4d844449723ff11f81ecd36_I20221104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8xOTUy_1eec3a6d-1a32-4f07-8400-2c91bc7aa2ad"
      unitRef="shares">29611720</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i93397e1b4eb84bd58369f6538fc60773_I20221104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xL2ZyYWc6NDQ1MzkzYjc1MmEzNGEwNWJlOGJhZmE1YjI1MGMxYmQvdGV4dHJlZ2lvbjo0NDUzOTNiNzUyYTM0YTA1YmU4YmFmYTViMjUwYzFiZF8xOTU5_4e42f980-6fa9-4fbf-a34d-8f382298962e"
      unitRef="shares">1405259</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMy0xLTEtMS0zNzA2Mg_8fecb078-e18b-428a-8469-c97906ffc713"
      unitRef="usd">38810000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMy0zLTEtMS0zNzA2Mg_53de9a6b-18ad-45ad-9280-3ac31a5ccd88"
      unitRef="usd">58932000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNC0xLTEtMS0zNzA2Mg_176fa2b6-a003-4ba3-8ea7-4f7b6c95fc09"
      unitRef="usd">49968000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNC0zLTEtMS0zNzA2Mg_f71f7626-7f50-452a-a4b9-1ee925abab97"
      unitRef="usd">46183000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNS0xLTEtMS0zNzA2Mg_6b02bd73-b81b-4437-a388-63fe641b0145"
      unitRef="usd">107000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNS0zLTEtMS0zNzA2Mg_088ba6ca-db77-495c-921b-e2b94c451c57"
      unitRef="usd">27000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNi0xLTEtMS0zNzA2Mg_525188a1-9108-4999-ba2c-1d7682131ccd"
      unitRef="usd">0</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNi0zLTEtMS0zNzA2Mg_5cfce639-f989-4af8-a48a-ec9df3815702"
      unitRef="usd">3116000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNy0xLTEtMS0zNzA2Mg_47eeda01-865e-4b47-b2f8-1a62a761bcac"
      unitRef="usd">1954000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfNy0zLTEtMS0zNzA2Mg_a2512c2b-43e6-453a-8659-5956c68ab444"
      unitRef="usd">1993000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOC0xLTEtMS0zNzA2Mg_af3bb34f-818a-464c-94e0-a310465f5cfa"
      unitRef="usd">90839000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOC0zLTEtMS0zNzA2Mg_9f2ad5a3-4cb9-4139-b28e-af8325f373e6"
      unitRef="usd">110251000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOS0xLTEtMS0zNzA2Mg_7358380c-49e6-4f40-b02d-a15a22d5a585"
      unitRef="usd">3107000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfOS0zLTEtMS0zNzA2Mg_ccb61e18-e6dc-4ee6-a5ce-439209d1434f"
      unitRef="usd">1773000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTAtMS0xLTEtMzcwNjI_6edc0d0f-8c3f-4c42-9457-2ae109b4dac1"
      unitRef="usd">22378000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTAtMy0xLTEtMzcwNjI_827a5eac-7e4e-40e5-83be-06a3934a67e6"
      unitRef="usd">34848000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTEtMS0xLTEtMzcwNjI_794a422f-a755-4006-baee-346158051f41"
      unitRef="usd">237000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTEtMy0xLTEtMzcwNjI_4a8f1353-9d83-4024-9e55-e1fed5096c54"
      unitRef="usd">157000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTItMS0xLTEtMzcwNjI_71f39353-c60c-4ada-a12a-e8579b964f47"
      unitRef="usd">116561000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTItMy0xLTEtMzcwNjI_d0fb6e76-2cf6-48a3-abb2-4014250e392e"
      unitRef="usd">147029000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTUtMS0xLTEtMzcwNjI_0d2a477c-cb9f-49e3-80f4-ea4a4a308340"
      unitRef="usd">1088000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTUtMy0xLTEtMzcwNjI_fc299a85-ec3c-40d5-82af-2a77a87bac06"
      unitRef="usd">1197000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTYtMS0xLTEtMzcwNjI_6f0faebf-625e-4bcf-96e4-462389f8d53d"
      unitRef="usd">4016000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTYtMy0xLTEtMzcwNjI_b890fbe0-efc4-47fd-8f84-61b1509da81f"
      unitRef="usd">3885000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:DeferredRentCreditCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTctMS0xLTEtMzcwNjI_ec9ffc1b-d29a-4edf-b45e-df1e9418c6d2"
      unitRef="usd">0</us-gaap:DeferredRentCreditCurrent>
    <us-gaap:DeferredRentCreditCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTctMy0xLTEtMzcwNjI_cd0ab7f9-f3b6-4343-9c67-9f362eac21e8"
      unitRef="usd">139000</us-gaap:DeferredRentCreditCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTgtMS0xLTEtMzcwNjI_6c910842-f82c-40be-93c5-2f250e58b254"
      unitRef="usd">472000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTgtMy0xLTEtMzcwNjI_5c4ec169-4b7d-4ae8-b81d-2f6f7a6ed422"
      unitRef="usd">74000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTktMS0xLTEtMzcwNjI_07bf8f27-6c18-4cd0-94a8-4037cfe0b013"
      unitRef="usd">3091000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMTktMy0xLTEtMzcwNjI_04befa9c-234c-4aba-81e7-f59d7c0fb5ad"
      unitRef="usd">3116000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjAtMS0xLTEtMzcwNjI_99e2d77a-1fa8-446a-bc13-5f28e313f891"
      unitRef="usd">8667000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjAtMy0xLTEtMzcwNjI_a247e77e-3238-4058-be6b-8e9350b1dc0a"
      unitRef="usd">8411000</us-gaap:LiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjEtMS0xLTEtMzcwNjI_06cff88f-6fc5-4451-982c-6bd058267c41"
      unitRef="usd">735000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjEtMy0xLTEtMzcwNjI_38e28812-1393-4d7d-8051-b2681b64d685"
      unitRef="usd">54000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjItMS0xLTEtMzcwNjI_99075f40-fe29-41d8-98a2-e770d5892415"
      unitRef="usd">9402000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjItMy0xLTEtMzcwNjI_37bd962f-e9ec-468d-8712-61399d00f761"
      unitRef="usd">8465000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjMtMS0xLTEtMzcwNjI_b1db2521-2d43-4f05-9b05-c9348c367c3d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjMtMy0xLTEtMzcwNjI_db3098fa-51a1-4137-8387-d40c881d8b08"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_360533f8-ca7d-451b-90c3-4512f12eab3b"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_91a52aae-4d40-44a6-bd42-32409e9db8e1"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_9bafda2d-5cf8-4ef7-a213-40d6243321d3"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xOA_fb81ffd9-6410-4aa9-b7b4-6576e6c67174"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18zMg_0a45ff04-e097-4262-8e64-04deb17b6175"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18zMg_22bd93ec-38a9-4c00-94da-c472511ed929"
      unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM183OA_02efb5f8-ab58-4961-a3d1-a4532a4c48fa"
      unitRef="shares">29611720</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM183OA_c5ed6a65-2fed-47ff-a660-a18313499feb"
      unitRef="shares">29611720</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM184NQ_4d220dc1-46ea-488d-b9ab-6d53ce1145a3"
      unitRef="shares">29368867</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM184NQ_693eb301-fbbe-4637-ab9b-ebd42e12e53e"
      unitRef="shares">29368867</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xNTc_98904ac7-8750-4950-85e8-7eb2e2b6789c"
      unitRef="shares">1500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18xNTc_c0f97ef3-d8b7-482b-803e-e415aad1294d"
      unitRef="shares">1500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_91f879d9-ca38-4567-bfbd-d7c7c35865cc"
      unitRef="shares">1405259</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_b459b7cf-681a-4398-90b7-7ba03d374604"
      unitRef="shares">1405259</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i07dcbd5c00ff43149d052ff104148f12_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_c165e02b-eedd-4c10-b401-3f7a2ec5ea6f"
      unitRef="shares">1405259</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic51ec012d9294cf09bca3ce7057820b2_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1M2M3YmI0NGY1ZmU0OTYwYjljMjgzZmUyZjY4MTcyM18yMDM_c9174940-34a5-4c02-acd7-4d55f705aa78"
      unitRef="shares">1405259</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMS0xLTEtMzcwNjI_9cd9fe78-4cfe-4c79-83e1-fa307939a817"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjUtMy0xLTEtMzcwNjI_6d7e8b3c-0bac-4874-a1df-f3d9d06aa4a4"
      unitRef="usd">3000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjYtMS0xLTEtMzcwNjI_de3a9c65-5633-446c-be6b-894a31ca18a0"
      unitRef="usd">309233000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjYtMy0xLTEtMzcwNjI_1393938b-8efc-4856-8414-98b1d8f53221"
      unitRef="usd">305212000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjctMS0xLTEtMzcwNjI_af735ae0-d1bd-4dcc-97fa-669a7260b8b3"
      unitRef="usd">-1169000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjctMy0xLTEtMzcwNjI_5b8377e1-ab39-4c60-aa6d-09cf869dd152"
      unitRef="usd">-183000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjgtMS0xLTEtMzcwNjI_10b00884-5e11-4419-9190-7605459e0b43"
      unitRef="usd">-200908000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjgtMy0xLTEtMzcwNjI_50aa95ef-6c65-4dc7-861f-c4a57689b674"
      unitRef="usd">-166468000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjktMS0xLTEtMzcwNjI_15f632d9-721b-4bed-99dd-24ea7db2bc47"
      unitRef="usd">107159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMjktMy0xLTEtMzcwNjI_21d953f1-8db2-448e-940e-6c22f94d335e"
      unitRef="usd">138564000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMzAtMS0xLTEtMzcwNjI_298f1db5-91ac-4e84-8571-841cd45f10d8"
      unitRef="usd">116561000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8xOS9mcmFnOjdlY2MxODVjMDBiYjQzMzZiMDg5Nzg0ODY2ZDYxMDIwL3RhYmxlOmYwMTc5MzFlMmIwOTQ4NDE4MGMxYjVjNDQxOTFjNmFlL3RhYmxlcmFuZ2U6ZjAxNzkzMWUyYjA5NDg0MTgwYzFiNWM0NDE5MWM2YWVfMzAtMy0xLTEtMzcwNjI_d11d78d2-5403-4420-b0f9-3ca8683204d6"
      unitRef="usd">147029000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi0xLTEtMS0zNzA2Mg_5ba4bbeb-7ce9-4f91-b013-272863376bb6"
      unitRef="usd">87000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi0zLTEtMS0zNzA2Mg_c54ad110-3751-4ff9-806a-60b491d67512"
      unitRef="usd">23000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi01LTEtMS0zNzA2Mg_9f72fbcf-1619-4e8c-b7c8-9c39eeef7a7b"
      unitRef="usd">203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMi03LTEtMS0zNzA2Mg_1231a0f6-cc18-4158-a2e0-823f9b65016f"
      unitRef="usd">56000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC0xLTEtMS0zNzA2Mg_852876b2-6aac-4717-b2ea-b4ad136a5bdb"
      unitRef="usd">58000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC0zLTEtMS0zNzA2Mg_63816436-9e7b-4871-8743-fe2321aa3546"
      unitRef="usd">10000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC01LTEtMS0zNzA2Mg_7b4708c5-67ca-4aee-a4b7-0cdcaa28c162"
      unitRef="usd">134000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNC03LTEtMS0zNzA2Mg_c1197b5d-3be5-484f-85af-1fe6abe802af"
      unitRef="usd">23000</sera:CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS0xLTEtMS0zNzA2Mg_7b11e5ec-ebc0-4d50-b0c4-aedc2951ecfc"
      unitRef="usd">4176000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS0zLTEtMS0zNzA2Mg_3b8dfb25-a46e-4332-aa2a-020d73436da4"
      unitRef="usd">2724000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS01LTEtMS0zNzA2Mg_d0940621-b4fa-42e9-82e1-dd11e70f2095"
      unitRef="usd">10759000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNS03LTEtMS0zNzA2Mg_5964cc7a-69b8-4231-af1f-bdf9004e6799"
      unitRef="usd">7944000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi0xLTEtMS0zNzA2Mg_f5f8d18d-0c48-46a4-bd0a-3c87ad1c83e1"
      unitRef="usd">2967000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi0zLTEtMS0zNzA2Mg_df15e0c1-baa5-48ff-94bf-08865b198a0b"
      unitRef="usd">2690000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi01LTEtMS0zNzA2Mg_bcdb3d8b-297d-41d9-b7f3-fdbe71c9dd7f"
      unitRef="usd">11644000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNi03LTEtMS0zNzA2Mg_5617fca6-a560-4985-8bd4-9405727d0dc2"
      unitRef="usd">5780000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy0xLTEtMS0zNzA2Mg_87083130-372c-47f7-9bc3-db62856bb39e"
      unitRef="usd">4074000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy0zLTEtMS0zNzA2Mg_efb57fc7-7cac-4562-9446-bc4b103311f1"
      unitRef="usd">4041000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy01LTEtMS0zNzA2Mg_1d95d7c6-b113-4479-975e-1488944ebce5"
      unitRef="usd">12900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfNy03LTEtMS0zNzA2Mg_e352de77-7f05-4447-abe8-8245051fe9ae"
      unitRef="usd">9157000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC0xLTEtMS0zNzA2Mg_64a093b3-cc90-470d-9aa4-41a276912228"
      unitRef="usd">11275000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC0zLTEtMS0zNzA2Mg_f8c20840-ca1b-4a6c-b7f1-e7128803c9e4"
      unitRef="usd">9465000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC01LTEtMS0zNzA2Mg_f11af073-2976-47ae-b938-ec253d2b8274"
      unitRef="usd">35437000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOC03LTEtMS0zNzA2Mg_ca9f9f4f-9422-4111-8237-762a0c008172"
      unitRef="usd">22904000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS0xLTEtMS0zNzA2Mg_32ab007e-c086-4b65-a37b-88ef4aa540af"
      unitRef="usd">-11188000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS0zLTEtMS0zNzA2Mg_ec5a6bbb-1e47-4082-af0d-3502fa1d66a5"
      unitRef="usd">-9442000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS01LTEtMS0zNzA2Mg_26b05e77-f86a-4f96-ba10-fede19e588a0"
      unitRef="usd">-35234000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfOS03LTEtMS0zNzA2Mg_f7bd8ff5-8243-4160-9867-9713644a21a9"
      unitRef="usd">-22848000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtMS0xLTEtMzcwNjI_e3876533-3ff1-4384-80cf-8bb0f91a3909"
      unitRef="usd">21000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtMy0xLTEtMzcwNjI_8b853423-07cd-45ca-b1d2-043c8e9c69fd"
      unitRef="usd">439000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtNS0xLTEtMzcwNjI_bddb0a41-cf15-416c-aecd-1422409431cb"
      unitRef="usd">43000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTAtNy0xLTEtMzcwNjI_07df0778-9d71-4afd-a57b-d520b9d0f44f"
      unitRef="usd">744000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtMS0xLTEtMzcwNjI_49ba993f-546c-405c-8b36-f1b55ea983cf"
      unitRef="usd">497000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtMy0xLTEtMzcwNjI_51c58287-a11c-4dfe-a8c3-42c032319bc1"
      unitRef="usd">22000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtNS0xLTEtMzcwNjI_b0f9185e-af6f-465f-8030-9dac14c435fb"
      unitRef="usd">837000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTEtNy0xLTEtMzcwNjI_8391f117-a874-413e-ab77-5a39651d14bf"
      unitRef="usd">1067000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItMS0xLTEtMzcwNjI_3898b511-dcae-41cb-b315-e89833817aeb"
      unitRef="usd">-10712000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItMy0xLTEtMzcwNjI_97e693b6-37cb-4982-ae57-42c9d264ac54"
      unitRef="usd">-9859000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItNS0xLTEtMzcwNjI_a588527f-f006-496a-b3ae-d85a900207f4"
      unitRef="usd">-34440000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTItNy0xLTEtMzcwNjI_b081293c-c97d-464c-9436-20c19bf7e0ee"
      unitRef="usd">-22525000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMS0xLTEtMzcwNjI_4db46595-4679-427d-8972-1ab3bf9261fd"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMS0xLTEtMzcwNjI_c75a6752-c0af-4b01-ac03-2e425685a39e"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMy0xLTEtMzcwNjI_7afbc0f9-7225-4bdc-b4f0-16cba030e110"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtMy0xLTEtMzcwNjI_ce3c771d-d504-426c-bc6a-e63cd0aa4078"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNS0xLTEtMzcwNjI_0c174933-80c8-4369-a04a-bbec70dde7e4"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNS0xLTEtMzcwNjI_e05d92e8-a4a1-4ace-b803-0dcec3e323a5"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNy0xLTEtMzcwNjI_81891113-f30a-4b15-bf20-42e7c7929d8b"
      unitRef="usdPerShare">-2.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTMtNy0xLTEtMzcwNjI_81ceb345-c81b-4463-8ddc-f50685131074"
      unitRef="usdPerShare">-2.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMS0xLTEtMzcwNjI_27605259-27d3-4cf2-b4d4-8c34a86dc7a2"
      unitRef="shares">31005978</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMS0xLTEtMzcwNjI_c8f842eb-9285-4ee7-a273-d98a46a94c7b"
      unitRef="shares">31005978</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMy0xLTEtMzcwNjI_539371d6-e09a-485a-bc2a-01f0f127cda8"
      unitRef="shares">25085013</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtMy0xLTEtMzcwNjI_daa4af1f-0963-4ef7-ada1-a79d4daa11c6"
      unitRef="shares">25085013</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNS0xLTEtMzcwNjI_17a36ce7-a223-49cc-8dbc-e5c3d01ede74"
      unitRef="shares">30918473</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNS0xLTEtMzcwNjI_ba3f14d7-935f-4ef2-825e-70077dd9ee99"
      unitRef="shares">30918473</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNy0xLTEtMzcwNjI_c4666c14-57de-4408-9623-3c57f5efe480"
      unitRef="shares">9707254</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTQtNy0xLTEtMzcwNjI_fdb21aff-adf9-43c5-b6d4-6686f811a78f"
      unitRef="shares">9707254</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtMS0xLTEtMzcwNjI_f5edab1d-2d09-4b03-8420-2a490bf7d70a"
      unitRef="usd">-351000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtMy0xLTEtMzcwNjI_7ea728e7-4896-4f37-8433-7dc80bb0d4cb"
      unitRef="usd">-25000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtNS0xLTEtMzcwNjI_50bf4eaf-bb1c-417e-a1a5-a4eded0f06f3"
      unitRef="usd">-986000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTYtNy0xLTEtMzcwNjI_a512e5de-e4e5-423e-bef1-2eb15e11dde0"
      unitRef="usd">-25000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctMS0xLTEtMzcwNjI_cd4b0270-c43f-4dff-b24b-9ac39d4a6c58"
      unitRef="usd">-351000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctMy0xLTEtMzcwNjI_969581db-138b-4657-b3dd-d6ca50725d3f"
      unitRef="usd">-25000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctNS0xLTEtMzcwNjI_d31691c8-a9a6-4cfc-a542-1c5f50fdab32"
      unitRef="usd">-986000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTctNy0xLTEtMzcwNjI_fc0d7f9a-e5db-4c18-94bd-69dfd6c26ffe"
      unitRef="usd">-25000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtMS0xLTEtMzcwNjI_c5460da8-6464-46f7-a9de-f4704835262e"
      unitRef="usd">-11063000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtMy0xLTEtMzcwNjI_81f09b3e-50fc-4878-9719-327de0b9ff14"
      unitRef="usd">-9884000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtNS0xLTEtMzcwNjI_5c8d4ac3-b688-4165-8cbc-d842b194a059"
      unitRef="usd">-35426000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yMi9mcmFnOmE2NmUwMWNlZDhmODQxNzk5ZjQwYzc4MzUwNzA0YzJmL3RhYmxlOjY1OWExNTNhNjFiYjRhZGVhOTYzMTdhOTk2YmQ1YWQxL3RhYmxlcmFuZ2U6NjU5YTE1M2E2MWJiNGFkZWE5NjMxN2E5OTZiZDVhZDFfMTgtNy0xLTEtMzcwNjI_e5ee1ec2-a210-4e11-985f-4241d9b221cc"
      unitRef="usd">-22550000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="id7d6832636f54cfb879106d568c3e932_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xLTEtMS0zNzA2Mg_b4c54548-9c5a-4566-b6e0-d05a3bc85446"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="id7d6832636f54cfb879106d568c3e932_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0zLTEtMS0zNzA2Mg_d7ca551b-c821-4a1b-8a94-fe7c12646ccc"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4568d701d67140978621ef6467b28490_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi01LTEtMS0zNzA2Mg_ce90c46a-8c21-4f65-a78b-06d939c9e162"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4568d701d67140978621ef6467b28490_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi03LTEtMS0zNzA2Mg_4bba6b4b-2f0b-4734-8d26-3164d1e395e8"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2ccbd1105a654fee862dae8d937f27b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xMC0xLTEtMzcwNjI_b24d8a53-78be-4d45-84d1-56189ce80e09"
      unitRef="shares">30774126</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2ccbd1105a654fee862dae8d937f27b5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xMi0xLTEtMzcwNjI_27346ddd-3416-44b3-b6f0-4b6d80552a10"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3d0d1d5bdbc7440ebc3c7e39076b89a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xNC0xLTEtMzcwNjI_232a1a6b-3bd9-4e04-bb74-f093df96c0dc"
      unitRef="usd">305212000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie2e001b0b3e94072999336b8b75218c5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xNi0xLTEtMzcwNjI_29fcc1a5-d7aa-48c4-9600-e5d4b4c6f3cd"
      unitRef="usd">-183000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46d6b66dc7804d95bad33599f8d253ed_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0xOC0xLTEtMzcwNjI_d08e4d51-024e-429f-b3b1-d8bce3783405"
      unitRef="usd">-166468000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMi0yMC0xLTEtMzcwNjI_b0512883-94a7-4adb-b6bd-3e1c654dad91"
      unitRef="usd">138564000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i890f658cedbc4a9488358a5cbd47a54f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMy0xMC0xLTEtMzcwNjI_729e59dd-2628-4ca7-b829-d6ffdb1503bb"
      unitRef="shares">123467</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if4c5d93068fb4cf5875603027219c407_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMy0xNC0xLTEtMzcwNjI_d315a5ce-358f-4004-a374-77898cdf4efa"
      unitRef="usd">98000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMy0yMC0xLTEtMzcwNjI_46cfdce8-4f19-47ab-bd67-7953b9d6a699"
      unitRef="usd">98000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if4c5d93068fb4cf5875603027219c407_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNC0xNC0xLTEtMzcwNjI_8b35f21f-44a8-4fbd-94fd-d2e910f1d747"
      unitRef="usd">1222000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNC0yMC0xLTEtMzcwNjI_f3de75cd-9985-406c-b43a-0a28e5186474"
      unitRef="usd">1222000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i17b2a2ad4e524d0eaa981607c6fbfc69_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNS0xNi0xLTEtMzcwNjI_de9be3ba-f675-4d66-bdd1-2a8e5206d577"
      unitRef="usd">-473000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNS0yMC0xLTEtMzcwNjI_4d77fabe-df56-424b-9810-4fd3b41d8d5c"
      unitRef="usd">-473000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ideecafdbfb2e400892c41acad085d37c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNi0xOC0xLTEtMzcwNjI_774443b3-1579-4405-8800-9f96077f201c"
      unitRef="usd">-12208000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5bddadeaea214c77bc152bec42effa85_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNi0yMC0xLTEtMzcwNjI_8d895827-13d4-47a8-98a5-fe8a4737bf18"
      unitRef="usd">-12208000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i675d2ddbd30b48f6aa38beea1d995af9_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xLTEtMS0zNzA2Mg_c46a0c6b-6398-44b5-ad53-c9943fdcc58a"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i675d2ddbd30b48f6aa38beea1d995af9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0zLTEtMS0zNzA2Mg_7d8ae96e-9383-4cf5-aa58-28f7612571c3"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ibe5ac4edad344a23add99975ad28e041_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy01LTEtMS0zNzA2Mg_79a1cab4-9d85-493b-9350-7b82ac58d67a"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ibe5ac4edad344a23add99975ad28e041_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy03LTEtMS0zNzA2Mg_fd9d5955-15eb-4791-9367-8c43d9af3d0f"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9acc8d4b939d44c7b49a30479bd930a8_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xMC0xLTEtMzcwNjI_12379f87-d3ab-43ab-8ffc-9934e4e137bb"
      unitRef="shares">30897593</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9acc8d4b939d44c7b49a30479bd930a8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xMi0xLTEtMzcwNjI_97731af0-d4f2-4b6f-98b8-7b6c921b5ecf"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib11ad9b4bb684f7f9f452c732964d9cd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xNC0xLTEtMzcwNjI_41148363-9486-4a21-80e5-245aa3f29db8"
      unitRef="usd">306532000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d38ca8b46774d8587bad81a1ff3a877_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xNi0xLTEtMzcwNjI_a95e4c14-5c4c-4008-ac30-736fddf32397"
      unitRef="usd">-656000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie1632c22e5a9407d8bfd8a93f29344c7_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0xOC0xLTEtMzcwNjI_1ca94930-dc0e-44db-b6bf-116380945125"
      unitRef="usd">-178676000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55bfa45f9f4a4292bcf081e5d15c70c5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfNy0yMC0xLTEtMzcwNjI_bacb8314-b279-46df-aa60-fb2aab1fa4df"
      unitRef="usd">127203000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i810fc88333fd484d9c7c13ec52d5a637_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOC0xMC0xLTEtMzcwNjI_82ba3ae6-51c3-4081-abb2-bc3e16335133"
      unitRef="shares">94393</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i63fb294666b2488e821ae0202b6a42af_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOC0xNC0xLTEtMzcwNjI_df8528dc-cfa2-4ae2-8920-0413d81cc46f"
      unitRef="usd">170000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOC0yMC0xLTEtMzcwNjI_3a82dcf0-708e-4507-a86e-96ac46ba5f1f"
      unitRef="usd">170000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i63fb294666b2488e821ae0202b6a42af_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOS0xNC0xLTEtMzcwNjI_f6cbab98-c55f-4ceb-b76a-359d949e62cd"
      unitRef="usd">1214000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfOS0yMC0xLTEtMzcwNjI_1e9c8819-2490-4b70-9ecd-4bb60f4f98c8"
      unitRef="usd">1214000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6b62659d21af4f5a9bfbc2ab6c0f6007_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTAtMTYtMS0xLTM3MDYy_f56963b0-5b3d-4d02-8332-400ec0418975"
      unitRef="usd">-162000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTAtMjAtMS0xLTM3MDYy_bff2f277-68d4-42ab-9198-c24d59e89a88"
      unitRef="usd">-162000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="id8fbca8e790a49b79263a594d6204f6e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTEtMTgtMS0xLTM3MDYy_bb16b6eb-c3d0-44b0-a64a-062c55a12733"
      unitRef="usd">-11520000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5fb5d2f7493345299483952b849fa14e_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTEtMjAtMS0xLTM3MDYy_d84c1c9f-3eaa-4926-8d31-7ed80b5a9786"
      unitRef="usd">-11520000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i92608e502e7d418c9ee082d453136131_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMS0xLTEtMzcwNjI_0ad5d10f-9eac-40f0-8d75-3b45601504bb"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i92608e502e7d418c9ee082d453136131_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMy0xLTEtMzcwNjI_3f7d8989-d39a-4e72-96f6-41fdc447f441"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i58ea917c84dd4e53aea6ee8957e300ae_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItNS0xLTEtMzcwNjI_47196452-8395-49af-bf97-8b74f74f0705"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i58ea917c84dd4e53aea6ee8957e300ae_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItNy0xLTEtMzcwNjI_cf397723-7017-433d-ba9d-f18db4f90b0b"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1201920f9ebb4530acebcd6bea512aed_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTAtMS0xLTM3MDYy_0147aa67-087f-4ab4-ac1d-e69d15640b84"
      unitRef="shares">30991986</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i1201920f9ebb4530acebcd6bea512aed_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTItMS0xLTM3MDYy_281bfd07-3871-4b6f-b0a6-6d35e0a18511"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i371f184bfcdc4926af9860e292313519_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTQtMS0xLTM3MDYy_cd49d6ce-54f6-4406-8587-09de8f4401ef"
      unitRef="usd">307916000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6649d2bf6df4035a225617e298f96cd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTYtMS0xLTM3MDYy_4d542c3f-dbd9-4eb0-ba72-968978064691"
      unitRef="usd">-818000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i26b85ca758534fa690d547a94d0fd16b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMTgtMS0xLTM3MDYy_3029563f-3405-4a95-a834-8c790c760ec5"
      unitRef="usd">-190196000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id7f27b7b00714ca6b49f201a81cb6811_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTItMjAtMS0xLTM3MDYy_e4fdebba-726e-4595-8007-852049e0d54a"
      unitRef="usd">116905000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iefdecb634e6746a9bdf022491041a261_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTMtMTAtMS0xLTM3MjU5_251f626b-7627-49d1-be5e-e3605eb83670"
      unitRef="shares">24993</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iac27b6b2000c4669a337bc703245dd6f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTMtMTQtMS0xLTM3Mjcz_5fba67e2-5d49-45ca-9099-8f71ac39f481"
      unitRef="usd">39000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTMtMjAtMS0xLTM3Mjk0_b34c656e-0d5c-4b8f-b369-ebdf30e145fe"
      unitRef="usd">39000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iac27b6b2000c4669a337bc703245dd6f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTQtMTQtMS0xLTM3Mjcz_b31396f6-1221-4b12-b9da-eff770e5b3d8"
      unitRef="usd">1278000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTQtMjAtMS0xLTM3Mjk0_414829f1-589c-4d4b-a4b4-b4a75757df91"
      unitRef="usd">1278000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie67812bd33894a75b67f8c3afd3db12f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTUtMTYtMS0xLTM3Mjgw_95c55adf-be32-46db-9a92-7397e87bba18"
      unitRef="usd">-351000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTUtMjAtMS0xLTM3Mjk0_94df64f5-51b3-4684-afac-b9675fa16a5c"
      unitRef="usd">-351000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="i407cbb66b130405f954523a0479a7435_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTYtMTgtMS0xLTM3Mjg3_72395e40-7f0a-484d-8522-4e9e09a4b019"
      unitRef="usd">-10712000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTYtMjAtMS0xLTM3Mjk0_cdc61ae7-4d3b-42f2-b23f-c6b894c218ef"
      unitRef="usd">-10712000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i37848c02dbe348d3ba5b833c88ca1596_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMS0xLTEtMzcyNDY_0bd5136f-2731-49fa-8ea4-1695279dd035"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i37848c02dbe348d3ba5b833c88ca1596_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMy0xLTEtMzcyNDY_1b067253-d113-4035-96c2-88bf483089ae"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iaf5a14cabce742aeb6dc76b5d7e721f2_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctNS0xLTEtMzcyNDY_daa58e40-85d4-4250-b696-ffcc1a20f8e3"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iaf5a14cabce742aeb6dc76b5d7e721f2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctNy0xLTEtMzcyNDY_66edb85e-faaf-495d-963b-8f50d9499d9c"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i233963b046f2403f9798a7e30959afe5_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTAtMS0xLTM3MjU5_df9df3cf-ca8c-4104-9960-43481c06dad6"
      unitRef="shares">31016979</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i233963b046f2403f9798a7e30959afe5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTItMS0xLTM3MjY2_863d4007-784f-4532-b66e-9da2bcb119f0"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2ea1a93ebbe64e8697b8dc87ea3b8db5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTQtMS0xLTM3Mjcz_8e5860fe-b91a-4bf6-9232-912dc1c552a1"
      unitRef="usd">309233000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i26bb98874bf94130aec2131d39b66870_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTYtMS0xLTM3Mjgw_956f7ab5-2c33-4882-a220-391979c0fed7"
      unitRef="usd">-1169000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia159ea90af2444349d3a5b6dc4fb041c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMTgtMS0xLTM3Mjg3_f2b47563-fb44-4148-91a2-97039b7c90c1"
      unitRef="usd">-200908000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOmM3NTcxYWMzZGRmMzQ5MzZiZDVlYTkxOGQ1OGUxMGU5L3RhYmxlcmFuZ2U6Yzc1NzFhYzNkZGYzNDkzNmJkNWVhOTE4ZDU4ZTEwZTlfMTctMjAtMS0xLTM3Mjk0_12ab3c6c-2af6-47fa-9c0e-e4a7f452fcac"
      unitRef="usd">107159000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i22c04c1aa9cc4ed1a3a5746977b13f78_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xLTEtMS0zNzA2Mg_efebfb5d-baa2-426c-bfb1-845cdddb80f8"
      unitRef="shares">5737440</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i22c04c1aa9cc4ed1a3a5746977b13f78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0zLTEtMS0zNzA2Mg_5eb4000d-2aba-47d3-a1f9-8215e20e45b8"
      unitRef="usd">50192000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i330c66d4416e4935ac95cf6c4b6c1b96_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi01LTEtMS0zNzA2Mg_5f9141db-eb83-4b0e-bc0f-249afea2afa9"
      unitRef="shares">9819480</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i330c66d4416e4935ac95cf6c4b6c1b96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi03LTEtMS0zNzA2Mg_0290fff2-d0db-4c3d-b07d-64016d393d3a"
      unitRef="usd">77844000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="i7144665eb1004d61979f59d59cd79ecb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xMC0xLTEtMzcwNjI_eb57493d-11eb-4bf3-8674-29d8c4cd4b39"
      unitRef="shares">1700625</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i7144665eb1004d61979f59d59cd79ecb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xMi0xLTEtMzcwNjI_f81d0bc7-d9b1-42c4-b1f0-53fae944d690"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5bee12794c5b43c48f79eadf2318e23e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xNC0xLTEtMzcwNjI_6606e935-b6c0-4f48-a368-249f2f9d855f"
      unitRef="usd">5889000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8286f00ec99f411cbde3e81b53bacd01_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xNi0xLTEtMzcwNjI_fa6c2360-6f68-42fa-bbe6-00fe44d92de6"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i66b9001f71b5420d9369d32a719c09c9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0xOC0xLTEtMzcwNjI_64636ab4-b674-480e-aad6-dc9f0939ca8f"
      unitRef="usd">-131459000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i744e357934604565b8a1ba77622b5d45_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMi0yMC0xLTEtMzcwNjI_811e94ee-53aa-4b77-9f8a-34540fd8eb8c"
      unitRef="usd">-125570000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i9de38b8fb9704048bc0348159dc7fec2_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjJjODA1MjllYWUxNzRjNjdiNjQ0N2JkMmEyNjI5ZmU5XzYz_1a662813-9fa1-4f5a-87b2-5a79495ffeae"
      unitRef="usdPerShare">12.46</us-gaap:SharesIssuedPricePerShare>
    <sera:TemporaryEquityStockIssuanceCosts
      contextRef="iaaad9d062dd346ed999353e204d90789_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjJjODA1MjllYWUxNzRjNjdiNjQ0N2JkMmEyNjI5ZmU5XzEwMg_be7cb1e0-ed24-4e78-806b-0138f0ab47a6"
      unitRef="usd">100000</sera:TemporaryEquityStockIssuanceCosts>
    <sera:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="ib44a2f2d0ad7493db173717bcd13180b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0xLTEtMS0zNzA2Mg_176eadb9-eb6f-491d-b3a8-ddaea94c517f"
      unitRef="shares">4938482</sera:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="ib44a2f2d0ad7493db173717bcd13180b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMy0zLTEtMS0zNzA2Mg_c72797e5-ae33-4f16-8599-ccdb36ba101a"
      unitRef="usd">60307000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNC0xNC0xLTEtMzcwNjI_d28daf90-eb2a-4625-99b4-7f4480329ba6"
      unitRef="usd">1071000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNC0yMC0xLTEtMzcwNjI_34e6c279-cf1c-4f86-9394-f6ff37e4d1d8"
      unitRef="usd">1071000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3acb9c650472454d93eaf5d1391c9c14_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNS0xMC0xLTEtMzcwNjI_82d75761-ce64-4a87-9dc3-cd103d179e72"
      unitRef="shares">281458</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNS0xNC0xLTEtMzcwNjI_5b303b09-c58e-45e6-9b14-852fa17aab04"
      unitRef="usd">229000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNS0yMC0xLTEtMzcwNjI_724a7a11-a3e6-4265-bc8e-cd261aa1e316"
      unitRef="usd">229000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6bbc76d5150c42ff8759dce9b0d242cf_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNi0xNC0xLTEtMzcwNjI_33145b42-f688-44e6-9e82-d7aec1137b56"
      unitRef="usd">239000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNi0yMC0xLTEtMzcwNjI_2cd960a7-ae2c-4c24-99f8-a467ce1cd827"
      unitRef="usd">239000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i12055f8d1ea64059813056f3f8ec3acd_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNy0xOC0xLTEtMzcwNjI_10abd250-379c-45ea-8b4f-52061501ae61"
      unitRef="usd">-6359000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i45ba210af966430b9dce918d169b1e5b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfNy0yMC0xLTEtMzcwNjI_847716bb-414d-4f17-b236-861eb2d5b300"
      unitRef="usd">-6359000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ied768dae55ea4525bbb0c49d70717a85_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xLTEtMS0zNzA2Mg_c85a6477-a280-459c-afea-8b732bd660bc"
      unitRef="shares">10675922</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ied768dae55ea4525bbb0c49d70717a85_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0zLTEtMS0zNzA2Mg_67d38b87-43ec-4e28-8c37-cfee6c2f9c14"
      unitRef="usd">110499000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i7b5e4c15c48145beb18f34a8858062fb_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC01LTEtMS0zNzA2Mg_25dca2ed-b07d-4839-a5f5-2d0265e0d695"
      unitRef="shares">9819480</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i7b5e4c15c48145beb18f34a8858062fb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC03LTEtMS0zNzA2Mg_fa9ba0c0-d28c-48aa-a418-572ddbed810e"
      unitRef="usd">77844000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="iccbc303ef6e74469bc7cc9ef0cc54b9b_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xMC0xLTEtMzcwNjI_ecbff756-4ac7-4a27-8c73-f79c297f587f"
      unitRef="shares">1982083</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iccbc303ef6e74469bc7cc9ef0cc54b9b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xMi0xLTEtMzcwNjI_3aafc148-4b41-42ef-9167-677a43d41dad"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8766f56549a44835bf6be9b33f3eae25_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xNC0xLTEtMzcwNjI_950e80ba-d9bb-4acd-a521-a572ed3027ce"
      unitRef="usd">7428000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if214de55f4ee4b85877312f75285700c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xNi0xLTEtMzcwNjI_b69b29bb-8346-45b0-9ab4-fd337c363f10"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4792be6cc7d049b68b1601a03021fcbb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0xOC0xLTEtMzcwNjI_3b5f6464-3909-485d-898f-5d33d5f31615"
      unitRef="usd">-137818000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i143503177ddd45eebbeb3dfa4a241265_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOC0yMC0xLTEtMzcwNjI_2b0ecb80-14b0-4449-a3bd-e95608c0461a"
      unitRef="usd">-130390000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i9de38b8fb9704048bc0348159dc7fec2_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjlhM2U4YjViMmUyNTQ5NzFhZTQ2N2U1ZmRmY2E5NThiXzYz_5a2c1c31-5c07-4598-92d8-912cb44b8c83"
      unitRef="usdPerShare">12.46</us-gaap:SharesIssuedPricePerShare>
    <sera:TemporaryEquityStockIssuanceCosts
      contextRef="iaaad9d062dd346ed999353e204d90789_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0wLTEtMS0zNzA2Mi90ZXh0cmVnaW9uOjlhM2U4YjViMmUyNTQ5NzFhZTQ2N2U1ZmRmY2E5NThiXzEwMg_1cafadc4-d912-4a0a-9033-b0687a6b7c0b"
      unitRef="usd">100000</sera:TemporaryEquityStockIssuanceCosts>
    <sera:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i4d1a20885eed4e00b8ec295d3a1a6126_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0xLTEtMS0zNzA2Mg_cbb54eec-028d-435b-87d2-31412b8a936d"
      unitRef="shares">3115657</sera:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i4d1a20885eed4e00b8ec295d3a1a6126_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfOS0zLTEtMS0zNzA2Mg_592e1ef6-1d9f-4762-abbe-2dec4f96e2bc"
      unitRef="usd">38645000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i368e83cd85ae4b37a1726dba858c0347_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTAtMTAtMS0xLTM3MDYy_9e2b3823-ca20-42a2-b1ae-4afbaa46c2dc"
      unitRef="shares">22872</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iacd7efb6e7484abdb0dd404594377877_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTAtMTQtMS0xLTM3MDYy_2657c6af-52be-4134-beef-a2a714c5267c"
      unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTAtMjAtMS0xLTM3MDYy_1c041171-d614-4e61-8f94-f6a046783918"
      unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iacd7efb6e7484abdb0dd404594377877_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTEtMTQtMS0xLTM3MDYy_e0696fa0-a283-4aa5-ac64-ba60227bd838"
      unitRef="usd">864000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTEtMjAtMS0xLTM3MDYy_3069c8ee-8525-4526-886e-5fe3d300871e"
      unitRef="usd">864000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i80965f98a9d044e49c5b70117ce9946b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTItMTgtMS0xLTM3MDYy_0292ed0e-f39a-4d13-a065-b71ef7f49828"
      unitRef="usd">-6307000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2e2e4c6f94e74ed89e9c2ae20f025580_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTItMjAtMS0xLTM3MDYy_0de366fb-92b9-492f-b76e-e18ba6a1e0b0"
      unitRef="usd">-6307000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i9417167952f443a098281a8844ff48bf_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMS0xLTEtMzcwNjI_26b5ae97-6e52-4cdf-92d0-7c18a472e764"
      unitRef="shares">13791579</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i9417167952f443a098281a8844ff48bf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMy0xLTEtMzcwNjI_4b63d69d-74a2-4772-9ca0-b66a0a3826d5"
      unitRef="usd">149144000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="if287f4a4ec254420821d8eb16d49742f_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtNS0xLTEtMzcwNjI_ef822d91-955b-4650-91b9-a1a806301133"
      unitRef="shares">9819480</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="if287f4a4ec254420821d8eb16d49742f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtNy0xLTEtMzcwNjI_0c13611f-5d6e-480b-9adc-c255c6e8a6ef"
      unitRef="usd">77844000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="icfa9c03858414b669711a350682a6c36_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTAtMS0xLTM3MDYy_c2ce1046-9e58-489e-8913-1add6db013a6"
      unitRef="shares">2004955</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icfa9c03858414b669711a350682a6c36_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTItMS0xLTM3MDYy_a8cc49c7-d6a2-4084-a61c-c5ebaef4d722"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if84aa7b043f54e55b61863de27a42471_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTQtMS0xLTM3MDYy_2be947ec-68fe-4d47-b4c7-0ff45167cdc1"
      unitRef="usd">8327000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i916da6c7f85d44858c10f7222fefaebe_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTYtMS0xLTM3MDYy_fec25152-11d6-4e12-8870-2d8d9d006173"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idb22c494aa524d09ba6a6867b74fdb09_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMTgtMS0xLTM3MDYy_be9e44bd-6ed4-4f08-b06f-1a662e3488c2"
      unitRef="usd">-144125000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i919c74b4f87b42dfa028394b09d3d6ac_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTMtMjAtMS0xLTM3MDYy_17cb7677-61d3-497b-be9f-6a75d810257f"
      unitRef="usd">-135798000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMTAtMS0xLTM3MzEx_e79f1a40-e8f4-46af-9597-dc67611372ef"
      unitRef="shares">4687500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMTItMS0xLTM3MzEx_cb91f895-bc85-49ec-b05a-2a0a1e225550"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMTQtMS0xLTM3MzEx_e2c37e21-b9da-4bf7-9961-e800f16e0895"
      unitRef="usd">66611000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTQtMjAtMS0xLTM3MzEx_cd35f9f0-e479-4b84-a809-5a51480b8380"
      unitRef="usd">66612000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <sera:TemporaryEquitySharesConversionOfPreferredStockToCommonStock
      contextRef="i44be0a10165d42f2911e8707f403fd1b_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMS0xLTEtMzczMTE_56daf640-7ca1-4bd2-b310-9e203faceb27"
      unitRef="shares">-13791579</sera:TemporaryEquitySharesConversionOfPreferredStockToCommonStock>
    <sera:TemporaryEquityValueConversionOfPreferredStockToCommonStock
      contextRef="i44be0a10165d42f2911e8707f403fd1b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMy0xLTEtMzczMTE_e2555ae0-968b-4b81-8798-36a9c0a4da2b"
      unitRef="usd">-149144000</sera:TemporaryEquityValueConversionOfPreferredStockToCommonStock>
    <sera:TemporaryEquitySharesConversionOfPreferredStockToCommonStock
      contextRef="i1496266b4fc3412b98a1edf4db2a6612_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtNS0xLTEtMzczMTE_6a3f8525-2a36-4026-a0ee-c432eb0754a4"
      unitRef="shares">-9819480</sera:TemporaryEquitySharesConversionOfPreferredStockToCommonStock>
    <sera:TemporaryEquityValueConversionOfPreferredStockToCommonStock
      contextRef="i1496266b4fc3412b98a1edf4db2a6612_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtNy0xLTEtMzczMTE_a26d587c-f7a4-4eec-b5f9-f28aa6f8c479"
      unitRef="usd">-77844000</sera:TemporaryEquityValueConversionOfPreferredStockToCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMTAtMS0xLTM3MzEx_ad193a57-799a-4b97-8a42-6d2dfada14d5"
      unitRef="shares">23839389</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMTItMS0xLTM3MzEx_812f6ac4-3d30-4e98-b427-5ac9d505ade5"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMTQtMS0xLTM3MzEx_ab249a38-3a03-41b0-aa9b-4e45a1ccef97"
      unitRef="usd">226990000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTUtMjAtMS0xLTM3MzEx_674c25c8-1620-4e45-952a-8f48075ddc2b"
      unitRef="usd">226992000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <sera:ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTYtMTQtMS0xLTM3MzEx_7a408aa5-17b5-4500-be13-ef5f1eaa20c0"
      unitRef="usd">929000</sera:ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment>
    <sera:ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTYtMjAtMS0xLTM3MzEx_6e4bc069-f2d5-4815-b39d-563c5ed882d9"
      unitRef="usd">929000</sera:ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTctMTAtMS0xLTM3MzEx_131dd9a6-e4b2-4892-b1f9-1419b7a498db"
      unitRef="shares">144874</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTctMTQtMS0xLTM3MzEx_7a282a7f-020a-4b92-95e3-83a86c63714c"
      unitRef="usd">273000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTctMjAtMS0xLTM3MzEx_c106145c-7725-4c39-8015-5d3938600e5f"
      unitRef="usd">273000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <sera:StockIssuedDuringPeriodSharesStockWarrantExercised
      contextRef="i1b061c9e007742eba69e1889997ef7b5_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTgtMTAtMS0xLTM3MzEx_d25b6f83-a40e-4ed3-bde7-f72ee15ba7b4"
      unitRef="shares">22372</sera:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic28dedecba064022874b838744cc8acc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTktMTQtMS0xLTM3MzEx_b86b3777-f357-4986-8a50-68e3c45d1e6d"
      unitRef="usd">914000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMTktMjAtMS0xLTM3MzEx_8339aad3-f375-4063-ab5d-d857ab36b000"
      unitRef="usd">914000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0211f8c70f4546fab653439ef8421171_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjAtMTYtMS0xLTM3MzEx_f4a44956-c3ca-46b6-b009-776bcf83cb68"
      unitRef="usd">-25000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjAtMjAtMS0xLTM3MzEx_0675fe5b-7b21-4fe6-b231-2ca421944422"
      unitRef="usd">-25000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="ib73f2e6d58834f169b6677f9ed409235_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjEtMTgtMS0xLTM3MzEx_ecab22a7-94fc-4bd9-9b1c-75918c85e651"
      unitRef="usd">-9859000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjEtMjAtMS0xLTM3MzEx_a2e2cd40-2b25-4ee5-9d2e-f6fe9dd11a15"
      unitRef="usd">-9859000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i581a92110a4843f6a5589fbed073bada_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMS0xLTEtMzczMTE_17157b3a-4333-4959-a9df-0f0cc0b971b9"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i581a92110a4843f6a5589fbed073bada_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMy0xLTEtMzczMTE_facdb166-0d9c-4a3f-a39a-d0bbd23e904f"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i793efebda0234678845dfb4d311cf810_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItNS0xLTEtMzczMTE_8fba36c4-585f-4f79-8bef-ab5d43e00c9c"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i793efebda0234678845dfb4d311cf810_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItNy0xLTEtMzczMTE_17da6589-c73e-4fb2-8caf-ccb5bcbf5e83"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesIssued
      contextRef="ice3e926ca9454ee092de309e776c0053_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTAtMS0xLTM3MzEx_bcf70ac3-d694-46b9-8e79-61fd360aa857"
      unitRef="shares">30699090</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ice3e926ca9454ee092de309e776c0053_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTItMS0xLTM3MzEx_bbb6a3cc-77e3-4a32-abf9-4602150f2864"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i982fe00fe53a4a749b3fe8ea6ceb21a7_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTQtMS0xLTM3MzEx_a24643a3-1320-4f42-9ee4-68d11515d351"
      unitRef="usd">304044000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i349bc20944944c1e90a30491176f1186_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTYtMS0xLTM3MzEx_cffd6a47-046f-4102-be84-07e6c8d3ddd6"
      unitRef="usd">-25000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a7b24ecb628442489324a85e9888015_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMTgtMS0xLTM3MzEx_5f1fed0e-e896-4678-8477-0cdc3d59eaf5"
      unitRef="usd">-153984000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifef247b0e8bf4cdf83aa0c89d64ed53f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yNS9mcmFnOmNlYWJiYWM0YzQ4NzRlMzRiMzFmNDg2MWJlZjQ0ZTVhL3RhYmxlOjc2ZjM1OTMyM2MwODRjZjQ5NDlhNGEwZDE1MmUxNmVkL3RhYmxlcmFuZ2U6NzZmMzU5MzIzYzA4NGNmNDk0OWE0YTBkMTUyZTE2ZWRfMjItMjAtMS0xLTM3MzEx_af9da4e6-faee-4c65-b18e-e0d1a6d50669"
      unitRef="usd">150038000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMy0xLTEtMS0zNzA2Mg_0a38fea4-6e25-4aa8-a8bb-f58fd221429b"
      unitRef="usd">-34440000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMy0zLTEtMS0zNzA2Mg_77bf7169-bdd2-4526-9c3a-b622e624b494"
      unitRef="usd">-22525000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNS0xLTEtMS0zNzA2Mg_552c4c97-bacb-41a0-b84d-e2dfe7b62de2"
      unitRef="usd">553000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNS0zLTEtMS0zNzA2Mg_f95f09d1-6492-4c8f-b4e2-bc8238ea2434"
      unitRef="usd">514000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNi0xLTEtMS0zNzA2Mg_f35edb2c-d5bf-4533-ae5c-757d72427536"
      unitRef="usd">3714000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNi0zLTEtMS0zNzA2Mg_1e7d2a51-1a5a-4c8b-a4a2-8511bdb6fbac"
      unitRef="usd">2017000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0xLTEtMS0zOTY3OQ_09d8cb2f-32a2-43f1-81f6-0caecd661153"
      unitRef="usd">337000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0zLTEtMS0zOTY3OQ_a0df5bd3-cb02-4ec1-a7af-fad09c156669"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:PaidInKindInterest
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNy0xLTEtMS0zNzA2Mg_bf22f6bb-7722-4ea5-9f01-6b7307a094b8"
      unitRef="usd">12000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNy0zLTEtMS0zNzA2Mg_20485783-fb96-46e4-8893-b583e4895bc4"
      unitRef="usd">588000</us-gaap:PaidInKindInterest>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0xLTEtMS0zNzA2Mg_16e69f0a-9f3a-4966-874a-67a6b1c27b68"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOC0zLTEtMS0zNzA2Mg_428666ed-84af-44c7-bed3-1c627e8bffb0"
      unitRef="usd">1050000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOS0xLTEtMS0zNzA2Mg_60e6fefd-a8dc-4fd4-ad6e-088212f1fab8"
      unitRef="usd">26000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfOS0zLTEtMS0zNzA2Mg_b39d0618-1798-4e5e-94a0-8ac75ec694c6"
      unitRef="usd">-32000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTEtMS0xLTEtMzcwNjI_6b881a61-09fb-45e2-8b02-27b4d15d8cf4"
      unitRef="usd">80000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTEtMy0xLTEtMzcwNjI_d566577c-b9e2-4160-8ffb-687ed8595706"
      unitRef="usd">33000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTItMS0xLTEtMzcwNjI_5a6f6e70-fa95-41f7-a906-bcbe7afb23d0"
      unitRef="usd">-3116000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTItMy0xLTEtMzcwNjI_bafb8049-c335-4f5b-9563-ba4629568aa6"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTMtMS0xLTEtMzcwNjI_1452685d-6cf5-4c42-b0dd-17accf23ae01"
      unitRef="usd">-205000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTMtMy0xLTEtMzcwNjI_8aadcb91-ab4a-46b7-bc26-ae741c12b6f6"
      unitRef="usd">2085000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTQtMS0xLTEtMzcwNjI_413c12de-81c4-420e-a461-adb5fb9223d6"
      unitRef="usd">-204000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTQtMy0xLTEtMzcwNjI_7a1d2f6c-5627-469c-abb4-58bc7a0747b5"
      unitRef="usd">518000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTUtMS0xLTEtMzcwNjI_fab56f72-2fb7-4e90-b69a-ec24abdfe94d"
      unitRef="usd">-534000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTUtMy0xLTEtMzcwNjI_7b28a9f8-b195-47c4-928a-388a88f45faa"
      unitRef="usd">-365000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <sera:IncreaseDecreaseInDeferredRent
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTYtMS0xLTEtMzcwNjI_c5cab9b5-06bd-4116-94cb-d70dd35bf3bd"
      unitRef="usd">0</sera:IncreaseDecreaseInDeferredRent>
    <sera:IncreaseDecreaseInDeferredRent
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTYtMy0xLTEtMzcwNjI_17079b9b-da60-4a1c-afa7-10d333e03f5d"
      unitRef="usd">-95000</sera:IncreaseDecreaseInDeferredRent>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTctMS0xLTEtMzcwNjI_e05dd581-20a6-41e8-931e-49b4b1d4a5be"
      unitRef="usd">-25000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTctMy0xLTEtMzcwNjI_2a6a535f-c184-4032-b24c-917116967c04"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTgtMS0xLTEtMzcwNjI_f8bb4b9e-8342-418d-9215-d89b3f5f2c5b"
      unitRef="usd">-27372000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMTgtMy0xLTEtMzcwNjI_53722bb3-33d9-4d66-b113-4e1901d2a411"
      unitRef="usd">-22484000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjAtMS0xLTEtMzcwNjI_7880f3d9-e617-4133-8080-c1a25328afc0"
      unitRef="usd">41588000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjAtMy0xLTEtMzcwNjI_19dc7630-4085-4d3b-be47-bd6faea0692e"
      unitRef="usd">67572000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjEtMS0xLTEtMzcwNjI_a04794a8-1f95-45b6-93cf-d2ec6a1e36f2"
      unitRef="usd">49299000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjEtMy0xLTEtMzcwNjI_3bd51d32-feff-4f2e-aa2e-52691ed3e9d8"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjItMS0xLTEtMzcwNjI_ee4b94ec-4693-4d71-9d13-004ae7fcc910"
      unitRef="usd">598000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjItMy0xLTEtMzcwNjI_e29f0199-39d9-4ccb-a874-b5d0d3c7a90f"
      unitRef="usd">555000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjMtMS0xLTEtMzcwNjI_4e076d8b-afd2-42ac-b655-1c767712c7dc"
      unitRef="usd">16000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjMtMy0xLTEtMzcwNjI_05f75e2e-5b90-40ea-8d7c-871b4fa2c862"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjQtMS0xLTEtMzcwNjI_255ff120-cf81-41ee-ad2e-026159b6b876"
      unitRef="usd">7129000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjQtMy0xLTEtMzcwNjI_0b07cf86-f4d3-4598-8b22-e5d42a7d2baa"
      unitRef="usd">-68127000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="ice5c668015774084978a3b33807344f8_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjYtMS0xLTEtMzcwNjI_e4cf2c29-3b57-4ebb-af2c-8b0d2b7ee905"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock
      contextRef="i100ed6658c0743798fcbfcfe1fc0bb18_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjYtMy0xLTEtMzcwNjI_ffba2e65-b1be-4c1c-a8eb-bc0cf5e9cc40"
      unitRef="usd">98983000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjctMS0xLTEtMzcwNjI_827fe702-749a-4ed8-a38d-5d15bd8d6615"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjctMy0xLTEtMzcwNjI_f7b10158-7c94-4576-a70b-e0016e6e904e"
      unitRef="usd">1071000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMS0xLTEtMzczOTA_04677464-da7e-415f-92c7-08fe767c011d"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMy0xLTEtMzczOTA_ab2a12f6-004e-479c-aed4-cdc04c06e532"
      unitRef="usd">66611000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMS0xLTEtMzcwNjI_f529a45e-6dc6-4db3-83b5-17d2f99973ca"
      unitRef="usd">307000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjgtMy0xLTEtMzcwNjI_949f4ef3-f322-486b-980f-9ef35038fae9"
      unitRef="usd">537000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjktMS0xLTEtMzcwNjI_35b627f6-db6c-4cda-b97d-ef2bd8e91080"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMjktMy0xLTEtMzcwNjI_07eac2eb-aafb-4726-a9ea-b347e7433eb4"
      unitRef="usd">4494000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzAtMS0xLTEtMzcwNjI_c1815865-34c2-4fd3-80d2-c128b4c07c0a"
      unitRef="usd">0</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzAtMy0xLTEtMzcwNjI_34333cd5-2583-4917-be12-b879c6d7a3f3"
      unitRef="usd">3100000</us-gaap:RepaymentsOfDebt>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzEtMS0xLTEtMzcwNjI_1894de57-d7db-4fd9-97e7-addce27b74e6"
      unitRef="usd">186000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzEtMy0xLTEtMzcwNjI_5d8e934e-8987-49d1-b11b-1960ec7ea43a"
      unitRef="usd">51000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzMtMS0xLTEtMzcwNjI_3923635b-56d6-4af4-828e-5d63fb7338d8"
      unitRef="usd">121000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzMtMy0xLTEtMzcwNjI_dcf15d36-eb82-4fe6-99bf-9e3ef925c3fc"
      unitRef="usd">159557000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzQtMS0xLTEtMzcwNjI_d2453bd1-f500-4707-95cd-232a1c0d4272"
      unitRef="usd">-20122000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzQtMy0xLTEtMzcwNjI_4cbaf007-7273-497d-b3c0-546a6bf2ab82"
      unitRef="usd">68946000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzUtMS0xLTEtMzcwNjI_135ae0af-eefd-4ccb-bab8-972a8ef7611b"
      unitRef="usd">58932000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i744e357934604565b8a1ba77622b5d45_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzUtMy0xLTEtMzcwNjI_58c05e4b-100d-4f96-b96e-c340704cd850"
      unitRef="usd">13533000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzYtMS0xLTEtMzcwNjI_19958610-15de-4c95-8af1-b178fffb067b"
      unitRef="usd">38810000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifef247b0e8bf4cdf83aa0c89d64ed53f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzYtMy0xLTEtMzcwNjI_6bbb54fa-b36e-42fe-8720-71481fc6553a"
      unitRef="usd">82479000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzgtMS0xLTEtMzcwNjI_20d81935-6201-448d-99fb-d1a4ccd7a7d5"
      unitRef="usd">30000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfMzgtMy0xLTEtMzcwNjI_d0663818-94c6-4a55-afbf-b9383d2e245b"
      unitRef="usd">1273000</us-gaap:InterestPaidNet>
    <sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDAtMS0xLTEtMzcwNjI_33db2247-72b3-4796-80f0-f0bad920e7c7"
      unitRef="usd">38000</sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities>
    <sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDAtMy0xLTEtMzcwNjI_e76f69e0-26fc-4bd2-b62c-f49bac618009"
      unitRef="usd">170000</sera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities>
    <sera:PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDItMS0xLTEtMzcwNjI_593e8bbe-2eab-4f17-a0f4-58af506df799"
      unitRef="usd">0</sera:PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock>
    <sera:PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8yOC9mcmFnOjViYzBjNmZhZWVmYzQ0OTI5NWQ5ZjY2MDQ4YWYwNDNiL3RhYmxlOmFmOTViYjQ0NGI0NjRkNmRiN2Y0MGE1ZmYwZDA3MWIzL3RhYmxlcmFuZ2U6YWY5NWJiNDQ0YjQ2NGQ2ZGI3ZjQwYTVmZjBkMDcxYjNfNDItMy0xLTEtMzcwNjI_bb88518e-526e-445a-b3f7-6b37b5edb1c1"
      unitRef="usd">26000</sera:PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNC9mcmFnOjVmYzllZTQwM2NkYTQ2NGZiOGU0ZDlhZTIyOTIyMDRjL3RleHRyZWdpb246NWZjOWVlNDAzY2RhNDY0ZmI4ZTRkOWFlMjI5MjIwNGNfMzYzNw_811c37bb-9aff-492d-8653-d6e0d4838692">Description of Business and Financial Condition&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sera Prognostics, Inc. (the &#x201c;Company&#x201d;) is a women&#x2019;s health company utilizing its proprietary proteomics and bioinformatics platform to discover, develop, and commercialize biomarker tests with an initial focus on improving pregnancy outcomes. The Company was incorporated in the State of Delaware on January 17, 2008 and its operations are located in Salt Lake City, Utah, including a Clinical Laboratory Improvement Amendments (&#x201c;CLIA&#x201d;)-certified laboratory.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since its inception, the Company&#x2019;s activities have consisted of performing research and development, conducting clinical studies, acquiring product rights, raising capital, establishing facilities, and organizing commercial operations to market the PreTRM test.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has incurred net losses and negative cash flows from operations since inception and had an accumulated deficit of $200.9&#160;million as of September&#160;30, 2022. The Company&#x2019;s management expects the Company to incur significant additional operating losses and negative cash flows for the foreseeable future, principally as a result of the Company&#x2019;s commercialization activities for the PreTRM test, and to support additional clinical and preclinical trials and anticipated research and development activities. There can be no assurance that the Company will eventually achieve significant revenues or profitability to sustain operations, or if achieved, can sustain either on a continuing basis. If the Company is unable to achieve significant revenues or raise additional funds, when needed, it may not be able to continue the development or commercialization of its diagnostic products and could be required to delay, scale back, or abandon some or all of its development programs and other operations. No assurance can be given that the Company will be successful in raising the required capital on reasonable terms and at the required times, or at all. Any additional equity financing, if available to the Company, may not be available on favorable terms and may be dilutive to current stockholders, and any debt financing, if available, may involve restrictive covenants and dilutive financing instruments. The Company&#x2019;s future operations are highly dependent on a combination of factors, including (i) the successful commercial launch and market acceptance of the PreTRM test; (ii) the success of clinical trials and other research and development programs; (iii) the development of competitive products by other biotechnology and laboratory companies; (iv) the Company&#x2019;s ability to manage growth of the organization; (v) the Company&#x2019;s ability to protect its intellectual property, technology, and products; and, ultimately (vi) the timely and successful completion of any additional financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The principal sources of the Company&#x2019;s working capital to date have been the proceeds from the sale and issuance of convertible preferred stock and convertible notes, bank loans, and the sale and issuance of Class A common stock in an initial public offering (&#x201c;IPO&#x201d;), which was completed in July 2021. See Note 10&#x2014;Capital Structure for additional details about the IPO. As of September&#160;30, 2022, the Company had aggregate cash, cash equivalents, and available-for-sale securities of $111.2 million. See Note 3&#x2014;Cash, Cash Equivalents and Marketable Securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that its existing financial resources are sufficient to continue operating activities at least 12 months from the issuance date of these unaudited condensed financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNC9mcmFnOjVmYzllZTQwM2NkYTQ2NGZiOGU0ZDlhZTIyOTIyMDRjL3RleHRyZWdpb246NWZjOWVlNDAzY2RhNDY0ZmI4ZTRkOWFlMjI5MjIwNGNfMTExNQ_21fc0314-8aac-4046-947a-fb3515dcdd88"
      unitRef="usd">-200900000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNC9mcmFnOjVmYzllZTQwM2NkYTQ2NGZiOGU0ZDlhZTIyOTIyMDRjL3RleHRyZWdpb246NWZjOWVlNDAzY2RhNDY0ZmI4ZTRkOWFlMjI5MjIwNGNfMzQxOQ_8bc056dd-aba7-40d8-92db-d2fe967dc6ea"
      unitRef="usd">111200000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4NQ_f49d6d8e-c98d-462d-8a36-66afb306614f">Significant Accounting Policies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021. The unaudited interim condensed financial statements have been &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2021, and, in the opinion of the Company&#x2019;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial results. The balance sheet as of December&#160;31, 2021 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2022, or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Topic 842&#x201d;) and its subsequent updates effective January 1, 2022. The Company adopted Topic 842 using a modified retrospective method. As such, comparative periods ending prior to January 1, 2022 are presented in accordance with ASC 840, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and periods ending after January 1, 2022 are presented in accordance with Topic 842. There was no impact to the Company&#x2019;s accumulated deficit as a result of adopting Topic 842. The Company used the package of practical expedients permitted under Topic 842. As a result, the Company did not reassess its lease population, classifications of existing leases, or initial direct costs of existing leases as of the adoption date. The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. The Company also elected not to separate lease components from non-lease components for all classes of leased assets except for building leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The adoption of Topic 842 resulted in a right-of-use asset of $0.5&#160;million related to the Company&#x2019;s operating lease being recognized in other assets on the condensed balance sheets as of January 1, 2022. A corresponding lease liability of $0.6&#160;million related to the Company&#x2019;s operating lease was recognized in accrued and other liabilities on the condensed balance sheets as of January 1, 2022. In addition, at January 1, 2022, approximately $0.1&#160;million of lease-related liabilities were removed from deferred rent, current portion as a reduction to the initial operating lease right-of-use asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of adopting Topic 842, leases classified as capital leases under ASC 840 are now called finance leases. Accordingly, the condensed balance sheet items formerly captioned &#x201c;Capital lease obligation, current portion&#x201d; and &#x201c;Capital lease obligation, net of current portion&#x201d; will now be captioned &#x201c;Finance lease obligation, current portion&#x201d; and &#x201c;Finance lease obligation, net of current portion&#x201d;, respectively, beginning in the current period. Amounts in these balance sheet items were capital leases under ASC 840 in periods ending prior to January 1, 2022, while amounts in these balance sheet items are finance leases under ASC 842 in periods ending subsequent to January 1, 2022. The Company&#x2019;s finance lease right-of-use asset and liability balances were not materially affected by the adoption of Topic 842. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#x2019;s assets or liabilities as of the date of the condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The objective of the standard is to provide information about expected credit losses on financial instruments at each reporting date and to change how other-than-temporary impairments on investment securities are recorded. The Company is currently an emerging growth company and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. As such, the guidance is effective for the Company beginning on January 1, 2023. The Company is currently evaluating the impact the standard may have on its financial statements and related disclosures but does not currently expect the standard will have a material impact.&lt;/span&gt;&lt;/div&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) and the SEC did not, or are not believed by the Company&#x2019;s management to, have a material impact on the Company&#x2019;s financial position, results of operations or cash flows.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4Ng_87177415-87ab-47c1-b3d8-7b5c0ea02963">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and applicable rules and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. As such, these unaudited condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021. The unaudited interim condensed financial statements have been &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;prepared on a basis consistent with the audited annual financial statements as of and for the year ended December&#160;31, 2021, and, in the opinion of the Company&#x2019;s management, reflect all adjustments, consisting solely of normal recurring adjustments, necessary for the fair presentation of the Company&#x2019;s financial results. The balance sheet as of December&#160;31, 2021 has been derived from the audited financial statements at that date but does not include all information and footnotes required by U.S. GAAP for complete financial statements. The results of the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results to be expected for the full year ending December&#160;31, 2022, or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4OA_bca08f99-7447-49be-a0cd-a2e380ef1f5c">&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adopted ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;Topic 842&#x201d;) and its subsequent updates effective January 1, 2022. The Company adopted Topic 842 using a modified retrospective method. As such, comparative periods ending prior to January 1, 2022 are presented in accordance with ASC 840, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and periods ending after January 1, 2022 are presented in accordance with Topic 842. There was no impact to the Company&#x2019;s accumulated deficit as a result of adopting Topic 842. The Company used the package of practical expedients permitted under Topic 842. As a result, the Company did not reassess its lease population, classifications of existing leases, or initial direct costs of existing leases as of the adoption date. The Company elected to treat leases with lease terms of 12 months or less as short-term leases. No right-of-use assets or lease liabilities are recognized for short-term leases. The Company also elected not to separate lease components from non-lease components for all classes of leased assets except for building leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The adoption of Topic 842 resulted in a right-of-use asset of $0.5&#160;million related to the Company&#x2019;s operating lease being recognized in other assets on the condensed balance sheets as of January 1, 2022. A corresponding lease liability of $0.6&#160;million related to the Company&#x2019;s operating lease was recognized in accrued and other liabilities on the condensed balance sheets as of January 1, 2022. In addition, at January 1, 2022, approximately $0.1&#160;million of lease-related liabilities were removed from deferred rent, current portion as a reduction to the initial operating lease right-of-use asset. &lt;/span&gt;&lt;/div&gt;As a result of adopting Topic 842, leases classified as capital leases under ASC 840 are now called finance leases. Accordingly, the condensed balance sheet items formerly captioned &#x201c;Capital lease obligation, current portion&#x201d; and &#x201c;Capital lease obligation, net of current portion&#x201d; will now be captioned &#x201c;Finance lease obligation, current portion&#x201d; and &#x201c;Finance lease obligation, net of current portion&#x201d;, respectively, beginning in the current period. Amounts in these balance sheet items were capital leases under ASC 840 in periods ending prior to January 1, 2022, while amounts in these balance sheet items are finance leases under ASC 842 in periods ending subsequent to January 1, 2022. The Company&#x2019;s finance lease right-of-use asset and liability balances were not materially affected by the adoption of Topic 842.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idef209848fc148788ca3494cf8345024_I20220101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfMzU2MA_e5d6f706-0dcd-4f76-96b7-1ca2dc194e5b"
      unitRef="usd">500000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="idef209848fc148788ca3494cf8345024_I20220101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfMzcyNw_07f3141a-600b-461a-8e2b-42469c89d876"
      unitRef="usd">600000</us-gaap:OperatingLeaseLiability>
    <sera:OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent
      contextRef="idef209848fc148788ca3494cf8345024_I20220101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfMzkyMQ_bc8ee7e0-fe99-4fdc-a2e4-4f5ea245aab6"
      unitRef="usd">100000</sera:OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent>
    <us-gaap:UseOfEstimates
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM4OQ_3086f215-27b8-4069-aa07-9b349436ae8e">&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the amounts reported in the condensed financial statements and accompanying notes. The Company evaluates these estimates on an ongoing basis. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ materially from those estimates. The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company&#x2019;s assets or liabilities as of the date of the condensed financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl8zNy9mcmFnOjRkYjE2YTAxN2IzODQ3YzZiODQxY2RiOGM2MjA1YmY2L3RleHRyZWdpb246NGRiMTZhMDE3YjM4NDdjNmI4NDFjZGI4YzYyMDViZjZfODM5MA_1326a147-7131-4e7f-95d9-803e8b3fce6d">&lt;div style="margin-top:11pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The objective of the standard is to provide information about expected credit losses on financial instruments at each reporting date and to change how other-than-temporary impairments on investment securities are recorded. The Company is currently an emerging growth company and has elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. As such, the guidance is effective for the Company beginning on January 1, 2023. The Company is currently evaluating the impact the standard may have on its financial statements and related disclosures but does not currently expect the standard will have a material impact.&lt;/span&gt;&lt;/div&gt;Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force) and the SEC did not, or are not believed by the Company&#x2019;s management to, have a material impact on the Company&#x2019;s financial position, results of operations or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMTExMA_914007a0-200a-4707-9ccc-d1422b57943c">Cash, Cash Equivalents and Marketable Securities&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has classified its marketable securities as available-for-sale. The Company&#x2019;s cash, cash equivalents and marketable securities by major security type as of September&#160;30, 2022 and December&#160;31, 2021 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;36,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s available-for-sale debt securities and cash equivalents with unrealized losses as of September&#160;30, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, the Company had no available-for-sale debt securities that had been in a continuous unrealized loss position for a period greater than 12 months. The Company determined that no available-for-sale securities were other-than-temporarily impaired as of September&#160;30, 2022 and December&#160;31, 2021. The Company attributes the declines in the fair value of its available-for-sale securities to normal market and interest rate fluctuations. The declines in fair value are not attributed to declines in credit quality. The Company does not intend to sell investments while they are in an unrealized loss position and does not believe that it is more likely than not that the Company will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities classified by contractual maturities as of September&#160;30, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMTExMQ_9929b1b9-da5e-4733-ac15-7f88d6c3f3d3">The Company&#x2019;s cash, cash equivalents and marketable securities by major security type as of September&#160;30, 2022 and December&#160;31, 2021 were as follows (in thousands):&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;36,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(515)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(196)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.475%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.051%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy0xLTEtMS0zNzA2Mg_2f7db22a-67b6-413f-b69f-3a4d9dcff556"
      unitRef="usd">404000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy0zLTEtMS0zNzA2Mg_e4e5504a-26bf-4262-896b-f0ed073f5bb1"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy01LTEtMS0zNzA2Mg_5003b74d-f334-4f4f-9822-2e4006828337"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i426c150219944b5e9da3b86ec1649f1d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMy03LTEtMS0zNzA2Mg_5d2684f5-b154-458b-af87-a8aa9fe865c0"
      unitRef="usd">404000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i41585eff29234897a3b80b9a1807b068_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC0xLTEtMS0zNzA2Mg_f8cb3664-7444-4162-8976-cca87daae016"
      unitRef="usd">1510000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i41585eff29234897a3b80b9a1807b068_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC0zLTEtMS0zNzA2Mg_b0df8356-27a9-43f5-bd42-982ec38b3655"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i41585eff29234897a3b80b9a1807b068_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC01LTEtMS0zNzA2Mg_8de721f1-abf5-4ebe-87bd-d9add85760d5"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i41585eff29234897a3b80b9a1807b068_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNC03LTEtMS0zNzA2Mg_56c9c0ec-2448-4dcd-9316-38858c376bfd"
      unitRef="usd">1510000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS0xLTEtMS0zNzA2Mg_5028f7ab-2b85-49e0-af8e-545f55b9c9c7"
      unitRef="usd">36902000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS0zLTEtMS0zNzA2Mg_eb952516-02ef-48cb-8f5a-45e60d0fc2bc"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS01LTEtMS0zNzA2Mg_fca89d3b-0211-4a2c-afdf-3346e5a578f4"
      unitRef="usd">6000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibb5a98ca9ba14803a311d4239d81f5a6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNS03LTEtMS0zNzA2Mg_6afba6f7-92aa-4af3-91d0-d420ef338cde"
      unitRef="usd">36896000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi0xLTEtMS0zNzA2Mg_13c59880-5854-4001-aaaf-2e7f6f511dea"
      unitRef="usd">38816000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi0zLTEtMS0zNzA2Mg_807419f3-814f-41fe-9fb5-e3240ba62efe"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi01LTEtMS0zNzA2Mg_59977cef-34b4-4afa-854a-943aa177d356"
      unitRef="usd">6000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i308ca8df8a3c450db8268afabcd6b278_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfNi03LTEtMS0zNzA2Mg_0098e089-e670-4d76-baf8-8cd5a34b513e"
      unitRef="usd">38810000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC0xLTEtMS0zNzA2Mg_ee506c93-3314-4cd6-91cc-5c1a9956b44a"
      unitRef="usd">15861000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC0zLTEtMS0zNzA2Mg_0141a4cd-f752-4789-818a-7f371c56c199"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC01LTEtMS0zNzA2Mg_bcaaaed4-28ce-4234-9384-8bf219788f2c"
      unitRef="usd">68000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b282321c2d246eb9b5f2e4dacded3e4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOC03LTEtMS0zNzA2Mg_c8d27232-11ce-4f8a-b86f-6f5e5cad4402"
      unitRef="usd">15793000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS0xLTEtMS0zNzA2Mg_8fff4ca1-517a-4792-bd98-a79537c1eb6e"
      unitRef="usd">506000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS0zLTEtMS0zNzA2Mg_4ee92e1b-7356-453d-aa79-5c122e520bdd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS01LTEtMS0zNzA2Mg_ae75c6a3-c9e2-476a-9c99-8656548120b4"
      unitRef="usd">10000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8e8252a2c5ce48f2be393976df7df3e2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfOS03LTEtMS0zNzA2Mg_e2dcd490-fd85-4109-ac0d-1c5cc1d42fa1"
      unitRef="usd">496000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtMS0xLTEtMzcwNjI_2d97a4a9-bc8b-436a-8b1b-d2c5f5634abd"
      unitRef="usd">25692000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtMy0xLTEtMzcwNjI_2839b82f-b2cb-4d79-ba12-5c40f7943758"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtNS0xLTEtMzcwNjI_44bda6de-f798-4074-a182-b05978ab0a70"
      unitRef="usd">515000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia94d6e17beb54943aec8dffc01b527b9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTAtNy0xLTEtMzcwNjI_12d98c3a-9c39-4eef-8da3-8e697b5bd531"
      unitRef="usd">25177000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtMS0xLTEtMzcwNjI_64380117-6f29-43a7-b9f6-51e71a6ae419"
      unitRef="usd">8698000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtMy0xLTEtMzcwNjI_c9e884ee-cad7-438b-b9e3-a1b8cb86b24c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtNS0xLTEtMzcwNjI_43b8a3ac-4f69-422b-bc35-98a7ae9c179b"
      unitRef="usd">196000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d808de0c1f94398ac6c5a6b1637c68a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTEtNy0xLTEtMzcwNjI_e57e648e-f63b-469e-a3ea-553297e2de3a"
      unitRef="usd">8502000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i27b735bee6644b40a873590cf5490f25_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItMS0xLTEtMzcwNjI_da12f696-85a6-40ac-81b7-7bf8850d5850"
      unitRef="usd">50757000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i27b735bee6644b40a873590cf5490f25_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItMy0xLTEtMzcwNjI_dc8d576a-3a74-44cd-bf37-26a0cf233735"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i27b735bee6644b40a873590cf5490f25_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItNS0xLTEtMzcwNjI_598edc40-2b6f-4934-89e8-feb5095a0b2f"
      unitRef="usd">789000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27b735bee6644b40a873590cf5490f25_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTItNy0xLTEtMzcwNjI_13b2eb8f-48cf-4131-953d-7af0f03ea422"
      unitRef="usd">49968000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtMS0xLTEtMzcwNjI_235f51ff-7907-4ca6-9d73-65e22e50be30"
      unitRef="usd">12024000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtMy0xLTEtMzcwNjI_10b5b35c-1b04-48d8-80b6-786ba715718c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtNS0xLTEtMzcwNjI_e1cc3633-dc8e-4d12-b018-71f5fb9f32b1"
      unitRef="usd">194000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5dfdc3fff2444683ab97d33895e30f14_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTQtNy0xLTEtMzcwNjI_28836961-a6f0-47e8-bc16-8c51b48099f7"
      unitRef="usd">11830000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i892e66ef1e914f91954762a487029ccd_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtMS0xLTEtMzcwNjI_8b4590d0-a3cf-4f8f-9354-1b91925d6781"
      unitRef="usd">10728000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i892e66ef1e914f91954762a487029ccd_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtMy0xLTEtMzcwNjI_2eaf7d97-95ac-4544-bc67-968305c9fcd9"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i892e66ef1e914f91954762a487029ccd_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtNS0xLTEtMzcwNjI_2e9bd87a-a56a-4707-8ce7-7115e1e4e963"
      unitRef="usd">181000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i892e66ef1e914f91954762a487029ccd_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTUtNy0xLTEtMzcwNjI_460b5684-92a7-4bed-9781-ce85e2530a56"
      unitRef="usd">10548000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtMS0xLTEtMzcwNjI_07da41ff-b7b0-4f55-8511-a3bec8f1a913"
      unitRef="usd">22752000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtMy0xLTEtMzcwNjI_22d777b8-5592-48d3-96f0-779ae6be4389"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtNS0xLTEtMzcwNjI_670d2656-9d66-48d5-9e08-7bcef3809d6c"
      unitRef="usd">375000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i02965420c7c14abd9839a8d8b42176d5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTYtNy0xLTEtMzcwNjI_ea094f5a-7918-47a0-80df-407b827d069a"
      unitRef="usd">22378000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctMS0xLTEtMzcwNjI_19514393-ea59-4c48-b2eb-46f6c754c85f"
      unitRef="usd">112325000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctMy0xLTEtMzcwNjI_15866a3c-1bfa-450a-bd4d-8fdf8d4c7920"
      unitRef="usd">1000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctNS0xLTEtMzcwNjI_1431508d-fe29-4a78-b8ad-6fcf92b40b5e"
      unitRef="usd">1170000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmM3MjQxNjdhZjA5MjQxMTk4Mzc5NjdmNmRhMzgwMTJkL3RhYmxlcmFuZ2U6YzcyNDE2N2FmMDkyNDExOTgzNzk2N2Y2ZGEzODAxMmRfMTctNy0xLTEtMzcwNjI_1282bc18-967e-4a7d-97ba-e1908702e35a"
      unitRef="usd">111156000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i295341f5241643588814e697d1be3629_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy0xLTEtMS0zNzA2Mg_1b6cf1b6-dcc6-46e4-ad63-773ccf4eff6b"
      unitRef="usd">70000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i295341f5241643588814e697d1be3629_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy0zLTEtMS0zNzA2Mg_42f8ac48-6228-4c34-839e-785c8f700209"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i295341f5241643588814e697d1be3629_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy01LTEtMS0zNzA2Mg_3ef5218f-6fce-4278-beda-bc9d176dfdc0"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i295341f5241643588814e697d1be3629_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMy03LTEtMS0zNzA2Mg_2ce021ee-a88f-4828-80d6-abd10a092080"
      unitRef="usd">70000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC0xLTEtMS0zNzA2Mg_c6a49f29-f688-40eb-b1f4-47c387d3275a"
      unitRef="usd">4021000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC0zLTEtMS0zNzA2Mg_3c789aa4-624d-41ce-828e-9d88add5ded7"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC01LTEtMS0zNzA2Mg_c8902e0c-b356-4bd0-9a6b-7e8a8fd341ba"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0fa9319e62f84c96a99782f165bbd352_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNC03LTEtMS0zNzA2Mg_adacf011-3527-455e-860f-e468835d6c46"
      unitRef="usd">4021000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS0xLTEtMS0zNzA2Mg_be597323-274d-404b-a5eb-5b8c02689119"
      unitRef="usd">54843000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS0zLTEtMS0zNzA2Mg_3e8d04da-1206-4e56-bea0-bdcdd2a0e69b"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS01LTEtMS0zNzA2Mg_88d11130-f6a2-4b6d-ba5c-68a6de987102"
      unitRef="usd">2000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i89f3e16ed78043789e8e75c2ef6e3598_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNS03LTEtMS0zNzA2Mg_6f60ef5a-438e-4fc6-8d4d-9fdb3065c081"
      unitRef="usd">54841000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <sera:CashAndCashEquivalentsAmortizedCost
      contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi0xLTEtMS0zNzA2Mg_51b9c450-df6c-426f-93bd-fd1a4517dcb7"
      unitRef="usd">58934000</sera:CashAndCashEquivalentsAmortizedCost>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi0zLTEtMS0zNzA2Mg_cc1f4c2e-95dc-4865-ae58-bf42fda1acef"
      unitRef="usd">0</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi01LTEtMS0zNzA2Mg_7e435fd0-eddd-40b5-a765-7bb928bb51a6"
      unitRef="usd">2000</sera:CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic362baeed4fd478d809c38fe093e5c6f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfNi03LTEtMS0zNzA2Mg_4d76adbe-7c9b-4373-9498-d7a429f6357a"
      unitRef="usd">58932000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC0xLTEtMS0zNzA2Mg_b74cc653-6dc6-47a3-ad49-a05392a72754"
      unitRef="usd">39696000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC0zLTEtMS0zNzA2Mg_57f78d4a-e7cc-4537-b9e6-e9812df9ea02"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC01LTEtMS0zNzA2Mg_f479b7e3-db71-4029-9441-add0a52ea6af"
      unitRef="usd">24000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3211865e368e427c97e8b1ed624dbcf0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOC03LTEtMS0zNzA2Mg_7717d214-fb12-4a06-908b-44953e59ebf5"
      unitRef="usd">39672000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS0xLTEtMS0zNzA2Mg_fcc81d90-d219-4a52-a369-19dc8f8c2056"
      unitRef="usd">6515000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS0zLTEtMS0zNzA2Mg_57962df5-03e5-46ab-a0cf-be4843e09300"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS01LTEtMS0zNzA2Mg_1809c7a6-3dc0-4c27-8b64-b64e7fdb8f9a"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifed49bd2be2f4fae81459611b2b9d6e1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfOS03LTEtMS0zNzA2Mg_1ca3d0e9-8e8d-4f7a-9196-03040c028ae4"
      unitRef="usd">6511000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtMS0xLTEtMzcwNjI_afc2c784-5177-460a-953e-b4b48557d4ea"
      unitRef="usd">46211000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtMy0xLTEtMzcwNjI_0a1ac08b-c305-489e-832a-56b8e25073f8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtNS0xLTEtMzcwNjI_3cf06410-c010-44a3-8ae3-f0968f74b8c2"
      unitRef="usd">28000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d35cb98b6f24f00b69ff76dd9475ab3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTAtNy0xLTEtMzcwNjI_f1cff219-e50e-4e72-b7c2-ec1d655d0ece"
      unitRef="usd">46183000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItMS0xLTEtMzcwNjI_0752459f-168e-4c8a-a1bf-8ffe69979d6e"
      unitRef="usd">25787000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItMy0xLTEtMzcwNjI_b26f0d11-e459-4955-a178-2c0fcdc8b0af"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItNS0xLTEtMzcwNjI_685c3d7b-4c7c-4d71-92b9-b5d54e74e3e3"
      unitRef="usd">112000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f65666786e8428dabc37121eed3caa2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTItNy0xLTEtMzcwNjI_b515bf93-97eb-473c-a5d5-2948dba7c493"
      unitRef="usd">25675000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtMS0xLTEtMzcwNjI_d5eeabc5-3f04-4e43-b559-e91a6f9f0f74"
      unitRef="usd">8694000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtMy0xLTEtMzcwNjI_1bf2fbba-bae7-49cb-bbfb-a6f47569cba6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtNS0xLTEtMzcwNjI_c9376615-744e-4d60-bc35-b307f87a3559"
      unitRef="usd">38000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9f6a85b4df004f85aba9cb3ea7bb435f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTMtNy0xLTEtMzcwNjI_03ef81fc-7ebb-4e5d-96bb-118990d51fdf"
      unitRef="usd">8656000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtMS0xLTEtMzcwNjI_633ec9c0-9d35-4ce2-94f2-a580ede46912"
      unitRef="usd">520000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtMy0xLTEtMzcwNjI_5f2d85b9-29ab-4035-8a02-346e9c8879b0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtNS0xLTEtMzcwNjI_b136ed5b-f439-4dc2-a575-11aa54c3f9bb"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3de9e5774c374348827a38ac65ce15c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTQtNy0xLTEtMzcwNjI_4ce7cae7-cb8a-4884-9aec-472f27358318"
      unitRef="usd">517000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia5ff086cec454294bcec367c74433793_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtMS0xLTEtMzcwNjI_e2584c2d-034a-42b1-a770-df6845957ca0"
      unitRef="usd">35001000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia5ff086cec454294bcec367c74433793_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtMy0xLTEtMzcwNjI_8aecb73e-8256-4690-a780-1f973f1078cb"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia5ff086cec454294bcec367c74433793_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtNS0xLTEtMzcwNjI_1ef1cfdd-c173-485f-a538-c86282b2aa60"
      unitRef="usd">153000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia5ff086cec454294bcec367c74433793_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTUtNy0xLTEtMzcwNjI_f2d16947-34b4-4027-a38c-51194942ce3d"
      unitRef="usd">34848000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtMS0xLTEtMzcwNjI_44f356e4-9d09-4861-bcc1-a035ca62dcdf"
      unitRef="usd">140146000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtMy0xLTEtMzcwNjI_205257a2-58a2-4994-bc27-0705b5c64845"
      unitRef="usd">0</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtNS0xLTEtMzcwNjI_6b5e5e09-a4cb-4961-9529-6bb0801e78f6"
      unitRef="usd">183000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax>
    <sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjg3ZmEzYzk2YzlkZjQxMjZiNjI2ODY1ZGNlZWIxYzcxL3RhYmxlcmFuZ2U6ODdmYTNjOTZjOWRmNDEyNmI2MjY4NjVkY2VlYjFjNzFfMTYtNy0xLTEtMzcwNjI_aea7f613-cd1c-418a-bdf8-0d11363a531c"
      unitRef="usd">139963000</sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfNTQ5NzU1ODE1MzIz_8c41a76f-b35f-4893-bc5d-8bfdbafddc88">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s available-for-sale debt securities and cash equivalents with unrealized losses as of September&#160;30, 2022, aggregated by major security type and the length of time that individual securities have been in a continuous loss position (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less than 12 months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or greater&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(319)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(113)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(657)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy0xLTEtMS0zODkyMQ_95e67cd1-cc51-4a19-abc6-348f6a413f3a"
      unitRef="usd">52689000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy0zLTEtMS0zODkyMQ_b1374263-894b-4369-814c-d00cebd0a0e7"
      unitRef="usd">74000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy01LTEtMS0zODkyMQ_d304426c-5a32-4824-b691-7743fbe2bdd4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy03LTEtMS0zODkyMQ_562717a4-da8d-4b86-904d-a9dd12061207"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy05LTEtMS0zODkyMQ_e9a13b76-e200-48c8-89f3-c7c121ef2c62"
      unitRef="usd">52689000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i7ee644e2f79d4b719b22c7db29592acb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfMy0xMS0xLTEtMzg5MjE_52e7834a-8052-426c-8247-6679dad337c4"
      unitRef="usd">74000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC0xLTEtMS0zODkyMQ_2af92c03-aa0f-4076-9e93-b5cbce0aee47"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC0zLTEtMS0zODkyMQ_fc23513f-e006-49c8-af48-38e54bd8a006"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC01LTEtMS0zODkyMQ_490537a9-267c-47e0-8bb2-94607d0d3aed"
      unitRef="usd">496000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC03LTEtMS0zODkyMQ_1ab350c4-808a-47a0-8924-ce195a7fa728"
      unitRef="usd">10000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC05LTEtMS0zODkyMQ_b45003e5-49d3-4e85-8b07-8a397b6d1e0b"
      unitRef="usd">496000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i1dfe35561df44ad7a3daf4a423c867c5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNC0xMS0xLTEtMzg5MjE_7889a4d1-5835-49df-a6c7-5acdb24f5286"
      unitRef="usd">10000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS0xLTEtMS0zODkyMQ_7af9afef-bbfd-450b-9e6b-e3681dd589fb"
      unitRef="usd">17882000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS0zLTEtMS0zODkyMQ_8a562b05-c3a7-46a4-abbc-6f932bd80db2"
      unitRef="usd">319000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS01LTEtMS0zODkyMQ_9838ef9f-00ca-43ff-b617-c0521a2ca67d"
      unitRef="usd">19125000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS03LTEtMS0zODkyMQ_db5b9435-1d64-449e-8b34-66b371d4f718"
      unitRef="usd">390000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS05LTEtMS0zODkyMQ_0a0cb36c-a5ef-4f30-960d-0ce616223b40"
      unitRef="usd">37007000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i14b38fa83e74416baa59ee3c628b9614_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNS0xMS0xLTEtMzg5MjE_56e3a79f-6b8a-4d7f-b4a2-e3f93f74d349"
      unitRef="usd">709000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi0xLTEtMS0zODkyMQ_8fb45869-df41-4034-8250-0bc016dd2823"
      unitRef="usd">14483000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi0zLTEtMS0zODkyMQ_28b8cdec-13d1-485b-b411-f0df7cd2a7e3"
      unitRef="usd">264000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi01LTEtMS0zODkyMQ_4f06a8f1-7483-4b41-90a3-b5e3ba7e5f36"
      unitRef="usd">3585000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi03LTEtMS0zODkyMQ_dcbb619c-b434-4df4-9d1a-2dee3bbbd211"
      unitRef="usd">113000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi05LTEtMS0zODkyMQ_7e2bc751-78c3-4644-b8f1-94b58aff2f78"
      unitRef="usd">18068000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i673eefc904b445ec8b3f3be9c96ef633_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNi0xMS0xLTEtMzg5MjE_d456a83d-e470-4641-8d39-02571bee15ab"
      unitRef="usd">377000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy0xLTEtMS0zODkyMQ_61e8463f-da38-43ef-884d-521ce622a1e5"
      unitRef="usd">85054000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy0zLTEtMS0zODkyMQ_5f31458d-d510-4c4d-bd3a-5b07a10b9e25"
      unitRef="usd">657000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy01LTEtMS0zODkyMQ_66839318-82ff-4264-ad70-dfbad001adda"
      unitRef="usd">23206000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy03LTEtMS0zODkyMQ_c781adaa-fe80-4334-9ac5-99d4849711b1"
      unitRef="usd">513000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy05LTEtMS0zODkyMQ_9f25a35f-f284-4f18-809a-c7318fd38b4c"
      unitRef="usd">108260000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOjQ3Nzc4OTFkZGRlNDQxN2ZhMmVhN2ViZmYxZjQ2NTBiL3RhYmxlcmFuZ2U6NDc3Nzg5MWRkZGU0NDE3ZmEyZWE3ZWJmZjFmNDY1MGJfNy0xMS0xLTEtMzg5MjE_6893cc37-6e8d-4f94-9c67-da56c62be7d0"
      unitRef="usd">1170000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMjU5_65d44360-ab31-4bc5-a236-531ca99eeed5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfNDE3_24221665-eb7d-4759-bca1-d6c14ab1f8ff"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld>
    <us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfNDE3_c544a6dd-7f07-49ee-abbd-63aec45a5e08"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RleHRyZWdpb246YzEwNDY0NWFmMzJhNDRkYTlmNGU2MTM5MmRlNTYwMDlfMTExMg_61d6f1b2-0ac9-4712-a039-42d62f3df5d1">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities classified by contractual maturities as of September&#160;30, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.657%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.719%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMS0xLTEtMS0zNzA2Mg_5162ae9d-e0fb-4352-baca-1629df30d798"
      unitRef="usd">50757000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMS0zLTEtMS0zNzA2Mg_d89b01ac-755e-4b19-9cc6-3b042168364d"
      unitRef="usd">49968000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMi0xLTEtMS0zNzA2Mg_f45eb450-158e-42f5-b608-1af4d09770b4"
      unitRef="usd">22752000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMi0zLTEtMS0zNzA2Mg_0f601655-5376-4c67-bac5-45fe22acf253"
      unitRef="usd">22378000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMy0xLTEtMS0zNzA2Mg_155a74a1-164e-4dbb-86bd-e18e1664c758"
      unitRef="usd">73509000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80My9mcmFnOmMxMDQ2NDVhZjMyYTQ0ZGE5ZjRlNjEzOTJkZTU2MDA5L3RhYmxlOmY4NWI1MmE5MDE5OTQxZTlhNDUzNzhjZjNmZTFhNmZmL3RhYmxlcmFuZ2U6Zjg1YjUyYTkwMTk5NDFlOWE0NTM3OGNmM2ZlMWE2ZmZfMy0zLTEtMS0zNzA2Mg_ef7f2231-4c4d-48ed-8bb6-de8a780dfd36"
      unitRef="usd">72346000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMjY5_8a391920-c339-439e-8442-da8565d2dee5">Property and Equipment&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net, as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Depreciation and amortization expense was $0.2&#160;million and $0.1 million for the three months ended September&#160;30, 2022 and 2021, respectively. Depreciation and amortization expense was $0.6 million and $0.5 million for the nine months ended September 30, 2022 and 2021, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMjY4_105fc13c-7cbe-4f79-bf4d-f14897d261b5">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of property and equipment, net, as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Less accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(6,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(5,967)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ic496e34f317b4d5b8d382d221926650f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMS0xLTEtMS0zNzA2Mg_230c6883-e5e7-4e89-9241-bec75872d867"
      unitRef="usd">5910000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i3172f410a08245ccaa4689e1ebcfe8fd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMS0zLTEtMS0zNzA2Mg_0639fd42-a861-4c13-80f1-a385a1b8c37b"
      unitRef="usd">5033000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ic107f77e19a641f2b66165932a7230ef_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMi0xLTEtMS0zNzA2Mg_3f721f5e-43b4-40a1-8911-39a0c0319ebd"
      unitRef="usd">1227000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i80780d051c164ea99d2de7902f458fa1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMi0zLTEtMS0zNzA2Mg_e5d3d6d2-1e51-407a-97fe-0fe2f9bb7973"
      unitRef="usd">1212000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i223dbecf860e4e39a728901fdebb9f9f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMy0xLTEtMS0zNzA2Mg_f8ac718e-7de9-49b8-9ef7-2db88556dd8a"
      unitRef="usd">710000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ic33a6f973d8841edaae5debeec90e7b3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfMy0zLTEtMS0zNzA2Mg_1261c087-62aa-4b57-b606-d37181e7c08c"
      unitRef="usd">710000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i9a394203b40c4fd299a9d183b56e5da5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNC0xLTEtMS0zNzA2Mg_6a82452a-58bd-4342-9edb-770d9c689b3a"
      unitRef="usd">992000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ie2896517d8854cdbb4a8622839fa7044_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNC0zLTEtMS0zNzA2Mg_ec678c7f-fc78-484c-aa62-7939587a142d"
      unitRef="usd">465000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i76721169755b495daf0275e4edcb974e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNS0xLTEtMS0zNzA2Mg_1d69636d-8126-48c6-ae15-790f20b3b411"
      unitRef="usd">320000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i1ea98596ebc94fb597a9a7ecb322370a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNS0zLTEtMS0zNzA2Mg_6ae1eace-058b-4426-a31d-7af91bc35d16"
      unitRef="usd">320000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNi0xLTEtMS0zNzA2Mg_152cc3bf-aa14-4b97-b5b9-58be70358236"
      unitRef="usd">9159000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNi0zLTEtMS0zNzA2Mg_e3a3f6aa-2e36-418c-afb7-18dfcd9978d5"
      unitRef="usd">7740000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNy0xLTEtMS0zNzA2Mg_4cfd28c7-c7b9-4959-8b48-b032853a91a2"
      unitRef="usd">6052000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfNy0zLTEtMS0zNzA2Mg_936f75db-528c-4f86-b3bd-fd0f2c56f3b9"
      unitRef="usd">5967000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfOC0xLTEtMS0zNzA2Mg_f41486ac-8af6-454a-937c-5565da8dcaa1"
      unitRef="usd">3107000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RhYmxlOjY1MzM0NDJiOTJjMTRmMGJhMTk4MmZjNmE0ZGQ0NGEyL3RhYmxlcmFuZ2U6NjUzMzQ0MmI5MmMxNGYwYmExOTgyZmM2YTRkZDQ0YTJfOC0zLTEtMS0zNzA2Mg_c476fc17-53e7-4718-a602-e4ebdab1f543"
      unitRef="usd">1773000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMTY0_e4224e3b-4bbe-497a-9cc7-3d8657a632b8"
      unitRef="usd">200000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfNTQ5NzU1ODE0MTY0_d2b6184e-77e8-44d2-afe2-c11791738c67"
      unitRef="usd">100000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfMjQ3_fd41b6ec-774d-467d-9d9e-95125dd53fe9"
      unitRef="usd">600000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80Ni9mcmFnOjI0ZmI0MTIxNjczMjQzMTNiNTlkYjIzYTc3Nzg5ZjBkL3RleHRyZWdpb246MjRmYjQxMjE2NzMyNDMxM2I1OWRiMjNhNzc3ODlmMGRfNTQ5NzU1ODE0MTg4_b798a6cf-5bf9-4634-83a5-baab7dafd41d"
      unitRef="usd">500000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RleHRyZWdpb246NDc0OTVhZGE2YTgyNGJmMDgzZDBiODBmMGE1YzA4NmNfMTI5_2bf4befa-aa98-48cf-9f5c-1adaf12c08c5">Accrued and Other Current Liabilities&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of accrued and other current liabilities as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued paid time off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued clinical study costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued 401(k) matching contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RleHRyZWdpb246NDc0OTVhZGE2YTgyNGJmMDgzZDBiODBmMGE1YzA4NmNfMTMw_842fff10-2d01-4585-aadd-a110652e004d">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of accrued and other current liabilities as of September&#160;30, 2022 and December&#160;31, 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued paid time off&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued clinical study costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Accrued 401(k) matching contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMS0xLTEtMS0zNzA2Mg_63c19817-9288-47c4-a771-a38fe61afdee"
      unitRef="usd">2033000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMS0zLTEtMS0zNzA2Mg_931dec2d-ac37-43ef-ab41-bd8c078f4702"
      unitRef="usd">2498000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMi0xLTEtMS0zNzA2Mg_48dbebd4-ec84-4bd6-9ef6-e0db452a977c"
      unitRef="usd">504000</us-gaap:AccruedVacationCurrent>
    <us-gaap:AccruedVacationCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMi0zLTEtMS0zNzA2Mg_36983372-f6fd-4123-b79f-854d647d59cc"
      unitRef="usd">460000</us-gaap:AccruedVacationCurrent>
    <sera:AccruedClinicalStudyCostsCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0xLTEtMS0zODQ2Nw_a7d41dcb-1385-427b-a309-e69188531b24"
      unitRef="usd">532000</sera:AccruedClinicalStudyCostsCurrent>
    <sera:AccruedClinicalStudyCostsCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0zLTEtMS0zODQ2Nw_a230cefe-1a9b-4f6a-b9c0-02ea9278beab"
      unitRef="usd">0</sera:AccruedClinicalStudyCostsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0xLTEtMS0zODQ2Nw_51498809-d64f-4caa-add7-a009d3ba59af"
      unitRef="usd">482000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0zLTEtMS0zODQ2Nw_1866a6dc-03fe-42b6-9697-3408e2834ef5"
      unitRef="usd">0</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0xLTEtMS0zNzA2Mg_111a6a41-feb0-4aef-b831-dd19cb7f2870"
      unitRef="usd">150000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfMy0zLTEtMS0zNzA2Mg_06b30835-df82-483d-bcb4-e657ac4b4856"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0xLTEtMS0zNzA2Mg_4bd37ba3-6176-4e24-9ba3-d2449f58dd5f"
      unitRef="usd">315000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNC0zLTEtMS0zNzA2Mg_7cf63238-b592-4619-84c3-c982d7a09394"
      unitRef="usd">927000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNS0xLTEtMS0zNzA2Mg_ca06a971-24ad-41ca-b215-d1f690ede1bf"
      unitRef="usd">4016000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl80OS9mcmFnOjQ3NDk1YWRhNmE4MjRiZjA4M2QwYjgwZjBhNWMwODZjL3RhYmxlOmIxM2ZmMzVkNTc0MDRkMjdiMDk5YTBjZDZmNjNlN2QwL3RhYmxlcmFuZ2U6YjEzZmYzNWQ1NzQwNGQyN2IwOTlhMGNkNmY2M2U3ZDBfNS0zLTEtMS0zNzA2Mg_5fd2297d-dd00-4a0e-a0ed-d4a5f1609f25"
      unitRef="usd">3885000</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RleHRyZWdpb246NzAxMTRjMDlhNDIwNDM5YThkMmI3YTU4MzhiOGIxZjRfMTI4_98e500a7-5978-4c48-b1a6-fdb96974b274">Other Income, net&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of other income, net, for the three and nine months ended September&#160;30, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;272&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Investment income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;369&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;565&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gain on extinguishment of PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other losses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;497&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;837&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RleHRyZWdpb246NzAxMTRjMDlhNDIwNDM5YThkMmI3YTU4MzhiOGIxZjRfMTI5_d045455f-d810-45f7-a34e-94c2f1de6063">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the components of other income, net, for the three and nine months ended September&#160;30, 2022 and 2021 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;272&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;53&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Investment income (loss), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;369&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;565&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Gain on extinguishment of PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other losses, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.37pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 4.37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;497&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;22&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;837&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1.37pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,067&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InterestIncomeOther
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi0xLTEtMS0zNzA2Mg_8e437bb4-8a4c-4101-8970-edee40d85c24"
      unitRef="usd">128000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi0zLTEtMS0zNzA2Mg_531342d0-b116-4020-a921-dacbceb96439"
      unitRef="usd">32000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi01LTEtMS0zNzA2Mg_9847dc88-8380-4f8f-9da2-53667c223c8c"
      unitRef="usd">272000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMi03LTEtMS0zNzA2Mg_f983ceb4-b1f8-47f6-84bd-3fae61eaec02"
      unitRef="usd">53000</us-gaap:InterestIncomeOther>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0xLTEtMS0zOTc3MA_f89fabb4-8c5d-45a5-8c30-f018262bc998"
      unitRef="usd">369000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0zLTEtMS0zOTc3MA_9606b8ef-0361-4da6-a496-3bd10d7f7384"
      unitRef="usd">-1000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy01LTEtMS0zOTc3MA_5e4954e6-98c8-4d32-a8a2-d79e3ea24593"
      unitRef="usd">565000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy03LTEtMS0zOTc3MA_3a2c210d-66a7-4706-9d65-421b5d50ad1d"
      unitRef="usd">-1000</us-gaap:InvestmentIncomeNetAmortizationOfDiscountAndPremium>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0xLTEtMS0zNzA2Mg_4a8ee47c-361b-48ff-a97f-af6be5c21c9f"
      unitRef="usd">0</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy0zLTEtMS0zNzA2Mg_021e3497-4817-4cf1-a13a-e103a3c67143"
      unitRef="usd">-9000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy01LTEtMS0zNzA2Mg_747cfa20-1d8a-439b-a356-d005d245bc06"
      unitRef="usd">0</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:FairValueOptionChangesInFairValueGainLoss1
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfMy03LTEtMS0zNzA2Mg_3f48f8e5-1707-498c-a2fb-77c943b07e65"
      unitRef="usd">-15000</us-gaap:FairValueOptionChangesInFairValueGainLoss1>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC0xLTEtMS0zNzA2Mg_44f7ad67-3fa8-45a6-b119-06f9dbf4775b"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC0zLTEtMS0zNzA2Mg_5661b599-a2b5-4327-a396-89768b573233"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC01LTEtMS0zNzA2Mg_fb3c0f89-9710-4de2-87dd-16a03b105a59"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNC03LTEtMS0zNzA2Mg_af13e88c-d542-43d3-a940-4953f54bd245"
      unitRef="usd">1050000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS0xLTEtMS0zNzA2Mg_dfd4ccde-b7c0-43db-b533-0517f60cd937"
      unitRef="usd">0</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS0zLTEtMS0zNzA2Mg_2781cb28-0709-406b-87f4-61563dbf0702"
      unitRef="usd">0</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS01LTEtMS0zNzA2Mg_9fcd0750-40f2-4193-93b7-d3a335113478"
      unitRef="usd">0</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:OtherNonoperatingGainsLosses
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNS03LTEtMS0zNzA2Mg_4423d8f2-d55d-4946-9f54-336c5cb37312"
      unitRef="usd">-20000</us-gaap:OtherNonoperatingGainsLosses>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi0xLTEtMS0zNzA2Mg_ef45a254-541d-41bb-8502-d03ab536e823"
      unitRef="usd">497000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi0zLTEtMS0zNzA2Mg_9b65ef78-2e94-4858-9c62-ab7e208d13a0"
      unitRef="usd">22000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi01LTEtMS0zNzA2Mg_a6149364-8cca-4c46-b3ec-f9b896c87737"
      unitRef="usd">837000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81Mi9mcmFnOjcwMTE0YzA5YTQyMDQzOWE4ZDJiN2E1ODM4YjhiMWY0L3RhYmxlOmU1NmZlZTc0NDA4YTQxYjRhYzEyODg5ZTA2OGFjOWYwL3RhYmxlcmFuZ2U6ZTU2ZmVlNzQ0MDhhNDFiNGFjMTI4ODllMDY4YWM5ZjBfNi03LTEtMS0zNzA2Mg_b5cd4aae-9694-4a35-beee-8a3187dfab4f"
      unitRef="usd">1067000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjYzMQ_a854db5a-2aa4-4e76-8f42-ee2ae3597c3b">Loans and Convertible Promissory Notes&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Bank Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2014, through a Loan and Security Agreement with a bank, the Company obtained a term loan for $10.0&#160;million. In March 2021, the Company repaid the outstanding principal of $2.0&#160;million, accrued interest of $6&#160;thousand, and the final payment fee of $0.1&#160;million related to this loan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Convertible Promissory Note&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2019, the Company authorized the issuance of a $6.4&#160;million subordinated convertible promissory note (the &#x201c;Note&#x201d;) to a stockholder of the Company, bearing 12% interest and a maturity date of February 26, 2021, to provide liquidity and additional working capital. On February&#160;15, 2021, the maturity date was extended to March 28, 2021. The Note was convertible at the option of the holder into shares of Series D Convertible Preferred Stock at a conversion price equal to 80% of the issuance price of the Series D Convertible Preferred Stock of $9.03 per share. In July 2019, $1.9&#160;million of the $6.4&#160;million Note&#x2019;s principal and $0.1&#160;million of accrued interest were converted into 277,507 shares of the Company&#x2019;s Series D Preferred Stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The conversion feature of the Note met the requirements for separate accounting and was recognized as a liability at the measurement date fair value of $2.4&#160;million, subject to remeasurement to fair value, with any changes in estimated fair value recognized as a component of other income, net. A corresponding discount, which reduced the carrying value of the Note, was also recorded. The unamortized discount was written off in proportion to the partial conversion, with the remaining discount accreted to interest expense until maturity. The Company recognized additional interest expense of $0.1&#160;million from accretion of the discount during the nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March&#160;24, 2021, the Company repaid the outstanding principal of $4.5&#160;million and accrued interest of $1.1&#160;million related to the Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Paycheck Protection Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the Company obtained a $1.1&#160;million loan through a bank under the Paycheck Protection Program (&#x201c;PPP&#x201d;) under the Coronavirus Aid, Relief, and Economic Security Act (&#x201c;CARES Act&#x201d;), as amended. The loan&#x2019;s purpose was to maintain payroll and make rent and utilities payments as specified under the terms of the PPP. Under the PPP, borrowers may apply for loan forgiveness if the funds are used for payroll costs, mortgage interest, rent, and utilities payments over a specified term following receipt of the loan funds. During the term of the agreement, the Company utilized the loan funds for forgivable purposes and applied for forgiveness. In June 2021, the outstanding $1.1&#160;million PPP loan was forgiven and removed from the Company&#x2019;s balance sheet. As a result of the forgiveness of the PPP loan, a $1.1&#160;million gain on extinguishment was recorded in other income, net for the nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LongTermLoansFromBank
      contextRef="i669added0b444346a5f738058ceb934b_I20141231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTE3_5597fce6-befe-4eea-99da-c5eeeb6013be"
      unitRef="usd">10000000</us-gaap:LongTermLoansFromBank>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i9e9ca69a921249c6a78aa32baee42b33_D20210301-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTc2_b814b4fe-9ca4-42a8-b1e4-6f040cca24d7"
      unitRef="usd">2000000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <sera:RepaymentOfAccruedInterestOnLongTermDebt
      contextRef="i9e9ca69a921249c6a78aa32baee42b33_D20210301-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjAw_b4644157-11bc-4da6-a8b7-3862d34e8f98"
      unitRef="usd">6000</sera:RepaymentOfAccruedInterestOnLongTermDebt>
    <us-gaap:DebtInstrumentFeeAmount
      contextRef="ib88c7314479a44d4bad72460fdabc6d9_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjMz_f16fd2b1-c19f-41f8-b42a-b8dc026ed55c"
      unitRef="usd">100000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMzM0_aac0a6c2-1aba-43df-8f56-ea83f86dc7bc"
      unitRef="usd">6400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfNDMy_a7bc404c-bbf3-4656-b48f-6272b11f0d34"
      unitRef="number">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i60a0864fc6dd4e8fbe07647b8d79a429_D20190201-20190228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfNzMy_a4b6967d-6888-4645-8d4b-42405b744773"
      unitRef="number">0.80</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODA0_2521182b-7f12-46a8-b666-e5dd4808c595"
      unitRef="usdPerShare">9.03</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionOriginalDebtAmount1
      contextRef="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODI1_4132c2f7-f185-452a-8fd3-4e3c17ae63bf"
      unitRef="usd">1900000</us-gaap:DebtConversionOriginalDebtAmount1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODM1_aac0a6c2-1aba-43df-8f56-ea83f86dc7bc"
      unitRef="usd">6400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestExpenseLongTermDebt
      contextRef="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfODU5_897a134d-3132-440e-a25c-5e052972ac94"
      unitRef="usd">100000</us-gaap:InterestExpenseLongTermDebt>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i8cca6bfafa474ca399d2559f5f8becab_D20190701-20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfOTAy_7e07f368-afab-4698-be9c-30dfbf495d24"
      unitRef="shares">277507</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ConvertibleDebtFairValueDisclosures
      contextRef="i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTEwOA_5e2585f7-5bcf-4155-8027-b9cc68479fda"
      unitRef="usd">2400000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i600787d311a2404994266e049f220010_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTU0MQ_a21b8111-d67e-4031-ad8c-39ef7dfde166"
      unitRef="usd">100000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="ifb4eddf3f2864ba99d2b3f2c498583d7_D20210324-20210324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTY2MQ_5136a739-7ef5-44c9-8c56-7e0082fa9f78"
      unitRef="usd">4500000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <sera:RepaymentOfAccruedInterestOnLongTermDebt
      contextRef="ifb4eddf3f2864ba99d2b3f2c498583d7_D20210324-20210324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTY4OA_894bc67a-3229-4103-a303-6fc0c0929d9d"
      unitRef="usd">1100000</sera:RepaymentOfAccruedInterestOnLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4e0ee74c3ff34aefb683e6d0f0a83a2c_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMTc2Nw_4be12af4-eab2-4d45-865e-6567e0477b66"
      unitRef="usd">1100000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentDecreaseForgiveness
      contextRef="id9bcf6ae0b3e42c2bef96302713690d0_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjQwMg_d8ca0c03-5fb0-48a0-a6b0-3388c20be28e"
      unitRef="usd">1100000</us-gaap:DebtInstrumentDecreaseForgiveness>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i1602ad9e54b945c9bc70c8e1b2cb0cef_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81NS9mcmFnOmNlMjQ1YmYyZTQ1MjQwNmM4MzBlZmEwMGUyYTA3ZWQ5L3RleHRyZWdpb246Y2UyNDViZjJlNDUyNDA2YzgzMGVmYTAwZTJhMDdlZDlfMjUyMw_122f6dd4-cd62-4f87-925a-011061b30b44"
      unitRef="usd">1100000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RleHRyZWdpb246ZjYzNTY4ZDIyNTkyNDI5YjgxMDVhZjU1OTI5ZWZkOTdfMTg5MA_65d7489c-6ead-46d1-8883-cea04915f6f1">Fair Value Measurements&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022 and December&#160;31, 2021, the carrying amounts of the Company&#x2019;s receivables, prepaid and other current assets, accounts payable, and accrued and other current liabilities approximate their fair values, principally due to the short-term nature of the assets and liabilities. The recorded values of the finance leases approximate fair value as the interest rates approximate market interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company follows a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. The three levels of the fair value hierarchy are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 inputs are observable, quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 inputs are observable inputs other than quoted prices included in Level 1 that are observable either directly or indirectly or quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 inputs are unobservable inputs in which there is little or no market data, which require the Company to develop its own assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;36,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;37,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;109,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;54,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;135,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RleHRyZWdpb246ZjYzNTY4ZDIyNTkyNDI5YjgxMDVhZjU1OTI5ZWZkOTdfMTg5MQ_9c7dd7d4-6fce-4210-b2f5-14a4d5e7ffb2">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of September&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;36,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;37,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;19,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;109,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the Company&#x2019;s assets measured at fair value on a recurring basis by level within the fair value hierarchy (in thousands) as of December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;54,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;39,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;25,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;135,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib74370533b2343e5948c7c3132692fee_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMy0xLTEtMS0zNzA2Mg_3dc462d8-65a2-44ed-b27d-c96347ab38de"
      unitRef="usd">1510000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icf7511108faf4cd0906efe6af85f04d8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMy0zLTEtMS0zNzA2Mg_45388c18-0da4-47bd-993c-8947d1820caf"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9d63d790f8f54a508f078691f2d26768_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMy01LTEtMS0zNzA2Mg_5e7dd0c5-039c-4f46-aefc-aeda116916d1"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i612e8b546ca046b0bfda86066a454cca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNC0xLTEtMS0zNzA2Mg_58971326-f180-49fa-82eb-c5cc20234599"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i42d2faf58839437f8edcd20d96b207ca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNC0zLTEtMS0zNzA2Mg_7ac9c760-bd6f-417a-a4b3-760ef25cc3e1"
      unitRef="usd">36896000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1458e22a9c914fb9ae75771117d8fd05_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNC01LTEtMS0zNzA2Mg_8d8cc70b-4ac8-4108-93b3-48c2fb94eb41"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9902d71bf4ff4310af77e9ffa184e4b1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNi0xLTEtMS0zNzA2Mg_5c4374df-183c-41a3-a662-c48c2f6f5343"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i63a5647d5c0340be84f03046f561d36e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNi0zLTEtMS0zNzA2Mg_dd61ff89-3e24-499c-a72c-b97c0efcf385"
      unitRef="usd">15793000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i414b0aaf127042bd88523a0bb531c307_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNi01LTEtMS0zNzA2Mg_9fc4e842-64c8-4456-93ca-20f27d680213"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib2a43bb4ef084888b75d6e3a33541d4f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNy0xLTEtMS0zNzA2Mg_bf24261f-4cd6-433a-b2b1-dd2a23bb937d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if96032a7e83741c18f2e92eaa33744cb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNy0zLTEtMS0zNzA2Mg_e79cfc24-d67e-4c82-bae2-3f856a0ad705"
      unitRef="usd">496000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8eda479567124bc7814e222145ebc019_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfNy01LTEtMS0zNzA2Mg_94a8648b-6741-4920-b05b-2816dcc7dcb2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i656a95c6ee6440fc959d2f83704886e6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOC0xLTEtMS0zNzA2Mg_0e5604e3-e1dd-4548-b5e1-88e1e045249f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i918d3cc73cc24feb9a410f56da474f96_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOC0zLTEtMS0zNzA2Mg_9d68c44c-3a41-4afd-ad15-d0287c5d82db"
      unitRef="usd">37007000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i57d6bf244c40409a995f2c8c55e870cb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOC01LTEtMS0zNzA2Mg_31093fcd-c9c7-4064-882f-d71c11815b45"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6e9ad3bbced74f1286c9edbd11d60a94_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOS0xLTEtMS0zNzA2Mg_e05a7163-8feb-4b1d-81d8-59c3415cfc4b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd27872ed39d473cabd931c1687ec88d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOS0zLTEtMS0zNzA2Mg_8fd6119a-c940-4593-9c6a-70005effe4ea"
      unitRef="usd">19050000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic9f7d318c031453095ba85b0e5175e30_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfOS01LTEtMS0zNzA2Mg_727f2c9a-24a5-4533-b43e-227cf41530f9"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie045a5e26f014139838acb18403afe93_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMTAtMS0xLTEtMzcwNjI_28624b81-787f-4e47-9cce-dc84e67741d0"
      unitRef="usd">1510000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib8f2c42715c1443cb59e29a781e6c0e7_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMTAtMy0xLTEtMzcwNjI_5bd4ce9b-a85b-4d07-8ee0-2870cd720c93"
      unitRef="usd">109242000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i395ae800742b4df1825940da3494ba86_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOmM2NzJjZjg1NTg2NDRjMGRhYTEyMDhmZDMwMDI4YjNhL3RhYmxlcmFuZ2U6YzY3MmNmODU1ODY0NGMwZGFhMTIwOGZkMzAwMjhiM2FfMTAtNS0xLTEtMzcwNjI_8cfab9d8-f459-45fa-a841-8c3150edb5aa"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idbac569dd2004b2d99ae63842688565b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMy0xLTEtMS0zNzA2Mg_607f6020-3b5b-48b5-a145-d8b824539527"
      unitRef="usd">4021000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2f27774bd30241ee8942a4cef573525d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMy0zLTEtMS0zNzA2Mg_1d807364-08ac-477e-9d80-aff8c7cbacb0"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib01e4104a4cb425bad5c8fe30243f72a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMy01LTEtMS0zNzA2Mg_8b4abaf8-111e-4b6b-817f-0caa5e3e99e3"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9132b6cdf5cd402dabd2fca792c7249d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNC0xLTEtMS0zNzA2Mg_89f215dd-57e3-47e4-8827-a8c0978715c5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i44df0ed744444847a688f0b9b2610c86_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNC0zLTEtMS0zNzA2Mg_ec28cdb8-e6ab-4e92-b633-ddeb38c227da"
      unitRef="usd">54841000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i84f85bd632c0444084e27b6374b41155_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNC01LTEtMS0zNzA2Mg_4085458b-3d78-42cf-8423-eafedf1fcf9e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i71c26cad06b949fb97802e9a0a40f61c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNi0xLTEtMS0zNzA2Mg_e43579e6-875a-4289-be68-cccc6e97e2ba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iab4c468c851148af9a6507c50ac2acc0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNi0zLTEtMS0zNzA2Mg_24aeb0f0-e17f-4bcc-a503-af9425bb37a1"
      unitRef="usd">39672000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icafec0a54060431fa19e8c1658de99f5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNi01LTEtMS0zNzA2Mg_65bb94e6-2f55-4b47-9bb1-32bebf48b0e5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0319da007e0a4472971df069b87d62c2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNy0xLTEtMS0zNzA2Mg_14494eb4-51d2-4b74-814b-f7a787abda2a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea0875504fe4402ab5ef06f8708cb41d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNy0zLTEtMS0zNzA2Mg_d99894aa-7185-4e2f-b8b9-944044261790"
      unitRef="usd">7028000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i664717ae0afe4dc8864dc9d40f13dcea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfNy01LTEtMS0zNzA2Mg_f2cc4293-4693-4f69-b838-e103782ea587"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7738521c4b514f00a138be71f2fa2aa8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOC0xLTEtMS0zNzA2Mg_23fac792-e275-4e39-bdfc-74ba877c4252"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4bf0489931cb444190182c5a4a0920c2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOC0zLTEtMS0zNzA2Mg_eb42704b-b2ee-4981-80b1-2c4975e00cf1"
      unitRef="usd">25675000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie44f5ba7c5664328b22fafcd4e4e4729_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOC01LTEtMS0zNzA2Mg_4a33e6aa-b15d-4b5b-896b-e18b56d12075"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i625bf249a07e4f79916f01e5b3ae9a49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOS0xLTEtMS0zNzA2Mg_3a789763-fe69-4fa0-be26-ceea773178a7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7ac1738373464afaa4f620044f28dc23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOS0zLTEtMS0zNzA2Mg_b4bde515-09b4-4aa4-9922-690ed989a792"
      unitRef="usd">8656000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i14a569c6473f4caba47df2fbed2a5e31_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfOS01LTEtMS0zNzA2Mg_8136f8c5-e232-4053-a47f-796685c43770"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icacf2d98943d4579b2ae6dce4e1d872e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMTAtMS0xLTEtMzcwNjI_dfca99c5-5e41-475e-baf3-acdd36382389"
      unitRef="usd">4021000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibf16684d7e4b4069b71370834c076b72_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMTAtMy0xLTEtMzcwNjI_f9ee15ee-c5b7-445f-b0a9-ab4da2ee7957"
      unitRef="usd">135872000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7696d66e3a844c518b0767e034d8b610_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl81OC9mcmFnOmY2MzU2OGQyMjU5MjQyOWI4MTA1YWY1NTkyOWVmZDk3L3RhYmxlOjBkOTAxNzM4YWU1ZjRjZDk5YzNjNGMzZTYyNmUzZTBmL3RhYmxlcmFuZ2U6MGQ5MDE3MzhhZTVmNGNkOTljM2M0YzNlNjI2ZTNlMGZfMTAtNS0xLTEtMzcwNjI_dfa9542d-666e-4f1c-920f-5fbe78735757"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfNTExNg_d7f39cbe-156f-4a9a-8377-282395b33a9d">Related Party Transactions&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, the Company entered into a master services agreement with Healthcore Inc. (&#x201c;Healthcore&#x201d;), a subsidiary of Elevance Health, Inc. (formerly known as Anthem, Inc., &#x201c;Elevance Health&#x201d;). This agreement covers a range of research projects, including Healthcore&#x2019;s role as a contract research organization for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;P&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rematurity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;R&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;isk Assessment Combined With Clinical &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;I&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nterventions for Improving Neonatal outco&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ME&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s (&#x201c;PRIME&#x201d;) study. The Company paid fees related to this agreement of $0.6&#160;million and $0.4&#160;million for the three months ended September&#160;30, 2022 and 2021, respectively, and $1.7&#160;million and $1.1 million for the nine months ended September 30, 2022 and 2021, respectively. In November 2020, the Company entered into a Laboratory Services Agreement with Elevance Health related to the PRIME study. This agreement provides a contracted rate for certain tests performed pursuant to the study. The Company recognized revenues related to this agreement of $17&#160;thousand for the three months ended September&#160;30, 2022 and 2021, and $59&#160;thousand and $41&#160;thousand for the nine months ended September 30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company entered into a commercial collaboration agreement with Elevance Health and its affiliates (the &#x201c;Commercial Collaboration Agreement&#x201d;). The Commercial Collaboration Agreement provides defined payment within a defined period for use of the PreTRM test within Elevance Health&#x2019;s network of covered members. Pursuant to the Commercial Collaboration Agreement, Elevance Health agreed to purchase a certain minimum number of tests for each of the first three years of the term of the agreement. Additionally, Elevance Health agreed to pay a certain minimum amount per year for the first three years of the term of the Commercial Collaboration Agreement. The Company received $3.1&#160;million during the nine months ended September 30, 2022, which amount related to the minimum payments for the year ended December&#160;31, 2021. Such minimum payments were initially recorded as deferred revenue at December&#160;31, 2021. Deferred revenue is recognized as revenue when the Company delivers PreTRM test results to Elevance Health patients pursuant to the Commercial Collaboration Agreement. There were no cash receipts related to the Commercial Collaboration Agreement for the nine months ended September 30, 2021. The Company also agreed to develop a sales, marketing, and customer service program, and to provide training and marketing to duly licensed physicians specializing in obstetrics and gynecology or family medicine, or licensed nurse midwives, at the reasonable request of Elevance Health.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Elevance Health has been participating in the Company&#x2019;s PRIME study and at the conclusion of the PRIME study, under the Commercial Collaboration Agreement, the parties agreed to use commercially reasonable efforts to enter into Elevance Health&#x2019;s standard lab provider agreement. Unless earlier terminated due to breach, the Commercial Collaboration Agreement will remain in effect until the later of (a) the third anniversary of the effective date or (b) the date on which Elevance Health has purchased a fixed number of PreTRM tests as agreed by the parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Commercial Collaboration Agreement with Elevance Health is considered to be within the scope of ASC Topic 808, Collaborative Arrangements (&#x201c;ASC 808&#x201d;), as the parties are active participants and exposed to the risks and rewards of the collaborative activity. The Company determined the PreTRM tests to be a performance obligation for which Elevance Health is a customer and a unit of account within the scope of ASC 606. The associated transaction price is based on the contractual minimum number of tests and the agreed upon defined payment amount per test. The transaction price was allocated to this single performance obligation, which will be recognized upon delivery of test results expected to &lt;/span&gt;&lt;/div&gt;occur over the term of the agreement. All other items promised to Elevance Health are immaterial in the context of the Commercial Collaboration Agreement. There were no material revenues related to the Commercial Collaboration Agreement for the three and nine months ended September&#160;30, 2022 and 2021.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i97f06024a3634a4a848d749268fa8321_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTM2OQ_3027bdaa-7d8d-402e-ba8f-b75a7b56d665"
      unitRef="usd">600000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i3f9decf253d24e629dc8d16e78c681cf_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTM3Ng_9910d5ac-7fe6-419b-a0e6-e4564274dff3"
      unitRef="usd">400000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i07d69dbf6533445b9b4296a542908776_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTQzNQ_b359a590-8c79-4db3-a377-c6d3d3fd20c0"
      unitRef="usd">1700000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i92b6834e9fa046c889b80dd680ca97ec_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTQ0Mg_543da520-acd7-4a00-8bc0-80382fc4a1ae"
      unitRef="usd">1100000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RevenueFromRelatedParties
      contextRef="id5a4a33f19a4405284072607fbcb712f_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTc1Ng_7f1c9745-213a-4b66-9599-866062dff571"
      unitRef="usd">17000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="ife1874e670534eb286f346549f8030e4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTc1Ng_838d0bcf-3a42-4aee-a75c-56c681426736"
      unitRef="usd">17000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="if953534ebfe5400a9f6434aa8ae8fe2c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTgyMg_59bf839e-dc3b-4f72-a044-4914bd36e325"
      unitRef="usd">59000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i7171c7eb9dbe490681930536b5adb751_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMTgyOQ_dc92ad8c-f210-498d-812e-d56a21aa9376"
      unitRef="usd">41000</us-gaap:RevenueFromRelatedParties>
    <sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm
      contextRef="ia4dfe18e2ba344628fb42a44cbb4c082_D20210201-20210228"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMjMzNQ_0f9986e0-d70d-42e5-b1ae-36f3fdef7487">P3Y</sera:RelatedPartyTransactionCommercialCollaborationAgreementTerm>
    <sera:RelatedPartyTransactionCashReceivedFromRelatedParty
      contextRef="i8faa0127d92747c19730bff7fe96a67d_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMjU3Nw_5f5358cb-de43-4368-97e2-80c05300095f"
      unitRef="usd">3100000</sera:RelatedPartyTransactionCashReceivedFromRelatedParty>
    <sera:RelatedPartyTransactionCashReceivedFromRelatedParty
      contextRef="i9cbb3338066a4c86bb22691782cdfd99_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82MS9mcmFnOjA0ZjE0Y2M1NmZiZjRhMmRhZTI5MDM0ZGQ4MzhjZjEzL3RleHRyZWdpb246MDRmMTRjYzU2ZmJmNGEyZGFlMjkwMzRkZDgzOGNmMTNfMjkxNQ_f5048181-8105-4be8-a982-31f19dc6d282"
      unitRef="usd">0</sera:RelatedPartyTransactionCashReceivedFromRelatedParty>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTE0Mw_55eb08cb-8eb9-451e-ab88-88aa5aae5bf2">Capital Structure&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July&#160;19, 2021, the Company completed its IPO and issued 4,687,500 shares of its Class A common stock at a price of $16.00 per share for net proceeds of approximately $66.6&#160;million, after deducting underwriting discounts and commissions and offering expenses payable by the Company. In connection with the IPO, all shares of convertible preferred stock converted into 22,434,130 shares of Class A common stock and 1,405,259 shares of Class B common stock and no new shares of convertible preferred stock have since been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two authorized classes of common stock, Class A and Class B. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting and conversion. Each share of Class A common stock is entitled to one vote and shares of Class B common stock are non-voting. Each share of Class B common stock may be converted at any time to one share of Class A common stock at the option of its holder, subject to the ownership limitations provided for in the Company&#x2019;s amended and restated certificate of incorporation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following shares of Class A common stock were reserved for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,532,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,287,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,822,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,136,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;598,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;305,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,730,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,517,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="if40be873cb3b4110921324e4559ce26b_D20210719-20210719"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNjA_e80c3d0a-be4c-4761-8c1c-559f0c0eb823"
      unitRef="shares">4687500</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="i9f4d8885752a4f3f92312b675720aa76_I20210719"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTEy_160fd871-f49c-44cc-93a2-51b3c5348132"
      unitRef="usdPerShare">16.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="ibe8b830e52ae447d8c81bd371da3cbc6_D20210719-20210719"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTU5_2f0095ae-c448-43f3-89b8-9f2ccbc6c87a"
      unitRef="usd">66600000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="id6cc8adcb35049f99e17c68122feee4f_D20210719-20210719"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMzQ5_784e1807-e1bd-4009-b60c-887018da59ce"
      unitRef="shares">22434130</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ied62654e4491444e97d0acab99397010_D20210719-20210719"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMzg3_b7ddb550-51df-424f-8f8c-484dbaa2441d"
      unitRef="shares">1405259</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i59217ebe2e3b446297d6e7d10cdd6508_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNDI1_63ecfbcc-b128-4f27-8d3d-a6d77103f224"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <sera:NumberOfCommonStockClassesAuthorized
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNTIz_01f1b594-64e2-4bea-9656-b625ee99801a"
      unitRef="common_stock_class">2</sera:NumberOfCommonStockClassesAuthorized>
    <sera:NumberOfVotesPerShare
      contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfNzU2_ea60e030-c27e-42da-925b-6e35a79d6a7e"
      unitRef="vote">1</sera:NumberOfVotesPerShare>
    <sera:CommonStockConversionRatio
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfODgy_2d1f76ed-2ffc-4cdb-8d1c-e5ae0cb8c996"
      unitRef="number">1</sera:CommonStockConversionRatio>
    <sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RleHRyZWdpb246MTlkMjg5N2NkNTBkNDg0NjkxYTE1MWFjNDRhNTA3NTRfMTE0NA_729d863f-2014-413c-9ad8-195bd6cca821">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following shares of Class A common stock were reserved for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,532,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,287,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,822,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,136,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;598,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;305,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;13,730,519&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12,517,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia28bd723960742d0bc535d70294b0cec_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMS0xLTEtMS0zNzA2Mg_68bca8e4-967c-4042-8fbd-86f681746718"
      unitRef="shares">2775978</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i795da5fab0804282a9b140098d707bf3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMS0zLTEtMS0zNzA2Mg_b4e351db-ddfe-42e7-bd6d-af083a22ea93"
      unitRef="shares">2788484</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i82559b67f9e148dab9ad2b1eed66b0c6_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMi0xLTEtMS0zNzA2Mg_5ffaa3c9-3052-4c5c-a4e2-1038257f0e7c"
      unitRef="shares">8532949</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i36bc42d96e4e433984ab7a8838c57a60_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMi0zLTEtMS0zNzA2Mg_f295acce-7107-4a33-8e27-2a92d2c29a8d"
      unitRef="shares">6287126</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i2e079d863e01425487bf0a16e4109cb1_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMy0xLTEtMS0zNzA2Mg_b2256230-6864-4f44-89c9-95533a7b7e1c"
      unitRef="shares">1822815</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i0ebe18a147e84a0e88b4ba20920b22e4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfMy0zLTEtMS0zNzA2Mg_2c9eb1c2-aeb0-4481-a602-9a9b0026dd44"
      unitRef="shares">3136737</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i600edf893f194531ba73533739a7ffe3_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNC0xLTEtMS0zNzA2Mg_f4cd07b5-f988-4a6c-822e-84526b38fc9c"
      unitRef="shares">598777</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5d186423a55d4d4eb1d92c41476d9b48_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNC0zLTEtMS0zNzA2Mg_a5efcf2e-edd1-4fa0-a1a7-3fa99dbddf8f"
      unitRef="shares">305089</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib7006217670f4919bc1f54ae58aca198_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNS0xLTEtMS0zNzA2Mg_56a740ee-1bcb-4ed8-88ac-708fc52d2fb8"
      unitRef="shares">13730519</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i92dcff96f0bf4fa39bb22e90238470f5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82NC9mcmFnOjE5ZDI4OTdjZDUwZDQ4NDY5MWExNTFhYzQ0YTUwNzU0L3RhYmxlOmNmYmVjZDEzMGYzODQ0YzE4MDg4M2E3NzllYjRiMGJjL3RhYmxlcmFuZ2U6Y2ZiZWNkMTMwZjM4NDRjMTgwODgzYTc3OWViNGIwYmNfNS0zLTEtMS0zNzA2Mg_57ae0b21-269d-4bfa-be05-955b2c4d7346"
      unitRef="shares">12517436</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4NA_e175d64a-0b8f-4bd3-aa81-bf069422fb2d">Stock-Based Compensation&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2011, the Company established the 2011 Employee, Director and Consultant Equity Incentive Plan (the &#x201c;2011 Plan&#x201d;) and reserved shares of the Company&#x2019;s common stock for sale and issuance under the 2011 Plan. Options granted under the 2011 Plan generally vest over a four-year period and generally expire ten years from the date of grant. Options are exercisable only to the extent vested. The 2011 Plan terminated in November 2021, and accordingly, no additional shares are available for grant under the 2011 Plan. The 2011 Plan continues to govern outstanding awards granted under the 2011 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;) was established in July 2021. The 2021 Plan provides for the grant of incentive and non-statutory stock options as well as other stock rights to employees, directors, and consultants of the Company. Options generally vest over a four-year period and options generally expire ten years from the date of grant. Options are exercisable only to the extent vested. The 2021 Plan includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 Plan. In addition, any shares that otherwise would be returned to the 2011 Plan as a result of the expiration or cancellation of stock options may be added to the 2021 Plan. As of September&#160;30, 2022, there were 1,822,815 shares of the Company&#x2019;s Class A common stock that were available for future grants under the 2021 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Employee Stock Purchase Plan (the &#x201c;2021 ESPP&#x201d;) was established in July 2021. The 2021 ESPP includes provisions for annual automatic increases to the number of shares of Class A common stock reserved for issuance under the 2021 ESPP. As of September&#160;30, 2022, no shares had been granted under the 2021 ESPP and there were 598,777 shares of the Company&#x2019;s Class A common stock that were available for future grants under the 2021 ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise noted, references to &#x201c;options&#x201d; in the subsequent disclosures, refers to the combined incentive and non-statutory stock options issued as employee and non-employee stock-based compensation, and authorized under the 2011 Plan and the 2021 Plan. The following table summarizes information about these options granted and outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Subject to&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (In Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;br/&gt;(In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,287,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,185,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(694,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(242,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,532,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and expected to vest at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,133,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and exercisable at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,800,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Sales and marketing expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total employee stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September&#160;30, 2022, there was $12.0&#160;million of unrecognized stock-based compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 2.6 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5924a4c2b8a04efd9f8a9b105681d3ac_D20111101-20111130"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4NQ_e2374dba-8152-4d8e-943e-0cd225f7da00">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i5924a4c2b8a04efd9f8a9b105681d3ac_D20111101-20111130"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMzM2_1449b96d-89fd-4141-8b59-bcfd1d9e0c47">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i370eabad665347dea0833447376cc361_D20111101-20111130"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4Ng_bbe3c97b-9ad9-44b0-bf5e-46737775076a">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i370eabad665347dea0833447376cc361_D20111101-20111130"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfOTY0_f713a246-dc76-47ae-a373-011758bfd8c5">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5105b69dd15f4d468202f02b3beddfd8_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMTM4Nw_0d225167-dab7-4d99-915e-56a2dfd808db"
      unitRef="shares">1822815</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i8b50f0c0967540a28d5b66bd6ed16b1a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMTc0Nw_db188e1b-18a7-4add-8938-2abe273df064"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="if5143f467fec4136b943ecc3bf4ebd64_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfNTQ5NzU1ODE2NDY3_84b8f723-a811-4b14-8787-4b3649e78065"
      unitRef="shares">598777</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4Nw_7905d25f-484e-4de0-8567-6c9abbd5773f">The following table summarizes information about these options granted and outstanding:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Shares&lt;br/&gt;Subject to&lt;br/&gt;Options&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life (In Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic Value&lt;br/&gt;(In Thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,287,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;4.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,185,510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(694,910)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(242,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Outstanding &#x2014; September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,532,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and expected to vest at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,133,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;7.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Vested and exercisable at September&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,800,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS0xLTEtMS0zNzA2Mg_b0e52e8a-1f25-4ce1-a8c3-bad019525744"
      unitRef="shares">6287126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS0zLTEtMS0zNzA2Mg_edb595db-1c70-47fb-9d7c-7dece6bdff5d"
      unitRef="usdPerShare">4.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ib8612108452442a088e51138f3c2554f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS01LTEtMS0zNzA2Mg_bcf4a248-8595-4d53-a7da-9cb071a7dadd">P7Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMS03LTEtMS0zNzA2Mg_28b2d3a5-701f-4de9-aaac-533c8ed554ba"
      unitRef="usd">20095000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMi0xLTEtMS0zNzA2Mg_d2480a9f-d92b-446a-a213-834c9f4e1ca7"
      unitRef="shares">3185510</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMi0zLTEtMS0zNzA2Mg_c1a2f6c0-0b4c-42b1-ac54-1478b4f8f4ff"
      unitRef="usdPerShare">3.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMy0xLTEtMS0zNzA2Mg_6c8c6f51-70e9-4d04-83da-49b7a9a7e63b"
      unitRef="shares">1924</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfMy0zLTEtMS0zNzA2Mg_99100338-03a4-44e8-9e47-3b4ffb55bd35"
      unitRef="usdPerShare">0.73</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNC0xLTEtMS0zNzA2Mg_d84b91a3-824d-4173-aedc-06f9406af549"
      unitRef="shares">694910</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNC0zLTEtMS0zNzA2Mg_e3db4658-4589-44e5-af16-161ada02c971"
      unitRef="usdPerShare">7.52</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNS0xLTEtMS0zNzA2Mg_b1dd3a5b-eed4-4f5f-bfd4-a9e273d9274c"
      unitRef="shares">242853</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNS0zLTEtMS0zNzA2Mg_b8f1d6d7-7fb3-44d5-9338-b9a63e0632cf"
      unitRef="usdPerShare">1.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi0xLTEtMS0zNzA2Mg_3699f145-ed85-402c-a949-0ceb0a9e6dfb"
      unitRef="shares">8532949</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi0zLTEtMS0zNzA2Mg_e15f52e7-1995-46e9-b184-ff3285b42cad"
      unitRef="usdPerShare">3.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi01LTEtMS0zNzA2Mg_e7a19b97-8a35-4aa7-9706-476a7550e3bb">P7Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNi03LTEtMS0zNzA2Mg_1039c8e1-a487-4c75-9d08-1c23bb141bce"
      unitRef="usd">444000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy0xLTEtMS0zNzA2Mg_a00b56be-54ec-4295-9d0f-d5e0ff193781"
      unitRef="shares">8133642</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy0zLTEtMS0zNzA2Mg_b2274efa-4770-4218-8a87-df9803c52540"
      unitRef="usdPerShare">3.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy01LTEtMS0zNzA2Mg_a70bdde3-7835-45a8-8adf-acfd6e11bf9c">P7Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfNy03LTEtMS0zNzA2Mg_4f93169b-1405-48be-8857-188b91417558"
      unitRef="usd">440000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC0xLTEtMS0zNzA2Mg_1fe40908-abad-41e6-a820-78b8d99d1ac4"
      unitRef="shares">3800098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC0zLTEtMS0zNzA2Mg_03e1c5db-8147-499b-b6a2-a7f8840ddff6"
      unitRef="usdPerShare">2.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC01LTEtMS0zNzA2Mg_d0c52794-929c-4e9a-ad0b-66b3291bc70e">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjYyYjc4ZDI1ZmNkNzQ3MDFhMTVkYWI2ZTFiZmFjZDQ5L3RhYmxlcmFuZ2U6NjJiNzhkMjVmY2Q3NDcwMWExNWRhYjZlMWJmYWNkNDlfOC03LTEtMS0zNzA2Mg_a95d0beb-9635-4ee8-85ec-60db88bfa94b"
      unitRef="usd">276000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4OA_7130e4ea-5fe1-4061-9185-b5423ef567f4">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the impact of stock-based compensation expense in the statements of operations for the periods indicated (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Sales and marketing expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Total employee stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia1ed6221f242409f8a9dbaaaee40c814_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi0xLTEtMS0zNzA2Mg_a963f566-73f9-4fd7-baa1-fba07326768b"
      unitRef="usd">453000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i52f60d8b08f641c0b0ced84d1a9fb159_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi0zLTEtMS0zNzA2Mg_f53af1a1-905d-4b9d-98c8-7fa6d9f35af2"
      unitRef="usd">283000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ae79d05fb1b4c4ea6d13b1014a59490_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi01LTEtMS0zNzA2Mg_e98d2d8a-929c-468e-bf07-db089d5a26b5"
      unitRef="usd">1287000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifc7ffa070afa4b67be9eacf9bbc4f4a5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMi03LTEtMS0zNzA2Mg_a5a9155b-5fd1-47ae-a686-9a9902998d4b"
      unitRef="usd">717000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i04312bc62a9c45d6b4ffb2e70999f7ce_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy0xLTEtMS0zNzA2Mg_9290266b-4107-4f35-8a86-50e50af84f9a"
      unitRef="usd">31000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0c3b67e645ef427c8250de0d5e967256_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy0zLTEtMS0zNzA2Mg_252c6480-2c97-4aa7-ba49-21e1c51e783f"
      unitRef="usd">179000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2708055ad45048f9b3a01fd826029750_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy01LTEtMS0zNzA2Mg_766cb8b4-b457-4a52-867e-24665261b835"
      unitRef="usd">420000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idc13b0c45ef84ef9ba43c43526394594_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfMy03LTEtMS0zNzA2Mg_d08f7a64-3811-4fb5-8993-194c0707e790"
      unitRef="usd">358000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i029f08fa15fd4befac391e8926338ac0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC0xLTEtMS0zNzA2Mg_d4ad641e-7aae-4593-b1f7-f569b44cc414"
      unitRef="usd">794000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0b51209f01d949d29b662db2c64c7f22_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC0zLTEtMS0zNzA2Mg_74d7c1df-2be3-43f7-9c9a-ffb12b4a84be"
      unitRef="usd">452000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i75437e864838472e87ecd3c91bc6d984_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC01LTEtMS0zNzA2Mg_07243a83-a2aa-4c80-92ee-00d751e5175a"
      unitRef="usd">2007000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i727bda5c34a14d11b2577e2b1119b092_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNC03LTEtMS0zNzA2Mg_a4c972cd-e120-4587-9e2d-3af0c6855160"
      unitRef="usd">942000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS0xLTEtMS0zNzA2Mg_11774427-dd3e-4312-9557-08d865b23893"
      unitRef="usd">1278000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id42a405e549543c2b5a35a17eef5232e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS0zLTEtMS0zNzA2Mg_b57ba982-8bac-42c1-8acc-768cf4a5716c"
      unitRef="usd">914000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS01LTEtMS0zNzA2Mg_fbd8a47e-ebf9-4efb-8edc-f43a09f5aaf0"
      unitRef="usd">3714000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RhYmxlOjBmMjlmODYzYTMxNTRkNGY5YTNkOGRhMGNhMmUwNTFkL3RhYmxlcmFuZ2U6MGYyOWY4NjNhMzE1NGQ0ZjlhM2Q4ZGEwY2EyZTA1MWRfNS03LTEtMS0zNzA2Mg_f094c82f-69a3-4b1b-9123-fd87d64b45d5"
      unitRef="usd">2017000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjMyOQ_9a73a34a-b96b-41eb-b3a4-ae8499cce087"
      unitRef="usd">12000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl82Ny9mcmFnOjk4ODdiODU5MzVhMjQ3YzJiMDI3NDNhOTY2YzYxOTkyL3RleHRyZWdpb246OTg4N2I4NTkzNWEyNDdjMmIwMjc0M2E5NjZjNjE5OTJfMjQ4Mg_a90ce44e-c7e0-4b6b-8053-b4c97c630a75">P2Y7M6D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <sera:WarrantsTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RleHRyZWdpb246YWIzNThmZTg4MWY1NDllNWI3ZGFhYjc5ZTY3OWE1ZWZfMzQ1_af7b1dd1-e3ea-4e42-a9b6-9b0af89f2671">Warrants&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All outstanding common stock warrants were exercisable immediately when granted. All outstanding common stock warrants are exercisable for shares of Class A common stock. The Company&#x2019;s common stock warrants outstanding were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Number of Warrants Outstanding as of:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;During the nine months ended September 30, 2022, 12,506 common stock warrants expired unexercised.</sera:WarrantsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RleHRyZWdpb246YWIzNThmZTg4MWY1NDllNWI3ZGFhYjc5ZTY3OWE1ZWZfMzQ2_50768c19-8be3-44f4-84d7-c8f0d8af057d">The Company&#x2019;s common stock warrants outstanding were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.832%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Number of Warrants Outstanding as of:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;5.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;3,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;15,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,032,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;10.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,009,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;12.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;20.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;722,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iee09ca5ea08d408baf262d9aee778543_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMi0wLTEtMS0zNzA2Mg_203b0939-c5af-409e-88f3-5bbd2bb8b033"
      unitRef="usdPerShare">5.20</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="iee09ca5ea08d408baf262d9aee778543_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMi0yLTEtMS0zNzA2Mg_094f4ec9-97b1-4064-86c4-6e6112e322ad"
      unitRef="shares">3473</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ida49535190ff4a67a90335be92a43202_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMi00LTEtMS0zNzA2Mg_35ea0c3a-ae2d-44a2-96d4-d9941a39d4d5"
      unitRef="shares">15979</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iec090a0935104562aa028436a6704741_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMy0wLTEtMS0zNzA2Mg_42b2293d-0e07-4fce-917f-c593c8b2f1a5"
      unitRef="usdPerShare">9.03</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="iec090a0935104562aa028436a6704741_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMy0yLTEtMS0zNzA2Mg_a92f75a1-6871-4916-86f8-fb6c41843628"
      unitRef="shares">1032404</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ib365f1c968bf458f93bb750efed2e461_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfMy00LTEtMS0zNzA2Mg_65e0537c-74e9-47ba-9c12-c61c47456038"
      unitRef="shares">1032404</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i04ebe87305d04e299c0f999d0935e08a_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNC0wLTEtMS0zNzA2Mg_b538305d-23f5-49d8-8702-40219b86eed6"
      unitRef="usdPerShare">10.84</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i04ebe87305d04e299c0f999d0935e08a_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNC0yLTEtMS0zNzA2Mg_b453c2d3-4650-4113-9589-c8327200a4c3"
      unitRef="shares">1009795</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i67ed818fbfe34672a57403d2698eb3a4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNC00LTEtMS0zNzA2Mg_a3635cbc-d95f-46a4-9b0c-443b333ff798"
      unitRef="shares">1009795</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ic24f885b56b948b4b07a19510189e079_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNS0wLTEtMS0zNzA2Mg_023f25a3-7d15-4396-ad52-cac49095d9a1"
      unitRef="usdPerShare">12.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ic24f885b56b948b4b07a19510189e079_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNS0yLTEtMS0zNzA2Mg_e4b7c343-061e-4a09-a266-bdb37ffc9ff4"
      unitRef="shares">8083</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="id1f25f3dbc48464aacede203398c9efb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNS00LTEtMS0zNzA2Mg_60b9f59f-cd9b-4f9f-b41a-b5154ac35654"
      unitRef="shares">8083</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i0530edb52e204249ab51018f35efa2ff_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNi0wLTEtMS0zNzA2Mg_ada10b57-0f6f-4591-ac8a-2d97230127a5"
      unitRef="usdPerShare">20.77</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i0530edb52e204249ab51018f35efa2ff_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNi0yLTEtMS0zNzA2Mg_11063818-5ab0-4bfd-8884-d3b974749e90"
      unitRef="shares">722223</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i84190d49c208410092379bb47e971ccc_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNi00LTEtMS0zNzA2Mg_e58d5592-b2e1-40a1-a2bf-86a3291b0f6b"
      unitRef="shares">722223</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNy0yLTEtMS0zNzA2Mg_63c7e4c4-d747-4649-a719-83721e4add28"
      unitRef="shares">2775978</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RhYmxlOjIyMzM0MDZiMjUwNTQwOWY5M2M2ZjA0MzVlZDU5NmY1L3RhYmxlcmFuZ2U6MjIzMzQwNmIyNTA1NDA5ZjkzYzZmMDQzNWVkNTk2ZjVfNy00LTEtMS0zNzA2Mg_2a87f42e-791c-4638-827d-e623908bbc22"
      unitRef="shares">2788484</us-gaap:ClassOfWarrantOrRightOutstanding>
    <sera:ClassOfWarrantOrRightExpired
      contextRef="ic6bde4ed70d0494f837109a7f9176ae6_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83MC9mcmFnOmFiMzU4ZmU4ODFmNTQ5ZTViN2RhYWI3OWU2NzlhNWVmL3RleHRyZWdpb246YWIzNThmZTg4MWY1NDllNWI3ZGFhYjc5ZTY3OWE1ZWZfNTQ5NzU1ODE0NDMy_49f1b307-7edb-4e8e-a0d9-e7f3868c22db"
      unitRef="shares">12506</sera:ClassOfWarrantOrRightExpired>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1Mg_1b43d263-bd6b-43e8-b0b4-cdb084216899">Commitments and Contingencies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is the lessee in all of its lease arrangements. The Company did not enter into any leases with related parties during the presented periods. The Company makes assumptions and judgments when assessing contracts for lease components, determining lease classifications, and calculating right-of-use asset and lease liability values. These assumptions and judgments may include the useful lives and fair values of the leased assets, the implicit rate underlying the Company&#x2019;s leases, the Company&#x2019;s incremental borrowing rate or the Company&#x2019;s intent to exercise or not exercise options available in lease contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of September&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease-Related Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Statement Line Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_0049bb1e-6361-4f5b-bc41-972d98f2f6a3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_7e1627ae-b748-46d6-9015-15e5ad4fd6be"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_5469c87e-2e2e-466c-9319-75c619518553"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_a4928ad8-769b-47ab-8011-2c8705edcb02"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_67f2aafd-7934-4f80-a929-ab372ba3fe4d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_b288df54-e98f-412a-96c5-369a8ce12b19"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs and other information consisted of the following (in thousands, except terms and rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for the Company&#x2019;s leases as of September&#160;30, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases a total of approximately 24,100 square feet of office and laboratory space under a single non-cancelable operating lease with a termination date of December 31, 2022. The terms of the lease agreement included an option to renew the lease for one additional five-year rental period, which the Company did not exercise. Instead, in October 2022, the Company entered into an amendment for its operating lease. See Note 15&#x2014;Subsequent Events&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company includes lease extension options in the right-of-use asset and lease liability when the Company is reasonably certain it will exercise the options. The rate implicit in the Company&#x2019;s operating lease is not readily determinable. As such, the Company uses its incremental borrowing rate to calculate the present value of its operating lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases certain equipment related to its information technology infrastructure and laboratory operations. All of the Company&#x2019;s current finance leases include bargain purchase options that the Company is reasonably certain to exercise. The Company has elected not to separate lease and non-lease components for its equipment leases. The rates implicit in the Company&#x2019;s finance leases are determinable, and the Company uses those rates to calculate the present value of its finance lease liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has agreed to indemnify its officers and directors for certain events or occurrences, while the officer or director is or was serving at the Company&#x2019;s request in such capacity. The maximum amount of potential future indemnification is unlimited; however, the Company purchases director and officer insurance coverage that provides for corporate reimbursements of covered obligations that limits the Company&#x2019;s exposure and enables it to recover a portion of potential future amounts paid. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements since these obligations are not capped but are conditional to the unique facts and circumstances involved. Accordingly, the Company has no liabilities recorded for these agreements as of September&#160;30, 2022 and December&#160;31, 2021. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has signed various employment agreements with key executives pursuant to which if their employment is terminated by the Company without cause or by the employees for good reason, or following a change of control of the Company, the employees are entitled to receive certain benefits, including severance payments, accelerated vesting of stock and stock options, and certain insurance benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is not currently a party to any material litigation or other material legal proceedings. The Company may, from time to time, be involved in various legal proceedings arising from the normal course of business activities, and an unfavorable resolution of any of these matters could materially affect the Company&#x2019;s future results of operations, cash flows, or financial position.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1Mw_6f7f1b44-c48f-42ca-a5d4-85466670ea65">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows right-of-use assets and lease liabilities, and the associated financial statement line items as of September&#160;30, 2022 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease-Related Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial Statement Line Items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_0049bb1e-6361-4f5b-bc41-972d98f2f6a3"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi0yLTEtMS0zNzA2Mg_7e1627ae-b748-46d6-9015-15e5ad4fd6be"&gt;Other assets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_5469c87e-2e2e-466c-9319-75c619518553"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy0yLTEtMS0zNzA2Mg_a4928ad8-769b-47ab-8011-2c8705edcb02"&gt;Property and equipment, net&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_67f2aafd-7934-4f80-a929-ab372ba3fe4d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy0yLTEtMS0zNzA2Mg_b288df54-e98f-412a-96c5-369a8ce12b19"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease obligation, net of current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMi00LTEtMS0zNzA2Mg_73076723-1718-4bdc-8291-1ddbfe64c751"
      unitRef="usd">116000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMy00LTEtMS0zNzA2Mg_cd460f54-02d4-4a12-a1da-8bca3887e90e"
      unitRef="usd">1401000</us-gaap:FinanceLeaseRightOfUseAsset>
    <sera:RightOfUseAssetTotal
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNC00LTEtMS0zNzA2Mg_af1a1f9a-2a0f-40d4-a2dc-e58ef935f837"
      unitRef="usd">1517000</sera:RightOfUseAssetTotal>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfNy00LTEtMS0zNzA2Mg_3f74fbd0-b91c-4873-91ec-25bf027a92fc"
      unitRef="usd">150000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfOC00LTEtMS0zNzA2Mg_9c1b71f5-1381-491b-ba8c-3798de2f0fd7"
      unitRef="usd">472000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfOS00LTEtMS0zNzA2Mg_87e445c8-7ce9-437f-be39-53af07c80e67"
      unitRef="usd">735000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sera:LeaseLiabilitiesTotal
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjMxNWFiNDg1ODYzNDQxMDRiMDUxNzNkMmZmYTk5MWMwL3RhYmxlcmFuZ2U6MzE1YWI0ODU4NjM0NDEwNGIwNTE3M2QyZmZhOTkxYzBfMTAtNC0xLTEtMzcwNjI_cf0890bb-61fb-4b37-a998-4b0ec6c02563"
      unitRef="usd">1357000</sera:LeaseLiabilitiesTotal>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1NA_c206719b-9164-4d23-8777-d64d3b54e8c1">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Lease costs and other information consisted of the following (in thousands, except terms and rates):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNC0yLTEtMS0zNzA2Mg_0597bdf7-405f-439d-8568-a32a28555251"
      unitRef="usd">83000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNC00LTEtMS0zNzA2Mg_18d71eb0-35f5-421f-977a-04d855585332"
      unitRef="usd">196000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNS0yLTEtMS0zNzA2Mg_df3aae68-15c4-4153-9508-f9fb2b854369"
      unitRef="usd">20000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNS00LTEtMS0zNzA2Mg_295c17ed-5fba-443f-ada3-2f75da1ac513"
      unitRef="usd">42000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNi0yLTEtMS0zNzA2Mg_614e5ca7-80e5-4fdd-8109-069d1b525ca9"
      unitRef="usd">116000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNi00LTEtMS0zNzA2Mg_c83f479c-1428-468c-9018-d4d90ad9659a"
      unitRef="usd">349000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCost
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNy0yLTEtMS0zNzA2Mg_349a6613-01d1-4432-9805-2d67fadb5533"
      unitRef="usd">219000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfNy00LTEtMS0zNzA2Mg_2c28e2e8-ffe5-4a90-9d71-d30488c88655"
      unitRef="usd">587000</us-gaap:LeaseCost>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTEtMi0xLTEtMzcwNjI_d4b80f03-a0e7-4bca-942d-96d7a68d16b7"
      unitRef="usd">17000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTEtNC0xLTEtMzcwNjI_c2e22063-fb0f-4dbf-86bf-95953f83a2b5"
      unitRef="usd">30000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTItMi0xLTEtMzcwNjI_53c44f1f-ceb8-444a-870c-720980344126"
      unitRef="usd">101000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTItNC0xLTEtMzcwNjI_5c61261c-1cb0-4913-84e9-65f6ed634e11"
      unitRef="usd">186000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTMtMi0xLTEtMzcwNjI_368e92f8-4dea-49dd-af32-99c310a92260"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTMtNC0xLTEtMzcwNjI_dfc6c902-02b9-4c05-b541-64ab2f8297d0"
      unitRef="usd">1253000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTQtMi0xLTEtMzcwNjI_179d41db-213b-4ece-a7ea-cd33006f8182">P2Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTQtNC0xLTEtMzcwNjI_46119b14-bd28-416a-8451-8313aea0e98c">P2Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTUtMi0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo0YjJkOTExMTAyNmE0NjViYWIxZGRlZTk4ZGNhYWUwZV80_9a01b0f3-46a0-4301-a735-36e26388b730"
      unitRef="number">0.064</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTUtNC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo2MmY3YTlhMDU2NGY0ZDZiOWNmZTE4NDZiNDUzYjI0MF80_f9571f51-de90-47fc-8be1-73ecdfe4593e"
      unitRef="number">0.064</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTctMi0xLTEtMzcwNjI_1e91f11a-788b-4dc9-b97f-b42c798f42ad"
      unitRef="usd">151000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTctNC0xLTEtMzcwNjI_b8a4f123-9dac-461b-a922-1cdb041b007e"
      unitRef="usd">453000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTgtMi0xLTEtMzcwNjI_cb47499e-95e7-4851-9cbc-4b629310ee86"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTgtNC0xLTEtMzcwNjI_78be28fa-f379-4fc7-b82b-e2b73c2b49ef"
      unitRef="usd">453000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTktMi0xLTEtMzcwNjI_ab0ab5d2-8f6e-4dca-b75f-4271b70aaee7">P0Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMTktNC0xLTEtMzcwNjI_4aa43446-d84e-41aa-b292-b5d75e0e0b4d">P0Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMjAtMi0xLTEtMzcwNjIvdGV4dHJlZ2lvbjo1MDM5NDBjYjU1NGM0YzI2OTZlZTY5MjVlNjBlNmUwNV80_2565caaf-64ce-4bdb-8fb3-f067659d2b21"
      unitRef="number">0.045</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOmYwYzViYjhiYmE3YjQwMmM4NWY3N2M0Zjg3YTIzNGU4L3RhYmxlcmFuZ2U6ZjBjNWJiOGJiYTdiNDAyYzg1Zjc3YzRmODdhMjM0ZThfMjAtNC0xLTEtMzcwNjIvdGV4dHJlZ2lvbjpjMGY2MzgxMDk3ZjQ0MjYzYjEyMmI4YWIxMGY2NTBjZV80_8e6e81df-1b76-45f4-b58d-d1663664ff4c"
      unitRef="number">0.045</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1NQ_17662460-228b-4921-808e-ec39d9c8464e">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for the Company&#x2019;s leases as of September&#160;30, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1NQ_d5077bd0-4c2b-43da-8ea9-bbe483bf973b">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for the Company&#x2019;s leases as of September&#160;30, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;735&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMS0yLTEtMS0zNzA2Mg_175eab11-2ee0-4008-bcb8-fcb373d4e31d"
      unitRef="usd">151000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMS00LTEtMS0zNzA2Mg_22d3f8ec-1716-4a09-b662-77b74facfabb"
      unitRef="usd">135000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <sera:LeaseLiabilityToBePaidRemainderOfFiscalYear
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMS02LTEtMS0zNzA2Mg_7eb7a424-39ea-4452-a9c7-ed4846d1b4fc"
      unitRef="usd">286000</sera:LeaseLiabilityToBePaidRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMi0yLTEtMS0zNzA2Mg_cabf5bbb-7d41-49b9-9e3d-0a7f537cf1ea"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMi00LTEtMS0zNzA2Mg_d842a815-f33f-4e04-8f8d-00f7654adcd2"
      unitRef="usd">518000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <sera:LeaseLiabilityToBePaidYearOne
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMi02LTEtMS0zNzA2Mg_be7641ba-84ae-443b-9ce6-26e82597d1fd"
      unitRef="usd">518000</sera:LeaseLiabilityToBePaidYearOne>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMy0yLTEtMS0zNzA2Mg_a978e131-2cb1-441b-9607-3cddaae9c53f"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMy00LTEtMS0zNzA2Mg_4461aa3c-1864-460b-8446-935c7f18524d"
      unitRef="usd">462000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <sera:LeaseLiabilityToBePaidYearTwo
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMy02LTEtMS0zNzA2Mg_9a55d4f6-d7d5-415f-97db-6315f80bc164"
      unitRef="usd">462000</sera:LeaseLiabilityToBePaidYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNC0yLTEtMS0zNzA2Mg_135660bb-dbfd-4c1c-af10-c4b51fc368c6"
      unitRef="usd">0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNC00LTEtMS0zNzA2Mg_f6e4a861-251f-48fc-9241-ae02dc438506"
      unitRef="usd">191000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <sera:LeaseLiabilityToBePaidYearThree
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNC02LTEtMS0zNzA2Mg_f7ed6f52-e05b-4fc9-ae17-93536c7836ba"
      unitRef="usd">191000</sera:LeaseLiabilityToBePaidYearThree>
    <sera:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNS0yLTEtMS0zNzA2Mg_30e72e91-51f6-4942-b855-32451aec75a6"
      unitRef="usd">0</sera:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter>
    <sera:FinanceLeaseLiabilityToBePaidYearFourAndThereafter
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNS00LTEtMS0zNzA2Mg_50694b33-bb9f-4f65-82c1-4e3862c060b0"
      unitRef="usd">0</sera:FinanceLeaseLiabilityToBePaidYearFourAndThereafter>
    <sera:LeaseLiabilityToBePaidYearFourAndThereafter
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNS02LTEtMS0zNzA2Mg_c1155acd-e6c7-4a87-96fc-f75ee0d6c5e1"
      unitRef="usd">0</sera:LeaseLiabilityToBePaidYearFourAndThereafter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNi0yLTEtMS0zNzA2Mg_57b60266-5891-4864-aea1-7fadd15f13a1"
      unitRef="usd">151000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNi00LTEtMS0zNzA2Mg_6ddf6c31-b095-46a0-922e-24cfd2a75d06"
      unitRef="usd">1306000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <sera:LeaseLiabilityPaymentDue
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNi02LTEtMS0zNzA2Mg_76e22ef1-ae70-4cf4-8395-ba2d83771bea"
      unitRef="usd">1457000</sera:LeaseLiabilityPaymentDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNy0yLTEtMS0zNzA2Mg_3367765f-b3ec-481c-95f2-7b4da3a971d7"
      unitRef="usd">1000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNy00LTEtMS0zNzA2Mg_268e5f2b-37df-4a1c-9bdb-10030cbe488a"
      unitRef="usd">99000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <sera:LeaseLiabilityUndiscountedExcessAmount
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfNy02LTEtMS0zNzA2Mg_6df8af43-abd1-4ff5-a972-2afe26f52a11"
      unitRef="usd">100000</sera:LeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOC0yLTEtMS0zNzA2Mg_98cef492-6312-43c6-9067-33cb087e0f85"
      unitRef="usd">150000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOC00LTEtMS0zNzA2Mg_df26efec-26ff-46aa-b2e3-875d267c3c12"
      unitRef="usd">1207000</us-gaap:FinanceLeaseLiability>
    <sera:LeaseLiabilitiesTotal
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOC02LTEtMS0zNzA2Mg_bd12aca4-d984-49d0-a22c-049c1ce5ae2a"
      unitRef="usd">1357000</sera:LeaseLiabilitiesTotal>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOS0yLTEtMS0zNzA2Mg_6f7fdcf9-da78-4fcb-976c-d5c5ade0d7e6"
      unitRef="usd">150000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOS00LTEtMS0zNzA2Mg_7a3ea570-b2e1-422a-847e-c40c638a8374"
      unitRef="usd">472000</us-gaap:FinanceLeaseLiabilityCurrent>
    <sera:LeaseLiabilityCurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfOS02LTEtMS0zNzA2Mg_5e0cef03-f4e7-4211-aa08-220ccc412ca8"
      unitRef="usd">622000</sera:LeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMTAtMi0xLTEtMzcwNjI_59dec747-482b-4c59-84e9-dc5149c06caa"
      unitRef="usd">0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMTAtNC0xLTEtMzcwNjI_9c496c14-e6bc-4bf7-b71b-c011e185d937"
      unitRef="usd">735000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <sera:LeaseLiabilityNoncurrent
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RhYmxlOjIzYjIwZTc1Zjk5MDQ0MjBiODhhY2YwODgzMzM1NmQ0L3RhYmxlcmFuZ2U6MjNiMjBlNzVmOTkwNDQyMGI4OGFjZjA4ODMzMzU2ZDRfMTAtNi0xLTEtMzcwNjI_88db63d6-d555-4d68-8f61-cab7a59de4f1"
      unitRef="usd">735000</sera:LeaseLiabilityNoncurrent>
    <sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory
      contextRef="if3480fe1ee8e4d4a882ed4f4391d52f4_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfMTA2Mw_378b7366-2760-4b88-8f68-eb1be9bcf8ee"
      unitRef="sqft">24100</sera:LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfNDA1Ng_b769d3ef-6c8d-4194-9bc3-ebe4dcdb6277">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <sera:IndemnificationLiability
      contextRef="i9527d69fa6764ba3bde674ace51bd382_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfMzA0NA_247c02eb-ebc2-47ff-ae0a-417453750451"
      unitRef="usd">0</sera:IndemnificationLiability>
    <sera:IndemnificationLiability
      contextRef="i70d0004071444462988600b21699ae89_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83My9mcmFnOjU5ODRmODExMjQ1NzRlZWY4NDBlNjQ2ZjdkY2FiNzQ2L3RleHRyZWdpb246NTk4NGY4MTEyNDU3NGVlZjg0MGU2NDZmN2RjYWI3NDZfMzA0NA_d0346fc7-1dd4-4fae-991f-c3ca2cb9cc8b"
      unitRef="usd">0</sera:IndemnificationLiability>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RleHRyZWdpb246ZGQ4OWM3NmU5M2QzNDA5Y2FiZWQ4NTlhYWQyNDc4ZmVfMjQ2NQ_9ee8e214-f2a8-4e9d-92e9-ea23c9e69d93">Net loss per share&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company calculates net loss per share of Class A and Class B common stock using the two-class method. For periods in which the Company reports a net loss, all potentially dilutive shares are anti-dilutive and are therefore excluded from the calculation of diluted net loss per share. For the three and nine months ended September&#160;30, 2022 and 2021, the Company reported net losses and as such, basic and diluted net loss per share are the same. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, including the liquidation and dividend rights, of the holders of the Company&#x2019;s Class A and Class B common stock are identical, except with respect to voting and conversion. The undistributed earnings for each period are allocated based on the contractual participation rights of the Class A and Class B common shares as if the earnings for the period had been distributed. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis and the resulting amount per share for Class A and Class B common stock was the same for the three and nine months ended September&#160;30, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of basic and diluted net loss per share of Class A and Class B common stock during the three and nine months ended September&#160;30, 2022 and 2021 (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(10,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average common stock outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29,600,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,405,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29,513,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,405,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(9,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(21,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average common stock outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23,954,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,130,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,326,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;380,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,532,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,018,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,308,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,806,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RleHRyZWdpb246ZGQ4OWM3NmU5M2QzNDA5Y2FiZWQ4NTlhYWQyNDc4ZmVfMjQ2Ng_41e62e2f-20a8-4630-beec-f6cca9d78010">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of basic and diluted net loss per share of Class A and Class B common stock during the three and nine months ended September&#160;30, 2022 and 2021 (in thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(10,227)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(32,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1,565)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average common stock outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29,600,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,405,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;29,513,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,405,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(1.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.354%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Three Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Nine Months Ended&lt;br/&gt;September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(9,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(444)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(21,641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Weighted average common stock outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;23,954,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;1,130,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;9,326,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;380,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 8.2pt;text-align:left;text-indent:-7.2pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Net loss per share &#x2014; basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(0.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;(2.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:0.75pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi0xLTEtMS0zNzA2Mg_ebf88fcb-cd16-4cd4-8fb9-1df7b168314d"
      unitRef="usd">-10227000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi0zLTEtMS0zNzA2Mg_481c4702-a174-4dfa-9664-83731b120454"
      unitRef="usd">-485000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi01LTEtMS0zNzA2Mg_29f3509b-d9e9-4482-9026-64d505b8f418"
      unitRef="usd">-32875000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMi03LTEtMS0zNzA2Mg_1b3832ff-78da-4f48-8f06-ac32a82f72e9"
      unitRef="usd">-1565000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0xLTEtMS0zNzA2Mg_04881b4e-0ac9-437f-ad7d-c11f9890afab"
      unitRef="shares">29600719</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0xLTEtMS0zNzA2Mg_baa21ec3-9053-490d-9e3e-ee7c66607e6f"
      unitRef="shares">29600719</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0zLTEtMS0zNzA2Mg_0328ab52-6b6b-4607-a0a3-41195fac3947"
      unitRef="shares">1405259</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy0zLTEtMS0zNzA2Mg_6b39ce45-1af5-4f73-b99e-b41a5cc2ac76"
      unitRef="shares">1405259</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy01LTEtMS0zNzA2Mg_045022b6-c42e-4128-92a2-5f855d986534"
      unitRef="shares">29513214</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy01LTEtMS0zNzA2Mg_469ea544-f669-4bd0-b835-f2eeb0c3f271"
      unitRef="shares">29513214</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy03LTEtMS0zNzA2Mg_5b6f3b3c-6476-4b53-9997-cb4364756f28"
      unitRef="shares">1405259</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfMy03LTEtMS0zNzA2Mg_9e5806be-5647-4871-bff1-a9c720888565"
      unitRef="shares">1405259</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0xLTEtMS0zNzA2Mg_870de139-03e3-4a38-aec3-7478d3516978"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0xLTEtMS0zNzA2Mg_f84e4e98-de02-4ebd-b758-c9085d0f2d95"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0zLTEtMS0zNzA2Mg_0034aab7-5a41-48db-8cd8-a222616db4ba"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i11423b1c5b9c486b9b7aeacd1a28dd0d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC0zLTEtMS0zNzA2Mg_2be3a57e-503b-47cc-985c-7c8c7ab72acc"
      unitRef="usdPerShare">-0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC01LTEtMS0zNzA2Mg_1758bcf3-0b58-48a2-bf56-a651f245f621"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i970f701f35d04e1aabd7a042616e5432_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC01LTEtMS0zNzA2Mg_d3914c5d-e9b4-432c-807b-10980fb202e6"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC03LTEtMS0zNzA2Mg_c1350b8f-e26c-45e0-aa0a-6009c2514699"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1a99b729c13b459bb450ca6c85cf8eed_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjNjNGJmYzY0ODhkYTRiOGJiYTQxYmEwMTk1MjYxYTI1L3RhYmxlcmFuZ2U6M2M0YmZjNjQ4OGRhNGI4YmJhNDFiYTAxOTUyNjFhMjVfNC03LTEtMS0zNzA2Mg_ec77644e-3028-4e80-8347-ad57fcb37642"
      unitRef="usdPerShare">-1.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS0xLTEtMS0zNzA2Mg_0082877c-5ded-4d1b-a2e3-02a62929163f"
      unitRef="usd">-9415000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS0zLTEtMS0zNzg4Ng_9b5d1e61-6f76-47e1-8428-7fd5bd441069"
      unitRef="usd">-444000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS0zLTEtMS0zNzA2Mg_b2fbf59b-381a-4bd5-8bb1-59262e9de49d"
      unitRef="usd">-21641000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMS03LTEtMS0zNzg5NA_e0cf8310-a4b9-48b1-9b23-c768218b6c40"
      unitRef="usd">-884000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0xLTEtMS0zNzA2Mg_8e3d8a03-cefb-42c3-b534-40fe6ceb3dea"
      unitRef="shares">23954696</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0xLTEtMS0zNzA2Mg_b9973be3-acd3-4838-acdf-83a4d58a1ba7"
      unitRef="shares">23954696</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzg4Ng_88656ad5-1af2-4753-846f-00e53870b7b1"
      unitRef="shares">1130317</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzg4Ng_8ec02904-0fd6-46be-9acc-801614c9eb20"
      unitRef="shares">1130317</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzA2Mg_46545ea7-4b83-4967-8307-b035e3d63340"
      unitRef="shares">9326341</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi0zLTEtMS0zNzA2Mg_bfce9e66-dcdb-4396-be34-0ad23d5de184"
      unitRef="shares">9326341</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi03LTEtMS0zNzg5NA_259c45d1-ba9b-4a32-9820-0748d06f04e8"
      unitRef="shares">380913</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMi03LTEtMS0zNzg5NA_80b31ae4-1257-4986-988f-55e558b3a1dc"
      unitRef="shares">380913</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0xLTEtMS0zNzA2Mg_7e3c1437-61e9-4175-8bd3-8e931e962a79"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="id4071bba3495429f9b1c1e0b3db36e28_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0xLTEtMS0zNzA2Mg_db275870-efa5-4146-9273-cc59fe0ba6d5"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzg4Ng_53ea1705-018e-4a71-9180-025d9fb1698d"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i423e8e3229e440b29de9987e9ab03338_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzg4Ng_f1efdec1-d5e2-4a04-aa21-a6c75d41494f"
      unitRef="usdPerShare">-0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzA2Mg_3a48bb2d-9f0c-4690-8fba-ab2893d69efa"
      unitRef="usdPerShare">-2.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i5caa3bf7e88248219af4d5f4dda79b71_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy0zLTEtMS0zNzA2Mg_da5a52e3-794f-48ee-a458-40c0eb727530"
      unitRef="usdPerShare">-2.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy03LTEtMS0zNzg5NA_a0877b53-6eb9-4d16-9847-47c0ead068e8"
      unitRef="usdPerShare">-2.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3dd2f5eadd19481b9a64d582e01211a5_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOmZjZTk3ODk4ZmJkYTQ0YTU4Y2JhYmQxYjU3MDEzYmUyL3RhYmxlcmFuZ2U6ZmNlOTc4OThmYmRhNDRhNThjYmFiZDFiNTcwMTNiZTJfMy03LTEtMS0zNzg5NA_aa8f013a-af40-4e34-a2d9-13ce55754d7f"
      unitRef="usdPerShare">-2.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RleHRyZWdpb246ZGQ4OWM3NmU5M2QzNDA5Y2FiZWQ4NTlhYWQyNDc4ZmVfMjQ2Nw_b9e5baa4-6963-426d-9d57-159c4f81ad5c">&lt;div style="margin-top:12pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company excluded the following potentially dilutive securities, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because their impact would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Warrants to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,775,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;2,788,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;Options to purchase Class A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,532,949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;6,018,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;11,308,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"&gt;8,806,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3f3d450f7a124081a7088d0b95d3115c_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNS0xLTEtMS0zNzA2Mg_11094d6b-9791-4157-b1e8-bf843876a579"
      unitRef="shares">2775978</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5fd78f55213f40769bb6407a882dcb00_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNS0zLTEtMS0zNzA2Mg_064b4e19-b9a3-48d6-8dc8-e66076681531"
      unitRef="shares">2788484</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1fec57d1a2df4384aef09573ccdf6570_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNi0xLTEtMS0zNzA2Mg_af0b773a-2686-4889-88a6-1da2b242d1fb"
      unitRef="shares">8532949</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i78569680632f4aa9bc2c2383b785be95_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNi0zLTEtMS0zNzA2Mg_65eaf8ce-e4aa-4021-9234-30774f705d0d"
      unitRef="shares">6018350</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNy0xLTEtMS0zNzA2Mg_28c7c3aa-7410-489e-a1e8-628ec19870a4"
      unitRef="shares">11308927</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i141836eb173a4dbf820aeae71c27e0e3_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83Ni9mcmFnOmRkODljNzZlOTNkMzQwOWNhYmVkODU5YWFkMjQ3OGZlL3RhYmxlOjk3MGFlMzMyMjMyMTRhZjg4OWQ2MTRmNWYyNTg3ZTZkL3RhYmxlcmFuZ2U6OTcwYWUzMzIyMzIxNGFmODg5ZDYxNGY1ZjI1ODdlNmRfNy0zLTEtMS0zNzA2Mg_f055f111-d7e1-4dfc-9bb0-10072bcb140d"
      unitRef="shares">8806834</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfMTM_4bdb29f4-fe6d-4016-9957-12b58dc462d8">Subsequent EventsLease AmendmentOn October 10, 2022, the Company entered into the Second Amendment to the Lease (the &#x201c;Second Amendment&#x201d;) with Eastland Regency, L.C. for its headquarters located in Salt Lake City, Utah. The Second Amendment modified the lease agreements, dated August 1, 2017 and amended on June 7, 2021 (the &#x201c;Lease&#x201d;), to extend the term of the Lease an additional &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfMTA5OTUxMTYyODQyNA_df1e695d-5bfe-4eae-921e-ce6dee848024"&gt;three&lt;/span&gt; years to expire on December 31, 2025 (the &#x201c;Extended Term&#x201d;), and provide the Company with an early termination right which termination would occur under certain circumstances as provided in the Second Amendment after July 1, 2024 if exercised. Subject to adjustment as set forth in the Second Amendment, the rent payable to Eastland Regency, L.C. during the Extended Term is an amount equal to approximately $1.9 million.</us-gaap:SubsequentEventsTextBlock>
    <sera:AdditionalMinimumOperatingLeasePaymentsDue
      contextRef="i287e032d20624fe0a98f6658b3eb78b3_I20221010"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjIwODRjMzViMjk2NzQxNjFiZWM0NWMxMDdiOWE5MmE2L3NlYzoyMDg0YzM1YjI5Njc0MTYxYmVjNDVjMTA3YjlhOTJhNl83OS9mcmFnOmFlOWIxYWRhZGYwOTQ1OTk4ZDUxOTczN2I1YTYxYWJjL3RleHRyZWdpb246YWU5YjFhZGFkZjA5NDU5OThkNTE5NzM3YjVhNjFhYmNfNTQ5NzU1ODE0MzQz_76296578-3689-4328-a113-89f12d1094d9"
      unitRef="usd">1900000</sera:AdditionalMinimumOperatingLeasePaymentsDue>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>76
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMZ;+4T_NH?55V?2UK!U[W;$IGF93L].\!-(X/P=OX#F$$&EJ%4 /L#5]#U
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M:X;P*<U0CZ2;4W<R_,2ZO7..ABXYUVBXZ%U"F_\ ?"9BRTJI&Z"-5H3GD0Z
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MUP'J_HHQN9OHWJGNE<._4$L#!!0    (  *":56GA*).[@4  -$:   8
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MS=T39]\]5:XQ[%US]\1YUMR]4;XU=_KH!)_+<[BYE79SJ_P%U]PK:-DRE-9
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M>PZSVC&_L6DY%B>P.(G%*1C.TF)]I,47\\ ?4QGS:KMZ=F!_PB^$PSDY-J?
MXB06IV X4U+LR AG9S#"F<^2+NV6:P.I@]4S*BO'9A58G,3B% QGZ>?("&=
M(YQY/.0T9XYNL$8X%,?'?0F!S2JQ. 7#6;HY,L+9=QCAS&?YQJ7]5/[U0))P
MI6"-<"A.C#TJ$IM7P7"65HZ,< 9^GZ+?>*"S!,^XF<<(]S^=ALW,L3B!Q4DL
M3L%PEOJ.C'!VHA$^0G&NO^U]2LT7Z-RY^6)\SZGY GT/JGGCO$^J#1RA\%,*
M=<*OUG==MVG:3?O^[;+]TOVU77V9]C?@L^YSCX_?[)H7KZ9?[IY^V"R6O0(N
MHD^+S69QO_]XU[6WW6H7T/_^\V*Q>?SAJN=_6ZQ^W>=X_V]02P,$%     @
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M4&HT.C\-0+?#V2ZLJOU K)2E\?)F2>\9:A= ^X52=K=P!/T+F?X%4$L#!!0
M   (  *":54M>JA\-@@  "TF   8    >&PO=V]R:W-H965T<R]S:&5E=#<N
M>&ULM5IM<Z.Z%?XK&O=.9W=FO482V#A-/)/-[K:=N??6<]UM/RL@Q^H"XB+A
M;/KKKP08,'I)W'&_)("/#L]YT7F.A&Z?>?5='"B5X$>>%>)N=I"RO%DL1'*@
M.1$?>4D+]<N>5SF1ZK9Z6HBRHB1M!N79 @7!<I$35LPVM\VS;;6YY;7,6$&W
M%1!UGI/JY1/-^//=#,Y.#WYC3P>I'RPVMR5YHCLJOY7;2MTM>BTIRVDA&"]
M1?=WLWMX\Q!&>D C\2]&G\7H&FA3'CG_KF_^GM[- HV(9C216@51_X[T@6:9
MUJ1P_-XIG?7OU /'UR?M7QOCE3&/1- 'GOV;I?)P-XMG(*5[4F?R-_[\-]H9
MU !,>"::O^"YDPUF(*F%Y'DW6"'(6='^)S\Z1XP&*#WV :@;@*8#0L< W W
MC:$MLL:LST22S6W%GT&EI94V?='XIAFMK&&%#N-.5NI7IL;)S0,O4A44FH*=
M))*J $D!^!X\$'$ 7U60!7A7%Z1.F:3I>S 'WW:?P;N?WH.? "O /P^\%J1(
MQ>U"*C!:Y2+I7ORI?3%RO'@-?N&%/ CP10%(S\<OE!&])>ADR2?D5;BCY4>
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M;%)[(WG9'.]YY%+RO+D\4)+22@NHW_=<+9^Z&_V"_H38Y@]02P,$%     @
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MV3PC[V2,P G+.WE"WF^^EE9_D>3>G#P-SNA2)LP@"K=>!66C'$)TB,H='BH
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MH_?0 KRO'-*4;TC!^'7PXK]02P,$%     @  H)I5;;/8&%I"@  5QT  !@
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M!1$*R-&C 8F!5MYC FA5WDCM1-7'FP=4ZE>11]_U,19K67"&QS$FNN2>[0B
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MDD+)6M.U/KGX!_C&?UV4S8KF#7/SXA"B7A#';DW.AYU3Q7@&A@8393.'?I!
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M,3,N>&ULE55=;]HP%/TK5^E4@82:+SY;0"I=M_6A&VKW\3#MP9 +L9K8F>T
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MPDIF]"%RL0;#%AF"\RZ,!D(#00LIW%"N0#H!?A#H$%LYH$D55F<I:%?(JP>
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MAC?@>Z9!!<T+*^C^9W#^#U!+ P04    "  "@FE5"6+L@:P%  !]#P  &0
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M1$0("D@M(7#\NX<;* H"0AIW#6;0A23'_G6+_M[ECKELN($;5?PF,IM?!LN
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MF 5,^\.>O[&J<@>LC;)X7'.7.9Z/09,!KF\5OF&:&PK0G;C7?P-02P,$%
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MCN[ @VDW)[V#4[)KR[X"/8_O J0RX3E*RS,F0DI>AI5MDT+15I0D('5WRE=
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M#1.:>7$R?28G.\:%'R6]2+8M13^AO,9NSAX.HEL*4;JK":P$D]3N*<V'-)[
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MVS)'JT:P5EW:V:08]/.[L>&I4^'HX!A?2;/R'ROX/%,KUYSH^[?]]Y#;YC/
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MYRY)X:RB"#/BNW0FX[/!T:(^^/'H6G>4=I@ADW>:P-MA\/P;/HSOCUP?&FE
MX)Z@I&H>@!Y&XK"PJO-C:*<L#35OUO070>T":'^OZ&Z."Y=@^B]M_@%02P,$
M%     @  H)I5;?LB%9?"@  G1L  !D   !X;"]W;W)K<VAE971S+W-H965T
M,C N>&ULK5G;CMLX$OT5PG-! KC=OO8EZ6Z@DTDP 9))D&1W'A;[0$N4S8TD
M>DC*;N_7[ZDB)4NRNR<SV ?+MD06ZW+J5)&ZV1G[S:V5\N*AR$MW.UA[OWEQ
M?NZ2M2JD&YF-*O$D,[:0'G_MZMQMK)(I3RKR\^EX?'%>2%T.[F[XWB=[=V,J
MG^M2?;+"544A[?Z5RLWN=C 9U#<^Z]7:TXWSNYN-7*DORO]C\\GBWWDC)=6%
M*ITVI; JNQW<3UZ\FM-X'O!/K7:N]5N0)4MCOM&?=^GM8$P*J5PEGB1(?&W5
M:Y7G) AJ_!%E#IHE:6+[=RW]+=L.6Y;2J=<F_UVG?GT[N!J(5&6RROUGL_M5
M17L6)"\QN>.KV(6QB^E ))7SIHB3H4&AR_ M'Z(?6A.NQH],F,8)4]8[+,1:
M_B*]O+NQ9B<LC88T^L&F\FPHITL*RA=O\51CGK][;8I">WC9.R'+5+PVI=?E
M2I6)<C?G'BO0N/,D2GL5I$T?D78M/F#^VHDW9:K2[OQS:-:H-ZW5>S5]4N 7
MM1F)V7@HIN/I] EYL\;<&<N;_65SM7+B%^V2W+C**O&O^Z7S%ICY]RDOA$7F
MIQ>A/'KA-C)1MP,DBE-VJP9W/_\PN1B_?,*$>6/"_"GI?SEB?U<:.>2] N"=
M^+I6>%!L9+D7V@F/O[ER3BFAD5=Y+DPF- 3D-%Q(:R4DL,Q19VZJ4U$:+_!$
M6<SU1M#M/*RRTWZ-/,^E5ZG82.M)@[2R4(>79%^6_%!9;=*>\$)^PWCI0"\;
M2OA@SW^J=!6LVZU528^A.$E,8"C%UPDP6]0\@2A3TN@A,ALZ(N%H;'R:8[;.
M=")9_)#E)S)/*JA,PRPQP)G)SBKR E;R/"3,SK5<ZES[O=C*O%)!^3#N$84+
M"6^725ZEBNV'U*S*(6BKPM!,:ANE401"6+!6&A:'AG1+%YM<)]H+"\>*"HEI
M\WWMT^B\GW^XFDXN7\8(QHG]9]#%<E1E+I;& K9L-$F%!T_/\!@N$&;UH&RB
M'8]D!#3_:].W4N=RF3.DZFC$"(4X9R;/PY*>Q[FUV;D3/G<GG*Y5#!=IB5$F
MT8RR3)<22(=!SN,&&2<H0X!F51"8R*_@(/Q; K$U$8EG4-*O3>4@TSU_$?+D
M['/$[OU!C?<'!<3;9K$OS6+O:;%WO-B)93X?&_="? 3Z ]YBWGR$4;:V_4<Q
MF5S$I50]XI-%$;> 'JFD_JCTAA8?BA((G0SGXXGX:BBJIYP)@</%Y#*8V';H
M"4WND\16!#\L8UBKI+(V./7@!TA<C/LJ=OX*L\SUBM-LV(C8&,MU?'XY?6(T
MF828]2==SA;1QB-@L(6S16UA8ER,7;! EZ'S(2E I-..0AS3[8#)#B*&P'>"
M< JBD"",TH20\G5M09OM*BE^(PQT[IR PHE;!WU[_J!;+\1]0;;_-V@.?4\'
M]VI&]E]?B'?$R0JR3'G"1].QF$_[ 0]K$]YF\^N.>_G!CV(ZN<9U<749,=KV
M93?^;3 ETJT%^L<LIP2'=I>XS&K$G!P!!.-Z=7$J8P /C^84;D6($)<U%:<6
MZ7>AP-PU?<F@F"YFXG=NZU1Z)K?0#Q-!@;)=%2C$'/V]DM8]%]/1@C]'$U,T
M%Z8J(P]?C.8_A4L_BYYTQ8(,G4.O_Z.A\[]CYG@TX\^?F#D?+7X*E[>5I[Z*
M*FI1%5'J1NY#K<L>J2"1'1XEXATP2T]#(KHC8CZX\GV79^K.AD'+HFKO3D 5
M@"[ A-NSQD^+R15_<'/>W)Q?3/F#FXOFYN1ZPA_<O*B+#O9+&?4\]9C^=]#C
M$>>07J"H\061-1.5 TI0URO/P8Z)^VSR7#R[OL9E,AX_!^ESNQ0:!')?%B)P
M)'Q,4!]?-BQ(POO\2:.(>"^(=TRY.F,\U$_;:+ID]]'UR/?M;JT.+)H#LASJ
MR<W&F@<->E#Y7DSG0UB!35HEH7.F JV;#.V7"@5>H@>1WMB]X%X[=#802-T=
MVH/2E&<)A3IT%:9'7=QL2A%ZO,!(*7<RF?A%)1%EDX"RT'\$+F_W64*N0.9<
MQV.?1J4OMC34]<"%V)8>QA/*T5\*F:::QL#P#-W<&>44#29/A-YVB'95)^MV
M3ARZY]@[C<#9*$82@X'ZCXDWI#0IW.G?0K<=@$+]MI#0.&6M21_JVWO.&2'3
ME/C-P!V318SLEVKIT#G0K#=;!DZW^XX.J/< ZL''C7O=X'%BJN_MD;E9]]UM
M!W+(P6=+H"-!-P-Z@O(()/8?33M)4^**03]FH:8%UN5)ENF# XN1H^F00V.U
M>BM 0!JANQ.N2M9='U<$9G+E$TTRO%_O%E1[0W/(T!.Q:+/VZ(B]CA.J]DS3
MY34[*BP?%#S48*^2=6ERLZ+X959BQULE3!*]#(M*L5?OPW[OE!]KULBZO5V]
MB5E*NR+=-I5%<6HU_WXM_7=$N[6/Z((/P@2?\ZB0(1CH%':0Y.B8J67*C-#?
MYS4I</!74/J 'O>G\.F92X35ALQAY]%!"\J4JU?X/FATUND"XQW(KRB;S>F1
M=YBI @;BR'U &Q.J#3UJJBU\:&SP2H.DD.Y$74D(<$*[*?!3'O,MR* 1M00*
M(*X[K$S''X3F;H0;WUDB%<>NI:R"&T#F8(#@_T(^<$&4!;<4\,/&T):2-E&Q
MG.F>Y5BY*G-=8 >7OA38(T)_VTW6&G_NH"_W^]$.7;K*LJ,3$YL:!BC*TU83
MQ;%WC-T8!IA5NEA6UH4##]Y\T#3:)#3[D@AQ5LN=](-ZV(2#)]ZB,6Z(4$(5
M88&H5G6]/>6'X"*'PJ[34?_$IF*!05B35G [5UO6I^=I5A=]7)Z*)3<+/#^4
M6!_.+5JG/%1S$Q4?M*VF5*"$1%0W<,BR\GP+^ZBF $(G/MPH-8 @,CZ1X8,5
M;9.JP+:<X(:8;$V^5; ,>TQC4ZKQ^VY4">:EZ72YY#E+53FVE^V2_4132<OW
MFX#),>.4A"PB-TJ*-&X<84ZJ,L7TN7.5#IF#,N=S/D'2A6LS<E"JC^&#DB/Q
M!N1C]JC']P?-^YHXO:*V?RO1.E3 $D]A,FN9RQW/-[4G#DTJSZ=(R 17R7!$
M$QH.S<RN;5L('?G%/HF"N.^XG<1BAX(05^%X)SY74>^0+BMCTHB](0TZ;)RE
MB!L53IS26],O+\.>/$(081\>36-^*%C3$-8275>FZ?@K%!Y:Q5&L.*?KQA>L
MG* YI+I&KJ-DP#BL[+Q)OC$&PJ]8I.)Q7]UX-!Q1KS9"45X!SQ^D]T2HO0SD
M+ CE$:DG^7QS+^(!*&6AI5PFW*[BCMW& XC#0Y8/%DI Y5#VZ/P3GLJL*032
MFG.=OH>4OW7V$,O6(#F2!K]J/AD-,M:4N6@4<J(!ZS@^RPH#L#\([U):QVKH
M*JLRDULP(O$$BI?)JYJJ2+D044<\$]P3N*6VC5R29:#BT_4U,!RD5GE@V$,_
M,@Q[9-X@!V0UIVP@5":9T:E#]_/6*Y-"V16_&&*U2A_>GC1WFW=/]^&5RV%X
M>''U 6T-\ "/9I@Z'ETN!J'-K?]XL^$7,$OCO2GXYQJMI;(T ,\S S*/?VB!
MYHW<W?\ 4$L#!!0    (  *":5710CPX+P4   ,.   9    >&PO=V]R:W-H
M965T<R]S:&5E=#(Q+GAM;*U7WV_;-A#^5P[N4+0 :^N7;2E-#"19A^VA7=!T
MZ\.P!UJB(Z*2J))4G/[WNR,E36X=-^CV8I^HX\?O.]X=J?.]TI],*82%A[IJ
MS,6LM+8]6RQ,7HJ:F[EJ18-O=DK7W.*COEN85@M>N$EUM8B"8+6HN6QFFW,W
M=J,WYZJSE6S$C0;3U3777ZY$I?87LW V#+R7=Z6E@<7FO.5WXE;8/]H;C4^+
M$:60M6B,5 UHL;N8789G5PGY.X<_I=B;B0VD9*O4)WKXK;B8!41(5"*WA,#Q
M[UY<BZHB(*3QN<><C4O2Q*D]H/_BM*.6+3?B6E4?96'+BUDZ@T+L>%?9]VK_
MJ^CU+ DO5Y5QO[#WOG$P@[PS5M7]9&10R\;_\X<^#I,)Z6,3HGY"Y'C[A1S+
MG[GEFW.M]J#)&]'(<%+=;"0G&]J46ZOQK<1Y=O,.][U2QD K<*M*KL7YPB(N
MO5WD/<:5QX@>P<C@K6IL:>!-4XCB</X"^8RDHH'45702\%:T<X@#!E$012?P
MXE%D[/#B1_#><-W(YL[ #8J\)9'PU^766(TY\?<QO1XN.0Y'=7)F6IZ+BQD6
M@A'Z7LPVSY^%J^#U";+)2#8YA?[$'3F)<9SAM\#PH11PK>J6-U\@YU7>5=P*
M \VWGFH'UQ7'H4O@3=';5Y"KNL;:PC3-/T%G,,A@$=/NU:O<N=3"EJJ8 Y80
MH4E5&) -[$N9E\YU6%Z+5FEK@(^K,^!5!:VRHK$2S2]0R*JC(O:<T!>)<7SY
M:GQ!W&@4D;&Z%5KB(:\Z3$O8:56[%0>AU!10EIN+[[\5[5D[/:46'ASS2$#M
MTUU0N@,FJQ7U%B<-&>L<T0C9$863E4@!\378$O.247>1N1MZG-.@#@ROD2!M
MH*;&@]&2#2D=MJ"2GSM9>)4>\EX6R'AT1^GD5ZJJ$-H,CSW9Y\_2*%R_-M_?
M=.)#P%9B7!F%&^.!3<R6*-BTV'S!*KA7EH@12JZ:>UP0>7GZ75-(+$6Y=8K%
M4*JX>?B 2>*SQN]U5:F<DQLUX@*0A-M0W XJY8YCNG"-3&3KA7NMH[836OJ$
MPN3TO@<\:*"G47)<7(@&)J3G<&F>$O.O8V4?5W^HEN"@U8KR![%QS.6*3Q]"
M0>YX"KD(UZIK["1?B/]W-W'/S9A4H^(?3'J_JSN%[/<N&?FVPM :3&5$MF6_
M977;V;$&GY3Y3VE!1:?''O1C].&%I*Q2G<$1,R9T7WSH-"E%%VOS\@P5TUK3
M4Q#>T:('(P/Y@?C7SV-__@E>A &+HO5+,I-TZ?[CB*5K;X9LN4+KH[MR(#+'
M@L(;U&$H\ 9F+!+&>!QK+5'&5D' UF$&(4N")8N6&0TNPYA%83(9/')NN/80
MO3X"B^R">>QICD8X#\.)\;]'*V-)Z%=*DL3]8^]=)7[--$W^:ZABEBT3MLI6
M&)40,R8.UY"Q.%JQ. DA3@.6A?&/Q"E[>6!$\SB:&-/3>3S&[$%Q'3\=18YE
M8*7 ]'7'?W/0,ONTG:H&;@^:+58)FQR8A\5ZHD0/FR6=](7L&[;(>6?<T24U
M2!2%!\->=16U5.3L>NK!67YVK$I=A7[D6G-2@ =+V^F\1&5C?AQL;,36ZR7+
MUBE9:<J2-('?6Q+RA,DI6V+-94D&*Q:$*8N7 7Q0%@^9,&1QD+(L6J-3&JQ8
M&B=P[.JWF%S,:Z'OW.>'P65P _P=?1P=OW N_<7^7W?_>?26ZSN)M"NQPZG!
M?+V<^6-E>+"J==?\K;+XT>#,$K_2A"8'?+]3F"O] RTP?O=M_@%02P,$%
M  @  H)I5=/7<^K  @  )@8  !D   !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&ULE55M;]HP$/XKIU2J-@F1$.@[( 'KM$VM6I5U^S#M@TF.Q&IBI_:EM/]^
M9P=2.E&T?2"Q[^YY_-S%=PQ7VCS8')'@N2R4'04Y474>AC;)L12VJRM4[%EJ
M4PKBK<E"6QD4J0>511A'T7%8"JF"\=#;;LUXJ&LJI,); [8N2V%>IECHU2CH
M!1O#G<QR<H9P/*Q$AG.D^^K6\"YL65)9HK)2*S"X' 63WOETX.)]P ^)*[NU
M!I?)0NL'M_F:CH+("<("$W(,@E]/.,.B<$0LXW'-&;1'.N#V>L/^V>?.N2R$
MQ9DN?LJ4\E%P&D"*2U$7=*=77W"=SY'C2W1A_1-636Q\%D!26]+E&LP*2JF:
MMWA>UV$+<!J] XC7@-CK;@[R*C\)$N.AT2LP+IK9W,*GZM$L3BKW4>9DV"L9
M1^-YO;#X6*,BN'SBIQV&Q+3.&29KBFE#$;]#<0;76E%NX5*EF+[%ARRGU11O
M-$WCO81SK+K0CSH01W&\AZ_?YMCW?/U_S1%^31:6#-^(W[O2;=@&N]E<EYS;
M2B0X"K@-+)HG#,:'![WCZ&*/UD&K=;"/_=^^QW]27"%?6YAP*Z7\HQL%-PGI
M!1KHK8O< <H19KJLA'H!CD&#*4A%VCOFF&B5OC+ VMX0?W#+PX/3.(XN_H[T
MYM[%1[[5E,.EL%0(]M]AABIYZ<!5=]8%'BT@^:OD/%0>:V'X= N%3@1Y$3 7
M!<&5>&"%DAAT3R+OPO==PDJ=RJ5DF--4>'DB,XC.:3N0>LI)G7%C0<_EWCL!
M)T@X!G;QG/A6*X037Y?>F]Q\MIN$.JX&^$P,\V>QYA+T<JLL@D=.FDHW>T3!
M=E:QZWZ$6[U;HLG\A+*0Z%I1T\:MM1V"DZ;W7\.;"7HM3"85EPZ7#(VZ)T<!
MF&8J-1O2E9\$"TT\5_S2U1R-"V#_4FO:;-P![5_#^ ]02P,$%     @  H)I
M55Y XD/@"0  D!L  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULM5EK
M;]RX%?TKA+=89('QO)PX:6(;&'N3;;:;A1&O6Q1%/W DS@P3B=22E,?NK^^Y
ME]1CQO+D ?2+K9'(R_L\]USI;&O=9[]1*HC[LC#^_&@30O5Z,O'91I72CVVE
M#)ZLK"MEP$^WGOC**9GSIK*8S*?3TTDIM3FZ..-[U^[BS-:AT$9=.^'KLI3N
MX5(5=GM^-#MJ;GS4ZTV@&Y.+LTJNU8T*M]6UPZ])*R77I3)>6R.<6IT?+6:O
M+U_2>E[P#ZVVOG<MR)*EM9_IQ_O\_&A*"JE"98$D2/R[4U>J*$@0U/@SR3QJ
MCZ2-_>M&^CNV';8LI5=7MOBGSL/F_.C5D<C52M9%^&BW?U/)GA<D+[.%Y[]B
M&]>^P.*L]L&6:3,T*+6)_^5]\D-OPZOI$QOF:<.<]8X'L98_RR OSIS="D>K
M(8TNV%3>#>6TH:#<!(>G&OO"Q8U>&[W2F31!+++,UB9HLQ;7MM"95EX\:ZY^
M.IL$G$>[)EF2?1EESY^0_5?QP9JP\>*MR56^NW\"/5MEYXVRE_.# F]4-18G
MTY&83^?S _).6N-/6-[)$_*&#/[W8NF#0[+\9\C@*._YL#PJH->^DIDZ/T*%
M>.7NU-'%CS_,3J=O#FC[O-7V^2'I%Y?2:R_L2ER3;!,DI?60DM\A1ORQ4:B0
MS):5- _DD-K(.M=!Y2*S")_QN%II(TVF92$\MBG49O!B(^^46"IE!&RNI,,Z
M;5B6R[%:(:'#AG\G5U=.0TA5P-EK99231?% SU45XMX 76X-GWU#Y["VBU(Y
MI*EX]N,/K^;SZ9O;\<U8_+)87//OV9N?A#2YD%6%.,IEH82KZ02ZZ=2Z+MA,
MEL3B:?>-RFJG@T[+WMYG&VG62ES9LM2>8><9+4XGWKR]:L^"2.ERLD:; ,7*
MGF_@!>O(TK&X4BX &+$HPB?C$(XR-BB1:Y\5UM<( V[@,?D!KBGJO//#H,L/
M.;KU2R\P702M$[;4@5Q;U<[75/;! I*SS;##QF+A^?&(U/'JZ_/";VQ=Y%!
M4+,@5;'A4VTB&K.N9& C;5 &A[2?E>0X_\A)5W$!16?V\HT7"V-J"/K(@1 X
MC0!<S*;'?Q>( V]Y4-()1;@D?E:9*I?*B9,9(\MLS-70&=J$^-L+@<)-30,%
MA\WX%[#RL>TRZCOL LY9<L37J#ZBE:/&+[;2AIR=DG[?3:4TZ+MTS(CZ*S5*
M@204,O^$QL/'CQJ]R?G>%@HI"FDQ7;$)!>3HT<X6 ZV\1XMO55Y)[435QYLG
M5.I7D4=C]3$62UEPAD>>$EWRR'8$P$?_YPC7'87)V?(KD@PEL,&?''?$LL:%
MY8H,39ZQ4_9+>&5MB-GHU)^UIF@O'WK51Z93XA8J#%=QM"R9V?@C;)Q2$2(
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M6@8\GTMI=C=V@_HCT?@_4$L#!!0    (  *":55=#=C@ 0,  *P&   9
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M2?] *(T#?=\(H?<#L\#X5[7\#U!+ P04    "  "@FE5=D#?$;4"  #D!0
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M^J,I)I3J9J%N863CYH^5-#C-.#''\5$HJX#G:XFYTB^L@V$@7?P-4$L#!!0
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M-.!+10F#B4!RF658/-\ Y>NAXSLO _=DOE!FP(T&.9[#%-1#/A&ZYY8N"<F
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MK9X.DRA*G**C>&ZKA!E7NN:PS86N"D&8!7H^Y5R]=$SA4=:9T4]02P,$%
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M(]W%L O&IFTADNB*M-WNUX^2%=$N:2;1!W)CZ^N<P_=0)!\=:;1G^0-?4RK
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M#U_&''8$VY0?E]PS(5A:;JXID<]SQ07R_)(Q\;A3?*]2?Y\T^1]02P,$%
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MQD2G'\\",.U :0/2M>_)A2;N<+\L> :C<0E\OM*:G@/7YOU4S_X 4$L#!!0
M   (  *":57^F;3LJ@(  ($'   9    >&PO=V]R:W-H965T<R]S:&5E=#,Y
M+GAM;+55WV^;,!#^5RQ639W4%6H"A(X@M<FJ[6%2U:S=LP-'L&HPM4W2[J^?
M;0C*5I*^K"_@'W??]]WY?$ZV7#S*$D"AYXK5<N:42C67KBNS$BHBSWD#M=XI
MN*B(TE.Q=F4C@.36J6(N]KS0K0BMG32Q:[<B37BK&*WA5B#95A41+]? ^';F
M7#B[A3NZ+I59<-.D(6M8@KIO;H6>N0-*3BNH)>4U$E#,G*N+R^O8V%N#!PI;
MN3=&)I(5YX]F\CV?.9X1! PR91"(_FU@#HP9("WCJ<=T!DKCN#_>H=_8V'4L
M*R)ASMDOFJMRYDP=E$-!6J;N^/8;]/$$!B_C3-HOVO:VGH.R5BI>]<Y:047K
M[D^>^SSL.6!\P 'W#MCJ[HBLR@51)$T$WR)AK#6:&=A0K;<61VMS*$LE]"[5
M?BJ=$UF>(?-%7Y]:NB$,:B41J7/T@XA'4&3% "TA:P55%"3Z?&!]SHB4M*"0
MH]4+FO-:"9WQEC!MKW9&IPOM2)G\A$X0K='/DK=24\G$53H6H\C->MW7G6Y\
M0/<2FG/D>V<(>QBC^^4"G9Y\^AO&U:D8\H&'?&"+ZQ_ O:JX4/2WCF+.I1K3
MU?E/QOW-';J4#<E@YNA+(D%LP$D_?K@(O2]'U/F#.O\8>KIH0=>'*G7N> WH
M!8@8D]B!A!;$W,I-&GA1$"7N9H1[,G!/WN0FA0(Q4"-5"MZN2U3HBV571@^R
M@PWVU& <!7A<33"H"8ZJ>?N<@E>TD1]X\3AM.-"&1\OCAE"!'@AK88PR?(?2
MB 9ET?\HC>A55B9Q'$['LS(=N*?O4QK3D=+PHP-JXD%-?%3-\3.*7]V-"/N3
M\!]*=Z^CFL=)][PUK25B4&@_[SS2FD77\+N)XHUMLBNN=,NVPU*_D2",@=XO
M.%>[B>G;PZN;_@%02P,$%     @  H)I54JZ97C? P  Z1,  !D   !X;"]W
M;W)K<VAE971S+W-H965T-# N>&ULM5A=CYLX%/TK%EM5K30=,(0PF4TBM9FM
M6JFMHJ;=?5CM@X?<3*P"IK9)9OKK:P/#1^+Q;"3RDMAP[\FYQQ=SXNF>\1]B
M"R#1?9ID8N9LI<RO75?$6TB)N&0Y9.K.AO&42#7E=Z[(.9!UF90FKN]Y8S<E
M-'/FT_+:DL^GK) )S6#)D2C2E/"'=Y"P_<S!SN.%K_1N*_4%=S[-R1VL0'[/
MEUS-W 9E35/(!&49XK"9.6_Q]<+W=$(9\3>%O>B,D2[EEK$?>O)Q/7,\S0@2
MB*6&(.IK!PM($HVD>/RL09WF-W5B=_R(_KXL7A5S2P0L6/(/7<OMS+ERT!HV
MI$CD5[;_ '5!H<:+62+*3[2O8ST'Q860+*V3%8.49M4WN:^%Z"3@T1,)?IW@
M_]^$H$X(RD(K9F59-T22^92S/>(Z6J'I0:E-F:VJH9E>QI7DZBY5>7*^Y*HC
MN'Q )%NCOWX6-%=K)-$;M&!ISC(U%HAMD#GL GU1C?;J!B2AB7BMLKZO;M"K
M%Z_1"T0S]&W+"J$2Q-25BJK^03>N:;VK:/E/T%I!?HD"[P+YGN\;TA?V]!N(
M53HNTW$_W54"-2KYC4I^B1<\H](%6B9$R=,7Z]]/*AQ]E)"*_TRE5M@C,[9^
M3J]%3F*8.>I!%,!WX,Q?_H''WI^FP@<"Z\D0-#($-O3Y-R9)@O)N+\"C"J;"
M*[1QB:;WD]U\@L/)U-UU"SH.BJ*1UP3UB(X:HB,KT4\@A-HAXB(M$B)AK1YL
M)4=,2;5U*-XD95S27^4%$_4*/^RP>C/V0O^ NR$JG(PC,_FP(1]:R2^-^EZ@
M#(PBAT<< NQ%!T2/@W 4!6:>XX;GV"XRN66<2,8?[%U@13FU_0<"ZQ4<-05'
M9]P%HB%E& BL)\-5(\/5H+O U5'OA1/L'32H(<@+GFC024-T8B6J7V&%!&ZG
M9\4X=5T& NN5B[WV7>Z=L4%K\(&4& JM+T7'UN!!F[2&Z^V0OG^XC1JCL&]N
M4]RZ"VQ]:ZO7E3*B6Y:L$4T5Y1UHEF;7-*B7& JM7W;K)G!PSG:U>I63I1@(
MK2]%ZU>PW;"<W*['SB,ZVE.?">I3;=T)MMN3%=O(/>%@I&5-/7E-!D+K%]K:
M&SP^9WL.:GN&0NM+T1H?;#44I[=G=-1YD\FA>38$C<;A$^W9FA-L=R?O"YY1
M67 H66[HO1Z;]U(KT,DK-!!:O^S6ZN#).9MU4!,T%%K_KWKK@GRKM3BY66NX
M[C_0P#_<2Y\)JJBZG7,8?0CVF? [F@F4P$9E>9>1ZG5>G2M5$\GR\FCFEDG)
MTG*X!;(&K@/4_0UC\G&B3WN:T[WY;U!+ P04    "  "@FE5_*)L_9X"  #=
M!P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6RM56UOTS 0_BM6F-"0
MQO+:#4H::6V*X,-0M3+X@/C@)M?&6A)GMM-N_'K.3AK:+2L3[$OC.]_SG.^E
M=^&&BQN9 2AR5^2E'%F94M70MF6204'E*:^@Q)LE%P55*(J5+2L!-#6@(K<]
MQSFS"\I**PJ-;B:BD-<J9R7,!)%U45!Q/X:<;T:6:VT55VR5*:VPH["B*YB#
MNJYF B6[8TE9 :5DO"0"EB/KPAU. VUO#+XQV,B=,]&1+#B_T<+G=&0Y^D&0
M0Z(T \7/&B:0YYH(GW';<EJ=2PW</6_9/YK8,98%E3#A^7>6JFQDO;-("DM:
MY^J*;SY!&\] \R4\E^:7;!K;<\<B22T5+UHPOJ!@9?.E=VT>=@#(TP_P6H#W
M$! \ ?!;@/]<#T$+")[K8= "3.AV$[M)7$P5C4+!-T1H:V33!Y-]@\9\L5+W
MR5P)O&6(4]%,8,L)=4]HF9+I;<TJ; )%WI(O5 BJBTB.8U"4Y?(-:J_G,3D^
M>D..""O)UXS7$G$RM!4^11/:2>MVW+CUGG#KDTM>JDR2:9E"VH./#^/?'\#;
MF((N#]XV#V/O(.$<JE/B.R?$<SROYSV3Y\/=OG#^S_OTG[WO)</OFL(W?/Y?
MFN*$S'**W;#?&S\N%E()_(?_[*M[PQST,^NI-Y0536!DX5B3(-9@1:]?N6?.
MA[ZDOR19_))DTQ<BVRM/T)4G.,0>Q8"D":/-I,7:T((+Q7X915]-&KHS0Z<7
MQSK"-1+:Z]U4/[9Q']K$CVT& W_?9MICXP:=31.OO3.O"A KLR@D27A=JJ9+
M.VVWBR[,"'Z@'[O#B=NCCW%W-:OF#WVS^"ZI6+%2DAR6Z,HY/<=Q*IIET@B*
M5V9:+KC"V6N.&>Y?$-H [Y><JZV@'70;/?H-4$L#!!0    (  *":57SK>C!
M%@,  #$)   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;*V6;6_:,!#'
MOXJ555,K=<TS#QT@M:!IDS85E79[,>V%20YBU8DSVX'R[7=.(*,D(";M#=CQ
M_>]^=['/&:R%?%$)@":O*<_4T$JTSF]M6T4)I%3=B!PR7%D(F5*-4[FT52Z!
MQJ4HY;;G.!T[I2RS1H/RV52.!J+0G&4PE405:4KEYAZX6 \MU]H]>&3+1)L'
M]FB0TR7,0#_G4XDSN_82LQ0RQ41&)"R&UIU[.^X;^]+@.X.UVAL3D\E<B!<S
M^1(/+<<  8=(&P\4_U8P!LZ-(\3XO?5IU2&-<'^\\_ZIS!USF5,%8\%_L%@G
M0ZMGD1@6M.#Z4:P_PS:?T/B+!%?E+UE7MEW?(E&AM$BW8B1(65;]T]=M'?8$
M;G!$X&T%WKD"?ROPRT0KLC*M"=5T-)!B3:2Q1F]F4-:F5&,V+#-O<:8EKC+4
MZ=%=%,D"8D*SF#SH!"09%U)"ILE71N>,,\U D<L):,JXNB(?R/-L0BXOKL@%
M81EY2D2A4*L&MD8:X]..MI'OJ\C>D<@SR&^([UP3S_&\%OGXM'P"$<K=4NZ^
ME=M8@[H07ET(K_3G'R^$*#*MR)1NZ)Q#69%==?9J<5T7Z.?=7&F)^_!76_)5
MM* ]FCF;MRJG$0PM/'P*Y JLT?MW;L?YV%:*_^3L36'\NC#^*>_U#HE$BJU#
M47/ZVA*NO'1*+Z9WK$:>X_L#>[6?2(M1T._51F\ @QHP. LPIRPF&EL,$8M%
M&V'E)MP+'CK! 6#3)N@X[7QAS1>>5T!<8!'E1.DBWF ]E6X]-F$3T_<.,)LV
M1R [-63G+,C <2]?KK##Z"AAV1(I,RW9O#!OO96VTRQ8[Y"V:7.$MEO3=D_2
M/N0@<2,B'P?LX81OS^?F&GMF=3IS(8_MU&X#QPV= ^2FS1'D7HW<.XU<-M<=
M'?_;4-H(>XWHOAL>$#9M^EZWG;%?,_9/,CX)C=N3[ET)XE^H^XW#C;NI<X#=
M-/)[O?" V]Z[T,S'Q#<JERQ3^+87*'-NNIBVK"[H:J)%7MYQ<Z'QQBR'"7[3
M@#0&N+X00N\FYMJLOY)&?P!02P,$%     @  H)I58_V];YB P  /PP  !D
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MB[Z:#5Z6JV5#LJ6IQQZ95-6=N4U5A0]<"]3S.6-RT] )ZO\,T5]02P,$%
M  @  H)I509-1;#< @  3P@  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N
M>&ULK59K;],P%/TK5IC0)L'RZ N--M+:@9BTH6K=X /B@YO<-M8<.]A.N_Y[
MKITT=".+V$0_M'[<<^XY=G)OQUNI[G4&8,A#SH6>>)DQQ9GOZR2#G.I368#
MG954.34X56M?%PIHZD Y]Z,@&/HY9<*+QVYMKN*Q+ UG N:*Z#+/J=I-@<OM
MQ N]_<(-6V?&+OCQN*!K6("Y*^8*9W[#DK(<A&92$ 6KB7<>GLU&-MX%?&.P
MU0=C8ITLI;RWD\MTX@56$'!(C&6@^+.!&7!NB5#&KYK3:U):X.%XS_[9>4<O
M2ZIA)OEWEIILXGWP2 HK6G)S([=?H/8SL'R)Y-I]DVT=&W@D*;61>0U&!3D3
MU2]]J,_A ( \[8"H!D1/ ?UG +T:T'-&*V7.U@4U-!XKN27*1B.;';BS<6AT
MPX2]Q851N,L09^(K284F5*1D)L4&E&%+#F2N9,ZTEFI'ODH#FKPG4RKNB8TF
MQQ=@*./Z!%?=@D4O("D5,SMROE8 >,T&=^\6%^3XZ(0<$2;(;29+C:%Z[!L4
M;M/[22UR6HF,GA$9DFLI3*;))Y%"^ACOH^'&=;1W/8TZ":^I.B6]\!V)@BAL
MT3/KAE] LH>'_0XYO>82>HZO]RS?TI!+H8TJW<G]N,( <FD@US_;3JMBZ[>S
MV??^3!<T@8F'+[8&M0$O?OLF' 8?VZS^)[)'QON-\7X7>WP+*B<<GZ$VEYW0
ME[JLR(:.S%:V31P&^!G[FQ;Y@T;^H%/^#11TYVY,K@B62&WP^69B30K%1,(*
MRMM\#?Z2$ATJJ?1V)G[EK0P;6\-_MT631)60XAML %.9-D<5W># T?")G<Z$
MK[0S:NR,.NU\9H)RLK>T FBS,&I[/IZ8Z$SS4A/^0<W.0:U=*],DD:4P5?EN
M5IMN>>Z:A/\GO&JU6,W6#*LXAQ5"@],1WH2JVE<U,;)P'6 I#?83-\RPXX.R
M ;B_DECDZXE-T/R'B'\#4$L#!!0    (  *":54UBW:#]P0  ,,:   9
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MY0Q/:EMMF]@%KZZV70M[D:PHG7:56RMMI8O6%+R6;=I*P=? B,S\W+-T$K;
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MA29AD2'8B5FFK5FFO;/+39IR2+$$5'!"8U+@#.&<E51V6:67=:E53,)\D[#
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M%,B3HJ(JJG<4U;M\7AV?1W7]%VOC99.YRY^IC3.2YT"3%&=B,\NJ2BE7CK%
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MM<!K),\&M*FU%C+.:U(F@%YD9;O-+X=RT2P0Z 74P;&+L1=Z3H"G,WMWS'/
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M0,YO*!6/'759[?Z<B'\"4$L#!!0    (  *":562V"G< P4  (PB   9
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M*ZQ_?!:0Z!.'C/WLZHXROM<=7XKC)2OP"J:&4#\&= ?&[.T?]M#ZT$6-3K!
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M$H%5^Z75B:!%N>5X3X6@67FX)7A%F J0]]>4BL.)VL5L=JVC_P!02P,$%
M  @  H)I50>\-MPX @  0P4  !D   !X;"]W;W)K<VAE971S+W-H965T-34N
M>&ULM53?;],P$/Y73D%"((TF39O"2A)I[88VB4&U"O: >'"3:V/-/X+M-N6_
MQW;24&#M&R_QG7W?=]\YODL;J9YTA6A@SYG065 94T_#4!<5<J('LD9A3]92
M<6*LJS:AKA62TH,X"^,HFH2<4!'DJ=];J#R56\.HP(4"O>6<J)\S9++)@F%P
MV'B@F\JXC3!/:[+!)9HO]4)9+^Q92LI1:"H%*%QGP=5P.DM<O _X2K'11S:X
M2E92/CGGKLR"R E"AH5Q#,0N.YPC8X[(ROC1<09]2@<\M@_L'WSMMI85T3B7
M[)&6ILJ"=P&4N"9;9AYD<XM=/5Y@(9GV7VC:V-%E ,56&\D[L%7 J6A7LN_N
MX0@0#T\ X@X0>]UM(J_RFAB2ITHVH%RT97.&+]6CK3@JW$]9&F5/J<69_)$H
M1831\ 8^.=/=$;RZ1D,HTZ_3T-@<+C(L.KY9RQ>?X+N$>RE,I>%&E%C^B0^M
MMEY@?! XB\\2+K$>P"BZ@#B*8] 54:C/T([ZND>>=GR"-AG$T7/5G46Y#IGJ
MFA28!;8%-*H=!OG+%\-)]/Z,IG&O:>S91R<TS1G1&N0:NI\"4H'O$OCVT8;"
MG4&NOS^G>OP?5">]ZN3L3?ZC^G.G^@)N]C55?[^"5G'+F7A.-SAV^3!.HDD:
M[HZEA$</FZ/:^/;54,BM,.T;[W?["7'5-L;O\':\W!.UH4(#P[6%1H.W-K=J
M6[9UC*Q]FZRDL4WGS<I..50NP)ZOI30'QR7HYV;^"U!+ P04    "  "@FE5
MOR@#"YD#  !.#@  &0   'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6R]5UUO
MTS 4_2M6F!!(W?+1IMU&&VG+F$ :HJ(,'A /;GK;6CAV9COK]N^QG2S]2D-5
M"B]MG/@<GW/M:U_W%US\DG, A9Y2RN3 F2N57;JN3.:08GG&,V#ZRY2+%"O=
M%#-79@+PQ()2Z@:>UW533)@3]>V[H8CZ/%>4,!@*)/,TQ>+Y&BA?#!S?>7GQ
MA<SFRKQPHWZ&9S "=9\-A6ZY%<N$I, DX0P)F Z<*_\R]ML&8'M\(["0*\_(
M6!ES_LLT/DX&CF<4 85$&0JL_QXA!DH-D];Q4)(ZU9@&N/K\PGYKS6LS8RPA
MYO0[F:CYP#EWT 2F.*?J"U]\@-)0:/@23J7]18NRK^>@))>*IR58*T@)*_[Q
M4QF(%4 GV $(2D"P+Z!= FSDW$*9M76#%8[Z@B^0,+TUFWFPL;%H[88P,XTC
M)?17HG$JBGF:$J7G14F$V03%G"G"9L 2D.@4W8$.D42$H5O",$L(IFBDL *#
M0&]N0&%"Y5O=\WYT@]Z<O$4GIO/7.<^EII-]5VF19B@W*05=%X*"'8)&D)VA
MMM="@1<$-?"X&7X#B8;[%NZOPUT=FBH^016?P/*U=_#9=7W*IZ>Y!(2E!"4O
MZTP5+)UZ%I.+ES+#"0P<G6P2Q",XT>M7?M=[5V?Q2&1KAMN5X783>_0Y X'-
M$D#4SGV=V8*A:QG,/O$8^7ZW[SZN>F@<Y4 /G<I#I]%#L5:AP4&!#U<==#Q_
MPT+C( =:""L+8:.%KUSI5!/;JZ_.3;CM)O1[&VX:QSO03;=RTVW,(KN-($KP
MF%"B"-3G4/>8.70DLC6[O<IN[Z]SJ%<S9][&E/6V\FS98TW8>27L?/_$0'Q,
MR0R;T[2ECQHAS):><6%>U"D^WU+<Z04;BK?[]#KUDB\JR1<'2F:ZR.'3?91?
M;*MJAQO*+[9B'>Y0[GO+L]7;(XGIYN*O/12][3VU'6[F</-X!ZYJ?Z56\/=<
MUS:A6Z@Z'>^UPRNS/[56R@,].<NJ8<@EL87;C_=/RI2!8PKH/<M32\G9S]JH
M_$&/FH/8O2_&!\/7X[.L%?S&D[E:J_\K.LUJAD(7^T(]V[H.'G*2F7%MWM0&
MZTALZ[%;EAW^OG5'&;V[,F&>6R@N4OS(T6O6<Y4D(H=))4/GK;5>+)J[QFR.
M_PUW$5EWI=@W-ZU/6,P(DWJ;F>K!O+.>WN=$<7DI&HIGMOX?<Z5O$_9QKB]\
M($P'_7W*N7IIF"M%=86,?@-02P,$%     @  H)I5=G9YB=R!   Q!4  !D
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MS"]93C+YR8X5*1;RL-C[/"\(WE9%:>*C()CX*::9MUI4[]T7JP4K14(S<E\
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M4^1<<VM^0U#:"69\+81^Z=A*U_S8Q/\ 4$L#!!0    (  *":557%>*W.P,
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M'=@UT3:-H:;I9%P']#?5G/:F;/PJW:!BSU)_FIOI"-N'^J3WBN9L8?N+O#6
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MP9Z2.$Y3/P*8WT$<8P@\C3B".0 /&!+']CVX\SZ*5N^I:/T?OM%O4$L#!!0
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MG7J7Z?.0R[7G:XW/_TZJI_.]^?KXR_+KY.R]7'!.MQ7E^2]02P,$%     @
M H)I5?\GIW7C 0  ;"0  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULS=I=3\(P
M% ;@OT)V:UCIU_R(<*/>JA?^@;H=9&%;F[8@_'N[ 28:)1I,?&]8H.UYSWJ2
MYXKKIZVC,-JT31>FV2)&=\58*!?4FI!;1UU:F5O?FIB^^A?F3+DT+\3$9%*P
MTG:1NCB.?8UL=GU+<[-JXNANDWX.M>VFF:<F9*.;W<8^:YH9YYJZ-#&MLW57
M?4H9[Q/R='+8$Q:U"V=I0\:^3.A7O@_8GWM8D_=U1:-'X^.]:=,NMFE8B-N&
M0GZ\Q!<]VOF\+JFRY:I-1_+@/)DJ+(ABV^2[HF?'DV.Z8=I]\I/SAS+' M/.
M1V]=2!/S]/NXPTCZTV.7"I&/]?%7?$],I4]^/^JG75'UP^QTO:_6+X=Y!#8\
M3K_CCS-^K__+/@1('Q*D#P72AP;IHP#IXQRDCPN0/BY!^N 3E$901.4HI'(4
M4SD*JAQ%58["*D=QE:/ RE%D%2BR"A19!8JL D56@2*K0)%5H,@J4&05*+(*
M%%DEBJP215:)(JM$D56BR"I19)4HLDH4626*K!)%5H4BJT*15:'(JE!D52BR
M*A19%8JL"D56A2*K0I%5H\BJ4635*+)J%%DUBJP:15:-(JM&D56CR*I19"U0
M9"U09"W^4]9G:Y=_'#\\\];4W2&?#7\RFKT!4$L! A0#%     @  H)I50=!
M36*!    L0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    "  "@FE5N4#"<>X    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    "  "@FE5F5R<(Q &  "<)P
M$P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   (  *":54B4-"L@ 8  *8E   8              " @0T(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    "  "@FE5_ETU]>D%  #F&
M&               @('##@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @  H)I539F9_+? @  -PL  !@              ("!XA0  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (  *":56GA*).[@4
M -$:   8              " @?<7  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    "  "@FE5#_KUA7(4  !R"0$ &               @($;
M'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @  H)I5286
MY*!Q @  +04  !@              ("!PS(  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    (  *":54M>JA\-@@  "TF   8
M  " @6HU  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    "  "
M@FE5<:VX2%4(   I%   &               @('6/0  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @  H)I5;;/8&%I"@  5QT  !@
M         ("!848  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   (  *":57^0P_4X08  !,4   9              " @0!1  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @  H)I5;U[V0GN @  FP8
M !D              ("!&%@  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    "  "@FE5W'V>%NT"  #Q!@  &0              @($]6P
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (  *":56AE&K@
MY@(  )(&   9              " @6%>  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @  H)I52@CUW"8!@  /Q   !D
M ("!?F$  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    "  "
M@FE5"6+L@:P%  !]#P  &0              @(%-:   >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (  *":56E&O'J: <  '84   9
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M970R,"YX;6Q02P$"% ,4    "  "@FE5T4(\."\%   ##@  &0
M    @(%VCP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M  *":573UW/JP (  "8&   9              " @=R4  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @  H)I55Y XD/@"0  D!L  !D
M             ("!TY<  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    "  "@FE57Z+5L?H%   P$@  &0              @('JH0  >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (  *":55=#=C@ 0,
M *P&   9              " @1NH  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @  H)I50W/!$__ @  [@8  !D              ("!
M4ZL  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    "  "@FE5
M#4_6E/T"  "C!@  &0              @(&)K@  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    (  *":56)%'1]<P,  &D)   9
M      " @;VQ  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @  H)I59[0VJ#Y @  KP8  !D              ("!9[4  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    "  "@FE58V&9J0\$  !A"0
M&0              @(&7N   >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    (  *":55V0-\1M0(  .0%   9              " @=V\  !X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @  H)I59?)OB,N
M!0  D1   !D              ("!R;\  'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    "  "@FE5QZS*<C0$  "<"@  &0
M@($NQ0  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (  *"
M:55,,3EZ? (  .P%   9              " @9G)  !X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @  H)I56YOYU3B @  <PH  !D
M         ("!3,P  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
M    "  "@FE5E0$I<?H(   71P  &0              @(%ESP  >&PO=V]R
M:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (  *":54PVJ&R+P4  *LD
M   9              " @9;8  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL
M4$L! A0#%     @  H)I51NET-5M @  X04  !D              ("!_-T
M 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    "  "@FE5_IFT
M[*H"  "!!P  &0              @(&@X   >&PO=V]R:W-H965T<R]S:&5E
M=#,Y+GAM;%!+ 0(4 Q0    (  *":55*NF5XWP,  .D3   9
M  " @8'C  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
M H)I5?RB;/V> @  W0<  !D              ("!E^<  'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    "  "@FE5\ZWHP18#   Q"0  &0
M            @(%LZ@  >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    (  *":56/]O6^8@,  #\,   9              " @;GM  !X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @  H)I509-1;#< @
M3P@  !D              ("!4O$  'AL+W=O<FMS:&5E=',O<VAE970T-"YX
M;6Q02P$"% ,4    "  "@FE5-8MV@_<$  ##&@  &0              @(%E
M]   >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    (  *":55S
M5%_9N ,  +,4   9              " @9/Y  !X;"]W;W)K<VAE971S+W-H
M965T-#8N>&UL4$L! A0#%     @  H)I55PV)R_]!@  1CL  !D
M     ("!@OT  'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
M"  "@FE5R(><K^\#  !1%P  &0              @(&V! $ >&PO=V]R:W-H
M965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (  *":54>0G-.& 4  #,?   9
M              " @=P( 0!X;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L!
M A0#%     @  H)I5<J-86N+ P  J!   !D              ("!*PX! 'AL
M+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    "  "@FE5DM@IW ,%
M  ",(@  &0              @('M$0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q
M+GAM;%!+ 0(4 Q0    (  *":57 OR\^GP4  -@<   9              "
M@2<7 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @  H)I
M5:?L]6W[ P  *14  !D              ("!_1P! 'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6Q02P$"% ,4    "  "@FE5RU'[ O0#  #!%@  &0
M        @($O(0$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0
M   (  *":54'O#;<. (  $,%   9              " @5HE 0!X;"]W;W)K
M<VAE971S+W-H965T-34N>&UL4$L! A0#%     @  H)I5;\H PN9 P  3@X
M !D              ("!R2<! 'AL+W=O<FMS:&5E=',O<VAE970U-BYX;6Q0
M2P$"% ,4    "  "@FE5V=GF)W($  #$%0  &0              @(&9*P$
M>&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (  *":56:R)W$
MX@0   X=   9              " @4(P 0!X;"]W;W)K<VAE971S+W-H965T
M-3@N>&UL4$L! A0#%     @  H)I5;/*(JC" @  Y @  !D
M ("!6S4! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"% ,4    "  "
M@FE5_)_1][0&   P-P  &0              @(%4. $ >&PO=V]R:W-H965T
M<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    (  *":57BQ!QE/0,  +(,   9
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M 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  "@FE5=TMQA08"  #Q)
M&@              @ '>3@$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  "@FE5_R>G=>,!  !L)   $P              @ $<40$
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     1@!& "$3   P4P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>259</ContextCount>
  <ElementCount>302</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>59</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Balance Sheets (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited</Role>
      <ShortName>Condensed Balance Sheets (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Balance Sheets (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical</Role>
      <ShortName>Condensed Balance Sheets (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Statements of Operations and Comprehensive Loss (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited</Role>
      <ShortName>Condensed Statements of Operations and Comprehensive Loss (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited</Role>
      <ShortName>Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical</Role>
      <ShortName>Condensed Statements of Convertible Preferred Stock and Stockholders??? Equity (Deficit) (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Statements of Cash Flows (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited</Role>
      <ShortName>Condensed Statements of Cash Flows (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Description of Business and Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition</Role>
      <ShortName>Description of Business and Financial Condition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Cash, Cash Equivalents and Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Accrued and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities</Role>
      <ShortName>Accrued and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Other Income, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/OtherIncomenet</Role>
      <ShortName>Other Income, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Loans and Convertible Promissory Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotes</Role>
      <ShortName>Loans and Convertible Promissory Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Capital Structure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructure</Role>
      <ShortName>Capital Structure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Commitments and Contingences</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingences</Role>
      <ShortName>Commitments and Contingences</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Net loss per share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/Netlosspershare</Role>
      <ShortName>Net loss per share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/PropertyandEquipment</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Accrued and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Other Income, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/OtherIncomenetTables</Role>
      <ShortName>Other Income, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/OtherIncomenet</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/FairValueMeasurements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Capital Structure (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructureTables</Role>
      <ShortName>Capital Structure (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/CapitalStructure</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/StockBasedCompensation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/Warrants</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Net loss per share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/NetlosspershareTables</Role>
      <ShortName>Net loss per share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/Netlosspershare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Description of Business and Financial Condition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails</Role>
      <ShortName>Description of Business and Financial Condition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails</Role>
      <ShortName>Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Property and Equipment - Components of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment - Components of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Property and Equipment - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails</Role>
      <ShortName>Property and Equipment - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Accrued and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Other Income, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/OtherIncomenetDetails</Role>
      <ShortName>Other Income, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/OtherIncomenetTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Loans and Convertible Promissory Notes - Bank Loan (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails</Role>
      <ShortName>Loans and Convertible Promissory Notes - Bank Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Loans and Convertible Promissory Notes - Convertible Promissory Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails</Role>
      <ShortName>Loans and Convertible Promissory Notes - Convertible Promissory Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Loans and Convertible Promissory Notes - Paycheck Protection Loan (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails</Role>
      <ShortName>Loans and Convertible Promissory Notes - Paycheck Protection Loan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/RelatedPartyTransactions</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Capital Structure - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails</Role>
      <ShortName>Capital Structure - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Capital Structure - Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails</Role>
      <ShortName>Capital Structure - Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Stock-Based Compensation - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Stock-Based Compensation - Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Warrants - Common Stock Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails</Role>
      <ShortName>Warrants - Common Stock Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/WarrantsNarrativeDetails</Role>
      <ShortName>Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Commitments and Contingences - Leases in Financial Statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails</Role>
      <ShortName>Commitments and Contingences - Leases in Financial Statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Commitments and Contingences - Lease Cost and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails</Role>
      <ShortName>Commitments and Contingences - Lease Cost and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Commitments and Contingences - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Commitments and Contingences - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails</Role>
      <ShortName>Commitments and Contingences - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Net loss per share - Computation of the Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Net loss per share - Computation of the Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails</Role>
      <ShortName>Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="sera-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.seraprognostics.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.seraprognostics.com/role/SubsequentEvents</ParentRole>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:LesseeOperatingLeaseRenewalTerm -  sera-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="sera-20220930.htm">sera-20220930.htm</File>
    <File>sera-20220930.xsd</File>
    <File>sera-20220930_cal.xml</File>
    <File>sera-20220930_def.xml</File>
    <File>sera-20220930_lab.xml</File>
    <File>sera-20220930_pre.xml</File>
    <File>sera-20220930x10qxex101.htm</File>
    <File>sera-20220930x10qxex311.htm</File>
    <File>sera-20220930x10qxex312.htm</File>
    <File>sera-20220930x10qxex321.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="787">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="32">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>82
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sera-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 17,
   "contextCount": 259,
   "dts": {
    "calculationLink": {
     "local": [
      "sera-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sera-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sera-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sera-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sera-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sera-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 479,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 7,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 12
   },
   "keyCustom": 45,
   "keyStandard": 257,
   "memberCustom": 27,
   "memberStandard": 29,
   "nsprefix": "sera",
   "nsuri": "http://www.seraprognostics.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.seraprognostics.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Cash, Cash Equivalents and Marketable Securities",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities",
     "shortName": "Cash, Cash Equivalents and Marketable Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Property and Equipment",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Accrued and Other Current Liabilities",
     "role": "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities",
     "shortName": "Accrued and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Other Income, net",
     "role": "http://www.seraprognostics.com/role/OtherIncomenet",
     "shortName": "Other Income, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Loans and Convertible Promissory Notes",
     "role": "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotes",
     "shortName": "Loans and Convertible Promissory Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Fair Value Measurements",
     "role": "http://www.seraprognostics.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Related Party Transactions",
     "role": "http://www.seraprognostics.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Capital Structure",
     "role": "http://www.seraprognostics.com/role/CapitalStructure",
     "shortName": "Capital Structure",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Stock-Based Compensation",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Warrants",
     "role": "http://www.seraprognostics.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:WarrantsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Balance Sheets (unaudited)",
     "role": "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
     "shortName": "Condensed Balance Sheets (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Commitments and Contingences",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingences",
     "shortName": "Commitments and Contingences",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Net loss per share",
     "role": "http://www.seraprognostics.com/role/Netlosspershare",
     "shortName": "Net loss per share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Subsequent Events",
     "role": "http://www.seraprognostics.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables)",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables",
     "shortName": "Cash, Cash Equivalents and Marketable Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Property and Equipment (Tables)",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Accrued and Other Current Liabilities (Tables)",
     "role": "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Other Income, net (Tables)",
     "role": "http://www.seraprognostics.com/role/OtherIncomenetTables",
     "shortName": "Other Income, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.seraprognostics.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Capital Structure (Tables)",
     "role": "http://www.seraprognostics.com/role/CapitalStructureTables",
     "shortName": "Capital Structure (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib7006217670f4919bc1f54ae58aca198_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Balance Sheets (unaudited) (Parenthetical)",
     "role": "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
     "shortName": "Condensed Balance Sheets (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib7006217670f4919bc1f54ae58aca198_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Warrants (Tables)",
     "role": "http://www.seraprognostics.com/role/WarrantsTables",
     "shortName": "Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Commitment and Contingencies (Tables)",
     "role": "http://www.seraprognostics.com/role/CommitmentandContingenciesTables",
     "shortName": "Commitment and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Net loss per share (Tables)",
     "role": "http://www.seraprognostics.com/role/NetlosspershareTables",
     "shortName": "Net loss per share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Description of Business and Financial Condition (Details)",
     "role": "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails",
     "shortName": "Description of Business and Financial Condition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "idef209848fc148788ca3494cf8345024_I20220101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Cash, Cash Equivalents and Marketable Securities by Major Security Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "sera:CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Marketable Securities and Cash Equivalents in Unrealized Loss Positions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Narrative (Details)",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)",
     "role": "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails",
     "shortName": "Cash, Cash Equivalents and Marketable Securities - Marketable Securities Classified by Contractual Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Statements of Operations and Comprehensive Loss (unaudited)",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
     "shortName": "Condensed Statements of Operations and Comprehensive Loss (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Property and Equipment - Components of Property and Equipment, Net (Details)",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails",
     "shortName": "Property and Equipment - Components of Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Property and Equipment - Narrative (Details)",
     "role": "http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails",
     "shortName": "Property and Equipment - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Accrued and Other Current Liabilities (Details)",
     "role": "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Other Income, net (Details)",
     "role": "http://www.seraprognostics.com/role/OtherIncomenetDetails",
     "shortName": "Other Income, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeOther",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i669added0b444346a5f738058ceb934b_I20141231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermLoansFromBank",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Loans and Convertible Promissory Notes - Bank Loan (Details)",
     "role": "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails",
     "shortName": "Loans and Convertible Promissory Notes - Bank Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i669added0b444346a5f738058ceb934b_I20141231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermLoansFromBank",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Loans and Convertible Promissory Notes - Convertible Promissory Notes (Details)",
     "role": "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
     "shortName": "Loans and Convertible Promissory Notes - Convertible Promissory Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i0a4e0e0d7fe741efb9d200dacc3890d8_I20190228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Loans and Convertible Promissory Notes - Paycheck Protection Loan (Details)",
     "role": "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails",
     "shortName": "Loans and Convertible Promissory Notes - Paycheck Protection Loan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i4e0ee74c3ff34aefb683e6d0f0a83a2c_I20200430",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "role": "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Financial Assets that are Measured at Fair Value on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ie045a5e26f014139838acb18403afe93_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i97f06024a3634a4a848d749268fa8321_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Related Party Transactions (Details)",
     "role": "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i97f06024a3634a4a848d749268fa8321_D20220701-20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Capital Structure - Narrative (Details)",
     "role": "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
     "shortName": "Capital Structure - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sera:NumberOfCommonStockClassesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "common_stock_class",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i22c04c1aa9cc4ed1a3a5746977b13f78_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited)",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
     "shortName": "Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib44a2f2d0ad7493db173717bcd13180b_D20210101-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sera:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib7006217670f4919bc1f54ae58aca198_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Capital Structure - Common Stock (Details)",
     "role": "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
     "shortName": "Capital Structure - Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia28bd723960742d0bc535d70294b0cec_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i70d0004071444462988600b21699ae89_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Stock-Based Compensation - Stock Options (Details)",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails",
     "shortName": "Stock-Based Compensation - Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Stock-Based Compensation - Expense (Details)",
     "role": "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation - Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Warrants - Common Stock Warrants Outstanding (Details)",
     "role": "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails",
     "shortName": "Warrants - Common Stock Warrants Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ic6bde4ed70d0494f837109a7f9176ae6_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sera:ClassOfWarrantOrRightExpired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Warrants - Narrative (Details)",
     "role": "http://www.seraprognostics.com/role/WarrantsNarrativeDetails",
     "shortName": "Warrants - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ic6bde4ed70d0494f837109a7f9176ae6_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "sera:ClassOfWarrantOrRightExpired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Commitments and Contingences - Leases in Financial Statement (Details)",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
     "shortName": "Commitments and Contingences - Leases in Financial Statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sera:ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Commitments and Contingences - Lease Cost and Other Information (Details)",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails",
     "shortName": "Commitments and Contingences - Lease Cost and Other Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Commitments and Contingences - Future Minimum Lease Payments (Details)",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
     "shortName": "Commitments and Contingences - Future Minimum Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Commitments and Contingences - Narrative (Details)",
     "role": "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails",
     "shortName": "Commitments and Contingences - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": "INF",
      "lang": "en-US",
      "name": "sera:IndemnificationLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9de38b8fb9704048bc0348159dc7fec2_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited) (Parenthetical)",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical",
     "shortName": "Condensed Statements of Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9de38b8fb9704048bc0348159dc7fec2_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssuedPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ib0c9a3d7bd9d4964875dd2cb6ecd9079_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Net loss per share - Computation of the Basic and Diluted Net Loss Per Share (Details)",
     "role": "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails",
     "shortName": "Net loss per share - Computation of the Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ie53ae7e59c324e92aa65161614069f7c_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "role": "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails",
     "shortName": "Net loss per share - Anti-Dilutive Securities Excluded from the Computation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i9527d69fa6764ba3bde674ace51bd382_I20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.seraprognostics.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "i287e032d20624fe0a98f6658b3eb78b3_I20221010",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sera:AdditionalMinimumOperatingLeasePaymentsDue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Condensed Statements of Cash Flows (unaudited)",
     "role": "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
     "shortName": "Condensed Statements of Cash Flows (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Description of Business and Financial Condition",
     "role": "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition",
     "shortName": "Description of Business and Financial Condition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Significant Accounting Policies",
     "role": "http://www.seraprognostics.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sera-20220930.htm",
      "contextRef": "ia8b4f8bfb7534760b5d5a25fc5c29b69_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 59,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sera_AccruedClinicalStudyCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Clinical Study Costs, Current",
        "label": "Accrued Clinical Study Costs, Current",
        "terseLabel": "Accrued clinical study costs"
       }
      }
     },
     "localname": "AccruedClinicalStudyCostsCurrent",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_AdditionalMinimumOperatingLeasePaymentsDue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Minimum Operating Lease Payments Due",
        "label": "Additional Minimum Operating Lease Payments Due",
        "terseLabel": "Additional Minimum Operating Lease Payments Due"
       }
      }
     },
     "localname": "AdditionalMinimumOperatingLeasePaymentsDue",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CapitalSharesReservedForFutureIssuanceAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table relating to information on capital stock reserved for future issuance.",
        "label": "Capital Shares Reserved for Future Issuance [Axis]",
        "terseLabel": "Capital Shares Reserved for Future Issuance [Axis]"
       }
      }
     },
     "localname": "CapitalSharesReservedForFutureIssuanceAxis",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_CapitalSharesReservedForFutureIssuanceDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information on capital stock reserved for future issuance.",
        "label": "Capital Shares Reserved For Future Issuance [Domain]",
        "terseLabel": "Capital Shares Reserved for Future Issuance [Domain]"
       }
      }
     },
     "localname": "CapitalSharesReservedForFutureIssuanceDomain",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 1.0,
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 3.0,
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash And Cash Equivalents, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Amortized Cost",
        "label": "Cash And Cash Equivalents, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAmortizedCost",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Gain, Before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Accumulated Gross Unrealized Loss, Before Tax",
        "negatedLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Amortized Cost",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleAmortizedCost",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value",
        "label": "Cash And Cash Equivalents, Debt Securities Available-For-Sale, Fair Value",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsDebtSecuritiesAvailableForSaleFairValue",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_ClassOfWarrantOrRightExpired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of Warrant Or Right, Expired",
        "label": "Class of Warrant Or Right, Expired",
        "terseLabel": "Class of Warrant Or Right, Expired"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpired",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "sera_CommercialCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the Commercial Collaboration Agreement with Anthem and its affiliates (the \"Commercial Collaboration Agreement\").",
        "label": "Commercial Collaboration Agreement [Member]",
        "terseLabel": "Commercial Collaboration Agreement"
       }
      }
     },
     "localname": "CommercialCollaborationAgreementMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommitmentsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments And Contingencies [Line Items]",
        "label": "Commitments And Contingencies [Line Items]",
        "terseLabel": "Commitments And Contingencies [Line Items]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesLineItems",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_CommitmentsAndContingenciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the table relating to information of commitments and contingencies.",
        "label": "Commitments And Contingencies [Table]",
        "terseLabel": "Commitments And Contingencies [Table]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesTable",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Available For Future Issuance Under2021 Employee Stock [Member]",
        "label": "Common Stock Available For Future Issuance Under2021 Employee Stock [Member]",
        "terseLabel": "Class A common stock available for future grants under the 2021 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "CommonStockAvailableForFutureIssuanceUnder2021EmployeeStockMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]",
        "label": "Common Stock Available For Future Issuance Under2021 Equity Incentive Plan [Member]",
        "terseLabel": "Class A common stock available for future grants under the 2021 Equity Incentive Plan"
       }
      }
     },
     "localname": "CommonStockAvailableForFutureIssuanceUnder2021EquityIncentivePlanMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Conversion Ratio",
        "label": "Common Stock, Conversion Ratio",
        "terseLabel": "Common stock, conversion ratio"
       }
      }
     },
     "localname": "CommonStockConversionRatio",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "sera_CommonStockWarrantAt10.84SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $10.84 per share.",
        "label": "Common Stock Warrant At10.84 Share Price [Member]",
        "terseLabel": "10.84"
       }
      }
     },
     "localname": "CommonStockWarrantAt10.84SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt1238SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrant At 12.38 Share Price [Member]",
        "label": "Common Stock Warrant At 12.38 Share Price [Member]",
        "terseLabel": "12.38"
       }
      }
     },
     "localname": "CommonStockWarrantAt1238SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt2077SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $20.77 per share.",
        "label": "Common Stock Warrant At 20.77 Share Price [Member]",
        "verboseLabel": "20.77"
       }
      }
     },
     "localname": "CommonStockWarrantAt2077SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt520SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrant At 5.20 Share Price [Member]",
        "label": "Common Stock Warrant At 5.20 Share Price [Member]",
        "terseLabel": "5.20"
       }
      }
     },
     "localname": "CommonStockWarrantAt520SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails",
      "http://www.seraprognostics.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_CommonStockWarrantAt9.03SharePriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant issued by the company that allows the purchase of shares of common stock at a price of $9.03 per share.",
        "label": "Common Stock Warrant At9.03 Share Price [Member]",
        "terseLabel": "9.03"
       }
      }
     },
     "localname": "CommonStockWarrantAt9.03SharePriceMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of Preferred Stock Warrants to Common Stock Warrants, Adjustment",
        "label": "Conversion of Preferred Stock Warrants to Common Stock Warrants, Adjustment",
        "terseLabel": "Conversion of preferred stock warrants to common stock warrants"
       }
      }
     },
     "localname": "ConversionOfPreferredStockWarrantsToCommonStockWarrantsAdjustment",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense",
        "label": "Cost Of Revenue, Excluding Selling, Marketing, General And Administrative Expense",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenueExcludingSellingMarketingGeneralAndAdministrativeExpense",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_CurrentMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current Marketable Securities [Member]",
        "label": "Current Marketable Securities [Member]",
        "terseLabel": "Current marketable securities:"
       }
      }
     },
     "localname": "CurrentMarketableSecuritiesMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_ElevanceHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Elevance Health, Inc",
        "label": "Elevance Health, Inc [Member]",
        "terseLabel": "Elevance Health, Inc"
       }
      }
     },
     "localname": "ElevanceHealthIncMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_February2019ConvertibleNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for February 2019 Convertible Note.",
        "label": "February2019 Convertible Note [Member]",
        "terseLabel": "February 2019 Convertible Note"
       }
      }
     },
     "localname": "February2019ConvertibleNoteMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_FinanceLeaseLiabilityToBePaidYearFourAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, Year Four and Thereafter",
        "label": "Finance Lease, Liability, to be Paid, Year Four and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidYearFourAndThereafter",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_FinanceLeasesOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Leases, Other Information",
        "label": "Finance Leases, Other Information [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "FinanceLeasesOtherInformationAbstract",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_HealthcoreIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Healthcore Inc., a wholly-owned subsidiary of Anthem Inc. (\"Anthem\").",
        "label": "Healthcore Inc [Member]",
        "terseLabel": "Healthcore Inc"
       }
      }
     },
     "localname": "HealthcoreIncMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_IncreaseDecreaseInDeferredRent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred rent.",
        "label": "Increase (Decrease) in Deferred Rent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRent",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_IndemnificationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of indemnification liability.",
        "label": "Indemnification Liability",
        "terseLabel": "Indemnification liability"
       }
      }
     },
     "localname": "IndemnificationLiability",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_JuniorConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Junior Convertible Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Junior Convertible Preferred Stock [Member]",
        "terseLabel": "Junior Convertible Preferred Stock"
       }
      }
     },
     "localname": "JuniorConvertiblePreferredStockMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_LaboratoryServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the laboratory services agreement.",
        "label": "Laboratory Services Agreement [Member]",
        "terseLabel": "Laboratory Services Agreement"
       }
      }
     },
     "localname": "LaboratoryServicesAgreementMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_LeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities",
        "label": "Lease Liabilities [Abstract]",
        "terseLabel": "Lease liabilities:"
       }
      }
     },
     "localname": "LeaseLiabilitiesAbstract",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_LeaseLiabilitiesTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liabilities, Total",
        "label": "Lease Liabilities, Total",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilitiesTotal",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability, Current",
        "label": "Lease Liability, Current",
        "terseLabel": "Less: current portion"
       }
      }
     },
     "localname": "LeaseLiabilityCurrent",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Liability, Noncurrent",
        "label": "Lease Liability, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "localname": "LeaseLiabilityNoncurrent",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityPaymentDue": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payment, Due",
        "label": "Lease, Liability, Payment, Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentDue",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityPaymentDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Payment, Due",
        "label": "Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "LeaseLiabilityPaymentDueAbstract",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_LeaseLiabilityToBePaidRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "label": "Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidRemainderOfFiscalYear",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityToBePaidYearFourAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year Four and Thereafter",
        "label": "Lease, Liability, to be Paid, Year Four and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidYearFourAndThereafter",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityToBePaidYearOne": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year One",
        "label": "Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidYearOne",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityToBePaidYearThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year Three",
        "label": "Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidYearThree",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityToBePaidYearTwo": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, to be Paid, Year Two",
        "label": "Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LeaseLiabilityToBePaidYearTwo",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilityPaymentDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease, Liability, Undiscounted Excess Amount",
        "label": "Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LeaseOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Other Information",
        "label": "Lease Other Information [Abstract]",
        "terseLabel": "Other information"
       }
      }
     },
     "localname": "LeaseOtherInformationAbstract",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The area of leased office and laboratory space.",
        "label": "Lessee Operating Lease Area Of Leased Space Office And Laboratory",
        "terseLabel": "Number of square feet under lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseAreaOfLeasedSpaceOfficeAndLaboratory",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "sera_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, Year Four and Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four and Thereafter",
        "terseLabel": "2026 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for loan and security agreement.",
        "label": "Loan And Security Agreement [Member]",
        "terseLabel": "Loan and Security Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_MasterServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the master services agreement.",
        "label": "Master Services Agreement [Member]",
        "terseLabel": "Master services agreement"
       }
      }
     },
     "localname": "MasterServicesAgreementMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_NonCurrentMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Current Marketable Securities [Member]",
        "label": "Non-Current Marketable Securities [Member]",
        "terseLabel": "Long-term marketable securities:"
       }
      }
     },
     "localname": "NonCurrentMarketableSecuritiesMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_NumberOfCommonStockClassesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Common Stock Classes Authorized",
        "label": "Number Of Common Stock Classes Authorized",
        "terseLabel": "Number of common stock classes authorized"
       }
      }
     },
     "localname": "NumberOfCommonStockClassesAuthorized",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sera_NumberOfVotesPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Votes Per Share",
        "label": "Number Of Votes Per Share",
        "terseLabel": "Number of votes per share"
       }
      }
     },
     "localname": "NumberOfVotesPerShare",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "sera_OfficeAndLaboratorySpaceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the information pertaining to office and laboratory space.",
        "label": "Office And Laboratory Space [Member]",
        "terseLabel": "Office and laboratory space"
       }
      }
     },
     "localname": "OfficeAndLaboratorySpaceMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Lease-Related Liabilities Removed From Deferred Rent",
        "label": "Operating Lease, Lease-Related Liabilities Removed From Deferred Rent",
        "terseLabel": "Lease-related liabilities removed from deferred rent"
       }
      }
     },
     "localname": "OperatingLeaseLeaseRelatedLiabilitiesRemovedFromDeferredRent",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_OperatingLeasesOtherInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Leases, Other Information",
        "label": "Operating Leases, Other Information [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "OperatingLeasesOtherInformationAbstract",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_PaycheckProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Paycheck Protection Program Loan under the Coronavirus Aid, Relief, and Economic Security Act (\"CARES Act\").",
        "label": "Paycheck Protection Program Loan [Member]",
        "terseLabel": "Paycheck Protection Program Loan"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoanMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_Plan2011Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2011 Employee, Director and Consultant Equity Incentive Plan.",
        "label": "Plan2011 [Member]",
        "terseLabel": "2011 Plan"
       }
      }
     },
     "localname": "Plan2011Member",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_Plan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2021 Equity Incentive Plan.",
        "label": "Plan2021 [Member]",
        "terseLabel": "2021 Plan"
       }
      }
     },
     "localname": "Plan2021Member",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_PlanEspp2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to 2021 Employee Stock Purchase Plan.",
        "label": "Plan Espp2021 [Member]",
        "terseLabel": "2021 ESPP"
       }
      }
     },
     "localname": "PlanEspp2021Member",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of senior convertible preferred stock offering costs prepaid and deferred in prior period and reclassified to Series E senior convertible preferred stock in the current period.",
        "label": "Prepaid And Deferred Offering Costs Reclassified To Senior Convertible Preferred Stock",
        "terseLabel": "Series E senior convertible preferred stock offering costs prepaid and deferred in prior period and reclassified to Series E senior convertible preferred stock"
       }
      }
     },
     "localname": "PrepaidAndDeferredOfferingCostsReclassifiedToSeniorConvertiblePreferredStock",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Purchases of property and equipment included in accounts payable or accrued expenses that were incurred during a noncash or partial noncash transaction.",
        "label": "Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities",
        "verboseLabel": "Purchases of property and equipment in accounts payable and accruals"
       }
      }
     },
     "localname": "PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_RelatedPartyTransactionCashReceivedFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Cash Received From Related Party",
        "label": "Related Party Transaction, Cash Received From Related Party",
        "terseLabel": "Cash receipts"
       }
      }
     },
     "localname": "RelatedPartyTransactionCashReceivedFromRelatedParty",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_RelatedPartyTransactionCommercialCollaborationAgreementTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for Commercial collaboration agreement , in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Related Party Transaction, Commercial Collaboration Agreement Term",
        "terseLabel": "Term of agreement"
       }
      }
     },
     "localname": "RelatedPartyTransactionCommercialCollaborationAgreementTerm",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "sera_RepaymentOfAccruedInterestOnLongTermDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for repayment of accrued interest on long-term debt.",
        "label": "Repayment Of Accrued Interest On Long Term Debt",
        "terseLabel": "Repayment of accrued interest"
       }
      }
     },
     "localname": "RepaymentOfAccruedInterestOnLongTermDebt",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_RightOfUseAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset",
        "label": "Right-of-Use Asset [Abstract]",
        "terseLabel": "Right-of-use assets:"
       }
      }
     },
     "localname": "RightOfUseAssetAbstract",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "sera_RightOfUseAssetTotal": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset, Total",
        "label": "Right-of-Use Asset, Total",
        "totalLabel": "Total right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseAssetTotal",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The tabular disclosure of common stock reserved for future issuance.",
        "label": "Schedule of Common Stock Reserved For Future Issuance [Table Text Block]",
        "terseLabel": "Schedule of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sera_ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leases In Statement Of Financial Position",
        "label": "Schedule Of Leases In Statement Of Financial Position [Table Text Block]",
        "terseLabel": "Schedule of Leases in Financial Statement"
       }
      }
     },
     "localname": "ScheduleOfLeasesInStatementOfFinancialPositionTableTextBlock",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sera_SeniorConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Convertible Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Senior Convertible Preferred Stock [Member]",
        "terseLabel": "Senior Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeniorConvertiblePreferredStockMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_SeriesDConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Series D Convertible Preferred Stock.",
        "label": "Series D Convertible Preferred Stock [Member]",
        "terseLabel": "Series D Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesDConvertiblePreferredStockMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_SeriesESeniorConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents information pertaining to Series E senior convertible preferred stock.",
        "label": "Series E Senior Convertible Preferred Stock [Member]",
        "terseLabel": "Series E Senior Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesESeniorConvertiblePreferredStockMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "sera_StockIssuedDuringPeriodSharesStockWarrantExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Stock Warrant Exercised",
        "label": "Stock Issued During Period, Shares, Stock Warrant Exercised",
        "terseLabel": "Stock warrant exercises (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockWarrantExercised",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "sera_TemporaryEquitySharesConversionOfPreferredStockToCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Shares, Conversion Of Preferred Stock To Common Stock",
        "label": "Temporary Equity, Shares, Conversion Of Preferred Stock To Common Stock",
        "terseLabel": "Conversion of preferred stock to common stock (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesConversionOfPreferredStockToCommonStock",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "sera_TemporaryEquityStockIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Issuance costs of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issuance Costs",
        "terseLabel": "Stock issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuanceCosts",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "sera_TemporaryEquityValueConversionOfPreferredStockToCommonStock": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Value, Conversion Of Preferred Stock To Common Stock",
        "label": "Temporary Equity, Value, Conversion Of Preferred Stock To Common Stock",
        "terseLabel": "Conversion of preferred stock to common stock"
       }
      }
     },
     "localname": "TemporaryEquityValueConversionOfPreferredStockToCommonStock",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sera_WarrantsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Warrants [Text Block]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantsTextBlock",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sera_WarrantsToPurchaseCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of common stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrants To Purchase Common Stock [Member]",
        "terseLabel": "Warrants to purchase Class A common stock"
       }
      }
     },
     "localname": "WarrantsToPurchaseCommonStockMember",
     "nsuri": "http://www.seraprognostics.com/20220930",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201602Member": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).",
        "label": "Accounting Standards Update 2016-02 [Member]",
        "terseLabel": "Accounting Standards Update 2016-02"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201602Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable and Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accounts Payable and Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r26",
      "r467"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r152",
      "r153"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Accrued 401(k) matching contributions"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesAndOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.",
        "label": "Accrued Liabilities and Other Liabilities",
        "totalLabel": "Total accrued and other current liabilities",
        "verboseLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r10",
      "r28"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedVacationCurrent": {
     "auth_ref": [
      "r28",
      "r297"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for unused vacation time owed to employees based on the entity's vacation benefit given to its employees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Vacation, Current",
        "terseLabel": "Accrued paid time off"
       }
      }
     },
     "localname": "AccruedVacationCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r21",
      "r41",
      "r42",
      "r43",
      "r536",
      "r551",
      "r555"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r40",
      "r43",
      "r50",
      "r51",
      "r52",
      "r92",
      "r93",
      "r94",
      "r369",
      "r456",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r19",
      "r467"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r350",
      "r351",
      "r352",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r95",
      "r96",
      "r97",
      "r98",
      "r107",
      "r155",
      "r156",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r350",
      "r351",
      "r352",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r417",
      "r418",
      "r427",
      "r428",
      "r429",
      "r430",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r504",
      "r505",
      "r506",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r308",
      "r354",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "auth_ref": [
      "r224",
      "r280",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "terseLabel": "Fair value of warrants to purchase common stock issued to Series E investor"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total employee stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r64",
      "r76",
      "r248",
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Accretion of discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive securities excluded from the computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r13",
      "r88",
      "r138",
      "r141",
      "r147",
      "r178",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r367",
      "r370",
      "r398",
      "r465",
      "r467",
      "r519",
      "r534"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r25",
      "r88",
      "r178",
      "r211",
      "r212",
      "r213",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r367",
      "r370",
      "r398",
      "r465",
      "r467"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r159",
      "r190"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "terseLabel": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r163",
      "r165",
      "r532"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r164"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r163",
      "r164",
      "r531"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r157",
      "r160",
      "r190",
      "r522"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Marketable securities:",
        "totalLabel": "Fair Value",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesClassifiedbyContractualMaturitiesDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r373",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r11",
      "r78"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails": {
       "order": 2.0,
       "parentTag": "sera_CashAndCashEquivalentsAmortizedCost",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents:",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).",
        "label": "Cash, Cash Equivalents, and Marketable Securities [Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r72",
      "r78",
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r72",
      "r408"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r85",
      "r88",
      "r110",
      "r111",
      "r112",
      "r114",
      "r116",
      "r124",
      "r125",
      "r126",
      "r178",
      "r211",
      "r216",
      "r217",
      "r218",
      "r222",
      "r223",
      "r264",
      "r265",
      "r269",
      "r273",
      "r280",
      "r398",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in usd per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails",
      "http://www.seraprognostics.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Number of warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r289",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails",
      "http://www.seraprognostics.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r34",
      "r523",
      "r539"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingences"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingences"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Class A common stock"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Class B common stock"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)",
        "verboseLabel": "Shares available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r92",
      "r93",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock (Class A and B)"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in shares)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Balance at the ending (in shares)",
        "periodStartLabel": "Balance at the beginning (in shares)",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r18",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r18",
      "r467"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.0001 par value; 150,000,000 Class A shares authorized as of September\u00a030, 2022 and December\u00a031, 2021; 29,611,720 and 29,368,867 Class A shares issued and outstanding as of September\u00a030, 2022 and December\u00a031, 2021, respectively; 1,500,000 Class B shares authorized as of September\u00a030, 2022 and December\u00a031, 2021; 1,405,259 Class B shares issued and outstanding as of September\u00a030, 2022 and December\u00a031, 2021."
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r46",
      "r48",
      "r49",
      "r57",
      "r526",
      "r542"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r291",
      "r292",
      "r295"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt, Fair Value Disclosures",
        "terseLabel": "Liability at the measurement date fair value"
       }
      }
     },
     "localname": "ConvertibleDebtFairValueDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "auth_ref": [
      "r264",
      "r265",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.",
        "label": "Convertible Preferred Stock [Member]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r298",
      "r306",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r80",
      "r81"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Debt conversion, converted instrument, shares issued (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "auth_ref": [
      "r80",
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Original Debt, Amount",
        "terseLabel": "Amount of original debt converted"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r84",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r242",
      "r249",
      "r250",
      "r252",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Loans and Convertible Promissory Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r227",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Debt instrument, convertible, conversion price (in usd per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r31",
      "r227",
      "r281",
      "r284",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Debt instrument, conversion price percentage"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentDecreaseForgiveness": {
     "auth_ref": [
      "r87"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.",
        "label": "Debt Instrument, Decrease, Forgiveness",
        "terseLabel": "Amount of debt outstanding"
       }
      }
     },
     "localname": "DebtInstrumentDecreaseForgiveness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r225",
      "r254",
      "r255",
      "r421",
      "r423",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument.",
        "label": "Debt Instrument, Fee Amount",
        "terseLabel": "Final payment fee"
       }
      }
     },
     "localname": "DebtInstrumentFeeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r30",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r33",
      "r87",
      "r90",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r232",
      "r238",
      "r239",
      "r240",
      "r241",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r251",
      "r254",
      "r255",
      "r256",
      "r257",
      "r281",
      "r285",
      "r286",
      "r287",
      "r420",
      "r421",
      "r423",
      "r424",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r171",
      "r195",
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r171",
      "r195"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r171",
      "r195",
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r171",
      "r195"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r169",
      "r192",
      "r198"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r170",
      "r193"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "terseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable": {
     "auth_ref": [
      "r191",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "terseLabel": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r168",
      "r194",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities and Cash Equivalents in Unrealized Loss Positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredRentCreditCurrent": {
     "auth_ref": [
      "r14",
      "r425",
      "r450"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of rental payment required by lease over rental income recognized, classified as current.",
        "label": "Deferred Rent Credit, Current",
        "terseLabel": "Deferred rent, current portion"
       }
      }
     },
     "localname": "DeferredRentCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r76",
      "r137"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/PropertyandEquipmentNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r311",
      "r312",
      "r344",
      "r345",
      "r347",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r58",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r108",
      "r110",
      "r114",
      "r115",
      "r116",
      "r120",
      "r121",
      "r386",
      "r387",
      "r527",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share, basic (in usd per share)",
        "verboseLabel": "Net loss per share \u2014 basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r58",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r110",
      "r114",
      "r115",
      "r116",
      "r120",
      "r121",
      "r386",
      "r387",
      "r527",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share, diluted (in usd per share)",
        "verboseLabel": "Net loss per share \u2014 diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r117",
      "r118",
      "r119",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net loss per share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/Netlosspershare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Unamortized stock-based compensation cost expected to be recognized over a weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r346"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized stock-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Options to purchase Class A common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r50",
      "r51",
      "r52",
      "r92",
      "r93",
      "r94",
      "r96",
      "r104",
      "r106",
      "r123",
      "r182",
      "r280",
      "r288",
      "r350",
      "r351",
      "r352",
      "r361",
      "r362",
      "r385",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r456",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r389",
      "r390",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r395",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets that are Measured at Fair Value on a Recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r240",
      "r254",
      "r255",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r390",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r389",
      "r390",
      "r392",
      "r393",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r240",
      "r298",
      "r299",
      "r304",
      "r306",
      "r390",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r240",
      "r254",
      "r255",
      "r298",
      "r299",
      "r304",
      "r306",
      "r390",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r240",
      "r254",
      "r255",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r390",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r240",
      "r254",
      "r255",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r394",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionChangesInFairValueGainLoss1": {
     "auth_ref": [
      "r399"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For each line item in the statement of financial position, the amounts of gains and losses from fair value changes included in earnings.",
        "label": "Fair Value, Option, Changes in Fair Value, Gain (Loss)",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "FairValueOptionChangesInFairValueGainLoss1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r434",
      "r441",
      "r449"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r436",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash outflows"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r432",
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Present value of future lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 3.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease obligation, current portion",
        "verboseLabel": "Less: current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 1.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligation, net of current portion",
        "verboseLabel": "Long-term portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r435",
      "r443"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Finance lease principal payments",
        "terseLabel": "Financing cash outflows"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails",
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 2.0,
       "parentTag": "sera_RightOfUseAssetTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r434",
      "r441",
      "r449"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r446",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r445",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r166",
      "r167",
      "r175",
      "r176",
      "r177",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r194",
      "r196",
      "r197",
      "r198",
      "r251",
      "r278",
      "r375",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails",
      "http://www.seraprognostics.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r76",
      "r258",
      "r259"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain on extinguishment of PPP loan",
        "terseLabel": "Gain on extinguishment of PPP loan"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails",
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "Initial Public Offering"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Impairment Effects on Earnings Per Share [Line Items]",
        "terseLabel": "Impairment Effects on Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "ImpairmentEffectsOnEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentEffectsOnEarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the effects of asset impairment charge on per share or per unit basis.",
        "label": "Impairment Effects on Earnings Per Share [Table]",
        "terseLabel": "Impairment Effects on Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ImpairmentEffectsOnEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r202",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r75",
      "r501"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedTerseLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r54",
      "r136",
      "r419",
      "r422",
      "r529"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseLongTermDebt": {
     "auth_ref": [
      "r528",
      "r568",
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest paid or due on all long-term debt.",
        "label": "Interest Expense, Long-Term Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest bearing assets classified as other.",
        "label": "Interest Income, Other",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r71",
      "r73",
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNetAmortizationOfDiscountAndPremium": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities.",
        "label": "Investment Income, Net, Amortization of Discount and Premium",
        "terseLabel": "Investment income (loss), net"
       }
      }
     },
     "localname": "InvestmentIncomeNetAmortizationOfDiscountAndPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Marketable Securities Classified by Contractual Maturities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r447",
      "r449"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease cost"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Lease Cost and Other Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r448"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Renewal period of lease"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails",
      "http://www.seraprognostics.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r27",
      "r88",
      "r142",
      "r178",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r368",
      "r370",
      "r371",
      "r398",
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r88",
      "r178",
      "r398",
      "r467",
      "r521",
      "r538"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r29",
      "r88",
      "r178",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r368",
      "r370",
      "r371",
      "r398",
      "r465",
      "r466",
      "r467"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermLoansFromBank": {
     "auth_ref": [
      "r15",
      "r520",
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.",
        "label": "Loans Payable to Bank, Noncurrent",
        "terseLabel": "Term loan"
       }
      }
     },
     "localname": "LongTermLoansFromBank",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r33",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesPaycheckProtectionLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r72",
      "r74",
      "r77"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r44",
      "r47",
      "r52",
      "r55",
      "r77",
      "r88",
      "r95",
      "r99",
      "r100",
      "r101",
      "r102",
      "r105",
      "r106",
      "r113",
      "r138",
      "r140",
      "r143",
      "r146",
      "r148",
      "r178",
      "r211",
      "r212",
      "r213",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r223",
      "r387",
      "r398",
      "r524",
      "r540"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash investing and financing information"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income, net",
        "totalLabel": "Other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r138",
      "r140",
      "r143",
      "r146",
      "r148"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r442",
      "r449"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liability",
        "totalLabel": "Present value of future lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 2.0,
       "parentTag": "sera_LeaseLiabilitiesTotal",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "netLabel": "Operating lease liability, current portion",
        "terseLabel": "Operating leases",
        "verboseLabel": "Less: current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails",
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r432"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesFutureMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r437",
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails": {
       "order": 1.0,
       "parentTag": "sera_RightOfUseAssetTotal",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails",
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Amortization Expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeasesinFinancialStatementDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r446",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r445",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Description of Business and Financial Condition"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialCondition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesAndOtherLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r12"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r38",
      "r39",
      "r41"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Unrealized loss on available-for-sale debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r45",
      "r48",
      "r50",
      "r51",
      "r53",
      "r56",
      "r280",
      "r409",
      "r414",
      "r415",
      "r525",
      "r541"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss",
        "totalLabel": "Total other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r296",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other Income, net"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingGainsLosses": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/OtherIncomenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Gains (Losses)",
        "terseLabel": "Other losses, net"
       }
      }
     },
     "localname": "OtherNonoperatingGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld": {
     "auth_ref": [
      "r172",
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of credit losses recognized in earnings related to debt securities held for which a portion of an other than temporary impairment (OTTI) was recognized in other comprehensive income (a component of shareholders' equity).",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held",
        "terseLabel": "Debt securities, available-for-sale, other than temporary impairment"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaidInKindInterest": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "PaidInKindInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r65",
      "r67",
      "r158"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r17",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from initial public offering of common stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of Series E senior convertible preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).",
        "label": "Proceeds from Issuance of Warrants",
        "terseLabel": "Proceeds allocated to issuance of common stock warrants in connection with Series E"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from maturities and sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from disposal of property and equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r69",
      "r349"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r200",
      "r434",
      "r441"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Less accumulated depreciation and amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r201",
      "r441"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r13",
      "r199",
      "r431"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails",
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r203",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "verboseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "verboseLabel": "Schedule of Components of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesNarrativeDetails",
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r305",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r459"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Fees paid"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r305",
      "r459",
      "r462",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r457",
      "r458",
      "r460",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedLabel": "Payment of convertible note payable"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Payment of loan payable"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "terseLabel": "Repayment of outstanding principal"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesBankLoanDetails",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r358",
      "r502",
      "r562"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r20",
      "r288",
      "r467",
      "r537",
      "r550",
      "r555"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
      "http://www.seraprognostics.com/role/DescriptionofBusinessandFinancialConditionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r92",
      "r93",
      "r94",
      "r96",
      "r104",
      "r106",
      "r182",
      "r350",
      "r351",
      "r352",
      "r361",
      "r362",
      "r385",
      "r546",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r134",
      "r135",
      "r139",
      "r144",
      "r145",
      "r149",
      "r150",
      "r151",
      "r293",
      "r294",
      "r503"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r60",
      "r214",
      "r216",
      "r217",
      "r221",
      "r222",
      "r223",
      "r557"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Recognized revenue"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r444",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r444",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CommitmentsandContingencesLeaseCostandOtherInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Components of Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/AccruedandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareAntiDilutiveSecuritiesExcludedfromtheComputationofDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Anti-dilutive Securities Excluded from the Computation of Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Marketable Securities by Major Security Type"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/NetlosspershareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r342",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Impact of Stock-based Compensation Expense in the Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Schedule of Components of Other Income, Net"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/OtherIncomenetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r307",
      "r309",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r315",
      "r331",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Options Granted and Outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r85",
      "r124",
      "r125",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r273",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r285",
      "r286",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r289",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Warrants or Rights"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing expense"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Shares granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding at the end (in shares)",
        "periodStartLabel": "Outstanding at the beginning (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares Subject to Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding at the end (in usd per share)",
        "periodStartLabel": "Outstanding at the beginning (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted- Average Exercise Price Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Number of shares subject to options outstanding, vested and exercisable at the end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "verboseLabel": "Weighted average exercise price per share, vested and exercisable at the end (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r335"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and expected to vest at the end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of shares subject to options outstanding, vested and expected to vest at the end (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price per share, vested and expected to vest at the end (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "verboseLabel": "Exercised (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "verboseLabel": "Expired (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancelled (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in usd per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual life, vested and exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Weighted average remaining contractual life, vested and expected to vest at the end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or per unit amount of equity securities issued.",
        "label": "Shares Issued, Price Per Share",
        "terseLabel": "Issue price per share (in usd per share)"
       }
      }
     },
     "localname": "SharesIssuedPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r83",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/PropertyandEquipmentComponentsofPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r16",
      "r17",
      "r18",
      "r85",
      "r88",
      "r110",
      "r111",
      "r112",
      "r114",
      "r116",
      "r124",
      "r125",
      "r126",
      "r178",
      "r211",
      "r216",
      "r217",
      "r218",
      "r222",
      "r223",
      "r264",
      "r265",
      "r269",
      "r273",
      "r280",
      "r398",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureCommonStockDetails",
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical",
      "http://www.seraprognostics.com/role/Cover",
      "http://www.seraprognostics.com/role/LoansandConvertiblePromissoryNotesConvertiblePromissoryNotesDetails",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails",
      "http://www.seraprognostics.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r37",
      "r50",
      "r51",
      "r52",
      "r92",
      "r93",
      "r94",
      "r96",
      "r104",
      "r106",
      "r123",
      "r182",
      "r280",
      "r288",
      "r350",
      "r351",
      "r352",
      "r361",
      "r362",
      "r385",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r456",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r92",
      "r93",
      "r94",
      "r123",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunauditedParenthetical",
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunauditedParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r36",
      "r243",
      "r280",
      "r281",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Common stock issued from conversion of convertible securities (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r17",
      "r18",
      "r280",
      "r281",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Conversion of preferred stock to common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r280",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Number of shares of common stock issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r17",
      "r18",
      "r280",
      "r288",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)",
        "terseLabel": "Issuance of common stock upon exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited",
      "http://www.seraprognostics.com/role/StockBasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfUnits": {
     "auth_ref": [
      "r37",
      "r280",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Value, Conversion of Units",
        "terseLabel": "Conversion of preferred stock to common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r17",
      "r18",
      "r280",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Common stock issuance for initial public offering, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r37",
      "r280",
      "r288"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r18",
      "r22",
      "r23",
      "r88",
      "r154",
      "r178",
      "r398",
      "r467"
     ],
     "calculation": {
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Balance at the ending",
        "periodStartLabel": "Balance at the beginning",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited",
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedBalanceSheetsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]",
        "terseLabel": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r86",
      "r265",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r279",
      "r288",
      "r290",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Capital Structure"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructure"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r416",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r416",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r416",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r416",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r468",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CapitalStructureNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosure of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofCashFlowsunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r211",
      "r216",
      "r217",
      "r218",
      "r222",
      "r223"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Balance at the ending",
        "periodStartLabel": "Balance at the beginning"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Balance at the ending (in shares)",
        "periodStartLabel": "Balance at the beginning (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Series E senior convertible preferred stock at $12.46 per share, net of issuance costs of $0.1 million"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofConvertiblePreferredStockandStockholdersEquityDeficitunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r166",
      "r167",
      "r175",
      "r176",
      "r177",
      "r251",
      "r278",
      "r375",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails",
      "http://www.seraprognostics.com/role/WarrantsCommonStockWarrantsOutstandingDetails",
      "http://www.seraprognostics.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r95",
      "r96",
      "r97",
      "r98",
      "r107",
      "r155",
      "r156",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r350",
      "r351",
      "r352",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r417",
      "r418",
      "r427",
      "r428",
      "r429",
      "r430",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r504",
      "r505",
      "r506",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r89",
      "r298",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "U.S. federal agency securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "U.S. government securities"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesCashCashEquivalentsandMarketableSecuritiesbyMajorSecurityTypeDetails",
      "http://www.seraprognostics.com/role/CashCashEquivalentsandMarketableSecuritiesMarketableSecuritiesandCashEquivalentsinUnrealizedLossPositionsDetails",
      "http://www.seraprognostics.com/role/FairValueMeasurementsFinancialAssetsthatareMeasuredatFairValueonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants and Rights Note Disclosure [Abstract]",
        "terseLabel": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r109",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average shares of common stock outstanding, diluted (In shares)",
        "verboseLabel": "Weighted average common stock outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r108",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares of common stock outstanding, basic (in shares)",
        "verboseLabel": "Weighted average common stock outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.seraprognostics.com/role/CondensedStatementsofOperationsandComprehensiveLossunaudited",
      "http://www.seraprognostics.com/role/NetlosspershareComputationoftheBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6284393-111563"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "https://asc.fasb.org/topic&trid=49130413"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "710",
   "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19396-108361"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "https://asc.fasb.org/topic&trid=2122503"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14172-108612"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "https://asc.fasb.org/extlink&oid=123415192&loc=d3e39927-112707"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL77916155-209984"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123408481&loc=SL77919140-209958"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "https://asc.fasb.org/topic&trid=2122745"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.8)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r563": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r564": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r565": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r566": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r567": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r568": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r569": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r570": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r571": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r572": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r573": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r574": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r575": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r576": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7,9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>83
<FILENAME>0001534969-22-000130-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001534969-22-000130-xbrl.zip
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M9UF>H^":H35)(.(/!!&%J1A"G"#7@C[*43FX7OEI%FQ^*4N/*TN>&1.3%'5
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MW<'(K#MDW[L0AD5K@,Q\6CJ\V>IB"] R;"$.Q3"W_V=LQ[R(1BX-+YEC009
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M5I[R[9Z-+RDGE_&=/0KHQ%$9W^Q9N;@MN+Q&R8W(;#%.T)FC.:V4EPWEL;E
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MO&19@UYZ\F -2'164=OB"E51VU34.;H@/42?)4+ Z4 @RZ6,V0E94572J&(
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M-2RB8ZV:'](8B28M]"HTYHKMM&</]S0O0R^,#MU^G,EI"9#KVA+^[5Y6YJ'
M_BW,X-@8AFH$;M$('"^.&\W6.K'@)+&L9/=% \1(S<J!O \@$Z.AY, SE8U
MR^,'EU*C>PY750RM&-HAZEPQ]$XQ=+X#/6-!F\")!%J2$CDECB9+A$>CC. 4
M@LH8"KI/^=+.<P<PM*'9_YQB_KK32J,S;= /</Q^,&R^6YW'+A_SUA^WK92,
MGFIE<\6G)7]OX+^OIYP6!OTA]M"7O"8<'I6JJ^%H6FCT./]XV!OD>WT_;O*J
MQ\U(UVG^]:R\(0XG,?12,\1PT$0.<1J;@0[GBZ_.+,G)UX+,=_IQ-&DR#I^.
MXSZ6#B<_?1Z$Z8?\&.6>SG[J1+;TVT?094D>3B__R!TN]J40*/,]P5P=VID_
MR]TV*,.I 2^DXS;31J:8BQZD9U0[BY:C>L?YVNF'/HR_-=E_'XD;1_R+8,H/
M^!3W/^/19.V?Y_=@WH!G%WU^O2Y=E91N;55FFI Q=S1N9@4_S4H=Q^6W\CUA
M9^ZE]V%<3-/__%@^.JM0P8"B'&60R4P%</TBV5^,#]^&)-SIGM47PL'KYZ\V
M>B]?[?RRO?-Z]\7FZW[OQ?;FDTMUNJN/L?D5HEY_!:8BH9V/<2;K6:#@7(91
M[]>SZ9SS3]H!4&F>[.^'0SP,@VD,_^C^O0Z&V6",#O,UPJ3?BU]\+';XP\RX
MA%X6QLG? D[Q\N>9VV7Y:1JS^\U$-'8^/]4^?IS$IZ<O?@J#R<=]/'HZ&#;W
MUGSHIY.+G=B5@HMS9KY9O=G;WR"S-,8NL'D25SOYYI.WGS1OS9&6V7L 3X2$
M2]^F3]BE[WWOLHP_H>;RCW[OLM]_#ZBJ-[M:-RNO=-D?1(5_>/)C%W[U K]\
MAC;WXX8N&()9@#@;\MC;RK_W8=)[GHU"^)<;_W/]:U.!GJ#]*XR!>JC+LYU_
M<IW56787G0DV7=4YZ_8"ENCN5<:(_?!I']62L394[B$N3-U+2^ZE-G.VS!-^
M0=CYW#@[W?S*G2S(%5S:LB*OXJ<X/(RW<R1]S\'X*R[!U:/QUWOX>XJW7_&I
MKQ%P=]1;%*&,J Y@%1@M0^#>J>B#I=J^>]8<6FK*R-5.+T\VW<_CT4&)@91;
M^',P_;!Y.,GK$<?/O_C]P[*.&Y-)S/\/':K>.=H:G,3;\^>W#W[_O/7G]O[;
M9Q\.=I[]5N+A\NW>;Y_?''O8.O[]\_;Q1K[N?PZ^QMOWWK#\W5^V=[<_E'MZ
ML_?JP]M?_LC7SM^^&_)__^)O#GYC;_[\[<M\O'U[[W?Y9O<YV^+/^=:?_QEL
M__+S7V_S<VSO;7W9YL_ESN[;P=MG?WQX^^SGM#4XB;6_IL?Y'OC6^W?2(3@7
M'=$^6@+),N(H$X1K;I006CFGUM;-8A_K+J:LM)2F5D&N@MQ7D O $:B,$JP$
MX;F3*"0RG1=#<L%C W+L%.18!;D.@-SQ',AY"1@8HT1HR3+()4L,54@4=6!9
M4/FG/)/ MMHN59"K(->!I[X&R*%QD(Q+3DL!.JN%#!*Y3%YZ;ITZ97*L,KGN
M@!R; SF;-$_.)\(4LR7YS!.GO2'6"QOSKM:HR\0E6E&NHMSC1#D&S A5AG\*
MA."2X10C1LT\UY%&<4+E6*5RW4$Y,8=R)7T/:5+$>V8(,&D(\DB)X2)E2R4I
M*]W+I5H)D&NSQ&(EHXPG>13#][WXY6-)M)@\O4KD^L;U\/4:W;E&JV71L(J[
M?W,T:9(AQQ?'VE>U152' \WY5O%I6?:==&*[O]KHUW$_W^/[+1S_%0LB_1*'
M^9?W-X9A(QP,AH/)=-QDF#Z? 56UX]>PX]N;"W%G([G1RG&BL)3*:*:)XQ&)
M*Y$:H5"ZD+T5N=C"H3:I?S!JW5IHM:KU?:GU?*15"<,4"$5LU*[TMV?$:! D
MQ2Q0AEF^4*HW%@?Z5;5^,&K=6C"QJO5]J?5\;%$[T-1X293V2 !C) A.$^J#
M1^3&,U5:/(JV.AM4O>Z@7K<6/JMZ?5]Z/1]-\XQ9G?&9"!=E-M>0B)&8"$M1
MH8N&<DPM'HQV+6:VFF&#5W$2<>P_-+4O(2O0_NACJ4QZ**U=.QP_^!;XGXD@
MX]*S;P+X"DHK4!^^&HCU>B%NH!UC449/HO.T#)<LY>$>",:0V6490YK\VCKT
MF5[Z"*#V=>VN1M]"5E;5Z+O1Z/F0@7 F),=E]BA4)" $)]FE0$(Y#5J 4*&,
MQ.-]S9?V+JI&=U>C;R$%J6KTW6CT?+0@4 M4<4:R1)$ CY88'AD)(=MN35,6
MGBQ!P+Y>OOUI5>GNJO0MY-M4E;X;E9X/%,CL-7FOD2CK3%9IP0@FEH@+R5(*
M46EKU]9UWT*7C'1-,3B)IS6A@H/3H%I--+BS0,')^F? ^AK2K'#5-EPM5K4E
MF4Q@)A#J(<.50LA(19$(;S0&YHV(K/@45K55V%9/+#JHSJU'":HZWXDZSX<(
M0F(R4I\="L1R3)$2L> 2H<8HZ9@U2$MI0U_9FECP@-6Y]1!!5><[4>?Y^(#S
MP8E@'.%6!P(L6.)T$B0%5YQ#&X).I4UV7RWO351][JX^MQX?J/I\)_J\$!Q0
M3">/BJ!4E( UDA@7H Q D9KK0(/G:^NRKTV7S'--)#A)KFF" W@NO::F$MQ9
MA."'&4X5N%H"KJ/%(@1-C6"B](7@I0@A:6*=%R0XQ8U4S@D;2S(!U5V*:M9S
MBJZ'":I.WYU.S\<*8G(RLQ%-M"^%15+QS$- $>?!,2H$8XDU.@UM3>"I.MU!
MG6X]5E!U^NYT>CY@4&8K!NVS$C-69L)H2ZR6D3 P)BMW=#Z6A +>MW1I#Z,J
M=7>5NO6 057JNU/J^:A!%)*'J+.A3E1FI09-2LD!,1PDE2Q%BYE\VSZ32Y_1
M=32E@--5C!K,9J6.%CIW//P![RL03?C:4.4$P285PMJ"L)W%)@8*,(O$">*]
MI00T#<0B @&&7"O+..?-O,\^UW(E&A+5.>^K&W2HJG^;JC\?9DC&EYENE'AD
MC@"JTFTQ,9+)*#>&"F\C%/8"JFI^U?S;#4U4S;]-S9\/1B3&,%$M2O:"RD8?
M(W%6&!(]ER)P9[C.FB]D'\2CZII?5?\> AA5]6]3]1?:):!--D')/N0\LWS&
M2M]13;3B2#VEANG21[[$(=M*7*H-2&]5=\NLUEX:CPY. QJCX<T"&2<+\Z"
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MK*\A18+&"P+<4\$%L\Z7GJ>+1_9571^,NK;N>U=U;4M=%[SP$JXV,BMI4HF
MDHD8*FCF_.@9>! R92_<+%]#4/6UN_K:NBO^'7VMI^4M*O-\T%M8EAC+MM?H
M4OXKLEH[K4EF2U9)%ABXDC/;I\OW&^]H+X.5=-RWX[2W/YHL9/S?8OE2LRQ=
M6H._W=+#=QNCNU':D/=?S6>Z#81^L1#-$,8:)QDCP6/,".T=<8))$O//A3!,
M8W2SF51LF:3F52K8K"A74>XNRC<JRMT>RLWQ4*NCLL(I(G0&.+"E<B-*76)
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M_QS>U0*=B8K/Z&$).5\6/'IHR[PYF_ T6\RRP'_?W,?)I+?1T.Y_+P3G;KC
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M5X+!XSD8U,%@M"H2*XP@I8R>($I#N$E:,2XU\^(1PV"E1%>G1"Y*]!"S&R@
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M2L)!(HK$;7"F<#?5EV+I;F@5[2K:=1?MKI,EIH(P'HT#I34$(XUV& Q#EI)
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MUTU0I52E5*54I52EM-I2NDY\*)CD/)JH+46P3ENN!$H+07$*22T1'\JN\+>
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MOUG=DA 2&&0$M* V=K! 4G=U9>555V;E07BN<QQF=$0GQJW60F-)DRO\J(F
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MU0Y:F=11,Q^TL)$[IBQ15 9GM= YFD;=_*#U0G3=58>KU9L'-2=Y-2$KI5#
MV@Y?8,RCZK_JP'6/[;W\</K)1.J8I@QY2S'BU%+DB(V(V^2LY=+3X+>V*6UK
MM:X"EDU$E$>I[(\.]Q^EE%8)-/-!Q>1R<0+-K0L.A\ Q%X8SI;2Z#H^O2&F[
MXOC["C0NI]TK NZ;BX!+I5!>VMS9P ',$L:1@Y6+++6*<"^H5/F\^]9GW46-
M"]@6*14I;:*45M@2::21>YD,ATTQ!FVB\=1&BA.F0FA<ML3F;8E?%FP0XC$G
M1!$4).&(1TF0!H&B)"WF4FEFB&[8EOC46T57FH"JYNKYI&'67;T5?^37L;20
M+L>314I%2D5*14H;(:42,UJ60I%2D=+&&+YK]P7OA"_CX>@8[(WA87\'9BZ/
MP'9?VT[8[;VP)YV1[5;G=!7K?S%'^M_&_XX[P\XHOHN#;W6*/%C,;Z/O?^Y5
M5ZF,YV(GKV0GOUIV'4<LC4P6YX9S#'%K!;)><C##)*94N: 9V,E:WKI_0%'[
M LY%2D5*FRBEA_0=ERVT:5OHHJN9P1;J=8Q("RH0%U0BK65$(D46&,9:D=BT
M+?2I1[7OQU&KVQ^6,/5R4EFD5*14I%2DM!E2*F'J92D4*14I%2D5*14I/08I
MK5*97&,C13+:FH YC]QXX10F1/EH#)?N!MZE*TJ4@T&\V_/]X_@76,6E.-WZ
M'$:[H[W#SQ<=1I@:&@..*#%C$0^$(8NE0$Z1F%3B1E.]M2W;#"^7H5RY.'G1
MXP;J\1J\Q$6/[UV/%QV_.$0F97+(4&<0-S2!"LN((M'.2DLB=KA1>MR4)@)F
ML86 N?L& NI2I?W==JOB)K8JT/Z_XUZLV1+#[5;6O-L7SIYK#D$N6.(;"'&K
M97H;3A21R@B:.&<6YVV-6*TY3XEKER[OEG!)@O=B?=WJ9@?CT7!D>WD&2SKW
M^F!N;P)Q<\U4I!,V&H5D%!1Q'U)NBX"1\D1;KFA4DN=F*FUE2%LHLZ93KIOI
MS0,?>]^A\F]N[ZC5GGTS 6^9TOT:VEU;3/R%'0Q.8;)VCF&*1SNCT:#CQB/K
MNO&P_QIPL#<J)&^MZ'=Z$?VXDRQ($Y#B%M!/*8J,MQ@Y*2VV3%,9<O<\;MJ$
MK^N ?R.@KW"@FW"@1#48])9'3P7G%&M*@HZ.R,"-XK1PH&:BP/X"!XI)4QH,
M048(A[@4&!D"-I\%A,_"(X2QK6W3UL2TN5YN*?>(<:!0H$*!;@5VA0(U#?P6
M*!#VA$E"<L=@&1' FT/&!H] RL++J*V,:6M;J;9^H@RH*7E^3Y=F^62-QTP+
MS0DP=FD4(98)+#6UTC-Y8YKUHJIP7%4BF._26=C56FVLQ8*!GOI(,)?(1*$!
M84Q$VA"&""Q;&1PFS,JM;=K&F+>!@3TED"GTJM"K6X'<%=6(?M*-/'5^Q(#.
MXJ!?J-/*R+9[$=FL]IX;KU"0V7V$-4=6$N!.(CH;$P^*TEF@3L&U@FM/$->2
MYM8JASE+@D<AG"1:LA"ILIQR1=:%:\4NO"VX+98===%P%3V2.H%A&+A"C@/6
MX92X(%+YX,G6MFXSNJYVN@7:"K0]^$.O<BA(9 !NII(6@?-<XI[@!%L^33'9
MZ&*A; U M0\742UE]R41%!$2).*14*2UPH@&'4S 6!+%"F4KN/;H<&V5 -;@
M* 7#)M>+H3Q@D^,=I9;**9Z"P^9J8+LB;K60M[N&N84@=.!ND7,7D(R!(YZP
M1@[+A(B5DD;&M?8T!S;P-J'+'K>;AZ\6A"L(UY2'7@7A##%><<>35H[3D"RF
MFAD.V!98D-87A&L:PBV5 %?>*:D4DB0PQ(UR"$ O(6F5")I@*E3*@:NBK8QN
M.L(]]8(M+^9;CW:F/4E!?UJ=7,S(=ELG8]?M^%8_I9A+[+=;O3C*0?VS#_O^
M<%0*OI3,L2*E(J4BI2*ES9!2*?AR/R%$!*Q?XDW$6"E.H[/21**U,4;%I)R8
MI.2J:4JNN5U?4GC$ZJT;YNB6T**;& %O+H86G;WZ\2DJDXCE&$6=..*Y29X1
M1J'@I9*$,$5S\")O2ZW: M\Z<KO!0/*T='S9H+^E@J_6U6M.O8L9OZ(&[U[4
M8.\,2=H(Y+P68,9'CQP6%E&++8F4"B$PF/%%<Q^MYGJJ0P1-=!9+CBG5BCO-
MX"?W7EOO[TISBW=NG6K]9F%CIIZI2 ER)EC$75+(&$E@G\8X$1DQJ/S6MI1M
MV*6+;F^6;C\Z(ZQ(J4BI^?MDX!0L'1$%-X(S3YVP3%BBX,D%9326?7(#]LDO
M"P:L#TPDD\" Y<K /IDCR#4V2%A!<BX>$"$\V2=I@_;)I][,]D6_!Z,99HWM
MI];)(*8X&,0P.< :]7.'V]F!UM/J;'OU*?RECCG.701+#Q,I . 2-81$K;!*
M'+,4B+N)8V[A2![&;2^OJ' NMH/T>BJT"@8/^W.Y@<5IMS[,>S]?<>IL[_#5
M)R&#36#I(>4M <@+%#E&,#*1@LBMCXZJGU:<6OGLOD$Q2$]5]Y?IS"T5_Y)0
MG,OTOB(S:U7[0G5NJ/:G%]4^9E>>C:#G4KO,= C2RFC$9,Y[M#Q8ZJXNM51T
M?O-T_O*#.&XDE=+QY!DGU!EM20R)!T>M!));]OM-5_S]A?U>6I:JWFG4,HDX
MIA)9'"/R'(Q6AY7@EO^LNE)1_<U3_4O.YVZG]V6[;[K6+VSW-I=.U,JCI"Q'
M/.9S/9$,2E1;*Y/V7)DKRPH]"I5O2MV@S<.51H?VS*/+>QA8"?%9K]FP&.)C
M S',"H64R>TTG%%(6TZ1##EM(UC"<XE6RMJ:F3;3ZRI0W41$>5K*_L Q/I?H
M>:$$*ZKR0JR/)C1)ZSG*C9.!$X#U[SA52%AO@L#"AIA5N6CPH]7@>XWU^<6=
MNJCW3=5[(>;'.LJ-91HQBQGB@-;(6N- T;FPQ/N8C +UIK)MS+J**!<E;W0X
M29%2D5*1TJ8$_90-\VXWS,7@'ZFXI\)K1"3%U3:)C* 6Z<0U5B($GX_$Z@VS
M2:RX9*O_+/KGNQT,;&\T7 P#FKU1DM1+'&J14I%2D5*1TD9(J22IEZ50I%2D
M]/2LYBK&Y.IXDK\GC/Y"7,GTCSOARW@X.JX:6!5+>05+^<.R:UF!.+6U A'E
M!.("8^0B80CDF4BTEF*/M[8-O?7I;U'J KU%2D5*FRBELD$^G0URR94<N?-8
MYOC* !ND)@(Y9@(2DGD1@]8TF*9MD$\]B71W6KJTGRXZBL<G\#+^B /?&5;O
MUG_NGV2!_9K[>&//RLJ)9I%2D5*14I'2QDJI)$(\RD2(ZLV#FI.\FI"5TDIY
MC33?+R=#$$9",%8BH/LTMU*FR)%D$.'$.&6YT<'5;5VT6E>W]B9"RJ/4]D<'
M_(]22DV-=K\"CHMC947$73IYH)I:E1"FN$H_H\B(R)!F5DLOF2+<;VU3Q0K:
M;I8>%[0M4BI2VMR3A[(GWMN>N%2TDH"AR85'2E&!N&<&:4P$$H$9IB7&4:2F
M[8E//6;]W7P(^NQPH<2BEW/L(J4BI2*E(J7-D%*)1=^TPX0J1.CZDX1)5% Y
M2;@##O]Y^20A4.%DT@R!-181CX$A%Z)"2=$8B7!6.9YS3]M,-:GP? ']IPCZ
M14I%2D5*14I%2D5*)>+XEDY Y"S0ZQQQ?!)[0UO9 O%'?AU+:'$Y6RI2*E(J
M4BI2V@@IE=#BLA2*E(J4&NI9OX>0T/,DVN%A?P=F+H_ =E_;3MCMO; GG9'M
M5E[VBO6_F"/];^-_QYUA9Q3?Q<&WCH^U1_YM]/W/O>HJ50A-B999R=/^=3F"
MU&GIF%(*)284XD9+I*W 2.K(/!>!1!FVM@TI\?H;IO8%G(N4BI0V/X*T;*%-
MVT(7 TXU8\;:P& +50)Q+!FR3@04M%#6,>E@;39M"WWJ :<'HZ,XJ+S,@W@$
M"M/Y%EO=_K!$G):#J2*E(J4BI2*ES9!2B3@M2Z%(J4BI2*E(Z3HIK=(1'5-"
MDO8*)RZX3-9)P3@S,6D.[RBR>D?TJ4.C,KU>S%M>NSTPQ.)?8'[MQ]%!.K0_
MBE-B%:=$=DCDLIOS3HG$+>=&2.29MXA+)Y'#V""EI/-),^^DWMJFXA;=S8OZ
M%I M4KH-R*[!65Q ]AY!=M'SBZ42*0J'E*,$\10!9"D#87D+NZ3AG%/:')!]
MZO'%L.Y_W<>[L6=7Y82Q2*E(J4BI2&ECI53BB,M2*%(J4BI2*E(J4GH,4EK%
M2>042S3*(+1F/!%IG)1*)1,#QX:RZVK=_,1)! ;QN5?H9A5MBJOH)JZB5Z.J
MJLV\JRAZZRBU"AF>/.(N&&0<\4@)0[37(DI!MK9-6XOE)E@W]Q85/6ZN'M^=
ML[?H\=WI\:++U])(/2 OHBY7EXU1(!-H1$FF:$(@Q!+1*#U>4Z3ODJ_WJIN&
MSK?IM2>7J*U2<[+@'S853MRITJI+E?9WVZT:V]EA[E[W+IZ,XK&+@YHR,=QN
M9?6;B0J>Y]>.KB8F>3TQSQF(+_3'KALKDWSZ[JA_\IQ<,-8W$ 57J]TG-+&&
M$H(MUYPE:870)KD8L&+.!OMI]X;]?P[C\4E_8 >GK_X[[HQ.ZVI]!^/1<&1[
M>08O(F'J_(@!G<5!OY3G6PD$=R< "&!XYL_V#E]](HH(Y9A%G#&&8#LSR)J0
M$$[8>^R,(L[,+)$UE>=;AS8]\+GW@P'&3_'Z ?#B'P\A_!6$WB0(7>:1OX:?
MRXEE"_#YP@X&IS!9.\<@@-'.:#3HN/'(PBP?]E\#LN8^R-?@:2&5-\33TXMX
MFJP/CDB)<#!@&UJ6D&7&HH"="Y1%@WDJ>'JK.*)"QBXG8\JPF*(+%E/&I=*:
MBY <#XP0GS3!A8PU#3SV%\B83LXRZ3D26B3$DS)(NYBJ%%3.(L;>^ (>A8P5
M,G879.S7\+.0L0;AZ>FB<1NL!$:-O&(1\-11I+U-R'LGG'=)1,T*GC8_(;$P
MOLL9GX]@4%#IK>&"QX@-#9%A$Y62'F/!;LSX7O2/C_N]JFAOS?;J!AJE,\9:
M3<7%SAC.)X6M9RA(PW->#]"]")Q/DA28Q-9JH;:V&6Y+8]K8X()0A?$5QK?.
M&HF_A)]7= 8]ZG=A[H8UZ2O4;65PW%T 1^>D93ZW_HPL.](HF,') $R"2 1.
M5$L.X%@PL6!BP<0U8J+1-$6,4Q3,<JNX<2Q%':WTT5%BU6TPL42SK!,PWRQ&
MLW#)F66(,(K!V.44F1@YDCH0(H@(+$>E,<S;F-^Z?%V!S0*;CQ\V5PD)9("4
MGF+#.?S?DVBP!5TSA"B9"-'R:MR\(A*PD,HU8.1")0V?4I"6*X2Y3(@33)&+
MFB.LHO0ZL!""7$^2=T'&@HP%&2MDI%8YRJ-WDFK.*=>&46ZUB$9KC8E8"S(6
M:KE.V%Q(>!")I!AP1%$;B?+9&-)< 8KZX%D0)MHDMK:)8&VCEZEEP<Z"G04[
M?\D83S%1KAR.VB7N0]+,6NRU"9+'(%@JQGA#$',IM2298'F4L(!B1-Q+@1S1
M * X$"N#P%*:C)BXC9E^!,9XE9GR[RJJ89IG,9<\<FP'GSN]ZM[F(ESY"*M]
ML&X])'BJB-45G^>^"AW_<]6D&%3S\"BVK,^EY&TOQVRT>OT1W,\.X,^]5@?&
M^GE@NZT3.QCE?),1?!ST->2.IJ&5.CW;\QUX?SBRHUBU>;B8>C(W)9/;<@$C
M/>D/JQX.SP>Q:T>=;_&W[YTP.H+'R&.:_]9$MOC\*]:!),>CJ[]RCY-])>H)
M&)-:R,*9^YE'6\$,Q9I[)APU4G$BB8N>"T^P<L8::N4GJK>F7SH:G*<F?8[(
M#:+]BFR"!WQNN]_MZ7#KWQ?7("S ^4E?G*\K9R6E.YN56A, =/N#JLO'<U#J
M.,B?@C'9QHRE=33(N]'_N5X^"E0H8T!6CA=Y(ZM4P&Y?)OO+\8'0^P6(J[++
M*CAX]^KM3NOUVX,_]P_>'>Z^>-=N[>Z_>':E3C?U,5[,(.K=#)@J"=GA4>N/
M;O_[U3#5 /2H'N&?XYX=A\XHAG\U?ZR='NP,_3%<(PRO'N[":H'!5MOG.=17
M^S4,NFM/AO'Y],5OH3,\Z=K3YYU>=>OJ2[]-+C;9'\1RL;YJ<NJWSZ'O&:[A
M;Y)2.KGSY.UGU5L+Y*-^3Y%G0#FO?!L_(U>^][/+$OH,ZZN_^K/+_OP]CN7=
M#);=Z++7I.U>&R%GECYZB>%7+_G[L7/TC7)S]^$OK3WXV-&P]0H0*/R/&_Q[
M>Y:CVV*X?8'BWG::YLSUFW+=9D\@V';TR@*7JSSMDYHRLLJB6GO*_%J?V=SH
MF:MM/.5MO)4&_>-6_R1F"@?62S8GOX&=$*^NDWKS$-];KJ]["$*^Z0C75#RW
M&6MBM?JXMR[;TK0'O;E_\;(G?" _X<T>;94S%JL=3]HEIP3C2F(G@K!4)"\\
M-4Z:JB -Q:0N2$,?=T&:@Q<3K^&7_W0^G/W^9?_XX]''O_]S_.'L#3XXA.__
M_49\_/*![KU\PS_\_>'[_LO]SLQK>/S'\<$A?._+&[S_YR[>__+VZ_[QV\X^
M_8#W_GQ%/AY_^/[QY0[;^WOW;-%K"->":_]O9__E&PS?I_M_OJ$?_]QE'[^\
M^?[A\#_''[_\_G7OI?_QX<M^FN4-O\-G^V<[=._S)VR93M%R)&,N1V.M1B!6
MAY+0*5!*.$AR:YOQ-N?+H>";7%>J@-+C!"7"B68R.J*8Y<$E3;&--BKBJ8HX
MLDF5+/(DJF1M""B=+8"24BXI(@UR(5#$!97(>&:1DY1&2;GCA@/MIFUQJZB9
M#2Z2]0!*.-='NC7JMP81U,YWNK'5F]"^_-?\VF?38)P]?YW>I7;!\]L8!DVA
M_W=)\JLEJ)J]'%[&$U@"G<IMW[*]T++'?1C<6?6'Q](AXV93<;^4^>*F-"\&
M>-V-^<5.+^S,2:-L1RML1[/R&.?;D1#4<V\4@C7K$"<6(Z=Y0)&&%!5L2B'2
MK6TA;IT7U#R67!1W?;2R*.Y=*^XBCTQ&)&P"09(;X)%>)^1XI,AY39F.EG(&
M/%*06V>F-(]);@*%J +$ %0S5<SA+[$W_'7VT,!^?\UG#U7=A=^S %[,S7^Q
M;=>&29TE,I&8B,%1CX)P"6Q;QI"-(M=Q5T%13D&T<FN;M=7M4:ET[FRL)J^=
M3A1-OG--7F07)*I K2"(6&$SNW#(<DN1%H2XX&2"I;VU3=N8J 9I\A-R4>SW
M>ZAR1G4C*$8K_LAZ$8MOXK[8Q<'4]_=7GO^W>50'Z?TP[@R'<31OY[RJ)5,
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MD 9E2:!)>B0D54 :C ?ZX#@2VGEEL>+*B5S@[-9I/\63\:N\83".8<Z!X<?
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MU.EVSJJ(ALK7V#\9=.+(#D[SZU'L'\.-*D&X3G\6\P!_.@&REG_+2)M#)_K
MD-M@8GV+W?Y)N\X/[!\?YW9X *9G,7\?YO5K'+0 G^%6WSNCHYI7UFW34]^/
MAZTLL..J]B:,Z&00/V?IG[;ZXQ%<+0Z?M3))G3QEZ[L=YAI6_<%)WK9KKVB>
MC$J-\TIZ"93R>^:O<-G_M; BX+&(:K<HQKH:8G[F?)Y1+96:ZH*J3Z_U#F:J
M]9?]"G?LC$[;K?<C>]3.=ZR+F\#4O@ I9;, /N7R&/IP@]UJ_!6,M';@9Z@
MI?7/J8C^VMV9R@?Y;%94_MKN[ )7;[%-79>=7&,]3V5^4:EQNY+#W&JLEMYY
M]=36D?U660_#SC!/=ITRFM=3GM<,SG;@CR8N[VI)Y4EL5_;&V%?A.'XZ]<,1
M2"."-EC_WW%G4"^<?OY8J[+=X)V![0RK[]B3; VU 7^RM=89'N6_)NLG1U/U
MNNW7&T?M@9\NX?EE DN^6LJCZBEA+SE\NU>MZAN+[@%LOLNWX;\Z,&< JW7,
MRXMZ?EIOX[ _'OAX-4MJZ%)<,F%_;J#6R]#%V*M/6?)Y"$"%;7WN3[X,"MIK
M.0O+M-WZ?M3Q1S5-.<[PEVDFW ]LK^Z$9N1U;(?#.*HA,[\[A#>&:>+1RMV,
MS@]"9R#9&=6CF<!7+X-L%]X9#^K>S&ZR(6X<,LR#]5$-UN/JT*D'N@/T:CB9
MA%[\7)G^Y^DUDP[5<THWK%%FBC#5]XYL/OG*$A\?C[L5;(>8.KY3.2C^<??Y
MR.+*0GUO81.%^0BO[""7[QGNG(_Q93W$FP7=RJ=&.P]?_=A_\XF2Y#$C'&EK
M/>*82V2XLB@Y)H@(/@2M<VT\_.RJK#E8SMUJG52A?>]@U<1C%P?UFPQG$D#I
M!3XQVZ=@W=O/]08>?YQ$/QK.;V<9_JN%7(D>=F]OX8/9C9CO?KY3 (!<M\3[
M@^K"\"_L>+'R':3Q"(R.]GFSDNYI?@2;-\5Q=^9X6QSR/->JH6ANLYW>9VZG
MJG<Z>)+A^ 38TX7QSW;6_)&3?*H\^7TT@.O7CP./W,G#RRIWU78]-X1JG@?Y
MX0%-,\)EF!P/JN8LHR,[NC"_WT%R+;A,;S2N']\?=>#7"],]R.^/<]CF(._V
M";:M"E9/ZV<:9N6;0X]V_EPG32\5VM5(II^+0$6!EU;(/[$=LO0JV'_6VKTP
MXYE2CWN5J.!.UPTM$X\X/[=IW O55@);3B_&D(<":'5L3[.W-<_-]-)3DZJZ
M^?RL5B?YB]*&99$)6.C8B74PY4#376;<#?GJ@QS6.JCC P*P8V"U%="TLH.\
MFB7KX MPQ2'P[>IW$,;TZG.C@,M_'MCC^O+]>OYFT_VLM3\OX8G4/\/R[UTA
M;GA[./; .(9IW,T;X92RU3OL9- 3_I8EE>L,]B=RB(/)."97/G_(O)G53S7*
M#_*LM0,WG!-'_N!HKL!_NUHDWVRG.Q7#W$C;%\0T^Q ,)MEO0-XOCB5_%CX7
M.MUQI?=9I'GS@[FK0BZ.^MT0!Q/*F><A1#>Z:B3UK3N];_WNM_Q\=2IW!2=@
M:L!7)G*>W6T^4!T^/*X(QN5H5R/.HAET!-MX-P_J)%8T8JH=QPZN/%URF=?T
M\S.<VT3_[/RKYCWGTIPCT5T[[DV 8L*@8>\&:*Z6R03:YE#J-[C<Q>M5.;B7
MX%&] J]$HNEJK2XXN>(%G4J501Q'G6KV9KKC3B=7!NMU%/U1#XC3YYHKGQML
M$UL:8"Y?_MN_+K=]SN&IWEY:GP?][V "3YZZ/^>M@LM<?Y7*/ <;I[:[1K';
MA=_&^7QF$J$'-MALQ.T)EM>/]5O^K=V"[02H!GSS%.XWF92L,=WZ 2]*\*0;
M9PSWH@[-EMI&TM/SIF 3D^>J'?9[?_!USH:L #2[&<Y-B%%UN;X'6)_0U]H
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M//=DV>>6LVD[P_E5;0>#:@%D8<>K(A+FO(CS_L.9DW,NS6#UU()Y8GNWNPX
MQ%P<]*#?@Y>^'E>)BJ[V);&W\XDP*BW)S3L((XA'E9 1P2"-<^ECEGR48?%
M-;-W&R4-7 1N8]16",Z")U($A;7?Q'WL;<P1A:#6NW7@P'P"P86UDW.<6A^
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M,2$*R41SBP2KD#-)(D&B(E;:R(G9VM9M:99C%\N18U'NXC]HLK(O,!-OHM9
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MO0$(5CEKM>&9*>E]%)(O+K3T[!.4'HF/.F_FXDY!.;"96Y*505>.)D\\RT!
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M$Q"2$X2 (_AG&[.@45MT925=U==D--]KN_)9;$A6+JQ<^,!<6&R6QF2I/+A
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M$]4*-*KG8BKQ)GQ74-'8SG>&QZ7'>',^X#^*9\5>,#K."CK *ZMT),H8@^@
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MIS=F5=\%I\7+1P\_B)P%./3SE1%)19JI,Z4+99/91BE\SVFHP?F[YK]V3KZ
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M_6Q +754)1@$ 2A0ZZR5F0<3I$Q&TX?P_ZN67@2>9UT)42K0YU!.( =-@"I
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M3\-;K>7Y;U]<0W"O0LPR1* \.A]Y#DY;'C0'6PVGI>2E:SK(&9LYDS$2J9-
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MSA\'NV>?\.[.EY/6V1<\YXCO=+XW#_=%B[:^MW9^_]Z"Y[? X=[=>4^:7_^
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M0/!H2D!K?7# :HA'4=B(O=/>&'F%=/T:9L9)2_VCT3AA*0<2*QQ<S[6F#L=
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M.>W$H1A#[B(L$G()?K*FU TR5'&_MDDY7==BWD.O0W4KJ^@O@<1-(*"F< ^
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M%,(Z:"D<9=JPDI^ZM!:K2U6N%:^D6H-M#;9WW2OCU'(LHN &7&9/G;!,6**
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M^?:'/P[W#M_R[2VX\NP+W=OZG)I_S74=)4I$ZPCX?#&"NX*Q1LX[C9)W3+'
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M*9OI)4_DI2!CB4#\<V3A<?#?T/ZQ.7FIUG$7],#/_PY?FKQ2UP[VV[UJ;+1
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M:2\^;1G/S$R7X?K^<2<T7#D#6:ZOG!GX>D:L <S1_OBEP;OQ<?S!]%MGJ,F
M!ZMZ!!/BCD?E3^!/G+L:,*;\?/"B01 :"5RL2AA]>^"/N\-17H@,T3_ZG1_Q
M_V?O39O;-K*%X;^"\LU]*ZDB&&PD >?>5&F\Y'J>6$IL9US.EU0#:(B(08#!
M(H7Y]>\YI[N!!A=M%BU2PE1E;)-$H_OTV5<XV4D$H$<W3+;JWRJB^=Y=@F].
M7_>,\S4VL:, :4NT^<G9W?^<6*<G?SC>++(<'H()$SFF-TL2G"'#P+:9>1-W
M-K&\B7TKS^[,BH&3>M;,]N!_4R?P_:EEA8X]#0+&_8"NT;8=UQZN\?ZN,;9<
M;YI$,]..8\_T$L;-(+ 3,W(CYD1A$$5^^.S'O-APG6SZ4C0U@3A=B?X*Y+"2
MS2AG!G %8J[O^;(F1XCP_;J6\(80SU ^$OF5<)38F[I8CC(!U3X49QBJJFK2
M<6*><%(L+ZLF%3(/#*P:.%^4L711Z;JJV-ZZ].FV.SXZE><5J)'%"LSTD_80
MQZ[V5.EY#M=UP<JT:$#(T@E)B];PBIQNG_D*E?>HJ=,+V ^H"%7#<I*_PFV2
MDDF1EOHB(%F5JPZEVZHGCW#9HD'9AZ8ZH)+\GDLP"SWBO"AB*91'^*.DR#)A
M\S(#E!20L$*CR.NR6+=K1FOKH6A%I0 0-I:* X?3M)I<R'.> %Z/I,6#;ZF0
M%$C948T.P!R((K!62CK4!6H)\#MX<U47T6>B,_$W:1T)\Z'U*+3*DWK;&B$@
M \#CI'G#!$O0T$I>IC>!VP9]B'2$YT1T<(X?+M.XGJO@G_:4#.18W2,LK(JL
MJ7<_H@5M(G)F?7V$M2?_C9.8UJ"C_?^\5+M9@@YJAH EGTUJ6O^<99=L53W[
MOD^30) Z -?/OO.$2;*W$PK&$"-?I]M^3BHD_@KVQ YF+\:\1&WBOU+'\KW(
MG81. ,J@/;5#'GF3R+9F8< "ATW_F &3$:[[!,@PKP679#]NN\8U3!>:0@*"
M<^8YMF>YB1<Z?AA[LUD$;_$FS'+Y[-E1R(J?^3GH[F]9#=AXU%)"NBJE9PBL
M(K"R6%FO#')LKPPTD-#/;*"*(LP:,H5QCI?V)8$##,0(K&Q@EU5?YU@PX-5)
M62P,L+C(#,,_1VA:*<,&#6 EIC96 \Z>8@!)KC%'HPK4T@PMM+(B7 P;^ &O
MX*>@5UV0.B48,T/U.6$7@/2(MB4GSBBM2-R<D"D5FH!TF]+L4V=#D"0)6,G;
M74O"^(15FTP8OYTK;@2BKYH;"<BS2L@V\@\AO!2COI%L(+*YGC"GSQY2U[J2
M6FQO?&5(C?FAE_AA$LXFKC>;6N$DGC!GDD23R G":?#'2[)%;<LV=\767K$R
M1U3YA9?OYZ (?(#%_Y6!F'Y@ ^4TE0;*XMWGLY?9GZ?__)Z=?3C]_/:?7R_/
M/I[.X3GX_+?)IX^O/X/AXI[]]'NV;J#\_M.OWMG'M^[IXK?)6^?7?TY?GDS0
MF/G]XZ_>Z8=L_NGCKV"X1-[OB_\DL(9S^NL? 4;<@<F:B<-\T^-!; 8.#TS.
M'#<*^#2( U=8DH!K/#Y!"R_P["":^*'/IL"=IWY@N],8<,N+@VG 6?+,X&#U
M+5%[*!N07Z>\-K("2 XPWJ@0Z)NI'#IV;Q4'U[[TV!AJZR=&,VL=0"0U,P8?
MG1!S$G__%SJ\%T4N]<J&6!URF_JR,"/ZR8*#,AV/C=? 1D0XDR)BFQ'-DJ.3
M#-,WU-N!#699YR_#>%2:D9HO]B3T9M#U4[/]@AAGR<6T1E#3,2 G0^DM"U8'
ME:R4GD7__L:AQ:[I/#CB5/CZ 88&'+F>@U62X[I7V;5HQ8ZV'%-['1=>,Z:"
M:R&K@,L(K^ZNC:DC&A6PDIO[Z \)ZR@<VC-H**\A_:M)8VF1$PC0<0M_43^7
M=M2\R&*4>#O"1==B*L(/%Z9TKQ'B"%RBL"<!KY8D- OCHB +BJRD(@=S"^.Z
M0D%HL,MB7:8AW1"7/)P,0\X LP6J"P0%NS 2=B9F_1B%B/6090@ROT&IRC#Q
M+%V*@XNSMF>[XBR2"BIIX_;W0=$>L8TY0V\PSPUMTQ3/O0',UV%5[SY]_[2X
M'.I"TO>-_FK$[:H-6@G=@R L?-<=?N/^K[U$#%(H(FA/_"64NDY)^Q7\[Z,Y
MCYN,GR7K*L"_D 6<Y/%+P0#(;'G2:L'Y'Y[-IPYW$H FJ@53US(!H2,SF481
M"^*9#Z!>%_-'P@D[QU$M@D>8&@+H7,\EG\ >^*VTNI%XN(FPCINRE=9?0#/&
MMQ2[!NL'/JE:5BK%%/Q($UHBT/7=\ULX6 DDG;N($GSA<C*VK/AS]9<?@!LM
M,[9ZGN8$8GKH![F8]#&A7V4MOY=P0'S=N5S&EG"[R%IC^6;Y]9B^6LM6%M]Y
MWMB=>#N_ML;VSN^N6M9VQI:_^]&KEKWZ.U!9A\T>UV8G-UKVFDKY:QM7!!L_
MW5)F(URO7Z>HQ+_.4K<]XJ3(P]X*UO4*6=?_A.7W/[;LRU"<ZP9%]8\51J?(
MW6\+HB_%)ZV*K*O/L,:S2:]$8TN5QF'#4LK7F[1HN.&QGR8$_W4?]/BH(33@
MV/WBV#WUD*0B,G_L+#?K3W7CPIS13PZD_%*( 6DPW+:/SVTPX^"+<PD2-R_.
MO0L(#K8(E\Y^FS$E?.(R/N.3('(=CP<.8].)/;7)\1TDLTAZ.V8];T>_'!<3
M.N!OZTX0P,4W.=BE_&= R.-H!7Q'#X@LUCW]\_2G?R\^_?/).GLY__SIP[OT
M[*=_IY\^_ KO>W7Y]L-G^^V?\.X/;^R-8EWGK?5I\3NL\*MW]M.[^>E/;[Q/
M"]C3R]?P_,G?9Q]^6\$YYV___$_2MGKING[Q,/%][)D9Q?;4]*+8,_TD#$P[
M3F:A/?5=VXMQ?LG(<39[ =]ZA,DMI<A#MNP;V-[ ]K:S/7C"<4,[FH1!Y/G3
M, AGC#.@'^;X<6S%]\;V!LYV&\[VSQIGPU&'WLQR3&;//-.+$V8&TRG.>)VY
M=F@[EC?!=J/^9A>"@:T-;.WIL;5@9B7 LQ)W$EL>MQD+XQFS/ <4.C[Q7&=K
M[&K0YAZ4Y]GK@R,#N#XK",TXX('I>;YC!I8S-:=>/+$FH9]XMO_L1]<9^;.!
M[0UL;V![H,VQ !0X)XAL-_0F00C_9T5L&OD3:AH2#VSO\-B>N\;V[-#U72=)
MS)D?,]-+/.S^8DU-%KD.\YUDYO  Y]E,ID?"]>ZIK_7Q.B,_TC^PTXVLV.TE
M*11-C86D>-0MF7$['>,W&.1U7,WW"52[^U=1'MC]^NPVTI7419V(>SIM,&1X
MEE#"4G76W1,E+QU'"ZNC8(*K#4^>Y?F^'7K<M%@$NI\[2TP6SP#!;3L)_,!B
M"0L/%%MD1ML&T@SXLD=\"1ES;!ZY8"%,7-,+K-@,N,M-SF?1=#JU9GR://O1
M"493RQK-[,UA\_?4O?& ^M,.DN+^W)R#I#@8RE_WC%JNX[-PXIC3<!J:'I"Z
MR2P&/,"V@TD"2G/@S0X46P9)\0#X,@W=(.+>Q+19,@'S:N::81!P,_1L-HDB
MAT58K&>//&LR<B:#H'AB@N(+'<>#H#@8PE]W)UO>!"XLG)J1YW 0#XYO@@W@
MF)/$GTSBP)].7.] L640% ^ +QZ6N$X\STRF4S!!P]@R0]^=F(G#>6A%;N+,
M;#(I)K8[<FQOD!1/2U)\H:]]D!0'0_GK'OA).$W<T(W,J3>; N5/7#,(@ID9
MA9X+'TVFB>,?*+8,DN(!\"7@$]^:AMR<3&G2W,PVPR2Q319$,\?R?7\RG1R)
M23$DCF]6FLJ.\-?'9FX8;-L^VL7J3W=YXH'[>X+18>L;5T;V5:'\_08QG)T!
M_JT%^H-DN(5D:&?J=9+!GUDQM]W M%SNFAYS?9-AE&+FS?S8A8L+9E=I$@>
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M@GJI>^53NAN&6RG3I;C"-,^+"];&]Z4[NRX*85 K_YD$:>?O/S8E%_F&EK&
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MNKLMRG.6RSC&<)W[4]H NF"H4FJ/1FA]]7M=A1_8[E?3[[9;\0/H]P7ZK@)
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M[Z%@X2DUT?W6]4:>MY,<#[N#[E>JT1EH9J"9==?6Q)D,-#/0S$ S-_8[VJ/
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MDT:WY5'F16[2_J(Y %%FZWA:9J5,U='U$^T(%2PC$KCTO&?*X5DK6A EGOL
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MJ V8(<^!U&M99@E0FJ=+2JX ^RX5/9NV'OGH(K=G:RC:9IU0CS_J>:8E:+X
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M 3C29ADP:T^8]2:7#0U8V:D.^LBQDI,I+:>DT-1EI4*"]1"*(NX81!FVRVV
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M<G0BN.GEPQ=ZB5I_/.6%F,8._Y=&G*[@&AU M">RG(@O!+);A83Y^9]4ZEI
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MLL@Z]? R_M):7#.ZG-@!-O/2XNB$GF*VC4>=M?M[RF:>**BX%/Q6=#1IV]4
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MX<7K47>_7($PO^3_36CH@=82!X'9%95T6P85H"(F,D!9>7DU;K/S>J'>8>0
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M0#ZW<M+D'5[05]3JTW'KY ,#SH73+]NCAR6C/;F?>4DQ =G3)&" GCHB0<X
ME7R1']+<;L?#1T^J3^>5( _U);B-?;BCK?3042B9C_P"WQQY1[\5-"WN<9I5
M!>9ST7)0F4FU$"^VU"MR!9^46#.'=@7F@N1[DJLY5 P[H7UX#TGB8[V"N!=
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M+$P<%>\?'_<IM743 9?]0X#5I;R7AV@Y&XE.P51>,Y)8&S$J33&-Z- U\Q)
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M[R@%2^F9Y=!#VA#Q&>])+E1#G7K/JTOW-W$\0KBW[*!I+O-SN?C"O0G?;.X
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MUFRA)O3&*=E+O3MLI0-=7S]DZN#(2PY4:"-MXVN=OV;0"H-+P"4('KDM 0P
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M:NY[R?*\\'D6J@95B&9\ !H0I4LR#/"FXT ,P[@\"@&N>#.KRK:6>%E+8QA
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MV%#,@8O6D9Y(I[.FE!/]YTU[YYW]\@/9OG+:=F:"LQ]D.10^+X=TKE4$.*/
MER?J[\>DG::[JA_2)"OQN^=AG""MW599*FXN5Y<=$77P9!N?Z/<V_WS:RBOY
M?LTHPZ9EFM9X]9^Y"'!VT%ZA-+A-'U\+(U2I+0>(O)O> *3&BX>N+"THK ,A
M,^#F%6X-,6;+T/"%[3NFUK-ZS1()BI6(/Z"[DYN]4&*6])0W3LL'JQ^8I3ST
M.]NC$=2S;[Y*L]@H2D%CL &Y9BT1$H-7QDT@,9RT8%K9(S"OGUV<)0(1,0%2
M(6L@N-QT-&UV3"]UN26&0Y]$I7)1J+&':-+-;92-/)?42"<E%^M%"#)H,YO-
M:">UW2\K[*60YR;D/02 3,U*V<+VVFB61V\B.QE^2R0)5-<O3D@(_PUL+;23
M-CT^,0R&TRF04GU78>.2%2\ASMELJJXS">$=#/L^:$DS7; F=3I:/;.2NJ/I
M.^A&37:+<EO4T7&KTTY/I7A3!F['83+/=F;]+(^9#]3^G_@NK2?]$>:C(">L
MO".6OTQ<+)E)D1MUMF4!$@2ZNTT-/[LWB4$A]L#'D^%OT-BD8FD-@<NE\@1I
M"E8<7"EI"MF/PO.IMD2 -<6*3UJ+6A5(E&5/T1)*9RD7E)@)J=6,]]IW:@-1
MR3AM"$]<98,I0)IH(A<8MD?O]/'YE\T6;# *Z;ZD(BJI24Z2)SS)HG+Z@F7B
M"^X9_\Z?+EV>MZ2-ABTSJC'?8S)SD..<6L5(E<)O6>>_.7EG3V[J1W AWWO]
M/DSGX9=_B0]E?J[N(7A;'B,D=DYZ2)Q8R:M+DO\L,:%O[RE;6]\.[UK0J!)P
M$@@8S$4E$K*;>06M4/WPPT;,!7NJ'_7XCV0B*4 9/% P; 5F.3V PL1Q.^E)
MW_G'<JF?T)CB4$(;O=*#*H2B7/<BZ"']2>DV@+;X8: Q C?.:E9R^:/\1!='
M"<94!)<"+5MP(CV7F_K^L*ZE;)(N@3U=TQ&\U,\/V-HLC9<&=\-8VAR^[*%1
M(&(:'M/5.P6S//_L-K3@@@A5663U#]J])+#!V*L<*00Y+_)3F)JN7WSYY1OE
M'/OBY17OMCWM:_ZMB@KC_:H[I.4_LH+G7926I]OHIMY65C!"3L>Q0>+"C<40
M-%0,(]MTY:ZB)C1V#=+-;Q@4:<)#VV-6C)+;S!IJ9X^AO7.QN*YOI9(DISON
M7&6]YRUZ?:C70*%JTB\ %&F_.24%$R0#\*HDO7C>H2%L*%,O-&UC?-'L:;'=
M'4//HGY6O+I=D4^:/[*>@<@KR$Z78PM"<)_+[ 0NZ3GJ>$V#6KV[!)G*5MRS
M?K@PG" =^(921V]NF(6K&I^Z^/KY!F@[9\2V!7L 6UTZ.)*WPV&W#B1$H*-W
M=DX_@R(FMW=)U*,#C/2].H4%![:]M6L\M+8)O)<J&:*/OUISX,.&ZY]JV.D$
M.-F'M6"9UB"?/=PRPEI$'Q$T*4.C<*8+,?8R?(M^DEW*Q%G.SEJ.B3J!SQ5
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MO%_R8S%N[D/KQW%E?CEX'\GWAS1&*G9QZ9(^ZA1B862B\4F2,^.X,H^;N$E
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M#,/ZL[$S=>V#+C&QJ!WY&>*)#;7YMW]Y/7KB<]"B:*<D R0+!NML:OE9X[4
MGWI]=@1A%!0SL3*[B%%F[7?)U_#S#+0BQ5&<,]%X#ZY;T%9;0:Y0[!/0K:8A
M/_KQ"NU SH(X$Q\=(*P-RR7F"-;9M_)B$$.ZTM'VU2CRKS=:+PF&$>5N7YF"
M/ "I \H!8>3VD#)8K]Q:_@<+1+A=-5'F-+I9>0"U*^98:!*YD&1%V/?4#_D9
MBFH].Y@ *]KS'9X'-P$$P@9U$(4OR&!$H3=#E1BP668K.MSEQ-8'B=$=C*+.
M5@GSK#K#0KLP,.03RIV:#,.*[!MNR@8%CP(<#JK+$,&D>LT-#$D//"?&Y2CH
MN_=-N>@UKU-2K9^&?@4[]3CE#FAR-U!H5 \C)#H:SV1H$YH,'@LDAXE7X%X7
M5,$3$H1TM4JG[Q&'+MS_P!>O\IH11M8(8^V*X1[-.(VA)_\HJ^NJYIBXF+L1
MI S@HS-X+X,#H/" D(OPT2E/3I&E#*7KQ6>%Z6>DE6$7J.:).9 :73.K*O'&
M<, > $PHF!=-\/5T]PQE+A.?<>(C#<&^& CG$R.IUL70\!G&U ?\NRMPV4BN
M#5^7'O]$.D[(AI>\H!.8!#(.C ,#Y@6H@-0,<1A:T4Z,_2OV7"5S@J%SFSRC
M(7&K%M0:*Q#C^W0)[Q6 27J1 LZF!_^,2YF]( 7M2%XICYNNA8'*:RBM2AU7
ML4OD$/;=@)(>@G$P&>FH[!QR,:J\)T6JM^D&A] 9H89>:X;+NUCG'G%S1G26
M>=&J;2ODK/\RJ,YTKZ7$[F3/@YBX^E8L;=+V\7KW4".]/U*K:MP?FSFBA$V?
M0HZT/C1K*@'!9Z3'MWYT.-'I4Z$Z0G'?HKIXR?OXP8"\HI06QW?^!8)-I9EN
M6&[4:K[+%A8:GHBE@EK-:!O SR^5.8^RSB(((>?9$B](1B5F>T'A4Z8*')"S
MK'&O,R%;,W%K^]'9V-_ZS"7/*$[-)EL:;Z3;RR0G4J<M*)C)ML"\$6=BA@W6
MFS=>9<+*Q^)8&8*DQ'.Y:-Z6X_8,@$^]E/IFQ&&;-]P<%Z#;2I8YZ$6"%5R@
M&1; WN)3Y,?WW7SZ8(QI)\*N3 K:FR'W5I\W"G3:Y,S$=<4VE(< -^@G30Z_
ME;?U4J/H_P)0/2918;K;;@31TQAVS]0NIR[D:)D&_K!PFO"YY2-)=;*L]S[@
MO$>#>6,42/?(5E+Z?ZPUM\@L\BHXD"C;=X-KUU^[@[GGO%/=>3KK6@+?+?1?
MN_70H &'P'\*":Y#NZG 58:A?XJ'B-$F6GXC+-^5J>WVE.1:Y8ZTV?+B.=*$
M*=Z<0#3%^L.GJ^B90IX[PYLJX0=J^UIA< _4WPB')M.HLS?H ]1K506(;W/7
M/$F\T0D8O13FX%:SKR:#H-W-'JEHR[8K80P"MJZK>5!_<]-CSD97EXCI%++#
MK!VJK233/S5ITNW3P;[R*P%K*W7;$Y2:!+$4935%W,[H>GM#^Y']IY13<C ^
M 2):>Y!*E+:7QXN_[-8.8_&#6]AU846;S!XASG7![ZC3:EVZA4E:EP0D[LD'
M4&P'V/F<#%/!8!D)EZ0;'Y78OBR#]6QND?8*76=Q(;JO\1N^94^;=F1@XY;P
MI+\?W,(RN(1,I>(+3PLHK34(;Z1>8FB$[(;NI/2A'>5B230 R2)K&ZW!=O0P
M=.XK9&C"V22J[/?M2+?CM;6LS$:H+WT_\LH,_0@DOPQ]1@JR+C-.<&M8VDHN
M)3[=VIMO\LFT?47;5[2?[RO:#^!9OI!^:$-HJBT/<?:70?*22NAJ+B+'X@T"
MX,!!:QD)<,G%R$$+Q]&G<+51H?_T,[YG? <"J]D,35!X:U$_="&*SG%R!GB5
MQ.<(&W%G\*@R\?CJF$B")9WJM\64P9L1'A]T_]')>4$1+?=\(R6  1>!FB8*
MLCE?RR$2@F;N''?^!#>1S_EJ$M]PGY\J(=;=T,H./9KL/!\8(;.INF,O(14]
M.@S!!6(=ZY".O(GJ9=:JP<;<)GTGY529W=O1PB-L]/@]L_Q,!,B0)!Y(YJ46
M%HC2!:%HME!$GG(X>A/%2SYC1%.=*!0QUKV;9(E=!''GF ES+"*$<^']A&%]
ML$KQKKZ]S>P\)X>"D@GEQ4&1S5??GCQO3=?!9YPOM/P__TY?Y-,_0CPVX]/#
M9S06RC4IT"6EE0J(9R.'VJ.&/< FZ7DXC#SGZR6ZCN#7OR1V'0^U'W_SXD7T
M #WZM;PV>"W3$]YJO^Y7Q#U6Q*^FL>2EL\D'?\VG[R?I]#U,Q7K%YN#E7\\U
M 1/D)Y4SO:6_0)0$%\WH?8E.;R$HIW.?/8J*:BY85Y?I!O_= )7M%4=),2._
M4OG".ENN2S'U5 >E^B!3%E-/*/]+^"3D[_(_T8$T39N%"/>^SYE#H\Z<.>-C
MZTE.-##N<6J^FVTSI4JV!,B!#=#],&\6DLI+ZUHPY$)'GI.(1&6RU[B%N\?E
MNIXNT@8O2-&ZO.E,QB&ZUIS+WE3S)$I_CT\8N(:_C#[$157-$CIG!5UD'X8>
MD%N*>2HOI5:GV$)*6;N@5Y=#*TM/>A*4#]=1H6PFTU+XQE0H0BCKOC@%M X*
M:)+(B>76$D9).[I87#30#F1" (*+T"CD*]91]=6^P]%Y.H<@[:2JM2]0.!0]
M&SS=QN,M^%YT%0RT4=A4-R>?DY?IC% F-415?PL(T";<%"^OMZ0DZ3);&4E5
MTWC$CJZ[+!40VAA".W(LII47B,^-4)UY8G$(F=!ZQ3GGX._)2Z/VR.Y77D_7
M2RX@T1ZE5;%J6"_"?N3&(2TV1)A LNRJZJ751B:VI-&TASQ5N*?O.;JHYH>C
M_^D4@ND7+<>QAV8^@ ;BIFD,EY]P9RN*M7,G+GER2=P/?<#2RA4L!/FF57$%
M?*P[@'*W3EG]1M:(J !R=]C691Y5*B0AQ"HP<O!M^SE>(0>D*=B#QA01&#-H
M@ JM09ME5+26CH9Y6C#'A(OLUK-U02N!>2P@OK*NN3%5+O$COGW&3ZQ=D#^>
MO=P?H;L\0MUA6;]W_L]UPO5!LGJELI$PAU9.3YL5\P,^<A@2R*(CO@"(W"^7
M,(Q]D7[]I._L#1>7?+E;^, [D-P21L#9$_1LL_@2:ZKK(PAK@72NS3)JWDD-
M_YA?NJ:C^6= *SESS_\[G\6I4?$&C6=GF,?FK2'9_M +84K@M\ULH,=)1&=Q
M%OEE:.R4(XD+ GIX^M=0JWG(@5"+B=[PW:>-^XU$U*EGC=%7O,_69F]W:"F@
MK9E03CGY7 V,]6UW/3JF5CQV]!NU5NR_*<9&)*Q4[KCJG<<XYDM:9;40)K**
MKDAY&@MOVY3]EMA;GD_AO'?MOG3P"F\!'[Z&++G$PNDX<[3D^QSZQ'CTTI,A
M;8]4:&GDK))/Z  >5.7QYREKAVV",C*MQIYU_YV2!(4G(&5NRUL7/00<69#P
MH#=&+NFK18SU(EQXJ,K W1_><I4M_;%(V,:7VVA;$>G71L"$@'D/OSYS-+@3
MF3=0L.3T=7G#P(&.(H_[J8Q3,WI"/"?L_;#U$)&V1MD'*6-+!29K#(2!\*FB
MW9<X.03>:+FX4D8EA*M=DQ)WD4T*Y]O6ELEPPD&3-J1:5K+^]^;<(/VHBQK$
M:' +)[.'Y[PZC5("4QGRX/5<G(PV)/F0E&9M=8\#N7+GID]L+E/14*)LAAQ'
MYD+RV\;_TF/X1M%8,((0S#,"( V'D*U6EJT;>'()'J^]<?P4QO$,QN]G74V!
M,A >&S6&_?R6__=MW+"MB8]D]&3\E!M=)-/1KLM' 0L,S\2MSSFY!37*Q_9D
M%@*4OC C.%-LP\EVL%?",E3T;XJE6RSU\V*=E4+B8F[LUV6321L <T(8,D]%
M620"<J$OT;_0U([!$=R!=XKRY61=-\H =LOW^F[TY/BIE$%D^+0,XO$[<;(F
M/KT$6BT=#/VCTG T2,5O.&S\EOFE1I%T&@P'>.X)3Y[ZYHEY[ C^?<UD.@0A
M)[I5SFH2AU[+Y_5/H,^*<V[TY#2^M+0R%00M#]&YWG!O/SZ%_;!K ,Z!>M<=
M+TL3&S&QU% R-/N03=<K32BNB-B6Z60K^0B"ZM-%MLPX'\,WIZ/1/A)OXY57
M?7W2XCL*T%_W-TJPU\W3;LXF]S$#'+'+-24[=>_&Z11!Y;B'GCC;MU^#GV(-
MZMQ8J=*69RLDKK*"[ KQ3H] DV29@GIV:''2Q;FC(.$&YK3PYOB*3[;U)9LY
M9WCK?/J>?2\ !0SB:9ZR5R:Y!_AU\IF[RQXYY)%#7^^10P_@63XE<JC7*'XF
M$PA;0J:=/3NA7C*AL#$SJ% %9@:!I+>U!\@/FV5%CKJ*]BE*O.].Q:3O# /!
M<S>[MM6J[8^R1W"420MC++9C&AI7(GP&>%)N :R<#^D#BG#N /[6FV693];-
MZ)U;JXP/;A;<T* 4Q<='XY/876O1>03=,\UV]_8I^64;Z."C+TZ+#)QP+MP
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MUL5/?90"/3D6V'G,4L+N$L,H,4'L/DHCKM?!<R=/^L&V[,!\$4M!,Q!@9DU
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MVL5B^FC-D0\U@_<EO*8+FL3R(N3.R>62=!J;@:H4,1,5'J7*>[\1OECG,RC
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M[@))<D1J<3 7_@3L8(,U;QT8-U"4P3->:8LVOI?KN3<8,-HA2N'8RU9OF4W
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M[A)5$1"V<4J@<ZE=4H,XL54;BT4VL>0DP($'YUL 0Q]F3<M%ON_VD#L$+PM
M"&CMN[N(>S[C9!3@=>=KJGID)$59\[K&G_F?[G5>LJ2>)^[]T=, N7V9KW0Q
MP1-U]]ZX"*IA8D#BF2W70'[2L&132<FU0=(\B >9\S<T!1T/XS)S"UT!='V>
M)Z.4V+7D&0MWHRV(9QPRAJ.0+/8KP#YBYT$\#SP; #Q05$@KJY&1^4*26Y&.
M?I<""\G0B'RFZ\A#!.4MYGE6S!H0-[HIJB6/-TO#!A0J^GUEW5?6O]E7UA_
MLWPADC$J ?%K. O<AEG[A ]8&[S]:$P0OUXUN<2HD9P$XTKSQAX)4+1FD2UK
M48%AK:6K4DOD,-[R*$CMS1'OEXCNVJA_C^L/QFE174<_YT2P;Z54"70Y/-[R
M-^EOOZJ/.'I#&KOLO/UV_O;7-XE]!A%WI.YV(^(7G02BA&4-/17/R(]DODS8
M?/&^] UDL%M2E810,B]#[F3H9+"?P&XOD1";V.8%4CE+KVF"B>- ?TQGBJ'=
M,:Z2'B!5)T!1B$$J2MM W1)&]49=(8JIU>\D%A%^<7GZ2+0(:>=8"X_&F^/Y
MN7TX=07Q"Z]L&_(!<0C5];U"5PE?E':P78;F5I?"O!\]*8]W*NNA)8^B)0X5
MQ5TWBAK>1-*M  BNG"EG![3EC-$F,OG,DCHQJ7_*YD<IZFYS8,RKH@")TUXZ
M95>M*E(V4&0X2"AT]D+@-1>H06FK#W5F'%U!)$E8_-U^OG8T7[>W0+IU@Q&2
M4$ ,PGZ.=KBGY+"D:JJX#M[,9S7[&O.\YH87L,GTS:#&>6;G&<)Z->9]OTR1
M>_()&/<H0P7".J]4#9845Z[XL*;^6")LWZ^1'=O=B>_5X7@R;YB9FW(U(CRG
MH ?"#,+75.(!<Z[?]MO1*ME/[JX/U:&-/5E+LD:R#-K0Q_*%U\'M,@E+-*%0
MG8Y<>C3#H15$/J&6$21%^8+8_R"38.N?^"N*[XL"89U?H.8F/R*=C#IZ!"UI
MFN?3S,_+ L!!<OY B],#,C'OH1<"-7_7NP#.KK1CM%^;NSR<I!B)#/.*@\%T
MXM8,039U?JJZ9^DF1A%$5E%1-=I^HO-IS,[6PD1>QD3<'$5O$&U*U*;9./=)
MDQ583X3]4TJ4Z&FV/SKC*A#]\*L2A9IO1VYM-IAE4MY.94_F<_,'WDVT$S-_
M)]C;=/:W-3<J[8WKSA8PL 1LL03W$_NU_=-/-':9=X$#<H\J"P-5C?T4[FH*
MH\2*)%LNW/E0!C"A3N:UHC!)P"(5US=E"*[LU/X*DF964I^GJ&K?($BSW4ZC
MZ(T8K1??1<NB]M%LIF-PT74AE9--I^3JTU^Y57Y&$XP'P[BK4(:*\WV4RF/E
MP\;W5G,;?4U7U?95=V^RCDO.UMDQ=!$%!HTZ?TLS:L@4,MZ6$?<HCNPWP@YM
M6>T# <1BHY1K?;YBJAWKZ76J8%OP9W"BDY8#IE)*=?X,A(7TA *4R+[Q+K@#
MLVWXO\\J.1JYIL9W;5JWK</&\S5#41<SE!\)00\S]\L"@*%X97J(K+MA4^T7
MW.X6G#4]M"0TXSP(?XB95@DM(60O @5C#(0VY-$L&J/J<1&PGPHA\!84[3C=
M9^+"2RE:44CL&^R)/1XFK"O*@G$2DF2B^->(<-64^9@H6T8!662?B1_;G3WH
MF P>!(<O?" 4%0L +-828DDCRGZ-?AJC&&  V95)-/<MUT&SN9^K7<V5QGGJ
MB?>&>]?.1-#V1OH"N0IUXU"Y-'A4;$3,V4Q=I6STBW8-O Y"DNY^3*@1JJ!6
MDFU*,GC<+4.(#7W*$'>"2[_W:6T-*@5:7EH)J"N"_JET&M)95-?95<6]*-=5
M7<RNJ4PF(#CNS8C4EDTN=RZM'C&9%"M@BFE4!!_;0\92BX+=DMBOW,I4[3K^
MJIZWH!/66JXG$O7%8C-6Z!1 !E(:L&4.[#MP0C$<"Q4GEBX)63,))K5<M7B&
MB$R$W 9I,2+DE G(?:8R;& $VA+;MU6;R8.^RDVG!AU%3+9( MT-Z):76>;9
M8'P/=JLU4 T_O6N.IZ/!8O&PBL='P0%[P[$KP]%-[A 9X_4&-#4UU9/SIJH-
M9HSC0Y'OX,9L6ZC&3*[1A5G5-?R2&11[JEIOL)_,7:9D-/HM/83.-C0RYF/.
MC8<:LOYM7>?-3(CL+-0 \/&MJ4,Q2DS^SS!39^=QEQB.QU >#8@%M<#=/%A6
M;MMSX.R^:WG#B%V,TI(^1)?TIA+(.I-1!KZB<+#TOIN"H?W-^%?1/3CK#AE!
M<H#0;^\LDU7S8X<;&7?[/#>"]8<>JR6$['X&"8^X]=7 GJEK3W%')KD/#0K.
MV%I@C<T(YR#U=[_XFV=F;" +N-^2NRU!T?ST8(JV8MT-C&@/9E4PZ_.C/9CU
M 3S+ETH3]=(V%<Z%\$2Z]30Q81".%_UFN$6>%.5J'D!;WAT[VE['99^H.:@W
M&S6-4_S#27 7A(2,_:-L3]-!,>Y87UW"(($TG9NTD[E,""0P(04&,<[:(EI]
MYCEOI+162M@L_+7YJI'HMP*U8\+%A61+(EEH?I6HXJZE%E1_%"%7Y24C<7-I
M8K[40R@QR"<J<!/UNI!S)0^,T0>8:N12LN:STOK4+A3/KA-"?*P..&/ ?^+*
ME7M*#:E]L[NFC4U1BSO,!3,Z7Q><"CZ@]]L8KA5)^>G\:_HF8LH(5Y5M'F.O
MS0:7$D6M^U\*%JPFHEV7 1E09&DDJ3(+N&?6.6\1\1G>A$X?]0T]U#W-T@JX
MX%JWX;<0FBYVV%O]Z)R$R5T A'2)]J"%6F)*YT-#NR/DWC=6E2Z4D;I&M=5>
MB;X*1$-IJ9)-$N4PE(T)9\+HWN*:D:Q",D*JSE=YOVK;:[Q]MX3:'P=&C^H?
MLF&6#&'),_:HLVX@A5@MEU4)N0]+V>UA[1<UG2\--T(*/#\::2IYIXW;>ZN;
M;F<,Z^'HSW)=) Z#V0P;Q1]P+*(&MBG3\XWDF!+.4.>DEU\F*B6;-;-)T(*D
MUT <XL((.A^JR17IJ#(A4\TI4G3X+KM/6?:,(%Z<VWE;CVL($2E10#P3(K[J
M]0[=DH>V>,@?RLS3Q^ $]I6"#J$&,S7*IXH5"ATR8'=+J?&9]CQB>Y6&=>N&
MF6;,_6GJ>PM7=4JQNYH[65]2OF]Q5DRJ69[UIRQ@WB#9D$ 9*>I3(H8=45P+
M*UYRQLN,>F/R!MV+G#)^6(=8]H%/L,]\@!V8<_YA#5 R>OCGO'6:&'OC6?RB
MH\8M;:\FVDH^*;52\,1BW^"<];W"M=H'.U=>U!;0?B&A6*UJM%P&OAOI 8R"
MND-9C8K*64Y1>-13U=-7])Q.AZ/?R1")W*TF(JTG86[<TO(9;@S@FB=<9ST2
MN.NY%Z[!B3LNT!"?)LBO& [4 DQJ<4Q3LECR6<U=".N2027]MLVPQF@;EK:_
MJP6'5V).,+I;Q][KU;L'-'562@^AG.-TVH43VKN.]NSD_@GJ7,B(WV\$S&KK
MN5J/U7.P8BZXPE]0.Z%O[&2V#JR#K%ZDE_ ,DM998[&N05XYE>RI+(&^$/3!
M^(<1ZR*EKYRS?L$,C.;EO$R $*_>%%7F!)V -&-)>>*NHI#GG\K559PAAIQE
M)B^/LYHD$5AZ@A8/SGXN3VI9LC_CC386D;FHC0Z/LWD];5-_* _R4,+]W^-V
M >QHH&'B<&IKA<#328''+! N#-K MV"<#JQRT/$AMSYX,PVZ%*B>0IN>5N8:
M3T8R+$5*X@N+7*R3<@6&BR3#:ZS/5PI,.'%-"9"YS265G@LM5JB&NO/^<Q2D
MZ^J#(M'&+TB ?+5POZ3T+0&&6,,'3#XH7DU)-S3!M?@*-K1I[08JBZ1JDYDN
M@QN;O8(U)#.C;C!HFP]W?:E*&+;C]@XPU&ANNMU-S6>-?1!W+%2>O9R?,C20
MS3M?]SUG#"&K# LC4C!1GB B?C.^A74 _(%@W!'[N<4(>Z!LLC4%L<U!,2+$
MP>EH4X@RQL,?M-H.03HKALG&6-7X;/69!_M(AG+@</3+#6!I'I"A%G0_]6&B
M%/+>\YO60='2&HSZ]^>]A G.3V :\K2F&-%.5+^;9S"&;,&RD@NZ#=<YR?H8
MK@.PC0D18<->$^(J,UX_KFOZ^Q+]_#CJ;)0V47:F)NM-B43.6_< <\=)ONJ=
M-.&=-=^_7F28&Z__IVDNHYY HKW.WM'41B*/7G^7GL<=$2ESJVJ2$YIW($;@
M%)H\'0W%144O""W=YI/[&?MZH:\7CO?UP@?P+/\\Y#=W+(Z]&02%B G1EI89
MIRD!QS1QUJ-S@[O)N-"T$_/51B8^\"D&-V&;J]S'>9;/$^XN P$<TL%1R!H_
MS UH'?A8"A/27WD5QIZ><7AP]HLXH-=Y*&.(TT!G3<D%.3I,J0Y&W&CK)13!
M?C49B!;KC0^5)_84XY;+J9+3D9)#+B$C3MBT75_(/;TD?.KNI'3[^,+L\#DG
MR50Z43E]KL>V&T%T&,_\2/CZN*J#7E7L6-/!+ZMD5>EU6L4 N2JA#7UA0(?"
MSR2[([USV0ZX37-J-%/!@4C\6')3QI13O1A$GZIFLDE3#NDI75/%H>+^-T\^
M2M.\JM>9\>)\*YR\,C=]%1NML#BSN6;PKS!(9M[3I+E$C [NR#:&%R*EP(-Q
MI*'%D$YGG[06>7+'B$^R]+R*+49R9-FWBA.-7I%O',@OXA6KZ[.[>&]>L3?L
MW!O9HX;WT2(M5 XGK^T] ]UE1Q;<C>L%933=(SCCR4OK;\X/YD&SQ%(>]K"F
M*)BN0B.$38"XV/M[0COMK$2J>D(T^(3[:U<Z.9A-I7FKGK(MRL1J 2&NF9H>
M>GIEG;>O:@<^Y89JDNYB8.(\7VE79X!'AO0.+84I*8%H _<:"Z[45)=Y%/,0
M-%FE<YA1)E6Q"^_R4LUF=<T!<]4(QN%:5(/E@FQ*VW^N:C\Z'-,@7@F9F59>
M1NR5*J]R+I/,\[Q.Z8"<<R:+IT6:0VFI4EX2*X[(8)AY84/QIVY*@P>:9'>8
M6-9(ZIQ@[AJ!Y!O;)VH]K3=R]IEII;70!)@KTG>4L<^L=EK_ED*0*;?%&1%=
M14R>X$-ZA[/#^-NL&T]]P?$5B/N8US4^/T..&K>VN%NLJFO=Y*QB@U("@JP8
M+WN!5"C$*MP(3S,YQ-QNZ^/G;;V D 7'R0=D%Z!D"VF\9B%+RNJY]$*?=-,K
MFH'2[ 7U9-8L\AW$NO)2!;PUJC3LQ8G5T.4&#/:8?3&C[^9N?:Z;K1Y&VM>1
M[=8"*8%S:[<+^V;&2>UN'HP4*MQ2#6GI&T(KJIRY^)RQUMX0DV202"#;AL3.
M'?HPL\*D4=>9^W8Z*71+L23@.E ?#K6LZ?Z-B"QLBDEGG/, 9M8E\";5E,<'
MW?LA+*F&G1A90"O?UZ$$E, G9$ICB/0KCFNEM!S5:Q6HM_T]\+D]#?% ?4Y=
M[L<6Z[QIOX&W=;!4G "=[7J,64W9>"0=$FZUL%S7,4)^+;/".D.F6./WC6%\
M%M-29X8RQO)U'X[. @%IEDOAL)6UK'MH2=M?&D)CT"[LJ3%XI9.@_A:&6A45
M^<!Q-@_>L)[0+33+4!Z?OFJ;:5#DFK-#,V]%33PI8*J!\DO0)OPI2Q>;@_,E
MN5XO*8\Y35V4PGE"*[7>^UF@81V=.S<+<MJCXZ/Q..D9*W1(LG"U'#9<;E#T
MIX]:F5V68Q;GW"<X%I8^V HB.;Z;;^[!GQ:0M<Q6B2EK=.Z3]@PM'414IU@5
M_)!F%> P#'6,@;1N["%=BWJG+ZSPST>>K899-_B*JN(2&',9IY-JG=V>0.XT
M6+HYUC7B\0#RS+Q!XR*[75<LWF+99 W3K\%8#A%).$O"MU#H$BI1_048"QOK
M08P\+)3- \/82%M97]V+*T8]^U+T_4CP_I+A=ZD!UGT,DS10)[J%6>HF=!+E
M)_P\&(C'=LC_CY306&VT38W<%8Q(1%R#5#AHBP;=A56LR1 4#V)+&M&V^=HS
MS:HI[K<5(XI\+J5^4I"T$(%S-^RH9T'#<=72@H S[AE.*>Q3GP%/&ZLPX$^U
M^^TJ\]7'DO$$RO/@KK)LLN(J:_Q;%;3J8;4Y@(^O*?&:9U,T-G*>X=IR7Z6^
M-DWL<? B+R T(_1 %UFYI@*Y#.-5FW1D+D^$=W'+E5V5U*.89W4ZQR"KZ"T3
MFO!!M:S*BH0L_L$;&WZ:'PYG#+)B?CCZG4O7@3 A5=Z \,K*'-!]\U8%.JZH
MDH!E=AWJ_7Y.DY';I&Y0?LBFWC\X3<PA150, 7_!-L@-3[D6$GC^"/:0</8D
MCYK1OK#'OH>P<?86G)C(O?/?!<<&:2:9:/O;H&ORZ,Q!E%#ND8MQ+CKJT%Q*
M5PJOGNUN 5Y>(I>F53<_4^VP ZE $M);ELM)Q!&N1]J\T#_V5_#""S&@P+11
MT#S9@.2:,97D9VE":I"P/^[\IP66DY5<3@3,2X\F]6^0?R +,^N[71O"N;;<
M_*39!?$]^@T5VG_(%'!##,G>DBG6A*5ZRHL:YQ0>4'@GC%ZT0:7(YNV&KDS.
M$=PY#3'86QQ!/<C )@G2:EC\;W>@=@<7,A &WT=<7$!B=H3AL@_."[2/%Z!:
M0=B*@4=R[5BD9P\2\""!XSU(X $\RY?:5&Q$71I(>6^J=;M.-R*ZIKES-ZJ
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M)*I=-XC5]/WG?X\[QKN_,C_6U$^KOA43"%/OY_2]9DZN*G)0"MDHA,0Q>0D
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MHS,CMYNV^\Y0[Y1/G%-&<@)HQ:,+W3B)U7H%1ERZ8_\VY#X^^X@)G 2(3EQ
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MS=QOE6B;^  2%)\T^8%UW5LX8=6(O._+(BW;$-[CH_%X]$J$MY+1#P+QX[/
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M6121@?%C'=6:8 :S;$DK39=K"Z2)^?+>!]<]>L'%/5OZ-N;RRP,O?;T'+SV
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M<H[G5&#K43#7$# NI7WIF+B6AJ.DQZP@4(C1H-%7R;0S#-)R28"  E;((F2
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MY;Z90Z5>NL>-*9GAS^_^#U!+ P04    "  "@FE5?/O4:O8@  #J2@$ %0
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M6C+L-V^7B],_WOXT?;\9P8U@7V;O9$D(B*6"L<)!*T(&'AE:$W) U;N J.L
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M2]D4Z;U60V8CAG!@MS[_3DL6HO;2EM;[L[82;LW+5V,%MJE"!8D23>_JP+T
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M3?^2QN<_S5$^'W_N@J[^>ZA[*O.2S6$L_N&MQY.>AZ-AW3I>T5\O_W5]QM9
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MA$)[LJ8W-*H0%9<\!-;^!LB&*(_"H=V$(2MN@O2IF![2CG?OKA3RYK1.!EA
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MQH0#X0*AJV.40A%D7R>!Z&WTVG:,5S[VJ&]>VSU(M'4=U>_CT>, )=/&2B7
MUEITI94%'XB0#M%AX,ZI9#NIO,O33D/KS>6ZMTJG^5$GF0@<30%3HB%*5HN8
M/&FP*:%+F A8ZWL[Z]&<JNO02/X],.-> ^TEC \>7UVP]^1>[(+[, Y(*P[<
MFQ^T9P7V8)CNM 9ADB^.&XC<UV'KUM2A60*R#8C&AJ15:S?F^,CWB*-SC-S;
M1&\].4-7;T'V,B;T0 LFJXS.9'#.1/"^MD=UPHGF+?MOGKY_(VA_6EMQ"FXA
M\A[Z]OPV'N'7A;GVXF*4;\SS9#$*)!LPD)4FM0:/J$&D7#@C=TR4UO/N5B-Y
M0J1HH(H^=H?Q^7F=W5EGK9$=>05*6I]K?]Y@HZOS&2TXG@4$[A.Y\=)E@ZTW
MBE5 GA ]=E=$#T;S94_O</9R1&*YJ(F=^5D:O2(?H6C(1=!9BD6"D]F!,2QK
MIWG!F!OS8PV44W6D6DB^A^L?[R=A-"TXF=([\ XGGX>UX?OKL@+MM-Y!GJ[^
MT64DHLM:^NJTTG =A_&RFA!DN>G&H;7;1P^7EFNB]Y:54"P(F^BP+F3(!:YI
MJ]>>25=''?C6^][Q,_41E^SHB;J)4O=F@:7@)"\^0V1TW"L7R67(CD$V NN\
M*,=C:PO]2"RPP^FVDT6VB6)Z<.B>CR>?QI,P6[J?<@F.&9VT1P')*5JDX+7C
MDO7@-'.)Z<A,#W;[ X">-'M:*:J'/><?[_X^_HR3T7PS_H"C=.\&RB7.'&DG
MCCR S<;2NIT"Y\F.E3)8+X3&X&QC0G7%]H2YU8OZ>G ?;^-<B4\PCMY' 59$
M#2HP<IB5U2"9+%*C3U:W/N4>P_2=5FW4M=;Y/&QGM57?"_?B.</1W9K^-^/I
M'.HN$QCVCO$0W=7Z$.]2?S5G&'?(F35"J!I:+SEX;<B;\$'1/K=!?[5&:/NZ
ML_M\7'L=7HPOIJL!7-\(N!ZVEY(T#+6O<]7J%:ED(!BR59E53@E?BE3->T^V
M@]_OO83'X-2.R.\_AA$7O]%O?IP.C$U8DB.WE-61"XI<U1"EAR!8"%I%5LQ^
MKS!LNH+]'V6'XO)FMR)Z94(//E_;U=RZO59_;4#6 5K'(KDB6$ 9:R *8^B,
MM[8(Q;5(K3ON][J@[ZP_/$]Z<%EW6]S5HEY/7HU''^:>D=:Y: 8L.EJ-$ Y\
MDAR0:Q6,$]PUC^2V7<%WFA^ "3WXR&U7L_S2(E.&8XZ04TR@9 FT.$]K]2X'
ME2/+YKAI_GUS/SJ>])!6?GAQJY<T8(J)K$L$=%R0-$.$@** ]BDI[4UDJ77P
M:!N<WRG;FU9[Z#^X#>;EEXG>I81*:C"VWL]7=>Y%':*#*67K$K,RMRZS; #[
M.T_WI?,>^A)NLX1K(2ZJE31Z-%P&8&[>NHXGB$%F"-Q)ZS!HEX]A.[V+>E\-
M';YEJNZ@YV/I!K&NAJ1H70/LA:CEYFWR/#@AR(#A$D6.2,)MG9[\INH0VQ.B
M8YGB)HHY^J*O#FOY7J:XAI]-"-)K]=<6VCUVQAIKL\^T$GJ-+:B@"CB3.1TX
M2;O$#=G2K3,7Q\_4+<L4CX:HFRAU;V6*+@C!4VW"77O$*V,#P6-(7T4EK$XZ
MVM:=K$^Q3'$CW78J4]Q$,7LO4T14F(6*($V=LE-+?X,3!IA/W@87;/+-[R&>
M<)GB;NQII:A#EBD6DZU)QD LO ZM" @>>8;"=/8Z&U94ZZ9P3Z1,<1=N]:*^
M0Y0I&A^#<)E!S$Q5CUU!2++.<+*J2*&DY:V[Y9]XF6(K6NVLKKV6*;Z9C.F$
MGGT-HUSKRS[5%=#Q_6D\JJ(9EU4__QUG.Q0=[OC$=B6$+9>^5!"8>"Y>)B/0
M,66*]]J'>J>:L6*+$GZPX[-WVURN/OS-6:!=\-837EWW?XU"D\+FT^$THY>!
MMC\78P'.8N*I2'I36C?V>!S5KIOJVB?0UXN- 5]AF.+;X8>/L]?E'U-\-IWB
M;-$]^U9T_1?\-$':1.:;VRA?SC"8_W4@DBM)LP FUJPE*C)/,EI@9*UXV@"<
MU:U+E_:PK/UO[8TYNKQA'QL5>O!WMEQBQ\4EIGFQLD#"8$!EJ<FMX_37DI3F
MD?[#6E_KZG5!WQG>F_I[\,*V75R9W:DS>6B%UK/ ZI)BM.0 F-J3L(ZFB5SE
M;&7(7+8>$MG_JKZSO%\B]. )WO3M7[O61<XL%V842X;.%U$O5R5?CYL,UO,<
M=$Z9')#&A.V*;5\I\9[)UHLJCB6?O79)/W^MOO,\\>"+<1(3(XN&U<MVN9;D
M!4^O@A5*V:R-:UV/T0'6H?+<_="AZP:WI5KV>1A7@)?!E2X0>TI8=X!WF#QT
M<]5VI<Z.>CD0A3"Z4KQ#0*;)Y-1<@]>9 :/#V3,LI/?6 ?6#4>>1Q/ Q,&<3
M=;1NI_XJQ)H@&D^^7B.[SC'*++A0D".O/G<($)',MI)LD5JAEV8I^;NFA_K:
M1QR1";VM-L;-1=E+NO;\TP59Z<NP>(R&",P '1.U^$&#XS(#=U+EY+VPK'6
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MX"!$GL$&% 9MC/0^/KV:H0/SL5\U]E%BOZV\?A^/%N&'*P?Q>ACQWVL$"_.
MI^1#CARXXAR4D06<9P88H[>ISLKD/AV+.?#H:IX<DX^$&#UTB+IV-A>M@5<O
M]/=Z46I*:.=KFKX?SVKSV)N?/R=7ZO?Q[/_@["TF\JQJ YQ;,;GI( 47R'<.
MM,@L0?FLR7.N-ZD"CT5I%F-HW3)S+PM[<B_"\=&E8;^LWA>YL*[HV+O\5OT]
M/LB%Z1*<!)F<@'I7';P1#) GB;7\@I?6D\'WN\+O;\GQ$*AAJ[$5I26/B7VZ
M3NZ+0A17"J)!"2B2KE5(@F1>YP!K)7-V@B?5O+-R*_#[*OD^M"5T$&4?2S5Y
M3?C4FV*+.X&>7)6H,W"9R%GA/M,"1*ZSV[@TR17N6]]3N?W\(Z@DVR<#EKMM
M;JN)/EI!7V*YNOG; 4U/!>5WD1RFF'Q[S:Q1\0YB[5_9' 5&I&T4I:F).2/
MQ:+!>AX-EURHY2*?;T+)C]2,]Z7C3:39NFRC0A&,\\N,JS'.6QD].,D-;4GH
M(*#G$%&B#!YMU-VF8-[]W/W;PKN(>-Q&/JU+O!=0Q!44Q,RTK!<3N*PU8%)
M%$:!RU;ZHJ0LMENAS-W/_=95M95\^GBK?IU^^G0+#K.)%N U9%T[(RN!X+73
MX$P0R0:==.Q6;'+_L[]ME>T@IUZF%:R[%^2-YJ6:;%KE>L6#9R#WH;9(X$+F
M)%#%]@-PCO?FY &MX#8ZZH$\*ZX8=4'T9.]9;J2NQZ_:;2/K_=RS-#%&K0V'
MHD,ACA-&[QT'>@%0ASJSY^FU)VVL_$U$O)][EMF6>NU#@RB^!BBU@J"D S0F
M*S0>2VZ=_#S2>Y8;Z>;Q>Y:;"':O?856USG^^J5^V;XH=.ES^RX)?6@92P6A
MSGN=C M>8%%"DL7&HHZ6O"/.1,*XIB!TZ0E[2&<].YM_T+".,EK.-]1,Q/0F
M?%R"]<I97L?NF;I=%7!)D]7D(\OD^9$UT[K6IO$2=AY[OG@2YM5 +K4W**@Q
M26O!V$S2<MK7B#L#:X4UA6B05.L <3=D^]\*#\G!>[/1VVNOUV9';62W<#9D
M*"QP<B)340J4B0E\= J$<=IZ0XLRS<N0^EC(OK)MQ\3;PS/B6-)P+T=T0N.U
M0?WJ<IUS8QJS9&@#K<+7T3XJ1W"*:2B9Q.Y,-L:T#DX\ .?PX8F#<66Y&68C
MG?71_G0UM*L.H!W ]12W>!#884(8S=38C1X[Z&#O1"E)9BN9!%'[T:M<(L1B
M(D@"K[5SR2_W@?@6"?)(E.,P_-A$]#WPHA:TTP=^?#;*O^!G/!M_JA@O#<FK
M&YS!6CKJ,W!?APEP11!%U"!#=.2M6T\X&[.C ZS]>P(-%3GN5PM]&/5X1C_Z
M0 A_"Y,_L%X96\+GZP1[8:&$7.U#Z\&9>OM&&93"6DDO3&O[_!%,IT21IO+O
M82/Y.XYP$LX(W[-\3G*>SA;W@N^"E,P@4]&#E\F"0E$@R*(@E&QL[33 3.N:
MDT[ 3HDI[36Q-LO61_SUJG7.K2M85]]Z?3&;SL(H$_=W",1N]H!V$=D=%K;<
M^#U8IZSE4HNH;+3!V5*"-D78F#DK@\T>U213=OGYKR=OAQ\^SF["!H(3;R6K
MF6&%-4><(:C$P?IB7)(^J>;W9QY&U"@S>/?3?_U"#NYPBF\FY*A>_W!Z^=,I
M'UB;9-(J UF1CEYH*\'I>H2;F'6I'9]X\SS2-D /EFIJP9\U&<8>5=7'X+Q5
MH&^]M0.)WH="FW9$6T,9VH'GJ,"84HJ162&V/D,?PW3ZK-E6 ?V5)MS%MXAR
M<1Y12TO.:92Z=K!5X%/MA9M<*E;'H'U/)0HKT.QYDL#>J+"YJ(\E^/QB. JC
M- QG-Y=Y%V705J#VGH&)VM0>V18\Z@2TW;DHA!$QMDZ+KH%RJ*!S*T6/VPN\
MAQUD/BNJX&1*/L(BN$[;VNNR NWT/7WD=/6/KBXW=%A+3T'FENLX3$RZ"4'&
M1Z;=8V>LRG0@)/*FN60%E*T-#\-\YHS@W"NC2O.I@<?/U$>"XT=/U$V4VF/;
MU,L3Y-E,"S9/6,[=C*N:-_+;BS8:;"P!E',1O& 2<O$IF1R+7+YV^7BORH<>
MN'^S_' J7=.TLID^FL]Z6('1_X7)>R!1.>ER+E"$(BD@(KUAP@#9)-Q+IZ.6
M'7NT=WSB=]8TU,@^MAK._N+4/90BL1*YE'6*&MFM66@(V160W.BBG(V"A:UY
ML_*1WXG34B<]MEJ^02FD6P$RI) M \9#(H>G7@23/ +#E&.*$6WPVQ-GQ1._
M\Z:A1AHVVEH+4C!K[X&,.@@TAH,)B@A>0@8GD@%&7VDT)8?0<2)1QR=^ITU#
MC:SM1=5GBJ]%K^VUG]4^<;=9/VT?O9$VYY"C4I9'E812#&4=Q^Z$&:S]U%[3
M<3E9U#8;(/5GX@06<"4P*'3T(,^2:_MMI.,6K\+J!,^GX03SP%OO%%,)@N*6
M3EQ4X$SQP*,7AMX]4SI>UG[H*4>7^=A$P7>WE5:RW%=.;!&>]3P9Q[.BPS#2
MV6@\ U^T!:L<3]FIE-JWSSWVE,<V'&@LZJ-/>;CBLY49-($G2UQ9"-$FR*J6
MUUE7+'^Z*8^-%-TUY;&!P(\]@-QE+=]3'IM&DC<A2*\ICRVT>^R,M2FQ(H0%
M4ULF*L\RA*P86!]X=BX9=*VWN^-GZK8ICV,AZB9*/5C*PR?N++.0(LZSY_76
M((G-,L\<^9\F?4]Y;*O2K5(>&^ACKVT7Z@*&L[DLPB@_)VN0Q(BCA$VB!!M\
M>KNXP;9+6HHD1,8T)L&R\(QVG!)383'ZPIDJW.<RV. Y.[[QET]Y=OLI0[QU
M29B++#+A B>] 67)AG3*9>)OS(9Y'Y/KUGJPR]-VVL!>X72*^)H,YE _^A6&
M*3Z;8'A=YE_F=Y]"+0\M].H0@%<ACB?UX[X.@E%H9:P7*VKU'T8'WA0-CAPN
M*:UD3G7+QVV+8-]S!EOK_<Z^M1<U]!"16(7[+8[PSW#V'B?G RNE+DX)VEAK
MX\)(.ZY/PD"VW'G&#1/-9Z@] NE4:-.'!EI;1R]I^SX?#8FU87%ZA#@\^__+
MN[;>-G8C_-[_0I3WRTL!GW-R'@[:V$!:]-'@97@B())2:14T_?4=2G)LR]YH
MI257BO,0(PF2Y<>9;[DS0_*;6??UGMD43?2R]%HM+5-\(-YA*&F3"\*7.SEN
MV.+1-\);\7(],[;81^V9\JYZ0KD)5@M%N,V12%[.BD(&(F02(BKN(0]KGGYL
MI-;5Q@D\7-68UU)SO%LM<57JOA9AU ZG51HH?=[U-R@9P#:)#$H&[H,F'E21
MSF2,E :L.$,5N0H><(*5OP\#8$U=BVS @4.5[LJ^:"'+W@>Q -SGA4,@MA+F
M/P[O0FK]M5T[E#HC_7(A"C$F0 +GA"D-&# S?(LL\R0*G\M)1^%<[5//%Z/.
ML1X 5\"<4]Q1.SQ])9_:YEG[&I$![H(5Y?-=Q$ZLCIA::4:$Y3%8;K0X[&74
M$\!\?YP+*)[7]LNRC5$G+;R]APYCHS4:9EV*A45;:]-MX^UE[CX6P2T,OQ?I
MM]FG30<)__7?\5_?P6I;6AQ1DJLR;KUB77TSO"CC02H*"\Q[+;UD(<:<C4Z1
M1J$9Y/LJ"$:J1,T_^]EJJSV3,\1N?;MXYU<+C,>^#?08]/M@993<$Z<4,MH;
M#/I#Q'Q;4UITG\&*ZG)U)^ ;^TU% ^\T.HJ9[\%[H-)S0K4JU81 23 6"*-<
M4X"4.:O=Z? 9@ L(E+3BPN'7\GQ#-ZCK_1O*,0A(-U]PH?@3WF^*D?:=$IYJ
M9VS?QGN5%3A\DTED69:[Q9J$8#/A3N.[[L!Z55O5X22 ;Y@U[1S5(#[O ;M?
MRE]@OD]21RY8)!DTAIR>Y5+?PDB$L42Y]%38VO?X3X3X\S&KBK,:]"LY-,*.
M\)*5^VM9D<QC)#)A#N-2U@3? P[1&RZK,^A5(&^8)^,-7_&N1A^H/6N1I"'D
M("BAD7*<J%4D^&!(CC1'[3DNAKPQ'_90?B)&G&/\WHL83:/Z_;E/Q6@J26D0
M16(R*$9LXG';8M<R6Y3B:@M]#L4VU<GJR;C2Q"G7L@/2WS H4@$T2T% I=+V
M!2PNCSP0"]KCN@G"L-KKT-4U8&OC^L']U4YQ03OYJJ>MA88@^FG[JYWDKN,M
MMLZQ]30LR#)SKJTAWFA>NI84@35J"0U2:QZXY8?WM7X8[Y_=7ZVR\T\Q<0NG
MOVP#1CG.3%),GH22I:N(*>4>!,@8N)2,LK9VR'&E_=5.\LWQ_FJG&+;%C;U'
M1+\\M%W.+H)CB92HB4CA,\%$R1(("2 :C]^ZZN*$+U"\)5>?8]C>MWJ"K:6;
M13?;ID2S+_ !XF:%X\#ZW7_CITV"5"S7?7R^[=%ZTZDVHF;;44U-=[!1I6+R
M1L3HC0.91?94<QV]H"& ]UX<;E35QC:RP1VB2;UH?D<T3Z#<YO[D#D.@%&S1
M,[,I$\DH)3X;4UY71K4/V@E6>;FJA7UTD\!Q.&[FR\VBN[<8MR@3,6(1"<V6
M0R[R$[ET%7?>0\#4.5R7 7? I_]$7(2S+WH+3N[T%EU*OC4/&SF=70*>50F^
M@1/MMY<,."5HW43 48=?\!"<KMT&L^X,IBJ;706#+^C\:RF\C9SX+U]??\"N
M!Y;75%@5B>=:H&L8(\YA;B%89!"4"<+5SL\;3N?R[0VG)VG=%;\:61I4&EY'
M]M[/'X[Y#<'7J.1X#-ME"I!70X9!)!WIR4LPSKHH=?F4@=2IM!#$H$B#)%Y)
M[I+"7[1V^>,R3#M2[/QAB7:* VN?V/YCLY@M5[\N%U]@U<UPX;]#AL!J!6E;
M5WHH!,F@%(^!\"C*?A%^!YPRNFP[0TZ..:6&W3P;--RUY$GGNFC9U+ZU]:(_
MP!"$U@@9 F>$*85!,RUW(K.V)/.<+55!)SOLZ/Z@X=X2 ^K;M_8:\" 8^<_E
MW685/_HU/!']>*CZ2ZJC]X;XQ#%]XEX22UGY862VQFA,R ?Y?\!@;\G[M6W;
MXIS?0S?T NGV<['T'EA.QL4B@" M+PW+DB8V.IPURRX;3Z,4M<^F]X)Y(Z2H
M:_3><WXM-ET^;,(:_K,IITN^;)6%SM\MZ7M4O6V.06 /E763DHRG'" +Z:3T
M2AC0SH@LP#M.[_L>.K*T^/RICR4KSV6FS&F".0:4G5:&X2?7) :N4V3&JNH7
M*_NPM%8UR0$#'ZH#KG["$0DT$!=")ME:$2!1C(%JG]ZZ&E63JCPX5<SD%,/7
MCCQO4MJ:U'_Z!QIWOID_AWGGO^X4S#9P'T$:'4$19@+==T;$")EH&9/1@FEM
MATDN#Q_S!R= 2PLWJ'(<S'U7@S0F@<RE ::/'K-N84DYFD2R5R& DS2!:KL
M3KK7T60!&&W8:]F!.)S(PWUZL%8+$Q2AH9R5-C:5(DTFU& X3;T!)VH+8O5
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M^;)8LZ4P Q3SOQ;E#]^O!%N7F'?*!2Y>8?X%MY=!\R.(0ABA'[\5\KM__Q<
M*CCRU4)]4ADP?_[ZZ=W%(>E/YHJ?ENJKF=F/*I^OY.<UR]?O&5<++7WYM/7S
MH_JW[XKYP^-";7]VGZOL_&,7>7[P5",E-5*BQ$CY/RX-]M,5XGN2=WTJJP?A
M2G4_^)*Q#=,/WL3]HOE!#2]P8YBK1:Y>J#=+.=:[NQOJ:M&'E]C7:[%:L\4(
MK\5^F(;("_.#]_IO]3#F02UD6HY34W=#5/5MK99256QY\&@PE__VG?[;;%/
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M4[:JWA)[D8=KRM:-TD#MVEH&?M%&;MV =+5XLWC"]5E1QWT<FGU=$I%Q1K&
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M.=>XN4<N:I\D'3G=U'-?NEKN=E'OEWSU*.NF8S.&>9Y#4@#)2 (@SC"@,$\
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M.W>(PM78.<PY=GV=.PQG:NL\;N[W<7B]>GRL\U.J?7@KQ6S&&9(%@@G(F4P
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M-_-OU@;,$I+R BKM9F2J %!R" BU9;,)HG&""YS%L\UJ0Q=N#H?[U%ZO[4Z
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MM,@5H(FV$I"0!) TPX!*F"@$N419[K-W<9ET:KN6+V:..AN1MT6/%EIJ3]?
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MJL1USRKH1+?;8(;$;& ;V!<NKR0$%RQZY21T#CQ:BH*+>NV,!:?K>U%:[2A
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MF.F9_#I?VO;6/\T;2ON?QPTKG"XR)+)(&$(@I@0"R&2L=\0* X1X'F="QKA
M]2*_78J_S!(WLHZZP%)_,R:TM.-$B6Y:K+]09.B@=7VEZ71B01<782+QGU/Y
M_E(QGXOPAH[S7)ZH9U4?+1^T<V+^]_9_MO-O=&&.7%_]F)>SC&$&)4& I40
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M :(,KM"$"AY>FV[<"**C\B=A1-?[^MF7MX]/B]6SE#9&6:7*UH\[45*F*A:
M(88 %!D&F"42B(3'<9QD"!5>20@79YJ:1:D3ALT1V),>\\$T):PBZ:],@YP=
M;:F?>;D,M)M="0+?T ;E7++_/D.[2?D?P+1<12>03;D\SZC&Y*JZQU;D^@T]
MBO&_R$<3^%@_FUW/YOGO=+&5>S+0C^JP"._+JL49.B-"%GJK(H!D!0$PA04@
M*,> ITCHC0V,D]2I=?JM@DS-^+08:E?JI/15FR1_"W3S6G4;J#%78&#[M=,B
MJM2XBZPB![S!']5QV;HI;F_3#(^T*AY5ZR.MSEA%ZL.NDE^]> !H.\O#;QE_
MO&KP "@<%'^'&.\&^NFJ;5.3#5R[V_M,X'T !F'*,T%R$%,: UA@ 7"19$!R
MADE&5580+Q_9:_:I?;JJS/Q*^KMH*7V[>'LA[WA:-Q2>0Q_BM:!L53TT6_.]
M\ ,5.O3"+20SMO/<XS-F^\)REDG;>Y">IX?&(KXORZT4;[8F8?;>EO!;>]K:
M"I1O?\@UG^MMVRRC"4EP#@'C*020%A!@Q+5?GG"22QGG:>S$B=5;@JE9-2.[
MS9'1[GC;]XZV3_I'68MMZ7(J1IQ*'\^S1^]U<CR,'!+]H0\3+)R5\%$E?52)
MOW/XJDN:\YJ=$@%/+/OB%^H(TWO^<<\T^\)S<LC9>Z"^^4P+\TY_?I!R\\$\
M!89*P-254RID;LHH]#-9 )@1"DB&""@*&2=(_Q'GU"^#Z?Q$4[-RM9R1%31J
M).U5M7\16S>3%0*Q@2U3/[!Z9"-U(Q$L_^C"-"-G''4K>YIC=.7Z&[9_%]J!
M'S>5;#64%/^]+3?FZ&/7@3K%J4B@R@#6^T, >48 $VD"T@(CP;A :9IX[PP#
M"#8UP]-JV6I:@$>&WO>@UVNI%8J$Z0=;[M3JL;$,L:8>>\Z15VKH[>CK]X9_
MV:$GKVF@NFM.3M7&=&K::69WLD%[\8;&.N06-H18X^]N X)Y=N,;<OR>B:/[
MLT(;KRQ?;3</J[4Q03,),Y&2K !2IAC  J6 4LP!C2E23!!MTYWJ]1SFFIHA
M/FS(6?'L170G;G_VO2Z\W2QJ(!0'-I*'G28K0:.]I &S<Z_#$2HUMV.F<?-R
MKZM\DI3K<,NMS!V?I&TB?D_7F^<O:[HL*;?;U%^?#_[%DDTD12HRP21@!>0
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M9Y!+E!5"@$)E!$!*%* PYT#2O"@H59P3KPY*GO-/S3Z]::C3UO*;7':\0$'
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M4.(<YU04 CN;<9^9IV;**]FCMU$E?=02/]K)7[U.'D;):RT<C/Y0" ]L^#W
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M/LWU@)51_23UC-^D>+=:O]MNMFMIK*_I.#2C.93<5)_F$A, D12 <9P I8B
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M[N[Z8;7\"O2DCY$1/-I+7M8M0SU3V\Y![/:QOA&XH:,#QYA]Z869]_>Z Y5
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M;X?_TK(-EHI)332\,CJ9$C'(5$$@59AD.$,T54ZZ^?9-3XV".OM 8Z 7FSC
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M:)(2-CL3'?:A+HA;G 9$PC$R,UI4;C3F-R@_Q4;987,?">V1]O*!47?;O'M
MU[M7=WG?>%MS#R^/=N(^SWO0_OLF<MM<0#V<>EJQX6V(Z]-2OTT#GSX\ORQ6
M;U(VG^_2T$B%,XY0!;.<ZLD@$P5D%2D@*2@KLH2*JK!2,PICSM2FB%;7Z_XX
M0LZVK@&]^@.J%7;^W ;-7XUS3<$!XR'8NMA=#?^@[?K2"#_K5AQ8<'@W6\Q
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M)61,D)SAG!-FI8QEV^#45D)[[?T_6I-K(XF\M=;_IN!-X.W8*R2<D0FK,=4
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M1PEX9)#\/%M-5]]?3T_PM[.U,VT)X5P8.AXM.>C*1 ;.D.=E?<Y"9C1*\J/
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MWH\G?UD5R<$1?B')Z&/AB+8<=Y%[8[G=</!\TJ>'R[(3D_#SM_0YS#[A^KK
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MP&4!$ZPH 5U(S:LM[U+1"5*.4^_MW.5QLNX!+>OLZYJ/%[_B>IRF,5%3A"'
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MKY6NWD:O;S?>O*]4Z+&EQLV,-$;* -(=&RN_S6>/,R29-E8J ;9>HBBM+/A
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M'>G#3#]-1:@3H10T%5Z>@W*,W(101R4X4UCAQMG\9YH^O'<<8G3 ]>3 XGP
MQ8."6(*&C$[95(23L;5\1HA.QZH4W0=] P><^RBZ T_C[>HS+FI2Z2.>UOJ&
MQ?<WIU_H+*MW=R^)G.FJ<HO+]YC(1E7NW\Q^#HO9=/9I>?WOW\YNRO'_QI,\
M<4Q)4SLV<8P4?-?3)P:F06B7DT6=2O/2TR'Y&3>'.> 6Z 8$?QH_9-OW7IZ$
MY7):IA1,?Z]FI:KM+)S\&E:7[_!'>C&S,V7]O),Y3)A/XPNEB!&3\J!9KA.C
MR/-W,1=P)6?%72FAM"Z:&M87>KAUQ)7,;SS3OQ0'UJ./HX6DL-9DVD2Q-QD
MI7@V+%GFFXOC*(*[]G3VP=9^'4!:JK$#QV979O\V77V>SM[.\']C6-SL,U$8
M%I>)V:21(FB?/'A>YV)B$$H3V[EY)>[Q5/=:FM <8@>"NY&^GQ'"7Q1:DQC^
M^'DQ/_OT^?7TZYKW6SVHG4TZ^("0@ZPS-+D&YSB'4J3/LJCL7.OIN4T9Z+7
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M1Q>];A;X$$["XNK3)\$++K(WH'U4Q+SB]?K!@A<ZDX^@A(JML_;;*1GYI<'
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M=:%^*R'CPN7\;LKIVN@ 4@_(7]Y4'L+]3QY*;V,QDJ7 7=!@;:W?9JL@.".
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MI?,^(=.M];P)GV][^)U/RA1K 97)M!WE0G)&!4$KX;.F_[/6<=M+-(V+XV[
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M&"[?"&Z?E"*Y:YL<^/K"O:(3 YQ(]"46'P)&E53K5TV:$-YCO#$TYMH"_P@
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M/BA QK7RZU>UP^K9\L\^T+\N+V%FQ'T?ZEATX< 4N(2LF\\+(*?Z>E)0[-(
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MM"B_)T,?"2FLGX+X*8W,\YQO0/BFRH$^,/'.U"3WZ-GCY?)YM.-I.]5(^29
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MG/0SJJJU1 B!(5NV/BB[<U"&!Y&?]],#)8C%G]1R1B5/B19:$C(WW#_\84F
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M&P!\V0:QX)0*=D?)?AON_YC8_.^+CT=MCGMZV<0#'S.<NJLVM_L>YYS-\#R
M9P/+3QF\KH]J/R\3:D">GA]6K@+DR_("SRYW=6NA.2998):_"' %*(^S3)72
MNGOH%2I^REPHW((EH3]97G%PO7R/7*CZ%GV@F2"N"ELWRQ>=U[?<Z&((2;'W
MEG9[R"<NHU?/^E[<W] ?_ M02P$"% ,4    "  "@FE5_63UP3'& @!#&!P
M$0              @ $     <V5R82TR,#(R,#DS,"YH=&U02P$"% ,4
M"  "@FE5;3.%F)<1  #+S   $0              @ %@Q@( <V5R82TR,#(R
M,#DS,"YX<V102P$"% ,4    "  "@FE5?/O4:O8@  #J2@$ %0
M    @ $FV ( <V5R82TR,#(R,#DS,%]C86PN>&UL4$L! A0#%     @  H)I
M5:J\]?.V50  ;ZP# !4              ( !3_D" '-E<F$M,C R,C Y,S!?
M9&5F+GAM;%!+ 0(4 Q0    (  *":57*!(53^N4  /B&"0 5
M  "  3A/ P!S97)A+3(P,C(P.3,P7VQA8BYX;6Q02P$"% ,4    "  "@FE5
M?(U&.6:&  ##+@8 %0              @ %E-00 <V5R82TR,#(R,#DS,%]P
M<F4N>&UL4$L! A0#%     @  H)I55"&+?_:$@  &ID  !L
M ( !_KL$ '-E<F$M,C R,C Y,S!X,3!Q>&5X,3 Q+FAT;5!+ 0(4 Q0    (
M  *":568-7G0<P<  (D?   ;              "  1'/! !S97)A+3(P,C(P
M.3,P>#$P<7AE>#,Q,2YH=&U02P$"% ,4    "  "@FE56LBN!ET'  !''P
M&P              @ &]U@0 <V5R82TR,#(R,#DS,'@Q,'%X97@S,3(N:'1M
M4$L! A0#%     @  H)I578;@++H!   _!<  !L              ( !4]X$
M '-E<F$M,C R,C Y,S!X,3!Q>&5X,S(Q+FAT;5!+!08     "@ * *X"  !T
%XP0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
